PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Galko, MJ; Tessier-Lavigne, M				Galko, MJ; Tessier-Lavigne, M			Function of an axonal chemoattractant modulated by metalloprotease activity	SCIENCE			English	Article							NECROSIS-FACTOR-ALPHA; NEURONAL GROWTH CONE; PLASMINOGEN-ACTIVATOR; NERVOUS-SYSTEM; SURFACE PROTEIN; GUIDANCE; DISINTEGRIN; DROSOPHILA; NETRIN-1; PEPTIDE	The axonal chemoattractant netrin-1 guides spinal commissural axons by activating its receptor DCC (Deleted in Colorectal Cancer). We have found that chemical inhibitors of metalloproteases potentiate netrin-mediated axon outgrowth in vitro. We have also found that DCC is a substrate for metalloprotease-dependent ectodomain shedding, and that the inhibitors block proteolytic processing of DCC and cause an increase in DCC protein levels on axons within spinal cord explants, Thus, potentiation of netrin activity by inhibitors may result from stabilization of DCC on the axons, and proteolytic activity may regulate axon migration by controlling the number of functional extracellular axon guidance receptors.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Tessier-Lavigne, M (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Anat, San Francisco, CA 94143 USA.			Galko, Michael/0000-0002-3759-2017				Arribas J, 1996, J BIOL CHEM, V271, P11376, DOI 10.1074/jbc.271.19.11376; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Black RA, 1998, CURR OPIN CELL BIOL, V10, P654, DOI 10.1016/S0955-0674(98)80042-2; BLOBEL CP, 1992, NATURE, V356, P248, DOI 10.1038/356248a0; Fambrough D, 1996, P NATL ACAD SCI USA, V93, P13233, DOI 10.1073/pnas.93.23.13233; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; Galko MJ, 2000, J BIOL CHEM, V275, P7832, DOI 10.1074/jbc.275.11.7832; GALKO MJ, UNPUB; GROBELNY D, 1992, BIOCHEMISTRY-US, V31, P7152, DOI 10.1021/bi00146a017; Hooper NM, 1997, BIOCHEM J, V321, P265, DOI 10.1042/bj3210265; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; KRYSTOSEK A, 1981, P NATL ACAD SCI-BIOL, V78, P7810, DOI 10.1073/pnas.78.12.7810; KRYSTOSEK A, 1981, SCIENCE, V213, P1532, DOI 10.1126/science.7197054; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; Nishiwaki K, 2000, SCIENCE, V288, P2205, DOI 10.1126/science.288.5474.2205; Oxford Rhodes Library, COMMUNICATION; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; PITTMAN RN, 1985, DEV BIOL, V110, P91, DOI 10.1016/0012-1606(85)90067-3; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; PRIMAKOFF P, 1987, J CELL BIOL, V104, P141, DOI 10.1083/jcb.104.1.141; Rooke J, 1996, SCIENCE, V273, P1227, DOI 10.1126/science.273.5279.1227; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Shirasaki R, 1998, SCIENCE, V279, P105, DOI 10.1126/science.279.5347.105; Shirasaki R, 1996, NEURON, V17, P1079, DOI 10.1016/S0896-6273(00)80241-X; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; TESSIERLAVIGNE M, 1988, NATURE, V336, P775, DOI 10.1038/336775a0; YAMAMOTO M, 1986, J NEUROSCI, V6, P3576	32	143	148	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 25	2000	289	5483					1365	1367		10.1126/science.289.5483.1365	http://dx.doi.org/10.1126/science.289.5483.1365			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347RF	10958786				2022-12-28	WOS:000088942400043
J	Nduati, R; Mbori-Ngacha, D; John, G; Richardson, B; Kreiss, J				Nduati, R; Mbori-Ngacha, D; John, G; Richardson, B; Kreiss, J			Breastfeeding in women with HIV - Reply	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									Univ Nairobi, Nairobi, Kenya; Univ Washington, Seattle, WA 98195 USA	University of Nairobi; University of Washington; University of Washington Seattle	Nduati, R (corresponding author), Univ Nairobi, Nairobi, Kenya.		Abrams, William R/A-5782-2008; John-Stewart, Grace/L-3650-2019; John-Stewart, Grace/U-3351-2019		NICHD NIH HHS [R01 HD023412] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD023412] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))			0	7	7	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 23	2000	284	8					956	957						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	344PX	10944630				2022-12-28	WOS:000088769000012
J	Ban, N; Nissen, P; Hansen, J; Moore, PB; Steitz, TA				Ban, N; Nissen, P; Hansen, J; Moore, PB; Steitz, TA			The complete atomic structure of the large ribosomal subunit at 2.4 angstrom resolution	SCIENCE			English	Article							PEPTIDYL TRANSFERASE CENTER; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; THERMUS-THERMOPHILUS; ELONGATION-FACTORS; 70S RIBOSOME; TRANSFER-RNA; PROTEIN; BINDING; LOOP	The large ribosomal subunit catalyzes peptide bond formation and binds initiation, termination, and elongation factors. We have determined the crystal structure of the Large ribosomal subunit from Haloarcula marismortui at 2.4 angstrom resolution, and it includes 2833 of the subunit's 3045 nucleotides and 27 of its 31 proteins. The domains of its RNAs all have irregular shapes and fit together in the ribosome Like the pieces of a three-dimensional jigsaw puzzle to form a Large, monolithic structure. Proteins are abundant everywhere on its surface except in the active site where peptide bond formation occurs and where it contacts the small subunit. Most of the proteins stabilize the structure by interacting with several RNA domains, often using idiosyncratically folded extensions that reach into the subunit's interior.	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Yale Univ, Dept Chem, New Haven, CT 06520 USA; Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Yale University; Howard Hughes Medical Institute	Steitz, TA (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA.		Steitz, Thomas A./C-6559-2009; Nissen, Poul/D-5774-2014	Nissen, Poul/0000-0003-0948-6628	NIGMS NIH HHS [GM54216, GM22778] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Agrawal RK, 1999, J BIOL CHEM, V274, P8723, DOI 10.1074/jbc.274.13.8723; Agrawal RK, 1998, P NATL ACAD SCI USA, V95, P6134, DOI 10.1073/pnas.95.11.6134; Ban N, 1998, CELL, V93, P1105, DOI 10.1016/S0092-8674(00)81455-5; Ban N, 1999, NATURE, V400, P841, DOI 10.1038/23641; Beckmann R, 1997, SCIENCE, V278, P2123, DOI 10.1126/science.278.5346.2123; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; Cate JH, 1999, SCIENCE, V285, P2095, DOI 10.1126/science.285.5436.2095; CHITTUM HS, 1994, J BACTERIOL, V176, P6192, DOI 10.1128/jb.176.20.6192-6198.1994; Clemons WM, 1999, NATURE, V400, P833, DOI 10.1038/23631; Conn GL, 1999, SCIENCE, V284, P1171, DOI 10.1126/science.284.5417.1171; Correll CC, 1997, CELL, V91, P705, DOI 10.1016/S0092-8674(00)80457-2; Correll CC, 1998, P NATL ACAD SCI USA, V95, P13436, DOI 10.1073/pnas.95.23.13436; Culver GM, 1999, SCIENCE, V285, P2133, DOI 10.1126/science.285.5436.2133; David L., 1996, Fizika A, V5, P55; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Dube P, 1998, STRUCTURE, V6, P389, DOI 10.1016/S0969-2126(98)00040-9; Garrett R. A., 2000, RIBOSOME STRUCTURE F; Garrett R. A., 1996, RIBOSOMAL RNA STRUCT, P327; Gerbi S.A., 1996, RIBOSOMAL RNA STRUCT, P71; GOLDEN BL, 1993, EMBO J, V12, P4901, DOI 10.1002/j.1460-2075.1993.tb06184.x; GUTELL RR, 1996, RIBOSOMAL RNA STRUCT, P111; GUTELL RR, UNPUB; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; LEFFERS H, 1987, J MOL BIOL, V195, P43, DOI 10.1016/0022-2836(87)90326-3; LEIJONMARCK M, 1980, NATURE, V286, P824, DOI 10.1038/286824a0; LILJAS A, 1991, INT REV CYTOL, V124, P103; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Mao HY, 1999, NAT STRUCT BIOL, V6, P1139; Markus MA, 1997, NAT STRUCT BIOL, V4, P70, DOI 10.1038/nsb0197-70; MOAZED D, 1988, NATURE, V334, P362, DOI 10.1038/334362a0; Moller W., 1986, STRUCTURE FUNCTION G, P309; Moore PB, 1999, ANNU REV BIOCHEM, V68, P287, DOI 10.1146/annurev.biochem.68.1.287; Mueller F, 2000, J MOL BIOL, V298, P35, DOI 10.1006/jmbi.2000.3635; Nakagawa A, 1999, EMBO J, V18, P1459, DOI 10.1093/emboj/18.6.1459; Nevskaya N, 2000, STRUCTURE, V8, P363, DOI 10.1016/S0969-2126(00)00116-7; NOLLER HF, 1990, RIBOSOME, P73; OAKES M, 1986, STRUCTURE FUNCTION G, P47; Ostergaard P, 1998, J MOL BIOL, V284, P227, DOI 10.1006/jmbi.1998.2185; OTWINOWSKI Z, 1993, DATA COLLECTION PROC, P52; Puglisi EV, 1997, NAT STRUCT BIOL, V4, P775; ROSSMANN MG, 1989, ANNU REV BIOCHEM, V58, P533, DOI 10.1146/annurev.bi.58.070189.002533; ROULD MA, 1989, SCIENCE, V246, P1135, DOI 10.1126/science.2479982; SHEVACK A, 1985, FEBS LETT, V184, P68, DOI 10.1016/0014-5793(85)80655-4; Stark H, 2000, CELL, V100, P301, DOI 10.1016/S0092-8674(00)80666-2; STOEFFLER G, 1986, STRUCTURE FUNCTION G, P28; SZEWCZAK AA, 1995, J MOL BIOL, V247, P81, DOI 10.1006/jmbi.1994.0124; Szymanski M, 1998, NUCLEIC ACIDS RES, V26, P156, DOI 10.1093/nar/26.1.156; Tocilj A, 1999, P NATL ACAD SCI USA, V96, P14252, DOI 10.1073/pnas.96.25.14252; TRAKHANOV SD, 1987, FEBS LETT, V220, P319, DOI 10.1016/0014-5793(87)80838-4; Tronrud DE, 1997, METHOD ENZYMOL, V277, P306, DOI 10.1016/S0076-6879(97)77017-4; Unge J, 1998, STRUCTURE, V6, P1577, DOI 10.1016/S0969-2126(98)00155-5; VONBOHLEN K, 1991, J MOL BIOL, V222, P11, DOI 10.1016/0022-2836(91)90730-T; WALLECZEK J, 1988, EMBO J, V7, P3571, DOI 10.1002/j.1460-2075.1988.tb03234.x; WARE VC, 1983, NUCLEIC ACIDS RES, V11, P7795, DOI 10.1093/nar/11.22.7795; Westhof E, 2000, STRUCTURE, V8, pR55, DOI 10.1016/S0969-2126(00)00112-X; WILSON KS, 1986, P NATL ACAD SCI USA, V83, P7251, DOI 10.1073/pnas.83.19.7251; Wimberly BT, 1999, CELL, V97, P491, DOI 10.1016/S0092-8674(00)80759-X; Wittmann-Liebold Brigitte, 1986, STRUCTURE FUNCTION G, P326; WITTMANNLIEBOLD B, 1990, RIBOSOME, P598; WOOL IG, 1992, TRENDS BIOCHEM SCI, V17, P266, DOI 10.1016/0968-0004(92)90407-Z; Wool IG, 1995, BIOCHEM CELL BIOL, V73, P933, DOI 10.1139/o95-101; Worbs M, 2000, EMBO J, V19, P807, DOI 10.1093/emboj/19.5.807; YONATH AE, 1980, BIOCHEM INT, V1, P428	67	2612	2707	4	268	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 11	2000	289	5481					905	920		10.1126/science.289.5481.905	http://dx.doi.org/10.1126/science.289.5481.905			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	343KH	10937989				2022-12-28	WOS:000088701200023
J	MacBeth, CE; Golombek, AP; Young, VG; Yang, C; Kuczera, K; Hendrich, MP; Borovik, AS				MacBeth, CE; Golombek, AP; Young, VG; Yang, C; Kuczera, K; Hendrich, MP; Borovik, AS			O-2 activation by nonheme iron complexes: A monomeric Fe(III)-oxo complex derived from O-2	SCIENCE			English	Article							BOND-DISSOCIATION ENERGIES; HEME-CONTAINING OXYGENASES; HORSERADISH-PEROXIDASE; EXAFS SPECTROSCOPY; COMPOUND-I; OXO; MANGANESE(III); RECOGNITION; HEMOGLOBIN; MECHANISMS	Iron species with terminal oxo Ligands are implicated as key intermediates in several synthetic and biochemical catalytic cycles. However, there is a dearth of structural information regarding these types of complexes because their instability has precluded isolation under ambient conditions. The isolation and structural characterization of an iron(III) complex with a terminal oxo Ligand, derived directly from dioxygen (O-2), is reported. A stable structure resulted from placing the oxoiron unit within a synthetic cavity Lined with hydrogen-bonding groups. The cavity creates a microenvironment around the iron center that aids in regulating O-2 activation and stabilizing the oxoiron unit. These cavities share properties with the active sites of metalloproteins, where function is correlated strongly with site structure.	Univ Kansas, Dept Chem, Lawrence, KS 66045 USA; Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA; Carnegie Mellon Univ, Dept Chem, Pittsburgh, PA 15213 USA; Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA	University of Kansas; University of Kansas; Carnegie Mellon University; University of Minnesota System; University of Minnesota Twin Cities	Borovik, AS (corresponding author), Univ Kansas, Dept Chem, Lawrence, KS 66045 USA.		Golombek, Adina/Q-1789-2019	Golombek, Adina/0000-0001-7176-7071	NIGMS NIH HHS [GM49970, GM50781] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM050781, R01GM050781, R01GM049970, R29GM049970, R37GM050781] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSSON LA, 1991, STRUCT BOND, V74, P1; BALCH AL, 1985, J AM CHEM SOC, V107, P3003, DOI 10.1021/ja00297a001; BORDWELL FG, 1990, J ORG CHEM, V55, P3337, DOI 10.1021/jo00297a064; BORDWELL FG, 1991, J AM CHEM SOC, V113, P9790, DOI 10.1021/ja00026a012; Collman JP, 1999, ACCOUNTS CHEM RES, V32, P455, DOI 10.1021/ar9603064; Debrunner P. G., 1989, IRON PORPHYRINS 3, P139; FULOP V, 1994, STRUCTURE, V2, P201, DOI 10.1016/S0969-2126(00)00021-6; Hammes BS, 1999, ANGEW CHEM INT EDIT, V38, P666, DOI 10.1002/(SICI)1521-3773(19990301)38:5<666::AID-ANIE666>3.0.CO;2-X; HERBER RH, 1979, INORG CHEM, V18, P2786, DOI 10.1021/ic50200a030; HOLM RH, 1987, CHEM REV, V87, P1401, DOI 10.1021/cr00082a005; HOPPER ML, 1982, ACTA CRYSTALLOGR B, V32, P2237; KICKHAM JE, 1993, J AM CHEM SOC, V115, P7031, DOI 10.1021/ja00068a094; KITAJIMA N, 1994, J AM CHEM SOC, V116, P11596, DOI 10.1021/ja00104a061; KURTZ DM, 1990, CHEM REV, V90, P585, DOI 10.1021/cr00102a002; Lange SJ, 1999, J AM CHEM SOC, V121, P6330, DOI 10.1021/ja990233u; Lipscomb WN, 1996, CHEM REV, V96, P2375, DOI 10.1021/cr950042j; Lu Y, 1997, CURR OPIN STRUC BIOL, V7, P495, DOI 10.1016/S0959-440X(97)80112-1; MAYER JM, 1985, J AM CHEM SOC, V107, P7454, DOI 10.1021/ja00311a039; MOMENTEAU M, 1994, CHEM REV, V94, P659, DOI 10.1021/cr00027a006; MORRIS RJ, 1988, POLYHEDRON, V7, P2001, DOI 10.1016/S0277-5387(00)80715-9; Mukai M, 1997, J AM CHEM SOC, V119, P1758, DOI 10.1021/ja962551o; Mukerjee S, 1997, J AM CHEM SOC, V119, P8097, DOI 10.1021/ja9709482; Ogo S, 1998, ANGEW CHEM INT EDIT, V37, P2102, DOI 10.1002/(SICI)1521-3773(19980817)37:15<2102::AID-ANIE2102>3.0.CO;2-A; PENNERHAHN JE, 1986, J AM CHEM SOC, V108, P7819, DOI 10.1021/ja00284a054; PERUTZ MF, 1987, ACCOUNTS CHEM RES, V20, P309, DOI 10.1021/ar00141a001; QUE L, 1990, PROG INORG CHEM, V38, P97; Schlichting I, 2000, SCIENCE, V287, P1615, DOI 10.1126/science.287.5458.1615; Shirin Z, 2000, J AM CHEM SOC, V122, P1836, DOI 10.1021/ja993818x; Solomon EI, 2000, CHEM REV, V100, P235, DOI 10.1021/cr9900275; Sono M, 1996, CHEM REV, V96, P2841, DOI 10.1021/cr9500500; SPALTENSTEIN E, 1989, J AM CHEM SOC, V111, P8741, DOI 10.1021/ja00205a038; SPRINGER BA, 1994, CHEM REV, V94, P699, DOI 10.1021/cr00027a007; WU YD, 1992, INORG CHEM, V31, P718, DOI 10.1021/ic00031a002	33	337	339	1	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 11	2000	289	5481					938	941		10.1126/science.289.5481.938	http://dx.doi.org/10.1126/science.289.5481.938			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	343KH	10937994				2022-12-28	WOS:000088701200028
J	Schneider, TD				Schneider, TD			The bottle - Force the weird stuff down	NATURE			English	Article									NIH, Frederick, MD USA	National Institutes of Health (NIH) - USA	Schneider, TD (corresponding author), NIH, Frederick, MD USA.								0	0	0	0	5	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 27	2000	406	6794					351	351		10.1038/35019183	http://dx.doi.org/10.1038/35019183			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	337WC	10935615	Bronze			2022-12-28	WOS:000088383800022
J	Tu, YH				Tu, YH			How robust is the Internet?	NATURE			English	Editorial Material							WORLD-WIDE-WEB		IBM Corp, Thomas J Watson Res Ctr, Yorktown Heights, NY 10598 USA	International Business Machines (IBM)	Tu, YH (corresponding author), IBM Corp, Thomas J Watson Res Ctr, POB 218, Yorktown Heights, NY 10598 USA.							Albert R, 1999, NATURE, V401, P130, DOI 10.1038/43601; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; ERDOS P, 1960, B INT STATIST INST, V38, P343; Faloutsos M, 1999, COMP COMM R, V29, P251, DOI 10.1145/316194.316229; Huberman BA, 1999, NATURE, V401, P131, DOI 10.1038/43604; Kauffman S. A., 1993, ORIGINS ORDER	6	44	47	0	1	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 27	2000	406	6794					353	354		10.1038/35019222	http://dx.doi.org/10.1038/35019222			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	337WC	10935616				2022-12-28	WOS:000088383800023
J	Marek, K; Seibyl, J				Marek, K; Seibyl, J			Imaging - A molecular map for neurodegeneration	SCIENCE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; DOPAMINE TRANSPORTERS; PROGRESSION; BRAIN; PET		Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA	Yale University	Marek, K (corresponding author), Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA.	Ken.Marek@yale.edu; jseibyl@calvin.med.yale.edu		Marek, Kenneth/0000-0002-4197-5627				Baird AE, 1999, CURR OPIN NEUROL, V12, P65, DOI 10.1097/00019052-199902000-00011; BERNHEIMER H, 1973, J NEUROL SCI, V20, P415, DOI 10.1016/0022-510X(73)90175-5; Brooks DJ, 2000, ANN NEUROL, V47, pS154; Brooks DJ, 1998, NEUROSURG CLIN N AM, V9, P263; Dezutter NA, 1999, EUR J NUCL MED, V26, P1392, DOI 10.1007/s002590050470; Doder M, 2000, NEUROLOGY, V54, pA112; Frey K A, 1998, Adv Pharmacol, V42, P269; Holloway R, 2000, CLIN NEUROPHARMACOL, V23, P34; Hussey D, 1998, J NUCL MED, V39, p209P; INNIS RB, 1993, P NATL ACAD SCI USA, V90, P11965, DOI 10.1073/pnas.90.24.11965; KENNEDY AM, 1995, NEUROSCI LETT, V186, P17, DOI 10.1016/0304-3940(95)11270-7; LEENDERS KL, 1995, NEUROLOGY, V45, pA220; Marek KL, 1999, NEUROLOGY, V52, pA91; Marek KL, 1996, NEUROLOGY, V46, P231, DOI 10.1212/WNL.46.1.231; MORRISH P, 1998, J NEUROL NEUROSUR PS, V59, P597; Morrish PK, 1996, BRAIN, V119, P585, DOI 10.1093/brain/119.2.585; Parkinson J, 1819, ESSAY SHAKING PALSY; Piccini P, 1999, NAT NEUROSCI, V2, P1137, DOI 10.1038/16060; Piccini P, 1999, ANN NEUROL, V45, P577, DOI 10.1002/1531-8249(199905)45:5<577::AID-ANA5>3.0.CO;2-O; Rascol O, 2000, NEW ENGL J MED, V342, P1484, DOI 10.1056/NEJM200005183422004; Reiman EM, 1996, NEW ENGL J MED, V334, P752, DOI 10.1056/NEJM199603213341202; Skovronsky DM, 2000, P NATL ACAD SCI USA, V97, P7609, DOI 10.1073/pnas.97.13.7609	22	15	17	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 21	2000	289	5478					409	411		10.1126/science.289.5478.409	http://dx.doi.org/10.1126/science.289.5478.409			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	336ME	10939953				2022-12-28	WOS:000088305500031
J	Bard, E; Rostek, F; Turon, JL; Gendreau, S				Bard, E; Rostek, F; Turon, JL; Gendreau, S			Hydrological impact of Heinrich events in the subtropical northeast Atlantic	SCIENCE			English	Article							SEA-SURFACE TEMPERATURE; LAST GLACIAL PERIOD; CORE-TOP CALIBRATION; ICE-RAFTED SAND; PALEOCEANOGRAPHIC CONDITIONS; MOLECULAR STRATIGRAPHY; ICEBERG DISCHARGES; YOUNGER DRYAS; NORDIC SEAS; OCEAN	Reconstructing the impact of Heinrich events outside the main belt of ice rafting is crucial to understanding the underlying causes of these abrupt climatic events. A high-resolution study of a marine sediment core from the Iberian margin demonstrates that this midlatitude area was strongly affected both by cooling and advection of low-salinity arctic water masses during the Last three Heinrich events. These paleoclimatic time series reveal the internal complexity of each of the last three Heinrich events and illustrate the value of parallel studies of the organic and inorganic fractions of the sediments.	CEREGE, CNRS, UMR 6635, F-13545 Aix En Provence 4, France; Univ Aix Marseille 3, F-13545 Aix En Provence, France; Univ Bordeaux 1, F-33405 Talence, France; Dept Geol & Oceanog, CNRS, UMR EPOC 5805, F-33405 Talence, France	UDICE-French Research Universities; PSL Research University Paris; College de France; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU)	Bard, E (corresponding author), CEREGE, CNRS, UMR 6635, Europole Arbois, F-13545 Aix En Provence 4, France.		Bard, Edouard/G-7717-2014					BARD E, 1987, NATURE, V328, P791, DOI 10.1038/328791a0; Bard E, 1998, RADIOCARBON, V40, P1085, DOI 10.1017/S0033822200019135; BARD E, 1994, EARTH PLANET SC LETT, V126, P275, DOI 10.1016/0012-821X(94)90112-0; Bond G, 1997, SCIENCE, V278, P1257, DOI 10.1126/science.278.5341.1257; BOND G, 1992, NATURE, V360, P245, DOI 10.1038/360245a0; BOND GC, 1995, SCIENCE, V267, P1005, DOI 10.1126/science.267.5200.1005; BRASSELL SC, 1986, NATURE, V320, P129, DOI 10.1038/320129a0; Cacho I, 1999, PALEOCEANOGRAPHY, V14, P698, DOI 10.1029/1999PA900044; Chapman MR, 1998, EARTH PLANET SC LETT, V159, P57, DOI 10.1016/S0012-821X(98)00068-5; Chapman MR, 1999, GEOLOGY, V27, P875, DOI 10.1130/0091-7613(1999)027<0875:LLFOMT>2.3.CO;2; Dokken TM, 1999, NATURE, V401, P458, DOI 10.1038/46753; DOWDESWELL JA, 1995, GEOLOGY, V23, P301, DOI 10.1130/0091-7613(1995)023<0297:IPDRAT>2.3.CO;2; Dowdeswell JA, 1999, NATURE, V400, P348, DOI 10.1038/22510; DUPLESSY JC, 1993, PALEOCEANOGRAPHY, V8, P341, DOI 10.1029/93PA00455; Elliot M, 1998, PALEOCEANOGRAPHY, V13, P433, DOI 10.1029/98PA01792; GRIMM EC, 1993, SCIENCE, V261, P198, DOI 10.1126/science.261.5118.198; GROUSSET F, 1993, PALEOCEANOGRAPHY, V8, P1075; Grousset FE, 2000, GEOLOGY, V28, P123; Gwiazda RH, 1996, PALEOCEANOGRAPHY, V11, P371, DOI 10.1029/96PA01022; Hemming SR, 1998, EARTH PLANET SC LETT, V164, P317, DOI 10.1016/S0012-821X(98)00224-6; KEIGWIN LD, 1994, PALEOCEANOGRAPHY, V9, P185, DOI 10.1029/94PA00032; Lebreiro SM, 1996, MAR GEOL, V131, P47, DOI 10.1016/0025-3227(95)00142-5; Mashiotta TA, 1999, EARTH PLANET SC LETT, V170, P417, DOI 10.1016/S0012-821X(99)00116-8; Muller PJ, 1998, GEOCHIM COSMOCHIM AC, V62, P1757, DOI 10.1016/S0016-7037(98)00097-0; PRAHL FG, 1988, GEOCHIM COSMOCHIM AC, V52, P2303, DOI 10.1016/0016-7037(88)90132-9; Rosell-Mele A, 1998, PALEOCEANOGRAPHY, V13, P694, DOI 10.1029/98PA02355; Rosell-Mele A, 1999, PALEOCEANOGRAPHY, V14, P770, DOI 10.1029/1999PA900037; ROSELLMELE A, 1995, GEOCHIM COSMOCHIM AC, V59, P3099, DOI 10.1016/0016-7037(95)00199-A; RUDDIMAN WF, 1977, GEOL SOC AM BULL, V88, P1813, DOI 10.1130/0016-7606(1977)88<1813:LQDOIS>2.0.CO;2; Ruhlemann C, 1999, NATURE, V402, P511, DOI 10.1038/990069; Sachs JP, 1999, SCIENCE, V286, P756, DOI 10.1126/science.286.5440.756; Schonfeld J, 2000, PALAEOGEOGR PALAEOCL, V159, P85, DOI 10.1016/S0031-0182(00)00035-3; Schulz HM, 2000, GEOCHIM COSMOCHIM AC, V64, P469, DOI 10.1016/S0016-7037(99)00332-4; Sikes EL, 1997, GEOCHIM COSMOCHIM AC, V61, P1495, DOI 10.1016/S0016-7037(97)00017-3; Snoeckx H, 1999, MAR GEOL, V158, P197, DOI 10.1016/S0025-3227(98)00168-6; Sonzogni C, 1997, DEEP-SEA RES PT II, V44, P1445, DOI 10.1016/S0967-0645(97)00010-6; Stocker TF, 1998, RADIOCARBON, V40, P359; Stuiver M, 1998, RADIOCARBON, V40, P1041, DOI 10.1017/S0033822200019123; Thouveny N, 2000, EARTH PLANET SC LETT, V180, P61, DOI 10.1016/S0012-821X(00)00155-2; Weaver PPE, 1999, PALEOCEANOGRAPHY, V14, P336, DOI 10.1029/1999PA900009; Zahn R, 1997, PALEOCEANOGRAPHY, V12, P696, DOI 10.1029/97PA00581; ZHAO M, 1995, PALEOCEANOGRAPHY, V10, P661, DOI 10.1029/94PA03354	42	474	500	3	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 25	2000	289	5483					1321	1324		10.1126/science.289.5483.1321	http://dx.doi.org/10.1126/science.289.5483.1321			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347RF	10958772				2022-12-28	WOS:000088942400029
J	Hattori, M; Osterfield, M; Flanagan, JG				Hattori, M; Osterfield, M; Flanagan, JG			Regulated cleavage of a contact-mediated axon repellent	SCIENCE			English	Article							LYMPHOCYTE L-SELECTIN; GUIDANCE; RECEPTOR; GROWTH; SYSTEM; DROSOPHILA; EXPRESSION; EPHRIN-A5; LIGANDS; NEURONS	Contact-mediated axon repulsion by ephrins raises an unresolved question: these cell surface Ligands form a high-affinity multivalent complex with their receptors present on axons, yet rather than being bound, axons can be rapidly repelled. We show here that ephrin-A2 forms a stable complex with the metalloprotease Kuzbanian, involving interactions outside the cleavage region and the protease domain. Eph receptor binding triggered ephrin-A2 cleavage in a Localized reaction specific to the cognate Ligand. A cleavage-inhibiting mutation in ephrin-A2 delayed axon withdrawal. These studies reveal mechanisms for protease recognition and control of cell surface proteins, and, for ephrin-A2, they may provide a means for efficient axon detachment and termination of signaling.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Flanagan, JG (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.		Hattori, Mitsuharu/F-3859-2010; Flanagan, John/AAM-2995-2020	Hattori, Mitsuharu/0000-0002-0503-4969; 	NEI NIH HHS [EY11559] Funding Source: Medline; NICHD NIH HHS [HD29417] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD029417, R01HD029417] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011559] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		COX EC, 1990, NEURON, V2, P31; Davenport RW, 1998, J NEUROSCI, V18, P975; DAVIS S, 1994, SCIENCE, V266, P816, DOI 10.1126/science.7973638; Davy A, 1999, GENE DEV, V13, P3125, DOI 10.1101/gad.13.23.3125; Drescher U, 1997, CURR OPIN NEUROBIOL, V7, P75, DOI 10.1016/S0959-4388(97)80123-7; Fambrough D, 1996, P NATL ACAD SCI USA, V93, P13233, DOI 10.1073/pnas.93.23.13233; Feehan C, 1996, J BIOL CHEM, V271, P7019, DOI 10.1074/jbc.271.12.7019; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Frisen J, 1998, NEURON, V20, P235, DOI 10.1016/S0896-6273(00)80452-3; Gale NW, 1997, CELL TISSUE RES, V290, P227, DOI 10.1007/s004410050927; Gao PP, 1996, P NATL ACAD SCI USA, V93, P11161, DOI 10.1073/pnas.93.20.11161; GODEMENT P, 1994, J NEUROSCI, V14, P704; Grundy WN, 1996, COMPUT APPL BIOSCI, V12, P303; Hooper NM, 1997, BIOCHEM J, V321, P265, DOI 10.1042/bj3210265; Lackmann M, 1997, J BIOL CHEM, V272, P16521, DOI 10.1074/jbc.272.26.16521; MASSAGUE J, 1993, ANNU REV BIOCHEM, V62, P515, DOI 10.1146/annurev.bi.62.070193.002503; Meima L, 1997, EUR J NEUROSCI, V9, P177, DOI 10.1111/j.1460-9568.1997.tb01365.x; Murray MJ, 1999, J NEUROSCI, V19, P7901; NAKAMURA H, 1989, J NEUROSCI, V9, P3776; Pan DJ, 1997, CELL, V90, P271, DOI 10.1016/S0092-8674(00)80335-9; Primakoff P, 2000, TRENDS GENET, V16, P83, DOI 10.1016/S0168-9525(99)01926-5; Schlondorff J, 1999, J CELL SCI, V112, P3603; SHOCKETT P, 1995, P NATL ACAD SCI USA, V92, P6522, DOI 10.1073/pnas.92.14.6522; Swarte VVR, 1998, CELL ADHES COMMUN, V6, P311, DOI 10.3109/15419069809010790; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Vecchi M, 1998, J BIOL CHEM, V273, P20589, DOI 10.1074/jbc.273.32.20589; Werb Z, 1998, SCIENCE, V282, P1279, DOI 10.1126/science.282.5392.1279; Wroblewski M, 1997, INT IMMUNOL, V9, P555, DOI 10.1093/intimm/9.4.555; Yavari R, 1998, HUM MOL GENET, V7, P1161, DOI 10.1093/hmg/7.7.1161; Zhang JH, 1996, J NEUROSCI, V16, P7182	31	448	455	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 25	2000	289	5483					1360	1365		10.1126/science.289.5483.1360	http://dx.doi.org/10.1126/science.289.5483.1360			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347RF	10958785				2022-12-28	WOS:000088942400042
J	Serio, TR; Cashikar, AG; Kowal, AS; Sawicki, GJ; Moslehi, JJ; Serpell, L; Arnsdorf, MF; Lindquist, SL				Serio, TR; Cashikar, AG; Kowal, AS; Sawicki, GJ; Moslehi, JJ; Serpell, L; Arnsdorf, MF; Lindquist, SL			Nucleated conformational conversion and the replication of conformational information by a prion determinant	SCIENCE			English	Article							YEAST PRION; PROTEIN; PROPAGATION; DISEASE; SCRAPIE; INHERITANCE; MECHANISM; HSP104; PSI(+); SUP35	Prion proteins can serve as genetic elements by adopting distinct physical and functional states that are self-perpetuating and heritable. The critical region of one prion protein, Sup35, is initially unstructured in solution and then forms self-seeded amyloid fibers. We examined in vitro the mechanism by which this state is attained and replicated. Structurally fluid oligomeric complexes appear to be crucial intermediates in de novo amyloid nucleus formation. Rapid assembly ensues when these complexes conformationally convert. upon association with nuclei. This model for replicating protein-based genetic information. nucleated conformational conversion, may be applicable to other protein assembly processes.	Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA; Univ Chicago, Howard Hughes Med Inst, Chicago, IL 60637 USA; Univ Chicago, Dept Med, Cardiol Sect, Chicago, IL 60637 USA; MRC Ctr, Div Neurobiol, Mol Biol Lab, Cambridge CB2 2QH, England	University of Chicago; Howard Hughes Medical Institute; University of Chicago; University of Chicago; MRC Laboratory Molecular Biology	Lindquist, SL (corresponding author), Univ Chicago, Dept Mol Genet & Cell Biol, 920 E 58th St, Chicago, IL 60637 USA.		Cashikar, Anil G/F-5968-2011; Serio, Tricia/GPP-7129-2022	Serio, Tricia/0000-0003-2687-7372; Serpell, Louise/0000-0001-9335-7751	NCRR NIH HHS [P41-RR017777] Funding Source: Medline; NIGMS NIH HHS [GM57840, GM025874] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR017777] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025874, R01GM057840, R37GM025874] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BEAVEN GH, 1969, EUR J BIOCHEM, V11, P37, DOI 10.1111/j.1432-1033.1969.tb00735.x; CASHIKAR AG, UNPUB; CASPAR DLD, 1980, BIOPHYS J, V32, P103, DOI 10.1016/S0006-3495(80)84929-0; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; COX BS, 1965, HEREDITY, V20, P505, DOI 10.1038/hdy.1965.65; DePace AH, 1998, CELL, V93, P1241, DOI 10.1016/S0092-8674(00)81467-1; Dill KA, 1999, PROTEIN SCI, V8, P1166, DOI 10.1110/ps.8.6.1166; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Glover JR, 1997, CELL, V89, P811, DOI 10.1016/S0092-8674(00)80264-0; GRIFFITH JS, 1967, NATURE, V215, P1043, DOI 10.1038/2151043a0; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; HOFRICHTER J, 1974, P NATL ACAD SCI USA, V71, P4864, DOI 10.1073/pnas.71.12.4864; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Lansbury PT, 1999, P NATL ACAD SCI USA, V96, P3342, DOI 10.1073/pnas.96.7.3342; LINDQUIST S, 1999, MOL CHAPERONES FOLDI, P347; Liu JJ, 1999, NATURE, V400, P573, DOI 10.1038/23048; Mayo KH, 2000, TRENDS BIOTECHNOL, V18, P212, DOI 10.1016/S0167-7799(00)01439-6; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Paushkin SV, 1997, SCIENCE, V277, P381, DOI 10.1126/science.277.5324.381; Paushkin SV, 1996, EMBO J, V15, P3127, DOI 10.1002/j.1460-2075.1996.tb00675.x; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Serio TR, 1999, ANNU REV CELL DEV BI, V15, P661, DOI 10.1146/annurev.cellbio.15.1.661; Serio TR, 1999, METHOD ENZYMOL, V309, P649; STRYER LUBERT, 1965, J MOL BIOL, V13, P482; Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348; URATANI Y, 1972, J MOL BIOL, V67, P85, DOI 10.1016/0022-2836(72)90388-9; WALL JS, 1986, ANNU REV BIOPHYS BIO, V15, P355; Weber-Ban EU, 1999, NATURE, V401, P90, DOI 10.1038/43481	28	793	806	1	114	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 25	2000	289	5483					1317	1321		10.1126/science.289.5483.1317	http://dx.doi.org/10.1126/science.289.5483.1317			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347RF	10958771				2022-12-28	WOS:000088942400028
J	Levinson, W; Gorawara-Bhat, R; Lamb, J				Levinson, W; Gorawara-Bhat, R; Lamb, J			A study of patient clues and physician responses in primary care and surgical settings	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MANAGED-CARE; EMPATHIC COMMUNICATION; MEDICAL-CARE; INTERVIEW; SKILL; SATISFACTION; OUTCOMES; SUPPORT; MODEL	Context Patients often present clues (direct or indirect comments about personal aspects of their lives or their emotions) during conversations with their physicians. These clues represent opportunities for physicians to demonstrate understanding and empathy and thus, to deepen the therapeutic alliance that is at the heart of clinical care. A paucity of information exists regarding how physicians address the psychological and social concerns of patients. Objectives To assess how patients present clues and how physicians respond to these clues in routine primary care and surgical settings. Design, Setting, and Participants Descriptive, qualitative study of 116 randomly selected routine office visits to 54 primary care physicians and 62 surgeons in community-based practices in Oregon and Colorado, audiotaped and transcribed in 1994. Main Outcome Measures Frequency of presentation of clues by patients during office visits, nature (emotional vs social) and content of clues, and nature of physician responses to clues, coded as positive or missed opportunity. Results Fifty-two percent and 53% of the visits in primary care and surgery, respectively, included 1 or more clues. During visits with clues, the mean number of clues per visit was 2.6 in primary care and 1.9 in surgery. Patients initiated approximately 70% of clues, and physicians initiated 30%. Seventy-six percent of patient-initiated clues in primary care settings and 60% in surgical settings were emotional in nature. In surgery, 70% of emotional clues related to patients' feelings about their biomedical condition, while in primary care, emotional clues more often related to psychological or social concerns (80%) in patients' lives. Physicians responded positively to patient emotions in 38% of cases in surgery and 21% in primary care, but more frequently they missed opportunities to adequately acknowledge patients' feelings. Visits with missed opportunities tended to be longer than visits with a positive response. Conclusion This study suggests that physicians in both primary care and surgery can improve their ability to respond to patient clues even in the context of their busy clinical practices.	Univ Chicago, Gen Internal Med Sect, Chicago, IL 60637 USA; Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Levinson, W (corresponding author), Univ Chicago, Gen Internal Med Sect, 5841 S Maryland Ave,MC 2007, Chicago, IL 60637 USA.				AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS007289] Funding Source: NIH RePORTER; AHRQ HHS [R01 HS07289] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Baumann AO, 1998, J ADV NURS, V28, P1040, DOI 10.1046/j.1365-2648.1998.00809.x; BECKMAN H, 1990, J GEN INTERN MED, V5, P42, DOI 10.1007/BF02602308; BELLET PS, 1991, JAMA-J AM MED ASSOC, V266, P1831, DOI 10.1001/jama.266.13.1831; Bolognini S, 1997, INT J PSYCHOANAL, V78, P279; BRANCH WT, 1993, JAMA-J AM MED ASSOC, V269, P1667, DOI 10.1001/jama.269.13.1667; BRYNE PS, 1976, DOCTORS TALIING PATI; DiMatteo M R, 1980, J Community Health, V6, P18; DIMATTEO MR, 1986, HEALTH PSYCHOL, V5, P581, DOI 10.1037/0278-6133.5.6.581; EMANUEL EJ, 1995, JAMA-J AM MED ASSOC, V273, P323, DOI 10.1001/jama.273.4.323; ENGEL GL, 1977, SCIENCE, V196, P129, DOI 10.1126/science.847460; Farber NJ, 1997, ARCH INTERN MED, V157, P2291, DOI 10.1001/archinte.157.20.2291; FRIEDMAN HS, 1982, INTERPERSONAL ISSUES, P51; Gianakos D, 1996, ARCH INTERN MED, V156, P135, DOI 10.1001/archinte.156.2.135; GOLD MR, 1995, NEW ENGL J MED, V333, P1678, DOI 10.1056/NEJM199512213332505; Gordon GH, 1995, WESTERN J MED, V163, P527; GREENFIELD S, 1985, ANN INTERN MED, V102, P520, DOI 10.7326/0003-4819-102-4-520; GREENFIELD S, 1988, J GEN INTERN MED, V3, P448, DOI 10.1007/BF02595921; GREENFIELD S, 1989, MED CARE, V27, P110; HAVENS L, 1978, PSYCHIATRY, V41, P336, DOI 10.1080/00332747.1978.11023993; HICKSON GB, 1992, JAMA-J AM MED ASSOC, V267, P1359, DOI 10.1001/jama.267.10.1359; Kelly D, 1998, J ADV NURS, V28, P728, DOI 10.1046/j.1365-2648.1998.00807.x; LAMONICA EL, 1976, NURS RES, V25, P447, DOI 10.1097/00006199-197611000-00013; Levinson W, 1999, JAMA-J AM MED ASSOC, V282, P1477, DOI 10.1001/jama.282.15.1477; Levinson W, 1997, JAMA-J AM MED ASSOC, V277, P553, DOI 10.1001/jama.277.7.553; Marvel M K, 1993, Arch Fam Med, V2, P629, DOI 10.1001/archfami.2.6.629; MATTHEWS DA, 1993, ANN INTERN MED, V118, P973, DOI 10.7326/0003-4819-118-12-199306150-00010; MERKEL WT, 1990, J GEN INTERN MED, V5, P40; MULLAN PB, 1990, SOC SCI MED, V31, P1337, DOI 10.1016/0277-9536(90)90073-2; PLATT FW, 1994, J GEN INTERN MED, V9, P222, DOI 10.1007/BF02600129; Putnam SM., 1995, MED INTERVIEW, P530; ROTER DL, 1995, ARCH INTERN MED, V155, P1877, DOI 10.1001/archinte.155.17.1877; Sourial S, 1997, J ADV NURS, V26, P1189, DOI 10.1111/j.1365-2648.1997.tb00812.x; SPIRO H, 1992, ANN INTERN MED, V116, P843, DOI 10.7326/0003-4819-116-10-843; STEWART MA, 1984, SOC SCI MED, V19, P167, DOI 10.1016/0277-9536(84)90284-3; STEWART MA, 1995, CAN MED ASSOC J, V152, P1423; Suchman AL, 1997, JAMA-J AM MED ASSOC, V277, P678, DOI 10.1001/jama.277.8.678; SUCHMAN AL, 1988, ANN INTERN MED, V108, P125, DOI 10.7326/0003-4819-108-1-125; *US DEP HHS, 1993, DEPR PRIM CAR, V1; WASSERMAN RC, 1984, PEDIATRICS, V74, P1047; Wiseman T, 1996, J ADV NURS, V23, P1162, DOI 10.1046/j.1365-2648.1996.12213.x; WOOLLEY FR, 1978, SOC SCI MED-MED SOC, V12, P123, DOI 10.1016/0160-7979(78)90034-6; ZINN W, 1993, ARCH INTERN MED, V153, P306, DOI 10.1001/archinte.153.3.306	42	438	440	0	37	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 23	2000	284	8					1021	1027		10.1001/jama.284.8.1021	http://dx.doi.org/10.1001/jama.284.8.1021			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	344PX	10944650	Bronze			2022-12-28	WOS:000088769000031
J	Churchill, D; Allen, J; Pringle, M; Hippisley-Cox, J; Ebdon, D; Macpherson, M; Bradley, S				Churchill, D; Allen, J; Pringle, M; Hippisley-Cox, J; Ebdon, D; Macpherson, M; Bradley, S			Consultation patterns and provision of contraception in general practice before teenage pregnancy: case-control study	BRITISH MEDICAL JOURNAL			English	Article							ADOLESCENTS; CARE	Objectives To determine patterns of consultation in general practice and provision of contraception before teenage pregnancy. Design Case-control study, with retrospective analysis of case notes. Setting 14 general practices in Trent region. Subjects 240 registered patients (cases) with a recorded conception before the age of 20. Three controls per case were matched by age and practice. Main outcome measures Consultations in general practice and provision of contraception in the 12 months before conception and recorded provision of contraception at any time before conception. Results Overall, 223 cases (93%) had consulted a health professional at least once in the year before conception, 171 (71%) had discussed contraception in this time, and 121 (50%) had been prescribed oral contraception. Cases were more likely to have consulted in the year before: conception than controls (odds ratio 2.70, 95% confidence interval 1.56 to 4.66). (odds ratio 2.70, 95% confidence interval 1.56 to 4.66). Most Of the difference was owing to consultation for contraception. Overall, 53 cases (22%,) resulted in a termination of pregnancy. Cases whose pregnancy ended in a termination were more likely to have received emergency contraception than either their controls (3.21, 1.32 to 7.79) or cases resulting in other outcomes (3.01, 1.06 to 8.51). Conclusions Most teenagers who became pregnant attended general practice in the year before pregnancy, and many had sought contraceptive advice. The reluctance of teenagers to attend general practice for contraception may be less than previously supposed. The association between provision of emergency contraception and pregnancy ending in termination emphasises the need for continuing follow up of teenagers consulting for this form of contraception.	Univ Nottingham, Sch Med, Queens Med Ctr, Div Gen Practice, Nottingham NG7 2UH, England; Univ Nottingham, Dept Geog, Nottingham NG7 2RD, England; Queens Med Ctr, Dept Obstet & Gynaecol, Nottingham NG7 2UH, England; Queens Med Ctr, Sch Nursing, Nottingham NG7 2UH, England	University of Nottingham; University of Nottingham; University of Nottingham; University of Nottingham	Churchill, D (corresponding author), Univ Nottingham, Sch Med, Queens Med Ctr, Div Gen Practice, Nottingham NG7 2UH, England.		Hippisley-Cox, Julia/AAY-2788-2020	Hippisley-Cox, Julia/0000-0002-2479-7283; Churchill, Richard/0000-0003-0049-8200; Bethea, Jane/0000-0003-0297-0468				COLEMAN J, 1999, KEY DATA ADOLESCENCE; Donovan C, 1997, BRIT J GEN PRACT, V47, P715; JACOBSON LD, 1994, FAM PRACT, V11, P296, DOI 10.1093/fampra/11.3.296; JACOBSON LD, 1994, BRIT J GEN PRACT, V44, P420; Kramer T, 1997, BRIT J GEN PRACT, V47, P327; MELVILLE AWT, 1989, FAM PRACT, V6, P245, DOI 10.1093/fampra/6.4.245; NHS Centre for Reviews and Dissemination University of York, 1997, EFFECTIVE HLTH CARE, V3, P1; PEARSON VAH, 1995, J ROY SOC MED, V88, P384; PEARSON VAH, 1995, BRIT J FAM PLAN, V21, P45; *SECR STAT HLTH, 1992, HLTH NAT; *SOC EXCL UN, 1999, CMND 4342; Stevenson J, 1996, BRIT J FAM PLAN, V22, P75	12	42	45	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	AUG 19	2000	321	7259					486	489		10.1136/bmj.321.7259.486	http://dx.doi.org/10.1136/bmj.321.7259.486			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	347MC	10948031	Green Published, Bronze			2022-12-28	WOS:000088932800023
J	Polman, CH; Uitdehaag, BMJ				Polman, CH; Uitdehaag, BMJ			Regular review - Drug treatment of multiple sclerosis	BRITISH MEDICAL JOURNAL			English	Review							MAGNETIC-RESONANCE TECHNIQUES; PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; INTERFERON BETA-1B; ACUTE RELAPSES; METHYLPREDNISOLONE; PROGRESSION; MULTICENTER; LESIONS; MRI		Vrije Univ Amsterdam, Acad Hosp, Dept Neurol, NL-1007 MB Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Polman, CH (corresponding author), Vrije Univ Amsterdam, Acad Hosp, Dept Neurol, POB 7057, NL-1007 MB Amsterdam, Netherlands.							Barnes D, 1997, LANCET, V349, P902, DOI 10.1016/S0140-6736(96)06453-7; Coles AJ, 1999, ANN NEUROL, V46, P296, DOI 10.1002/1531-8249(199909)46:3<296::AID-ANA4>3.0.CO;2-#; Comi G, 1999, NEUROLOGY, V52, pA289; COMI G, 1995, MULT SCLER, V1, P24; DUQUETTE P, 1993, NEUROLOGY, V43, P655, DOI 10.1212/wnl.43.4.655; Ebers G, 1999, NEUROLOGY, V53, P679; Ebers GC, 1998, LANCET, V352, P1498, DOI 10.1016/S0140-6736(98)03334-0; Forbes RB, 1999, BMJ-BRIT MED J, V319, P1529, DOI 10.1136/bmj.319.7224.1529; GOODKIN DE, 1995, ANN NEUROL, V37, P30, DOI 10.1002/ana.410370108; Hohlfeld R, 1997, BRAIN, V120, P865, DOI 10.1093/brain/120.5.865; Jacobs LD, 1996, ANN NEUROL, V39, P285, DOI 10.1002/ana.410390304; JOHNSON KP, 1995, NEUROLOGY, V45, P1268, DOI 10.1212/WNL.45.7.1268; Kappos L, 1998, LANCET, V352, P1491, DOI 10.1016/S0140-6736(98)10039-9; Li DKB, 1999, ANN NEUROL, V46, P197, DOI 10.1002/1531-8249(199908)46:2<197::AID-ANA9>3.0.CO;2-P; Lucchinetti C, 1999, BRAIN, V122, P2279, DOI 10.1093/brain/122.12.2279; Lucchinetti CF, 1996, BRAIN PATHOL, V6, P259, DOI 10.1111/j.1750-3639.1996.tb00854.x; Miller DH, 1996, ANN NEUROL, V39, P6, DOI 10.1002/ana.410390104; Miller DH, 1998, BRAIN, V121, P3, DOI 10.1093/brain/121.1.3; Oksenberg JR, 1997, CURR OPIN NEUROL, V10, P181, DOI 10.1097/00019052-199706000-00003; Paolillo A, 1999, NEUROLOGY, V53, P751, DOI 10.1212/WNL.53.4.751; Parkin D, 2000, J NEUROL NEUROSUR PS, V68, P144, DOI 10.1136/jnnp.68.2.144; PATY DW, 1993, NEUROLOGY, V43, P662, DOI 10.1212/WNL.43.4.662; Simon JH, 1998, ANN NEUROL, V43, P79, DOI 10.1002/ana.410430114; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Uitdehaag BMJ, 1998, CNS DRUGS, V10, P233, DOI 10.2165/00023210-199810040-00001; WEINSHENKER BG, 1995, NEUROL CLIN, V13, P119, DOI 10.1016/S0733-8619(18)30064-1; YUDKIN PL, 1991, LANCET, V338, P1051, DOI 10.1016/0140-6736(91)91909-E	27	46	55	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	AUG 19	2000	321	7259					490	494		10.1136/bmj.321.7259.490	http://dx.doi.org/10.1136/bmj.321.7259.490			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	347MC	10948033	Green Published			2022-12-28	WOS:000088932800024
J	Kawasaki, Y; Senda, T; Ishidate, T; Koyama, R; Morishita, T; Iwayama, Y; Higuchi, O; Akiyama, T				Kawasaki, Y; Senda, T; Ishidate, T; Koyama, R; Morishita, T; Iwayama, Y; Higuchi, O; Akiyama, T			Asef, a link between the tumor suppressor APC and G-protein signaling	SCIENCE			English	Article							BETA-CATENIN; DROSOPHILA HOMOLOG; CELL-MIGRATION; GENE-PRODUCT; AXIN; IDENTIFICATION; ASSOCIATION; LOCALIZATION; GSK-3-BETA; GSK3-BETA	The adenomatous polyposis coli gene (APC) is mutated in familiar adenomatous polyposis and in sporadic colorectal tumors. Here the APC gene product is shown to bind through its armadillo repeat domain to a Rac-specific guanine nucleotide exchange factor (GEF), termed Asef. Endogenous APC colocalized with Asef in mouse colon epithelial cells and neuronal cells. Furthermore, APC enhanced the CEF activity of Asef and stimulated Asef-mediated cell flattening, membrane ruffling, and Lamellipodia formation in MDCK cells. These results suggest that the APC-Asef complex may regulate the actin cytoskeletal network, cell morphology and migration, and neuronal function.	Univ Tokyo, Inst Mol & Cellular Biosci, Lab Mol & Genet Informat, Bunkyo Ku, Tokyo 113, Japan; Nagoya Univ, Sch Med, Dept Anat 1, Showa Ku, Nagoya, Aichi 466, Japan; Osaka Univ, Inst Microbial Dis, Dept Oncogene Res, Suita, Osaka 565, Japan	University of Tokyo; Nagoya University; Osaka University	Akiyama, T (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Lab Mol & Genet Informat, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 113, Japan.							BAEG GH, 1995, EMBO J, V14, P5618, DOI 10.1002/j.1460-2075.1995.tb00249.x; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Bienz M, 1999, CURR OPIN GENET DEV, V9, P595, DOI 10.1016/S0959-437X(99)00016-7; Brakeman JSF, 1999, NEUROSCIENCE, V91, P661, DOI 10.1016/S0306-4522(98)00605-8; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Cerione RA, 1996, CURR OPIN CELL BIOL, V8, P216, DOI 10.1016/S0955-0674(96)80068-8; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hamada F, 1999, GENES CELLS, V4, P465, DOI 10.1046/j.1365-2443.1999.00272.x; Hamada F, 1999, SCIENCE, V283, P1739, DOI 10.1126/science.283.5408.1739; Hart MJ, 1998, CURR BIOL, V8, P573, DOI 10.1016/S0960-9822(98)70226-X; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; KAWASAKI Y, UNPUB; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Matsumine A, 1996, SCIENCE, V272, P1020, DOI 10.1126/science.272.5264.1020; McCartney BM, 1999, J CELL BIOL, V146, P1303, DOI 10.1083/jcb.146.6.1303; MIKI T, 1993, NATURE, V362, P462, DOI 10.1038/362462a0; Miller JR, 1996, GENE DEV, V10, P2527, DOI 10.1101/gad.10.20.2527; Nakagawa H, 1998, CANCER RES, V58, P5176; Nakamura T, 1998, GENES CELLS, V3, P395, DOI 10.1046/j.1365-2443.1998.00198.x; Nathke IS, 1996, J CELL BIOL, V134, P165, DOI 10.1083/jcb.134.1.165; Polakis P, 1997, BBA-REV CANCER, V1332, pF127, DOI 10.1016/S0304-419X(97)00008-5; RUBINFELD B, 1993, SCIENCE, V262, P1731, DOI 10.1126/science.8259518; Senda T, 1998, NEUROSCIENCE, V83, P857, DOI 10.1016/S0306-4522(97)00459-4; SU LK, 1993, SCIENCE, V262, P1734, DOI 10.1126/science.8259519; SU LK, 1995, CANCER RES, V55, P2972; VAN AL, 1997, GENE DEV, V11, P2295; van Es JH, 1999, CURR BIOL, V9, P105, DOI 10.1016/S0960-9822(99)80024-4; Whitehead IP, 1997, BBA-REV CANCER, V1332, pF1, DOI 10.1016/S0304-419X(96)00040-6; Wong MH, 1996, P NATL ACAD SCI USA, V93, P9588, DOI 10.1073/pnas.93.18.9588; Yu X, 1999, NAT CELL BIOL, V1, P144, DOI 10.1038/11064	30	284	296	3	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 18	2000	289	5482					1194	1197		10.1126/science.289.5482.1194	http://dx.doi.org/10.1126/science.289.5482.1194			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	346JE	10947987				2022-12-28	WOS:000088866600043
J	Gale, EAM				Gale, EAM			Oral tolerance and autoimmune diabetes - will hope triumph over experience?	LANCET			English	Editorial Material									Southmead Gen Hosp, Med Sch Unit, Dept Diabet & Metab, Bristol BS10 5NB, Avon, England	Southmead Hospital	Gale, EAM (corresponding author), Southmead Gen Hosp, Med Sch Unit, Dept Diabet & Metab, Bristol BS10 5NB, Avon, England.							[Anonymous], 1995, TRANSPLANT P, V27, P3377; Diabet Control Complications Trial Res Grp, 1998, ANN INTERN MED, V128, P517, DOI 10.7326/0003-4819-128-7-199804010-00001; Gardner SG, 1999, DIABETES CARE, V22, P2049, DOI 10.2337/diacare.22.12.2049; HUSBY S, 1994, J IMMUNOL, V152, P4663; Weiner HL, 1997, ANNU REV MED, V48, P341; ZHANG ZJ, 1991, P NATL ACAD SCI USA, V88, P10252, DOI 10.1073/pnas.88.22.10252; Ziegler AG, 1999, DIABETES, V48, P460, DOI 10.2337/diabetes.48.3.460	7	3	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 12	2000	356	9229					526	527		10.1016/S0140-6736(00)02573-3	http://dx.doi.org/10.1016/S0140-6736(00)02573-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	345MY	10950225				2022-12-28	WOS:000088820800005
J	Giesecke, J				Giesecke, J			Prevention, not panic - epidemics and trade sanctions	LANCET			English	Editorial Material									WHO, CDS EXD, Int Hlth Regulat Revis Team, CH-1211 Geneva, Switzerland	World Health Organization	Giesecke, J (corresponding author), WHO, CDS EXD, Int Hlth Regulat Revis Team, CH-1211 Geneva, Switzerland.								0	5	5	1	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 12	2000	356	9229					588	589		10.1016/S0140-6736(00)02592-7	http://dx.doi.org/10.1016/S0140-6736(00)02592-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	345MY	10950249				2022-12-28	WOS:000088820800040
J	Roberts, RJ; Casey, D; Morgan, DA; Petrovic, M				Roberts, RJ; Casey, D; Morgan, DA; Petrovic, M			Comparison of wet combing with malathion for treatment of head lice in the UK: a pragmatic randomised controlled trial	LANCET			English	Article							LINDANE SHAMPOO; CAPITIS; ERADICATION; RINSE	Background Concern about the effectiveness and toxicity of insecticide lotions has led to promotion of mechanical methods to remove head lice. We compared the effectiveness of "bug-busting" (wet combing with a fine-toothed comb) and malathion lotion. Methods We screened 4037 schoolchildren in two counties in Wales. UK (intermediate resistance to malathion). Of 167 found to have head lice, 81 (aged 3-14 years) were eligible to participate in a randomised controlled trial that compared mechanical removal of lice by a commercial kit every 3-4 days for 2 weeks with two applications of 0.5% malathion lotion 7 days apart; parents carried out both treatments. The outcome measure was the presence of live lice 7 days after the end of treatment. Analyses were by intention to treat. Findings 74 children completed the study and 72 were included in the analysis. The cure rate was 38% (12 of 32) for bug-busting and 78% (31 of 40) for malathion. Children assigned bug-busting were 2.8 (95% CI 1.5-5.2) times more likely than those assigned malathion to have lice at the end of treatment (p=0.0006). Interpretation Malathion lotion was twice as effective as bug busting, even in an area with intermediate resistance. Policies advocating bug-busting as first-line treatment for head lice in the general population are inappropriate. Assessment of the outcome of treatment 1-2 weeks after completion is essential for successful management. Only about 50% of participants complied fully with treatment, so future trials should be pragmatic in design, avoid false incentives, and study representative samples of children.	N Wales Hlth Author, Dept Publ Hlth, Mold CH7 1PZ, Wales		Roberts, RJ (corresponding author), N Wales Hlth Author, Dept Publ Hlth, Mold CH7 1PZ, Wales.							Bainbridge CV, 1998, CLIN PEDIATR, V37, P17, DOI 10.1177/000992289803700103; BOWERMAN JG, 1987, PEDIATR INFECT DIS J, V6, P252, DOI 10.1097/00006454-198703000-00008; BRANDENBURG K, 1986, AM J DIS CHILD, V140, P894, DOI 10.1001/archpedi.1986.02140230064034; BURGESS I, 1996, PRESCRIBER, V7, P87; Burgess I. F., 1999, P 3 INT C URB PESTS, P634; Burgess IF, 1998, PRACTITIONER, V242, P126; BURGESS IF, 1994, CLIN THER, V16, P57; BURGESS IF, 1995, BRIT MED J, V311, P752, DOI 10.1136/bmj.311.7007.752; CARSON DS, 1988, AM J DIS CHILD, V142, P768, DOI 10.1001/archpedi.1988.02150070082031; *DEP HLTH, 1996, PREV TREATM HEAD LIC; DINAPOLI JB, 1988, AM J PUBLIC HEALTH, V78, P978, DOI 10.2105/AJPH.78.8.978; DODD CS, 1999, COCHRANE LIBRARY; Downs AMR, 1999, EPIDEMIOL INFECT, V122, P471, DOI 10.1017/S0950268899002277; Hollis S, 1999, BRIT MED J, V319, P670, DOI 10.1136/bmj.319.7211.670; Iannantuono RF, 1997, ADV THER, V14, P134; Ibarra J, 1996, ARCH DIS CHILD, V75, P471, DOI 10.1136/adc.75.6.471; LINNANE E, 1999, P C EP CONTR COMM DI, P24; MUMCUOGLU KY, 1995, MED VET ENTOMOL, V9, P427, DOI 10.1111/j.1365-2915.1995.tb00018.x; PITMAN NK, 1987, CLIN THER, V9, P368; Pollack RJ, 1999, ARCH PEDIAT ADOL MED, V153, P969, DOI 10.1001/archpedi.153.9.969; ROBINSON DH, 1980, CURR THER RES CLIN E, V27, P1; SACKETT DL, 1997, EVIDENCE BASED MED; TAPLIN D, 1982, JAMA-J AM MED ASSOC, V247, P3103, DOI 10.1001/jama.247.22.3103; Taplin D, 1986, Pediatr Dermatol, V3, P344, DOI 10.1111/j.1525-1470.1986.tb00538.x; 1997, COMMUN DIS REP CDR W, V7, P365	25	80	87	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 12	2000	356	9229					540	544		10.1016/S0140-6736(00)02578-2	http://dx.doi.org/10.1016/S0140-6736(00)02578-2			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	345MY	10950230				2022-12-28	WOS:000088820800010
J	Vanrenterghem, Y				Vanrenterghem, Y			Cautious approach to use of non-heart-beating donors	LANCET			English	Editorial Material							TRANSPLANTATION; KIDNEYS		Univ Hosp Gasthuisberg, Dept Nephrol, B-3000 Louvain, Belgium	KU Leuven; University Hospital Leuven	Vanrenterghem, Y (corresponding author), Univ Hosp Gasthuisberg, Dept Nephrol, B-3000 Louvain, Belgium.							Balupuri S, 2000, TRANSPLANTATION, V69, P842; BOS MA, 1995, TRANSPLANT P, V27, P2929; Cho YW, 1998, NEW ENGL J MED, V338, P221, DOI 10.1056/NEJM199801223380403; Daemen JWHC, 1997, TRANSPLANTATION, V63, P89, DOI 10.1097/00007890-199701150-00017; *I MED NAT AC SCI, 1997, NONH BEAT ORG TRANSP; Kootstra G, 1997, TRANSPLANTATION, V63, P917, DOI 10.1097/00007890-199704150-00001; KOOTSTRA G, 1995, TRANSPLANT P, V27, P2893; *PMC, 1993, KENNEDY INST ETHIC J, V3, pA1; WIJNEN RMH, 1995, LANCET, V345, P1067, DOI 10.1016/S0140-6736(95)90815-3	9	25	25	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 12	2000	356	9229					528	528		10.1016/S0140-6736(00)02575-7	http://dx.doi.org/10.1016/S0140-6736(00)02575-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	345MY	10950227				2022-12-28	WOS:000088820800007
J	Sharma, K; Leonard, AE; Lettieri, K; Pfaff, SL				Sharma, K; Leonard, AE; Lettieri, K; Pfaff, SL			Genetic and epigenetic mechanisms contribute to motor neuron pathfinding	NATURE			English	Article							MOTONEURON PROJECTION PATTERNS; EMBRYONIC STEM-CELLS; SPINAL-CORD; INNERVATION; EXPRESSION; REQUIREMENT; MUSCULATURE; IDENTITY; SUBTYPES; WINGS	Many lines of evidence indicate that genetically distinct subtypes of motor neurons are specified during development(1), with each type having characteristic properties of axon guidance and cell-body migration(2). Motor neuron subtypes express unique combinations of LIM-type homeodomain factors that may act as intrinsic genetic regulators of the cytoskeletal events that mediate cell migration, axon navigation or both(3-7). Although experimentally displaced motor neurons can pioneer new routes to their targets(8-11), in many cases the axons of motor neurons in complete isolation from their normal territories passively follow stereotypical pathways dictated by the environment(12-16). To investigate the nonspecific versus genetically controlled regulation of motor connectivity we forced all motor neurons to express ectopically a LIM gene combination appropriate for the subgroup that innervates axial muscles. Here we show that this genetic alteration is sufficient to convert the cell body settling pattern, gene-expression profile and axonal projections of all motor neurons to that of the axial subclass. Nevertheless, elevated occupancy of the axial pathway can override their genetic program, causing some axons to project to alternative targets.	Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA	Salk Institute	Pfaff, SL (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.							Appel B, 1995, DEVELOPMENT, V121, P4117; Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; Bell E, 1999, SCIENCE, V284, P2168, DOI 10.1126/science.284.5423.2168; FERGUSON BA, 1983, J NEUROSCI, V3, P1760; FERNS MJ, 1993, J NEUROSCI, V13, P2463, DOI 10.1523/JNEUROSCI.13-06-02463.1993; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; Goodhill GJ, 1999, TRENDS NEUROSCI, V22, P529, DOI 10.1016/S0166-2236(99)01469-1; Jurata LW, 2000, CURR OPIN NEUROBIOL, V10, P72, DOI 10.1016/S0959-4388(99)00053-7; LANCEJONES C, 1980, J PHYSIOL-LONDON, V302, P559; LANCEJONES C, 1980, J PHYSIOL-LONDON, V302, P581; LANCEJONES CC, 1986, DEV BIOL, V116, P387, DOI 10.1016/0012-1606(86)90141-7; LANDMESSER L, 1978, J PHYSIOL-LONDON, V284, P391, DOI 10.1113/jphysiol.1978.sp012546; Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5; O'Gorman S, 1997, P NATL ACAD SCI USA, V94, P14602, DOI 10.1073/pnas.94.26.14602; OBRIEN MK, 1990, J NEUROBIOL, V21, P341, DOI 10.1002/neu.480210208; Pfaff S, 1998, CURR OPIN NEUROBIOL, V8, P27, DOI 10.1016/S0959-4388(98)80005-6; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; Sharma K, 1998, CELL, V95, P817, DOI 10.1016/S0092-8674(00)81704-3; STRAZNICKY C, 1983, ANAT EMBRYOL, V167, P247, DOI 10.1007/BF00298514; SUMMERBELL D, 1981, J EMBRYOL EXP MORPH, V61, P233; Tanabe Y, 1996, SCIENCE, V274, P1115, DOI 10.1126/science.274.5290.1115; Thaler J, 1999, NEURON, V23, P675, DOI 10.1016/S0896-6273(01)80027-1; Thor S, 1999, NATURE, V397, P76, DOI 10.1038/16275; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; VarelaEchavarria A, 1996, MOL CELL NEUROSCI, V8, P242, DOI 10.1006/mcne.1996.0061; WETTS R, 1994, NEUROSCIENCE, V63, P1117, DOI 10.1016/0306-4522(94)90577-0; WHITELAW V, 1983, J NEUROSCI, V3, P1216	27	102	103	0	7	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 3	2000	406	6795					515	519		10.1038/35020078	http://dx.doi.org/10.1038/35020078			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	340ML	10952312				2022-12-28	WOS:000088538000046
J	Triplett, W				Triplett, W			Astronomers silenced in star-name wars	NATURE			English	News Item																			0	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 3	2000	406	6795					448	448		10.1038/35020232	http://dx.doi.org/10.1038/35020232			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	340ML	10952281	Bronze			2022-12-28	WOS:000088538000009
J	Scolnick, DM; Halazonetis, TD				Scolnick, DM; Halazonetis, TD			Chfr defines a mitotic stress checkpoint that delays entry into metaphase	NATURE			English	Article							HUMAN CANCERS; DNA-DAMAGE; CELL-LINES; IDENTIFICATION; MITOSIS; MUTATION; TARGETS; FINGER; DOMAIN; GENES	Chemicals that target microtubules induce mitotic stress by affecting several processes that occur during mitosis. These processes include separation of the centrosomes in prophase, alignment of the chromosomes on the spindle in metaphase and sister-chromatid separation in anaphase(1,2). Many human cancers are sensitive to mitotic stress. This sensitivity is being exploited for therapy and implies checkpoint defects(2-8). The known mitotic checkpoint genes, which prevent entry into anaphase when the chromosomes are not properly aligned on the mitotic spindle, are, however, rarely inactivated in human cancer(9-13). Here we describe the chfr gene, which is inactivated owing to lack of expression or by mutation in four out of eight human cancer cell lines examined. Normal primary cells and tumour cell lines that express wild-type chfr exhibited delayed entry into metaphase when centrosome separation was inhibited by mitotic stress. In contrast, the tumour cell lines that had lost chfr function entered metaphase without delay. Ectopic expression of wild-type chfr restored the cell cycle delay and increased the ability of the cells to survive mitotic stress. Thus, chfr defines a checkpoint that delays entry into metaphase in response to mitotic stress.	Wistar Inst, Philadelphia, PA 19104 USA; Univ Penn, Grad Program Biochem, Philadelphia, PA 19104 USA	The Wistar Institute; University of Pennsylvania	Halazonetis, TD (corresponding author), Wistar Inst, 3601 Spruce St, Philadelphia, PA 19104 USA.		Halazonetis, Thanos/D-7923-2011					Amon A, 1999, CURR OPIN GENET DEV, V9, P69, DOI 10.1016/S0959-437X(99)80010-0; BORDEN KLB, 1995, EMBO J, V14, P1532, DOI 10.1002/j.1460-2075.1995.tb07139.x; Cahill DP, 1999, GENOMICS, V58, P181, DOI 10.1006/geno.1999.5831; Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; Chehab NH, 1999, P NATL ACAD SCI USA, V96, P13777, DOI 10.1073/pnas.96.24.13777; Elledge SJ, 1998, SCIENCE, V279, P999, DOI 10.1126/science.279.5353.999; Furuno N, 1999, J CELL BIOL, V147, P295, DOI 10.1083/jcb.147.2.295; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; HOFMANN K, 1995, TRENDS BIOCHEM SCI, V20, P347, DOI 10.1016/S0968-0004(00)89072-6; HOLLIDAY R, 1993, MUTAT RES, V285, P61, DOI 10.1016/0027-5107(93)90052-H; Janss AJ, 1998, EXP CELL RES, V243, P29, DOI 10.1006/excr.1998.4122; Jin DY, 1998, CELL, V93, P81, DOI 10.1016/S0092-8674(00)81148-4; Jordan MA, 1998, CURR OPIN CELL BIOL, V10, P123, DOI 10.1016/S0955-0674(98)80095-1; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Li Y, 1996, SCIENCE, V274, P246, DOI 10.1126/science.274.5285.246; LOVERING R, 1993, P NATL ACAD SCI USA, V90, P2112, DOI 10.1073/pnas.90.6.2112; MCINTOSH JR, 1989, SCIENCE, V246, P622; Muhua L, 1998, NATURE, V393, P487, DOI 10.1038/31014; Murone M, 1996, EMBO J, V15, P6605, DOI 10.1002/j.1460-2075.1996.tb01051.x; Weinert T, 1998, CELL, V94, P555, DOI 10.1016/S0092-8674(00)81597-4; Yamaguchi K, 1999, CANCER LETT, V139, P183, DOI 10.1016/S0304-3835(99)00035-X; Zimmerman W, 1999, CURR OPIN CELL BIOL, V11, P122, DOI 10.1016/S0955-0674(99)80015-5; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418	24	319	333	0	40	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 27	2000	406	6794					430	435		10.1038/35019108	http://dx.doi.org/10.1038/35019108			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	337WC	10935642				2022-12-28	WOS:000088383800052
J	Brittle, EE; Waters, MG				Brittle, EE; Waters, MG			Cell biology - ER-to-Golgi traffic - This bud's for you	SCIENCE			English	Editorial Material							ENDOPLASMIC-RETICULUM; TRANSPORT; ENDOSOME; DOCKING; COMPLEX		Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University	Brittle, EE (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.			Zumbrun, Elizabeth/0000-0002-9897-7201				Allan BB, 2000, SCIENCE, V289, P444, DOI 10.1126/science.289.5478.444; Cao XC, 2000, J CELL BIOL, V149, P55, DOI 10.1083/jcb.149.1.55; Christoforidis S, 1999, NATURE, V397, P621, DOI 10.1038/17618; Guo W, 2000, TRENDS CELL BIOL, V10, P251, DOI 10.1016/S0962-8924(00)01754-2; Mellman I, 2000, CELL, V100, P99, DOI 10.1016/S0092-8674(00)81687-6; NUOFFER C, 1994, J CELL BIOL, V125, P225, DOI 10.1083/jcb.125.2.225; Peterson MR, 1999, CURR BIOL, V9, P159, DOI 10.1016/S0960-9822(99)80071-2; Rowe T, 1998, SCIENCE, V279, P696, DOI 10.1126/science.279.5351.696; Sonnichsen B, 1998, J CELL BIOL, V140, P1013, DOI 10.1083/jcb.140.5.1013; Springer S, 1998, SCIENCE, V281, P698, DOI 10.1126/science.281.5377.698; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Ungermann C, 1998, NATURE, V396, P543, DOI 10.1038/25069; Waters MG, 1999, CURR OPIN CELL BIOL, V11, P453, DOI 10.1016/S0955-0674(99)80065-9; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X	14	7	7	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 21	2000	289	5478					403	404		10.1126/science.289.5478.403	http://dx.doi.org/10.1126/science.289.5478.403			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	336ME	10939952				2022-12-28	WOS:000088305500028
J	Takakura, N; Watanabe, T; Suenobu, S; Yamada, Y; Noda, T; Ito, Y; Satake, M; Suda, T				Takakura, N; Watanabe, T; Suenobu, S; Yamada, Y; Noda, T; Ito, Y; Satake, M; Suda, T			A role for hematopoietic stem cells in promoting angiogenesis	CELL			English	Article							RECEPTOR TYROSINE KINASE; BLOOD-VESSEL FORMATION; DEFINITIVE HEMATOPOIESIS; TIE2 RECEPTOR; YOLK-SAC; VASCULAR DEVELOPMENT; MOUSE EMBRYOS; ANGIOPOIETIN-1; MICE; LEUKEMIA	Angiogenesis is an important event for embryonic organogenesis as well as for tissue repair in the adult. Here, we show that hematopoietic stem cells (HSCs) play important roles for angiogenesis during embryogenesis. To investigate the role of HSCs in endothelial cell (EC) development, we analyzed AML1-deficient embryos, which lack definitive hematopoiesis. These embryos showed defective angiogenesis in the head and pericardium. Pars-aortic splanchnopleural (P-Sp) explant cultures on stromal cells (P-Sp culture) did not generate definitive hematopoietic cells and showed defective angiogenesis in the AML1 null embryo. Disrupted angiogenesis in P-Sp cultures from AML1 null embryos was rescued by addition of HSCs or angiopoietin-1 (Ang1). HSCs, which express Ang1, directly promoted migration of ECs in vivo and in vitro. These results indicate that HSCs are critical for angiogenesis.	Kumamoto Univ, Sch Med, Inst Mol Embryol & Genet, Dept Cell Differentiat, Kumamoto 8600811, Japan; Tohoku Univ, Inst Dev Aging & Canc, Dept Mol Immunol, Sendai, Miyagi 9800872, Japan; Inst Canc Res, Dept Cell Biol, Toshima Ku, Tokyo 1708455, Japan; Kyoto Univ, Inst Virus Res, Dept Viral Oncol, Sakyo Ku, Kyoto 6068507, Japan	Kumamoto University; Tohoku University; Kyoto University	Takakura, N (corresponding author), Kumamoto Univ, Sch Med, Inst Mol Embryol & Genet, Dept Cell Differentiat, 2-2-1 Honjo, Kumamoto 8600811, Japan.	ntakaku@gpo.kumamoto-u.ac.jp; sudato@gpo.kumamoto-u.ac.jp	Suda, Toshio/H-6761-2013; Noda, Tetsuo/B-1667-2016	Suda, Toshio/0000-0001-7540-1771; 				Asahara T, 1998, CIRC RES, V83, P233, DOI 10.1161/01.RES.83.3.233; Cumano A, 1996, CELL, V86, P907, DOI 10.1016/S0092-8674(00)80166-X; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; Dumont DJ, 1998, SCIENCE, V282, P946, DOI 10.1126/science.282.5390.946; DUMONT DJ, 1994, GENE DEV, V8, P1897, DOI 10.1101/gad.8.16.1897; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Folkman J, 1996, CELL, V87, P1153, DOI 10.1016/S0092-8674(00)81810-3; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; Gale NW, 1999, GENE DEV, V13, P1055, DOI 10.1101/gad.13.9.1055; GODIN I, 1995, P NATL ACAD SCI USA, V92, P773, DOI 10.1073/pnas.92.3.773; Hanahan D, 1997, SCIENCE, V277, P48, DOI 10.1126/science.277.5322.48; Holash J, 1999, SCIENCE, V284, P1994, DOI 10.1126/science.284.5422.1994; Janowska-Wieczorek A, 1999, BLOOD, V93, P3379, DOI 10.1182/blood.V93.10.3379.410k09_3379_3390; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; MUCENSKI ML, 1991, CELL, V65, P677, DOI 10.1016/0092-8674(91)90099-K; NAKANO T, 1994, SCIENCE, V265, P1098, DOI 10.1126/science.8066449; North T, 1999, DEVELOPMENT, V126, P2563; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Okada H, 1998, ONCOGENE, V17, P2287, DOI 10.1038/sj.onc.1202151; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; PASSANITI A, 1992, LAB INVEST, V67, P519; PURI MC, 1995, EMBO J, V14, P5884, DOI 10.1002/j.1460-2075.1995.tb00276.x; ROBB L, 1995, P NATL ACAD SCI USA, V92, P7075, DOI 10.1073/pnas.92.15.7075; Sato A, 1998, INT IMMUNOL, V10, P1217, DOI 10.1093/intimm/10.8.1217; SATO TN, 1995, NATURE, V376, P70, DOI 10.1038/376070a0; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; SHIVDASANI RA, 1995, CELL, V81, P695, DOI 10.1016/0092-8674(95)90531-6; SHIVDASANI RA, 1995, NATURE, V373, P432, DOI 10.1038/373432a0; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Suri C, 1998, SCIENCE, V282, P468, DOI 10.1126/science.282.5388.468; Takakura N, 1996, J EXP MED, V184, P2301, DOI 10.1084/jem.184.6.2301; Takakura N, 1998, IMMUNITY, V9, P677, DOI 10.1016/S1074-7613(00)80665-2; Tenen DG, 1997, BLOOD, V90, P489, DOI 10.1182/blood.V90.2.489.489_489_519; Visvader JE, 1998, GENE DEV, V12, P473, DOI 10.1101/gad.12.4.473; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; Witzenbichler B, 1998, J BIOL CHEM, V273, P18514, DOI 10.1074/jbc.273.29.18514; Yano M, 1997, BLOOD, V89, P4317, DOI 10.1182/blood.V89.12.4317; Yoder MC, 1997, IMMUNITY, V7, P335, DOI 10.1016/S1074-7613(00)80355-6	39	425	457	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 21	2000	102	2					199	209		10.1016/S0092-8674(00)00025-8	http://dx.doi.org/10.1016/S0092-8674(00)00025-8			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	337NA	10943840	Bronze			2022-12-28	WOS:000088366800010
J	Agami, R; Bernards, R				Agami, R; Bernards, R			Distinct initiation and maintenance mechanisms cooperate to induce G1 cell cycle arrest in response to DNA damage	CELL			English	Article							MAMMALIAN-CELLS; C-ABL; D1; PROTEOLYSIS; PROGRESSION; P53; SEQUESTRATION; DEGRADATION; ACTIVATION; UBIQUITIN	DNA damage causes stabilization of p53, leading to G1 arrest through induction of p21(cip1). As this process requires transcription, several hours are needed to exert this response. We show that DNA damage causes an immediate and p53-independent G1 arrest, caused by rapid proteolysis of cyclin D1. Degradation is mediated through a previously unrecognized destruction box in cyclin D1 and leads to a release of p21(cip1) from CDK4 to inhibit CDK2. Interference with cyclin D1 degradation prevents initiation of G1 arrest and renders cells more susceptible to DNA damage, indicating that cyclin D1 degradation is an essential component of the cellular response to genotoxic stress. Thus, induction of G1 arrest in response to DNA damage is minimally a two step process: a fast p53-independent initiation of G1 arrest mediated by cyclin D1 proteolysis and a slower maintenance of arrest resulting from increased p53 stability.	Netherlands Canc Inst, Div Mol Carcinogenesis, NL-1066 CX Amsterdam, Netherlands; Netherlands Canc Inst, Ctr Biomed Genet, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute	Bernards, R (corresponding author), Netherlands Canc Inst, Div Mol Carcinogenesis, NL-1066 CX Amsterdam, Netherlands.		agami, reuven/GOG-8289-2022	Agami, Reuven/0000-0002-2848-2473; Bernards, Rene/0000-0001-8677-3423				Agami R, 1999, NATURE, V399, P809; Bouchard C, 1999, EMBO J, V18, P5321, DOI 10.1093/emboj/18.19.5321; Brandeis M, 1996, EMBO J, V15, P5280, DOI 10.1002/j.1460-2075.1996.tb00913.x; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Cooper KF, 1997, EMBO J, V16, P4665, DOI 10.1093/emboj/16.15.4665; Diehl JA, 1997, GENE DEV, V11, P957, DOI 10.1101/gad.11.8.957; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Geng Y, 1999, CELL, V97, P767, DOI 10.1016/S0092-8674(00)80788-6; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; IMIGER S, 1995, CELL, V81, P269; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; KING RW, 1995, CELL, V81, P279, DOI 10.1016/0092-8674(95)90338-0; King RW, 1996, SCIENCE, V274, P1652, DOI 10.1126/science.274.5293.1652; Kramer ER, 1998, CURR BIOL, V8, P1207, DOI 10.1016/S0960-9822(07)00510-6; Lakin ND, 1999, ONCOGENE, V18, P7644, DOI 10.1038/sj.onc.1203015; Lipinski MM, 1999, ONCOGENE, V18, P7873, DOI 10.1038/sj.onc.1203244; Meek DW, 1999, ONCOGENE, V18, P7666, DOI 10.1038/sj.onc.1202951; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Morin PJ, 1999, BIOESSAYS, V21, P1021, DOI 10.1002/(SICI)1521-1878(199912)22:1<1021::AID-BIES6>3.0.CO;2-P; Perez-Roger I, 1999, EMBO J, V18, P5310, DOI 10.1093/emboj/18.19.5310; QUELLE DE, 1995, CELL, V83, P993; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; SHERR CJ, 1994, CELL, V79, P551, DOI 10.1016/0092-8674(94)90540-1; Sionov RV, 1999, ONCOGENE, V18, P6145, DOI 10.1038/sj.onc.1203130; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; WALDMAN T, 1995, CANCER RES, V55, P5187; Weinert T, 1998, CELL, V94, P555, DOI 10.1016/S0092-8674(00)81597-4; Yuan ZM, 1996, NATURE, V382, P272, DOI 10.1038/382272a0; Zwijsen RML, 1997, CELL, V88, P405, DOI 10.1016/S0092-8674(00)81879-6	34	312	327	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 7	2000	102	1					55	66		10.1016/S0092-8674(00)00010-6	http://dx.doi.org/10.1016/S0092-8674(00)00010-6			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	332UL	10929713	Green Published, Bronze			2022-12-28	WOS:000088091700008
J	Rask-Nissila, L; Jokinen, E; Terho, P; Tammi, A; Lapinleimu, H; Ronnemaa, T; Viikari, J; Seppanen, R; Korhonen, T; Tuominen, J; Valimaki, I; Simell, O				Rask-Nissila, L; Jokinen, E; Terho, P; Tammi, A; Lapinleimu, H; Ronnemaa, T; Viikari, J; Seppanen, R; Korhonen, T; Tuominen, J; Valimaki, I; Simell, O			Neurological development of 5-year-old children receiving a low-saturated fat, low-cholesterol diet since infancy - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY HEART-DISEASE; SERUM-CHOLESTEROL; RISK-FACTORS; GROWTH; REDUCTION; AGE; ATHEROSCLEROSIS; INTERVENTION; ASSOCIATION; CHILDHOOD	Context Early childhood introduction of nutritional habits aimed at atherosclerosis prevention is compatible with normal growth, but its effect on neurological development is unknown. Objective To analyze how parental counseling aimed at keeping children's diets low in saturated fat and cholesterol influences neurodevelopment during the first 5 years of life. Design Randomized controlled trial conducted between February 1990 and November 1996. Setting Outpatient clinic of a university department in Turku, Finland. Participants A total of 1062 seven-month-old infants and their parents, recruited at well-baby clinics between 1990 and 1992. At age 5 years, 496 children still living in the city of Turku were available to participate in neurodevelopmental testing. Intervention Participants were randomly assigned to receive individualized counseling aimed at limiting the child's fat intake to 30% to 35% of daily energy, with a saturated: monounsaturated:polyunsaturated fatty acid ratio of 1:1:1 and a cholesterol intake of less than 200 mg/d (n = 540) or usual health education (control group, n = 522). Main Outcome Measures Nutrient intake, serum lipid concentrations, and neurological development at 5 years, among children in the intervention vs control groups. Results Absolute and relative intakes of fat, saturated fatty acids, and cholesterol among children in the intervention group were markedly less than the respective values of control children. Mean (SD) percentages of daily energy at age 5 years for the intervention vs control groups were as follows: for total fat, 30.6% (4.5%) vs 33.4% (4.4%) (P<.001); and for saturated fat, 11.7% (2.3%) vs 14.5% (2.4%) (P<.001). Mean intakes of cholesterol were 164.2 mg (60.1 mg) and 192.5 mg (71.9 mg) (P<.001) for the intervention and control groups, respectively Serum cholesterol concentrations were continuously 3% to 5% lower in children in the intervention group than in children in the control group. At age 5 years, mean (SD) serum cholesterol concentration of the intervention group was 4.27 (0.63) mmol/L (165 [24] mg/dL) and of the control group, 4.41 (0.74) mmol/L (170 [29] mg/dL) (P=.04). Neurological development of children in the intervention group was at least as good as that of children in the control group. Relative risks for children in the intervention group to fail tests of speech and language skills, gross motor functioning plus perception, and visual motor skills were 0.95 (90% confidence interval [CI], 0.60-1.49), 0.95 (90% CI, 0.58-1.55), and 0.65 (90% CI, 0.39-1.08), respectively (P=.85, .86, and .16, respectively, vs control children). Conclusion Our data indicate that repeated child-targeted dietary counseling of parents during the first 5 years of a child's life lessens age-associated increases in children's serum cholesterol and is compatible with normal neurological development.	Univ Turku, Cardiovasc Res Unit, FIN-20520 Turku, Finland; Univ Turku, Dept Pediat, FIN-20520 Turku, Finland; Univ Turku, Dept Med, FIN-20520 Turku, Finland; Univ Turku, Dept Biostat, FIN-20520 Turku, Finland; Univ Turku, Dept Child Psychiat & Psychol, FIN-20520 Turku, Finland; City Turku, Social Insurance Inst, Res & Dev Unit, Turku, Finland; City Turku, Child & Adolescent Hlth Care, Turku, Finland; Univ Helsinki, Hosp Children & Adolescents, Helsinki, Finland	University of Turku; University of Turku; University of Turku; University of Turku; University of Turku; University of Helsinki	Rask-Nissila, L (corresponding author), Univ Turku, Cardiovasc Res Unit, Kiinamyllynkatu 10, FIN-20520 Turku, Finland.	leena.rask-nissila@utu.fi	Lapinleimu, Helena/AAT-8415-2021					AGGETT PJ, 1994, J PEDIATR GASTR NUTR, V19, P261; Altman DG., 1995, PRACTICAL STAT MED R; American Academy of Pediatrics. Committee on Nutrition, 1998, Pediatrics, V101, P141; [Anonymous], 1995, JAMA, V273, P1429; AYRES JA, 1980, SO CALIFORNIA SENSOR; BAX M, 1987, DEV MED CHILD NEUROL, V29, P40; Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302; BOULTON TJC, 1995, ACTA PAEDIATR, V84, P146, DOI 10.1111/j.1651-2227.1995.tb13597.x; DiGeorge AM., 1996, NELSON TXB PEDIAT, P1640; *EUR AG EV MED PRO, 2000, POINTS CONS BIOST ME; Fisher EA, 1997, CIRCULATION, V95, P2332, DOI 10.1161/01.CIR.95.9.2332; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; FRIEDMAN G, 1976, PEDIATRICS, V58, P655; GALLER JR, 1987, J PEDIATR GASTR NUTR, V6, P847, DOI 10.1097/00005176-198711000-00005; Hakala P, 1996, FOOD CHEM, V57, P71, DOI 10.1016/0308-8146(96)00077-5; HAND D, 1996, PRACTICAL LONGITUDIN; Harris, 1963, CHILDRENS DRAWINGS M; KLAG MJ, 1993, NEW ENGL J MED, V328, P313, DOI 10.1056/NEJM199302043280504; KOPPITZ EM, 1963, BENDER GESTALT TEST; LAPINLEIMU H, 1995, LANCET, V345, P471, DOI 10.1016/S0140-6736(95)90580-4; LAW MR, 1994, BMJ-BRIT MED J, V308, P367, DOI 10.1136/bmj.308.6925.367; LIFSHITZ F, 1989, AM J DIS CHILD, V143, P537, DOI 10.1001/archpedi.1989.02150170035015; LIUKSILA PR, 1993, TURUN KAUPUNGIN TERV, V8, P1; Miller L. J, 1988, MILLER ASSESSMENT PR; NEURINGER M, 1994, J PEDIATR-US, V125, pS39, DOI 10.1016/S0022-3476(06)80735-3; NEWMAN WP, 1986, NEW ENGL J MED, V314, P138, DOI 10.1056/NEJM198601163140302; Niinikoski H, 1997, PEDIATRICS, V99, P687, DOI 10.1542/peds.99.5.687; Niinikoski H, 1997, PEDIATRICS, V100, P810, DOI 10.1542/peds.100.5.810; Niinikoski H, 1996, CIRCULATION, V94, P1386, DOI 10.1161/01.CIR.94.6.1386; POLONSKY SM, 1993, PEDIATRICS, V91, P92; PUGLIESE MT, 1987, PEDIATRICS, V80, P175; RASTAS M, 1993, NUTR COMP FOODS; Salo P, 1999, EUR J CLIN NUTR, V53, P927, DOI 10.1038/sj.ejcn.1600872; SAS, 1996, SAS STAT SOFTW CHANG; SHANNON BM, 1994, PEDIATRICS, V94, P923; SHEA S, 1993, PEDIATRICS, V92, P579; Stott D.H., 1984, TEST MOTOR IMPAIRMEN; WALTER HJ, 1988, NEW ENGL J MED, V318, P1093, DOI 10.1056/NEJM198804283181704; WEBBER LS, 1991, AM J EPIDEMIOL, V133, P884, DOI 10.1093/oxfordjournals.aje.a115968; WISSLER RW, 1993, ARTERIOSCLER THROMB, V13, P1291	40	61	62	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 23	2000	284	8					993	1000		10.1001/jama.284.8.993	http://dx.doi.org/10.1001/jama.284.8.993			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	344PX	10944645				2022-12-28	WOS:000088769000026
J	Berger, A				Berger, A			Persistence of tuberculosis explained	BRITISH MEDICAL JOURNAL			English	News Item																		McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074	1	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	AUG 19	2000	321	7259					469	469						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	347MC	10948020				2022-12-28	WOS:000088932800012
J	Zhu, YY; Chen, HR; Fan, JH; Wang, YY; Li, Y; Chen, JB; Fan, JX; Yang, SS; Hu, LP; Leung, H; Mew, TW; Teng, PS; Wang, ZH; Mundt, CC				Zhu, YY; Chen, HR; Fan, JH; Wang, YY; Li, Y; Chen, JB; Fan, JX; Yang, SS; Hu, LP; Leung, H; Mew, TW; Teng, PS; Wang, ZH; Mundt, CC			Genetic diversity and disease control in rice	NATURE			English	Article							GREEN-REVOLUTION; RESISTANCE; MIXTURES; PATHOGEN; SPREAD	Crop heterogeneity is a possible solution to the vulnerability of monocultured crops to disease(1-3). Both theory(4) and observation(2,3) indicate that genetic heterogeneity provides greater disease suppression when used over large areas, though experimental data are lacking. Here we report a unique cooperation among farmers, researchers and extension personnel in Yunnan Province, China-genetically diversified rice crops were planted in all the rice fields in five townships in 1998 and ten townships in 1999. Control plots of monocultured crops allowed us to calculate the effect of diversity on the severity of rice blast, the major disease of rice(5). Disease-susceptible rice varieties planted in mixtures with resistant varieties had 89% greater yield and blast was 94% less severe than when they were grown in monoculture. The experiment was so successful that fungicidal sprays were no longer applied by the end of the two-year programme. Our results support the view that intraspecific crop diversification provides an ecological approach to disease control that can be highly effective over a large area and contribute to the sustainability of crop production.	Int Rice Res Inst, Div Entomol & Plant Pathol, Makati City 1271, Philippines; Yunnan Agr Univ, Phytopathol Lab Yunnan Prov, Kunming 650201, Yunnan, Peoples R China; Honghe Prefecture Plant Protect Stn Yunnan Prov, Kaiyuan 661400, Peoples R China; Jianshui Cty Plant Protect Stn Yunnan Prov, Jianshui 654300, Peoples R China; Shiping Cty Plant Protect Stn Yunnan Prov, Shiping 662200, Peoples R China; Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA	CGIAR; International Rice Research Institute (IRRI); Yunnan Agricultural University; Oregon State University	Mundt, CC (corresponding author), Int Rice Res Inst, Div Entomol & Plant Pathol, MCPO Box 3127, Makati City 1271, Philippines.							Baker B, 1997, SCIENCE, V276, P726, DOI 10.1126/science.276.5313.726; BONMAN JM, 1992, ANNU REV PHYTOPATHOL, V30, P507, DOI 10.1146/annurev.py.30.090192.002451; BOUDREAU MA, 1997, ENV SAFE APPROACHES, P33; Browning J. A., 1981, Strategies for the control of cereal disease, P37; BROWNING JA, 1969, ANNU REV PHYTOPATHOL, V7, P355, DOI 10.1146/annurev.py.07.090169.002035; Calonnec A, 1996, EUR J PLANT PATHOL, V102, P733, DOI 10.1007/BF01877147; CHIN KM, 1984, PLANT PATHOL, V33, P89, DOI 10.1111/j.1365-3059.1984.tb00592.x; Dwyer G, 1998, AM NAT, V152, P485, DOI 10.1086/286185; Francis C. A., 1986, Multiple cropping systems, P1; Garrett KA, 1999, PHYTOPATHOLOGY, V89, P984, DOI 10.1094/PHYTO.1999.89.11.984; George MLC, 1998, PHYTOPATHOLOGY, V88, P223, DOI 10.1094/PHYTO.1998.88.3.223; *INT RIC RES I, 1997, IRRI RIC FACTS; KIYOSAWA S, 1982, ANNU REV PHYTOPATHOL, V20, P93, DOI 10.1146/annurev.py.20.090182.000521; Mann C, 1997, SCIENCE, V277, P1038, DOI 10.1126/science.277.5329.1038; Matson PA, 1997, SCIENCE, V277, P504, DOI 10.1126/science.277.5325.504; Mundt C.C., 1985, CEREAL RUSTS, V2, P527, DOI DOI 10.1016/B978-0-12-148402-6.50025-0; MUNDT CC, 1994, RICE BLAST DISEASE, P293; MUNDT CC, 1989, PLANT DIS EPIDEMIOLO, V2, P150; OU SH, 1980, ANNU REV PHYTOPATHOL, V18, P167, DOI 10.1146/annurev.py.18.090180.001123; Ou SH, 1985, RICE DIS; *PEOPL REP CHIN, 1996, 157901995 GBT PEOPL, P1; Polis GA, 1997, ANNU REV ECOL SYST, V28, P289, DOI 10.1146/annurev.ecolsys.28.1.289; SCHMIDT RA, 1978, PLANT DIS ADV TREATI, P287; Schwartz MW, 1999, ANNU REV ECOL SYST, V30, P83, DOI 10.1146/annurev.ecolsys.30.1.83; STASKAWICZ BJ, 1995, SCIENCE, V268, P661, DOI 10.1126/science.7732374; Tilman D, 1998, NATURE, V396, P211, DOI 10.1038/24254; Waide RB, 1999, ANNU REV ECOL SYST, V30, P257, DOI 10.1146/annurev.ecolsys.30.1.257; WOLFE MS, 1985, ANNU REV PHYTOPATHOL, V23, P251, DOI 10.1146/annurev.py.23.090185.001343; WOLFE MS, 1992, BARLEY GENET, V6, P1055	29	889	1218	29	629	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 17	2000	406	6797					718	722		10.1038/35021046	http://dx.doi.org/10.1038/35021046			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	344PH	10963595				2022-12-28	WOS:000088767700042
J	Delgado, P; Fernandez, E; Dave, V; Kappes, D; Alarcon, B				Delgado, P; Fernandez, E; Dave, V; Kappes, D; Alarcon, B			CD3 delta couples T-cell receptor signalling to ERK activation and thymocyte positive selection	NATURE			English	Article							ALPHA-BETA; LINEAGE COMMITMENT; ENGAGEMENT; PATHWAY; MICE; PHOSPHORYLATION; REQUIREMENT; INVOLVEMENT; LAT	Thymocytes from mice lacking the CD3 delta chain of the T-cell receptor (TCR), unlike those of other CD3-deficient mice(1,2), progress from a CD4(-)CD8(-) double-negative to a CD4(+)CD8(+) double-positive stage. However, CD3 delta(-/-) double-positive cells fail to undergo positive selection, by which double-positive cells differentiate into more mature thymocytes(3). Positive selection is also impaired in mice expressing inactive components of the Ras/mitogen activated protein (MAP) kinase signalling pathway(4-6). Here we show that CD3 delta(-/-) thymocytes are defective in the induction of extracellular signal-regulated protein kinase (ERK) MAP kinases upon TCR engagement, whereas activation of other MAP kinases is unaffected. The requirement for CD3d maps to its extracellular or transmembrane domains, or both, as expression of a tail-less CD3d rescues both ERK activation and positive selection in CD3 delta(-/-) mice. Furthermore, the defect correlates with severely impaired tyrosine phosphorylation of the linker protein LAT, and of the CD3 zeta chain that is localized to membrane lipid rafts upon TCR engagement. Our data indicate that the blockade of positive selection of CD3 delta(-/-) thymocytes may derive from defective tyrosine phosphorylation of CD3z in lipid rafts, resulting in impaired activation of the LAT/Ras/ERK pathway.	Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain; Fox Chase Canc Ctr, Philadelphia, PA 19111 USA	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Fox Chase Cancer Center	Alarcon, B (corresponding author), Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain.		Delgado, Pilar/F-3365-2016; Alarcon, Balbino/N-9648-2016	Delgado, Pilar/0000-0002-8431-8002; Alarcon, Balbino/0000-0001-7820-1070				ALBEROLAILA J, 1995, NATURE, V373, P620, DOI 10.1038/373620a0; Backstrom BT, 1998, SCIENCE, V281, P835, DOI 10.1126/science.281.5378.835; Bommhardt U, 1999, J IMMUNOL, V163, P715; Bustelo XR, 2000, MOL CELL BIOL, V20, P1461, DOI 10.1128/MCB.20.5.1461-1477.2000; Clements JL, 1998, SCIENCE, V281, P416, DOI 10.1126/science.281.5375.416; DAMBROSIO D, 1994, EUR J IMMUNOL, V24, P616, DOI 10.1002/eji.1830240319; Dave VP, 1998, INT IMMUNOL, V10, P1481, DOI 10.1093/intimm/10.10.1481; Dave VP, 1997, EMBO J, V16, P1360, DOI 10.1093/emboj/16.6.1360; DAVE VP, UNPUB IMMUNITY; DUTZ JP, 1995, J IMMUNOL, V154, P2588; Finco TS, 1998, IMMUNITY, V9, P617, DOI 10.1016/S1074-7613(00)80659-7; Haks MC, 1998, EMBO J, V17, P1871, DOI 10.1093/emboj/17.7.1871; JAMESON SC, 1995, ANNU REV IMMUNOL, V13, P93, DOI 10.1146/annurev.iy.13.040195.000521; Kersh EN, 1998, SCIENCE, V281, P572, DOI 10.1126/science.281.5376.572; MALISSEN M, 1995, EMBO J, V14, P4641, DOI 10.1002/j.1460-2075.1995.tb00146.x; MILISSEN B, 1999, ADV IMMUNOL, V72, P103; Montixi C, 1998, EMBO J, V17, P5334, DOI 10.1093/emboj/17.18.5334; Neel BG, 1997, CURR OPIN IMMUNOL, V9, P405, DOI 10.1016/S0952-7915(97)80088-X; OShea CC, 1996, EUR J IMMUNOL, V26, P2350, DOI 10.1002/eji.1830261012; Pages G, 1999, SCIENCE, V286, P1374, DOI 10.1126/science.286.5443.1374; Rudd CE, 1999, CELL, V96, P5, DOI 10.1016/S0092-8674(00)80953-8; Sahuquillo AG, 1998, J EXP MED, V187, P1179, DOI 10.1084/jem.187.8.1179; Schaeffer HJ, 1999, MOL CELL BIOL, V19, P2435; Sharp LL, 1997, IMMUNITY, V7, P609, DOI 10.1016/S1074-7613(00)80382-9; SWAN KA, 1995, EMBO J, V14, P276, DOI 10.1002/j.1460-2075.1995.tb07001.x; Xavier R, 1998, IMMUNITY, V8, P723, DOI 10.1016/S1074-7613(00)80577-4; Zhang WG, 1999, IMMUNITY, V10, P323, DOI 10.1016/S1074-7613(00)80032-1; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8	28	114	115	0	8	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 27	2000	406	6794					426	430		10.1038/35019102	http://dx.doi.org/10.1038/35019102			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	337WC	10935641				2022-12-28	WOS:000088383800051
J	Shingleton, BJ; O'Donoghue, MW				Shingleton, BJ; O'Donoghue, MW			Primary care: Blurred vision	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							ISCHEMIC OPTIC NEUROPATHY; VISUAL-LOSS; MACULAR DEGENERATION; ORBITAL CELLULITIS; OCULAR TOXICITY; NEURITIS; EYE; APPEARANCE; ONSET		Ophthalm Consultants Boston, Boston, MA USA	Ophthalmic Consultants of Boston	Shingleton, BJ (corresponding author), 50 Staniford St,Suite 600, Boston, MA 02114 USA.			Shingleton, Bradford/0000-0001-8134-8639				BARRESI BJ, 1984, OCULAR ASSESSMENT MA, P35; BRESSLER NM, 1988, SURV OPHTHALMOL, V32, P375, DOI 10.1016/0039-6257(88)90052-5; BRESSLER SB, 1990, ARCH OPHTHALMOL-CHIC, V108, P1442, DOI 10.1001/archopht.1990.01070120090035; Cleary PA, 1997, J NEURO-OPHTHALMOL, V17, P18; Donahue SP, 1998, OPHTHALMOLOGY, V105, P1902, DOI 10.1016/S0161-6420(98)91038-7; Elfervig L S, 1998, Insight, V23, P66, DOI 10.1016/S1060-135X(98)90029-X; EVA PR, 1982, BRIT J OPHTHALMOL, V66, P500, DOI 10.1136/bjo.66.8.500; FLEDELIUS HC, 1986, ACTA OPHTHALMOL, V64, P33; Fong DS, 1999, AM J OPHTHALMOL, V127, P137, DOI 10.1016/S0002-9394(98)00309-2; FRAUNFELDER FT, 1983, OPHTHALMOLOGY, V90, P1; FREDERICK AR, 1993, RETINA-J RET VIT DIS, V13, P3, DOI 10.1097/00006982-199313010-00002; FREEMAN NR, 1980, SOUTHERN MED J, V73, P1398, DOI 10.1097/00007611-198010000-00033; GASTON H, 1989, PRACTITIONER, V233, P1566; Gipson IK., 1994, PRINCIPLES PRACTICE, P3; Gordon LK, 1998, JAMA-J AM MED ASSOC, V280, P385, DOI 10.1001/jama.280.4.385; GOTTSCH JD, 1990, RETINA-J RET VIT DIS, V10, pS65, DOI 10.1097/00006982-199010001-00011; Hayreh SS, 1997, AM J OPHTHALMOL, V124, P641, DOI 10.1016/S0002-9394(14)70902-X; Kapoor R, 1998, NEUROLOGY, V50, P230, DOI 10.1212/WNL.50.1.230; Kosmorsky GS, 1999, CLIN GERIATR MED, V15, P1; Krakau C E, 1994, Surv Ophthalmol, V38 Suppl, pS18, DOI 10.1016/0039-6257(94)90043-4; Landau K, 1998, Surv Ophthalmol, V42, P491; Martin C J, 1997, J Am Optom Assoc, V68, P775; Mathews D E, 1996, Optom Clin, V5, P175; MAZZUCA SA, 1994, J RHEUMATOL, V21, P59; ROSENBAUM JT, 1991, INT OPHTHALMOL CLIN, V31, P131, DOI 10.1097/00004397-199103130-00011; SAMMARTINO JP, 1985, AM FAM PHYSICIAN, V31, P226; SHINGLETON BJ, 1991, NEW ENGL J MED, V325, P408; SILVERMAN H, 1992, AM FAM PHYSICIAN, V45, P2279; Spraul CW, 1997, SURV OPHTHALMOL, V42, P3, DOI 10.1016/S0039-6257(97)84041-6; Trevino R, 1995, J Am Optom Assoc, V66, P559; Uzcategui N, 1998, J PEDIAT OPHTH STRAB, V35, P73; UZCATEGUI N, 1998, J PEDIATR OPHTHALMOL, V35, P110; VANDALEN JTW, 1982, DOC OPHTHALMOL, V52, P259, DOI 10.1007/BF01675856; Warner JEA, 1997, ARCH OPHTHALMOL-CHIC, V115, P1408, DOI 10.1001/archopht.1997.01100160578009; WHITCHER JP, 1990, INT OPHTHALMOL CLIN, V30, P30, DOI 10.1097/00004397-199030010-00015; Wong V K, 1997, Hawaii Med J, V56, P289	36	4	4	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 24	2000	343	8					556	562		10.1056/NEJM200008243430807	http://dx.doi.org/10.1056/NEJM200008243430807			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	346QM	10954765				2022-12-28	WOS:000088882600007
J	Smith, R				Smith, R			The BMJ christmas revue - Send us your sketches	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	AUG 19	2000	321	7259					466	466		10.1136/bmj.321.7259.466	http://dx.doi.org/10.1136/bmj.321.7259.466			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	347MC	10948013	Green Published			2022-12-28	WOS:000088932800006
J	Taylor, G; Lehrer, MS; Jensen, PJ; Sun, TT; Lavker, RM				Taylor, G; Lehrer, MS; Jensen, PJ; Sun, TT; Lavker, RM			Involvement of follicular stem cells in forming not only the follicle but also the epidermis	CELL			English	Article							LABEL-RETAINING CELLS; CORNEAL EPITHELIAL-CELLS; OCULAR SURFACE DISORDERS; HAIR FOLLICLE; IN-VITRO; AUTOGRAFT TRANSPLANTATION; MOUSE EPIDERMIS; SMALL-INTESTINE; CLONAL ANALYSIS; EARLY ANAGEN	The location of follicular and epidermal stem cells in mammalian skin is a crucial issue in cutaneous biology. We demonstrate that hair follicular stem cells, located in the bulge region, can give rise to several cell types of the hair follicle as well as upper follicular cells. Moreover, we devised a double-label technique to show that upper follicular keratinocytes emigrate into the epidermis in normal newborn mouse skin, and in adult mouse skin in response to a penetrating wound. These findings indicate that the hair follicle represents a major repository of keratinocyte stem cells in mouse skin, and that follicular bulge stem cells are potentially bipotent as they can give rise to not only the hair follicle, but also the epidermis.	NYU, Sch Med, Ronald O Perelman Dept Dermatol, Epithelial Biol Unit, New York, NY 10016 USA; NYU, Sch Med, Kaplan Canc Ctr, Dept Pharmacol, New York, NY 10016 USA; NYU, Sch Med, Kaplan Canc Ctr, Dept Urol, New York, NY 10016 USA; Univ Penn, Sch Med, Dept Dermatol, Philadelphia, PA 19104 USA	New York University; New York University; New York University; University of Pennsylvania	Lavker, RM (corresponding author), NYU, Sch Med, Ronald O Perelman Dept Dermatol, Epithelial Biol Unit, New York, NY 10016 USA.	sunt0l@med.nyu.edu; lavker@mail.med.upenn.edu	Sun, Tung-Tien/J-4425-2015	Sun, Tung-Tien/0000-0002-6841-1063; Taylor, Gina/0000-0002-3611-5286	NEI NIH HHS [EY06769] Funding Source: Medline; NIAMS NIH HHS [AR42998] Funding Source: Medline; NIDDK NIH HHS [DK39753] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR042998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039753] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARGYRIS TS, 1976, AM J PATHOL, V83, P329; AURAN JD, 1995, OPHTHALMOLOGY, V102, P33; BICKENBACH JR, 1981, J DENT RES, V60, P1611, DOI 10.1177/002203458106000311011; Bickenbach JR, 1998, EXP CELL RES, V244, P184, DOI 10.1006/excr.1998.4163; Binder RL, 1998, CANCER RES, V58, P4314; BUCK RC, 1985, INVEST OPHTH VIS SCI, V26, P1296; BURNS ER, 1975, CELL TISSUE KINET, V8, P61, DOI 10.1111/j.1365-2184.1975.tb01207.x; Buschke W, 1943, B JOHNS HOPKINS HOSP, V73, P143; Chen TT, 1997, MOL CELL BIOL, V17, P3056, DOI 10.1128/MCB.17.6.3056; CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; COTSARELIS G, 1989, CELL, V57, P201, DOI 10.1016/0092-8674(89)90958-6; DAVANGER M, 1971, NATURE, V229, P560, DOI 10.1038/229560a0; EBATO B, 1988, INVEST OPHTH VIS SCI, V29, P1533; FOGLE JA, 1980, A GRAEF ARCH KLIN EX, V213, P143, DOI 10.1007/BF00410983; Fuchs E, 2000, CELL, V100, P143, DOI 10.1016/S0092-8674(00)81691-8; FUCHS E, 1990, J CELL BIOL, V111, P2807, DOI 10.1083/jcb.111.6.2807; Ghazizadeh S, 1999, GENE THER, V6, P1267, DOI 10.1038/sj.gt.3300956; HANSEN LA, 1994, P NATL ACAD SCI USA, V91, P7822, DOI 10.1073/pnas.91.16.7822; HARDY MH, 1992, TRENDS GENET, V8, P55, DOI 10.1016/0168-9525(92)90350-D; Hodson S, 1997, NATURE, V387, P449, DOI 10.1038/387449a0; HUANG AJW, 1991, INVEST OPHTH VIS SCI, V32, P96; Jensen PJ, 1999, J INVEST DERMATOL, V112, P240, DOI 10.1046/j.1523-1747.1999.00494.x; Kamimura J, 1997, J INVEST DERMATOL, V109, P534, DOI 10.1111/1523-1747.ep12336704; KAUR P, 1986, CELL TISSUE KINET, V19, P601, DOI 10.1111/j.1365-2184.1986.tb00761.x; KENYON KR, 1989, OPHTHALMOLOGY, V96, P709; KRUSE FE, 1990, INVEST OPHTH VIS SCI, V31, P1903; LAVKER RM, 1983, J INVEST DERMATOL, V81, pS121, DOI 10.1111/1523-1747.ep12540880; LAVKER RM, 1993, J INVEST DERMATOL, V101, pS16, DOI 10.1111/1523-1747.ep12362556; Lavker RM, 1998, INVEST OPHTH VIS SCI, V39, P301; LAVKER RM, 1999, FITZPATRICKS DERMATO, P230; Lehrer MS, 1998, J CELL SCI, V111, P2867; Li A, 1998, P NATL ACAD SCI USA, V95, P3902, DOI 10.1073/pnas.95.7.3902; LINDBERG K, 1993, INVEST OPHTH VIS SCI, V34, P2672; Lyle S, 1998, J CELL SCI, V111, P3179; Mackenzie IC, 1997, J INVEST DERMATOL, V109, P377, DOI 10.1111/1523-1747.ep12336255; MILLER SJ, 1993, J INVEST DERMATOL, V101, P591, DOI 10.1111/1523-1747.ep12366045; MILLER SJ, 1993, SEMIN DEV BIOL, V4, P217; Morris RJ, 1997, CANCER RES, V57, P3436; Morris RJ, 2000, CANCER RES, V60, P226; MORRIS RJ, 1994, CELL PROLIFERAT, V27, P279, DOI 10.1111/j.1365-2184.1994.tb01425.x; Morris RJ, 1999, J INVEST DERMATOL, V112, P470, DOI 10.1046/j.1523-1747.1999.00537.x; OLIVER RF, 1966, J EMBRYOL EXP MORPH, V15, P331; Pellegrini G, 1997, LANCET, V349, P990, DOI 10.1016/S0140-6736(96)11188-0; Pellegrini G, 1999, J CELL BIOL, V145, P769, DOI 10.1083/jcb.145.4.769; Pizzarello LD, 1978, OCULAR ADNEXAL TUMOR, P553; POTTEN CS, 1987, VIRCHOWS ARCH B, V53, P279, DOI 10.1007/BF02890254; POTTEN CS, 1982, CELL TISSUE KINET, V15, P305, DOI 10.1111/j.1365-2184.1982.tb01050.x; QUESENBERRY P, 1979, NEW ENGL J MED, V301, P819, DOI 10.1056/NEJM197910113011505; ROCHAT A, 1994, CELL, V76, P1063, DOI 10.1016/0092-8674(94)90383-2; RODRIGUES M, 1987, DIFFERENTIATION, V34, P60, DOI 10.1111/j.1432-0436.1987.tb00051.x; RUSSELL WO, 1956, CANCER, V9, P1, DOI 10.1002/1097-0142(195601/02)9:1&lt;1::AID-CNCR2820090102&gt;3.0.CO;2-Z; SCHERMER A, 1986, J CELL BIOL, V103, P49, DOI 10.1083/jcb.103.1.49; SCHEVING LE, 1967, J CELL BIOL, V32, P677, DOI 10.1083/jcb.32.3.677; Schmitt A, 1996, J VIROL, V70, P1912, DOI 10.1128/JVI.70.3.1912-1922.1996; STENBACK F, 1981, BRIT J CANCER, V44, P1, DOI 10.1038/bjc.1981.141; Suter MM, 1997, VET DERMATOL, V8, P67, DOI 10.1046/j.1365-3164.1997.d01-5.x; SZABO G, 1967, PHILOS T ROY SOC B, V252, P447, DOI 10.1098/rstb.1967.0029; TSAI RJF, 1990, OPHTHALMOLOGY, V97, P446, DOI 10.1016/S0161-6420(90)32575-7; TSENG SCG, 1989, EYE, V3, P141, DOI 10.1038/eye.1989.22; TSENG SCG, 1999, CORNEAL SURG THEORY, P9; TSUBOTA K, 1995, OPHTHALMOLOGY, V102, P1486; Voelker R, 1997, JAMA-J AM MED ASSOC, V278, P1477, DOI 10.1001/jama.278.18.1477; Watt FM, 1998, PHILOS T R SOC B, V353, P831, DOI 10.1098/rstb.1998.0247; WEI ZG, 1993, INVEST OPHTH VIS SCI, V34, P1814; WEI ZG, 1995, INVEST OPHTH VIS SCI, V36, P236; WILSON C, 1994, DIFFERENTIATION, V55, P127, DOI 10.1046/j.1432-0436.1994.5520127.x; YANG JS, 1993, J INVEST DERMATOL, V101, P652, DOI 10.1111/1523-1747.ep12371671	68	843	950	2	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 18	2000	102	4					451	461		10.1016/S0092-8674(00)00050-7	http://dx.doi.org/10.1016/S0092-8674(00)00050-7			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	347BX	10966107	Bronze			2022-12-28	WOS:000088908000007
J	Wilson, JE; Pestova, TV; Hellen, CUT; Sarnow, P				Wilson, JE; Pestova, TV; Hellen, CUT; Sarnow, P			Initiation of protein synthesis from the A site of the ribosome	CELL			English	Article							PICORNA-LIKE VIRUS; MESSENGER-RNA; TRANSLATION INITIATION; EUKARYOTIC RIBOSOMES; NUCLEOTIDE-SEQUENCE; BINDING; INHIBITION; IDENTIFICATION; SUBUNITS; COMPLEX	Positioning of the translation initiation complex on mRNAs requires interaction between the anticodon of initiator Met-tRNA, associated with elF2-GTP and 40S ribosomal subunit, and the cognate start codon of the mRNA. We show that an internal ribosome entry site located in the genome of cricket paralysis virus can form 80S ribosomes without initiator Met-tRNA, elF2, or GTP hydrolysis, with a CCU triplet in the ribosomal P site and a GCU triplet in the A site. P-site mutagenesis revealed that the P site was not decoded, and protein sequence analysis showed that translation initiates at the triplet in the A site. Translational initiation from the A site of the ribosome suggests that the repertoire of translated open reading frames in eukaryotic mRNAs may be greater than anticipated.	Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; SUNY Hlth Sci Ctr, Morse Inst Mol Genet, Dept Microbiol & Immunol, Brooklyn, NY 11203 USA	Stanford University; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Sarnow, P (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA.			Sarnow, Peter/0000-0002-2043-2770	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055979] Funding Source: NIH RePORTER; NIAID NIH HHS [AI44108] Funding Source: Medline; NIGMS NIH HHS [GM55979] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANTHONY DD, 1992, J BIOL CHEM, V267, P1554; Carrasco L, 1974, Methods Enzymol, V30, P282; CHEN CY, 1995, SCIENCE, V268, P415, DOI 10.1126/science.7536344; Domier LL, 2000, VIROLOGY, V268, P264, DOI 10.1006/viro.2000.0189; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; GRAY NK, 1994, EMBO J, V13, P3882, DOI 10.1002/j.1460-2075.1994.tb06699.x; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; HOLSCHUH K, 1980, BIOCHEMISTRY-US, V19, P5857, DOI 10.1021/bi00566a030; JACKSON RJ, 1996, TRANSLATIONAL CONTRO, P71; Johannes G, 1999, P NATL ACAD SCI USA, V96, P13118, DOI 10.1073/pnas.96.23.13118; Johnson KN, 1998, J GEN VIROL, V79, P191, DOI 10.1099/0022-1317-79-1-191; Joseph S, 1998, EMBO J, V17, P3478, DOI 10.1093/emboj/17.12.3478; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; KOZAK M, 1978, J BIOL CHEM, V253, P6568; LAZARO E, 1991, BIOCHEMISTRY-US, V30, P9642, DOI 10.1021/bi00104a011; Merrick WC., 1996, TRANSLATION CONTROL, P31; Moon JS, 1998, VIROLOGY, V243, P54, DOI 10.1006/viro.1998.9043; Murali N, 1997, BIOPHYS J, V72, P2275, DOI 10.1016/S0006-3495(97)78872-6; Muto A, 1998, TRENDS BIOCHEM SCI, V23, P25, DOI 10.1016/S0968-0004(97)01159-6; Nakashima N, 1999, ARCH VIROL, V144, P2051, DOI 10.1007/s007050050726; ODOM OW, 1978, J BIOL CHEM, V253, P1807; Pestova TV, 2000, NATURE, V403, P332, DOI 10.1038/35002118; Pestova TV, 1998, GENE DEV, V12, P67, DOI 10.1101/gad.12.1.67; Pestova TV, 1998, NATURE, V394, P854, DOI 10.1038/29703; Pestova TV, 1996, MOL CELL BIOL, V16, P6859, DOI 10.1128/mcb.16.12.6859; Sachs AB, 1997, CELL, V89, P831, DOI 10.1016/S0092-8674(00)80268-8; Sasaki J, 2000, P NATL ACAD SCI USA, V97, P1512, DOI 10.1073/pnas.010426997; Sasaki J, 1999, J VIROL, V73, P1219, DOI 10.1128/JVI.73.2.1219-1226.1999; Sasaki J, 1998, VIROLOGY, V244, P50, DOI 10.1006/viro.1998.9094; Shi YG, 1998, MOL CELL BIOL, V18, P7499, DOI 10.1128/MCB.18.12.7499; SZER W, 1970, Biochimica et Biophysica Acta, V224, P477, DOI 10.1016/0005-2787(70)90580-0; WALTER R, 1980, MOL CELL BIOCHEM, V30, P111; Wilson JE, 2000, MOL CELL BIOL, V20, P4990, DOI 10.1128/MCB.20.14.4990-4999.2000; WONG WL, 1993, BIOCHEM J, V289, P71, DOI 10.1042/bj2890071	34	340	347	0	16	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 18	2000	102	4					511	520		10.1016/S0092-8674(00)00055-6	http://dx.doi.org/10.1016/S0092-8674(00)00055-6			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	347BX	10966112	Bronze			2022-12-28	WOS:000088908000012
J	Denison, R				Denison, R			Worlds of IIF - The facts in the case of doomed, frozen Shankara 3	NATURE			English	Article									European Commiss, Directorate 15, Brussels, Belgium		Denison, R (corresponding author), European Commiss, Directorate 15, Brussels, Belgium.								0	0	0	0	1	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 17	2000	406	6797					680	680		10.1038/35021149	http://dx.doi.org/10.1038/35021149			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	344PH	10963575	Bronze			2022-12-28	WOS:000088767700022
J	Nader, K; Schafe, GE; Le Doux, JE				Nader, K; Schafe, GE; Le Doux, JE			Fear memories require protein synthesis in the amygdala for reconsolidation after retrieval	NATURE			English	Article							ELEMENT-BINDING PROTEIN; LONG-TERM-MEMORY; CONSOLIDATION; PHASE	'New' memories are initially labile and sensitive to disruption before being consolidated into stable long-term memories(1-5). Much evidence indicates that this consolidation involves the synthesis of new proteins in neurons(6-9). The lateral and basal nuclei of the amygdala (LBA) are believed to be a site of memory storage in fear learning(10). Infusion of the protein synthesis inhibitor anisomycin into the LBA shortly after training prevents consolidation of fear memories(11). Here we show that consolidated fear memories, when reactivated during retrieval, return to a labile state in which infusion of anisomycin shortly after memory reactivation produces amnesia on later tests, regardless of whether reactivation was performed 1 or 14 days after conditioning. The same treatment with anisomycin, in the absence of memory reactivation, left memory intact. Consistent with a time-limited role for protein synthesis production in consolidation, delay of the infusion until six hours after memory reactivation produced no amnesia. Our data show that consolidated fear memories, when reactivated, return to a labile state that requires de novo protein synthesis for reconsolidation. These findings are not predicted by traditional theories of memory consolidation.	NYU, Ctr Neural Sci, WM Keck Fdn, Neurobiol Lab, New York, NY 10003 USA	New York University	Nader, K (corresponding author), NYU, Ctr Neural Sci, WM Keck Fdn, Neurobiol Lab, New York, NY 10003 USA.							Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; Agranoff BW, 1981, BASIC NEUROCHEMISTRY, P801; Bartlett F. C., 1932, REMEMBERING; BLANCHARD RJ, 1969, J COMP PHYSIOL PSYCH, V67, P370, DOI 10.1037/h0026779; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; BRADY JV, 1952, J COMP PHYSIOL PSYCH, V45, P9, DOI 10.1037/h0062178; Burnham WH, 1903, AM J PSYCHOL, V14, P382; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; Davis M, 1997, J NEUROPSYCH CLIN N, V9, P382; Dudai Y, 1996, NEURON, V17, P367, DOI 10.1016/S0896-6273(00)80168-3; DUNCAN CP, 1949, J COMP PHYSIOL PSYCH, V42, P32, DOI 10.1037/h0058173; Fanselow MS, 1998, NEURON, V20, P625, DOI 10.1016/S0896-6273(00)81002-8; Fanselow MS, 1999, NEURON, V23, P229, DOI 10.1016/S0896-6273(00)80775-8; FLEXNER LB, 1965, EXP NEUROL, V13, P264, DOI 10.1016/0014-4886(65)90114-7; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; GOELET P, 1986, NATURE, V322, P419, DOI 10.1038/322419a0; Guzowski JF, 1997, P NATL ACAD SCI USA, V94, P2693, DOI 10.1073/pnas.94.6.2693; Hebb Donald O., 1949, ORG BEHAV; JUDGE ME, 1982, PHYSIOL BEHAV, V28, P585, DOI 10.1016/0031-9384(82)90034-8; Lamprecht R, 1997, J NEUROSCI, V17, P8443; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; MACTUTUS CF, 1979, SCIENCE, V204, P1319, DOI 10.1126/science.572083; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Misanin JR, 1968, SCIENCE, V160, P203; MULLER GE, 2000, Z PSYCHOL S, V1; ROSENBLUM K, 1993, BEHAV NEURAL BIOL, V59, P49, DOI 10.1016/0163-1047(93)91145-D; Sara SJ, 2000, LEARN MEMORY, V7, P73, DOI 10.1101/lm.7.2.73; SCHAFE GE, IN PRESS J NEUROSCI; SCHOLEY AB, 1993, NEUROSCIENCE, V55, P499, DOI 10.1016/0306-4522(93)90519-L	30	1807	1858	6	227	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 17	2000	406	6797					722	726		10.1038/35021052	http://dx.doi.org/10.1038/35021052			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	344PH	10963596				2022-12-28	WOS:000088767700043
J	Starr, C				Starr, C			Powerful reactions - Nuclear power has taken a meandering route, but it is here to stay	NATURE			English	Article									Elect Power Res Inst, Palo Alto, CA 94304 USA	Electric Power Research Institute (EPRI)	Starr, C (corresponding author), Elect Power Res Inst, 3412 Hillview Ave, Palo Alto, CA 94304 USA.								0	3	3	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 17	2000	406	6797					679	679		10.1038/35021146	http://dx.doi.org/10.1038/35021146			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	344PH	10963574				2022-12-28	WOS:000088767700021
J	Gottlieb, S				Gottlieb, S			Sildenafil may help diabetic patients	BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	AUG 12	2000	321	7258					401	401						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	344QC	10938040				2022-12-28	WOS:000088769500011
J	Hemmings, K; Griffiths, B; Hobkirk, J; Scully, C				Hemmings, K; Griffiths, B; Hobkirk, J; Scully, C			ABC of oral health - Improving occlusion and orofacial aesthetics: tooth repair and replacement	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DENTAL AMALGAM		Univ London, Univ Coll London, Eastman Dent Inst Oral Hlth Care Sci, Dept Conservat Dent, London WC1E 7HU, England; Univ London, Univ Coll London, Eastman Dent Inst Oral Hlth Care Sci, Dept Prosthet Dent, London WC1E 7HU, England	University of London; University College London; University of London; University College London	Hemmings, K (corresponding author), Univ London, Univ Coll London, Eastman Dent Inst Oral Hlth Care Sci, Dept Conservat Dent, London WC1E 7HU, England.							ALBREKTSSON T, 1991, J CLIN PERIODONTOL, V18, P474, DOI 10.1111/j.1600-051X.1991.tb02319.x; Barclay CW, 1998, FIXED REMOVABLE PROS; Echeverria D, 1998, FASEB J, V12, P971, DOI 10.1096/fasebj.12.11.971; Eley BM, 1997, BRIT DENT J, V182, P455, DOI 10.1038/sj.bdj.4809412; Mount J, 1998, PRESERVATION RESTORA; Schmalz G, 1998, EUR J ORAL SCI, V106, P696, DOI 10.1046/j.0909-8836.1998.eos10602ii05.x; SHELDON T, 1999, EFFECTIVE HLTH CARE, V5, P1; Wasylko L, 1998, J Can Dent Assoc, V64, P434	8	2	2	1	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 12	2000	321	7258					438	441		10.1136/bmj.321.7258.438	http://dx.doi.org/10.1136/bmj.321.7258.438			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	344QC	10938058	Green Published			2022-12-28	WOS:000088769500029
J	Sass, HJ; Buldt, G; Gessenich, R; Hehn, D; Neff, D; Schlesinger, R; Berendzen, J; Ormos, P				Sass, HJ; Buldt, G; Gessenich, R; Hehn, D; Neff, D; Schlesinger, R; Berendzen, J; Ormos, P			Structural alterations for proton translocation in the M state of wild-type bacteriorhodopsin	NATURE			English	Article							TRANSFORM-INFRARED-SPECTROSCOPY; X-RAY-DIFFRACTION; NEUTRON-DIFFRACTION; ANGSTROM RESOLUTION; WATER MOLECULE; SCHIFF-BASE; PHOTOCYCLE; INTERMEDIATE; MODEL; CRYSTALLOGRAPHY	The transport of protons across membranes is an important process in cellular bioenergetics. The light-driven proton pump bacteriorhodopsin is the best-characterized protein providing this function. Photon energy is absorbed by the chromophore retinal, covalently bound to Lys 216 via a protonated Schiff base. The light-induced all-trans to 13-cis isomerization of the retinal results in deprotonation of the Schiff base followed by alterations in protonatable groups within bacteriorhodopsin. The changed force field induces changes, even in the tertiary structure(1-3), which are necessary for proton pumping. The recent report(4) of a high-resolution X-ray crystal structure for the late M intermediate of a mutant bacteriorhopsin (with Asp 96-->Asn) displays the structure of a proton pathway highly disturbed by the mutation. To observe an unperturbed proton pathway, we determined the structure of the late M intermediate of wild-type bacteriorhodopsin (2.25 Angstrom resolution). The cytoplasmic side of our M(2) structure shows a water net that allows proton transfer from the proton donor group Asp 96 towards the Schiff base. An enlarged cavity system above Asp 96 is observed, which facilitates the de- and reprotonation of this group by fluctuating water molecules in the last part of the cycle.	Forschungszentrum Julich, Inst Biol Struct, D-52425 Julich, Germany; Los Alamos Natl Lab, Biophys Grp, Los Alamos, NM 87545 USA; Hungarian Acad Sci, Biol Res Ctr, Inst Biophys, H-6701 Szeged, Hungary	Helmholtz Association; Research Center Julich; United States Department of Energy (DOE); Los Alamos National Laboratory; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center	Buldt, G (corresponding author), Forschungszentrum Julich, Inst Biol Struct, Postfach 1913, D-52425 Julich, Germany.	g.bueldt@fz-juelich.de	Buldt, Georg/K-5345-2013; Schlesinger, Ramona/W-2620-2018; Büldt, Georg/H-9509-2014	Schlesinger, Ramona/0000-0002-7716-4439; Ormos, Pal/0000-0003-2541-5686; Ormos, Pal/0000-0003-1424-9221; Berendzen, Joel/0000-0002-9454-9074				BHAT TN, 1984, J APPL CRYSTALLOGR, V17, P244, DOI 10.1107/S0021889884011456; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BUTT HJ, 1989, EMBO J, V8, P1657, DOI 10.1002/j.1460-2075.1989.tb03556.x; DENCHER NA, 1989, P NATL ACAD SCI USA, V86, P7876, DOI 10.1073/pnas.86.20.7876; Dioumaev AK, 1998, BIOCHEMISTRY-US, V37, P2496, DOI 10.1021/bi971842m; Edman K, 1999, NATURE, V401, P822, DOI 10.1038/44623; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; Genick UK, 1997, SCIENCE, V275, P1471, DOI 10.1126/science.275.5305.1471; GERWERT K, 1989, P NATL ACAD SCI USA, V86, P4943, DOI 10.1073/pnas.86.13.4943; KOCH MHJ, 1991, EMBO J, V10, P521, DOI 10.1002/j.1460-2075.1991.tb07978.x; Landau EM, 1996, P NATL ACAD SCI USA, V93, P14532, DOI 10.1073/pnas.93.25.14532; Lanyi JK, 1998, J STRUCT BIOL, V124, P164, DOI 10.1006/jsbi.1998.4044; Luecke H, 1999, SCIENCE, V286, P255, DOI 10.1126/science.286.5438.255; Luecke H, 1998, SCIENCE, V280, P1934, DOI 10.1126/science.280.5371.1934; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; MAEDA A, 1994, BIOCHEMISTRY-US, V33, P1713, DOI 10.1021/bi00173a013; Oesterhelt D, 1998, CURR OPIN STRUC BIOL, V8, P489, DOI 10.1016/S0959-440X(98)80128-0; Rammelsberg R, 1998, BIOCHEMISTRY-US, V37, P5001, DOI 10.1021/bi971701k; Richter HT, 1996, BIOCHEMISTRY-US, V35, P4054, DOI 10.1021/bi952883q; Sass HJ, 1998, BIOPHYS J, V75, P399, DOI 10.1016/S0006-3495(98)77524-1; Sass HJ, 1997, EMBO J, V16, P1484, DOI 10.1093/emboj/16.7.1484; Scharnagl C, 1996, CHEM PHYS, V212, P231, DOI 10.1016/S0301-0104(96)00192-9; SUBRAMANIAM S, 1993, EMBO J, V12, P1; Weik M, 1998, J MOL BIOL, V275, P625, DOI 10.1006/jmbi.1997.1488; Xu D, 1995, BIOPHYS J, V69, P2745, DOI 10.1016/S0006-3495(95)80146-3; Yamazaki Y, 1998, BIOCHEMISTRY-US, V37, P1559, DOI 10.1021/bi972044z; ZIMANYI L, 1993, BIOPHYS J, V64, P240, DOI 10.1016/S0006-3495(93)81360-2; Zscherp C, 1999, P NATL ACAD SCI USA, V96, P5498, DOI 10.1073/pnas.96.10.5498	28	306	315	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 10	2000	406	6796					649	653		10.1038/35020607	http://dx.doi.org/10.1038/35020607			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	342PF	10949308				2022-12-28	WOS:000088653800053
J	Mueth, DM; Debregeas, GF; Karczmar, GS; Eng, PJ; Nagel, SR; Jaeger, HM				Mueth, DM; Debregeas, GF; Karczmar, GS; Eng, PJ; Nagel, SR; Jaeger, HM			Signatures of granular microstructure in dense shear flows	NATURE			English	Article							MAGNETIC-RESONANCE; COUETTE EXPERIMENT; CONVECTION; TRANSITION; THICKNESS; MODEL; BANDS	Granular materials and ordinary fluids react differently to shear stresses. Rather than deforming uniformly, materials such as dry sand or cohesionless powders develop shear bands(1-5)-narrow zones of large relative particle motion, with essentially rigid adjacent regions. Because shear bands mark areas of flow, material failure and energy dissipation, they are important in many industrial, civil engineering and geophysical processes(6). They are also relevant to lubricating fluids confined to ultrathin molecular layers(7). However, detailed three-dimensional information on motion within a shear band, including the degree of particle rotation and interparticle slip, is lacking. Similarly, very little is known about how the microstructure of individual grains affects movement in densely packed material(5). Here we combine magnetic resonance imaging, X-ray tomography and high-speed-video particle tracking to obtain the local steady-state particle velocity, rotation and packing density for shear flow in a three-dimensional Couette geometry. We find that key characteristics of the granular microstructure determine the shape of the velocity profile.	Univ Chicago, James Franck Inst, Chicago, IL 60637 USA; Univ Chicago, Dept Phys, Chicago, IL 60637 USA; Univ Chicago, Dept Radiol, Chicago, IL 60637 USA; Univ Chicago, Ctr Adv Radiat Sources, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago	Jaeger, HM (corresponding author), Univ Chicago, James Franck Inst, 5640 S Ellis Ave, Chicago, IL 60637 USA.		Eng, Peter/ABA-8842-2021	Eng, Peter/0000-0002-8072-3203; Debregeas, Georges/0000-0003-3698-4497				BRIDGWATER J, 1980, GEOTECHNIQUE, V30, P533, DOI 10.1680/geot.1980.30.4.533; DEBREGEAS G, 2000, CONDMAT9901336; DRAKE TG, 1990, J GEOPHYS RES-SOLID, V95, P8681, DOI 10.1029/JB095iB06p08681; EHRICHS EE, 1995, SCIENCE, V267, P1632, DOI 10.1126/science.267.5204.1632; Fukushima E, 1999, ANNU REV FLUID MECH, V31, P95, DOI 10.1146/annurev.fluid.31.1.95; Granick S, 1999, PHYS TODAY, V52, P26, DOI 10.1063/1.882747; HANES DM, 1985, J FLUID MECH, V150, P357, DOI 10.1017/S0022112085000167; HOPKINS MA, 1993, MECH MATER, V16, P179, DOI 10.1016/0167-6636(93)90041-O; Howell D, 1999, PHYS REV LETT, V82, P5241, DOI 10.1103/PhysRevLett.82.5241; Josserand C, 1999, EUROPHYS LETT, V48, P36, DOI 10.1209/epl/i1999-00110-7; Karion A, 2000, POWDER TECHNOL, V109, P145, DOI 10.1016/S0032-5910(99)00233-8; Khosropour R, 1997, PHYS REV E, V56, P4467, DOI 10.1103/PhysRevE.56.4467; LOSERT W, 2000, CONDMAT0004401; MUHLHAUS HB, 1987, GEOTECHNIQUE, V37, P271; NEDDERMAN RM, 1980, POWDER TECHNOL, V25, P91, DOI 10.1016/0032-5910(80)87014-8; Oda M, 1998, GEOTECHNIQUE, V48, P465, DOI 10.1680/geot.1998.48.4.465; POULIQUEN O, 1996, PHYS REV E, V53, P557; Rajchenbach J, 2000, ADV PHYS, V49, P229, DOI 10.1080/000187300243372; Scott DR, 1996, NATURE, V381, P592, DOI 10.1038/381592a0; TKACHENKO A, 1999, CONDMAT9912187; TUZUN U, 1982, POWDER TECHNOL, V31, P27, DOI 10.1016/0032-5910(82)80002-8; Veje CT, 1999, PHYS REV E, V59, P739, DOI 10.1103/PhysRevE.59.739	22	338	342	5	119	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 27	2000	406	6794					385	389		10.1038/35019032	http://dx.doi.org/10.1038/35019032			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	337WC	10935630	Green Submitted			2022-12-28	WOS:000088383800040
J	Daily, GC; Soderqvist, T; Aniyar, S; Arrow, K; Dasgupta, P; Ehrlich, PR; Folke, C; Jansson, A; Jansson, BO; Kautsky, N; Levin, S; Lubchenco, J; Maler, KG; Simpson, D; Starrett, D; Tilman, D; Walker, B				Daily, GC; Soderqvist, T; Aniyar, S; Arrow, K; Dasgupta, P; Ehrlich, PR; Folke, C; Jansson, A; Jansson, BO; Kautsky, N; Levin, S; Lubchenco, J; Maler, KG; Simpson, D; Starrett, D; Tilman, D; Walker, B			Ecology - The value of nature and the nature of value	SCIENCE			English	Article									Royal Swedish Acad Sci, Beijer Inst, S-10405 Stockholm, Sweden	Royal Swedish Academy of Sciences; Beijer Institute of Ecological Economics	Daily, GC (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.		Walker, Brian H/F-2386-2011; Folke, Carl/Z-1545-2019; Tilman, David/ABD-5309-2021; Levin, Simon A/J-1218-2014	Levin, Simon A/0000-0002-8216-5639; Folke, Carl/0000-0002-4050-3281; Soderqvist, Tore/0000-0001-7347-9567				[Anonymous], 1996, CLIMATE CHANGE 1995; [Anonymous], 1997, NATURES SERVICES; Berkes F., 1998, LINKING SOCIAL ECOLO, V1st, DOI DOI 10.1017/CBO9780511541957; CASTRO R, 1998, COSTA RICAN EXPERIEN; Chichilnisky G, 1998, NATURE, V391, P629, DOI 10.1038/35481; CORK S, 2000, P 3 QUEENSL ENV C 25; Costanza R, 2000, ECOSYSTEMS, V3, P4, DOI 10.1007/s100210000002; Daily Gretchen C., 1999, Conservation Ecology, V3, pUnpaginated; ECHAVARRIA M, 1999, POLICY MECHANISMS WA; Gatto M, 2000, BIOSCIENCE, V50, P347, DOI 10.1641/0006-3568(2000)050[0347:PBAEST]2.3.CO;2; HEAL G, IN PRESS NATURE MARK; HOSKING L, 2000, FOR GREEN EC C COSP; Janzen D, 1999, P NATL ACAD SCI USA, V96, P5987, DOI 10.1073/pnas.96.11.5987; Kremen C, 2000, SCIENCE, V288, P1828, DOI 10.1126/science.288.5472.1828; LOBO RG, 1999, BIODIVERSIDAD GENTES; Ludwig D, 2000, ECOSYSTEMS, V3, P31, DOI 10.1007/s100210000007; Masood E, 1998, NATURE, V395, P426, DOI 10.1038/26587; National Research Council, 2000, WAT MAN POT WAT SUPP; Naylor RL, 1998, SCIENCE, V282, P883, DOI 10.1126/science.282.5390.883; REID W, IN PRESS MANAGING HU; Scheffer M., 1998, ECOLOGY SHALLOW LAKE; SCHNEIDER S, IN PRESS PACIFIC ASI; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494	23	573	735	18	406	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 21	2000	289	5478					395	396		10.1126/science.289.5478.395	http://dx.doi.org/10.1126/science.289.5478.395			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	336ME	10939949				2022-12-28	WOS:000088305500022
J	Furst, DE				Furst, DE			Aggressive strategies for treating aggressive rheumatoid arthritis: has the case been proven?	LANCET			English	Editorial Material									Virginia Mason Res Ctr, Arthrit Clin Res Ctr, Seattle, WA 98101 USA	Virginia Mason Medical Center	Furst, DE (corresponding author), Virginia Mason Res Ctr, Arthrit Clin Res Ctr, 1000 Seneca St, Seattle, WA 98101 USA.							BENSEN WG, 1990, J RHEUMATOL, V17, P987; Boers M, 1997, LANCET, V350, P309, DOI 10.1016/S0140-6736(97)01300-7; Firestein GS, 1996, ARTHRITIS RHEUM, V39, P1781, DOI 10.1002/art.1780391103; FRIES JF, 1990, J RHEUMATOL, V17, P12; Hawley D J, 1992, Arthritis Care Res, V5, P130, DOI 10.1002/art.1790050304; HAWLEY DJ, 1992, ARTHRIT CARE RES, V5, P229; Mottonen T, 1988, Scand J Rheumatol Suppl, V75, P244; PINCUS T, 1984, ARTHRITIS RHEUM-US, V27, P864, DOI 10.1002/art.1780270805; Sokka T, 2000, RHEUMATOLOGY, V39, P34, DOI 10.1093/rheumatology/39.1.34; VANDEPUTTE LBA, 1995, CLIN EXP RHEUMATOL, V13, P27; VANSCHAARDENBURG D, 1993, J RHEUMATOL, V20, P45; WILSKE KR, 1989, J RHEUMATOL, V16, P565; WORDSWORTH P, 1994, ARTHRITIS RHEUM, V37, P1166	13	6	6	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 15	2000	356	9225					183	184		10.1016/S0140-6736(00)02477-6	http://dx.doi.org/10.1016/S0140-6736(00)02477-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	334GQ	10963194				2022-12-28	WOS:000088179100007
J	Strauss, HW; Narula, J; Blankenberg, FG				Strauss, HW; Narula, J; Blankenberg, FG			Radioimaging to identify myocardial cell death and probably injury	LANCET			English	Editorial Material							ANNEXIN-V		Stanford Univ, Sch Med, Div Nucl Med, Stanford, CA 94306 USA; Hahneman Sch Med, Div Cardiol, Philadelphia, PA USA; Stanford Univ, Sch Med, Div Pediat Radiol, Stanford, CA 94305 USA	Stanford University; Drexel University; Stanford University	Strauss, HW (corresponding author), Stanford Univ, Sch Med, Div Nucl Med, Stanford, CA 94306 USA.							Acio ER, 2000, J NUCL MED, V41, p127P; Blankenberg FG, 1998, P NATL ACAD SCI USA, V95, P6349, DOI 10.1073/pnas.95.11.6349; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; Gidon-Jeangirard C, 1999, BIOCHEM BIOPH RES CO, V265, P709, DOI 10.1006/bbrc.1999.1752; Kaneko N, 1996, CLIN CHIM ACTA, V251, P65, DOI 10.1016/0009-8981(96)06294-8; Matteo RG, 2000, CARDIOVASC RES, V45, P961, DOI 10.1016/S0008-6363(99)00409-5; Narula J, 2000, J NUCL MED, V41, p173P; Trouve P, 1999, AM J PHYSIOL-HEART C, V276, pH1159, DOI 10.1152/ajpheart.1999.276.4.H1159	8	42	46	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 15	2000	356	9225					180	181		10.1016/S0140-6736(00)02474-0	http://dx.doi.org/10.1016/S0140-6736(00)02474-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	334GQ	10963191				2022-12-28	WOS:000088179100004
J	Carson, AJ; MacHale, S; Allen, K; Lawrie, SM; Dennis, M; House, A; Sharpe, M				Carson, AJ; MacHale, S; Allen, K; Lawrie, SM; Dennis, M; House, A; Sharpe, M			Depression after stroke and lesion location: a systematic review	LANCET			English	Review							DEXAMETHASONE SUPPRESSION TEST; POSTSTROKE DEPRESSION; MOOD DISORDERS; FREQUENCY; REHABILITATION; BRAIN	Background There is conflicting evidence on the hypothesis that the risk of depression after stroke is influenced by the location of the brain lesion. We undertook a systematic review to examine the hypotheses that depression is more commonly associated with left-hemisphere strokes than with right-hemisphere strokes and with lesions of the left anterior brain than with other regions. Methods We did a computer-aided search of MEDLINE, BIDS ISI, and PsychLit databases supplemented by hand searches of key journals. We included all reports on the association of depression after stroke with the location of the brain lesion. Studies were systematically and independently examined by two investigators. Fixed-effects and random-effects meta-analyses were done. Findings 143 reports were identified by the search strategy. 48 were eligible for inclusion. Not all reports included original data. Only two reports of original data supported the hypotheses and seven clearly did not. The pooled (random-effects) relative risk of depression after a left-hemisphere stroke, compared with a right-hemisphere stroke, was 0.95 (95% CI 0.83-1.10). For depression after a left anterior lesion compared with all other brain areas the pooled (random-effects) relative risk was 1.17 (0.87-1.62). Restriction of the analyses to reports from high-quality studies or major depressive disorder did not substantially affect the findings. Nor were they affected by stratification of the time between stroke and the assessment of depression. Multiple publications from the same samples of patients were apparent. Interpretation This systematic review offered no support for the hypothesis that the risk of depression after stroke is affected by the location of the brain lesion.	Univ Edinburgh, Royal Edinburgh Hosp, Dept Psychiat, Edinburgh EH10 5HF, Midlothian, Scotland; Royal Infirm Edinburgh, Edinburgh, Midlothian, Scotland; Western Gen Hosp, Univ Dept Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland; Univ Leeds, Leeds, W Yorkshire, England	Royal Infirmary of Edinburgh; University of Edinburgh; Royal Infirmary of Edinburgh; University of Edinburgh; University of Leeds	Carson, AJ (corresponding author), Univ Edinburgh, Royal Edinburgh Hosp, Dept Psychiat, Edinburgh EH10 5HF, Midlothian, Scotland.		Lawrie, Stephen MacGregor/AAD-1607-2021	Lawrie, Stephen MacGregor/0000-0002-2444-5675; sharpe, michael/0000-0002-6474-9980; House, Allan/0000-0001-8721-8026				AGARWAL A, 1987, INDIAN J MED RES, V85, P297; AGRELL B, 1994, AGING-CLIN EXP RES, V6, P49, DOI 10.1007/BF03324213; ANDERSEN G, 1995, ACTA PSYCHIAT SCAND, V92, P193, DOI 10.1111/j.1600-0447.1995.tb09567.x; ASTROM M, 1993, STROKE, V24, P976, DOI 10.1161/01.STR.24.7.976; BACHER Y, 1990, CAN J REHABIL, V4, P27; Burvill PW, 1996, CEREBROVASC DIS, V6, P208, DOI 10.1159/000108023; EASTWOOD MR, 1989, BRIT J PSYCHIAT, V154, P195, DOI 10.1192/bjp.154.2.195; EBRAHIM S, 1987, BRIT J PSYCHIAT, V151, P52, DOI 10.1192/bjp.151.1.52; FEIBEL JH, 1982, ARCH PHYS MED REHAB, V63, P276; FINKLESTEIN S, 1982, ANN NEUROL, V12, P463, DOI 10.1002/ana.410120509; FOLSTEIN MF, 1977, J NEUROL NEUROSUR PS, V40, P1018, DOI 10.1136/jnnp.40.10.1018; Gainotti G, 1999, BRIT J PSYCHIAT, V175, P163, DOI 10.1192/bjp.175.2.163; Gonzalez-Torrecillas J L, 1995, Int Psychogeriatr, V7, P547, DOI 10.1017/S1041610295002286; GONZALEZTORRECILLAS JL, 1995, ACTAS LUSO-ESP NEUR, V23, P52; GORDON WA, 1991, REHABIL PSYCHOL, V36, P71, DOI 10.1037/0090-5550.36.2.71; GRASSO MG, 1994, STROKE, V25, P980, DOI 10.1161/01.STR.25.5.980; HERRMANN M, 1995, STROKE, V26, P850, DOI 10.1161/01.STR.26.5.850; HIBBARD MR, 1992, REHABIL PSYCHOL, V37, P103, DOI 10.1037/0090-5550.37.2.103; HOUSE A, 1990, BRAIN, V113, P1113, DOI 10.1093/brain/113.4.1113; IACOBONI M, 1995, ITAL J NEUROL SCI, V16, P209, DOI 10.1007/BF02282991; Kase CS, 1998, STROKE, V29, P805, DOI 10.1161/01.STR.29.4.805; Kotila M, 1998, STROKE, V29, P368, DOI 10.1161/01.STR.29.2.368; Lincoln NB., 1987, CLIN REHABIL, V1, P27, DOI [10.1177/026921558700100107, DOI 10.1177/026921558700100107]; MacHale SM, 1998, J NEUROL NEUROSUR PS, V64, P371, DOI 10.1136/jnnp.64.3.371; MALEC JF, 1990, ARCH PHYS MED REHAB, V71, P279; MAYBERG HS, 1988, AM J PSYCHIAT, V145, P937; Morris PLP, 1996, J NEUROPSYCH CLIN N, V8, P399; MORRIS PLP, 1990, INT J PSYCHIAT MED, V20, P349, DOI 10.2190/N8VU-6LWU-FLJN-XQKV; Nagaraja D, 1997, J ASSOC PHYSICIAN I, V45, P179; NG KC, 1995, ACTA PSYCHIAT SCAND, V92, P75, DOI 10.1111/j.1600-0447.1995.tb09546.x; PARIKH RM, 1990, ARCH NEUROL-CHICAGO, V47, P785, DOI 10.1001/archneur.1990.00530070083014; Pohjasvaara T, 1998, STROKE, V29, P2311, DOI 10.1161/01.STR.29.11.2311; ROBINSON RG, 1975, NATURE, V255, P332, DOI 10.1038/255332a0; ROBINSON RG, 1983, COMPR PSYCHIAT, V24, P556; SCHWARTZ JA, 1993, BIOL PSYCHIAT, V33, P694, DOI 10.1016/0006-3223(93)90118-W; SHARPE M, 1990, PSYCHOL MED, V20, P815, DOI 10.1017/S0033291700036503; Singh A, 1998, CAN J PSYCHIAT, V43, P921, DOI 10.1177/070674379804300907; VANROOIJEN MA, 1990, PHYSICAL OCCUPATIONA, V9, P25; WADE DT, 1987, BRIT J PSYCHIAT, V151, P200, DOI 10.1192/bjp.151.2.200	39	432	460	1	31	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 8	2000	356	9224					122	126		10.1016/S0140-6736(00)02448-X	http://dx.doi.org/10.1016/S0140-6736(00)02448-X			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	331UG	10963248				2022-12-28	WOS:000088036600012
J	Young, RA				Young, RA			Biomedical discovery with DNA arrays	CELL			English	Review							GENE-EXPRESSION; OLIGONUCLEOTIDE ARRAYS; CELL-CYCLE; PATTERNS; GENOME; YEAST		Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Young, RA (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	young@wl.mit.edu	Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647				Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Alon U, 1999, P NATL ACAD SCI USA, V96, P6745, DOI 10.1073/pnas.96.12.6745; Andl T, 1998, CANCER RES, V58, P5; Arkin A, 1998, GENETICS, V149, P1633; Bishop CM., 1995, NEURAL NETWORKS PATT; Brazma A, 2000, NATURE, V403, P699, DOI 10.1038/35001676; Chervitz SA, 1998, SCIENCE, V282, P2022, DOI 10.1126/science.282.5396.2022; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Debouck C, 2000, ANNU REV PHARMACOL, V40, P193, DOI 10.1146/annurev.pharmtox.40.1.193; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Eisenberg D, 2000, NATURE, V405, P823, DOI 10.1038/35015694; Galitski T, 1999, SCIENCE, V285, P251, DOI 10.1126/science.285.5425.251; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Lee TI, 2000, NATURE, V405, P701, DOI 10.1038/35015104; Lipshutz RJ, 1999, NAT GENET, V21, P20, DOI 10.1038/4447; Lockhart DJ, 2000, NATURE, V405, P827, DOI 10.1038/35015701; Luo L, 1999, NAT MED, V5, P117, DOI 10.1038/4806; Ly DH, 2000, SCIENCE, V287, P2486, DOI 10.1126/science.287.5462.2486; Manger ID, 2000, CURR OPIN IMMUNOL, V12, P215, DOI 10.1016/S0952-7915(99)00077-1; Martin S, 1998, EUR PHYS J D, V4, P1, DOI 10.1007/s100530050178; McNeill W.H., 1976, PLAGUES PEOPLES, V1st ed.; Oldstone M.B.A., 1998, VIRUSES PLAGUES HIST; Pandey A, 2000, NATURE, V405, P837, DOI 10.1038/35015709; Perou CM, 1999, P NATL ACAD SCI USA, V96, P9212, DOI 10.1073/pnas.96.16.9212; RELMAN DA, 1991, NEW ENGL J MED, V324, P1514; Roses AD, 2000, NATURE, V405, P857, DOI 10.1038/35015728; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; ROWLEY AH, 1990, LANCET, V335, P440, DOI 10.1016/0140-6736(90)90667-T; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; White KP, 1999, SCIENCE, V286, P2179, DOI 10.1126/science.286.5447.2179; Wyrick JJ, 1999, NATURE, V402, P418, DOI 10.1038/46567	37	285	302	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 7	2000	102	1					9	15		10.1016/S0092-8674(00)00005-2	http://dx.doi.org/10.1016/S0092-8674(00)00005-2			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	332UL	10929708	Bronze			2022-12-28	WOS:000088091700003
J	Krummel, MF; Sjaastad, MD; Wulfing, C; Davis, MM				Krummel, MF; Sjaastad, MD; Wulfing, C; Davis, MM			Differential clustering of CD4 and CD3 zeta during T cell recognition	SCIENCE			English	Article							RECEPTOR ZETA-CHAIN; SIGNAL-TRANSDUCTION; ANTIGEN-RECEPTOR; TYROSINE KINASE; BINDING-SITE; ACTIVATION; MHC; LIGANDS; COSTIMULATION; CYTOSKELETON	Whereas T helper cells recognize peptide-major histocompatibility complex (MHC) class II complexes through their T cell receptors (TCRs), CD4 binds to an antigen-independent region of the MHC. Using green fluorescent protein-tagged chimeras and three-dimensional video microscopy, we show that CD4 and TCR-associated CD3 zeta cluster in the interface coincident with increases in intracellular calcium. Signaling-, costimulation-, and cytoskeleton-dependent processes then stabilize CD3 zeta in a single cluster at the center of the interface, while CD4 moves to the periphery. Thus, the CD4 coreceptor may serve primarily to "boost" recognition of ligand by the TCR and may not be required once activation has been initiated.	Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Howard Hughes Med Inst, Stanford, CA 94305 USA; Universal Imaging Corp, W Chester, PA 19380 USA	Stanford University; Howard Hughes Medical Institute	Davis, MM (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA.			Wuelfing, Christoph/0000-0002-6156-9861; Davis, Mark/0000-0001-6868-657X				BARCLAY N, UNPUB; Boniface JJ, 1998, IMMUNITY, V9, P459, DOI 10.1016/S1074-7613(00)80629-9; Bootman MD, 1997, CELL, V91, P367, DOI 10.1016/S0092-8674(00)80420-1; CAMMAROTA G, 1992, NATURE, V356, P799, DOI 10.1038/356799a0; CAPLAN S, 1995, P NATL ACAD SCI USA, V92, P4768, DOI 10.1073/pnas.92.11.4768; Cochran JR, 2000, IMMUNITY, V12, P241, DOI 10.1016/S1074-7613(00)80177-6; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Hampl J, 1997, IMMUNITY, V7, P379, DOI 10.1016/S1074-7613(00)80359-3; JANEWAY CA, 1992, ANNU REV IMMUNOL, V10, P645, DOI 10.1146/annurev.immunol.10.1.645; KAYE J, 1988, NATURE, V336, P580, DOI 10.1038/336580a0; KAYE J, 1983, J EXP MED, V158, P836, DOI 10.1084/jem.158.3.836; KONIG R, 1992, NATURE, V356, P796, DOI 10.1038/356796a0; KUPFER A, 1989, J EXP MED, V170, P1697, DOI 10.1084/jem.170.5.1697; Madrenas J, 1997, J EXP MED, V185, P219, DOI 10.1084/jem.185.2.219; MARRACK P, 1983, J EXP MED, V158, P1077, DOI 10.1084/jem.158.4.1077; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; NEGULESCU PA, 1994, P NATL ACAD SCI USA, V91, P2873, DOI 10.1073/pnas.91.7.2873; Reich Z, 1997, NATURE, V387, P617, DOI 10.1038/42500; ROZDZIAL MM, 1995, IMMUNITY, V3, P623, DOI 10.1016/1074-7613(95)90133-7; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; TURNER JM, 1990, CELL, V60, P755, DOI 10.1016/0092-8674(90)90090-2; Viola A, 1996, SCIENCE, V273, P104, DOI 10.1126/science.273.5271.104; Viola A, 1999, SCIENCE, V283, P680, DOI 10.1126/science.283.5402.680; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Wulfing C, 1998, P NATL ACAD SCI USA, V95, P6302, DOI 10.1073/pnas.95.11.6302; Wulfing C, 1998, SCIENCE, V282, P2266, DOI 10.1126/science.282.5397.2266; WULFING C, UNPUB	28	315	319	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 25	2000	289	5483					1349	1352		10.1126/science.289.5483.1349	http://dx.doi.org/10.1126/science.289.5483.1349			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347RF	10958781				2022-12-28	WOS:000088942400038
J	Herrington, DM; Reboussin, DM; Brosnihan, KB; Sharp, PC; Shumaker, SA; Snyder, TE; Furberg, CD; Kowalchuk, GJ; Stuckey, TD; Rogers, WJ; Givens, DH; Waters, D				Herrington, DM; Reboussin, DM; Brosnihan, KB; Sharp, PC; Shumaker, SA; Snyder, TE; Furberg, CD; Kowalchuk, GJ; Stuckey, TD; Rogers, WJ; Givens, DH; Waters, D			Effects of estrogen replacement on the progression of coronary-artery atherosclerosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							C-REACTIVE PROTEIN; POSTMENOPAUSAL WOMEN; 17-BETA ESTRADIOL; HEART-DISEASE; THERAPY; CHOLESTEROL; RISK; ENDOTHELIUM; PREVENTION; PROGESTIN	Background: Heart disease is a major cause of illness and death in women. To understand better the role of estrogen in the treatment and prevention of heart disease, more information is needed about its effects on coronary atherosclerosis and the extent to which concomitant progestin therapy may modify these effects. Methods: We randomly assigned a total of 309 women with angiographically verified coronary disease to receive 0.625 mg of conjugated estrogen per day, 0.625 mg of conjugated estrogen plus 2.5 mg of medroxyprogesterone acetate per day, or placebo. The women were followed for a mean (+/-SD) of 3.2+/-0.6 years. Base-line and follow-up coronary angiograms were analyzed by quantitative methods. Results: Estrogen and estrogen plus medroxyprogesterone acetate produced significant reductions in low-density lipoprotein cholesterol levels (9.4 percent and 16.5 percent, respectively) and significant increases in high-density lipoprotein cholesterol levels (18.8 percent and 14.2 percent, respectively); however, neither treatment altered the progression of coronary atherosclerosis. After adjustment for measurements at base line, the mean (+/-SE) minimal coronary-artery diameters at follow-up were 1.87+/-0.02 mm, 1.84+/-0.02 mm, and 1.87+/-0.02 mm in women assigned to estrogen, estrogen plus medroxyprogesterone acetate, and placebo, respectively. The differences between the values for the two active-treatment groups and the value for the placebo group were not significant. Analyses of several secondary angiographic outcomes and subgroups of women produced similar results. The rates of clinical cardiovascular events were also similar among the treatment groups. Conclusions: Neither estrogen alone nor estrogen plus medroxyprogesterone acetate affected the progression of coronary atherosclerosis in women with established disease. These results suggest that such women should not use estrogen replacement with an expectation of cardiovascular benefit. (N Engl J Med 2000;343:522-9.) (C)2000, Massachusetts Medical Society.	Wake Forest Univ, Bowman Gray Sch Med, Dept Internal Med, Cardiol Sect, Winston Salem, NC 27157 USA; Wake Forest Univ, Bowman Gray Sch Med, Dept Publ Hlth Sci, Winston Salem, NC 27157 USA; Wake Forest Univ, Bowman Gray Sch Med, Hypertens & Vasc Dis Ctr, Winston Salem, NC 27157 USA; Wake Forest Univ, Bowman Gray Sch Med, Dept Family & Community Med, Winston Salem, NC 27157 USA; Wake Forest Univ, Bowman Gray Sch Med, Dept Obstet & Gynecol, Winston Salem, NC 27157 USA; Carolinas Med Ctr, Dept Cardiol, Charlotte, NC 28203 USA; LeBauer Cardiovasc Associates, Greensboro, NC USA; Univ Alabama, Div Cardiol, Birmingham, AL USA; Winston Salem Cardiol Associates, Winston Salem, NC USA; San Francisco Gen Hosp, Div Cardiol, San Francisco, CA 94110 USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Carolinas Medical Center; LeBauer-Brodie Center for Cardiovascular Research & Education; University of Alabama System; University of Alabama Birmingham; San Francisco General Hospital Medical Center	Herrington, DM (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Internal Med, Cardiol Sect, Med Ctr Blvd, Winston Salem, NC 27157 USA.				NCRR NIH HHS [M01 RR07122] Funding Source: Medline; NHLBI NIH HHS [U01 HL-45488] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR007122] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ADAMS MR, 1990, ARTERIOSCLEROSIS, V10, P1051, DOI 10.1161/01.ATV.10.6.1051; Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61; Azen SP, 1996, CIRCULATION, V93, P34, DOI 10.1161/01.CIR.93.1.34; Brown BG, 1998, CIRCULATION, V98, P635; BUCHWALD H, 1992, JAMA-J AM MED ASSOC, V268, P1429, DOI 10.1001/jama.268.11.1429; Bush TL, 1998, J WOMENS HEALTH, V7, P781, DOI 10.1089/jwh.1998.7.781; Cushman M, 1999, ARTERIOSCL THROM VAS, V19, P893, DOI 10.1161/01.ATV.19.4.893; Cushman M, 1999, CIRCULATION, V100, P717, DOI 10.1161/01.CIR.100.7.717; GERHARD M, 1995, CIRCULATION, V92, P5, DOI 10.1161/01.CIR.92.1.5; GRADY D, 1992, ANN INTERN MED, V117, P1016, DOI 10.7326/0003-4819-117-12-1016; Grady D, 1998, CONTROL CLIN TRIALS, V19, P314, DOI 10.1016/S0197-2456(98)00010-5; Grodstein F, 1996, NEW ENGL J MED, V335, P453, DOI 10.1056/NEJM199608153350701; Grodstein F, 1996, NEW ENGL J MED, V335, P1406; Grundy Scott M., 1994, Circulation, V89, P1329; Grundy SM, 1997, CIRCULATION, V95, P2329, DOI 10.1161/01.CIR.95.9.2329; HAARBO J, 1991, J CLIN INVEST, V87, P1274, DOI 10.1172/JCI115129; Hanke H, 1999, ATHEROSCLEROSIS, V147, P123, DOI 10.1016/S0021-9150(99)00182-3; Herrington DM, 2000, CONTROL CLIN TRIALS, V21, P257, DOI 10.1016/S0197-2456(00)00054-4; Herrington DM, 1999, ANN INTERN MED, V131, P463, DOI 10.7326/0003-4819-131-6-199909210-00012; HERRINGTON DM, 1997, HORMONAL METABOLIC C, P175; Holm P, 1999, CIRCULATION, V100, P1727, DOI 10.1161/01.CIR.100.16.1727; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; LEUNG WH, 1991, CATHETER CARDIO DIAG, V24, P121, DOI 10.1002/ccd.1810240211; Mendelsohn ME, 1999, NEW ENGL J MED, V340, P1801, DOI 10.1056/NEJM199906103402306; Ong PJL, 1999, JAMA-J AM MED ASSOC, V281, P794; ORNISH D, 1990, LANCET, V336, P129, DOI 10.1016/0140-6736(90)91656-U; Ridker PM, 1999, CIRCULATION, V100, P713, DOI 10.1161/01.CIR.100.7.713; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; SMITH SC, 1995, CIRCULATION, V92, P2; van Baal WM, 1999, THROMB HAEMOSTASIS, V81, P925, DOI 10.1055/s-0037-1614600; VITA JA, 1990, CIRCULATION, V81, P491, DOI 10.1161/01.CIR.81.2.491; VOGEL RA, 1999, TXB INTERVENTIONAL C, P111; WATERS D, 1993, CIRCULATION, V87, P1067, DOI 10.1161/01.CIR.87.4.1067; WENGER NK, 1998, PREV CARDIOL, V1, P9; WILLIAMS JK, 1995, ARTERIOSCL THROM VAS, V15, P827, DOI 10.1161/01.ATV.15.7.827	35	926	948	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 24	2000	343	8					522	529		10.1056/NEJM200008243430801	http://dx.doi.org/10.1056/NEJM200008243430801			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	346QM	10954759				2022-12-28	WOS:000088882600001
J	Drew, WL				Drew, WL			Ganciclovir resistance: a matter of time and titre	LANCET			English	Editorial Material							CYTOMEGALOVIRUS-INFECTION		Univ Calif San Francisco, Mt Zion Med Ctr, Dept Lab Med & Infect Dis, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Medical Center at Mount Zion	Drew, WL (corresponding author), Univ Calif San Francisco, Mt Zion Med Ctr, Dept Lab Med & Infect Dis, San Francisco, CA 94143 USA.							Cherrington JM, 1996, J INFECT DIS, V173, P987, DOI 10.1093/infdis/173.4.987; Chou SW, 1998, J INFECT DIS, V178, P526, DOI 10.1086/515648; DREW WL, 1991, J INFECT DIS, V163, P716, DOI 10.1093/infdis/163.4.716; Jabs DA, 1998, J INFECT DIS, V177, P770, DOI 10.1086/514249; KOST RG, 1993, NEW ENGL J MED, V329, P1777, DOI 10.1056/NEJM199312093292405; Kruger RM, 1999, TRANSPLANTATION, V68, P1272, DOI 10.1097/00007890-199911150-00010; LELEZARI JP, 1998, 5 C RETR OPP INF CHI; Lewis RA, 1996, ARCH OPHTHALMOL-CHIC, V114, P23; SAFRIN S, 1996, ANTIVIRAL DRUG RESIS, P103; Wolf DG, 1998, J INFECT DIS, V178, P535, DOI 10.1086/517468	10	27	28	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 19	2000	356	9230					609	610		10.1016/S0140-6736(00)02597-6	http://dx.doi.org/10.1016/S0140-6736(00)02597-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	346RD	10968428				2022-12-28	WOS:000088884100003
J	Farmer, RDT; Williams, TJ; Simpson, EL; Nightingale, AL				Farmer, RDT; Williams, TJ; Simpson, EL; Nightingale, AL			Effect of 1995 pill scare on rates of venous thromboembolism among women taking combined oral contraceptives: analysis of General Practice Research Database	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RISK	Objective To compare the incidence of venous rhromboembolism among women taking combined oral contraceptives before and after the October 1995 pill scare. Design Analysis of General Practice Research Database. Setting United Kingdom, January 1993 to December 1998. Subjects Women aged 15-49 taking combined oral contraceptives. Main outcome measures Incidence of venous thromboembolism. Results Use of so called "third generation" combined oral contraceptives fell from 53% during January 1993 to October 1995 to 14% during November 1995 to December 1998. There was no significant change in the incidence of venous thromboembolism between the two periods after age was adjusted for (incidence ratio 1.04, 95%, confidence interval 0.78 to 1.39). Conclusions The findings are not compatible with the assertion that third generation oral contraceptives are associated with a twofold increase in risk of venous thromboembolism compared with older progestogens.	Univ Surrey, Postgrad Med Sch, Guildford GU2 7DJ, Surrey, England	University of Surrey	Farmer, RDT (corresponding author), Univ Surrey, Postgrad Med Sch, Guildford GU2 7DJ, Surrey, England.	r.farmer@surrey.ac.uk		Nightingale, Alison/0000-0001-8611-2940				Bloemenkamp KWM, 1999, ARCH INTERN MED, V159, P65, DOI 10.1001/archinte.159.1.65; Committee on the Safety of Medicines, 1995, COMB OR CONTR THROMB; Farmer RDT, 2000, BRIT J CLIN PHARMACO, V49, P580, DOI 10.1046/j.1365-2125.2000.00198.x; Farmer RDT, 1997, LANCET, V349, P83, DOI 10.1016/S0140-6736(96)07496-X; JICK H, 1991, BRIT MED J, V302, P766, DOI 10.1136/bmj.302.6779.766; JICK H, 1995, LANCET, V346, P1589, DOI 10.1016/S0140-6736(95)91928-7; Lawrenson R, 2000, BRIT J CLIN PHARMACO, V49, P591, DOI 10.1046/j.1365-2125.2000.00199.x; Lawrenson RA, 1999, BRIT MED J, V319, P387, DOI 10.1136/bmj.319.7206.387; Lewis MA, 1999, HUM REPROD, V14, P1493, DOI 10.1093/humrep/14.6.1493; Lidegaard O, 1998, CONTRACEPTION, V57, P291, DOI 10.1016/S0010-7824(98)00033-X; Mayor S, 1999, BRIT MED J, V318, P1026, DOI 10.1136/bmj.318.7190.1026a; Mellemkjaer L, 1999, BRIT MED J, V319, P820, DOI 10.1136/bmj.319.7213.820; Parkin L, 2000, LANCET, V355, P2133, DOI 10.1016/S0140-6736(00)02382-5; POULTER NR, 1995, LANCET, V346, P1575; Spitzer WO, 1996, BRIT MED J, V312, P83; *STAT CORP, 1997, STAT STAT SOFTW REL; Suissa S, 1998, CONTRACEPTION, V57, P64	17	53	53	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 19	2000	321	7259					477	479		10.1136/bmj.321.7259.477	http://dx.doi.org/10.1136/bmj.321.7259.477			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	347MC	10948026	Bronze, Green Published			2022-12-28	WOS:000088932800019
J	Moseler, M; Landman, U				Moseler, M; Landman, U			Formation, stability, and breakup of nanojets	SCIENCE			English	Article							DROP FORMATION; FREE-SURFACE; LIQUID JET; DYNAMICS; FLOWS	Atomistic molecular dynamics simulations reveal the formation of nanojets with velocities up to 400 meters per second, created by pressurized injection of fluid propane through nanoscale convergent gold nozzles with heating or coating of the nozzle exterior surface to prevent formation of thick blocking films. The atomistic description is related to continuum hydrodynamic modeling through the derivation of a stochastic Lubrication equation that includes thermally triggered fluctuations whose influence on the dynamical evolution increases as the jet dimensions become smaller. Emergence of double-cone neck shapes is predicted when the jet approaches nanoscale molecular dimensions, deviating from the Long-thread universal similarity solution obtained in the absence of such fluctuations.	Georgia Inst Technol, Sch Phys, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology	Landman, U (corresponding author), Georgia Inst Technol, Sch Phys, Atlanta, GA 30332 USA.		Moseler, Michael/AAV-4925-2021	Moseler, Michael/0000-0002-7064-1351				[Anonymous], 1878, NEUZEIT 1004, P3; BECHTEL SE, 1992, STABILITY APPL ANAL, V2, P59; BRENNER MP, 1994, PHYS REV LETT, V73, P3391, DOI 10.1103/PhysRevLett.73.3391; Chandrasekhar S., 1961, HYDRODYNAMIC HYDRODY; Chesnokov YG, 1998, APPL SCI RES, V59, P77; EGGERS J, 1994, J FLUID MECH, V262, P205, DOI 10.1017/S0022112094000480; Eggers J, 1997, REV MOD PHYS, V69, P865, DOI 10.1103/RevModPhys.69.865; FOX RF, 1970, PHYS FLUIDS, V13, P1893, DOI 10.1063/1.1693183; Furth PA, 1997, MOL BIOTECHNOL, V7, P139, DOI 10.1007/BF02761749; Hayes DJ, 1998, J ELECTRON MANUF, V8, P209, DOI 10.1142/S0960313198000197; Israelachvili J.N., 1991, INTERMOLECULAR SURFA; JORGENSEN WL, 1984, J AM CHEM SOC, V106, P6638, DOI 10.1021/ja00334a030; Kawano S, 1998, PHYS REV E, V58, P4468, DOI 10.1103/PhysRevE.58.4468; KELLER JB, 1983, SIAM J APPL MATH, V43, P268, DOI 10.1137/0143018; Kenyon R. W., 1996, CHEM TECHNOLOGY PRIN, P113; KOPLIK J, 1993, PHYS FLUIDS A-FLUID, V5, P521, DOI 10.1063/1.858879; KUO K, 1996, RECENT ADV SPRAY COM, V1; KUO K, 1996, RECENT ADV SPRAY COM, V2; Landau L.D., 1984, FLUID MECH; LEE HC, 1974, IBM J RES DEV, V18, P364, DOI 10.1147/rd.184.0364; Lin SP, 1998, ANNU REV FLUID MECH, V30, P85, DOI 10.1146/annurev.fluid.30.1.85; McCarthy M. J., 1974, Chemical Engineering Journal, V7, P1, DOI 10.1016/0300-9467(74)80021-3; Middleman S, 1995, MODELING AXISYMMETRI; OH DJ, 1988, J MATER RES, V3, P471, DOI 10.1557/JMR.1988.0471; PEREGRINE DH, 1990, J FLUID MECH, V212, P25, DOI 10.1017/S0022112090001835; PLOEG P, 1982, J CHEM PHYS, V76, P3271; Rayleigh L., 1892, PHILOS MAG, V34, P145, DOI [10.1080/14786449208620301, DOI 10.1080/14786449208620301]; SHI XD, 1994, SCIENCE, V265, P219, DOI 10.1126/science.265.5169.219; Summers DA., 1995, WATERJETTING TECHNOL, V1; Weber C, 1931, Z ANGEW MATH MECH, V11, P136, DOI 10.1002/zamm.19310110207; XIA TK, 1992, PHYS REV LETT, V69, P1967, DOI 10.1103/PhysRevLett.69.1967; Yamaguchi K., 1997, P 1997 INT S MICR HU, P33; Yarin A.L., 1993, FREE LIQUID JETS FIL	33	308	313	5	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 18	2000	289	5482					1165	1169		10.1126/science.289.5482.1165	http://dx.doi.org/10.1126/science.289.5482.1165			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	346JE	10947978	Green Submitted			2022-12-28	WOS:000088866600034
J	Triplett, W				Triplett, W			NASA pins hopes on bigger, costlier mission to Mars	NATURE			English	News Item																		2000, NATURE, V406, P554	1	0	0	0	1	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 17	2000	406	6797					666	666		10.1038/35021275	http://dx.doi.org/10.1038/35021275			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	344PH	10963566	Bronze			2022-12-28	WOS:000088767700009
J	Walsh, C				Walsh, C			Molecular mechanisms that confer antibacterial drug resistance	NATURE			English	Review							2-COMPONENT SIGNAL-TRANSDUCTION; ENTEROCOCCUS-FAECIUM BACTEREMIA; STAPHYLOCOCCUS-AUREUS; ANTIBIOTIC-RESISTANCE; BACTERIAL-RESISTANCE; CRYSTAL-STRUCTURE; NATURAL-PRODUCTS; VANCOMYCIN; PROTEIN; TARGET	Antibiotics - compounds that are literally 'against life' - are typically antibacterial drugs, interfering with some structure or process that is essential to bacterial growth or survival without harm to the eukaryotic host harbouring the infecting bacteria. We live in an era when antibiotic resistance has spread at an alarming rate(1-4) and when dire predictions concerning the lack of effective antibacterial drugs occur with increasing frequency. In this context it is apposite to ask a few simple questions about these life-saving molecules. What are antibiotics? Where do they come from? How do they work? Why do they stop being effective? How do we find new antibiotics? And can we slow down the development of antibiotic-resistant superbugs?	Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Walsh, C (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.							AGOURIDAS C, 1995, 35 INT C ANT AG CHEM, pF158; ARTHUR M, 1993, ANTIMICROB AGENTS CH, V37, P1563, DOI 10.1128/AAC.37.8.1563; Barrett J. F., 1995, ANNU REP MED CHEM, V30, P111, DOI 10.1016/s0065-7743(08)60925-2; Barrett JF, 1998, ANTIMICROB AGENTS CH, V42, P1529, DOI 10.1128/AAC.42.7.1529; BARRY AL, 1995, ANTIMICROB AGENTS CH, V39, P238, DOI 10.1128/AAC.39.1.238; Biavasco F, 1997, ANTIMICROB AGENTS CH, V41, P2165, DOI 10.1128/AAC.41.10.2165; BRISSONNOEL A, 1988, J ANTIMICROB CHEMOTH, V22, P13, DOI 10.1093/jac/22.Supplement_B.13; BUGG TDH, 1991, BIOCHEMISTRY-US, V30, P10408, DOI 10.1021/bi00107a007; Bussiere DE, 1998, BIOCHEMISTRY-US, V37, P7103, DOI 10.1021/bi973113c; Cane DE, 1998, SCIENCE, V282, P63, DOI 10.1126/science.282.5386.63; Chan MK, 1997, BIOCHEMISTRY-US, V36, P13904, DOI 10.1021/bi9711543; Chen DZ, 2000, BIOCHEMISTRY-US, V39, P1256, DOI 10.1021/bi992245y; Chien JW, 2000, CLIN INFECT DIS, V30, P146, DOI 10.1086/313597; Chopra I, 1997, ANTIMICROB AGENTS CH, V41, P497, DOI 10.1128/AAC.41.3.497; Chopra I., 1985, HDB EXPT PHARM, V78, P317; Chow JW, 1997, CLIN INFECT DIS, V24, P90, DOI 10.1093/clinids/24.1.90; Chu DTW, 1996, J MED CHEM, V39, P3853, DOI 10.1021/jm960294s; DAVIES J, 1994, SCIENCE, V264, P375, DOI 10.1126/science.8153624; Davies J, 1996, NATURE, V383, P219, DOI 10.1038/383219a0; FERRERO L, 1995, ANTIMICROB AGENTS CH, V39, P1554, DOI 10.1128/AAC.39.7.1554; Fourmy D, 1996, SCIENCE, V274, P1367, DOI 10.1126/science.274.5291.1367; Ge M, 1999, SCIENCE, V284, P507, DOI 10.1126/science.284.5413.507; Gold HS, 1996, NEW ENGL J MED, V335, P1445, DOI 10.1056/NEJM199611073351907; Hon WC, 1997, CELL, V89, P887, DOI 10.1016/S0092-8674(00)80274-3; JACOBY GA, 1991, NEW ENGL J MED, V324, P601, DOI 10.1056/NEJM199102283240906; Katz L, 1997, CHEM REV, V97, P2557, DOI 10.1021/cr960025+; Khosla C, 1997, CHEM REV, V97, P2577, DOI 10.1021/cr960027u; Kleerebezem M, 1997, MOL MICROBIOL, V24, P895, DOI 10.1046/j.1365-2958.1997.4251782.x; Kloss P, 1999, J MOL BIOL, V294, P93, DOI 10.1006/jmbi.1999.3247; KNOWLES JR, 1985, ACCOUNTS CHEM RES, V18, P97, DOI 10.1021/ar00112a001; Kurz M, 1996, BIOCHEMISTRY-US, V35, P12570, DOI 10.1021/bi961017q; Leadlay PF, 1997, CURR OPIN CHEM BIOL, V1, P162, DOI 10.1016/S1367-5931(97)80005-1; Levy SB, 1998, NEW ENGL J MED, V338, P1376, DOI 10.1056/NEJM199805073381909; Levy SB, 1998, SCI AM, V278, P46, DOI 10.1038/scientificamerican0398-46; LEVY SB, 1992, ANTIMICROB AGENTS CH, V36, P695, DOI 10.1128/AAC.36.4.695; Linden PK, 1997, J ANTIMICROB CHEMOTH, V39, P145, DOI 10.1093/jac/39.suppl_1.145; Maxwell A, 1997, TRENDS MICROBIOL, V5, P102, DOI 10.1016/S0966-842X(96)10085-8; McDaniel R, 1999, P NATL ACAD SCI USA, V96, P1846, DOI 10.1073/pnas.96.5.1846; Murray BE, 1997, AM J MED, V102, P284, DOI 10.1016/S0002-9343(99)80270-8; NELSON ML, 1994, J MED CHEM, V37, P1355, DOI 10.1021/jm00035a016; NEU HC, 1992, SCIENCE, V257, P1064, DOI 10.1126/science.257.5073.1064; Paulsen IT, 1996, MICROBIOL REV, V60, P575, DOI 10.1128/MMBR.60.4.575-608.1996; Philippon A., 1985, ANTIMICROB AGENTS CH, V28, P302; Reimmann C, 1997, MOL MICROBIOL, V24, P309, DOI 10.1046/j.1365-2958.1997.3291701.x; ROSS JI, 1990, MOL MICROBIOL, V4, P1207, DOI 10.1111/j.1365-2958.1990.tb00696.x; Schentag JJ, 1998, CLIN INFECT DIS, V26, P1204, DOI 10.1086/520287; SHAW KJ, 1993, MICROBIOL REV, V57, P138, DOI 10.1128/MMBR.57.1.138-163.1993; Shen Linus L., 1993, P77; Shlaes DM, 1997, CLIN INFECT DIS, V25, P584, DOI 10.1086/513766; Sofia MJ, 1999, J MED CHEM, V42, P3193, DOI 10.1021/jm990212a; SONG MD, 1987, FEBS LETT, V221, P167, DOI 10.1016/0014-5793(87)80373-3; SPRATT BG, 1988, REV INFECT DIS, V10, P699; SPRATT BG, 1994, SCIENCE, V264, P388, DOI 10.1126/science.8153626; Stephens C, 1997, CHEM BIOL, V4, P637, DOI 10.1016/S1074-5521(97)90217-9; Tan DS, 1998, J AM CHEM SOC, V120, P8565, DOI 10.1021/ja981746o; Waldvogel FA, 1999, NEW ENGL J MED, V340, P556, DOI 10.1056/NEJM199902183400709; Walsh C, 1999, SCIENCE, V284, P442, DOI 10.1126/science.284.5413.442; Walsh CT, 1996, CHEM BIOL, V3, P21, DOI 10.1016/S1074-5521(96)90079-4; Williams DH, 1996, NAT PROD REP, V13, P469, DOI 10.1039/np9961300469; Williams DH, 1998, SCIENCE, V280, P711, DOI 10.1126/science.280.5364.711; Witte W, 1998, SCIENCE, V279, P996, DOI 10.1126/science.279.5353.996; Zhao LS, 1999, J AM CHEM SOC, V121, P9881, DOI 10.1021/ja992810k; 1999, MED LETT, V41, P95; 2000, MED LETT, V42, P1	64	1075	1124	17	565	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 17	2000	406	6797					775	781		10.1038/35021219	http://dx.doi.org/10.1038/35021219			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	344PH	10963607				2022-12-28	WOS:000088767700054
J	Rothman, KJ; Michels, KB; Baum, M				Rothman, KJ; Michels, KB; Baum, M			For and against - Declaration of Helsinki should be strengthened	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CLINICAL RESEARCH; PLACEBO ORTHODOXY; ETHICS; MYTHS	The World Medical Association is now debating the next revision of the Declaration of Helsinki. Kenneth Rothman and Karin Michels argue that critics of the declaration, notably the US Food and Drug Administration, are trying to give scientists greater latitude than the declaration allows. In particular, Rothman and Michels dispute the morality of performing placebo controlled trials when there is an existing accepted treatment, and they offer other suggestions to strengthen the protection of patients who participate in medical experiments. Michael Baum argues against their absolutism on this issue and against what he considers their anti-science stance.	Boston Univ, Sch Publ Hlth, Med Ctr, Dept Epidemiol & Biostat, Boston, MA 02118 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Obstet & Gynecol Epidemiol Ctr, Boston, MA 02115 USA; UCL, Dept Surg, London W1P 7LD, England	Boston University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of London; University College London	Rothman, KJ (corresponding author), Boston Univ, Sch Publ Hlth, Med Ctr, Dept Epidemiol & Biostat, Boston, MA 02118 USA.	KRothman@bu.edu		Rothman, Kenneth/0000-0003-2398-1705				Angell M, 2000, NEW ENGL J MED, V342, P967, DOI 10.1056/NEJM200003303421309; Angell M, 1997, NEW ENGL J MED, V337, P847, DOI 10.1056/NEJM199709183371209; Brennan TA, 1999, NEW ENGL J MED, V341, P527, DOI 10.1056/NEJM199908123410712; DENNY WF, 1995, NEW ENGL J MED, V332, P61; FREEDMAN B, 1987, NEW ENGL J MED, V317, P141, DOI 10.1056/NEJM198707163170304; Freedman B, 1996, J LAW MED ETHICS, V24, P243, DOI 10.1111/j.1748-720X.1996.tb01859.x; Freedman B, 1996, J LAW MED ETHICS, V24, P252, DOI 10.1111/j.1748-720X.1996.tb01860.x; HILL AB, 1963, BMJ-BRIT MED J, P1043, DOI 10.1136/bmj.1.5337.1043; LASAGNA L, 1995, J CLIN PSYCHOPHARM, V15, P96, DOI 10.1097/00004714-199504000-00002; Levine RJ, 1999, NEW ENGL J MED, V341, P531, DOI 10.1056/NEJM199908123410713; Lurie P, 1997, NEW ENGL J MED, V337, P853, DOI 10.1056/NEJM199709183371212; NICHOLSON RH, 2000, HASTINGS CTR REP JAN; Rothman KJ, 1996, BMJ-BRIT MED J, V313, P3, DOI 10.1136/bmj.313.7048.3a; ROTHMAN KJ, 1994, NEW ENGL J MED, V331, P394, DOI 10.1056/NEJM199408113310611; Shapiro A. K., 1997, PLACEBO EFFECT INTER; Temple R, 1982, DRUG INF J, V10-17, DOI DOI 10.1177/009286158201600102; Temple Robert, 1996, Account Res, V4, P267, DOI 10.1080/08989629608573887; Tramer MR, 1998, BMJ-BRIT MED J, V317, P875, DOI 10.1136/bmj.317.7162.875; Varmus H, 1997, NEW ENGL J MED, V337, P1003, DOI 10.1056/NEJM199710023371411; *WORLD MED ASS DEC, 1997, JAMA-J AM MED ASSOC, V277, P925, DOI DOI 10.1001/JAMA.1997.03540350075038; 1998, LANCET, V351, P225	21	61	67	1	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 12	2000	321	7258					442	445		10.1136/bmj.321.7258.442	http://dx.doi.org/10.1136/bmj.321.7258.442			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	344QC	10938059	Green Published			2022-12-28	WOS:000088769500030
J	Stratton, IM; Adler, AI; Neil, HAW; Matthews, DR; Manley, SE; Cull, CA; Hadden, D; Turner, RC; Holman, RR				Stratton, IM; Adler, AI; Neil, HAW; Matthews, DR; Manley, SE; Cull, CA; Hadden, D; Turner, RC; Holman, RR		UK Prospective Diabetes Study Grp	Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY HEART-DISEASE; RISK-FACTORS; CARDIOVASCULAR MORTALITY; SENSORY NEUROPATHY; GLYCEMIC THRESHOLD; FOLLOW-UP; MELLITUS; NIDDM; GLUCOSE; STROKE	Objective To determine the relation between exposure to glycaemia over time and the risk of macro vascular or microvascular complications in patients with type 2 diabetes. Design Prospective observational study. Setting 23 hospital based clinics in England, Scotland, and Northern ireland. Participants 4585 white, Asian Indian, and Afro-Caribbean UKPDS patients, whether randomised or not to treatment, were included in analyses of incidence; of these, 3642 were included in analyses of relative risk. Outcome measures Primary predefined aggregate clinical outcomes: any end point or deaths related to diabetes and all cause mortality. Secondary aggregate outcomes: myocardial infarction, stroke, amputation (including death from peripheral vascular disease), and microvascular disease (predominantly retinal photocoagulation). Single end points: non-fatal heart failure and cataract extraction. Risk reduction associated with a 1% reduction in updated mean HbA(1c) adjusted for possible confounders at diagnosis of diabetes. Results The incidence of clinical complications was significantly associated with glycaemia. Each 1% reduction in updated mean HbA(1c) was associated with reductions in risk of 21% for any end point related to diabetes (95% confidence interval 17% to 24%, P < 0.0001), 21% for deaths related to diabetes (15% to 27%, P < 0.0001), 14% for myocardial infarction (8% to 21%, P< 0.0001), and 37% for microvascular complications (33% to 41%, P < 0.0001). No threshold of risk was observed for any end point Conclusions Ln patients with type 2 diabetes the risk of diabetic complications was strongly associated with previous hyperglycaemia. Any reduction in HbA(1c) is likely to reduce the risk of complications, with the lowest risk being in those with HbA(1c) values in the normal range (< 6.0%).	Univ Oxford, Radcliffe Infirm, Oxford Ctr Diabet Endocrinol & Metab, Diabet Trials Unit, Oxford OX2 6HE, England; Univ Oxford, Inst Hlth Sci, Div Publ Hlth & Primary Care, Oxford OX3 7LF, England; Royal Victoria Hosp, Belfast BT12 6BA, Antrim, North Ireland; Univ Oxford, Radcliffe Infirm, Oxford Ctr Diabet Endocrinol & Metab, Diabet Res Labs, Oxford OX2 6HE, England	Radcliffe Infirmary; University of Oxford; University of Oxford; Radcliffe Infirmary; University of Oxford	Stratton, IM (corresponding author), Univ Oxford, Radcliffe Infirm, Oxford Ctr Diabet Endocrinol & Metab, Diabet Trials Unit, Oxford OX2 6HE, England.	irene.stratton@dtu.ox.ac.uk	stratton, irene/AAZ-3627-2020	stratton, irene/0000-0003-1172-7865; Manley, Susan/0000-0002-8298-4511				Adler A, 1998, DIABETES, V47, pA71; Adler AI, 1999, DIABETES CARE, V22, P1029, DOI 10.2337/diacare.22.7.1029; Adler AI, 2000, BMJ-BRIT MED J, V321, P412, DOI 10.1136/bmj.321.7258.412; Adler AI, 1997, DIABETES CARE, V20, P1162, DOI 10.2337/diacare.20.7.1162; Agresti A., 1990, CATEGORICAL DATA ANA, pXV; *AM DIAB ASS, 1998, DIABETES CARE S1, V21, P5; [Anonymous], 1996, DIABETES, V45, P1289; Balkau B, 1999, DIABETES CARE, V22, P696, DOI 10.2337/diacare.22.5.696; Balkau B, 1998, DIABETES CARE, V21, P360, DOI 10.2337/diacare.21.3.360; Breslow NE., 1987, STAT METHODS CANC RE, P81; Coutinho M, 1999, DIABETES CARE, V22, P233, DOI 10.2337/diacare.22.2.233; Cull CA, 1997, CLIN CHEM, V43, P1913; EASTON DF, 1991, STAT MED, V10, P1025, DOI 10.1002/sim.4780100703; FRANKLIN GM, 1994, DIABETES CARE, V17, P1172, DOI 10.2337/diacare.17.10.1172; FULLER JH, 1983, BMJ-BRIT MED J, V287, P867, DOI 10.1136/bmj.287.6396.867; GOODKIN G, 1975, J OCCUP ENVIRON MED, V17, P716; Groeneveld Y, 1999, DIABETIC MED, V16, P2, DOI 10.1046/j.1464-5491.1999.00003.x; Hanefeld M, 1996, DIABETOLOGIA, V39, P1577, DOI 10.1007/s001250050617; HARRIS M, 1993, DIABETES CARE, V16, P1446, DOI 10.2337/diacare.16.11.1446; JARRETT RJ, 1976, LANCET, V2, P1009; KLEIN R, 1995, DIABETES CARE, V18, P258, DOI 10.2337/diacare.18.2.258; KNUIMAN MW, 1992, AM J EPIDEMIOL, V135, P638, DOI 10.1093/oxfordjournals.aje.a116343; KROLEWSKI AS, 1995, NEW ENGL J MED, V332, P1251, DOI 10.1056/NEJM199505113321902; KUUSISTO J, 1994, DIABETES, V43, P960, DOI 10.2337/diabetes.43.8.960; Lehto S, 1996, STROKE, V27, P63, DOI 10.1161/01.STR.27.1.63; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; Manley SE, 2000, DIABETES, V49, pA180; MANLEY SE, 1994, DIABETIC MED, V11, P534; Orchard TJ, 1997, ARCH INTERN MED, V157, P1851, DOI 10.1001/archinte.157.16.1851; PALUMBO PJ, 1976, DIABETES, V25, P566, DOI 10.2337/diabetes.25.7.566; PANZRAM G, 1987, DIABETOLOGIA, V30, P123, DOI 10.1007/BF00274216; PETTITT DJ, 1980, LANCET, V2, P1050; Pirart J., 1978, DIABETES CARE, V1, P168, DOI 10.2337/diacare.1.3.168; *SAS I, 1990, SAS VERS 6; SASAKI A, 1983, Tohoku Journal of Experimental Medicine, V141, P639; STAMLER J, 1993, DIABETES CARE, V16, P434, DOI 10.2337/diacare.16.2.434; STAMLER J, 1987, CARDIOLOGY, P1; Standl E, 1996, DIABETOLOGIA, V39, P1540, DOI 10.1007/s001250050612; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Turner RC, 1998, BMJ-BRIT MED J, V316, P823, DOI 10.1136/bmj.316.7134.823; TURNER RC, 1991, DIABETOLOGIA, V34, P877; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; UUSITUPA MIJ, 1993, DIABETOLOGIA, V36, P1175, DOI 10.1007/BF00401063; Wei M, 1998, DIABETES CARE, V21, P1167, DOI 10.2337/diacare.21.7.1167; WETTERHALL SF, 1992, DIABETES CARE, V15, P960, DOI 10.2337/diacare.15.8.960; Wright A, 1998, ANN INTERN MED, V128, P165, DOI 10.7326/0003-4819-128-3-199802010-00001	47	5660	6037	13	357	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 12	2000	321	7258					405	412		10.1136/bmj.321.7258.405	http://dx.doi.org/10.1136/bmj.321.7258.405			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	344QC	10938048	Green Published, Bronze			2022-12-28	WOS:000088769500019
J	Gershon, D				Gershon, D			Collaborations prepare to untangle the circuitry of the brain	NATURE			English	Article																			0	0	0	0	1	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 3	2000	406	6795					545	546		10.1038/35020199	http://dx.doi.org/10.1038/35020199			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	340ML	10952319				2022-12-28	WOS:000088538000053
J	Neumann, P; Koeniger, N; Koeniger, G; Tingek, S; Kryger, P; Moritz, RFA				Neumann, P; Koeniger, N; Koeniger, G; Tingek, S; Kryger, P; Moritz, RFA			Entomology - Home-site fidelity in migratory honeybees	NATURE			English	Article							DORSATA; POLYANDRY		Univ Halle Wittenberg, Inst Zool, D-06099 Halle, Germany; Rhodes Univ, Dept Zool & Entomol, ZA-6140 Grahamstown, South Africa; Goethe Univ Frankfurt, D-61440 Oberursel, Germany; Agr Res Stn, Tenom 89908, Sabah, Malaysia; Univ Pretoria, Dept Zool & Entomol, ZA-0001 Pretoria, South Africa	Martin Luther University Halle Wittenberg; Rhodes University; Goethe University Frankfurt; University of Pretoria	Neumann, P (corresponding author), Univ Halle Wittenberg, Inst Zool, D-06099 Halle, Germany.	p.neumann@ru.ac.za	Neumann, Peter/C-9964-2015; Kryger, Per/C-1773-2013; Moritz, Robin FA/K-6053-2012	Neumann, Peter/0000-0001-5163-5215; Kryger, Per/0000-0001-5306-3230; Moritz, Robin FA/0000-0003-0791-887X				BREED MD, 1995, ANIM BEHAV, V50, P489, DOI 10.1006/anbe.1995.0263; ESTOUP A, 1994, P ROY SOC B-BIOL SCI, V258, P1, DOI 10.1098/rspb.1994.0133; ESTOUP A, 1993, NUCLEIC ACIDS RES, V21, P1427, DOI 10.1093/nar/21.6.1427; KOENIGER N, 1980, J APICULT RES, V19, P21, DOI 10.1080/00218839.1980.11099994; LINDAUER M, 1956, Z VERGL PHYSIOL, V38, P521, DOI 10.1007/BF00341108; MORITZ RFA, 1995, BEHAV ECOL SOCIOBIOL, V37, P357, DOI 10.1007/BF00174141; Neumann P, 1999, APIDOLOGIE, V30, P505, DOI 10.1051/apido:19990605; Oldroyd BP, 1996, ANN ENTOMOL SOC AM, V89, P276, DOI 10.1093/aesa/89.2.276; Otis G.W., 1990, P378; RUTTNER F, 1988, TAXONOMY BIOGEOGRAPH; THAPA R, 1999, SOCIAL INSECTS TURN, P469; VISSCHER PK, 1985, INSECT SOC, V32, P217, DOI 10.1007/BF02224236	12	31	37	0	18	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 3	2000	406	6795					474	475		10.1038/35020193	http://dx.doi.org/10.1038/35020193			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	340ML	10952299				2022-12-28	WOS:000088538000033
J	Sternberg, RJ				Sternberg, RJ			Perspectives: Cognition - The Holey Grail of general intelligence	SCIENCE			English	Editorial Material									Yale Univ, Dept Psychol, New Haven, CT 06520 USA	Yale University	Sternberg, RJ (corresponding author), Yale Univ, Dept Psychol, Box 208205, New Haven, CT 06520 USA.	robert.sternberg@yale.edu						Binet A., 1916, DEV INTELLIGENCE CHI; BORING EG, 1923, NEW REPUBLIC, P35; Carroll J. B., 1993, HUMAN COGNITIVE ABIL, DOI DOI 1017/CBO9780511571312; Duncan J, 2000, SCIENCE, V289, P457, DOI 10.1126/science.289.5478.457; HAIER RJ, 1992, INTELLIGENCE, V16, P415, DOI 10.1016/0160-2896(92)90018-M; Jensen A.R., 1998, G FACTOR SCI MENTAL; Klintsova AY, 1999, CURR OPIN NEUROBIOL, V9, P203, DOI 10.1016/S0959-4388(99)80028-2; Sternberg R., 1999, REV GEN PSYCHOL, V3, P292, DOI [DOI 10.1037/1089-2680.3.4.292, 10.1037/1089-2680.3.4.292]; Sternberg R. J., 2000, PRACTICAL INTELLIGEN; Sternberg R. J., 1985, IQ TRIARCHIC THEORY; Sternberg RJ, 1999, EUR J PSYCHOL ASSESS, V15, P3, DOI 10.1027//1015-5759.15.1.3; STERNBERG RJ, IN PRESS INTELLIGENC; STERNBERG RJ, IN PRESS EUR J PSYCH; Wechsler D., 1939, MEASUREMENT ADULT IN; 2000, US NEWS WORLD R 0403, P20	15	34	35	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 21	2000	289	5478					399	+		10.1126/science.289.5478.399	http://dx.doi.org/10.1126/science.289.5478.399			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	336ME	10939950				2022-12-28	WOS:000088305500026
J	Adamek, HE; Albert, J; Breer, H; Weitz, M; Schilling, D; Riemann, JF				Adamek, HE; Albert, J; Breer, H; Weitz, M; Schilling, D; Riemann, JF			Pancreatic cancer detection with magnetic resonance cholangiopancreatography and endoscopic retrograde cholangiopancreatography: a prospective controlled study	LANCET			English	Article							BILE-DUCT OBSTRUCTION; SPIN-ECHO TECHNIQUE; PHASE HELICAL CT; MR-CHOLANGIOPANCREATOGRAPHY; CHOLANGIOGRAPHY; ERCP; DIAGNOSIS; CHOLEDOCHOLITHIASIS; COMPLICATIONS; SONOGRAPHY	Background Magnetic resonance cholangiopancreatography (MRCP) is a non-invasive and increasingly used procedure in cases involving biliary and pancreatic diseases. However, the accuracy of MRCP in differential diagnosis between pancreatic cancer and chronic pancreatitis has never been documented in a large prospective controlled study. Methods 124 patients were recruited for the study, selected from 141 consecutive patients with an average age of 55 years (range 19-80) who presented to our department between February, 1996, and January, 1998, with a strong clinical suspicion of pancreatic cancer. MRCP images were interpreted by a radiologist and a gastroenterologist who were unaware of the clinical diagnosis of patients. The exact diagnosis was based upon histological evidence from biopsy examination (surgical and fine needle biopsy) or a followup of at least 12 months. Findings Of the 124 patients, 37 (30%) had pancreatic carcinoma; 17 (14%) had other neoplastic pancreatic diseases; 57 (46%) had chronic pancreatitis; 13 (10%) pancreatic ducts were dear. The sensitivity of MRCP with respect to diagnosing pancreatic cancer was 84% and its specificity 97%. The corresponding values for endoscopic retrograde cholangiopancreatography (ERCP) were 70% and 94%, cholangiopancreatography respectively. Interpretation MRCP is as sensitive as ERCP when detecting pancreatic carcinomas. Furthermore, it is feasible to presume that the use of MRCP may prevent inappropriate explorations of the pancreatic and common bileducts in cases of suspected pancreatic carcinomas, where interventional endoscopic therapy (ie, palliative common-bileduct drainage) is unlikely.	Johannes Gutenberg Univ Mainz, Acad Hosp, Klinikum Ludwigshafen, Dept Med, Ludwigshafen, Germany; Johannes Gutenberg Univ Mainz, Acad Hosp, Klinikum Ludwigshafen, Dept Radiol, Ludwigshafen, Germany	Johannes Gutenberg University of Mainz; Ludwigshafen Hospital; Johannes Gutenberg University of Mainz; Ludwigshafen Hospital	Adamek, HE (corresponding author), Klinikum Stadt Ludwigshafen, Dept Med C, Bremserstr 79, D-67063 Ludwigshafen, Germany.							Adamek HE, 1997, ENDOSCOPY, V29, P741, DOI 10.1055/s-2007-1004299; Adamek HE, 1998, GUT, V43, P680, DOI 10.1136/gut.43.5.680; Barish MA, 1999, NEW ENGL J MED, V341, P258, DOI 10.1056/NEJM199907223410407; BARISH MA, 1995, AM J ROENTGENOL, V165, P295, DOI 10.2214/ajr.165.2.7618543; BILBAO MK, 1976, GASTROENTEROLOGY, V70, P314; BRANSHALL SR, 1998, INT J PANCREATOL, V23, P83; Diehl SJ, 1999, ROFO-FORTSCHR RONTG, V170, P463, DOI 10.1055/s-2007-1011074; Diehl SJ, 1998, RADIOLOGY, V206, P373, DOI 10.1148/radiology.206.2.9457188; Fulcher AS, 1998, RADIOLOGY, V207, P21, DOI 10.1148/radiology.207.1.9530295; GUIBAUD L, 1995, RADIOLOGY, V197, P109, DOI 10.1148/radiology.197.1.7568807; Hintze RE, 1997, ENDOSCOPY, V29, P182, DOI 10.1055/s-2007-1004160; Holzknecht N, 1998, RADIOLOGY, V206, P657, DOI 10.1148/radiology.206.3.9494483; ISHIZAKI Y, 1993, AM J GASTROENTEROL, V88, P2072; Koito K, 1998, RADIOLOGY, V208, P231, DOI 10.1148/radiology.208.1.9646818; Kubo S, 1997, AM J GASTROENTEROL, V92, P629; LAUBENBERGER R, 1995, MAGNET RESON MED, V33, P18, DOI 10.1002/mrm.1910330104; Legmann P, 1998, AM J ROENTGENOL, V170, P1315, DOI 10.2214/ajr.170.5.9574609; Lomanto D, 1997, AM J SURG, V174, P33, DOI 10.1016/S0002-9610(97)00022-6; Loperfido S, 1998, GASTROINTEST ENDOSC, V48, P1, DOI 10.1016/S0016-5107(98)70121-X; Matos C, 1997, RADIOLOGY, V203, P435, DOI 10.1148/radiology.203.2.9114101; ROSCH T, 1992, GASTROENTEROLOGY, V102, P188; Rosewicz S, 1997, LANCET, V349, P485; SOTO JA, 1995, RADIOLOGY, V196, P459, DOI 10.1148/radiology.196.2.7617861; Soto JA, 1996, GASTROENTEROLOGY, V110, P589, DOI 10.1053/gast.1996.v110.pm8566608; SUGIYAMA M, 1998, AM J GASTROENTEROL, V93, P156; Ueno E, 1998, PANCREAS, V16, P418, DOI 10.1097/00006676-199804000-00034; Zidi SH, 1999, GUT, V44, P118, DOI 10.1136/gut.44.1.118	27	171	185	1	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 15	2000	356	9225					190	193		10.1016/S0140-6736(00)02479-X	http://dx.doi.org/10.1016/S0140-6736(00)02479-X			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	334GQ	10963196				2022-12-28	WOS:000088179100009
J	LaPook, JD; Magun, AM; Nickerson, KG; Meltzer, JI				LaPook, JD; Magun, AM; Nickerson, KG; Meltzer, JI			Sheep, watercress, and the Internet	LANCET			English	Article									Columbia Presbyterian Med Ctr, Dept Med, New York, NY 10032 USA	Columbia University; NewYork-Presbyterian Hospital	LaPook, JD (corresponding author), 16 E 60th St, New York, NY 10022 USA.							Behm CA, 1999, FASCIOLOSIS, P185; SINCLAIR KB, 1968, RES VET SCI, V9, P181	2	17	17	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 15	2000	356	9225					218	218		10.1016/S0140-6736(00)02484-3	http://dx.doi.org/10.1016/S0140-6736(00)02484-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	334GQ	10963201				2022-12-28	WOS:000088179100014
J	Platzer, J; Engel, J; Schrott-Fischer, A; Stephan, K; Bova, S; Chen, H; Zheng, H; Striessnig, J				Platzer, J; Engel, J; Schrott-Fischer, A; Stephan, K; Bova, S; Chen, H; Zheng, H; Striessnig, J			Congenital deafness and sinoatrial node dysfunction in mice lacking class D L-type Ca2+ channels	CELL			English	Article							STATIONARY NIGHT BLINDNESS; SENSITIVE CALCIUM CHANNELS; HEART-RATE REGULATION; HAIR-CELLS; BETA-SUBUNIT; FUNCTIONAL EXPRESSION; CREB PHOSPHORYLATION; HIPPOCAMPAL-NEURONS; KINETIC-ANALYSIS; GENE-EXPRESSION	Voltage-Elated L-type Ca2+ channels (LTCCs) containing a pore-forming alpha 1D subunit (D-LTCCs) are expressed in neurons and neuroendocrine cells. Their relative contribution to total L-type Ca2+ currents and their physiological role and significance as a drug target remain unknown. Therefore, we generated D-LTCC deficient mice (alpha 1D(-/-)) that were viable with no major disturbances of glucose metabolism. alpha 1D(-/-) mice were deaf due to the complete absence of L-type currents in cochlear inner hair cells and degeneration of outer and inner hair cells. In wild-type controls, D-LTCC-mediated currents showed low activation thresholds and slow inactivation kinetics. Electrocardiogram recordings revealed sinoatrial node dysfunction (bradycardia and arrhythmia) in alpha 1D(-/-) mice. We conclude that alpha 1D can form LTCCs with negative activation thresholds essential for normal auditory function and control of cardiac pacemaker activity.	Inst Biochem Pharmakol, A-6020 Innsbruck, Austria; Univ Tubingen, HNO Klin, Sekt Sensor Biophys, Inst Physiol 2, D-72026 Tubingen, Germany; Univ Innsbruck, Klin Hals Nasen & Ohrenheilkunde, A-6020 Innsbruck, Austria; Univ Padua, Dipartimento Farmacol, I-35131 Padua, Italy; Merck Res Labs, Dept Metab Disorders, Rahway, NJ 07065 USA	Eberhard Karls University of Tubingen; University of Innsbruck; University of Padua; Merck & Company	Striessnig, J (corresponding author), Inst Biochem Pharmakol, Peter Mayrstr 1, A-6020 Innsbruck, Austria.	joerg.striessnig@uibk.ac.at	Tuluc, Petronel/C-2527-2011; Striessnig, Joerg/S-9334-2017; Stephan, Kurt/AAK-9124-2020	Striessnig, Joerg/0000-0002-9406-7120; schrott-fischer, Annelies/0000-0002-4514-9867				ASHCROFT FM, 1989, PROG BIOPHYS MOL BIO, V54, P87, DOI 10.1016/0079-6107(89)90013-8; Bech-Hansen NT, 1998, NAT GENET, V19, P264, DOI 10.1038/947; BOHMER A, 1988, ACTA OTO-LARYNGOL, V106, P368, DOI 10.3109/00016488809122259; Boyer C, 1998, EUR J NEUROSCI, V10, P971, DOI 10.1046/j.1460-9568.1998.00107.x; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; DIFRANCESCO D, 1991, J PHYSIOL-LONDON, V434, P23, DOI 10.1113/jphysiol.1991.sp018457; Forrest D, 1996, NAT GENET, V13, P354, DOI 10.1038/ng0796-354; FUCHS PA, 1990, J PHYSIOL-LONDON, V429, P553, DOI 10.1113/jphysiol.1990.sp018272; Glowatzki E, 1997, NEUROPHARMACOLOGY, V36, P1269, DOI 10.1016/S0028-3908(97)00108-1; Graef IA, 1999, NATURE, V401, P703, DOI 10.1038/44378; Green GE, 1996, J NEUROCHEM, V67, P37; GUO JQ, 1995, J PHYSIOL-LONDON, V483, P1; HAGIWARA N, 1988, J PHYSIOL-LONDON, V395, P233, DOI 10.1113/jphysiol.1988.sp016916; Hardingham GE, 1998, CELL CALCIUM, V23, P131, DOI 10.1016/S0143-4160(98)90111-7; HELL JW, 1993, J CELL BIOL, V123, P949, DOI 10.1083/jcb.123.4.949; HUDSPETH AJ, 1988, J PHYSIOL-LONDON, V400, P237, DOI 10.1113/jphysiol.1988.sp017119; IRISAWA H, 1993, PHYSIOL REV, V73, P197, DOI 10.1152/physrev.1993.73.1.197; Ison JR, 1997, HEARING RES, V106, P179, DOI 10.1016/S0378-5955(96)00216-X; IWASHIMA Y, 1993, DIABETES, V42, P948, DOI 10.2337/diabetes.42.7.948; Johansson C, 1997, ACTA PHYSIOL SCAND, V160, P133, DOI 10.1046/j.1365-201X.1997.00134.x; Jumrussirikul P, 1998, J CLIN INVEST, V102, P1279, DOI 10.1172/JCI2843; Kodama I, 1997, AM J PHYSIOL-HEART C, V272, pH2793, DOI 10.1152/ajpheart.1997.272.6.H2793; Kollmar R, 1997, P NATL ACAD SCI USA, V94, P14883, DOI 10.1073/pnas.94.26.14883; LIBERMAN MC, 1984, HEARING RES, V16, P55, DOI 10.1016/0378-5955(84)90025-X; Lopez I, 1999, NEUROSCIENCE, V92, P773, DOI 10.1016/S0306-4522(99)00005-6; MartinezDunst C, 1997, J NEUROSCI, V17, P9133; MIKAMI A, 1989, NATURE, V340, P230, DOI 10.1038/340230a0; Moser T, 2000, P NATL ACAD SCI USA, V97, P883, DOI 10.1073/pnas.97.2.883; MURPHY TH, 1991, NEURON, V7, P625, DOI 10.1016/0896-6273(91)90375-A; Pichler M, 1997, J BIOL CHEM, V272, P13877, DOI 10.1074/jbc.272.21.13877; Rajadhyaksha A, 1999, J NEUROSCI, V19, P6348; Safayhi H, 1997, MOL ENDOCRINOL, V11, P619, DOI 10.1210/me.11.5.619; SCHROTT A, 1990, EUR ARCH OTO-RHINO-L, V247, P8; SINGEWALD N, 1993, N-S ARCH PHARMACOL, V347, P21; Striessnig J, 1999, CELL PHYSIOL BIOCHEM, V9, P242, DOI 10.1159/000016320; STRIESSNIG J, 1990, P NATL ACAD SCI USA, V87, P9108, DOI 10.1073/pnas.87.23.9108; Strom TM, 1998, NAT GENET, V19, P260, DOI 10.1038/940; Takimoto K, 1997, J MOL CELL CARDIOL, V29, P3035, DOI 10.1006/jmcc.1997.0532; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; TAO X, 1998, NEURON, V20, P1297; Verheijck EE, 1999, AM J PHYSIOL-HEART C, V276, pH1064, DOI 10.1152/ajpheart.1999.276.3.H1064; Wickman K, 1998, NEURON, V20, P103, DOI 10.1016/S0896-6273(00)80438-9; WILLIAMS ME, 1992, NEURON, V8, P71, DOI 10.1016/0896-6273(92)90109-Q; YAMADA Y, 1995, GENOMICS, V27, P312, DOI 10.1006/geno.1995.1048; Zheng QY, 1999, HEARING RES, V130, P94, DOI 10.1016/S0378-5955(99)00003-9; ZIDANIC M, 1995, BIOPHYS J, V68, P1323, DOI 10.1016/S0006-3495(95)80305-X	46	631	655	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 7	2000	102	1					89	97		10.1016/S0092-8674(00)00013-1	http://dx.doi.org/10.1016/S0092-8674(00)00013-1			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	332UL	10929716	Bronze			2022-12-28	WOS:000088091700011
J	MacLean, CH; Louie, R; Leake, B; McCaffrey, DF; Paulus, HE; Brook, RH; Shekelle, PG				MacLean, CH; Louie, R; Leake, B; McCaffrey, DF; Paulus, HE; Brook, RH; Shekelle, PG			Quality of care for patients with rheumatoid arthritis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; ASSOCIATION TASK-FORCE; PRACTICE GUIDELINES; UNITED-STATES; PHYSICIAN MASTERFILE; DEATH; SENSITIVITY; MANAGEMENT; MAMMOGRAPHY; IMPROVEMENT	Context Patients with rheumatoid arthritis are at risk for substantial morbidity because of their arthritis and premature mortality due to comorbid diseases. However, little is known about the quality of the health care that these patients receive. Objective To assess the quality of the health care that rheumatoid arthritis patients receive for their arthritis, comorbid diseases, and health care maintenance and to determine the effect of patterns of specialty care on quality. Design, Setting, and Participants Historical cohort study of 1355 adult rheumatoid arthritis patients en rolled in the fee-for-service or discounted fee-for-service plans of a nationwide US insurance company, Patients were identified and followed up through administrative data between 1991 and 1995. Main Outcome Measures Quality scores for arthritis, comorbid disease, and health care maintenance were developed from performance on explicit process measures that related to each of these domains and described the percentage of indicated health care processes performed within each domain during each person-year of the study. Results During 4598 person-years of follow-up, quality scores were 62% (95% confidence interval [CI], 61%-64%) for arthritis care, 52% (95% CI, 49%-55%) for comorbid disease care, and 42% (95% CI, 40%-43%) for health care maintenance. Across domains, care patterns including relevant specialists yielded performance scores 30% to 187% higher than those that did not (P<.001) and 45% to 67% of person-years were associated with patterns of care that did not include a relevant specialist. Presence of primary care without specialty care yielded health care maintenance scores that were 43% higher than those for patterns that included neither primary nor relevant specialty care (P<.001). Conclusions In this population, health care quality appears to be suboptimal for arthritis, comorbid disease, and health care maintenance. Patterns of care that included relevant specialists were associated with substantially higher quality across all domains. Patterns that included generalists were associated with substantially higher quality health care maintenance than patterns that included neither a generalist nor a relevant specialist. The optimal roles of primary care physicians and specialists in the care of patients with complex conditions should be reassessed.	Univ Calif Los Angeles, Div Rheumatol, Dept Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Publ Hlth, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Nursing, Los Angeles, CA 90095 USA; RAND Corp, Hlth Program, Santa Monica, CA USA; Greater Los Angeles VA Hlth Care Syst, Los Angeles, CA USA; Vet Affairs Hlth Serv Res & Dev Serv, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; RAND Corporation; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	MacLean, CH (corresponding author), Univ Calif Los Angeles, Div Rheumatol, Dept Med, 1000 Vet Ave,Room 32-59, Los Angeles, CA 90095 USA.				NIAMS NIH HHS [P60-AR36834] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P60AR036834] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		*AM COLL OBST GYN, 1993, OBST GYN PRIM PREV H; American Cancer Society, 1993, GUID CANC REL CHECK; ANDERSON LM, 1995, AM J PUBLIC HEALTH, V85, P840, DOI 10.2105/AJPH.85.6.840; [Anonymous], 2000, Diabetes Care, V23 Suppl 1, pS1; ASCH S, 1995, ACCESS CARE ELDERLY; Bendor R, 1999, ANN INTERN MED, V131, P150, DOI 10.7326/0003-4819-131-2-199907200-00015; BRAND DA, 1995, J AM COLL CARDIOL, V26, P1432, DOI 10.1016/0735-1097(95)00362-2; BRECHNER RJ, 1993, JAMA-J AM MED ASSOC, V270, P1714, DOI 10.1001/jama.270.14.1714; Brook RH, 1996, NEW ENGL J MED, V335, P966, DOI 10.1056/NEJM199609263351311; CHERKIN D, 1977, MED CARE, V15, P767; COBB S, 1953, NEW ENGL J MED, V249, P553, DOI 10.1056/NEJM195310012491402; Feldman AM, 2000, J AM COLL CARDIOL, V35, P537, DOI 10.1016/S0735-1097(99)00600-2; Fontana SA, 1997, AM J PUBLIC HEALTH, V87, P1190, DOI 10.2105/AJPH.87.7.1190; Fowles J B, 1995, Health Care Financ Rev, V16, P189; GABRIEL SE, 1991, ANN INTERN MED, V115, P787, DOI 10.7326/0003-4819-115-10-787; GABRIEL SE, 1994, ARTHRITIS RHEUM, V37, P821, DOI 10.1002/art.1780370607; Gibbons RJ, 1999, J AM COLL CARDIOL, V33, P2092, DOI 10.1016/S0735-1097(99)00150-3; GILES WH, 1993, JAMA-J AM MED ASSOC, V269, P1133, DOI 10.1001/jama.269.9.1133; Greenfield S, 1999, J GEN INTERN MED, V14, P516, DOI 10.1046/j.1525-1497.1999.05059.x; Harrold LR, 1999, J GEN INTERN MED, V14, P499, DOI 10.1046/j.1525-1497.1999.08168.x; Huber P., 1967, P 5 BERK S MATH STAT; Ives DG, 1996, PUBLIC HEALTH REP, V111, P244; KASSIRER JP, 1994, NEW ENGL J MED, V331, P1151, DOI 10.1056/NEJM199410273311709; Katz JN, 1997, ARTHRITIS RHEUM, V40, P1594, DOI 10.1002/art.1780400908; Katz P P, 1995, Arthritis Care Res, V8, P272, DOI 10.1002/art.1790080411; KATZ SJ, 1994, JAMA-J AM MED ASSOC, V272, P530, DOI 10.1001/jama.272.7.530; Klempner MS, 1999, J GEN INTERN MED, V14, P514, DOI 10.1046/j.1525-1497.1999.06069.x; Kwoh CK, 1996, ARTHRITIS RHEUM-US, V39, P713; Lawrence RC, 1998, ARTHRITIS RHEUM-US, V41, P778, DOI 10.1002/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V; LEWIS P, 1980, ANN RHEUM DIS, V39, P457, DOI 10.1136/ard.39.5.457; LUKERT BP, 1990, ANN INTERN MED, V112, P352, DOI 10.7326/0003-4819-112-5-352; MANT J, 1995, BMJ-BRIT MED J, V311, P793, DOI 10.1136/bmj.311.7008.793; McCarthy BD, 1996, AM J PREV MED, V12, P91, DOI 10.1016/S0749-3797(18)30350-7; McLaughlin TJ, 1997, J GEN INTERN MED, V12, P1, DOI 10.1046/j.1525-1497.1997.12105.x; MEEHAN TP, 1995, ANN INTERN MED, V122, P928, DOI 10.7326/0003-4819-122-12-199506150-00007; MENDELSSOHN DC, 1995, ARCH INTERN MED, V155, P2473, DOI 10.1001/archinte.155.22.2473; MITCHELL DM, 1986, ARTHRITIS RHEUM-US, V29, P706, DOI 10.1002/art.1780290602; MONSON RR, 1976, J CHRON DIS, V29, P459, DOI 10.1016/0021-9681(76)90086-2; Nash DB, 1997, ANN INTERN MED, V127, P72, DOI 10.7326/0003-4819-127-1-199707010-00012; *NAT COMM QUAL ASS, 2000, MEAS QUAL AM HLTH CA; PINCUS T, 1986, J RHEUMATOL, V13, P841; PINCUS T, 1984, ARTHRITIS RHEUM, V27, P846; RASKER JJ, 1981, ANN RHEUM DIS, V40, P115, DOI 10.1136/ard.40.2.115; Redelmeier DA, 1998, NEW ENGL J MED, V338, P1516, DOI 10.1056/NEJM199805213382106; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; ROMANO P, 1995, AHCPR PUB; Ryan TJ, 1999, CIRCULATION, V100, P1016, DOI 10.1161/01.CIR.100.9.1016; Shea JA, 1999, MED CARE, V37, P333, DOI 10.1097/00005650-199904000-00003; Simms RW, 1996, ARTHRITIS RHEUM-US, V39, P723; Soumeral SB, 1997, JAMA-J AM MED ASSOC, V277, P115, DOI 10.1001/jama.277.2.115; *US PREV SERV TASK, 1996, GUID CLIN PREV SERV, P105; US Preventive Services Task Force, 1996, GUID CLIN PREV SERV, P73; VANDENBROUCKE JP, 1984, J RHEUMATOL, V11, P158; Wallberg-Jonsson S, 2000, J RHEUMATOL, V27, P71; Weiner J P, 1990, QRB Qual Rev Bull, V16, P424; WEINER JP, 1995, JAMA-J AM MED ASSOC, V273, P1503, DOI 10.1001/jama.273.19.1503; WEIR GC, 1994, DIABETES CARE, V17, P1514, DOI 10.2337/diacare.17.12.1514; WILLIAMS JF, 1995, J AM COLL CARDIOL, V26, P1376; Wisdom K, 1997, DIABETES CARE, V20, P971, DOI 10.2337/diacare.20.6.971; YELIN E, 1987, J RHEUMATOL, V14, P710	60	180	181	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 23	2000	284	8					984	992		10.1001/jama.284.8.984	http://dx.doi.org/10.1001/jama.284.8.984			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	344PX	10944644				2022-12-28	WOS:000088769000025
J	Barber, PH; Palumbi, SR; Erdmann, MV; Moosa, MK				Barber, PH; Palumbi, SR; Erdmann, MV; Moosa, MK			Biogeography - A marine Wallace's line?	NATURE			English	Article							CORAL-REEF FISH; RECRUITMENT; POPULATION		Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; Pusat Penelitian dan Pengembangan Oseanol, Jakarta 1048, Indonesia	Harvard University; University of California System; University of California Berkeley	Barber, PH (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.							Barber PH, 2000, J CRUSTACEAN BIOL, V20, P20, DOI 10.1163/1937240X-90000004; EXCOFFIER L, 1992, GENETICS, V131, P479; Jones GP, 1999, NATURE, V402, P802, DOI 10.1038/45538; KNOWLTON N, 1986, B MAR SCI, V39, P213; LLEWELLYN G, 1999, CONSERVATION ASSESSM; LUKAS R, 1991, J GEOPHYS RES-OCEANS, V96, P7089, DOI 10.1029/91JC00062; MCMANUS JW, 1985, 5TH P INT COR REEF C, V4, P133; PALUMBI SR, 1997, CORAL REEFS S, V16, P47; PALUMBI SR, IN PRESS MARINE COMM; PORTER SC, 1989, QUATERNARY RES, V32, P245, DOI 10.1016/0033-5894(89)90092-6; Randall JE, 1998, ZOOL STUD, V37, P227; Roberts CM, 1997, SCIENCE, V278, P1454, DOI 10.1126/science.278.5342.1454; Swearer SE, 1999, NATURE, V402, P799, DOI 10.1038/45533; Wyrtki K, 1961, NAGA REPORT, V2	14	298	304	1	89	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 17	2000	406	6797					692	693		10.1038/35021135	http://dx.doi.org/10.1038/35021135			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	344PH	10963585				2022-12-28	WOS:000088767700032
J	Perou, CM; Sorlie, T; Eisen, MB; van de Rijn, M; Jeffrey, SS; Rees, CA; Pollack, JR; Ross, DT; Johnsen, H; Akslen, LA; Fluge, O; Pergamenschikov, A; Williams, C; Zhu, SX; Lonning, PE; Borresen-Dale, AL; Brown, PO; Botstein, D				Perou, CM; Sorlie, T; Eisen, MB; van de Rijn, M; Jeffrey, SS; Rees, CA; Pollack, JR; Ross, DT; Johnsen, H; Akslen, LA; Fluge, O; Pergamenschikov, A; Williams, C; Zhu, SX; Lonning, PE; Borresen-Dale, AL; Brown, PO; Botstein, D			Molecular portraits of human breast tumours	NATURE			English	Article							MAMMARY EPITHELIAL-CELLS; GENE-EXPRESSION; MALIGNANT BREAST; CDNA MICROARRAYS; CANCER; AMPLIFICATION; CARCINOMAS; PATTERNS; BENIGN	Human breast tumours are diverse in their natural history and in their responsiveness to treatments(1). Variation in transcriptional programs accounts for much of the biological diversity of human cells and tumours. In each cell, signal transduction and regulatory systems transduce information from the cell's identity to its environmental status, thereby controlling the level of expression of every gene in the genome. Here we have characterized variation in gene expression patterns in a set of 65 surgical specimens of human breast tumours from 42 different individuals, using complementary DNA microarrays representing 8,102 human genes. These patterns provided a distinctive molecular portrait of each tumour. Twenty of the tumours were sampled twice, before and after a 16-week course of doxorubicin chemotherapy, and two tumours were paired with a lymph node metastasis from the same patient. Gene expression patterns in two tumour samples from the same individual were almost always more similar to each other than either was to any other sample. Sets of co-expressed genes were identified for which variation in messenger RNA levels could be related to specific features of physiological variation. The tumours could be classified into subtypes distinguished by pervasive differences in their gene expression patterns.	Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; Norwegian Radium Hosp, Dept Genet, N-0310 Oslo, Norway; Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Surg, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA; Haukeland Univ Hosp, Gade Inst, Dept Pathol, N-5021 Bergen, Norway; Univ Bergen, Dept Mol Biol, N-5020 Bergen, Norway; Haukeland Univ Hosp, Dept Oncol, N-5021 Bergen, Norway; Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; University of Oslo; Stanford University; Stanford University; Stanford University; University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; Haukeland University Hospital; Howard Hughes Medical Institute; Stanford University	Botstein, D (corresponding author), Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA.	pbrown@cmgm.stanford.edu; botstein@genome.stanford.edu	Perou, Charles M/H-9934-2014; Akslen, Lars A./AAG-6097-2021; Sørlie, Therese/B-1413-2015; Akslen, Lars A/C-1202-2017	Perou, Charles M/0000-0001-9827-2247; Akslen, Lars A./0000-0003-2710-9543; Sørlie, Therese/0000-0002-5995-2319; Akslen, Lars A/0000-0003-2710-9543; van de Rijn, Matt/0000-0002-1909-9739; Eisen, Michael/0000-0002-7528-738X; Jeffrey, Stefanie/0000-0003-4478-2764; Lonning, Per Eystein/0000-0002-8890-6303	NATIONAL CANCER INSTITUTE [P50CA058223] Funding Source: NIH RePORTER; NCI NIH HHS [P50 CA058223] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aas T, 1996, NAT MED, V2, P811, DOI 10.1038/nm0796-811; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; BERNASCONI R, 1992, PHARM COMMUN, V2, P28; DAIRKEE SH, 1988, J NATL CANCER I, V80, P691, DOI 10.1093/jnci/80.9.691; DAIRKEE SH, 1987, LANCET, V1, P514; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Eisen MB, 1999, METHOD ENZYMOL, V303, P179; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; GUELSTEIN VI, 1988, INT J CANCER, V42, P147, DOI 10.1002/ijc.2910420202; GUSTERSON BA, 1982, CANCER RES, V42, P4763; HEINTZ NH, 1990, ARCH PATHOL LAB MED, V114, P160; Hoch RV, 1999, INT J CANCER, V84, P122; Malzahn K, 1998, VIRCHOWS ARCH, V433, P119, DOI 10.1007/s004280050226; NAGLE RB, 1986, J HISTOCHEM CYTOCHEM, V34, P869, DOI 10.1177/34.7.2423579; Pauletti G, 1996, ONCOGENE, V13, P63; Perou CM, 1999, P NATL ACAD SCI USA, V96, P9212, DOI 10.1073/pnas.96.16.9212; Pollack JR, 1999, NAT GENET, V23, P41, DOI 10.1038/12640; RonnovJessen L, 1996, PHYSIOL REV, V76, P69, DOI 10.1152/physrev.1996.76.1.69; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Tavassoli FA, 1992, PATHOLOGY BREAST, P193; TAYLORPAPADIMITRIOU J, 1989, J CELL SCI, V94, P403; Yang GP, 1999, NUCLEIC ACIDS RES, V27, P1517, DOI 10.1093/nar/27.6.1517	23	10718	11379	47	1291	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 17	2000	406	6797					747	752		10.1038/35021093	http://dx.doi.org/10.1038/35021093			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	344PH	10963602	Green Submitted			2022-12-28	WOS:000088767700049
J	Salazar-Lindo, E; Santisteban-Ponce, J; Chea-Woo, E; Gutierrez, M				Salazar-Lindo, E; Santisteban-Ponce, J; Chea-Woo, E; Gutierrez, M			Racecadotril in the treatment of acute watery diarrhea in children	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ENKEPHALINASE INHIBITOR; DOUBLE-BLIND; ACETORPHAN; LOPERAMIDE; TRANSIT; DISEASE; TRIAL	Background: Racecadotril (acetorphan), an enkephalinase inhibitor with antisecretory and antidiarrheal actions, is an effective and safe treatment for acute diarrhea in adults and children. Whether treatment with racecadotril and oral rehydration therapy is more effective than treatment with oral rehydration alone in hospitalized children with acute watery diarrhea is not known. Methods: We treated 135 boys 3 to 35 months of age who had watery diarrhea of five days' duration or less with racecadotril (1.5 mg per kilogram of body weight orally every eight hours) or placebo, in addition to oral rehydration solution. The primary end point was the 48-hour stool output (measured in grams); the total stool output, duration of diarrhea, and total intake of oral rehydration solution were also measured. Results: The mean (+/-SE) 48-hour stool output was 92+/-12 g per kilogram in the racecadotril group and 170+/-15 g per kilogram in the placebo group (P<0.001), a 46 percent reduction with racecadotril. The results were similar among the 73 boys with rotavirus infections. The total stool output was 157+/-27 g per kilogram in the racecadotril group and 331+/-39 g per kilogram in the placebo group (P<0.001). The median duration of diarrhea was significantly less (P<0.001) in the racecadotril group (28 hours regardless of rotavirus status) than in the placebo group (72 and 52 hours, respectively, for rotavirus-positive and rotavirus-negative patients). The intake of oral rehydration solution was significantly lower in the racecadotril group than in the placebo group (P<0.001). Racecadotril was well tolerated; only seven patients taking racecadotril had adverse effects, which were all mild and transient. Conclusions: In young boys with acute watery diarrhea, racecadotril is an effective and safe treatment. (N Engl J Med 2000;343:463-7.) (C)2000, Massachusetts Medical Society.	Hosp Nacl Cayetano Heredia, Dept Pediat, Lima, Peru		Salazar-Lindo, E (corresponding author), Av Benavides 264,Of 501, Lima 18, Peru.							Ball JM, 1996, SCIENCE, V272, P101, DOI 10.1126/science.272.5258.101; BAUMER P, 1992, GUT, V33, P753, DOI 10.1136/gut.33.6.753; BERGMANN JF, 1992, ALIMENT PHARM THER, V6, P305; BERN C, 1992, B WORLD HEALTH ORGAN, V70, P705; BROWN JW, 1979, JAMA-J AM MED ASSOC, V241, P501, DOI 10.1001/jama.241.5.501; Cezard JP, 1996, GASTROENTEROLOGY, V110, pA795; Cohen M L, 1988, Infect Dis Clin North Am, V2, P557; Duval-Iflah Y, 1999, ALIMENT PHARM THER, V13, P9; FIGUEROAQUINTANILLA D, 1993, NEW ENGL J MED, V328, P1653, DOI 10.1056/NEJM199306103282301; Hamza H, 1999, ALIMENT PHARM THERAP, V13, P15; Hinterleitner TA, 1997, EUR J GASTROEN HEPAT, V9, P887, DOI 10.1097/00042737-199709000-00012; KACHEL G, 1986, GASTROENTEROLOGY, V90, P85, DOI 10.1016/0016-5085(86)90079-X; LECOMTE JM, 1986, J PHARMACOL EXP THER, V237, P937; Lundgren O, 2000, SCIENCE, V287, P491, DOI 10.1126/science.287.5452.491; MARCAISCOLLADO H, 1987, EUR J PHARMACOL, V144, P125, DOI 10.1016/0014-2999(87)90510-3; Primi MP, 1999, ALIMENT PHARM THERAP, V13, P3, DOI 10.1046/j.1365-2036.13.s6.3.x; RACHMILEWITZ D, 1983, EUR J PHARMACOL, V93, P169, DOI 10.1016/0014-2999(83)90134-6; ROGE J, 1993, SCAND J GASTROENTERO, V28, P352, DOI 10.3109/00365529309090255; SCHWARTZ JC, 1989, DESIGN ENZYME INHIBI, P206; SNINSKY CA, 1986, GASTROENTEROLOGY, V90, P68, DOI 10.1016/0016-5085(86)90076-4; Vetel JM, 1999, ALIMENT PHARM THERAP, V13, P21; *WHO, 1990, WHOCDDSER802	22	145	152	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 17	2000	343	7					463	467		10.1056/NEJM200008173430703	http://dx.doi.org/10.1056/NEJM200008173430703			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	344FC	10944563	Bronze			2022-12-28	WOS:000088747700003
J	Antman, EM; Cohen, M; Bernink, PJLM; McCabe, CH; Horacek, T; Papuchis, G; Mautner, B; Corbalan, R; Radley, D; Braunwald, E				Antman, EM; Cohen, M; Bernink, PJLM; McCabe, CH; Horacek, T; Papuchis, G; Mautner, B; Corbalan, R; Radley, D; Braunwald, E			The TIMI risk score for unstable angina/non-ST elevation MI - A method for prognostication and therapeutic decision making	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							WAVE MYOCARDIAL-INFARCTION; ACUTE CORONARY SYNDROMES; CARDIAC TROPONIN-T; ACUTE CHEST PAIN; EMERGENCY ROOM; ARTERY DISEASE; STRATIFICATION; ISCHEMIA; TRIAL; ELECTROCARDIOGRAM	Context Patients with unstable angina/non-ST-segment elevation myocardial infarction (MI) (UA/NSTEMI) present with a wide spectrum of risk for death and cardiac ischemic events. Objective To develop a simple risk score that has broad applicability, is easily calculated at patient presentation, does not require a computer, and identifies patients with different responses to treatments for UA/NSTEMI. Design, Setting, and Patients Two phase 3, international, randomized, double-blind trials (the Thrombolysis in Myocardial Infarction [TIMI] 11B trial [August 1996-March 1998] and the Efficacy and Safety of Subcutaneous Enoxaparin in Unstable Angina and Non-Q-Wave MI trial [ESSENCE; October 1994-May 1996]). A total of 1957 patients with UA/NSTEMI were assigned to receive unfractionated heparin (test cohort) and 1953 to receive enoxaparin in TIMI 11B; 1564 and 1607 were assigned respectively in ESSENCE. The 3 validation cohorts were the unfractionated heparin group from ESSENCE and both enoxaparin groups. Main Outcome Measures The TIMI risk score was derived in the test cohort by selection of independent prognostic variables using multivariate logistic regression, assignment of Value of 1 when a factor was present and 0 when it was absent, and summing the number of factors present to categorize patients into risk strata. Relative differences in response to therapeutic interventions were determined by comparing the slopes of the rates of events with increasing score in treatment groups and by testing for an interaction between risk score and treatment. Outcomes were TIMI risk score for developing at least 1 component of the primary end point (all-cause mortality, new or recurrent MI, or severe recurrent ischemia requiring urgent revascularization) through 14 days after randomization. Results The 7 TIMI risk score predictor variables were age 65 years or older, at least 3 risk factors for coronary artery disease, prior coronary stenosis of 50% or more, ST-segment deviation on electrocardiogram at presentation, at least 2 anginal events in prior 24 hours, use of aspirin in prior 7 days, and elevated serum card iac markers. Event rates increased significantly as the TIMI risk score increased in the test cohort in TIMI 11B: 4.7% for a score of 0/1; 8.3% for 2; 13.2% for 3; 19.9% for 4; 26.2% for 5; and 40.9% for 6/7 (P<.001 by chi(2) for trend). The pattern of increasing event rates with increasing TIMI risk score was confirmed in all 3 validation groups (P<.001). The slope of the increase in event rates with increasing numbers of risk factors was significantly lower in the enoxaparin groups in both TIMI 11B (P=.01) and ESSENCE (P=.03) and there was a significant interaction between TIMI risk score and treatment (P=.02). Conclusions In patients with UA/NSTEMI, the TIMI risk score is a simple prognostication scheme that categorizes a patient's risk of death and ischemic events and provides a basis for therapeutic decision making.	Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Boston, MA 02115 USA; Hahnemann Univ Hosp, Div Cardiol, Philadelphia, PA 19102 USA; Martini Hosp, Dept Cardiol, Groningen, Netherlands; Evangel Krankenhaus, Witten, Germany; Washington Cty Hosp, Hagerstown, MD USA; Fdn Favaloro, Buenos Aires, DF, Argentina; Pontificia Univ Catolica Chile, Santiago, Chile; Rhone Poulenc Rorer, Collegeville, PA USA	Harvard University; Brigham & Women's Hospital; Drexel University; Martini Hospital; Pontificia Universidad Catolica de Chile	Antman, EM (corresponding author), Brigham & Womens Hosp, Dept Med, Div Cardiovasc, 75 Francis St, Boston, MA 02115 USA.							Antman EM, 1999, CIRCULATION, V100, P1593, DOI 10.1161/01.CIR.100.15.1593; Antman EM, 1999, CIRCULATION, V100, P1602, DOI 10.1161/01.CIR.100.15.1602; Antman EM, 1996, NEW ENGL J MED, V335, P1342, DOI 10.1056/NEJM199610313351802; Armstrong PW, 1998, CIRCULATION, V98, P1860, DOI 10.1161/01.CIR.98.18.1860; BRAUNWALD E, 1994, CLIN PRACTICE GUIDEL, V10; CALVIN JE, 1995, JAMA-J AM MED ASSOC, V273, P136; Cannon CP, 1997, J AM COLL CARDIOL, V30, P133, DOI 10.1016/S0735-1097(97)00160-5; CENTOR RM, 1986, ANN INTERN MED, V105, P892, DOI 10.7326/0003-4819-105-6-892; COHEN M, 1991, AM J CARDIOL, V67, P1368, DOI 10.1016/0002-9149(91)90467-Y; Cohen M, 1997, NEW ENGL J MED, V337, P447, DOI 10.1056/NEJM199708143370702; Croft RP, 2000, LANCET, V355, P1603, DOI 10.1016/S0140-6736(00)02216-9; FARHI JI, 1986, AM J CARDIOL, V58, P547, DOI 10.1016/0002-9149(86)90031-7; Hamm CW, 1997, NEW ENGL J MED, V337, P1648, DOI 10.1056/NEJM199712043372302; Hamm CW, 1999, NEW ENGL J MED, V340, P1623, DOI 10.1056/NEJM199905273402103; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hochman JS, 1999, NEW ENGL J MED, V341, P226, DOI 10.1056/NEJM199907223410402; Holper EM, 1998, CIRCULATION, V98, P493; HOSMER DW, 1989, APPL LOGISTIC REGRES; Hutter AM, 2000, J AM COLL CARDIOL, V35, P853; JAYES RL, 1992, J CLIN EPIDEMIOL, V45, P621, DOI 10.1016/0895-4356(92)90134-9; LEE KL, 1995, CIRCULATION, V91, P1659, DOI 10.1161/01.CIR.91.6.1659; LEE TH, 1985, ARCH INTERN MED, V145, P65, DOI 10.1001/archinte.145.1.65; Lindahl B, 1996, CIRCULATION, V93, P1651, DOI 10.1161/01.CIR.93.9.1651; Luscher MS, 1997, CIRCULATION, V96, P2578, DOI 10.1161/01.CIR.96.8.2578; Maseri A, 1997, CIRCULATION, V96, P4141; NYMAN I, 1993, J INTERN MED, V234, P293, DOI 10.1111/j.1365-2796.1993.tb00746.x; Ohman EM, 1996, NEW ENGL J MED, V335, P1333, DOI 10.1056/NEJM199610313351801; Schmid CH, 1998, STAT MED, V17, P1923, DOI 10.1002/(SICI)1097-0258(19980915)17:17<1923::AID-SIM874>3.0.CO;2-6; Selker HP, 1998, ANN INTERN MED, V129, P845, DOI 10.7326/0003-4819-129-11_Part_1-199812010-00002; Topol E, 1998, NEW ENGL J MED, V339, P436; VanderWerf F, 1997, EUR HEART J, V18, P1371; WILLICH SN, 1987, AM HEART J, V114, P1110, DOI 10.1016/0002-8703(87)90186-4; Zaacks SM, 1999, J AM COLL CARDIOL, V33, P107, DOI 10.1016/S0735-1097(98)00553-1	33	2174	2322	2	70	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 16	2000	284	7					835	842		10.1001/jama.284.7.835	http://dx.doi.org/10.1001/jama.284.7.835			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	342PM	10938172	Bronze			2022-12-28	WOS:000088654400025
J	Williams, G				Williams, G			From scalpel to surfboard	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	AUG 12	2000	321	7258					459	459		10.1136/bmj.321.7258.459	http://dx.doi.org/10.1136/bmj.321.7258.459			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	344QC	10938068	Green Published			2022-12-28	WOS:000088769500068
J	Hoppener, JWM; Ahren, B; Lips, CJM				Hoppener, JWM; Ahren, B; Lips, CJM			Islet amyloid and type 2 diabetes mellitus	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							TRANSGENIC MICE; POLYPEPTIDE AMYLIN; INSULIN-SECRETION; FIBRIL FORMATION; P COMPONENT; BETA-CELLS; GENE; EXPRESSION; NIDDM; PEPTIDE		Univ Utrecht, Med Ctr, Dept Internal Med, Utrecht, Netherlands; Univ Utrecht, Med Ctr, Dept Pathol, Utrecht, Netherlands; Lund Univ, Dept Med, Malmo, Sweden; Malmo Univ Hosp, Malmo, Sweden	Utrecht University; Utrecht University; Lund University; Lund University; Skane University Hospital	Hoppener, JWM (corresponding author), Univ Utrecht Hosp, H 04-312,POB 85500, NL-3508 GA Utrecht, Netherlands.	j.w.m.hoeppener@lb.azu.nl						Ahren B, 1998, DIABETOLOGIA, V41, P1374, DOI 10.1007/s001250051079; Booth DR, 1997, NATURE, V385, P787, DOI 10.1038/385787a0; Botto M, 1997, NAT MED, V3, P855, DOI 10.1038/nm0897-855; Castillo GM, 1998, DIABETES, V47, P612, DOI 10.2337/diabetes.47.4.612; Chuang LM, 1998, DIABETOLOGIA, V41, P1250; COOK JTE, 1991, DIABETOLOGIA, V34, P103, DOI 10.1007/BF00500380; DALESSIO DA, 1994, DIABETES, V43, P1457, DOI 10.2337/diabetes.43.12.1457; DEKONING EJP, 1994, P NATL ACAD SCI USA, V91, P8467, DOI 10.1073/pnas.91.18.8467; Ferrannini E, 1998, ENDOCR REV, V19, P477, DOI 10.1210/edrv.19.4.0336; FOX N, 1993, FEBS LETT, V323, P40, DOI 10.1016/0014-5793(93)81444-5; Gebre-Medhin S, 1998, BIOCHEM BIOPH RES CO, V250, P271, DOI 10.1006/bbrc.1998.9308; GERMAN MS, 1992, MOL CELL BIOL, V12, P1777, DOI 10.1128/MCB.12.4.1777; Gillmore JD, 1997, BRIT J HAEMATOL, V99, P245, DOI 10.1046/j.1365-2141.1997.303194.x; GLENNER GG, 1980, NEW ENGL J MED, V302, P1283, DOI 10.1056/NEJM198006053022305; Hiddinga HJ, 1999, AM J PATHOL, V154, P1077, DOI 10.1016/S0002-9440(10)65360-6; HOPPENER JWM, 1994, J CELL BIOCHEM, V55, P39, DOI 10.1002/jcb.240550006; Hoppener JWM, 1999, DIABETOLOGIA, V42, P427, DOI 10.1007/s001250051175; HOPPENER JWM, 1993, DIABETOLOGIA, V36, P1258, DOI 10.1007/BF00400803; Hou X, 1999, DIABETOLOGIA, V42, P188, DOI 10.1007/s001250051138; HOWARD CF, 1986, DIABETOLOGIA, V29, P301, DOI 10.1007/BF00452067; Inzucchi SE, 1998, NEW ENGL J MED, V338, P867, DOI 10.1056/NEJM199803263381303; Janciauskiene S, 1998, BIOCHEM BIOPH RES CO, V251, P888, DOI 10.1006/bbrc.1998.9574; Janciauskiene S, 1997, BIOCHEM BIOPH RES CO, V236, P580, DOI 10.1006/bbrc.1997.7014; Janson J, 1996, P NATL ACAD SCI USA, V93, P7283, DOI 10.1073/pnas.93.14.7283; Janson J, 1999, DIABETES, V48, P491, DOI 10.2337/diabetes.48.3.491; JOHNSON KH, 1989, NEW ENGL J MED, V321, P513; Kahn BB, 1998, CELL, V92, P593, DOI 10.1016/S0092-8674(00)81125-3; Kahn SE, 1999, DIABETES, V48, P241, DOI 10.2337/diabetes.48.2.241; Kapurniotu A, 1998, EUR J BIOCHEM, V251, P208, DOI 10.1046/j.1432-1327.1998.2510208.x; Kisilevsky R, 1996, DRUG AGING, V8, P75, DOI 10.2165/00002512-199608020-00001; Kulkarni RN, 1996, J ENDOCRINOL, V151, P341, DOI 10.1677/joe.0.1510341; Lindstrom T, 1997, DIABETIC MED, V14, P472, DOI 10.1002/(SICI)1096-9136(199706)14:6<472::AID-DIA388>3.0.CO;2-Q; LORENZO A, 1994, NATURE, V368, P756, DOI 10.1038/368756a0; MCLEAN LR, 1992, BIOCHIM BIOPHYS ACTA, V1122, P317, DOI 10.1016/0167-4838(92)90411-6; Mirzabekov TA, 1996, J BIOL CHEM, V271, P1988, DOI 10.1074/jbc.271.4.1988; Moriarty DF, 1999, BIOCHEMISTRY-US, V38, P1811, DOI 10.1021/bi981658g; MOSSELMAN S, 1988, FEBS LETT, V239, P227, DOI 10.1016/0014-5793(88)80922-0; MOSSELMAN S, 1990, FEBS LETT, V271, P33, DOI 10.1016/0014-5793(90)80365-P; NISHI M, 1990, DIABETOLOGIA, V33, P628, DOI 10.1007/BF00400208; Novials A, 1998, PANCREAS, V17, P182, DOI 10.1097/00006676-199808000-00012; Opie EL, 1901, J EXP MED, V5, P527, DOI 10.1084/jem.5.5.527; Pepys MB, 1997, AMYLOID, V4, P274, DOI 10.3109/13506129709003838; PEPYS MB, 1998, HORIZONS MED, V10, P397; PIMENTA W, 1995, JAMA-J AM MED ASSOC, V273, P1855, DOI 10.1001/jama.273.23.1855; Rachman J, 1998, DIABETES CARE, V21, P810, DOI 10.2337/diacare.21.5.810; Soeller WC, 1998, DIABETES, V47, P743, DOI 10.2337/diabetes.47.5.743; Solomon B, 1997, P NATL ACAD SCI USA, V94, P4109, DOI 10.1073/pnas.94.8.4109; Soto C, 1998, NAT MED, V4, P822, DOI 10.1038/nm0798-822; Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348; Westermark G, 1999, METABOLISM, V48, P448, DOI 10.1016/S0026-0495(99)90102-6; WESTERMARK P, 1990, P NATL ACAD SCI USA, V87, P5036, DOI 10.1073/pnas.87.13.5036; WESTERMARK P, 1986, BIOCHEM BIOPH RES CO, V140, P827, DOI 10.1016/0006-291X(86)90708-4; WESTERMARK P, 1994, AMYLOID, V1, P47, DOI 10.3109/13506129409148624; YAGUI K, 1995, EUR J ENDOCRINOL, V132, P487, DOI 10.1530/eje.0.1320487; Zapecka-Dubno B., 1997, Diabetologia, V40, pA316; Zhang SP, 1999, FEBS LETT, V455, P315, DOI 10.1016/S0014-5793(99)00894-7	56	426	442	0	33	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 10	2000	343	6					411	419						9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	342DT	10933741				2022-12-28	WOS:000088630500007
J	Henney, JE				Henney, JE			Elevated cholesterol treatment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item											Henney, JE (corresponding author), HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	2	3	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 9	2000	284	6					685	685		10.1001/jama.284.6.685	http://dx.doi.org/10.1001/jama.284.6.685			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	341JM	10950660				2022-12-28	WOS:000088587300005
J	Gershon, D				Gershon, D			Mahoney centre set to tackle brain cancer head on	NATURE			English	Article																			0	0	0	0	1	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 3	2000	406	6795					546	546		10.1038/35020204	http://dx.doi.org/10.1038/35020204			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	340ML	10952320				2022-12-28	WOS:000088538000054
J	Tamura, K; Sudo, T; Senftleben, U; Dadak, AM; Johnson, R; Karin, M				Tamura, K; Sudo, T; Senftleben, U; Dadak, AM; Johnson, R; Karin, M			Requirement for p38 alpha in erythropoietin expression: A role for stress kinases in erythropoiesis	CELL			English	Article							ATF1 TRANSCRIPTION FACTOR; HEMATOPOIETIC STEM-CELLS; INDUCIBLE FACTOR 1-ALPHA; MAP KINASE; MESSENGER-RNA; C-JUN; SIGNAL-TRANSDUCTION; PROTEIN-KINASES; FISSION YEAST; SPC1 KINASE	Activity of the p38 alpha MAP kinase is stimulated by various stresses and hematopoietic growth factors. A role for p38 alpha in mouse development and physiology was investigated by targeted disruption of the p38 alpha locus. Whereas some p38 alpha(-/-) embryos die between embryonic days 11.5 and 12.5, those that develop past this stage have normal morphology but are anemic owing to failed definitive erythropoiesis, caused by diminished erythropoietin (Epo) gene expression. As p38 alpha-deficient hematopoietic stem cells reconstitute lethally irradiated hosts, p38 alpha function is not required downstream of Epo receptor. Inhibition of p38 activity also interferes with stabilization of Epo mRNA in human hepatoma cells undergoing hypoxic stress. The p38a MAP kinase plays a critical role linking developmental and stress-induced erythropoiesis through regulation of Epo expression.	Univ Calif San Diego, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA; Inst Phys & Chem Res, Biodesign Grp, Wako, Saitama 3510198, Japan	University of California System; University of California San Diego; University of California System; University of California San Diego; RIKEN	Karin, M (corresponding author), Univ Calif San Diego, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA.		Johnson, Randall/AAM-1189-2021	Johnson, Randall/0000-0002-4084-6639; Dadak, Agnes/0000-0002-0948-4764	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL035018] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES006376, R37ES004151, R01ES004151] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL35018] Funding Source: Medline; NIEHS NIH HHS [ES06376, ES04151] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ADAMS RH, 2000, IN PRESS MOL CELL; Allen M, 2000, J EXP MED, V191, P859, DOI 10.1084/jem.191.5.859; BREWSTER JL, 1993, SCIENCE, V259, P1760, DOI 10.1126/science.7681220; Chen CY, 1998, SCIENCE, V280, P1945, DOI 10.1126/science.280.5371.1945; Conrad PW, 1999, J BIOL CHEM, V274, P23570, DOI 10.1074/jbc.274.33.23570; Crawley JB, 1997, J BIOL CHEM, V272, P15023, DOI 10.1074/jbc.272.23.15023; Dean JLE, 1999, J BIOL CHEM, V274, P264, DOI 10.1074/jbc.274.1.264; Degols G, 1997, MOL CELL BIOL, V17, P3356, DOI 10.1128/MCB.17.6.3356; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; Ebert BL, 1999, BLOOD, V94, P1864; Eferl R, 1999, J CELL BIOL, V145, P1049, DOI 10.1083/jcb.145.5.1049; Fahnenstich H, 1996, J PERINAT MED, V24, P85, DOI 10.1515/jpme.1996.24.1.85; Foltz IN, 1997, J BIOL CHEM, V272, P3296, DOI 10.1074/jbc.272.6.3296; Ghaffari S, 1999, EXP HEMATOL, V27, P978, DOI 10.1016/S0301-472X(99)00023-5; Godin I, 1999, J EXP MED, V190, P43, DOI 10.1084/jem.190.1.43; GOLDBERG MA, 1991, BLOOD, V77, P271; GREENBERG ME, 1987, CURRENT PROTOCOLS MO; GREGORY CJ, 1978, BLOOD, V51, P527; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; IKUTA K, 1992, P NATL ACAD SCI USA, V89, P1502, DOI 10.1073/pnas.89.4.1502; IKUTA K, 1990, CELL, V62, P863, DOI 10.1016/0092-8674(90)90262-D; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; KANSAS GS, 1990, BLOOD, V76, P2483; Kato T, 1996, FEBS LETT, V378, P207, DOI 10.1016/0014-5793(95)01442-X; Kuan CY, 1999, NEURON, V22, P667, DOI 10.1016/S0896-6273(00)80727-8; Lee JC, 1996, J LEUKOCYTE BIOL, V59, P152, DOI 10.1002/jlb.59.2.152; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Nagata Y, 1997, BLOOD, V90, P929, DOI 10.1182/blood.V90.3.929.929_929_934; Neubauer H, 1998, CELL, V93, P397, DOI 10.1016/S0092-8674(00)81168-X; New LG, 1998, TRENDS CARDIOVAS MED, V8, P220, DOI 10.1016/S1050-1738(98)00012-7; Pages G, 1999, SCIENCE, V286, P1374, DOI 10.1126/science.286.5443.1374; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; Puri PL, 2000, GENE DEV, V14, P574; Richard DE, 1999, J BIOL CHEM, V274, P32631, DOI 10.1074/jbc.274.46.32631; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Sabapathy K, 1999, MECH DEVELOP, V89, P115, DOI 10.1016/S0925-4773(99)00213-0; Sabapathy K, 1999, CURR BIOL, V9, P116, DOI 10.1016/S0960-9822(99)80065-7; Shiozaki K, 1996, GENE DEV, V10, P2276, DOI 10.1101/gad.10.18.2276; Su B, 1996, CURR OPIN IMMUNOL, V8, P402, DOI 10.1016/S0952-7915(96)80131-2; SUDO T, 2000, IN PRESS METH ENZYMO; WASKIEWICZ AJ, 1995, CURR OPIN CELL BIOL, V7, P798, DOI 10.1016/0955-0674(95)80063-8; WEISS MJ, 1994, GENE DEV, V8, P1184, DOI 10.1101/gad.8.10.1184; WHITELAW E, 1990, MOL CELL BIOL, V10, P6596, DOI 10.1128/MCB.10.12.6596; Winzen R, 1999, EMBO J, V18, P4969, DOI 10.1093/emboj/18.18.4969; WU H, 1995, CELL, V83, P59, DOI 10.1016/0092-8674(95)90234-1; Wu ZG, 2000, MOL CELL BIOL, V20, P3951, DOI 10.1128/MCB.20.11.3951-3964.2000; Yang DD, 1997, NATURE, V389, P865, DOI 10.1038/39899; Zetser A, 1999, J BIOL CHEM, V274, P5193, DOI 10.1074/jbc.274.8.5193	51	294	308	1	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 21	2000	102	2					221	231		10.1016/S0092-8674(00)00027-1	http://dx.doi.org/10.1016/S0092-8674(00)00027-1			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	337NA	10943842	Bronze			2022-12-28	WOS:000088366800012
J	Green, DR				Green, DR			Apoptotic pathways: Paper wraps stone blunts scissors	CELL			English	Review							CYTOCHROME-C; EVENTS; DEATH		La Jolla Inst Allergy & Immunol, San Diego, CA 92121 USA	La Jolla Institute for Immunology	Green, DR (corresponding author), La Jolla Inst Allergy & Immunol, 10355 Sci Ctr Dr, San Diego, CA 92121 USA.		Green, Douglas R/N-8083-2018	Green, Douglas R/0000-0002-7332-1417				Cain K, 2000, J BIOL CHEM, V275, P6067, DOI 10.1074/jbc.275.9.6067; Chen FL, 2000, SCIENCE, V287, P1485, DOI 10.1126/science.287.5457.1485; Deshmukh M, 1998, NEURON, V21, P695, DOI 10.1016/S0896-6273(00)80587-5; Deveraux QL, 1998, EMBO J, V17, P2215, DOI 10.1093/emboj/17.8.2215; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Eskes R, 2000, MOL CELL BIOL, V20, P929, DOI 10.1128/MCB.20.3.929-935.2000; Goyal L, 2000, EMBO J, V19, P589, DOI 10.1093/emboj/19.4.589; Green DR, 1998, CELL, V94, P695, DOI 10.1016/S0092-8674(00)81728-6; Li F, 1997, J BIOL CHEM, V272, P30299, DOI 10.1074/jbc.272.48.30299; Li K, 2000, CELL, V101, P389, DOI 10.1016/S0092-8674(00)80849-1; Matsuyama S, 2000, NAT CELL BIOL, V2, P318, DOI 10.1038/35014006; Meisenholder GW, 1996, J BIOL CHEM, V271, P16260, DOI 10.1074/jbc.271.27.16260; Moriishi K, 1999, P NATL ACAD SCI USA, V96, P9683, DOI 10.1073/pnas.96.17.9683; Newmeyer DD, 2000, CELL DEATH DIFFER, V7, P402, DOI 10.1038/sj.cdd.4400665; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; White K, 2000, CURR BIOL, V10, pR167, DOI 10.1016/S0960-9822(00)00333-X; Wolf BB, 1999, J BIOL CHEM, V274, P20049, DOI 10.1074/jbc.274.29.20049; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874	19	843	896	1	41	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 7	2000	102	1					1	4		10.1016/S0092-8674(00)00003-9	http://dx.doi.org/10.1016/S0092-8674(00)00003-9			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	332UL	10929706	Bronze			2022-12-28	WOS:000088091700001
J	New, B				New, B			Commentary: An open debate is not an admission of failure	BRITISH MEDICAL JOURNAL			English	Editorial Material											New, B (corresponding author), 9 Countess Rd, London NW5 2NS, England.							Harrison A, 1997, BRIT MED J, V314, P139, DOI 10.1136/bmj.314.7074.139	1	1	1	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUL 1	2000	321	7252					45	45						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	331QQ	10939809				2022-12-28	WOS:000088030100029
J	Camma, C; Giunta, M; Fiorica, F; Pagliaro, L; Craxi, A; Cottone, M				Camma, C; Giunta, M; Fiorica, F; Pagliaro, L; Craxi, A; Cottone, M			Preoperative radiotherapy for resectable rectal cancer - A meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RANDOMIZED MULTICENTER TRIAL; CLINICAL-TRIALS; POSTOPERATIVE RADIOTHERAPY; EUROPEAN-ORGANIZATION; DOSE FRACTIONATION; RADICAL SURGERY; CARCINOMA; METAANALYSIS; IRRADIATION; THERAPY	Context The benefit of adjuvant radiotherapy for resectable rectal cancer has been extensively studied, but data on survival are still equivocal despite a reduction in the rate of local recurrence. Objective To assess the effectiveness of preoperative radiotherapy followed by surgery in the reduction of overall and cancer-related mortality and in the prevention of local recurrence and distant metastases. Data Sources Computerized bibliographic searches of MEDLINE and CANCERLIT (1970 to December 1999), including non-English sources, were supplemented with hand searches of reference lists. The medical subject headings used were rectal cancer, radiotherapy, surgery, RCT, randomized, and clinical trial, Study Selection Studies were included if they were randomized controlled trials (RCTs) comparing preoperative radiotherapy plus surgery with surgery alone and if they included patients with resectable histologically proven rectal adenocarcinoma, without metastatic disease. Fourteen RCTs were analyzed. Data Extraction Data on population, intervention, and outcomes were extracted from each RCT according to the intention-to-treat method by 3 independent observers and combined using the DerSimonian and Laird method. Data Synthesis Radiotherapy plus surgery compared with surgery alone significantly reduced the 5-year overall mortality rate (odds ratio [OR] 0.84; 95% confidence interval [CI], 0.72-0.98; P=.03), cancer-related mortality rate (OR, 0.71; 95% CI, 0.61-0.82; P<.001), and local recurrence rate (OR, 0.49; 95% CI, 0.38-0.62; P<.001). No reduction was observed in the occurrence of distant metastases (OR, 0.93; 95% ci, 0.73-1.18; P=.54). Conclusions In patients with resectable rectal cancer, preoperative radiotherapy significantly improved overall and cancer-specific survival compared with surgery alone. The magnitude of the benefit is relatively small and criteria are needed to identify patients most likely to benefit from adjuvant radiotherapy.	Univ Palermo, Ist Clin Med, Cattedra Gastroenterol, I-90127 Palermo, Italy; CNR, Ist Metodol Diagnost Avanzate, Palermo, Italy; Univ Palermo, Ist Med Gen & Pneumol, Palermo, Italy	University of Palermo; Consiglio Nazionale delle Ricerche (CNR); University of Palermo	Camma, C (corresponding author), Univ Palermo, Ist Clin Med, Cattedra Gastroenterol, Piazza Clin 2, I-90127 Palermo, Italy.		fiorica, francesco/K-8036-2016; Craxi, Antonio/K-9529-2016	fiorica, francesco/0000-0002-9404-3655; Cottone, Mario/0000-0003-1523-7556; CAMMA', CALOGERO/0000-0002-9224-1914; Craxi, Antonio/0000-0002-4480-9544				BARENDSEN GW, 1982, INT J RADIAT ONCOL, V8, P1981, DOI 10.1016/0360-3016(82)90459-X; BOULISWASSIF S, 1984, CANCER-AM CANCER SOC, V53, P1811, DOI 10.1002/1097-0142(19840501)53:9<1811::AID-CNCR2820530902>3.0.CO;2-H; Boyle P., 1998, MANAGEMENT COLORECTA, P19; BRADY LW, 1974, CANCER, V34, P960, DOI 10.1002/1097-0142(197409)34:3+<960::AID-CNCR2820340726>3.0.CO;2-8; BUYSE M, 1988, JAMA-J AM MED ASSOC, V259, P3571; Cedermark B, 1996, ANN SURG ONCOL, V3, P423; CEDERMARK B, 1985, CANCER-AM CANCER SOC, V55, P1182, DOI 10.1002/1097-0142(19850315)55:6<1182::AID-CNCR2820550607>3.0.CO;2-7; CEDERMARK B, 1994, P AN M AM SOC CLIN, V14, P198; COHEN AM, 1997, CANC PRINCIPLES PRAC, P1145; CUMMINGS BJ, 1985, BRIT J SURG, V72, pS64, DOI 10.1002/bjs.1800721335; DAHL O, 1990, CANCER-AM CANCER SOC, V66, P2286, DOI 10.1002/1097-0142(19901201)66:11<2286::AID-CNCR2820661106>3.0.CO;2-T; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DUKES CE, 1958, BRIT J CANCER, V12, P309, DOI 10.1038/bjc.1958.37; FLETCHER WS, 1965, AM J SURG, V109, P76, DOI 10.1016/S0002-9610(65)80107-6; FRYKHOLM GJ, 1993, DIS COLON RECTUM, V36, P564, DOI 10.1007/BF02049863; GERARD A, 1988, ANN SURG, V208, P606, DOI 10.1097/00000658-198811000-00011; Glimelius B, 1997, INT J RADIAT ONCOL, V37, P281, DOI 10.1016/S0360-3016(96)00510-X; GLIMELIUS B, 1982, ACTA RADIOL ONCOL, V21, P373, DOI 10.3109/02841868209134315; GOLDBERG PA, 1994, EUR J CANCER, V30A, P1602, DOI 10.1016/0959-8049(94)00312-S; GUNDERSON L L, 1986, International Journal of Radiation Oncology, Biology, Physics, V12, P169; HALL WH, 1990, JAMA-J AM MED ASSOC, V264, P1444; HEDGES L, 1985, STAT METH METAANALYS; HIGGINS GA, 1986, CANCER, V58, P352, DOI 10.1002/1097-0142(19860715)58:2<352::AID-CNCR2820580226>3.0.CO;2-D; HORN A, 1990, DIS COLON RECTUM, V33, P823, DOI 10.1007/BF02051916; JAESCHKE R, 1990, AM J MED, V88, P279, DOI 10.1016/0002-9343(90)90154-6; Juni P, 1999, JAMA-J AM MED ASSOC, V282, P1054, DOI 10.1001/jama.282.11.1054; Kataria, 2016, SAUDI J SPORTS MED, V16, P139; KLIGERMAN MM, 1975, CANCER, V36, P691, DOI 10.1002/1097-0142(197508)36:2+<691::AID-CNCR2820360812>3.0.CO;2-E; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; MACFARLANE JK, 1993, LANCET, V341, P457, DOI 10.1016/0140-6736(93)90207-W; MANTEL N, 1959, J NATL CANCER I, V22, P719; MARSH PJ, 1994, DIS COLON RECTUM, V37, P1205, DOI 10.1007/BF02257783; MCARDLE CS, 1991, BRIT MED J, V302, P1501, DOI 10.1136/bmj.302.6791.1501; NETO JAR, 1989, DIS COLON RECTUM, V32, P702, DOI 10.1007/BF02555778; NICOLUCCI A, 1989, JAMA-J AM MED ASSOC, V262, P2101, DOI 10.1001/jama.262.15.2101; Oates GD, 1996, LANCET, V348, P1605; PAHLMAN L, 1990, ANN SURG, V211, P187, DOI 10.1097/00000658-199002000-00011; Pahlman L, 1997, NEW ENGL J MED, V336, P980; PAHLMAN L, 1985, BRIT J SURG, V72, P961, DOI 10.1002/bjs.1800721209; PAHLMAN L, 1993, BRIT J SURG, V80, P1333, DOI 10.1002/bjs.1800801040; PORTER NH, 1985, BR J SURG S, V72, P62; RIDER WD, 1977, CAN J SURG, V20, P335; ROSWIT B, 1975, CANCER, V35, P1597, DOI 10.1002/1097-0142(197506)35:6<1597::AID-CNCR2820350618>3.0.CO;2-S; RUFF CC, 1961, SURG GYNECOL OBSTET, V112, P715; Schmid CH, 1998, STAT MED, V17, P1923, DOI 10.1002/(SICI)1097-0258(19980915)17:17<1923::AID-SIM874>3.0.CO;2-6; Sharp S, 1998, STATA TECH B, V7, DOI DOI 10.1002/SIM.1187/FULL); SMITH AN, 1984, BRIT J SURG, V71, P21; SMITH AN, 1982, BRIT J SURG, V69, P513; STEARNS MW, 1974, SURG GYNECOL OBSTET, V138, P584; *SWED RECT CANC TR, 1996, INT J COLORECTAL DIS, V11, P128; Thompson SG, 1999, STAT MED, V18, P2693, DOI 10.1002/(SICI)1097-0258(19991030)18:20<2693::AID-SIM235>3.0.CO;2-V; WANG CC, 1962, RADIOLOGY, V79, P1; WILKING N, 1990, CANCER, V66, P49; YUSUF S, 1985, PROG CARDIOVASC DIS, V27, P335, DOI 10.1016/S0033-0620(85)80003-7	54	567	601	0	13	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 23	2000	284	8					1008	1015		10.1001/jama.284.8.1008	http://dx.doi.org/10.1001/jama.284.8.1008			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	344PX	10944647				2022-12-28	WOS:000088769000028
J	Taylor, MA; Reilly, D; Llewellyn-Jones, RH; McSharry, C; Aitchison, TC				Taylor, MA; Reilly, D; Llewellyn-Jones, RH; McSharry, C; Aitchison, TC			Randomised controlled trial of homoeopathy versus placebo in perennial allergic rhinitis with overview of four trial series	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CLINICAL-TRIALS; FLOW-RATE; METAANALYSIS; HOMEOPATHT; PATENCY	Objective To test the hypothesis that homoeopathy is a placebo by examining its effect in patients with allergic rhinitis and so contest the evidence from three previous trials in this series. Design Randomised, double blind, placebo controlled, parallel group, multicentre study. Setting Four general practices and a hospital ear, nose, and throat outpatient department. Participants 51 patients with perennial allergic rhinitis. Intervention Random assignment to an oral 30c homoeopathic preparation of principal inhalant allergen or to placebo. Main outcome measures Changes from baseline in nasal inspiratory peak now and symptom visual analogue scale score over third and fourth weeks after randomisation. Results Fifty patients completed the study. The homoeopathy group had a significant objective improvement in nasal airflow compared with the placebo group (mean difference 19.8 1/min, 95% confidence interval 10.4 to 29.1, P = 0.0001). Both groups reported improvement in symptoms, with patients taking homoeopathy reporting more improvement in all but one of the centres, which had more patients with aggravations. On average no significant difference between the groups was seen on visual analogue scale scores. Initial aggravations of rhinitis symptoms were more common with homoeopathy than placebo (7 (30%) v 2 (7%), P = 0.04). Addition of these results to those of three previous trials (n = 253) showed a mean symptom reduction on visual analogue scores of 28% (10.9 mm) for homoeopathy compared with 3% (1.1 mm) for placebo (95% confidence interval 4.2 to 15.4, P = 0.0007). Conclusion The objective results reinforce earlier evidence that homoeopathic dilutions differ from placebo.	Univ Glasgow, Royal Infirm, Dept Med, Glasgow G31 2ER, Lanark, Scotland; Univ Sydney, Dept Med Psychol, Sydney, NSW 2006, Australia; Univ Glasgow, Western Infirm, Dept Immunol, Glasgow G11 6NT, Lanark, Scotland; Univ Glasgow, Dept Stat, Glasgow G12 8QQ, Lanark, Scotland	Royal Infirmary of Edinburgh; University of Glasgow; University of Sydney; University of Glasgow; University of Glasgow	Reilly, D (corresponding author), Glasgow Homoeopath Hosp, Acad Dept, Glasgow G12 0XQ, Lanark, Scotland.	davidreilly1@compuserve.com	Reilly, David/AAG-9067-2020	McSharry, Charles/0000-0003-4758-9038				Aby JS, 1996, ANN ALLERG ASTHMA IM, V76, P348, DOI 10.1016/S1081-1206(10)60036-1; BELLAVITE P, 1995, HOMOEOPATHY; Bracken Michael B., 1992, P13; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; FAIRLEY JW, 1993, CLIN OTOLARYNGOL, V18, P19, DOI 10.1111/j.1365-2273.1993.tb00803.x; GLEESON MJ, 1986, CLIN OTOLARYNGOL, V11, P99, DOI 10.1111/j.1365-2273.1986.tb00114.x; HAHNEMANN H, 1796, HUFELANDS J, V2, P391; HAHNEMANN H, 1796, HUFELANDS J, V2, P465; HOLMSTROM M, 1990, Rhinology (Utrecht), V28, P191; *HOM MED RES GROUP, 1994, REP EUR COMM DIR GEN, V1, P16; JONES AS, 1991, CLIN OTOLARYNGOL, V16, P206, DOI 10.1111/j.1365-2273.1991.tb01978.x; Kiene H, 1996, Altern Ther Health Med, V2, P74; Kiene H, 1996, Altern Ther Health Med, V2, P59; KLEIJNEN J, 1991, BRIT MED J, V302, P316, DOI 10.1136/bmj.302.6772.316; KNIPSCHILD P, 1991, J CLIN EPIDEMIOL, V44, P461, DOI 10.1016/0895-4356(91)90208-Q; KRAYENBUHL MC, 1988, CLIN ALLERGY, V18, P157, DOI 10.1111/j.1365-2222.1988.tb02855.x; Linde K, 1997, LANCET, V350, P834, DOI 10.1016/S0140-6736(97)02293-9; LINDER A, 1988, CLIN ALLERGY, V18, P29, DOI 10.1111/j.1365-2222.1988.tb02840.x; LUCZYNSKA CM, 1989, J IMMUNOL METHODS, V118, P227, DOI 10.1016/0022-1759(89)90010-0; MALMBERG H, 1991, Rhinology (Utrecht), V29, P137; Mygind N., 1979, NASAL ALLERGY, p224 ; Pocock S, 1983, CLIN TRIALS; REIL GH, 1985, Z KARDIOL, V74, P65; REILLY, 1994, LANCET, V344, P1506; REILLY D, 1994, LANCET, V344, P1601, DOI 10.1016/S0140-6736(94)90407-3; REILLY DT, 1986, LANCET, V2, P881; SCADDING GK, 1986, CLIN ALLERGY, V16, P483, DOI 10.1111/j.1365-2222.1986.tb01983.x; SHAPIRO AK, 1997, POWERFUL PLACEBO, P226; STEWART LA, 1993, LANCET, V341, P418, DOI 10.1016/0140-6736(93)93004-K; VELLEMAN PF, 1980, J AM STAT ASSOC, V75, P609, DOI 10.2307/2287657; VITHOULKAS G, 1985, HOMOEOPATHY, P72; WIHL JA, 1988, ANN ALLERGY, V61, P50; Youlten LJ., 1980, ALLERGOL IMMUNOPATH, V8, P344	33	107	109	1	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 19	2000	321	7259					471	476		10.1136/bmj.321.7259.471	http://dx.doi.org/10.1136/bmj.321.7259.471			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	347MC	10948025	Green Published, Green Accepted			2022-12-28	WOS:000088932800017
J	Lennon, BW; Williams, CH; Ludwig, ML				Lennon, BW; Williams, CH; Ludwig, ML			Twists in catalysis: Alternating conformations of Escherichia coli thioredoxin reductase	SCIENCE			English	Article							GLUTATHIONE-REDUCTASE; MECHANISM; DISULFIDE; ROTATION; MOTIONS; FLAVIN	In thioredoxin reductase (TrxR) from Escherichia coli, cycles of reduction and reoxidation of the flavin adenine dinucleotide (FAD) cofactor depend on rate-limiting rearrangements of the FAD and NADPH (reduced form of nicotinamide adenine dinucleotide phosphate) domains. We describe the structure of the ftavin-reducing conformation of E. coli TrxR at a resolution of 3.0 angstroms. The orientation of the two domains permits reduction of FAD by NADPH and oxidation of the enzyme dithiol by the protein substrate, thioredoxin. The alternate conformation, described by Kuriyan and co-workers, permits internal transfer of reducing equivalents from reduced FAD to the active-site disulfide. Comparison of these structures demonstrates that switching between the two conformations involves a "ball-and-socket" motion in which the pyridine nucleotide-binding domain rotates by 67 degrees.	Univ Michigan, Div Biophys Res, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; Dept Vet Affairs Med Ctr, Ann Arbor, MI 48105 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Ludwig, ML (corresponding author), Univ Michigan, Div Biophys Res, Ann Arbor, MI 48109 USA.	mlludwig@umich.edu			NIGMS NIH HHS [GM16429, GM18723, GM21444] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arscott LD, 1997, P NATL ACAD SCI USA, V94, P3621, DOI 10.1073/pnas.94.8.3621; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; DOESBURG HM, 1983, ACTA CRYSTALLOGR A, V39, P368, DOI 10.1107/S0108767383000811; EKLUND H, 1984, EMBO J, V3, P1443, DOI 10.1002/j.1460-2075.1984.tb01994.x; EKLUND H, 1991, PROTEINS, V11, P13, DOI 10.1002/prot.340110103; GERSTEIN M, 1993, J MOL BIOL, V234, P357, DOI 10.1006/jmbi.1993.1592; Gerstein M, 1998, NUCLEIC ACIDS RES, V26, P4280, DOI 10.1093/nar/26.18.4280; Gilberger TW, 1998, FEBS LETT, V425, P407, DOI 10.1016/S0014-5793(98)00270-1; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; Herzberg O, 1996, P NATL ACAD SCI USA, V93, P2652, DOI 10.1073/pnas.93.7.2652; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Lennon BW, 1997, BIOCHEMISTRY-US, V36, P9464, DOI 10.1021/bi970307j; LESK AM, 1988, NATURE, V335, P188, DOI 10.1038/335188a0; MARK DF, 1976, P NATL ACAD SCI USA, V73, P780, DOI 10.1073/pnas.73.3.780; Mulrooney SB, 1997, PROTEIN SCI, V6, P2188; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PAI EF, 1983, J BIOL CHEM, V258, P1752; Schulz GE, 1991, CURR OPIN STRUC BIOL, V1, P883, DOI 10.1016/0959-440X(91)90082-5; THELANDER L, 1979, ANNU REV BIOCHEM, V48, P133, DOI 10.1146/annurev.bi.48.070179.001025; Tong L, 1997, METHOD ENZYMOL, V276, P594, DOI 10.1016/S0076-6879(97)76080-4; Veine DM, 1998, PROTEIN SCI, V7, P1441, DOI 10.1002/pro.5560070621; Veine DM, 1998, PROTEIN SCI, V7, P369; WAKSMAN G, 1994, J MOL BIOL, V236, P800, DOI 10.1006/jmbi.1994.1190; Wang PF, 1996, BIOCHEMISTRY-US, V35, P4812, DOI 10.1021/bi9526793; WILLIAMS CH, 1995, FASEB J, V9, P1267, DOI 10.1096/fasebj.9.13.7557016; WILLIAMS CH, 1992, CHEM BIOCH FLAVOENZY, V3, pCH5	28	192	197	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 18	2000	289	5482					1190	1194		10.1126/science.289.5482.1190	http://dx.doi.org/10.1126/science.289.5482.1190			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	346JE	10947986				2022-12-28	WOS:000088866600042
J	Smaglik, P				Smaglik, P			'Quiet revolution' in chemistry could revive public and private sectors	NATURE			English	Article																			0	16	16	0	6	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 17	2000	406	6797					807	808		10.1038/35021181	http://dx.doi.org/10.1038/35021181			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	344PH	10963612				2022-12-28	WOS:000088767700060
J	Bingley, PJ; Douek, IF; Rogers, CA; Gale, EAM				Bingley, PJ; Douek, IF; Rogers, CA; Gale, EAM		BOX Barts Oxford Study Grp	Influence of maternal age at delivery and birth order on risk of type 1 diabetes in childhood: prospective population based family study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FINNISH CHILDREN; IDDM; MELLITUS; ONSET; YOUNGER; ASTHMA	Objectives To examine the influence of parental age at delivery; and birth order on subsequent risk of childhood diabetes. Design Prospective population based family study Setting Area formerly administered by the Oxford Regional Health Authority. Participants 1375 families in which one child or more had diabetes. Of 3221 offspring, 1431 had diabetes (median age at diagnosis 10.5 years, range 0.5-28.5) and 1790 remained non-diabetic at a median age of 16.1 years. Main outcome measures Disease free survival and hazard ratios for the development of type 1 diabetes in all offspring, assessed by Cox proportional hazard regression. Results Maternal age at delivery was strongly related to risk of type 1 diabetes in the offspring, risk increased by 25% (95% confidence interval 17% to 34%) for each five year band of maternal age, so that maternal age at delivery of 45 years or more was associated with a relative risk of 3.11 (2.07 to 4.66) compared with a maternal age of less than 20 years. Paternal age was also associated with a 9% (3% to 16%) increase for each five year increase in paternal age. The relative risk of diabetes, adjusted for parental age at delivery and sex of offspring, decreased with increasing birth order; the overall effect was a 15% risk reduction (10% to 21%) per child born Conclusions A strong association was found between increasing maternal age at delivery and risk of diabetes in the child. Risk was highest in firstborn children and decreased progressively with higher birth order. The fetal environment seems to have a strong influence on risk of trpe I diabetes in the child. The increase in maternal age at delivery in the United Kingdom over the past two decades could partly account for the increase in incidence of childhood diabetes over this period.	Univ Bristol, Southmead Hosp, Div Med, Bristol BS10 5NB, Avon, England; Southmead Hosp, Res & Dev Support Unit, Southmead, England	Southmead Hospital; University of Bristol; Southmead Hospital	Gale, EAM (corresponding author), Univ Bristol, Southmead Hosp, Div Med, Bristol BS10 5NB, Avon, England.	edwin.gale@bristol.ac.uk						Bache I, 1999, DIABETES CARE, V22, P1063, DOI 10.2337/diacare.22.7.1063; BLOM L, 1989, DIABETOLOGIA, V32, P7; COLLETT D, 1994, MODELLING SURVIVAL D, P54; Dahlquist G, 1996, BRIT MED J, V313, P1174, DOI 10.1136/bmj.313.7066.1174; DAHLQUIST GG, 1995, DIABETES, V44, P408, DOI 10.2337/diabetes.44.4.408; Douek IF, 1999, LANCET, V353, P1850, DOI 10.1016/S0140-6736(99)00988-5; FLOOD TM, 1982, DIABETES CARE, V5, P571, DOI 10.2337/diacare.5.6.571; Gardner SG, 1997, BRIT MED J, V315, P713, DOI 10.1136/bmj.315.7110.713; GINSBERGFELLNER F, 1985, REV INFECT DIS, V7, pS170; HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; HYOTY H, 1995, DIABETES, V44, P652, DOI 10.2337/diabetes.44.6.652; Karvonen M, 1999, DIABETES CARE, V22, P1066, DOI 10.2337/diacare.22.7.1066; KHAN N, 1994, DIABETES CARE, V17, P653, DOI 10.2337/diacare.17.7.653; Lewis S, 1996, THORAX, V51, P670, DOI 10.1136/thx.51.7.670; MAYER EJ, 1988, DIABETES, V37, P1625, DOI 10.2337/diabetes.37.12.1625; METCALFE MA, 1992, ARCH DIS CHILD, V67, P731, DOI 10.1136/adc.67.6.731; *ORG EC COOP DEV, 1996, BEYOND 2000 NEW SOC; PATTERSON CC, 1994, DIABETES CARE, V17, P376, DOI 10.2337/diacare.17.5.376; SCHWARTZ J, 1990, AM REV RESPIR DIS, V142, P555, DOI 10.1164/ajrccm/142.3.555; Svanes C, 1998, EUR RESPIR J, V12, P1366, DOI 10.1183/09031936.98.12061366; Tuomilehto J, 1999, DIABETOLOGIA, V42, P655, DOI 10.1007/s001250051212; WAGENER DK, 1983, DIABETOLOGIA, V25, P82; WRYOBEK AJ, 1996, EXP MOL MUTAGEN, V28, P254; Ziegler AG, 1999, DIABETES, V48, P460, DOI 10.2337/diabetes.48.3.460	24	100	101	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 12	2000	321	7258					420	424		10.1136/bmj.321.7258.420	http://dx.doi.org/10.1136/bmj.321.7258.420			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	344QC	10938050	Green Published, Bronze			2022-12-28	WOS:000088769500021
J	Campbell, SM; Cantrill, JA; Roberts, D				Campbell, SM; Cantrill, JA; Roberts, D			Prescribing indicators for UK general practice: Delphi consultation study	BRITISH MEDICAL JOURNAL			English	Article							APPROPRIATENESS; PRACTITIONERS; CARE	Objectives To identify prescribing indicators based on prescribing analysis and cost (PACT) data that have face validity for measuring quality or cost minimisation. Design Modified two round Delphi questionnaire requiring quantitative and qualitative answers. Setting Health authorities in England. Participants All health authority, medical and pharmaceutical advisers in the first round and lead prescribing advisers for each health authority in the second round. Main outcome measures Face validity (median rating of 7-9 on a nine point scale without disagreement) and reliability (rating 8 or 9) of indicators for assessing quality and cost minimisation. Results Completed second round questionnaires were received from 79 respondents out of 99. The median rating was 7 for cost minimisation and 6 for quality, and in all except four cases individual respondents rated indicators significantly higher for cost than for quality. Of the 41 indicators tested, only seven were rated valid and reliable for cost minimisation and five for quality. Conclusion The 12 indicators rated as valid by leading prescribing advisers had a narrow focus and would allow only a limited examination of prescribing at a general practice, primary care group, or health authority level.	Univ Manchester, Natl Primary Care Res & Dev Ctr, Manchester M13 9PL, Lancs, England; Brunswick Court, Prescribing Support Unit, Leeds, W Yorkshire, England	University of Manchester	Campbell, SM (corresponding author), Univ Manchester, Natl Primary Care Res & Dev Ctr, Manchester M13 9PL, Lancs, England.			Campbell, Stephen/0000-0002-2328-4136				*AUD COMM, 1994, PRESCR IMPR MOR RAT; Avery AJ, 1998, J CLIN PHARM THER, V23, P441, DOI 10.1046/j.1365-2710.1998.00187.x; Bateman DN, 1996, BRIT J GEN PRACT, V46, P20; Blades S, 1998, EUR J GEN PRACT, V4, P60; Brook R H, 1986, Int J Technol Assess Health Care, V2, P53; Brook RH., 1995, RAND UCLA APPROPRIAT; Buetow SA, 1997, SOC SCI MED, V45, P261, DOI 10.1016/S0277-9536(96)00342-5; Campbell SM, 1998, J PUBLIC HEALTH MED, V20, P414, DOI 10.1093/oxfordjournals.pubmed.a024796; CAMPBELL SM, IN PRESS SOC SCI MED; CANTRILL J, 1999, IMPROVING QUALITY PR; Cantrill JA, 1998, QUAL HEALTH CARE, V7, P130, DOI 10.1136/qshc.7.3.130; Cantrill JA, 2011, INT J PHARM PRACT, V4, P67, DOI DOI 10.1111/J.2042-7174.1996.TB00844.X; *DEP HLTH, 1998, QUAL NEW NHS 1 CLASS; JONES J, 1995, BRIT MED J, V311, P376, DOI 10.1136/bmj.311.7001.376; Majeed A, 1997, BRIT MED J, V315, P1515, DOI 10.1136/bmj.315.7121.1515; *NAT PRESC CTR NHS, 1998, GP PRESCR SUPP UN RE; *PRESCR SUPP UN, 1998, PRESCR MEAS APPL EXP; QUEENBOROUGH R, 1999, PRESCRIBER, V10, P47; ROLAND M, 1999, QUALITY ASSESSMENT G; *SECR STAT HLTH, 1998, CM3807; Shekelle Paul G., 1995, JGIM, V10, P81	21	139	141	1	10	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	AUG 12	2000	321	7258					425	428B		10.1136/bmj.321.7258.425	http://dx.doi.org/10.1136/bmj.321.7258.425			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	344QC	10938052	Green Published, Bronze			2022-12-28	WOS:000088769500026
J	Gottlieb, S				Gottlieb, S			Gene therapy can reduce tumours	BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	AUG 12	2000	321	7258					400	400		10.1136/bmj.321.7258.400	http://dx.doi.org/10.1136/bmj.321.7258.400			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	344QC	10938036	Green Published			2022-12-28	WOS:000088769500008
J	Israel, E				Israel, E			Assessment of therapeutic index of inhaled steroids	LANCET			English	Editorial Material									Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Pulm & Crit Care Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Israel, E (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Pulm & Crit Care Med, Boston, MA 02115 USA.							GREENING AP, 1994, LANCET, V344, P219, DOI 10.1016/S0140-6736(94)92996-3; Kamada AK, 1996, AM J RESP CRIT CARE, V153, P1739, DOI 10.1164/ajrccm.153.6.8665030; LIPWORTH BJ, 1995, THORAX, V50, P105, DOI 10.1136/thx.50.2.105; Lofdahl CG, 1999, BMJ-BRIT MED J, V319, P87, DOI 10.1136/bmj.319.7202.87	4	4	5	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 12	2000	356	9229					527	528		10.1016/S0140-6736(00)02574-5	http://dx.doi.org/10.1016/S0140-6736(00)02574-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	345MY	10950226				2022-12-28	WOS:000088820800006
J	Kent, GM; Singh, SC; Harding, AJ; Sinha, MC; Orcutt, JA; Barton, PJ; White, RS; Bazin, S; Hobbs, RW; Tong, CH; Pye, JW				Kent, GM; Singh, SC; Harding, AJ; Sinha, MC; Orcutt, JA; Barton, PJ; White, RS; Bazin, S; Hobbs, RW; Tong, CH; Pye, JW			Evidence from three-dimensional seismic reflectivity images for enhanced melt supply beneath mid-ocean-ridge discontinuities	NATURE			English	Article							EAST PACIFIC RISE; OVERLAPPING SPREADING CENTERS; MAGMA CHAMBER BENEATH; AXIS DISCONTINUITIES; CRUSTAL; LAYER; 9-DEGREES-03'N; SEGMENTATION; ACCRETION; THICKNESS	Quantifying the melt distribution and crustal structure across ridge-axis discontinuities is essential for understanding the relationship between magmatic, tectonic and petrologic segmentation of mid-ocean-ridge spreading centres. The geometry and continuity of magma bodies beneath features such as overlapping spreading centres can strongly influence the composition of erupted lavas(1) and may give insight into the underlying pattern of mantle flow. Here we present three-dimensional images of seismic reflectivity beneath a mid-ocean ridge to investigate the nature of melt distribution across a ridge-axis discontinuity. Reflectivity slices through the 9 degrees 03' N overlapping spreading centre on East Pacific Rise suggest that it has a robust magma supply, with melt bodies underlying both limbs and ponding of melt beneath large areas of the overlap basin. The geometry of melt distribution beneath this offset is inconsistent with large-scale, crustal redistribution of melt away from centres of upwelling(2,3). The complex distribution of melt seems instead to be caused by a combination of vertical melt transport from the underlying mantle and subsequent focusing of melt beneath a magma freezing boundary in the mid-crust.	Univ Calif San Diego, Cecil H & Ida M Green Inst Geophys & Planetary Ph, La Jolla, CA 92093 USA; Univ Cambridge, Bullard Labs, Dept Earth Sci, Cambridge CB3 0EZ, England; Univ Cambridge, British Inst Reflect Profiling Syndicate, Cambridge CB3 0EZ, England	University of California System; University of California San Diego; University of Cambridge; University of Cambridge	Kent, GM (corresponding author), Univ Calif San Diego, Cecil H & Ida M Green Inst Geophys & Planetary Ph, La Jolla, CA 92093 USA.	gkent@ucsd.edu	Bazin, Sara/A-5654-2011; Hobbs, Richard/F-1054-2013; White, Robert/B-8453-2015; Bazin, Sara/AAL-3694-2020	Hobbs, Richard/0000-0001-5131-9239; Bazin, Sara/0000-0001-6478-7760; Tong, Vincent/0000-0002-2597-5934; Orcutt, John/0000-0001-5508-0050				Barth GA, 1996, J GEOPHYS RES-SOL EA, V101, P17951, DOI 10.1029/96JB00814; BATIZA R, 1996, J GEOPHYS RES, V101, P17951; BAZIN S, 2000, THESIS U CALIFORNIA; CARBOTTE S, 1992, J GEOPHYS RES-SOL EA, V97, P6959, DOI 10.1029/91JB03065; Carbotte SM, 1997, J GEOPHYS RES-SOL EA, V102, P10165, DOI 10.1029/96JB03910; Christeson GL, 1996, J GEOPHYS RES-SOL EA, V101, P2859, DOI 10.1029/95JB03212; COLLIER J, 1990, NATURE, V346, P646, DOI 10.1038/346646a0; DETRICK RS, 1987, NATURE, V326, P35, DOI 10.1038/326035a0; Dunn RA, 1997, NATURE, V388, P259, DOI 10.1038/40831; HARDING AJ, 1993, J GEOPHYS RES-SOL EA, V98, P13925, DOI 10.1029/93JB00886; Hooft EEE, 1996, EARTH PLANET SC LETT, V142, P289, DOI 10.1016/0012-821X(96)00101-X; KENT GM, 1990, NATURE, V344, P650, DOI 10.1038/344650a0; KENT GM, 1993, J GEOPHYS RES-SOL EA, V98, P13971, DOI 10.1029/93JB00706; LANGMUIR CH, 1986, NATURE, V322, P422, DOI 10.1038/322422a0; LONSDALE P, 1989, J GEOPHYS RES-SOLID, V94, P12197, DOI 10.1029/JB094iB09p12197; LONSDALE P, 1983, J GEOPHYS RES, V88, P9393, DOI 10.1029/JB088iB11p09393; MACDONALD KC, 1988, NATURE, V335, P217, DOI 10.1038/335217a0; MACDONALD KC, 1983, NATURE, V302, P55, DOI 10.1038/302055a0; MAGDE LS, 1995, J GEOPHYS RES-SOL EA, V100, P3747, DOI 10.1029/94JB02869; MORGAN JP, 1985, J GEOPHYS RES-SOLID, V90, P8603, DOI 10.1029/JB090iB10p08603; MUTTER JC, 1988, NATURE, V336, P156, DOI 10.1038/336156a0; PHIPPSMORGAN J, 1993, J GEOPHYS RES, V98, P6283; SCHEIRER DS, 1993, J GEOPHYS RES-SOL EA, V98, P7871, DOI 10.1029/93JB00015; SEMPERE JC, 1984, GEOPHYS J ROY ASTR S, V79, P799, DOI 10.1111/j.1365-246X.1984.tb02869.x; Singh SC, 1999, GEOLOGY, V27, P219, DOI 10.1130/0091-7613(1999)027<0219:SEFAHL>2.3.CO;2; Singh SC, 1998, NATURE, V394, P874, DOI 10.1038/29740; SINTON JM, 1983, EARTH PLANET SC LETT, V62, P193, DOI 10.1016/0012-821X(83)90083-3; TOOMEY DR, 1990, NATURE, V347, P639, DOI 10.1038/347639a0; Wang XJ, 1996, J GEOPHYS RES-SOL EA, V101, P17927, DOI 10.1029/96JB00194; Yilmaz O., 1987, SEISMIC DATA PROCESS	30	88	89	2	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 10	2000	406	6796					614	618		10.1038/35020543	http://dx.doi.org/10.1038/35020543			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	342PF	10949299				2022-12-28	WOS:000088653800044
J	Thiel, PA; Dubois, JM				Thiel, PA; Dubois, JM			Quasicrystals - Electrons in a strange sea	NATURE			English	Editorial Material							QUASI-CRYSTALS		Iowa State Univ, Ames Lab, Ames, IA 50011 USA; Iowa State Univ, Dept Chem, Ames, IA 50011 USA; Ecole Mines, Sci & Genie Mat Met Lab, INPL, CNRS,UMR 7584, F-54042 Nancy, France	Iowa State University; United States Department of Energy (DOE); Ames National Laboratory; Iowa State University; Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine	Thiel, PA (corresponding author), Iowa State Univ, Ames Lab, 1605 Gilman Hall, Ames, IA 50011 USA.							Belin-Ferre E, 1999, MATER RES SOC SYMP P, V553, P347; Fisher IR, 1999, PHILOS MAG B, V79, P425, DOI 10.1080/13642819908206417; JANOT C, 1994, PHYS REV LETT, V72, P1674, DOI 10.1103/PhysRevLett.72.1674; Macia E, 2000, PHYS REV B, V61, P8771, DOI 10.1103/PhysRevB.61.8771; MARTIN S, 1991, PHYS REV LETT, V67, P719, DOI 10.1103/PhysRevLett.67.719; PIERCE FS, 1993, PHYS REV B, V47, P5670, DOI 10.1103/PhysRevB.47.5670; Rotenberg E, 2000, NATURE, V406, P602, DOI 10.1038/35020519	7	24	24	0	10	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 10	2000	406	6796					570	573		10.1038/35020657	http://dx.doi.org/10.1038/35020657			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	342PF	10949280				2022-12-28	WOS:000088653800024
J	Henney, JE				Henney, JE			Surgical sealant for lung cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item											Henney, JE (corresponding author), HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	2	3	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 9	2000	284	6					685	685		10.1001/jama.284.6.685	http://dx.doi.org/10.1001/jama.284.6.685			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	341JM	10950660				2022-12-28	WOS:000088587300004
J	Korswagen, HC; Herman, MA; Clevers, HC				Korswagen, HC; Herman, MA; Clevers, HC			Distinct beta-catenins mediate adhesion and signalling functions in C-elegans	NATURE			English	Article							HOX GENE-EXPRESSION; CAENORHABDITIS-ELEGANS; POLARITY SIGNALS; AXIS FORMATION; CELL-ADHESION; MAP KINASE; PROTEIN; HOMOLOG; EMBRYOS; DROSOPHILA	In flies and vertebrates, Armadillo/beta-catenin forms a complex with Tcf/Lef-1 transcription factors, serving as an essential coactivator to mediate Wnt signalling. It also associates with cadherins to mediate adhesion. In Caenorhabditis elegans, three putative beta-catenin homologues have been identified: WRM-1, BAR-1 and HMP-2. WRM-1 and the Tcf homologue POP-1 mediate Wnt signalling by a mechanism that has challenged current views of the Wnt pathway(1-3). Here we show that BAR-1 is the only beta-catenin homologue that interacts directly with POP-1. BAR-1 mediates Wnt signalling by forming a BAR-1/POP-1 bipartite transcription factor that activates expression of Wnt target genes such as the Hox gene mab-5. HMP-2 is the only beta-catenin homologue that interacts with the single cadherin of C. elegans, HMR-1. We conclude that a canonical Wnt pathway exists in C. elegans. Furthermore, our analysis shows that the functions of C. elegans beta-catenins in adhesion and in signalling are performed by separate proteins.	Univ Med Ctr Utrecht, Dept Immunol, NL-3584 CX Utrecht, Netherlands; Univ Med Ctr Utrecht, Ctr Biomed Genet, NL-3584 CX Utrecht, Netherlands; Kansas State Univ, Div Biol, Program Mol Cellular & Dev Biol, Manhattan, KS 66506 USA	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Kansas State University	Korswagen, HC (corresponding author), Univ Med Ctr Utrecht, Dept Immunol, Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands.		Korswagen, Hendrik/I-8782-2012	Herman, Michael/0000-0001-6796-1568				Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Brunner E, 1997, NATURE, V385, P829, DOI 10.1038/385829a0; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Christofori G, 1999, TRENDS BIOCHEM SCI, V24, P73, DOI 10.1016/S0968-0004(98)01343-7; Costa M, 1998, J CELL BIOL, V141, P297, DOI 10.1083/jcb.141.1.297; Eisenmann DM, 1998, DEVELOPMENT, V125, P3667; Fagotto F, 1996, J CELL BIOL, V132, P1105, DOI 10.1083/jcb.132.6.1105; Harris J, 1996, DEVELOPMENT, V122, P3117; KENYON C, 1986, CELL, V46, P477, DOI 10.1016/0092-8674(86)90668-9; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Lin RL, 1998, CELL, V92, P229, DOI 10.1016/S0092-8674(00)80917-4; LIN RL, 1995, CELL, V83, P599, DOI 10.1016/0092-8674(95)90100-0; Maloof JN, 1999, DEVELOPMENT, V126, P37; Meneghini MD, 1999, NATURE, V399, P793, DOI 10.1038/21666; Miller JR, 1996, GENE DEV, V10, P2527, DOI 10.1101/gad.10.20.2527; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Orsulic S, 1996, J CELL BIOL, V134, P1283, DOI 10.1083/jcb.134.5.1283; Riese J, 1997, CELL, V88, P777, DOI 10.1016/S0092-8674(00)81924-8; Rocheleau CE, 1999, CELL, V97, P717, DOI 10.1016/S0092-8674(00)80784-9; Rocheleau CE, 1997, CELL, V90, P707, DOI 10.1016/S0092-8674(00)80531-0; Rubinfeld B, 1997, SCIENCE, V275, P1790, DOI 10.1126/science.275.5307.1790; Ruvkun G, 1998, SCIENCE, V282, P2033, DOI 10.1126/science.282.5396.2033; SALSER SJ, 1992, NATURE, V355, P255, DOI 10.1038/355255a0; Sawa H, 1996, GENE DEV, V10, P2189, DOI 10.1101/gad.10.17.2189; Shin TH, 1999, MOL CELL, V4, P275, DOI 10.1016/S1097-2765(00)80375-5; Simcha I, 1998, J CELL BIOL, V141, P1433, DOI 10.1083/jcb.141.6.1433; Thorpe CJ, 1997, CELL, V90, P695, DOI 10.1016/S0092-8674(00)80530-9; Thorpe CJ, 2000, TRENDS CELL BIOL, V10, P10, DOI 10.1016/S0962-8924(99)01672-4; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X	30	171	190	0	4	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 3	2000	406	6795					527	532		10.1038/35020099	http://dx.doi.org/10.1038/35020099			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	340ML	10952315				2022-12-28	WOS:000088538000049
J	Holliman, R				Holliman, R			Commentary: Congenital toxoplasmosis-further thought for food	BRITISH MEDICAL JOURNAL			English	Editorial Material									St Georges Hosp & Med Sch, London SW17 0QT, England	St Georges University London	Holliman, R (corresponding author), St Georges Hosp & Med Sch, London SW17 0QT, England.							CHATTERTON JM, 1992, HUMAN TOXOPLASMOSIS, P174; HOLLIMAN RE, 1995, J HOSP INFECT, V30, P179, DOI 10.1016/0195-6701(95)90018-7; *MULT WORK GROUP, 1992, PREN SCREEN TOX UK	3	2	2	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUL 15	2000	321	7254					147	147						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	336MG	10950535				2022-12-28	WOS:000088305700020
J	Van de Perre, P				Van de Perre, P			HIV voluntary counselling and testing in community health services	LANCET			English	Editorial Material							HUMAN-IMMUNODEFICIENCY-VIRUS; TRIMETHOPRIM-SULFAMETHOXAZOLE; RANDOMIZED TRIAL; COTE-DIVOIRE; TRANSMISSION; ABIDJAN		Ctr Muraz, OCCGE, Bobo Dioulasso, Burkina Faso	Centre Muraz	Van de Perre, P (corresponding author), Ctr Muraz, OCCGE, Bobo Dioulasso, Burkina Faso.		Van de Perre, Philippe/B-9692-2008	Van de Perre, Philippe/0000-0002-3912-0427				Anglaret X, 1999, LANCET, V353, P1463, DOI 10.1016/S0140-6736(98)07399-1; Cartoux M, 1998, AIDS, V12, P2489, DOI 10.1097/00002030-199818000-00019; FOSTER S, 1995, LANCET, V346, P225, DOI 10.1016/S0140-6736(95)91272-X; Guay LA, 1999, LANCET, V354, P795, DOI 10.1016/S0140-6736(99)80008-7; MEDA N, 1999, WHO B, V77, P731; MERTENS TE, 1994, LANCET, V343, P1293, DOI 10.1016/S0140-6736(94)92183-0; Van de Perre P, 1999, J INFECT DIS, V179, pS405, DOI 10.1086/314793; Wiktor SZ, 1999, LANCET, V353, P1469, DOI 10.1016/S0140-6736(99)03465-0	8	24	25	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 8	2000	356	9224					86	87		10.1016/S0140-6736(00)02462-4	http://dx.doi.org/10.1016/S0140-6736(00)02462-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	331UG	10963238				2022-12-28	WOS:000088036600002
J	Kaul, A; Koster, M; Neuhaus, H; Braun, T				Kaul, A; Koster, M; Neuhaus, H; Braun, T			Myf-5 revisited: Loss of early myotome formation does not lead to a rib phenotype in homozygous Myf-5 mutant mice	CELL			English	Article							BHLH GENE MRF4; MYOGENIN; SPECIFICATION; INACTIVATION; SOMITE; DEATH; CELLS		Univ Halle Wittenberg, Inst Physiol Chem, D-06097 Halle, Germany	Martin Luther University Halle Wittenberg	Braun, T (corresponding author), Univ Halle Wittenberg, Inst Physiol Chem, Hollystr 1, D-06097 Halle, Germany.	thomas.braun@medizin.uni-halle.de	Braun, Thomas/B-2310-2008	Braun, Thomas/0000-0002-6165-4804				BRAUN T, 1992, CELL, V71, P369, DOI 10.1016/0092-8674(92)90507-9; BRAUN T, 1995, EMBO J, V14, P1176, DOI 10.1002/j.1460-2075.1995.tb07101.x; Grass S, 1996, DEVELOPMENT, V122, P141; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; Henderson DJ, 1999, DEV BIOL, V209, P143, DOI 10.1006/dbio.1999.9215; Huang RJ, 2000, DEVELOPMENT, V127, P527; Olson EN, 1996, CELL, V85, P1, DOI 10.1016/S0092-8674(00)81073-9; PATAPOUTIAN A, 1995, DEVELOPMENT, V121, P3347; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Tajbakhsh S, 1996, NATURE, V384, P266, DOI 10.1038/384266a0; VENUTI JM, 1995, J CELL BIOL, V128, P563, DOI 10.1083/jcb.128.4.563; WEINTRAUB H, 1991, SCIENCE, V251, P761, DOI 10.1126/science.1846704; ZHANG W, 1995, GENE DEV, V9, P1388, DOI 10.1101/gad.9.11.1388	13	75	79	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 7	2000	102	1					17	19		10.1016/S0092-8674(00)00006-4	http://dx.doi.org/10.1016/S0092-8674(00)00006-4			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	332UL	10929709	Bronze			2022-12-28	WOS:000088091700004
J	Johnson, BA; Roache, JD; Javors, MA; DiClemente, CC; Cloninger, CR; Prihoda, TJ; Bordnick, PS; Ait-Daoud, N; Hensler, J				Johnson, BA; Roache, JD; Javors, MA; DiClemente, CC; Cloninger, CR; Prihoda, TJ; Bordnick, PS; Ait-Daoud, N; Hensler, J			Ondansetron for reduction of drinking among biologically predisposed alcoholic patients - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARBOHYDRATE-DEFICIENT TRANSFERRIN; 5-HT3 RECEPTOR ANTAGONIST; STRUCTURED CLINICAL INTERVIEW; NCB-20 NEUROBLASTOMA-CELLS; SEROTONIN TRANSPORTER; MESOLIMBIC SYSTEM; EARLY-ONSET; ETHANOL; ABUSE; RATS	Context Early-onset alcoholism differs from late-onset alcoholism by its association with greater serotonergic abnormality and antisocial behaviors. Thus, individuals with early-onset alcoholism may be responsive to treatment with a selective serotonergic agent. Objective To test the hypothesis that drinking outcomes associated with early vs late-onset alcoholism are differentially improved by the selective 5-HT3 (serotonin) antagonist ondansetron. Design Double-blind, randomized, placebo-controlled clinical trial. Settings University of Texas Health Science Center in Houston (April 1995-June 1998) and University of Texas Health Science Center in San Antonio (July 1998-December 1999). Participants A total of 321 patients with diagnosed alcoholism (mean age, 40.6 years; 70.5% male; 78.6% white) were enrolled, 271 of whom proceeded to randomization. Interventions After 1 lead-in week of single-blind placebo, patients were randomly assigned to receive 11 weeks of treatment with ondansetron, 1 mu g/kg (n = 67), 4 mu g/kg (n=77), or 16 mu g/kg (n=71) twice per day; or identical placebo (n=56). All patients also participated in weekly standardized group cognitive behavioral therapy. Main Outcome Measures Self-reported alcohol consumption (drinks per day, drinks per drinking day, percentage of days abstinent, and total days abstinent per study week); and plasma carbohydrate deficient transferrin (CDT) level, an objective and sensitive marker of transient alcohol consumption. Results Patients with early-onset alcoholism who received ondansetron (1,4, and 16 mu g/kg twice per day) compared with those who were administered placebo, had fewer drinks per day (1.89, 1.56, and 1.87 vs 3.30; P=.03, P=.01, and P=.02, respectively) and drinks per drinking day (4.75, 4.28, and 5.18 vs 6.90; P=.03, P=.004, and P=.03, respectively), Ondansetron, 4 mu g/kg twice per day, was superior to placebo in increasing percentage of days abstinent (70.10 vs 50.20; P=.02) and total days abstinent per study week (6.74 vs 5.92; P=.03). Among patients with early-onset alcoholism, there was a significant difference in the mean log CDT ratio between those who received ondansetron (1 and 4 mu g/kg twice per day) compared with those who received the placebo (-0.17 and -0.19 vs 0.12; P=.03 and P=.01, respectively). Conclusion Our results suggest that ondansetron (particularly the 4 mu g/kg twice per day dosage) is an effective treatment for patients with early-onset alcoholism, presumably by ameliorating an underlying serotonergic abnormality.	Univ Texas, Hlth Sci Ctr, Dept Psychiat, San Antonio, TX 78229 USA; Univ Maryland, Dept Psychol, Baltimore, MD 21201 USA; Washington Univ, Sch Med, St Louis, MO USA	University of Texas System; University of Texas Health San Antonio; University System of Maryland; University of Maryland Baltimore; Washington University (WUSTL)	Johnson, BA (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Psychiat, 7703 Floyd Curl Dr,Mail Stop 7792, San Antonio, TX 78229 USA.	bjohnson@uthscsa.edu	DiClemente, Carlo C/F-6208-2011; Cloninger, Claude/F-5357-2012	Cloninger, Claude/0000-0003-3096-4807; Roache, John/0000-0002-7010-8119	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA010522] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Anton RF, 1996, ALCOHOL CLIN EXP RES, V20, pA3, DOI 10.1111/j.1530-0277.1996.tb01183.x; BABOR TF, 1992, BRIT J ADDICT, V87, P1415; BALLENGER JC, 1979, ARCH GEN PSYCHIAT, V36, P224; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Barnes NM, 1999, NEUROPHARMACOLOGY, V38, P1083, DOI 10.1016/S0028-3908(99)00010-6; BEARDSLEY PM, 1994, ALCOHOL, V11, P389, DOI 10.1016/0741-8329(94)90023-X; Bloom FE, 1998, NEUROCHEM RES, V23, P653, DOI 10.1023/A:1022486705184; Bouffard R, 2003, CAN J PSYCHIAT, V48, P546, DOI 10.1177/070674370304800806; BROWN J, 1994, ANN NY ACAD SCI, V708, P22; BUYDENSBRANCHEY L, 1989, ARCH GEN PSYCHIAT, V46, P225; CLONINGER CR, 1987, SCIENCE, V236, P410, DOI 10.1126/science.2882604; CLONINGER CR, 1981, ARCH GEN PSYCHIAT, V38, P861; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; COSTALL B, 1987, BRIT J PHARMACOL, V92, P881, DOI 10.1111/j.1476-5381.1987.tb11394.x; DelBoca FK, 1996, ALCOHOL CLIN EXP RES, V20, P1412; DICHIARA G, 1988, P NATL ACAD SCI USA, V85, P5274; DOTY P, 1994, BEHAV PHARMACOL, V5, P461, DOI 10.1097/00008877-199408000-00007; FADDA F, 1991, ALCOHOL ALCOHOLISM, V26, P107, DOI 10.1093/oxfordjournals.alcalc.a045088; FilsAime ML, 1996, ARCH GEN PSYCHIAT, V53, P211; George D, 1998, CLIN PHARMACOL THER, V63, P203; George DT, 1999, ALCOHOL CLIN EXP RES, V23, P272, DOI 10.1111/j.1530-0277.1999.tb04110.x; GRAYBILL FA, 1970, THEORY APPL LINEAR M, P207; Heinz A, 2000, BIOL PSYCHIAT, V47, P643, DOI 10.1016/S0006-3223(99)00171-7; Hemby Scott E., 1997, P137; HODGE CW, 1993, ALCOHOL, V10, P191, DOI 10.1016/0741-8329(93)90034-L; Hollingshead August B., 1958, SOCIAL CLASS MENTAL; Huseby NE, 1997, ALCOHOL CLIN EXP RES, V21, P1343, DOI 10.1097/00000374-199710000-00027; Ishiguro H, 1999, ALCOHOL CLIN EXP RES, V23, P1281; Johnson BA, 2000, PSYCHOPHARMACOLOGY, V149, P327, DOI 10.1007/s002130000371; Johnson BA, 2000, AM J ADDICTION, V9, P17; JOHNSON BA, 1993, PSYCHOPHARMACOLOGY, V112, P142, DOI 10.1007/BF02247375; JOHNSON BA, 1993, DRUG DEVELOP RES, V30, P153, DOI 10.1002/ddr.430300308; JOHNSON BA, 1993, PSYCHOPHARMACOLOGY, V112, P145, DOI 10.1007/BF02247376; JOHNSON BA, IN PRESS ALCOHOL CLI; KILPATRICK GJ, 1987, NATURE, V330, P746, DOI 10.1038/330746a0; Kilpatrick GJ, 1996, BEHAV BRAIN RES, V73, P11; KOOB GF, 1992, ANN NY ACAD SCI, V654, P171, DOI 10.1111/j.1749-6632.1992.tb25966.x; KOULU M, 1990, PSYCHOPHARMACOLOGY, V101, P168, DOI 10.1007/BF02244121; Kranzler HR, 1996, ALCOHOL CLIN EXP RES, V20, P1534, DOI 10.1111/j.1530-0277.1996.tb01696.x; LEMARQUAND D, 1994, BIOL PSYCHIAT, V36, P326, DOI 10.1016/0006-3223(94)90630-0; LEMARQUAND D, 1994, BIOL PSYCHIAT, V36, P395, DOI 10.1016/0006-3223(94)91215-7; LITT MD, 1992, ARCH GEN PSYCHIAT, V49, P609; Little KY, 1998, AM J PSYCHIAT, V155, P207; LOVINGER DM, 1991, J NEUROPHYSIOL, V66, P1329, DOI 10.1152/jn.1991.66.4.1329; Lovinger DR, 1999, NEUROCHEM INT, V35, P125, DOI 10.1016/S0197-0186(99)00054-6; Marlatt GA., 1985, RELAPSE PREVENTION; McBride WJ, 1998, CRIT REV NEUROBIOL, V12, P339, DOI 10.1615/CritRevNeurobiol.v12.i4.40; MCLELLAN AT, 1985, J NERV MENT DIS, V173, P412, DOI 10.1097/00005053-198507000-00005; MEERT TF, 1993, ALCOHOL ALCOHOLISM, V28, P157; Meinert CL., 1986, CLIN TRIALS DESIGN C; MILLER WR, 1984, MANUAL COMPREHENSIVE; Monti P, 1989, TREATING ALCOHOL DEP; NIEMELA O, 1995, ALCOHOL CLIN EXP RES, V19, P1203, DOI 10.1111/j.1530-0277.1995.tb01601.x; RODDHENRICK ZA, 1999, INTRACRANIAL SELF AD; *SAS I INC, 1997, SAS US GUID STAT VER; Schuckit MA, 1999, BIOL PSYCHIAT, V45, P647, DOI 10.1016/S0006-3223(98)00248-0; SELLERS EM, 1994, ALCOHOL CLIN EXP RES, V18, P879, DOI 10.1111/j.1530-0277.1994.tb00054.x; SELZER ML, 1971, AM J PSYCHIAT, V127, P1653, DOI 10.1176/ajp.127.12.1653; SENN S, 1994, STAT MED, V13, P1715, DOI 10.1002/sim.4780131703; SOBELL LC, 1992, MEASURING ALCOHOL CONSUMPTION, P41, DOI 10.1007/978-1-4612-0357-5_3; SPITZER RL, 1992, ARCH GEN PSYCHIAT, V49, P624; STIBLER H, 1991, CLIN CHEM, V37, P2029; STIBLER H, 1991, ALCOHOL ALCOHOLISM, P451; STOUT RL, 1994, J STUD ALCOHOL, P70, DOI 10.15288/jsas.1994.s12.70; SULLIVAN JT, 1989, BRIT J ADDICT, V84, P1353; Swann AC, 1999, PSYCHOPHARMACOLOGY, V143, P380, DOI 10.1007/s002130050962; Swift RM, 1996, BIOL PSYCHIAT, V40, P514, DOI 10.1016/0006-3223(95)00432-7; TOMKINS DM, 1995, PSYCHOPHARMACOLOGY, V117, P479, DOI 10.1007/BF02246222; *US DEP HHS, 1992, COGN BEH COP SKILLS; VIKKUNEN M, 1997, RECENT DEV ALCOHOLIS, P173; VIRKKUNEN M, 1990, ANN MED, V22, P327, DOI 10.3109/07853899009147915; WILLIAMS JBW, 1992, ARCH GEN PSYCHIAT, V49, P630; WISE RA, 1987, PSYCHOL REV, V94, P469, DOI 10.1037/0033-295X.94.4.469; Zhou Q, 1996, J PHARMACOL EXP THER, V278, P732	74	317	327	1	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 23	2000	284	8					963	971		10.1001/jama.284.8.963	http://dx.doi.org/10.1001/jama.284.8.963			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	344PX	10944641	Bronze			2022-12-28	WOS:000088769000022
J	Amrani, A; Verdaguer, J; Serra, P; Tafuro, S; Tan, RS; Santamaria, P				Amrani, A; Verdaguer, J; Serra, P; Tafuro, S; Tan, RS; Santamaria, P			Progression of autoimmune diabetes driven by avidity maturation of a T-cell population	NATURE			English	Article							GLUTAMIC-ACID DECARBOXYLASE; IMMUNE-RESPONSE; MICE; INSULITIS; COMPLEX; LIGANDS; TCR; AFFINITIES; MOLECULES; KINETICS	For unknown reasons, autoimmune diseases such as type 1 diabetes develop after prolonged periods of inflammation of mononuclear cells in target tissues 1. Here we show that progression of pancreatic islet inflammation to overt diabetes in nonobese diabetic (NOD) mice is driven by the 'avidity maturation' of a prevailing, pancreatic beta-cell-specirc T-lymphocyte population carrying the CD8 antigen. This T-lymphocyte population recognizes two related peptides (NRP and NRP-A7)(2) in the context of H-2K(d) class I molecules of the major histocompatibility complex (MHC). As pre-diabetic NOD mice age, their islet-associated CD8(+) T lymphocytes contain increasing numbers of NRP-A7-reactive cells, and these cells bind NRP-A7/H-2K(d) tetramers with increased specificity, increased avidity and longer half-lives. Repeated treatment of pre-diabetic NOD mice with soluble NRP-A7 peptide blunts the avidity maturation of the NRP-A7-reactive CD8(+) T-cell population by selectively deleting those clonotypes expressing T-cell receptors with the highest affinity and lowest dissociation rates for peptide-MHC binding. This inhibits the local production of T cells that are cytotoxic to beta cells, and halts the progression from severe insulitis to diabetes. We conclude that avidity maturation of pathogenic T-cell populations may be the key event in the progression of benign inflammation to overt disease in autoimmunity.	Univ Calgary, Hlth Sci Ctr, Dept Microbiol & Infect Dis, Fac Med, Calgary, AB T2N 4N1, Canada; John Radcliffe Hosp, Inst Mol Med, MRC, Human Immunol Unit, Oxford OX3 9DU, England; British Columbia Childrens Hosp, Vancouver, BC V6H 3V4, Canada; Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V6H 3V4, Canada	University of Calgary; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Oxford; BC Childrens Hospital; University of British Columbia; University of British Columbia	Santamaria, P (corresponding author), Univ Calgary, Hlth Sci Ctr, Dept Microbiol & Infect Dis, Fac Med, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.		Autonell, Joan Verdaguer/A-2059-2010; Santamaria, Pere/ABF-6823-2021	Autonell, Joan Verdaguer/0000-0003-1768-9310; Tan, Rusung/0000-0002-2204-2004				ABIRU N, 1999, CAN J DIABETES CARE, V23, P59; Alam SM, 1996, NATURE, V381, P616, DOI 10.1038/381616a0; Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Anderson B, 1999, P NATL ACAD SCI USA, V96, P9311, DOI 10.1073/pnas.96.16.9311; Delovitch TL, 1997, IMMUNITY, V7, P727, DOI 10.1016/S1074-7613(00)80392-1; DiLorenzo TP, 1998, P NATL ACAD SCI USA, V95, P12538, DOI 10.1073/pnas.95.21.12538; KATZ J, 1993, EUR J IMMUNOL, V23, P3358, DOI 10.1002/eji.1830231244; KAUFMAN DL, 1993, NATURE, V366, P69, DOI 10.1038/366069a0; Kersh GJ, 1998, IMMUNITY, V9, P817, DOI 10.1016/S1074-7613(00)80647-0; Lyons DS, 1996, IMMUNITY, V5, P53, DOI 10.1016/S1074-7613(00)80309-X; MATSUI K, 1994, P NATL ACAD SCI USA, V91, P12862, DOI 10.1073/pnas.91.26.12862; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; NAGATA M, 1994, J IMMUNOL, V152, P2042; RAMMENSEE HG, 1995, IMMUNOGENETICS, V41, P178, DOI 10.1007/BF00172063; Reich Z, 1997, NATURE, V387, P617, DOI 10.1038/42500; SANTAMARIA P, 1995, J IMMUNOL, V154, P2494; Savage PA, 1999, IMMUNITY, V10, P485, DOI 10.1016/S1074-7613(00)80048-5; SERREZE DV, 1994, DIABETES, V43, P505, DOI 10.2337/diabetes.43.3.505; TISCH R, 1993, NATURE, V366, P72, DOI 10.1038/366072a0; Verdaguer J, 1997, J EXP MED, V186, P1663, DOI 10.1084/jem.186.10.1663; Verdaguer J, 1996, J IMMUNOL, V157, P4726; Wegmann DR, 1996, CURR OPIN IMMUNOL, V8, P860, DOI 10.1016/S0952-7915(96)80016-1; WICKER LS, 1994, DIABETES, V43, P500, DOI 10.2337/diabetes.43.3.500; Wong FS, 1999, NAT MED, V5, P1026, DOI 10.1038/12465	24	285	296	0	17	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 17	2000	406	6797					739	742		10.1038/35021081	http://dx.doi.org/10.1038/35021081			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	344PH	10963600				2022-12-28	WOS:000088767700047
J	Iwasato, T; Datwani, A; Wolf, AM; Nishiyama, H; Taguchi, Y; Tonegawa, S; Knopfel, T; Erzurumlu, RS; Itohara, S				Iwasato, T; Datwani, A; Wolf, AM; Nishiyama, H; Taguchi, Y; Tonegawa, S; Knopfel, T; Erzurumlu, RS; Itohara, S			Cortex-restricted disruption of NMDAR1 impairs neuronal patterns in the barrel cortex	NATURE			English	Article							RAT SOMATOSENSORY CORTEX; CEREBRAL-CORTEX; CRITICAL PERIOD; MOUSE; PLASTICITY; MICE; ORGANIZATION; CONNECTIONS; AFFERENTS; BLOCKADE	In the rodent primary somatosensory cortex, the configuration of whiskers and sinus hairs on the snout and of receptor-dense zones on the paws is topographically represented as discrete modules of layer IV granule cells (barrels) and thalamocortical afferent terminals(1,2). The role of neural activity, particularly activity mediated by NMDARs (N-methyl-D-aspartate receptors), in patterning of the somatosensory cortex has been a subject of debate(3-6). We have generated mice in which deletion of the NMDAR1 (NR1) gene is restricted to excitatory cortical neurons, and here we show that sensory periphery-related patterns develop normally in the brainstem and thalamic somatosensory relay stations of these mice. In the somatosensory cortex, thalamocortical afferents corresponding to large whiskers form patterns and display critical period plasticity, but their patterning is not as distinct as that seen in the cortex of normal mice. Other thalamocortical patterns corresponding to sinus hairs and digits are mostly absent. The cellular aggregates known as barrels and barrel boundaries do not develop even at sites where thalamocortical afferents cluster. Our findings indicate that cortical NMDARs are essential for the aggregation of layer IV cells into barrels and for development of the full complement of thalamocortical patterns.	RIKEN, Brain Sci Inst, Lab Behav Genet, Wako, Saitama 3510198, Japan; LSUHSC, Dept Anat & Cell Biol, New Orleans, LA 70112 USA; LSUHSC, Ctr Neurosci, New Orleans, LA 70112 USA; RIKEN, Brain Sci Inst, Lab Neuronal Circuit Dynam, Wako, Saitama 3510198, Japan; Kyoto Univ, Inst Virus Res, Sakyo Ku, Kyoto 6068507, Japan; MIT, RIKEN MIT Neurosci Res Ctr, Howard Hughes Med Inst, Ctr Learning & Memory, Cambridge, MA 02139 USA	RIKEN; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; RIKEN; Kyoto University; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); RIKEN	Itohara, S (corresponding author), RIKEN, Brain Sci Inst, Lab Behav Genet, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	sitohara@brain.riken.go.jp	Knöpfel, Thomas/B-1128-2008; Itohara, Shigeyoshi/I-8769-2012	Knöpfel, Thomas/0000-0002-5718-0765; Itohara, Shigeyoshi/0000-0002-2410-9989; Wolf, Alexander/0000-0002-5755-8756	NINDS NIH HHS [R01 NS039050] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039050] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Cases O, 1996, NEURON, V16, P297, DOI 10.1016/S0896-6273(00)80048-3; CHIAIA NL, 1992, DEV BRAIN RES, V66, P244, DOI 10.1016/0165-3806(92)90086-C; CONSTANTINEPATON M, 1990, ANNU REV NEUROSCI, V13, P129, DOI 10.1146/annurev.neuro.13.1.129; Cramer Karina S., 1995, Current Opinion in Neurobiology, V5, P106, DOI 10.1016/0959-4388(95)80094-8; ERZURUMLU RS, 1990, DEV BRAIN RES, V56, P229; Feldmeyer D, 1999, J PHYSIOL-LONDON, V521, P169, DOI 10.1111/j.1469-7793.1999.00169.x; Fox K, 1996, P NATL ACAD SCI USA, V93, P5584, DOI 10.1073/pnas.93.11.5584; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; Gulisano M, 1996, EUR J NEUROSCI, V8, P1037, DOI 10.1111/j.1460-9568.1996.tb01590.x; HARRIS RM, 1981, J COMP NEUROL, V196, P357, DOI 10.1002/cne.901960302; Iwasato T, 1997, NEURON, V19, P1201, DOI 10.1016/S0896-6273(00)80412-2; JHAVERI S, 1991, P NATL ACAD SCI USA, V88, P4489, DOI 10.1073/pnas.88.10.4489; Jhaveri S, 1992, DEV CENTRAL NERVOUS, P167; KATZ LC, 1988, J NEUROSCI, V8, P3160; Kutsuwada T, 1996, NEURON, V16, P333, DOI 10.1016/S0896-6273(00)80051-3; LI YQ, 1994, CELL, V76, P427, DOI 10.1016/0092-8674(94)90108-2; Messersmith EK, 1997, MOL CELL NEUROSCI, V9, P347, DOI 10.1006/mcne.1997.0646; Molnar Z, 2000, RES PRO CEL, V30, P293; O'Leary D D, 1994, Curr Opin Neurobiol, V4, P535, DOI 10.1016/0959-4388(94)90054-X; OTTERSEN OP, 1984, J COMP NEUROL, V229, P374, DOI 10.1002/cne.902290308; Parnavelas JG, 2000, TRENDS NEUROSCI, V23, P126, DOI 10.1016/S0166-2236(00)01553-8; Rajan I, 1998, J NEUROSCI, V18, P7836; Sakai K, 1997, BIOCHEM BIOPH RES CO, V237, P318, DOI 10.1006/bbrc.1997.7111; SCHLAGGAR BL, 1993, NATURE, V364, P623, DOI 10.1038/364623a0; Tanifuji M, 1996, BRAIN RES, V738, P83, DOI 10.1016/0006-8993(96)00767-6; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; WONGRILEY MTT, 1980, P NATL ACAD SCI-BIOL, V77, P2333, DOI 10.1073/pnas.77.4.2333; Woolsey T.A., 1990, P461; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X; Yoshida M, 1997, DEVELOPMENT, V124, P101	30	403	410	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 17	2000	406	6797					726	731		10.1038/35021059	http://dx.doi.org/10.1038/35021059			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	344PH	10963597	Green Accepted			2022-12-28	WOS:000088767700044
J	Wolfe, JM; Alvarez, GA; Horowitz, TS				Wolfe, JM; Alvarez, GA; Horowitz, TS			Attention is fast but volition is slow	NATURE			English	Article									Harvard Univ, Sch Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Ctr Ophthalm Res, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Wolfe, JM (corresponding author), Harvard Univ, Sch Med, 221 Longwood Ave, Boston, MA 02115 USA.		Horowitz, Todd S/J-3376-2013; Wolfe, Jeremy M/A-9248-2016; Wolfe, Jeremy M/C-1621-2012	Wolfe, Jeremy M/0000-0002-6475-1984; Wolfe, Jeremy M/0000-0002-6475-1984; Horowitz, Todd/0000-0001-5571-6266				Horowitz TS, 1998, NATURE, V394, P575, DOI 10.1038/29068; Noton D., 1971, PERCEPTION MECH MODE, P218; Wolfe Jeremy M, 2010, Curr Biol, V20, pR346, DOI 10.1016/j.cub.2010.02.016	3	98	99	1	22	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 17	2000	406	6797					691	691		10.1038/35021132	http://dx.doi.org/10.1038/35021132			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	344PH	10963584				2022-12-28	WOS:000088767700031
J	Dixon, MJ; Smilek, D; Cudahy, C; Merikle, PM				Dixon, MJ; Smilek, D; Cudahy, C; Merikle, PM			Five plus two equals yellow	NATURE			English	Article							DIGIT		Univ Waterloo, Dept Psychol, Waterloo, ON N2L 3G1, Canada	University of Waterloo	Dixon, MJ (corresponding author), Univ Waterloo, Dept Psychol, Waterloo, ON N2L 3G1, Canada.							Bailey M. E. S., 1997, SYNAESTHESIA CLASSIC, P182; BARONCOHEN S, 1987, PERCEPTION, V16, P761, DOI 10.1068/p160761; Cytowic RE, 1993, MAN WHO TASTED SHAPE; Frith C.D., 1997, SYNAESTHESIA CLASSIC, P123; Mills CB, 1999, COGNITIVE NEUROPSYCH, V16, P181, DOI 10.1080/026432999380951; Odgaard EC, 1999, PERCEPTION, V28, P651, DOI 10.1068/p2910	6	190	190	0	31	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 27	2000	406	6794					365	365		10.1038/35019148	http://dx.doi.org/10.1038/35019148			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	337WC	10935623	Bronze			2022-12-28	WOS:000088383800030
J	Van Esch, H; Groenen, P; Nesbit, MA; Schuffenhauer, S; Lichtner, P; Vanderlinden, G; Harding, B; Beetz, R; Bilous, RW; Holdaway, I; Shaw, NJ; Fryns, JP; Van de Ven, WV; Thakker, RV; Devriendt, K				Van Esch, H; Groenen, P; Nesbit, MA; Schuffenhauer, S; Lichtner, P; Vanderlinden, G; Harding, B; Beetz, R; Bilous, RW; Holdaway, I; Shaw, NJ; Fryns, JP; Van de Ven, WV; Thakker, RV; Devriendt, K			GATA3 haplo-insufficiency causes human HDR syndrome	NATURE			English	Article							TRANSCRIPTION FACTOR GATA-3; EMBRYONIC EXPRESSION; DIGEORGE-SYNDROME; GENE; MUTATIONS; 10P; HYPOPARATHYROIDISM; DEAFNESS; REGION; SYSTEM	Terminal deletions of chromosome 10p result in a DiGeorge-like phenotype that includes hypoparathyroidism, heart defects, immune deficiency, deafness and renal malformations(1). Studies in patients with 10p deletions have defined two non-overlapping regions that contribute to this complex phenotype. These are the DiGeorge critical region II (refs 1, 2), which is located on 10p13-14, and the region for the hypoparathyroidism, sensorineural deafness, renal anomaly (HDR) syndrome(3) (Mendelian Inheritance in Man number 146255)(4), which is located more telomeric (10p14-10pter)(5,6). We have performed deletion-mapping studies in two HDR patients, and here we define a critical 200-kilobase region which contains the GATA3 gene(7). This gene belongs to a family of zinc-finger transcription factors that are involved in vertebrate embryonic development(8-10). Investigation for GATA3 mutations in three other HDR probands identified one nonsense mutation and two intragenic deletions that predicted a loss of function, as confirmed by absence of DNA binding by the mutant GATA3 protein. These results show that GATA3 is essential in the embryonic development of the parathyroids, auditory system and kidneys, and indicate that other GATA family members may be involved in the aetiology of human malformations.	Univ Leuven, Ctr Human Genet, Dept Clin Genet, B-3000 Louvain, Belgium; Birmingham Childrens Hosp, Dept Endocrinol, Birmingham B46 1YH, W Midlands, England; Auckland Hosp, Dept Endocrinol, Auckland 1, New Zealand; Med Sch Newcastle Upon Tyne, Dept Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Univ Mainz, Childrens Hosp, D-55101 Mainz, Germany; Univ Munich, Childrens Hosp, Dept Med Genet, D-80336 Munich, Germany; Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Mol Endocrinol Grp, Oxford OX3 9DU, England; Univ Leuven, Ctr Human Genet, Oncol Mol Lab, B-3000 Louvain, Belgium; Flanders Interuniv Inst Biotechnol, B-3000 Louvain, Belgium	KU Leuven; University of Birmingham; Auckland City Hospital; Newcastle University - UK; Johannes Gutenberg University of Mainz; University of Munich; University of Oxford; KU Leuven	Devriendt, K (corresponding author), Univ Leuven, Ctr Human Genet, Dept Clin Genet, Herestr 49, B-3000 Louvain, Belgium.		Van+Esch, Hilde/AAU-5688-2020	Van Esch, Hilde/0000-0002-9604-5726; Thakker, Rajesh/0000-0002-1438-3220				Beetz R, 1997, MONATSSCHR KINDERH, V145, P347, DOI 10.1007/s001120050131; BILOUS RW, 1992, NEW ENGL J MED, V327, P1069, DOI 10.1056/NEJM199210083271506; Brown SA, 1998, NAT GENET, V20, P180, DOI 10.1038/2484; Daw SCM, 1996, NAT GENET, V13, P458, DOI 10.1038/ng0896-458; Debacker C, 1999, MECH DEVELOP, V85, P183, DOI 10.1016/S0925-4773(99)00088-X; GEORGE KM, 1994, DEVELOPMENT, V120, P2673; Hendriks RW, 1999, EUR J IMMUNOL, V29, P1912, DOI 10.1002/(SICI)1521-4141(199906)29:06<1912::AID-IMMU1912>3.3.CO;2-4; Kuo CT, 1997, GENE DEV, V11, P1048, DOI 10.1101/gad.11.8.1048; LABASTIE MC, 1995, KIDNEY INT, V47, P1597, DOI 10.1038/ki.1995.223; LABASTIE MC, 1994, GENOMICS, V21, P1, DOI 10.1006/geno.1994.1217; Latchman D. S., 1993, TRANSCRIPTION FACTOR; Lichtner P, 2000, J MED GENET, V37, P33, DOI 10.1136/jmg.37.1.33; Lloyd SE, 1996, NATURE, V379, P445, DOI 10.1038/379445a0; McKusick V.A., 1998, MENDELIAN INHERITANC; Momeni P, 2000, NAT GENET, V24, P71, DOI 10.1038/71717; Nanni L, 1999, HUM MOL GENET, V8, P2479, DOI 10.1093/hmg/8.13.2479; Nichols KE, 2000, NAT GENET, V24, P266, DOI 10.1038/73480; PANDOLFI PP, 1995, NAT GENET, V11, P40, DOI 10.1038/ng0995-40; Rivolta MN, 1998, J NEUROCYTOL, V27, P637, DOI 10.1023/A:1006951813063; Rosenthal N, 1999, J CLIN INVEST, V104, P1483, DOI 10.1172/JCI8825; Schuffenhauer S, 1998, EUR J HUM GENET, V6, P213, DOI 10.1038/sj.ejhg.5200183; Schuler GD, 1996, SCIENCE, V274, P540, DOI 10.1126/science.274.5287.540; SIMON MC, 1995, NAT GENET, V11, P9, DOI 10.1038/ng0995-9; Soderlund C, 1997, COMPUT APPL BIOSCI, V13, P523; SULSTON J, 1989, COMPUT APPL BIOSCI, V5, P101; Ting CN, 1996, NATURE, V384, P474, DOI 10.1038/384474a0; Van Esch H, 1999, CLIN GENET, V55, P269, DOI 10.1034/j.1399-0004.1999.550410.x; YANG ZY, 1994, MOL CELL BIOL, V14, P2201, DOI 10.1128/MCB.14.3.2201	28	372	377	0	14	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 27	2000	406	6794					419	422		10.1038/35019088	http://dx.doi.org/10.1038/35019088			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	337WC	10935639				2022-12-28	WOS:000088383800049
J	Tarnow-Mordi, WO; Hau, C; Warden, A; Shearer, AJ				Tarnow-Mordi, WO; Hau, C; Warden, A; Shearer, AJ			Hospital mortality in relation to staff workload: a 4-year study in an adult intensive-care unit	LANCET			English	Article							SOCIETY APACHE-II; CASE-MIX; BRITAIN; IRELAND; DISEASE	Background Few studies have examined mortality rates in relation to the workload of hospital staff. We investigated this issue in one adult intensive-care unit (ICU) in the UK. Methods We measured ICU workload per shift during each patient's stay for all admissions between 1992 and 1995 that met criteria for adjustment of mortality risk by the APACHE II equation (n=1050). APACHE II data were Validated by one observer. Measures of workload in each patient's stay included occupancy, total ICU nursing requirement as defined by the UK Intensive Care Society, and the ratio of occupied to appropriately staffed beds. Over the period, staffing was appropriate for between 4.1 and 5.3 occupied beds (1.3 nurses per patient). Findings There were 337 deaths, 49 more (95% CI 34-65) than predicted by the APACHE II equation. Median occupancy was 5.8 beds, and median nursing requirement was 1.6 per patient. On multiple logistic regression analysis, adjusted mortality was more than two times higher (odds ratio 3.1 [1.9-5.0]) in patients exposed to high than in those exposed to low ICU workload, defined by average nursing requirement per occupied bed and peak occupancy; the unadjusted odds ratio for this comparison was 4.0 (2.6-6.2). After exclusion of measures of nursing requirement, adjusted mortality increased with the ratio of occupied to appropriately staffed beds during each patient's stay. All logistic regression models fitted the data satisfactorily. Interpretation Variations in mortality may be partly explained by excess ICU workload. This methodology may have implications for planning and clinical governance.	Westmead Hosp, Westmead, NSW 2145, Australia; Univ Dundee, Tayside Inst Child Hlth, MRC, Hlth Serv Res Collaborat,Perinatal Epidemiol Grp, Dundee, Scotland; Univ Dundee, Dept Epidemiol & Publ Hlth, Dundee, Scotland; Univ Dundee, Ninewells Hosp & Med Sch, Intens Care Unit, Dundee DD1 9SY, Scotland; Univ Sydney, New Childrens Hosp, Neonatal Serv, Sydney, NSW 2006, Australia	University of Sydney; University of Dundee; University of Dundee; University of Dundee; University of Sydney	Tarnow-Mordi, WO (corresponding author), Westmead Hosp, Westmead, NSW 2145, Australia.							Bastos PG, 1996, INTENS CARE MED, V22, P664, DOI 10.1007/s001340050148; DONCHIN Y, 1995, CRIT CARE MED, V23, P294, DOI 10.1097/00003246-199502000-00015; Fowlie PW, 1998, CRIT CARE MED, V26, P163, DOI 10.1097/00003246-199801000-00033; FRANKLIN CM, 1988, ARCH INTERN MED, V148, P1403, DOI 10.1001/archinte.148.6.1403; GIRAUD T, 1993, CRIT CARE MED, V21, P40, DOI 10.1097/00003246-199301000-00011; Goldblum R. M., 1981, Nutrition Research, V1, P449, DOI 10.1016/S0271-5317(81)80049-8; Goldhill DR, 1998, ANAESTHESIA, V53, P937, DOI 10.1046/j.1365-2044.1998.00534.x; HALEY RW, 1982, J INFECT DIS, V145, P875, DOI 10.1093/infdis/145.6.875; *INT CAR SOC, 1990, INT CAR AUD; ISAACS D, 1988, ARCH DIS CHILD, V63, P533, DOI 10.1136/adc.63.5.533; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Lyons RA, 2000, LANCET, V355, P595, DOI 10.1016/S0140-6736(00)01265-4; Metcalfe MA, 1997, LANCET, V350, P7, DOI 10.1016/S0140-6736(96)10018-0; Polderman KH, 1999, LANCET, V353, P380, DOI 10.1016/S0140-6736(05)74953-9; ROWAN KM, 1994, CRIT CARE MED, V22, P1392, DOI 10.1097/00003246-199409000-00007; ROWAN KM, 1993, BRIT MED J, V307, P977, DOI 10.1136/bmj.307.6910.977; ROWAN KM, 1993, BRIT MED J, V307, P972, DOI 10.1136/bmj.307.6910.972; TARNOWMORDI WO, 1997, SEMIN NEONATOL, V2, P171; THORENS JB, 1995, CRIT CARE MED, V23, P1807, DOI 10.1097/00003246-199511000-00004; Wallis CB, 1997, ANAESTHESIA, V52, P9, DOI 10.1111/j.1365-2044.1997.003-az002.x	20	346	357	0	11	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 15	2000	356	9225					185	189		10.1016/S0140-6736(00)02478-8	http://dx.doi.org/10.1016/S0140-6736(00)02478-8			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	334GQ	10963195				2022-12-28	WOS:000088179100008
J	Lipworth, BJ				Lipworth, BJ			Therapeutic implications of non-genomic glucocorticoid activity	LANCET			English	Editorial Material							A-STIMULATED THYMOCYTES; ENERGY-METABOLISM; METHYLPREDNISOLONE; HIERARCHY		Univ Dundee, Ninewells Hosp & Med Sch, Dept Clin Pharmacol & Therapeut, Asthma & Allergy Res Grp, Dundee DD1 9SY, Scotland	University of Dundee	Lipworth, BJ (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Dept Clin Pharmacol & Therapeut, Asthma & Allergy Res Grp, Dundee DD1 9SY, Scotland.							Barnes PJ, 1998, CLIN SCI, V94, P557, DOI 10.1042/cs0940557; BUTTGEREIT F, 1993, BIOSCIENCE REP, V13, P41, DOI 10.1007/BF01138177; Buttgereit F, 1999, BIOCHEM PHARMACOL, V58, P363, DOI 10.1016/S0006-2952(99)00090-8; Buttgereit F, 1997, BIOCHEM J, V326, P329, DOI 10.1042/bj3260329; BUTTGEREIT F, 1995, BIOCHEM J, V312, P163, DOI 10.1042/bj3120163; BUTTGEREIT F, 1994, EUR J BIOCHEM, V223, P513, DOI 10.1111/j.1432-1033.1994.tb19020.x; Buttgereit F, 1998, ARTHRITIS RHEUM, V41, P761, DOI 10.1002/1529-0131(199805)41:5<761::AID-ART2>3.0.CO;2-M; MARTENS ME, 1991, BIOCHIM BIOPHYS ACTA, V1058, P152, DOI 10.1016/S0005-2728(05)80232-4; Sanden S, 2000, J RHEUMATOL, V27, P1265; SILVA CM, 1994, STEROIDS, V59, P436, DOI 10.1016/0039-128X(94)90013-2; Wehling M, 1997, ANNU REV PHYSIOL, V59, P365, DOI 10.1146/annurev.physiol.59.1.365	11	71	74	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 8	2000	356	9224					87	89		10.1016/S0140-6736(00)02463-6	http://dx.doi.org/10.1016/S0140-6736(00)02463-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	331UG	10963239				2022-12-28	WOS:000088036600003
J	Marshall, BC; Liou, TG				Marshall, BC; Liou, TG			Elusiveness of ideal approach to Pseudomonas aeruginosa infection complicating cystic fibrosis	LANCET			English	Editorial Material									Univ Utah, Hlth Sci Ctr, Intermt Cyst Fibrosis Ctr, Salt Lake City, UT 84132 USA; Vet Adm Med Ctr, Salt Lake City, UT 84148 USA	Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Marshall, BC (corresponding author), Univ Utah, Hlth Sci Ctr, Intermt Cyst Fibrosis Ctr, Salt Lake City, UT 84132 USA.		Liou, Theodore/AAI-3667-2021	Liou, Theodore/0000-0003-0121-4847	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL003656] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Elborn JS, 2000, THORAX, V55, P355, DOI 10.1136/thorax.55.5.355; Frederiksen B, 1997, PEDIATR PULM, V23, P330, DOI 10.1002/(SICI)1099-0496(199705)23:5<330::AID-PPUL4>3.0.CO;2-O; HOIBY N, 1989, ACTA PAEDIATR SCAND, V78, P395, DOI 10.1111/j.1651-2227.1989.tb11099.x; Morgan WJ, 1999, PEDIATR PULM, V28, P231, DOI 10.1002/(SICI)1099-0496(199910)28:4<231::AID-PPUL1>3.3.CO;2-U; QUAN J, 1999, 23 EUR CYST FIBR C H, pS84; Ramsey BW, 1999, NEW ENGL J MED, V340, P23, DOI 10.1056/NEJM199901073400104; SZAFF M, 1983, ACTA PAEDIATR SCAND, V72, P651, DOI 10.1111/j.1651-2227.1983.tb09789.x; WOHL ME, 1998, PEDIATR PULM, V17, P148	8	3	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 19	2000	356	9230					613	614		10.1016/S0140-6736(00)02600-3	http://dx.doi.org/10.1016/S0140-6736(00)02600-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	346RD	10968431				2022-12-28	WOS:000088884100006
J	van Gijn, J				van Gijn, J			White matters: small vessels and slow thinking in old age	LANCET			English	Editorial Material							FOLLOW-UP; PREVENTION; DEMENTIA; LESIONS		Univ Med Ctr, Dept Neurol, NL-3584 CX Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	van Gijn, J (corresponding author), Univ Med Ctr, Dept Neurol, NL-3584 CX Utrecht, Netherlands.		van Gijn, Jan/A-9444-2008					de Groot JC, 2000, ANN NEUROL, V47, P145; de Leeuw FE, 1999, ANN NEUROL, V46, P827, DOI 10.1002/1531-8249(199912)46:6<827::AID-ANA4>3.0.CO;2-H; Forette F, 1998, LANCET, V352, P1347, DOI 10.1016/S0140-6736(98)03086-4; HACHINSKI VC, 1987, ARCH NEUROL-CHICAGO, V44, P21, DOI 10.1001/archneur.1987.00520130013009; Pantoni L, 1997, STROKE, V28, P652, DOI 10.1161/01.STR.28.3.652; Post Jerrold M., 1993, ILLNESS STRIKES LEAD; Pullicino P, 1996, ARCH NEUROL-CHICAGO, V53, P723, DOI 10.1001/archneur.1996.00550080033010; Schmidt R, 1999, NEUROLOGY, V53, P132, DOI 10.1212/WNL.53.1.132; van Gijn J, 1998, NEUROLOGY, V51, pS3, DOI 10.1212/WNL.51.3_Suppl_3.S3; VANSWIETEN JC, 1991, BRAIN, V114, P761	10	18	18	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 19	2000	356	9230					612	613		10.1016/S0140-6736(00)02599-X	http://dx.doi.org/10.1016/S0140-6736(00)02599-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	346RD	10968430				2022-12-28	WOS:000088884100005
J	Hazzard, WR				Hazzard, WR			The department of internal medicine: Hub of the academic health center response to the aging imperative	ANNALS OF INTERNAL MEDICINE			English	Article								In the 21st century, geriatrics will increasingly dominate U.S. health care as the median age of the population progressively increases. Academic departments of geriatrics have been created in nations that have already experienced this shift. As an alternative strategy that builds on traditional strengths of academic medicine in the United States, departments of internal medicine should lead a multidepartmental, pan-institutional response to the aging imperative. Recognition of gerontology and geriatric medicine as central to the missions of internal medicine in clinical care, education, and research must be increased. In the process, academic departments of internal medicine will develop a high level of geriatric expertise and will launch many programs that address this challenge. Successful development of geriatric programs will serve as a catalyst to strengthen the integration among and between generalists and subspecialists. This will entail developing optimal sites and systems of geriatric care-at different levels of care and over time-that can enhance the geriatric education of medical students, residents, fellows, and practicing physicians. The study of aging and geriatric health care will also become an integral part of departmental research, in its subspecialty divisions as well as its divisions of general internal medicine and geriatrics. This strategy is urgently recommended as both a challenge and an opportunity for all departments of internal medicine.	Vet Affairs Puget Sound Hlth Care Syst, Seattle, WA 98108 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System	Hazzard, WR (corresponding author), Vet Affairs Puget Sound Hlth Care Syst, 1660 S Columbian Way, Seattle, WA 98108 USA.	william.hazzard@med.va.gov						HAZZARD WR, 1986, AGE AGEING, V15, P307, DOI 10.1093/ageing/15.5.307; HAZZARD WR, 1979, AGE AGEING, V8, P141, DOI 10.1093/ageing/8.3.141; HAZZARD WR, 1994, AM J MED, V97; HAZZARD WR, 1990, AGING NEW DIMENSIONS	4	17	18	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 15	2000	133	4					293	296		10.7326/0003-4819-133-4-200008150-00014	http://dx.doi.org/10.7326/0003-4819-133-4-200008150-00014			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	346NG	10929171				2022-12-28	WOS:000088877500007
J	Kidane, G; Morrow, RH				Kidane, G; Morrow, RH			Teaching mothers to provide home treatment of malaria in Tigray, Ethiopa: a randomised trial	LANCET			English	Article							TREATED BED NETS; RURAL AREA; VERBAL AUTOPSIES; HEALTH-CARE; MORTALITY; CHILDREN; MORBIDITY; BEDNETS; PROGRAM; AFRICA	Background No satisfactory strategy for reducing high child mortality from malaria has yet been established in tropical Africa. We compared the effect on under-5 mortality of leaching mothers to promptly provide antimalarials to their sick children at home, with the present community health worker approach. Methods Of 37 tabias (cluster of villages) in two districts with hyperendemic to holoendemic malaria, tabias reported to have the highest malaria morbidity were selected. A census was done which included a maternity history to determine under-5 mortality. Tabias (population 70 506) were paired according to under-5 mortality rates. One tabia from each pair was allocated by random number to an intervention group and the other was allocated to the control group. In the intervention tabias, mother coordinators were trained to teach other local mothers to recognise symptoms of malaria in their children and to promptly give chloroquine. In both intervention and control tabias, all births and deaths of under-5s were recorded monthly. Findings From January to December 1997, 190 of 6383 (29.8 per 1000) children under-5 died in the intervention tabias compared with 366 of 7294 (50.2 per 1000) in the control tabias. Under-5 mortality was reduced by 40% in the intervention localities (95% CI from 29.2-50.6; paired t test, p<0.003). For every third child who died, a structured verbal autopsy was undertaken to ascribe cause of mortality as consistent with malaria or possible malaria, or not consistent with malaria. Of the 190 verbal autopsies, 13 (19%) of 70 in the intervention tabias were consistent with possible malaria compared with 68 (57%) of 120 in the control tabias, Interpretation A major reduction in under-5 mortality can be achieved in holoendemic malaria areas through training local mother coordinators to teach mothers to give under-5 children antimalarial drugs.	Johns Hopkins Univ, Sch Hyg & Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA	Johns Hopkins University	Morrow, RH (corresponding author), Johns Hopkins Univ, Sch Hyg & Publ Hlth, Dept Int Hlth, 615 N Wolfe St, Baltimore, MD 21205 USA.							ALONSO PL, 1991, LANCET, V337, P1499, DOI 10.1016/0140-6736(91)93194-E; ALONSO PL, 1993, T ROY SOC TROP MED H, V87, P37, DOI 10.1016/0035-9203(93)90174-O; Barnabas G A, 1997, Health Policy Plan, V12, P38, DOI 10.1093/heapol/12.1.38; Binka FN, 1996, TROP MED INT HEALTH, V1, P147; D'Alessandro U, 1997, T ROY SOC TROP MED H, V91, P638, DOI 10.1016/S0035-9203(97)90502-2; DABIS F, 1989, B WORLD HEALTH ORGAN, V67, P675; Engers HD, 1998, PARASITOL TODAY, V14, P56, DOI 10.1016/S0169-4758(97)01184-8; GHEBREYESUS TA, 1996, ACTA TROP, V61, P45; Grant James P., 1995, STATE WORLDS CHILDRE; KASEJE D C O, 1987, Annals of Tropical Medicine and Parasitology, V81, P111; Kloos H, 1998, SOC SCI MED, V46, P505, DOI 10.1016/S0277-9536(97)00194-9; MENON A, 1988, J TROP MED HYG, V91, P49; MENON A, 1990, T R SOC TROP MED HYG, V84, P968; MORROW RH, 2000, INFECT DIS EPIDEMIOL; MWABU GM, 1986, SOC SCI MED, V22, P315, DOI 10.1016/0277-9536(86)90129-2; Nevill CG, 1996, TROP MED INT HEALTH, V1, P139; Pagnoni F, 1997, T ROY SOC TROP MED H, V91, P512, DOI 10.1016/S0035-9203(97)90006-7; PLASEK P, 1997, QUAL HEALTH CARE, V6, P40; Quigley MA, 1996, B WORLD HEALTH ORGAN, V74, P147; RUEBUSH TK, 1995, B WORLD HEALTH ORGAN, V73, P229; SALUM FM, 1994, ACTA TROP, V58, P29, DOI 10.1016/0001-706X(94)90119-8; SMITH PG, 1991, METHODS FIELD TRIALS; SNOW RW, 1992, LANCET, V340, P351, DOI 10.1016/0140-6736(92)91414-4; SPENCER H C, 1987, Annals of Tropical Medicine and Parasitology, V81, P36; *WHO, 1984, WHO STUD GROUP TECHN, V712; [WHO] World Health Organization, 1993, WHO TECHN REP SER	26	275	276	0	11	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 12	2000	356	9229					550	555		10.1016/S0140-6736(00)02580-0	http://dx.doi.org/10.1016/S0140-6736(00)02580-0			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	345MY	10950232				2022-12-28	WOS:000088820800012
J	Coleman, P				Coleman, P			Superconductivity - On the verge of magnetism	NATURE			English	Editorial Material									Rutgers State Univ, Dept Phys & Astron, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick	Coleman, P (corresponding author), Rutgers State Univ, Dept Phys & Astron, 136 Frelinghuysen Rd, Piscataway, NJ 08854 USA.							BERK NF, 1966, PHYS REV LETT, V17, P433, DOI 10.1103/PhysRevLett.17.433; BRINKMAN WF, 1974, PHYS REV A, V10, P2386, DOI 10.1103/PhysRevA.10.2386; BRUECKNER KA, 1960, PHYS REV, V118, P1442, DOI 10.1103/PhysRev.118.1442; FEY D, 1980, PHYS REV B, V22, P3173; NAKAJIMA S, 1973, PROG THEOR PHYS, V50, P1101, DOI 10.1143/PTP.50.1101; Saxena SS, 2000, NATURE, V406, P587, DOI 10.1038/35020500	6	14	14	0	3	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 10	2000	406	6796					580	581		10.1038/35020678	http://dx.doi.org/10.1038/35020678			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	342PF	10949286				2022-12-28	WOS:000088653800030
J	Yurke, B; Turberfield, AJ; Mills, AP; Simmel, FC; Neumann, JL				Yurke, B; Turberfield, AJ; Mills, AP; Simmel, FC; Neumann, JL			A DNA-fuelled molecular machine made of DNA	NATURE			English	Article							PICONEWTON FORCES; BRANCH MIGRATION; SINGLE; RIBOZYME; DESIGN	Molecular recognition between complementary strands of DNA allows construction on a nanometre length scale. For example, DNA tags may be used to organize the assembly of colloidal particles(1,2), and DNA templates can direct the growth of semiconductor nanocrystals(3) and metal wires(4). As a structural material in its own right, DNA can be used to make ordered static arrays of tiles(5), linked rings(6) and polyhedra(7). The construction of active devices is also possible-for example, a nanomechanical switch(8), whose conformation is changed by inducing a transition in the chirality of the DNA double helix. Melting of chemically modified DNA has been induced by optical absorption(9), and conformational changes caused by the binding of oligonucleotides or other small groups have been shown to change the enzymatic activity of ribozymes(10-13). Here we report the construction of a DNA machine in which the DNA is used not only as a structural material, but also as 'fuel'. The machine, made from three strands of DNA, has the form of a pair of tweezers. It may be closed and opened by addition of auxiliary strands of 'fuel' DNA; each cycle produces a duplex DNA waste product.	Bell Labs, Lucent Technol, Murray Hill, NJ 07974 USA; Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England	Alcatel-Lucent; Lucent Technologies; AT&T; University of Oxford	Yurke, B (corresponding author), Bell Labs, Lucent Technol, 600 Mt Ave, Murray Hill, NJ 07974 USA.		Turberfield, Andrew J/O-2135-2017; Simmel, Friedrich/G-3281-2010	Turberfield, Andrew J/0000-0002-3876-0190; Simmel, Friedrich/0000-0003-3829-3446				Alivisatos AP, 1996, NATURE, V382, P609, DOI 10.1038/382609a0; Araki M, 1998, NUCLEIC ACIDS RES, V26, P3379, DOI 10.1093/nar/26.14.3379; Asanuma H, 1999, ANGEW CHEM INT EDIT, V38, P2393, DOI 10.1002/(SICI)1521-3773(19990816)38:16<2393::AID-ANIE2393>3.0.CO;2-7; Bockelmann U, 1997, PHYS REV LETT, V79, P4489, DOI 10.1103/PhysRevLett.79.4489; Braun E, 1998, NATURE, V391, P775, DOI 10.1038/35826; CHEN JH, 1991, NATURE, V350, P631, DOI 10.1038/350631a0; Coffer JL, 1996, APPL PHYS LETT, V69, P3851, DOI 10.1063/1.117126; FINER JT, 1994, NATURE, V368, P113, DOI 10.1038/368113a0; GREEN C, 1981, NUCLEIC ACIDS RES, V9, P1905, DOI 10.1093/nar/9.8.1905; HELLER MJ, 1985, RAPID DETECTION IDEN, P245; ISHIJIMA A, 1994, BIOCHEM BIOPH RES CO, V199, P1057, DOI 10.1006/bbrc.1994.1336; KUO SC, 1993, SCIENCE, V260, P232, DOI 10.1126/science.8469975; LEE CS, 1970, J MOL BIOL, V48, P1, DOI 10.1016/0022-2836(70)90215-9; MANNING GS, 1981, BIOPOLYMERS, V20, P1751, DOI 10.1002/bip.1981.360200815; Mao CD, 1999, NATURE, V397, P144, DOI 10.1038/16437; Mao CD, 1997, NATURE, V386, P137, DOI 10.1038/386137b0; Mirkin CA, 1996, NATURE, V382, P607, DOI 10.1038/382607a0; PORTA H, 1995, BIO-TECHNOL, V13, P161, DOI 10.1038/nbt0295-161; RADDING CM, 1977, J MOL BIOL, V116, P825, DOI 10.1016/0022-2836(77)90273-X; RECORD MT, 1978, Q REV BIOPHYS, V11, P103, DOI 10.1017/S003358350000202X; Robertson MP, 1999, NAT BIOTECHNOL, V17, P62, DOI 10.1038/5236; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; Smith SB, 1996, SCIENCE, V271, P795, DOI 10.1126/science.271.5250.795; SMITH SB, 1992, SCIENCE, V258, P1122, DOI 10.1126/science.1439819; STRYER L, 1967, P NATL ACAD SCI USA, V58, P719, DOI 10.1073/pnas.58.2.719; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; Tang J, 1997, CHEM BIOL, V4, P453, DOI 10.1016/S1074-5521(97)90197-6; TURBERFIELD AJ, 1999, B AM PHYS SOC, V44, P1711; WETMUR JG, 1968, J MOL BIOL, V31, P349, DOI 10.1016/0022-2836(68)90414-2; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998	30	1663	1758	50	783	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 10	2000	406	6796					605	608		10.1038/35020524	http://dx.doi.org/10.1038/35020524			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	342PF	10949296				2022-12-28	WOS:000088653800041
J	Jackson, I				Jackson, I			Geophysics - Taking the Earth's temperature	NATURE			English	Editorial Material							ANELASTICITY; TOMOGRAPHY		Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia	Australian National University	Jackson, I (corresponding author), Australian Natl Univ, Res Sch Earth Sci, GPO Box 4, Canberra, ACT 0200, Australia.	ian.jackson@anu.edu.au	jackson, ian/H-4739-2011	jackson, ian/0000-0001-5200-9734				BERCKHEMER H, 1982, PHYS EARTH PLANET IN, V29, P30, DOI 10.1016/0031-9201(82)90135-2; Bijwaard H, 1998, J GEOPHYS RES-SOL EA, V103, P30055, DOI 10.1029/98JB02467; FURLONG KP, 1995, TECTONOPHYSICS, V244, P107, DOI 10.1016/0040-1951(94)00220-4; Goes S, 2000, J GEOPHYS RES-SOL EA, V105, P11153, DOI 10.1029/1999JB900300; GOETZE C, 1977, HIGH PRESSURE RES AP, P3; Gribb TT, 1998, J GEOPHYS RES-SOL EA, V103, P27267, DOI 10.1029/98JB02786; Jackson I., 2000, EARTHS DEEP INTERIOR, P265; Jordan T. H., 1979, MANTLE SAMPLE INCLUS, P1, DOI DOI 10.1029/SP016P0001; KARATO S, 1993, GEOPHYS RES LETT, V20, P1623, DOI 10.1029/93GL01767; Marquering H, 1996, GEOPHYS J INT, V127, P283, DOI 10.1111/j.1365-246X.1996.tb04720.x; MINSTER JB, 1981, PHILOS T R SOC A, V299, P319, DOI 10.1098/rsta.1981.0025; Roth EG, 2000, GEOPHYS RES LETT, V27, P601, DOI 10.1029/1999GL005418; Sobolev SV, 1996, EARTH PLANET SC LETT, V139, P147, DOI 10.1016/0012-821X(95)00238-8	13	3	3	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 3	2000	406	6795					470	471		10.1038/35020182	http://dx.doi.org/10.1038/35020182			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	340ML	10952296				2022-12-28	WOS:000088538000030
J	Kassen, R; Buckling, A; Bell, G; Rainey, PB				Kassen, R; Buckling, A; Bell, G; Rainey, PB			Diversity peaks at intermediate productivity in a laboratory microcosm	NATURE			English	Article							SPECIES RICHNESS; STANDING CROP; COMPETITION; ENVIRONMENT; VEGETATION; MODEL; GRADIENTS; DOMINANCE; COMMUNITY; ECOSYSTEM	The species diversity of natural communities is often strongly related to their productivity. The pattern of this relationship seems to vary: diversity is known to increase monotonically with productivity, to decrease monotonically with productivity, and to be unimodally related to productivity, with maximum diversity occurring at intermediate levels of productivity(1-3). The mechanism underlying these patterns remains obscure, although many possibilities have been suggested(3-6). Here we outline a simple mechanism-involving selection in a heterogeneous environment-to explain these patterns, and test it using laboratory cultures of the bacterium Pseudomonas fluorescens. We grew diverse cultures over a wide range of nutrient concentrations, and found a strongly unimodal relationship between diversity and productivity in heterogeneous, but not in homogeneous, environments. Our result provides experimental evidence that the unimodal relationship often observed in natural communities can be caused by selection for specialized types in a heterogeneous environment.	McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; McGill Univ, Redpath Museum, Montreal, PQ H3A 2K6, Canada; Univ Oxford, Dept Plant Sci, Oxford OX1 3RB, England	McGill University; McGill University; University of Oxford	Kassen, R (corresponding author), McGill Univ, Dept Biol, 1205 Doctor Penfield Ave, Montreal, PQ H3A 1B1, Canada.	rkassen@biol.lan.mcgill.ca	Rainey, Paul/A-3207-2008	Rainey, Paul/0000-0003-0879-5795; Buckling, Angus/0000-0003-1170-4604				ABRAMS PA, 1995, ECOLOGY, V76, P2019, DOI 10.2307/1941677; ABRAMSKY Z, 1984, NATURE, V309, P150, DOI 10.1038/309150a0; ALMUFTI MM, 1977, J ECOL, V65, P759, DOI 10.2307/2259378; BAKELAAR RG, 1978, ECOLOGY, V59, P660, DOI 10.2307/1938767; BELL G, 1992, EVOLUTION, V46, P561, DOI 10.1111/j.1558-5646.1992.tb02060.x; BELL G, 1993, OECOLOGIA, V96, P114, DOI 10.1007/BF00318038; CURRIE DJ, 1991, AM NAT, V137, P27, DOI 10.1086/285144; DEMPSTER ER, 1955, COLD SPRING HARB SYM, V20, P25, DOI 10.1101/SQB.1955.020.01.005; GOLDBERG DE, 1990, ECOLOGY, V71, P213, DOI 10.2307/1940261; GRIME JP, 1973, J ENVIRON MANAGE, V1, P151; HOLT RD, 1994, AM NAT, V144, P741, DOI 10.1086/285705; Leibold MA, 1996, AM NAT, V147, P784, DOI 10.1086/285879; LEVENE H, 1953, AM NAT, V87, P331, DOI 10.1086/281792; MOORE DRJ, 1989, VEGETATIO, V79, P99; ODUM E. P, 1959, FUNDAMENTALS ECOLOGY; Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900; ROSENSZWEIG ML, 1995, SPECIES DIVERSITY SP; Rosenzweig Michael L., 1993, P52; SCHINDLER DW, 1990, OIKOS, V57, P25, DOI 10.2307/3565733; SHIPLEY B, 1991, ECOLOGY, V72, P1658, DOI 10.2307/1940965; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; SMITH JM, 1980, GENET RES, V35, P45, DOI 10.1017/S0016672300013926; Tilman D., 1982, Monographs in Population Biology, pi; Tilman David, 1993, P13; Waide RB, 1999, ANNU REV ECOL SYST, V30, P257, DOI 10.1146/annurev.ecolsys.30.1.257; WHEELER BD, 1991, J ECOL, V79, P285, DOI 10.2307/2260713; WILSON SD, 1991, ECOLOGY, V72, P1050, DOI 10.2307/1940605; WISHEU IC, 1989, CAN J BOT, V67, P1609, DOI 10.1139/b89-203; YOUNT JL, 1956, LIMNOL OCEANOGR, V1, P286, DOI 10.4319/lo.1956.1.4.0286	29	231	276	0	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 3	2000	406	6795					508	512		10.1038/35020060	http://dx.doi.org/10.1038/35020060			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	340ML	10952310				2022-12-28	WOS:000088538000044
J	Joyce, GF				Joyce, GF			Perspectives: RNA structure - Ribozyme evolution at the crossroads	SCIENCE			English	Editorial Material							HEPATITIS-DELTA-VIRUS; SEQUENCES		Scripps Res Inst, Dept Chem & Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Joyce, GF (corresponding author), Scripps Res Inst, Dept Chem & Mol Biol, La Jolla, CA 92037 USA.							EKLAND EH, 1995, SCIENCE, V269, P364, DOI 10.1126/science.7618102; Ferre-D'Amare AR, 1998, NATURE, V395, P567, DOI 10.1038/26912; Fontana W, 1998, SCIENCE, V280, P1451, DOI 10.1126/science.280.5368.1451; JENSEN RA, 1976, ANNU REV MICROBIOL, V30, P409, DOI 10.1146/annurev.mi.30.100176.002205; KUO MYP, 1988, J VIROL, V62, P4439, DOI 10.1128/JVI.62.12.4439-4444.1988; O'Brien PJ, 1999, CHEM BIOL, V6, pR91, DOI 10.1016/S1074-5521(99)80033-7; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Schultes EA, 2000, SCIENCE, V289, P448, DOI 10.1126/science.289.5478.448; Wedemayer GJ, 1997, SCIENCE, V276, P1665, DOI 10.1126/science.276.5319.1665	9	11	11	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 21	2000	289	5478					401	402		10.1126/science.289.5478.401	http://dx.doi.org/10.1126/science.289.5478.401			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	336ME	10939951				2022-12-28	WOS:000088305500027
J	Hochhauser, D				Hochhauser, D			Relevance of mitochondrial DNA in cancer	LANCET			English	Editorial Material							MUTATIONS; DAMAGE		Royal Free & UCL Sch Med, Dept Oncol, London NW3 2QG, England	University of London; University College London	Hochhauser, D (corresponding author), Royal Free & UCL Sch Med, Dept Oncol, London NW3 2QG, England.			Hochhauser, Daniel/0000-0001-5522-9281				Ahrendt S A, 1999, Surg Oncol Clin N Am, V8, P641; ELLIS CN, 1987, BIOCHEM J, V245, P309, DOI 10.1042/bj2450309; Fliss MS, 2000, SCIENCE, V287, P2017, DOI 10.1126/science.287.5460.2017; Kamata H, 1999, CELL SIGNAL, V11, P1, DOI 10.1016/S0898-6568(98)00037-0; LEDOUX SP, 1992, CARCINOGENESIS, V13, P1967, DOI 10.1093/carcin/13.11.1967; Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774; ModicaNapolitano JS, 1996, CANCER RES, V56, P544; Polyak K, 1998, NAT GENET, V20, P291, DOI 10.1038/3108; Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409; Singh KK, 1999, ONCOGENE, V18, P6641, DOI 10.1038/sj.onc.1203056; Yeh JJ, 2000, ONCOGENE, V19, P2060, DOI 10.1038/sj.onc.1203537	11	35	42	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 15	2000	356	9225					181	182		10.1016/S0140-6736(00)02475-2	http://dx.doi.org/10.1016/S0140-6736(00)02475-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	334GQ	10963192				2022-12-28	WOS:000088179100005
J	Cromheecke, ME; Levi, M; Colly, LP; de Mol, BJM; Prins, MH; Hutten, BA; Mak, R; Keyzers, KCJ; Buller, HR				Cromheecke, ME; Levi, M; Colly, LP; de Mol, BJM; Prins, MH; Hutten, BA; Mak, R; Keyzers, KCJ; Buller, HR			Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison	LANCET			English	Article							HEMORRHAGIC COMPLICATIONS; THERAPY; MONITOR; DETERMINANTS; PREVENTION; SYSTEM; TRIAL; DRUGS	Background Vitamin K antagonist treatment is effective for prevention and treatment of thromboembolic events but frequent laboratory control and dose-adjustment are essential. Small portable devices have enabled patient self-monitoring of anticoagulation and self-adjustment of the dose. We compared this self-management of oral anticoagulant therapy with conventional management by a specialist anticoagulation clinic in a randomised cross-over study. Methods 50 patients on long-term oral anticoagulant treatment were included in a randomised controlled crossover study. Patients were self-managed or were managed by the anticoagulation clinic for a period of 3 months. After this period the alternative strategy was followed for each patient. Prothrombin time (expressed as international normalised ratio [INR]) were measured at intervals of 1-2 weeks in both periods without knowledge of type of management. The primary endpoint was the number of measurements within the therapeutic range (therapeutic target value +/-50.5 INR units). Findings There was no significant difference in the overall quality of control of anticoagulation between the two study periods. Patients were for 55% and for 49% of the treatment period within a range of +/-0.5 from the therapeutic target INR during self-management and anticoagulation clinic management, respectively (p=0.06). The proportion of patients who spent most time in the therapeutic target range was larger during self-management than during anticoagulation clinic-guided management. The odds ratio for a better control of anticoagulation (defined as the period of time in the therapeutic target range) during self-management compared with anticoagulation clinic-guided management was 4.6 (95% CI 2.1-10.2). A patient-satisfaction assessment showed superiority of self-management over conventional care. Interpretation Self-management of INR in the population in this study is feasible and appears to result in control of anticoagulation that is at least equivalent to management by a specialist anticoagulation clinic. It is also better appreciated by patients. Larger studies are required to assess the effect of this novel management strategy on the incidence of thromboembolic or bleeding complications.	Univ Amsterdam, Acad Med Ctr, Dept Cardiopulm Surg, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Internal Med, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol & Biostat, NL-1105 AZ Amsterdam, Netherlands; Amsterdam Thrombosis Serv, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Levi, M (corresponding author), Univ Amsterdam, Acad Med Ctr F4, Dept Vasc Med Internal Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.		Levi, Marcel/AAZ-8559-2020	de Mol, Bastian/0000-0001-6888-9430				ANDERSON DR, 1993, ARCH INTERN MED, V153, P1441, DOI 10.1001/archinte.153.12.1441; Ansell JE, 1999, JAMA-J AM MED ASSOC, V281, P182, DOI 10.1001/jama.281.2.182; ANSELL JE, 1995, ARCH INTERN MED, V155, P2185, DOI 10.1001/archinte.155.20.2185; AZAR AJ, 1994, THROMB HAEMOSTASIS, V72, P347; BERNARDO A, 1996, J THROMB THROMBOLYS, V2, P321; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; CANNEGIETER SC, 1995, NEW ENGL J MED, V333, P11, DOI 10.1056/NEJM199507063330103; CORTELAZZO S, 1993, THROMB HAEMOSTASIS, V69, P316; Douketis JD, 1998, THROMB RES, V92, P11, DOI 10.1016/S0049-3848(98)00098-X; ERRICHETTI AM, 1984, ARCH INTERN MED, V144, P1966, DOI 10.1001/archinte.144.10.1966; Fairweather RB, 1998, ARCH PATHOL LAB MED, V122, P768; Hasenkam JM, 1997, EUR J CARDIO-THORAC, V11, P935, DOI 10.1016/S1010-7940(97)01204-9; HIRSH J, 1991, NEW ENGL J MED, V324, P1865; Hirsh J, 1998, CHEST, V114, p445S, DOI 10.1378/chest.114.5_Supplement.445S; Horstkotte D., 1996, European Heart Journal, V17, P230; JONKER JJC, 1994, LANCET, V343, P499; KAATZ SS, 1995, ARCH INTERN MED, V155, P1861, DOI 10.1001/archinte.155.17.1861; Kitchen S, 1997, J CLIN PATHOL, V50, P951, DOI 10.1136/jcp.50.11.951; Kok G, 1997, PATIENT EDUC COUNS, V30, P19, DOI 10.1016/S0738-3991(96)00953-6; KRAMER MS, 1981, CLIN PHARMACOL THER, V29, P111, DOI 10.1038/clpt.1981.18; LANDEFELD CS, 1993, AM J MED, V95, P315, DOI 10.1016/0002-9343(93)90285-W; Leaning, 1996, J Thromb Thrombolysis, V3, P377; Levine MN, 1998, CHEST, V114, p511S, DOI 10.1378/chest.114.5_Supplement.511S; Morsdorf S, 1999, SEMIN THROMB HEMOST, V25, P109, DOI 10.1055/s-2007-996433; OREILLY RA, 1970, PHARMACOL REV, V22, P35; Poller L, 1998, LANCET, V352, P1505, DOI 10.1016/S0140-6736(98)04147-6; Sawicki PT, 1999, JAMA-J AM MED ASSOC, V281, P145, DOI 10.1001/jama.281.2.145; Taborski U, 1999, SEMIN THROMB HEMOST, V25, P103, DOI 10.1055/s-2007-996432; TODD C, 1994, HDB PSYCHOL DIABETES, P15; Tripodi A, 1997, THROMB HAEMOSTASIS, V78, P855; vandenBesselaar AMHP, 1995, BLOOD COAGUL FIBRIN, V6, P726, DOI 10.1097/00001721-199512000-00005; VANDERMEER FJM, 1993, ARCH INTERN MED, V153, P1557, DOI 10.1001/archinte.153.13.1557; vanderMeer FJM, 1997, BRIT J HAEMATOL, V98, P893, DOI 10.1046/j.1365-2141.1997.d01-3544.x; VANDERMEER J, 1993, LANCET, V342, P257, DOI 10.1016/0140-6736(93)91815-4; WHITE RH, 1989, ANN INTERN MED, V111, P730, DOI 10.7326/0003-4819-111-9-730	35	226	233	0	20	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 8	2000	356	9224					97	102		10.1016/S0140-6736(00)02470-3	http://dx.doi.org/10.1016/S0140-6736(00)02470-3			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	331UG	10963245				2022-12-28	WOS:000088036600009
J	Steidler, L; Hans, W; Schotte, L; Neirynck, S; Obermeier, F; Falk, W; Fiers, W; Remaut, E				Steidler, L; Hans, W; Schotte, L; Neirynck, S; Obermeier, F; Falk, W; Fiers, W; Remaut, E			Treatment of murine colitis by Lactococcus lactis secreting interleukin-10	SCIENCE			English	Article							MONOCLONAL-ANTIBODY CA2; CROHNS-DISEASE; PREVENTS COLITIS; MICE; INFLAMMATION; ENTEROCOLITIS; RESPONSES; INDUCTION; CYTOKINE; INTEGRIN	The cytokine interleukin-10 (IL-10) has shown promise in clinical trials for treatment of inflammatory bower disease (IBD), Using two mouse models, we show that the therapeutic dose of IL-10 can be reduced by Localized delivery of a bacterium genetically engineered to secrete the cytokine, Intragastric administration of IL-10-secreting Lactococcus lactis caused a 50% reduction in colitis in mice treated with dextran sulfate sodium and prevented the onset of colitis in IL-10(-/-) mice. This approach may Lead to better methods for cost-effective and Long-term management of IBD in humans.	Univ Ghent, Dept Mol Biol, B-9000 Ghent, Belgium; Flanders Interuniv Inst Biotechnol, B-9000 Ghent, Belgium; Univ Regensburg, Dept Internal Med 1, D-93042 Regensburg, Germany	Ghent University; University of Regensburg	Steidler, L (corresponding author), Univ Ghent, Dept Mol Biol, KL Ledeganckstr 35, B-9000 Ghent, Belgium.	lothar.steidler@dmb.rug.ac.be						Berg DJ, 1996, J CLIN INVEST, V98, P1010, DOI 10.1172/JCI118861; Boirivant M, 1998, J EXP MED, V188, P1929, DOI 10.1084/jem.188.10.1929; COLLINS JK, 1999, GASTROENTEROLOGY, V116, pG2981; Corthier G, 1998, APPL ENVIRON MICROB, V64, P2721; D'Haens G, 1999, GASTROENTEROLOGY, V116, P1029, DOI 10.1016/S0016-5085(99)70005-3; Ehrhardt RO, 1997, J IMMUNOL, V158, P566; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Kojouharoff G, 1997, CLIN EXP IMMUNOL, V107, P353, DOI 10.1111/j.1365-2249.1997.291-ce1184.x; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; MacDonald TT, 2000, SCAND J IMMUNOL, V51, P2; Madsen KL, 1999, GASTROENTEROLOGY, V116, P1107, DOI 10.1016/S0016-5085(99)70013-2; NEURATH MF, 1995, J EXP MED, V182, P1281, DOI 10.1084/jem.182.5.1281; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Pender SLF, 1998, GASTROENTEROLOGY, V115, P573, DOI 10.1016/S0016-5085(98)70136-2; Picarella D, 1997, J IMMUNOL, V158, P2099; PODOLSKY DK, 1993, J CLIN INVEST, V92, P372, DOI 10.1172/JCI116575; Rath HC, 1996, J CLIN INVEST, V98, P945, DOI 10.1172/JCI118878; Rennick DM, 1997, J LEUKOCYTE BIOL, V61, P389, DOI 10.1002/jlb.61.4.389; Sartor RB, 1997, AM J GASTROENTEROL, V92, pS5; Sellon RK, 1998, INFECT IMMUN, V66, P5224, DOI 10.1128/IAI.66.11.5224-5231.1998; Steidler L, 1998, INFECT IMMUN, V66, P3183, DOI 10.1128/IAI.66.7.3183-3189.1998; STEIDLER L, 1995, APPL ENVIRON MICROB, V61, P1627, DOI 10.1128/AEM.61.4.1627-1629.1995; STEIDLER L, 1996, NATO ASI SERIES H, V98, P63; Stordeur P, 1998, Int Rev Immunol, V16, P501, DOI 10.3109/08830189809043006; Targan SR, 1997, NEW ENGL J MED, V337, P1029, DOI 10.1056/NEJM199710093371502; THOMPSONSNIPES LA, 1991, J EXP MED, V173, P507, DOI 10.1084/jem.173.2.507; vanDeventer SJH, 1997, GASTROENTEROLOGY, V113, P383, DOI 10.1053/gast.1997.v113.pm9247454; VANDULLEMEN HM, 1995, GASTROENTEROLOGY, V109, P129, DOI 10.1016/0016-5085(95)90277-5; WYSOCKA M, 1995, EUR J IMMUNOL, V25, P672, DOI 10.1002/eji.1830250307	29	1064	1181	14	152	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 25	2000	289	5483					1352	1355		10.1126/science.289.5483.1352	http://dx.doi.org/10.1126/science.289.5483.1352			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347RF	10958782				2022-12-28	WOS:000088942400039
J	Rouleau, JL; Pfeffer, MA; Stewart, DJ; Isaac, D; Sestier, F; Kerut, EK; Porter, CB; Proulx, G; Qian, CL; Block, AJ				Rouleau, JL; Pfeffer, MA; Stewart, DJ; Isaac, D; Sestier, F; Kerut, EK; Porter, CB; Proulx, G; Qian, CL; Block, AJ		IMPRESS Investigators	Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trial	LANCET			English	Article							ANGIOTENSIN-CONVERTING ENZYME; LEFT-VENTRICULAR DYSFUNCTION; NEUTRAL ENDOPEPTIDASE; ORAL MILRINONE; ENALAPRIL; MORTALITY	Background We aimed to assess in patients with congestive heart failure whether dual inhibition of neutral endopeptidase and angiotensin-converting enzyme (ACE) with the vasopeptidase inhibitor omapatrilat is better than ACE inhibition alone with lisinopril on functional capacity and clinical outcome. Methods We did a prospective, randomised, double-blind, parallel trial of 573 patients with New York Heart Association (NYHA) class It-IV congestive heart failure, left-ventricular ejection fraction of 40% or less, and receiving an ACE inhibitor. Patients were randomly assigned omapatrilat at a daily target dose of 40 mg (n=289) or lisinopril at a daily target dose of 20 mg (n=284) for 24 weeks, The primary endpoint was improvement in maximum exercise treadmill test (ETT) at week 12. Secondary endpoints included death and comorbid events indicative of worsening heart failure. Findings Week 12 ETT increased similarly in the omapatrilat and lisinopril groups 124 vs 31 s, p=0.45). The two drugs were fairly well tolerated, but there were fewer cardiovascular-system serious adverse events in the omapatrilat group than in the lisinopril group (20 [7%] vs 34 [12%], p=0.04). There was a suggestive trend in favour of omapatrilat on the combined endpoint of death or admission for worsening heart failure (p=0.052; hazard ratio 0.53 [95% CI 0.27-1.02]) and a significant benefit of omapatrilat in the composite of death, admission, or discontinuation of study treatment for worsening heart failure (p=0.035; 0.52 [0.28-0.96]). Omapatrilat improved NYHA class more than lisinopril in patients who had NYHA class III and IV (p=0.035), but not if patients with NYHA class II were included. Interpretation Our findings suggest that omapatrilat could have some advantages over lisinopril in the treatment of patients with congestive vasopeptidase inhibitors heart could failure. Thus use of constitute a potentially important treatment for further improving the prognosis and well being of patients with this disorder.	Univ Toronto, Toronto Gen Hosp, Div Cardiol, Toronto, ON M5G 2C4, Canada; Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiol, Boston, MA 02115 USA; Univ Toronto, St Michaels Hosp, Div Cardiol, Toronto, ON M5G 2C4, Canada; Univ Calgary, Foothills Gen Hosp, Dept Cardiol, Calgary, AB, Canada; Ctr Hosp Univ Montreal, Dept Cardiol, Montreal, PQ, Canada; Heart Clin Louisiana, Marrero, LA USA; Mid Amer Cardiol Associates, Kansas City, MO USA; Univ Montreal, Montreal Heart Inst, Div Cardiol, Montreal, PQ H3C 3J7, Canada; Bristol Myers Squibb Co, Pharmaceut Res Inst, Princeton, NJ 08543 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Calgary; Universite de Montreal; Universite de Montreal; Bristol-Myers Squibb	Rouleau, JL (corresponding author), Univ Toronto, Toronto Gen Hosp, Div Cardiol, Eaton N 13-312, Toronto, ON M5G 2C4, Canada.		Arnold, Malcolm/G-2869-2011; Kerut, Edmund Kenneth/I-8445-2019	Kerut, Edmund Kenneth/0000-0003-3880-3987				Abramson BL, 1999, CIRCULATION, V99, P1810, DOI 10.1161/01.CIR.99.14.1810; BENEDICT CR, 1994, J AM COLL CARDIOL, V23, P1410, DOI 10.1016/0735-1097(94)90385-9; BURNETT JC, 1999, J HYPERTENSION S1, V17, pS38; CAVERO PG, 1990, CIRCULATION, V82, P196, DOI 10.1161/01.CIR.82.1.196; COHN JN, 1991, NEW ENGL J MED, V325, P303, DOI 10.1056/NEJM199108013250502; DIBIANCO R, 1989, NEW ENGL J MED, V320, P677, DOI 10.1056/NEJM198903163201101; Dickstein K, 1998, EUR HEART J, V19, P1747; GOHLKE P, 1994, HYPERTENSION, V23, P411, DOI 10.1161/01.HYP.23.4.411; Ikram Hamid, 1999, Journal of the American College of Cardiology, V33, p185A; KONSTAM MA, 1993, CIRCULATION, V88, P2277, DOI 10.1161/01.CIR.88.5.2277; Lechat P, 1999, LANCET, V353, P9; Levin ER, 1998, NEW ENGL J MED, V339, P321; Mitchell GF, 1999, CIRCULATION, V100, P646; NARUSE M, 1994, HYPERTENSION S1, V23, P231; Packer M, 1996, NEW ENGL J MED, V334, P1349, DOI 10.1056/NEJM199605233342101; PACKER M, 1991, NEW ENGL J MED, V325, P1468, DOI 10.1056/NEJM199111213252103; Remme WJ, 1997, DRUGS, V54, P59, DOI 10.2165/00003495-199700545-00009; Rouleau JL, 1993, J AM COLL CARDIOL, V22, P390, DOI 10.1016/0735-1097(93)90042-Y; ROULEAU JL, 1996, CAN J CARDIOL SF, V12, P3; Thomas CV, 1998, J CARDIOVASC PHARM, V32, P902, DOI 10.1097/00005344-199812000-00006; Trippodo NC, 1999, J CARDIOVASC PHARM, V34, P782, DOI 10.1097/00005344-199912000-00003; YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501	22	313	332	0	7	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 19	2000	356	9230					615	620		10.1016/S0140-6736(00)02602-7	http://dx.doi.org/10.1016/S0140-6736(00)02602-7			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	346RD	10968433				2022-12-28	WOS:000088884100008
J	Jones, JW; Gruber, SA; Barker, JH; Breidenbach, WC				Jones, JW; Gruber, SA; Barker, JH; Breidenbach, WC		Louisville Hand Transplant Team	Successful hand transplantation - One-year follow-up	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COMPOSITE TISSUE ALLOGRAFT; MOFETIL THERAPY; TACROLIMUS; SURVIVAL; FK506; MODEL	Background: On the basis of positive results in studies of the transplantation of pig extremities and the information exchanged at an international symposium on composite-tissue transplantation, we developed a protocol for human hand transplantation. Methods: After a comprehensive pretransplantation evaluation and informed-consent process, the left hand of a 58-year-old cadaveric donor, matched for size, sex, and skin tone, was transplanted to a 37-year-old man who had lost his dominant left hand 13 years earlier. Immunosuppression consisted of basiliximab for induction therapy and tacrolimus, mycophenolate mofetil, and prednisone for maintenance therapy. Results: The cold-ischemia time of the donor hand was 310 minutes. There were no intraoperative or early postoperative complications. Moderate acute cellular rejection of the skin of the graft developed 6, 20, and 27 weeks after transplantation. All three episodes resolved completely after treatment with intravenous methylprednisolone and topical tacrolimus and clobetasol. Temperature, pain, and pressure sensation had developed in the hand and fingers by one year. At one year, the patient could perform many functional activities with his left hand that he had not been able to perform with his prosthesis, such as throwing a baseball, turning the pages of a newspaper, writing, and tying his shoelaces. Conclusions: Early success has been achieved in hand transplantation with the use of currently available immunosuppressive drugs. (N Engl J Med 2000;343:468-73.) (C)2000, Massachusetts Medical Society.	Univ Louisville, Sch Med, Dept Surg, Div Gen Surg, Louisville, KY 40292 USA; Univ Louisville, Sch Med, Dept Surg, Div Plast & Reconstruct Surg, Louisville, KY 40292 USA; Univ Louisville, Sch Med, Dept Surg, Div Hand & Microsurg, Louisville, KY 40292 USA; Univ Texas, Houston Hlth Sci Ctr, Dept Surg, Div Immunol & Organ Transplantat, Houston, TX USA	University of Louisville; University of Louisville; University of Louisville; University of Texas System; University of Texas Health Science Center Houston	Jones, JW (corresponding author), Carolinas Med Ctr, Transplant Serv, 1000 Blythe Blvd, Charlotte, NC 28203 USA.							BARKER J, 1998, TRANSPLANT P, V30, P2687; Dubernard JM, 1999, LANCET, V353, P1315, DOI 10.1016/S0140-6736(99)02062-0; Jones JW, 1999, SURGERY, V126, P384, DOI 10.1016/S0039-6060(99)70181-9; MacFarlane G, 1996, THER DRUG MONIT, V18, P698, DOI 10.1097/00007691-199612000-00012; McCabe S, 1998, TRANSPLANT P, V30, P2783, DOI 10.1016/S0041-1345(98)00808-2; Meiser BM, 1999, J HEART LUNG TRANSPL, V18, P143, DOI 10.1016/S1053-2498(98)00002-3; Ren XP, 2000, MICROSURG, V20, P143, DOI 10.1002/(SICI)1098-2752(2000)20:3<143::AID-MICR9>3.0.CO;2-9; SCHEKER LR, 1995, J HAND SURG-BRIT EUR, V20B, P584, DOI 10.1016/S0266-7681(05)80115-9; SKANES SE, 1986, TRANSPL P, V18, P898; STARK GB, 1987, TRANSPLANT P, V19, P3968; STEVENS HPJD, 1991, TRANSPLANT P, V23, P623; Ustuner ET, 1998, TRANSPLANTATION, V66, P1581; Wang MS, 1997, J PHARMACOL EXP THER, V282, P1084; Zdichavsky M, 1999, J SURG RES, V85, P1, DOI 10.1006/jsre.1999.5673	14	316	338	3	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 17	2000	343	7					468	473		10.1056/NEJM200008173430704	http://dx.doi.org/10.1056/NEJM200008173430704			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	344FC	10950668	Bronze			2022-12-28	WOS:000088747700004
J	Richardson, WS; Wilson, MC; Williams, JW; Moyer, VA; Naylor, CD				Richardson, WS; Wilson, MC; Williams, JW; Moyer, VA; Naylor, CD		Evidence-Based Med Working Grp	Users' guides to the medical literature - XXIV. How to use an article on the clinical manifestations of disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PNEUMOCYSTIS-CARINII PNEUMONIA; NOTHING GOES WRONG; DIFFERENTIAL-DIAGNOSIS; MYOCARDIAL-INFARCTION; AORTIC-ANEURYSM; FEATURES; NUMERATORS; INTERNIST; IF	Clinicians rely on knowledge about the clinical manifestations of disease to make clinical diagnoses. Before using research on the frequency of clinical features found in patients with a disease, clinicians should appraise the evidence for its validity, results, and applicability. For validity, 4 issues are important-how the diagnoses were verified, how the study sample relates to all patients with the disease, how the clinical findings were sought, and how the clinical findings were characterized, Ideally, investigators will verify the presence of disease in study patients using credible criteria that are independent of the clinical manifestations under study. Also, ideally the study patients will represent the full spectrum of the disease, undergo a thorough and consistent search for clinical findings, and these findings will be well characterized in nature and timing, The main results of these studies are expressed as the number and percentages of patients with each manifestation. Confidence intervals can describe the precision of these frequencies. Most clinical findings occur with only intermediate frequency, and since these frequencies are equivalent to diagnostic sensitivities, this means that the absence of a single finding is rarely powerful enough to exclude the disease, Before acting on the evidence, clinicians should consider whether it applies to their own patients and whether it has been superseded by new developments, Detailed knowledge of the clinical manifestations of disease should increase clinicians' ability to raise diagnostic hypotheses, select differential diagnoses, and verify final diagnoses.	Univ Texas, Hlth Sci Ctr, S Texas Vet Hlth Care Syst & Med, Dept Ambulatory Care, San Antonio, TX USA; Univ Texas, Hlth Sci Ctr, S Texas Vet Hlth Care Syst & Med, Res Dept, San Antonio, TX USA; Wake Forest Univ, Sch Med, Dept Med, Winston Salem, NC USA; Univ Texas, Hlth Sci Ctr, Dept Internal Med, Houston, TX 77225 USA; Univ Texas, Hlth Sci Ctr, Ctr Evidence Based Med & Populat Hlth, Houston, TX 77225 USA; Univ Toronto, Fac Med, Dept Med, Toronto, ON, Canada; Univ Toronto, Fac Med, Off Dean, Toronto, ON, Canada	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Wake Forest University; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Toronto; University of Toronto	Richardson, WS (corresponding author), McMaster Univ, Fac Hlth Sci, Dept Clin Epidemiol & Biostat, Room 2C12,1200 Main St W, Hamilton, ON L8N 3Z5, Canada.			Wilson, Mark/0000-0003-1271-9664				Altman D.G., 2000, EVIDENCE BASED MED P, P233; BARONDESS JA, 1994, DIFFERENTIAL DIAGNOS; BAYER AJ, 1986, J AM GERIATR SOC, V34, P263, DOI 10.1111/j.1532-5415.1986.tb04221.x; BELL WR, 1977, AM J MED, V62, P355, DOI 10.1016/0002-9343(77)90832-4; BORDAGE G, 1994, ACAD MED, V69, P883, DOI 10.1097/00001888-199411000-00004; CAPUTO GM, 1994, J GEN INTERN MED, V9, P528, DOI 10.1007/BF02599229; Department of Clinical Epidemiology and Biostatistics McMaster University Hamilton Ontario, 1980, CAN MED ASSOC J, V123, P613; Flegel KM, 1997, CAN MED ASSOC J, V157, P286; Fletcher RH, 1988, CLIN EPIDEMIOLOGY ES; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Glass R. D., 1996, DIAGNOSIS BRIEF INTR; Glasziou P, 1998, ACP J Club, V129, pA15; GUDJONSSON B, 1978, CANCER, V42, P2494, DOI 10.1002/1097-0142(197811)42:5<2494::AID-CNCR2820420554>3.0.CO;2-R; Hagan PG, 2000, JAMA-J AM MED ASSOC, V283, P897, DOI 10.1001/jama.283.7.897; HALL S, 1985, ANN INTERN MED, V103, P271, DOI 10.7326/0003-4819-103-2-271; HANLEY JA, 1983, JAMA-J AM MED ASSOC, V249, P1743, DOI 10.1001/jama.249.13.1743; Hunt DL, 2000, JAMA-J AM MED ASSOC, V283, P1875, DOI 10.1001/jama.283.14.1875; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P389, DOI 10.1001/jama.271.5.389; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P703, DOI 10.1001/jama.271.9.703; KASSIRER JP, 1991, LEARNING CLIN REASON, P32; King Lester S., 1982, MED THINKING HIST PR; KOVACS JA, 1984, ANN INTERN MED, V100, P663, DOI 10.7326/0003-4819-100-5-663; LEDERLE FA, 1994, AM J MED, V96, P163, DOI 10.1016/0002-9343(94)90137-6; Manoukian MA, 1999, ARCH INTERN MED, V159, P601, DOI 10.1001/archinte.159.6.601; McKibbon K.A., 1999, PDQ EVIDENCE BASED P; MORGENTHALER TI, 1995, MAYO CLIN PROC, V70, P417, DOI 10.4065/70.5.417; Murphy EA, 1997, LOGIC MED; NEWMAN TB, 1995, JAMA-J AM MED ASSOC, V274, P1013, DOI 10.1001/jama.1995.03530130019013; Panju AA, 1998, JAMA-J AM MED ASSOC, V280, P1256, DOI 10.1001/jama.280.14.1256; RANSOHOFF DF, 1978, NEW ENGL J MED, V299, P926, DOI 10.1056/NEJM197810262991705; Regehr G, 1996, ACAD MED, V71, P988, DOI 10.1097/00001888-199609000-00015; Richardson WS, 1999, JAMA-J AM MED ASSOC, V281, P1214, DOI 10.1001/jama.281.13.1214; Sackett D., 2000, EVIDENCE BASED MED P, DOI DOI 10.1136/BMJ.H3089; SACKETT DL, 1980, CAN MED ASSOC J, V123, P499; Sackett DL, 1991, CLIN EPIDEMIOLOGY BA, P4; SCHMIDT HG, 1990, ACAD MED, V65, P611, DOI 10.1097/00001888-199010000-00001; SLATER EE, 1976, AM J MED, V60, P625, DOI 10.1016/0002-9343(76)90496-4; SPITTELL PC, 1993, MAYO CLIN PROC, V68, P642, DOI 10.1016/S0025-6196(12)60599-0; Trentham DE, 1998, ANN INTERN MED, V129, P114, DOI 10.7326/0003-4819-129-2-199807150-00011; WALZER PD, 1974, ANN INTERN MED, V80, P83, DOI 10.7326/0003-4819-80-1-83; Wulff H. R., 1981, RATIONAL DIAGNOSIS T	41	27	29	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 16	2000	284	7					869	875		10.1001/jama.284.7.869	http://dx.doi.org/10.1001/jama.284.7.869			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	342PM	10938177				2022-12-28	WOS:000088654400030
J	Weinstock, MA				Weinstock, MA			Early detection of melanoma	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CUTANEOUS MALIGNANT-MELANOMA; SKIN-CANCER PREVENTION; FAMILY PHYSICIANS; SCREENING-PROGRAM; SELF-EXAMINATION; EARLY DIAGNOSIS; FOLLOW-UP; DERMATOLOGISTS; DELAY; CARE		VA Med Ctr 111D, Dermatoepidemiol Unit, Providence, RI 02908 USA; Rhode Isl Hosp, Dept Dermatol, Providence, RI USA; Brown Univ, Providence, RI 02912 USA	Lifespan Health Rhode Island; Rhode Island Hospital; Brown University	Weinstock, MA (corresponding author), VA Med Ctr 111D, Dermatoepidemiol Unit, 830 Chalkstone Ave, Providence, RI 02908 USA.	maw@brown.edu						ACKERMAN AB, 1985, J DERMATOL SURG ONC, V11, P771, DOI 10.1016/S0190-9622(85)80242-5; *AM MED ASS, IN PRESS PHYS CHAR D; Berwick M, 1996, J NATL CANCER I, V88, P17, DOI 10.1093/jnci/88.1.17; BINDER M, 1995, ARCH DERMATOL, V131, P286, DOI 10.1001/archderm.131.3.286; Blum A, 1999, BRIT J DERMATOL, V141, P783, DOI 10.1046/j.1365-2133.1999.03196.x; Burton RC, 1998, J MED SCREEN, V5, P156, DOI 10.1136/jms.5.3.156; CASSILETH BR, 1988, J AM ACAD DERMATOL, V18, P591, DOI 10.1016/S0190-9622(88)70081-X; CASSILETH BR, 1986, J AM ACAD DERMATOL, V14, P555, DOI 10.1016/S0190-9622(86)70068-6; *CONS DEV PAN, 1992, NIH CONSENSUS STATE, V10, P1; CRISTOFOLINI M, 1993, CANCER, V71, P370, DOI 10.1002/1097-0142(19930115)71:2&lt;370::AID-CNCR2820710217&gt;3.0.CO;2-M; Elwood JM, 1988, PIGMENT CELL RES, V9, P118; Engelberg D, 1999, J AM ACAD DERMATOL, V41, P37, DOI 10.1016/S0190-9622(99)70403-2; Federman DG, 1997, ARCH DERMATOL, V133, P1423, DOI 10.1001/archderm.133.11.1423; Freedberg KA, 1999, J AM ACAD DERMATOL, V41, P738, DOI 10.1016/S0190-9622(99)70010-1; Gerbert B, 1998, J GEN INTERN MED, V13, P91, DOI 10.1046/j.1525-1497.1998.00024.x; Gerbert B, 1996, ARCH DERMATOL, V132, P1030, DOI 10.1001/archderm.132.9.1030; Girgis A, 1996, CANCER DETECT PREV, V20, P316; Girgis A, 1996, J Med Screen, V3, P47; Girgis A, 1995, MED EDUC, V29, P364, DOI 10.1111/j.1365-2923.1995.tb00027.x; Hill L, 1998, CA-CANCER J CLIN, V48, P232, DOI 10.3322/canjclin.48.4.232; Jonna BP, 1998, PREV MED, V27, P611, DOI 10.1006/pmed.1998.0334; Kelly JW, 1997, MED J AUSTRALIA, V167, P191, DOI 10.5694/j.1326-5377.1997.tb138843.x; KOH HK, 1990, CANCER, V65, P375, DOI 10.1002/1097-0142(19900115)65:2<375::AID-CNCR2820650233>3.0.CO;2-Z; KOH HK, 1992, J AM ACAD DERMATOL, V26, P914, DOI 10.1016/0190-9622(92)70132-Y; Koh HK, 1996, J AM ACAD DERMATOL, V34, P971, DOI 10.1016/S0190-9622(96)90274-1; KRIGE JEJ, 1991, CANCER, V68, P2064, DOI 10.1002/1097-0142(19911101)68:9<2064::AID-CNCR2820680937>3.0.CO;2-3; Laidlaw JM, 1996, MED EDUC, V30, P226, DOI 10.1111/j.1365-2923.1996.tb00747.x; Lindelof Bernt, 1994, Journal of Dermatology (Tokyo), V21, P461; LNADIS SH, 2000, CA-CANCER J CLIN, V50, P1; MacKenzie-Wood A R, 1998, Australas J Dermatol, V39, P31, DOI 10.1111/j.1440-0960.1998.tb01238.x; MACKIE RM, 1992, BRIT MED J, V304, P1012, DOI 10.1136/bmj.304.6833.1012; MASRI GD, 1990, J AM ACAD DERMATOL, V22, P1042, DOI 10.1016/0190-9622(90)70149-C; Mikkilineni R., 2000, Journal of Investigative Dermatology, V114, P888; Mikkilineni R., 2000, Journal of Investigative Dermatology, V114, P775; Miller DR, 1996, J AM ACAD DERMATOL, V34, P962, DOI 10.1016/S0190-9622(96)90273-X; Morton CA, 1998, BRIT J DERMATOL, V138, P283; *NCI, 1999, SEER CANC INC PUBL U; NELSON C, 1998, VITAL HLTH STAT, V13, P1; Polster AM, 1998, ARCH DERMATOL, V134, P1095, DOI 10.1001/archderm.134.9.1095; Richard MA, 1999, ARCH DERMATOL, V135, P269, DOI 10.1001/archderm.135.3.269; Schuchter L, 1996, ANN INTERN MED, V125, P369, DOI 10.7326/0003-4819-125-5-199609010-00003; Smith ES, 1998, DERMATOL SURG, V24, P981, DOI 10.1111/j.1524-4725.1998.tb04291.x; Stephenson A, 1997, J AM ACAD DERMATOL, V37, P953, DOI 10.1016/S0190-9622(97)70071-9; TUCKER MA, 1993, J INVEST DERMATOL, V100, pS350, DOI 10.1111/1523-1747.ep12470264; *US PREV SERV TASK, 1996, GUID CLIN PREV SERV, P141; VASEN HFA, 1989, EUR J CANCER CLIN ON, V25, P337, DOI 10.1016/0277-5379(89)90027-8; Weinstock MA, 1999, AM J PREV MED, V17, P169, DOI 10.1016/S0749-3797(99)00077-X; Weinstock MA, 1999, J INVEST DERMATOL, V112, P664; Weinstock MA, 1996, J AM ACAD DERMATOL, V34, P1063, DOI 10.1016/S0190-9622(96)90287-X; WENDER RC, 1995, CANCER, V75, P691, DOI 10.1002/1097-0142(19950115)75:2+<691::AID-CNCR2820751412>3.0.CO;2-G	50	78	80	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 16	2000	284	7					886	889		10.1001/jama.284.7.886	http://dx.doi.org/10.1001/jama.284.7.886			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	342PM	10938181				2022-12-28	WOS:000088654400034
J	Xu, ZA; Ong, NP; Wang, Y; Kakeshita, T; Uchida, S				Xu, ZA; Ong, NP; Wang, Y; Kakeshita, T; Uchida, S			Vortex-like excitations and the onset of superconducting phase fluctuation in underdoped La2-xSrxCuO4	NATURE			English	Article							T-C SUPERCONDUCTORS; NORMAL-STATE; NERNST; BI2SR2CACU2O8+DELTA; PSEUDOGAP	Two general features of a superconductor, which appear at the critical temperature, are the formation of an energy gap and the expulsion of magnetic flux (the Meissner effect). In underdoped copper oxides, there is strong evidence that an energy gap (the pseudogap 1) opens up at a temperature significantly higher than the critical temperature (by 100-220 K). Certain features of the pseudogap suggest that it is closely related to the gap that appears at the critical temperature (for example, the variation of the gap magnitudes around the Fermi surface and their maximum amplitudes are very similar(2,3)). However, the Meissner effect is absent in the pseudogap state. The nature of the pseudogap state, and its relation (if any) to the superconducting state are central issues in understanding copper oxide superconductivity. Recent evidence suggests that, in the underdoped regime, the Meissner state is destroyed above the critical temperature by strong phase fluctuations(1,4-7) (as opposed to a vanishing of the superfluid density). Here we report evidence for vortices (or vortex-like excitations) in La2-xSrxCuO4 at temperatures significantly above the critical temperature. A thermal gradient is applied to the sample in a magnetic field. Vortices are detected by the large transverse electric field produced as they diffuse down the gradient (the Nernst effect). We rnd that the Nernst signal is anomalously enhanced at temperatures as high as 150 K.	Princeton Univ, Joseph Henry Labs Phys, Princeton, NJ 08544 USA; Univ Tokyo, Sch Frontier Sci, Bunkyo Ku, Tokyo 1138656, Japan	Princeton University; University of Tokyo	Ong, NP (corresponding author), Princeton Univ, Joseph Henry Labs Phys, Princeton, NJ 08544 USA.	npo@princeton.edu	Ong, N. Phuan/Z-1626-2019; Xu, Zhu'an/B-1419-2009	Xu, Zhu'an/0000-0001-9290-2762; Ong, N. Phuan/0000-0001-7166-1058				AMBEGAOKAR V, 1980, PHYS REV B, V21, P1806, DOI 10.1103/PhysRevB.21.1806; CLAYHOLD JA, 1994, PHYS REV B, V50, P4252, DOI 10.1103/PhysRevB.50.4252; Corson J, 1999, NATURE, V398, P221, DOI 10.1038/18402; Ding H, 1996, NATURE, V382, P51, DOI 10.1038/382051a0; HAGEN SJ, 1990, PHYS REV B, V42, P6777, DOI 10.1103/PhysRevB.42.6777; Lee PA, 1997, PHYS REV LETT, V78, P4111, DOI 10.1103/PhysRevLett.78.4111; Loeser AG, 1996, SCIENCE, V273, P325, DOI 10.1126/science.273.5273.325; Loram J. W., 1996, Proceedings of the 10th Anniversary HTS Workshop on Physics, Materials and Applications, P341; Norman MR, 1998, PHYS REV B, V57, pR11093, DOI 10.1103/PhysRevB.57.R11093; RI HC, 1994, PHYS REV B, V50, P3312, DOI 10.1103/PhysRevB.50.3312; SONDHEIMER EH, 1948, PROC R SOC LON SER-A, V193, P484, DOI 10.1098/rspa.1948.0058; TAKAGI H, 1989, PHYS REV B, V40, P2254, DOI 10.1103/PhysRevB.40.2254; Timusk T, 1999, REP PROG PHYS, V62, P61, DOI 10.1088/0034-4885/62/1/002; TRANQUADA JM, 1995, NATURE, V375, P561, DOI 10.1038/375561a0	15	571	581	1	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 3	2000	406	6795					486	488		10.1038/35020016	http://dx.doi.org/10.1038/35020016			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	340ML	10952303				2022-12-28	WOS:000088538000037
J	Xie, W; Barwick, JL; Downes, M; Blumberg, B; Simon, CM; Nelson, MC; Neuschwander-Tetri, BA; Bruntk, EM; Guzelian, PS; Evans, RM				Xie, W; Barwick, JL; Downes, M; Blumberg, B; Simon, CM; Nelson, MC; Neuschwander-Tetri, BA; Bruntk, EM; Guzelian, PS; Evans, RM			Humanized xenobiotic response in mice expressing nuclear receptor SXR	NATURE			English	Article							SMALL-BOWEL ENTEROCYTES; TRANSCRIPTIONAL ACTIVATION; SIGNALING PATHWAY; TRANSGENIC MICE; ADULT-RAT; INDUCTION; CYTOCHROME-P-450; CYP3A4; LIVER; IDENTIFICATION	The cytochrome CYP3A gene products, expressed in mammalian liver, are essential for the metabolism of lipophilic substrates, including endogenous steroid hormones and prescription drugs(1,2). CYP3A enzymes are extremely versatile and are inducible by many of their natural and xenobiotic substrates. Consequently, they form the molecular basis for many clinical drug-drug interactions(3). The induction of CYP3A enzymes is species-specific(4,5), and we have postulated that it involves one or more cellular factors, or receptor-like xeno-sensors(6). Here we identify one such factor unequivocally as the nuclear receptor pregnenolone X receptor (PXR)(7,8) and its human homologue, steroid and xenobiotic receptor (SXR)(8-10). We show that targeted disruption of the mouse PXR gene abolishes induction of CYP3A by prototypic inducers such as dexamethasone or pregnenolone-16 alpha-carbonitrile. In transgenic mice, an activated form of SXR causes constitutive upregulation of CYP3A gene expression and enhanced protection against toxic xenobiotic compounds. Furthermore, we show that the species origin of the receptor, rather than the promoter structure of CYP3A genes, dictates the species-specific pattern of CYP3A inducibility. Thus, we can generate 'humanized' transgenic mice that are responsive to human-specific inducers such as the antibiotic rifampicin. We conclude that SXR/PXR genes encode the primary species-specific xeno-sensors that mediate the adaptive hepatic response, and may represent the critical biochemical mechanism of human xenoprotection.	Salk Inst Biol Studies, Howard Hughes Med Inst, Gene Express Lab, La Jolla, CA 92037 USA; Univ Colorado, Hlth Sci Ctr, Denver, CO 80262 USA; Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA; St Louis Univ, Sch Med, Dept Pathol, Kansas City, MO 64108 USA; St Louis Univ, Sch Med, Div Gastroenterol & Hepatol, Kansas City, MO 64108 USA	Howard Hughes Medical Institute; Salk Institute; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of California System; University of California Irvine; Saint Louis University; Saint Louis University	Evans, RM (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Evans, Ronald/AAF-4001-2019; Xie, Wen/M-1768-2016	Evans, Ronald/0000-0002-9986-5965; 				Barwick JL, 1996, MOL PHARMACOL, V50, P10; Bertilsson G, 1998, P NATL ACAD SCI USA, V95, P12208, DOI 10.1073/pnas.95.21.12208; Blumberg B, 1998, GENE DEV, V12, P3195, DOI 10.1101/gad.12.20.3195; Blumberg B, 1998, GENE DEV, V12, P3149, DOI 10.1101/gad.12.20.3149; BOCHERDING SM, 1992, ARCH INTERN MED, V152, P711; BURGER HJ, 1992, P NATL ACAD SCI USA, V89, P2145, DOI 10.1073/pnas.89.6.2145; DENISON MS, 1995, J BIOL CHEM, V270, P18175, DOI 10.1074/jbc.270.31.18175; GONZALEZ FJ, 1992, TRENDS PHARMACOL SCI, V13, P346, DOI 10.1016/0165-6147(92)90107-H; GONZALEZ FJ, 1990, PHARMACOL THERAPEUT, V45, P11; HASHIMOTO H, 1993, EUR J BIOCHEM, V218, P585, DOI 10.1111/j.1432-1033.1993.tb18412.x; HEBERT MF, 1992, CLIN PHARMACOL THER, V52, P453, DOI 10.1038/clpt.1992.171; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; JELINEK DF, 1990, J BIOL CHEM, V265, P8190; Jones SA, 2000, MOL ENDOCRINOL, V14, P27, DOI 10.1210/me.14.1.27; KIMURA S, 1984, NUCLEIC ACIDS RES, V12, P2917, DOI 10.1093/nar/12.6.2917; Kliewer SA, 1998, CELL, V92, P73, DOI 10.1016/S0092-8674(00)80900-9; KOLARS JC, 1992, J CLIN INVEST, V90, P1871, DOI 10.1172/JCI116064; KOLARS JC, 1994, GASTROENTEROLOGY, V106, P433, DOI 10.1016/0016-5085(94)90602-5; Lehmann JM, 1998, J CLIN INVEST, V102, P1016, DOI 10.1172/JCI3703; MAUREL P, 1996, CYTOCHROMES P450 MET, P241; Nelson DR, 1999, ARCH BIOCHEM BIOPHYS, V369, P1, DOI 10.1006/abbi.1999.1352; PINKERT CA, 1987, GENE DEV, V1, P268, DOI 10.1101/gad.1.3.268; Savas U, 1999, MOL PHARMACOL, V56, P851, DOI 10.1124/mol.56.5.851; SCHUETZ EG, 1984, J BIOL CHEM, V259, P2007; Schuetz EG, 1996, P NATL ACAD SCI USA, V93, P4001, DOI 10.1073/pnas.93.9.4001; SELYE H, 1971, J PHARM SCI, V60, P1, DOI 10.1002/jps.2600600102; Waxman DJ, 1999, ARCH BIOCHEM BIOPHYS, V369, P11, DOI 10.1006/abbi.1999.1351; WRIGHTON SA, 1985, MOL PHARMACOL, V28, P312; Xie W, 1999, ONCOGENE, V18, P3593, DOI 10.1038/sj.onc.1202673; YANAGIMOTO T, 1992, BIOCHIM BIOPHYS ACTA, V1130, P329, DOI 10.1016/0167-4781(92)90447-8	30	561	593	6	22	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 27	2000	406	6794					435	439		10.1038/35019116	http://dx.doi.org/10.1038/35019116			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	337WC	10935643				2022-12-28	WOS:000088383800053
J	Diagne, N; Rogier, C; Sokhna, CS; Tall, A; Fontenille, D; Roussilhon, C; Spiegel, A; Trape, JF				Diagne, N; Rogier, C; Sokhna, CS; Tall, A; Fontenille, D; Roussilhon, C; Spiegel, A; Trape, JF			Increased susceptibility to malaria during the early postpartum period	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PLASMODIUM-FALCIPARUM; CHONDROITIN SULFATE; CLINICAL MALARIA; HOLOENDEMIC AREA; IMMUNE-RESPONSE; PREGNANT-WOMEN; INFECTION; PLACENTA; ANTIGENS; ADHESION	Background Pregnancy is associated with increased susceptibility to malaria. It is generally agreed that this increased risk ends with delivery, but the possible persistence of increased susceptibility during the puerperium has not been investigated. Methods From June 1 1990, to December 31, 1998, we monitored exposure to malaria, parasitemia, and morbidity among the residents of a village in gal in which the rate of transmission of malaria was In this population we analyzed 71 pregnancies in 38 women from the year before conception through one year after delivery. Results Among the 38 women, there were 58 episodes of clinical Plasmodium falciparum malaria during 61, 081 person-days of observation. The incidence of malaria was 20.2 episodes per 1000 person-months during the year preceding conception and 12.0 episodes per 1000 person-months during the period from 91 to 365 days after delivery. The incidence of episodes of malaria increased significantly during the second and third trimesters of pregnancy and reached a maximum of 75.1 episodes per 1000 person-months during the first 60 days after delivery. The adjusted relative risk of an episode of malaria was 4.1 (95 percent confidence interval, 1.8 to 9.5) during the first 60 days post partum, as compared with the year ceding pregnancy. The duration of fever during the episodes of malaria was longer and the prevalence and density of asymptomatic malarial parasitemia were significantly higher during pregnancy and the early postpartum period than during the other periods. Conclusions Among women who live in areas with high rates of transmission of malaria, the susceptibility to malaria is highest during the second and third trimesters of pregnancy and the early postpartum period. (N Engl J Med 2000; 343: 598-603.) (C) 2000, Massachusetts Medical Society.	Inst Rech Dev, Lab Paludol, F-34032 Montpellier, France; Inst Rech Dev, Lab Paludol, Dakar, Senegal; Inst Rech Dev, Lab Zool Med, Dakar, Senegal; Serv Sante Armees, Inst Trop Med, Marseille, France; Inst Pasteur, Serv Epidemiol, Dakar, Senegal; Inst Pasteur, Dept Immunol, Dakar, Senegal	Institut de Recherche pour le Developpement (IRD); Institut de Recherche pour le Developpement (IRD); Institut de Recherche pour le Developpement (IRD); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar	Trape, JF (corresponding author), Inst Rech Dev, Lab Paludol, BP 5045, F-34032 Montpellier, France.		FONTENILLE, didier/G-4091-2013; ROGIER, Christophe/C-2550-2008	FONTENILLE, didier/0000-0002-0544-3885				BRABIN B, 1991, APPL FIELD RES MALAR, V1; BRABIN BJ, 1983, B WORLD HEALTH ORGAN, V61, P1005; BRAY RS, 1979, T ROY SOC TROP MED H, V73, P427, DOI 10.1016/0035-9203(79)90170-6; Diagne N, 1997, T ROY SOC TROP MED H, V91, P166, DOI 10.1016/S0035-9203(97)90209-1; Fievet N, 1997, CLIN EXP IMMUNOL, V107, P462, DOI 10.1046/j.1365-2249.1997.d01-966.x; Fontenille D, 1997, AM J TROP MED HYG, V56, P247, DOI 10.4269/ajtmh.1997.56.247; Fried M, 1998, J MOL MED-JMM, V76, P162, DOI 10.1007/s001090050205; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Gysin J, 1997, MOL BIOCHEM PARASIT, V88, P267, DOI 10.1016/S0166-6851(97)00082-0; HART CA, 1988, BAILLIERE CLIN IMMUN, V2, P735; KORTMANN HFC, 1972, THESIS U AMSTERDAM; MCGREGOR IA, 1983, T ROY SOC TROP MED H, V77, P232, DOI 10.1016/0035-9203(83)90081-0; MCGREGOR IA, 1984, AM J TROP MED HYG, V33, P517, DOI 10.4269/ajtmh.1984.33.517; MENENDEZ C, 1994, T ROY SOC TROP MED H, V88, P590, DOI 10.1016/0035-9203(94)90176-7; MENENDEZ C, 1995, PARASITOL TODAY, V11, P178, DOI 10.1016/0169-4758(95)80151-0; Miller LH, 1998, NAT MED, V4, P1244, DOI 10.1038/3223; *MIN C MAL, 1992, WKLY EPIDEMIOL REC, V47, P349; MOUNT DL, 1989, B WORLD HEALTH ORGAN, V67, P295; Nahmias AJ, 1997, CLIN PERINATOL, V24, P497, DOI 10.1016/S0095-5108(18)30178-7; NGUYENDINH P, 1988, LANCET, V2, P751; RASHEED FN, 1993, AM J TROP MED HYG, V48, P154, DOI 10.4269/ajtmh.1993.48.154; Reid TMS, 1998, LANCET, V351, P1670, DOI 10.1016/S0140-6736(98)22023-X; RILEY EM, 1989, AM J TROP MED HYG, V40, P141, DOI 10.4269/ajtmh.1989.40.141; Rogier C, 1999, AM J TROP MED HYG, V60, P410, DOI 10.4269/ajtmh.1999.60.410; Rogier C, 1996, AM J TROP MED HYG, V54, P613, DOI 10.4269/ajtmh.1996.54.613; Smith NC, 1996, PARASITOL TODAY, V12, P4, DOI 10.1016/0169-4758(96)80637-5; TRAPE JF, 1994, AM J TROP MED HYG, V51, P123, DOI 10.4269/ajtmh.1994.51.123; VLEUGELS MPH, 1987, BRIT J OBSTET GYNAEC, V94, P758, DOI 10.1111/j.1471-0528.1987.tb03722.x; VLEUGELS MPH, 1989, T ROY SOC TROP MED H, V83, P173, DOI 10.1016/0035-9203(89)90632-9; WEINBERG ED, 1984, REV INFECT DIS, V6, P814; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	31	91	93	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 31	2000	343	9					598	603		10.1056/NEJM200008313430901	http://dx.doi.org/10.1056/NEJM200008313430901			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	348RE	10965006				2022-12-28	WOS:000088999600001
J	Cropley, IM; Lockwood, DNJ; Mack, D; Pasvol, G; Davidson, RN				Cropley, IM; Lockwood, DNJ; Mack, D; Pasvol, G; Davidson, RN			Rapid diagnosis of falciparum malaria by using the ParaSight F test in travellers returning to the United Kingdom: prospective study	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Northwick Pk Hosp & Clin Res Ctr, Lister Unit, Harrow HA1 3UJ, Middx, England; Northwick Pk Hosp & Clin Res Ctr, Dept Haematol, Harrow HA1 3UJ, Middx, England	Imperial College London; Imperial College London	Lockwood, DNJ (corresponding author), Hosp Trop Dis, London WC1E 6AU, England.	diana.lockwood@ishtm.ac.uk						BEADLE C, 1994, LANCET, V343, P564, DOI 10.1016/S0140-6736(94)91520-2; Genton Blaise, 1998, Southeast Asian Journal of Tropical Medicine and Public Health, V29, P35; Pieroni P, 1998, T ROY SOC TROP MED H, V92, P166, DOI 10.1016/S0035-9203(98)90730-1; SHIFF CJ, 1993, T ROY SOC TROP MED H, V87, P646, DOI 10.1016/0035-9203(93)90273-S; Van den Ende J, 1998, T ROY SOC TROP MED H, V92, P285, DOI 10.1016/S0035-9203(98)91013-6	5	12	13	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 19	2000	321	7259					484	485		10.1136/bmj.321.7259.484	http://dx.doi.org/10.1136/bmj.321.7259.484			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	347MC	10948029	Bronze, Green Published			2022-12-28	WOS:000088932800022
J	Belaaouaj, AA; Kim, KS; Shapiro, SD				Belaaouaj, AA; Kim, KS; Shapiro, SD			Degradation of outer membrane protein A in Escherichia coli killing by neutrophil elastase	SCIENCE			English	Article							IMMUNOGOLD TECHNIQUE; CATHEPSIN-G; CLONING; MICE	In determining the mechanism of neutrophil elastase (NE)-mediated killing of Escherichia coli, we found that NE degraded outer membrane protein A (OmpA), Localized on the surface of Cram-negative bacteria. NE killed wild-type, but not OmpA-deficient, E, coli. Also, whereas NE-deficient mice had impaired survival in response to E, coli sepsis, as compared to wild-type mice, the presence or absence of NE had no influence on survival in response to sepsis that had been induced with OmpA-deficient E. coli. These findings define a mechanism of nonoxidative bacterial killing by NE and point to OmpA as a bacterial target in host defense.	Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; Childrens Hosp, Div Infect Dis, Los Angeles, CA 90027 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Children's Hospital Los Angeles	Belaaouaj, AA (corresponding author), Washington Univ, Sch Med, Div Pulm & Crit Care Med, 660 S Euclid Ave,Campus Box 8052, St Louis, MO 63110 USA.		Bentaher, Abderrazzaq/M-4424-2017; A, Bentaher/F-6531-2018	A, Bentaher/0000-0001-6001-5456				BEESLEY JE, 1984, J GEN MICROBIOL, V130, P1481; Belaaouaj A, 1998, NAT MED, V4, P615, DOI 10.1038/nm0598-615; Betsuyaku T, 1999, AM J RESP CELL MOL, V20, P1303, DOI 10.1165/ajrcmb.20.6.3558; Blondin J., 1978, NEUTRAL PROTEASES HU, P39; KLOSE M, 1988, J BIOL CHEM, V263, P13291; MacIvor DM, 1999, BLOOD, V94, P4282, DOI 10.1182/blood.V94.12.4282.424k45_4282_4293; NIKAIDO H, 1983, J BACTERIOL, V153, P241, DOI 10.1128/JB.153.1.241-252.1983; Prasadarao NV, 1996, INFECT IMMUN, V64, P146, DOI 10.1128/IAI.64.1.146-153.1996; REST RF, 1981, INFECT IMMUN, V34, P62, DOI 10.1128/IAI.34.1.62-68.1981; Shafer WM, 1996, INFECT IMMUN, V64, P4842, DOI 10.1128/IAI.64.11.4842-4845.1996; SHAPIRO SD, 1993, J BIOL CHEM, V268, P23824; SLOT JW, 1988, METHOD MICROBIOL, V20, P211, DOI 10.1016/S0580-9517(08)70053-9; ZIMMER M, 1992, P NATL ACAD SCI USA, V89, P8215, DOI 10.1073/pnas.89.17.8215; Zitnik RJ, 1997, BIOCHEM BIOPH RES CO, V232, P687, DOI 10.1006/bbrc.1997.6358	14	273	282	2	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 18	2000	289	5482					1185	1187		10.1126/science.289.5482.1185	http://dx.doi.org/10.1126/science.289.5482.1185			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	346JE	10947984				2022-12-28	WOS:000088866600040
J	Ikura, T; Ogryzko, VV; Grigoriev, M; Groisman, R; Wang, J; Horikoshi, M; Scully, R; Qin, J; Nakatani, Y				Ikura, T; Ogryzko, VV; Grigoriev, M; Groisman, R; Wang, J; Horikoshi, M; Scully, R; Qin, J; Nakatani, Y			Involvement of the TIP60 histone acetylase complex in DNA repair and apoptosis	CELL			English	Article							GCN5-RELATED N-ACETYLTRANSFERASE; STRAND BREAK REPAIR; RUVB-LIKE PROTEIN; COENZYME-A; CRYSTAL-STRUCTURE; SUPERFAMILY; CHROMATIN; SWI/SNF; COACTIVATOR; COMPONENTS	It is well known that histone acetylases are important chromatin modifiers and that they play a central role in chromatin transcription. Here, we present evidence for novel roles of histone acetylases. The TIP60 histone acetylase purifies as a multimeric protein complex. Besides histone acetylase activity on chromatin, the TIP60 complex possesses ATPase, DNA helicase, and structural DNA binding activities. Ectopic expression of mutated TIP60 lacking histone acetylase activity results in cells with defective double-strand DNA break repair. Importantly, the resulting cells lose their apoptotic competence, suggesting a defect in the cells' ability to signal the existence of DNA damage to the apoptotic machinery. These results indicate that the histone acetylase TIP60-containing complex plays a role in DNA repair and apoptosis.	Dana Farber Canc Inst, Boston, MA 02115 USA; NIDDKD, NIH, Bethesda, MD 20892 USA; NICHHD, NIH, Bethesda, MD 20892 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Baylor Coll Med, Dept Biochem, Houston, TX 77030 USA; Baylor Coll Med, Dept Cell Biol, Houston, TX 77030 USA; Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan; Japan Sci & Technol Corp, Exploratory Res Adv Technol, Horikoshi Gene Selector Project, Tsukuba, Ibaraki 3002635, Japan	Harvard University; Dana-Farber Cancer Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Harvard University; Harvard Medical School; Baylor College of Medicine; Baylor College of Medicine; University of Tokyo; Japan Science & Technology Agency (JST)	Nakatani, Y (corresponding author), Dana Farber Canc Inst, Boston, MA 02115 USA.		Scully, Ralph/F-5008-2013; Ogryzko, Vasily/M-6665-2015	Ogryzko, Vasily/0000-0002-8548-1389; Grigoriev, Michel/0000-0002-0252-2254; Groisman, Regina/0000-0003-3990-7622; Groisman, Sonia/0000-0003-1153-3841	NATIONAL CANCER INSTITUTE [K01CA079576] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Allard S, 1999, EMBO J, V18, P5108, DOI 10.1093/emboj/18.18.5108; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; Cairns BR, 1998, MOL CELL, V2, P639, DOI 10.1016/S1097-2765(00)80162-8; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; Chen HW, 1997, CELL, V90, P569, DOI 10.1016/S0092-8674(00)80516-4; Clements A, 1999, EMBO J, V18, P3521, DOI 10.1093/emboj/18.13.3521; D'Atri S, 1998, MOL PHARMACOL, V54, P334, DOI 10.1124/mol.54.2.334; Dutnall RN, 1998, CELL, V94, P427, DOI 10.1016/S0092-8674(00)81584-6; Galarneau L, 2000, MOL CELL, V5, P927, DOI 10.1016/S1097-2765(00)80258-0; Grant PA, 1998, CELL, V94, P45, DOI 10.1016/S0092-8674(00)81220-9; Hoffmann A, 1996, NATURE, V380, P356, DOI 10.1038/380356a0; Kamine J, 1996, VIROLOGY, V216, P357, DOI 10.1006/viro.1996.0071; Kanemaki M, 1999, J BIOL CHEM, V274, P22437, DOI 10.1074/jbc.274.32.22437; Karran P, 2000, CURR OPIN GENET DEV, V10, P144, DOI 10.1016/S0959-437X(00)00069-1; Kuo MH, 1998, BIOESSAYS, V20, P615, DOI 10.1002/(SICI)1521-1878(199808)20:8<615::AID-BIES4>3.0.CO;2-H; Lim DS, 2000, NATURE, V404, P613, DOI 10.1038/35007091; Lin YX, 1999, NATURE, V400, P86, DOI 10.1038/21922; Makino Y, 1999, J BIOL CHEM, V274, P15329, DOI 10.1074/jbc.274.22.15329; McMahon SB, 1998, CELL, V94, P363, DOI 10.1016/S0092-8674(00)81479-8; Mizzen CA, 1996, CELL, V87, P1261, DOI 10.1016/S0092-8674(00)81821-8; Nakatani Y, 1996, J BIOL CHEM, V271, P6575, DOI 10.1074/jbc.271.12.6575; Nelms BE, 1998, SCIENCE, V280, P590, DOI 10.1126/science.280.5363.590; Neuwald AF, 1997, TRENDS BIOCHEM SCI, V22, P154, DOI 10.1016/S0968-0004(97)01034-7; Ogryzko VV, 1998, CELL, V94, P35, DOI 10.1016/S0092-8674(00)81219-2; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; PANYUTIN IG, 1994, P NATL ACAD SCI USA, V91, P2021, DOI 10.1073/pnas.91.6.2021; Peterson CL, 1998, J BIOL CHEM, V273, P23641, DOI 10.1074/jbc.273.37.23641; Petrini JHJ, 2000, CURR OPIN CELL BIOL, V12, P293, DOI 10.1016/S0955-0674(00)00091-0; Qiu XB, 1998, J BIOL CHEM, V273, P27786, DOI 10.1074/jbc.273.43.27786; Rojas JR, 1999, NATURE, V401, P93, DOI 10.1038/43487; Schiltz RL, 2000, BBA-REV CANCER, V1470, pM37, DOI 10.1016/S0304-419X(99)00037-2; Scully R, 1999, MOL CELL, V4, P1093, DOI 10.1016/S1097-2765(00)80238-5; SHEN X, IN PRESS NATURE; SIMON RH, 1979, NUCLEIC ACIDS RES, V6, P689, DOI 10.1093/nar/6.2.689; Spencer TE, 1997, NATURE, V389, P194, DOI 10.1038/38304; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Vassilev A, 1998, MOL CELL, V2, P869, DOI 10.1016/S1097-2765(00)80301-9; West SC, 1997, ANNU REV GENET, V31, P213, DOI 10.1146/annurev.genet.31.1.213; Wolf E, 1998, CELL, V94, P439, DOI 10.1016/S0092-8674(00)81585-8; WONG I, 1993, P NATL ACAD SCI USA, V90, P5428, DOI 10.1073/pnas.90.12.5428; Workman JL, 1998, ANNU REV BIOCHEM, V67, P545, DOI 10.1146/annurev.biochem.67.1.545; WU X, 2000, IN PRESS NATURE; Xie XL, 1996, NATURE, V380, P316, DOI 10.1038/380316a0; Yamamoto T, 1997, J BIOL CHEM, V272, P30595, DOI 10.1074/jbc.272.49.30595; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5	47	839	869	3	47	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 18	2000	102	4					463	473		10.1016/S0092-8674(00)00051-9	http://dx.doi.org/10.1016/S0092-8674(00)00051-9			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	347BX	10966108	Bronze			2022-12-28	WOS:000088908000008
J	Neutze, R; Wouts, R; van der Spoel, D; Weckert, E; Hajdu, J				Neutze, R; Wouts, R; van der Spoel, D; Weckert, E; Hajdu, J			Potential for biomolecular imaging with femtosecond X-ray pulses	NATURE			English	Article							ELECTRON; RESOLUTION; CRYSTALLOGRAPHY; DIFFRACTION; MICROSCOPY; SPECIMENS; PROTEIN; VIRUS; LASER	Sample damage by X-rays and other radiation limits the resolution of structural studies on non-repetitive and non-reproducible structures such as individual biomolecules or cells(1). Cooling can slow sample deterioration, but cannot eliminate damage-induced sample movement during the time needed for conventional measurements(1,2). Analyses of the dynamics of damage formation(3-5) suggest that the conventional damage barrier (about 200 X-ray photons per Angstrom(2) with X-rays of 12 keV energy or 1 Angstrom wavelength 2) may be extended at very high dose rates and very short exposure times. Here we have used computer simulations to investigate the structural information that can be recovered from the scattering of intense femtosecond X-ray pulses by single protein molecules and small assemblies. Estimations of radiation damage as a function of photon energy, pulse length, integrated pulse intensity and sample size show that experiments using very high X-ray dose rates and ultrashort exposures may provide useful structural information before radiation damage destroys the sample. We predict that such ultrashort, high-intensity X-ray pulses from free-electron lasers(6,7) that are currently under development, in combination with container-free sample handling methods based on spraying techniques, will provide a new approach to structural determinations with X-rays.	Uppsala Univ, Ctr Biomed, Dept Biochem, S-75123 Uppsala, Sweden; Univ Karlsruhe, Inst Kristallog, D-76128 Karlsruhe, Germany	Uppsala University; Helmholtz Association; Karlsruhe Institute of Technology	Hajdu, J (corresponding author), Uppsala Univ, Ctr Biomed, Dept Biochem, Box 576, S-75123 Uppsala, Sweden.	janos@xray.bmc.uu.se	Neutze, Richard/A-7573-2010; van der Spoel, David/A-5471-2008; van der Spoel, David/AAD-9820-2019	Neutze, Richard/0000-0003-0986-6153; van der Spoel, David/0000-0002-7659-8526; van der Spoel, David/0000-0002-7659-8526				BEENDSEN HJC, 1981, INTERMOLECULAR FORCE, P331; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Bottcher B, 1997, NATURE, V386, P88, DOI 10.1038/386088a0; Ditmire T, 1998, PHYS REV A, V57, pR4094, DOI 10.1103/PhysRevA.57.R4094; Doniach S, 1996, J SYNCHROTRON RADIAT, V3, P260, DOI 10.1107/S0909049596009739; Dyson N., 1973, XRAYS ATOMIC NUCL PH; Faigel G, 1999, REP PROG PHYS, V62, P355, DOI 10.1088/0034-4885/62/3/002; HAJDU J, 1990, ALFRED BENZON SYMP S, V28, P375; HARRISON SC, 1978, NATURE, V276, P368, DOI 10.1038/276368a0; HENDERSON R, 1995, Q REV BIOPHYS, V28, P171, DOI 10.1017/S003358350000305X; HENDERSON R, 1990, P ROY SOC B-BIOL SCI, V241, P6, DOI 10.1098/rspb.1990.0057; Hubbell J. H., 1975, Journal of Physical and Chemical Reference Data, V4, P471, DOI 10.1063/1.555523; KRAUSE MO, 1979, J PHYS CHEM REF DATA, V8, P329, DOI 10.1063/1.555595; Lin F., 1996, DISCRETE CONTINUOUS, V2, P1, DOI [10.3934/dcds.1996.2.1, DOI 10.3934/DCDS.1996.2.1, DOI 10.3934/dcds.1996.2.1]; Miao JW, 1999, NATURE, V400, P342, DOI 10.1038/22498; Mueller F, 2000, J MOL BIOL, V298, P35, DOI 10.1006/jmbi.2000.3635; Reiss HR, 1997, LASER PHYS, V7, P543; Rischel C, 1997, NATURE, V390, P490, DOI 10.1038/37317; Rostom AA, 2000, P NATL ACAD SCI USA, V97, P5185, DOI 10.1073/pnas.97.10.5185; Siuzdak G, 1996, CHEM BIOL, V3, P45, DOI 10.1016/S1074-5521(96)90083-6; SOLEM JC, 1986, J OPT SOC AM B, V3, P1551, DOI 10.1364/JOSAB.3.001551; Stowell MHB, 1998, CURR OPIN STRUC BIOL, V8, P595, DOI 10.1016/S0959-440X(98)80150-4; SZOKE A, 1993, ACTA CRYSTALLOGR A, V49, P853, DOI 10.1107/S0108767393004076; Tito MA, 2000, J AM CHEM SOC, V122, P3550, DOI 10.1021/ja993740k; Van Gunsteren WF, 1987, GROMOS 87 MANUAL; van Heel M, 1997, SCANNING MICROSC, V11, P195; Veigele Wm. J., 1973, Atomic Data, V5, P51, DOI 10.1016/S0092-640X(73)80015-4; WEAVER LH, 1987, J MOL BIOL, V193, P189, DOI 10.1016/0022-2836(87)90636-X; Wiik BH, 1997, NUCL INSTRUM METH A, V398, P1, DOI 10.1016/S0168-9002(97)00978-9; Winick H, 1995, J ELECTRON SPECTROSC, V75, P1, DOI 10.1016/0368-2048(95)02385-2	30	1453	1477	8	322	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 17	2000	406	6797					752	757		10.1038/35021099	http://dx.doi.org/10.1038/35021099			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	344PH	10963603				2022-12-28	WOS:000088767700050
J	Lee, PA				Lee, PA			High-temperature superconductors - Some vortices like it hot	NATURE			English	Editorial Material							PHASE		MIT, Dept Phys, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Lee, PA (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.							BEDNORZ JG, 1986, Z PHYS B CON MAT, V64, P189, DOI 10.1007/BF01303701; Berezinskii V. L., 1971, ZH EKSP TEOR FIZ+, V32, P493; Corson J, 1999, NATURE, V398, P221, DOI 10.1038/18402; Kosterlitz JM, 1973, J PHYS C SOLID STATE, V6, P1181, DOI 10.1088/0022-3719/6/7/010; Wen XG, 1996, PHYS REV LETT, V76, P503, DOI 10.1103/PhysRevLett.76.503; Xu ZA, 2000, NATURE, V406, P486, DOI 10.1038/35020016	7	9	9	0	2	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 3	2000	406	6795					467	468		10.1038/35020173	http://dx.doi.org/10.1038/35020173			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	340ML	10952293				2022-12-28	WOS:000088538000027
J	Whyatt, D; Lindeboom, F; Karis, A; Ferreira, R; Milot, E; Hendriks, R; de Bruijn, M; Langeveld, A; Gribnau, J; Grosveld, F; Philipsen, S				Whyatt, D; Lindeboom, F; Karis, A; Ferreira, R; Milot, E; Hendriks, R; de Bruijn, M; Langeveld, A; Gribnau, J; Grosveld, F; Philipsen, S			An intrinsic but cell-nonautonomous defect in GATA-1-overexpressing mouse erythroid cells	NATURE			English	Article							TRANSCRIPTION FACTOR GATA-1; X-CHROMOSOME INACTIVATION; CHIMERIC MICE; RETINOBLASTOMA GENE; IN-VIVO; DIFFERENTIATION; PRECURSORS; MUTATION; ERYTHROPOIESIS; STABILIZATION	GATA-1 is a tissue-specific transcription factor that is essential for the production of red blood cells(1,2). Here we show that overexpression of GATA-1 in erythroid cells inhibits their differentiation, leading to a lethal anaemia. Using chromosome-X-inactivation of a GATA-1 transgene and chimaeric animals, we show that this defect is intrinsic to erythroid cells, but nevertheless cell nonautonomous. Usually, cell nonautonomy is thought to reflect aberrant gene function in cells other than those that exhibit the phenotype(3). On the basis of our data, we propose an alternative mechanism in which a signal originating from wild-type erythroid cells restores normal differentiation to cells overexpressing GATA-1 in vivo. The existence of such a signalling mechanism indicates that previous interpretations of cell-nonautonomous defects may be erroneous in some cases and may in fact assign gene function to incorrect cell types.	Erasmus Univ, Dept Cell Biol & Genet, Ctr Med Genet, NL-3000 DR Rotterdam, Netherlands; Netherlands Canc Inst, Div Mol Carcinogenesis, NL-1066 CX Amsterdam, Netherlands	Erasmus University Rotterdam; Netherlands Cancer Institute	Grosveld, F (corresponding author), Erasmus Univ, Dept Cell Biol & Genet, Ctr Med Genet, POB 1738, NL-3000 DR Rotterdam, Netherlands.		Ferreira, Rita/GZL-4970-2022; Whyatt, David J/H-6088-2014	Whyatt, David J/0000-0002-6905-1979; Ferreira, Rita/0000-0001-7440-2246				ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Apfeld J, 1998, CELL, V95, P199, DOI 10.1016/S0092-8674(00)81751-1; BERNARD J, 1991, BLOOD CELLS, V17, P5; Bessis M, 1983, HEMATOLOGY, P257; Briegel K, 1996, DEVELOPMENT, V122, P3839; CORMACK D, 1976, EXP HEMATOL, V4, P319; De Maria R, 1999, NATURE, V401, P489, DOI 10.1038/46809; Dubart A, 1996, BLOOD, V87, P3711, DOI 10.1182/blood.V87.9.3711.bloodjournal8793711; Elefanty AG, 1996, EMBO J, V15, P319, DOI 10.1002/j.1460-2075.1996.tb00362.x; Fujiwara Y, 1996, P NATL ACAD SCI USA, V93, P12355, DOI 10.1073/pnas.93.22.12355; Hendriks RW, 1996, EMBO J, V15, P4862, DOI 10.1002/j.1460-2075.1996.tb00867.x; Hu NP, 1997, CANCER RES, V57, P4123; Kuroda MI, 1997, CELL, V91, P9, DOI 10.1016/S0092-8674(01)80003-9; MAANDAG ECR, 1994, EMBO J, V13, P4260, DOI 10.1002/j.1460-2075.1994.tb06746.x; MULDER MP, 1995, HUM GENET, V96, P133, DOI 10.1007/BF00207368; NAGAMINE CM, 1989, SCIENCE, V243, P80, DOI 10.1126/science.2563174; PANDOLFI PP, 1995, NAT GENET, V11, P40, DOI 10.1038/ng0995-40; Panning B, 1997, CELL, V90, P907, DOI 10.1016/S0092-8674(00)80355-4; PEVNY L, 1991, NATURE, V349, P257, DOI 10.1038/349257a0; Rossant J, 1998, TRENDS GENET, V14, P358, DOI 10.1016/S0168-9525(98)01552-2; SAWADA K, 1989, J CLIN INVEST, V83, P1701, DOI 10.1172/JCI114070; Sheardown SA, 1997, CELL, V91, P99, DOI 10.1016/S0092-8674(01)80012-X; Takahashi S, 1998, BLOOD, V92, P434, DOI 10.1182/blood.V92.2.434.414k24_434_442; Tsai FY, 1998, DEV BIOL, V196, P218, DOI 10.1006/dbio.1997.8842; WEISS MJ, 1994, GENE DEV, V8, P1184, DOI 10.1101/gad.8.10.1184; WEISS MJ, 1995, P NATL ACAD SCI USA, V92, P9623, DOI 10.1073/pnas.92.21.9623; Whyatt David J., 1997, Genes and Function, V1, P11; WIJGERDE M, 1995, NATURE, V377, P209, DOI 10.1038/377209a0; WILLIAMS BO, 1994, EMBO J, V13, P4251, DOI 10.1002/j.1460-2075.1994.tb06745.x; WONG PMC, 1986, P NATL ACAD SCI USA, V83, P3851, DOI 10.1073/pnas.83.11.3851	30	91	93	1	5	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 3	2000	406	6795					519	524		10.1038/35020086	http://dx.doi.org/10.1038/35020086			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	340ML	10952313				2022-12-28	WOS:000088538000047
J	Meyer, RR; Sloan, J; Dunin-Borkowski, RE; Kirkland, AI; Novotny, MC; Bailey, SR; Hutchison, JL; Green, MLH				Meyer, RR; Sloan, J; Dunin-Borkowski, RE; Kirkland, AI; Novotny, MC; Bailey, SR; Hutchison, JL; Green, MLH			Discrete atom imaging of one-dimensional crystals formed within single-walled carbon nanotubes	SCIENCE			English	Article							TRANSMISSION ELECTRON-MICROSCOPY; FOCUS-VARIATION; RECONSTRUCTION; RESOLUTION; PARTICLES	The complete crystallography of a one-dimensional crystal of potassium iodide encapsulated within a 1.6-nanometer-diameter single-wailed carbon nanotube has been determined with high-resolution transmission electron microscopy. Individual atoms of potassium and iodine within the crystal were identified from a phase image that was reconstructed with a modified focal series restoration approach. The lattice spacings within the crystal are substantially different from those in bulk potassium iodide. This is attributed to the reduced coordination of the surface atoms of the crystal and the close proximity of the van der Waals surface of the confining nanotube.	Univ Oxford, Inorgan Chem Lab, Wolfson Catalysis Ctr, Carbon nanotechnol Grp, Oxford OX1 3QR, England; Univ Cambridge, Dept Mat Sci, Cambridge CB2 3QZ, England; Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; Univ Oxford, Dept Mat, Oxford OX1 3PH, England	University of Oxford; University of Cambridge; University of Cambridge; University of Oxford	Sloan, J (corresponding author), Univ Oxford, Inorgan Chem Lab, Wolfson Catalysis Ctr, Carbon nanotechnol Grp, S Parks Rd, Oxford OX1 3QR, England.	jeremy.sloan@chem.ox.ac.uk	Dunin-Borkowski, Rafal/G-5597-2012; Sloan, Jeremy/C-7144-2009	Dunin-Borkowski, Rafal/0000-0001-8082-0647; Sloan, Jeremy/0000-0001-8612-7456				AHTEE M, 1969, ANN ACAD SCI FENN A, V0313; Boothroyd CB, 1998, J MICROSC-OXFORD, V190, P99, DOI 10.1046/j.1365-2818.1998.2910843.x; COENE W, 1992, PHYS REV LETT, V69, P3743, DOI 10.1103/PhysRevLett.69.3743; Coene WMJ, 1996, ULTRAMICROSCOPY, V64, P109, DOI 10.1016/0304-3991(96)00010-1; DRESSELHAUS MS, 1995, CARBON, V33, P883, DOI 10.1016/0008-6223(95)00017-8; FISKE TG, 1992, PHYS REV B, V45, P1414, DOI 10.1103/PhysRevB.45.1414; HUTCHISON JL, 1985, ULTRAMICROSCOPY, V18, P435, DOI 10.1016/0304-3991(85)90162-7; HUTCHISON JL, 1999, JEOL NEWS E, V34, P10; IIJIMA S, 1977, OPTIK, V48, P193; Journet C, 1997, NATURE, V388, P756, DOI 10.1038/41972; KAWASAKI T, 1992, PHYS REV LETT, V69, P293, DOI 10.1103/PhysRevLett.69.293; Kirk D, 1997, PROSTATE CANCER P D, V1, P11, DOI 10.1038/sj.pcan.4500207; KIRKLAND AI, 1995, ULTRAMICROSCOPY, V57, P355, DOI 10.1016/0304-3991(94)00191-O; Kirkland AI, 1999, INST PHYS CONF SER, P259; Kondo Y, 1997, PHYS REV LETT, V79, P3455, DOI 10.1103/PhysRevLett.79.3455; MARKS LD, 1984, PHYS REV LETT, V52, P656, DOI 10.1103/PhysRevLett.52.656; MARKS LD, 1983, NATURE, V303, P316, DOI 10.1038/303316a0; Meyer RR, 2000, MICROSC RES TECHNIQ, V49, P269; Meyer RR, 1999, INST PHYS CONF SER, P295; Simmons G., 1971, SINGLE CRYSTAL ELAST; Sloan J, 1999, CHEM COMMUN, P699, DOI 10.1039/a901572h; VANDYCK D, 1993, OPTIK, V93, P103; VANDYCK D, 1992, ELECT MICROSCOPY MAT, P193	23	369	377	2	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 25	2000	289	5483					1324	1326		10.1126/science.289.5483.1324	http://dx.doi.org/10.1126/science.289.5483.1324			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347RF	10958773				2022-12-28	WOS:000088942400030
J	Irvin, GL; Carneiro, DM				Irvin, GL; Carneiro, DM			Management changes in primary hyperparathyroidism	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SPORADIC PRIMARY HYPERPARATHYROIDISM; MINIMALLY INVASIVE PARATHYROIDECTOMY; MULTIGLANDULAR DISEASE; HORMONE ASSAY; SURGERY		Univ Miami, Jackson Mem Hosp, Dept Surg, Miami, FL 33136 USA; Dept Vet Affairs Med Ctr, Miami, FL USA	University of Miami	Irvin, GL (corresponding author), Dept Surg, POB 016310 M-875, Miami, FL 33101 USA.	girvin@miami.edu						Boggs JE, 1999, SURGERY, V126, P998, DOI 10.1016/S0039-6060(99)70053-X; Carneiro DM, 1999, OPERATIVE TECHNIQUES, V1, P18; Chen H, 1999, SURGERY, V126, P1016, DOI 10.1067/msy.2099.101433; Garner SC, 1999, SURGERY, V126, P1132, DOI 10.1067/msy.2099.101429; Gordon LL, 1999, SURGERY, V126, P1030, DOI 10.1067/msy.2099.101833; Irvin GL, 1999, ANN SURG, V229, P874, DOI 10.1097/00000658-199906000-00015; MALMAEUS J, 1988, ACTA CHIR SCAND, V154, P409; Molinari AS, 1996, SURGERY, V120, P934, DOI 10.1016/S0039-6060(96)80036-5; Norman J, 1997, SURGERY, V122, P998, DOI 10.1016/S0039-6060(97)90201-4; NUSSBAUM SR, 1987, CLIN CHEM, V33, P1364; Pattou F, 1999, SURGERY, V126, P1123, DOI 10.1067/msy.2099.101579; POTTS JT, 1991, ANN INTERN MED, V114, P593, DOI 10.7326/0003-4819-114-7-593; PROYE CAG, 1992, SURGERY, V112, P1118; SCHOLZ DA, 1981, MAYO CLIN PROC, V56, P473; Silverberg SJ, 1999, NEW ENGL J MED, V341, P1249, DOI 10.1056/NEJM199910213411701; TEZELMAN S, 1993, ANN SURG, V218, P300, DOI 10.1097/00000658-199309000-00009; UDELSMAN R, IN PRESS ANN SURG; UDEN P, 1992, WORLD J SURG, V16, P791, DOI 10.1007/BF02067389; VANHEERDEN JA, 1991, WORLD J SURG, V15, P688, DOI 10.1007/BF01665301; WEBER CJ, 1994, SURGERY, V116, P991	20	52	53	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 23	2000	284	8					934	936		10.1001/jama.284.8.934	http://dx.doi.org/10.1001/jama.284.8.934			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	344PX	10944618				2022-12-28	WOS:000088769000001
J	Denef, N; Neubuser, D; Perez, L; Cohen, SM				Denef, N; Neubuser, D; Perez, L; Cohen, SM			Hedgehog induces opposite changes in turnover and subcellular localization of patched and smoothened	CELL			English	Article							DROSOPHILA CUBITUS INTERRUPTUS; TARGET GENE-EXPRESSION; PROXIMAL-DISTAL AXIS; RECEPTOR COMPLEX; TRANSCRIPTIONAL ACTIVATOR; SIGNAL-TRANSDUCTION; PROTEIN-KINASE; SONIC HEDGEHOG; IMAGINAL DISKS; WINGLESS	Secreted signaling proteins of the Hedgehog family organize spatial pattern during animal development. Two integral membrane proteins have been identified with distinct roles in Hedgehog signaling. Patched functions in Hedgehog binding, and Smoothened functions in transducing the signal. Current models view Patched and Smoothened as a preformed receptor complex that is activated by Hedgehog binding. Here we present evidence that Patched destabilizes Smoothened in the absence of Hedgehog. Hedgehog binding causes removal of Patched from the cell surface. In contrast, Hedgehog causes phosphorylation, stabilization, and accumulation of Smoothened at the cell surface. Comparable effects can be produced by removing Patched from cells by RNA-mediated interference. These findings raise the possibility that Patched acts indirectly to regulate Smoothened activity.	European Mol Biol Lab, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Cohen, SM (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.		Cohen, Stephen M/G-9930-2011; Perez, Lidia/F-7695-2016	Cohen, Stephen M/0000-0003-2858-9163; Perez, Lidia/0000-0002-8821-1202				Alcedo J, 1997, BIOL CHEM, V378, P583; Alcedo J, 1996, CELL, V86, P221, DOI 10.1016/S0092-8674(00)80094-X; Alexandre C, 1996, GENE DEV, V10, P2003, DOI 10.1101/gad.10.16.2003; Alves G, 1998, MECH DEVELOP, V78, P17, DOI 10.1016/S0925-4773(98)00130-0; Aza-Blanc P, 1999, TRENDS GENET, V15, P458, DOI 10.1016/S0168-9525(99)01869-7; AzaBlanc P, 1997, CELL, V89, P1043, DOI 10.1016/S0092-8674(00)80292-5; BASLER K, 1994, NATURE, V368, P208, DOI 10.1038/368208a0; Brook WJ, 1996, SCIENCE, V273, P1373, DOI 10.1126/science.273.5280.1373; Burke R, 1999, CELL, V99, P803, DOI 10.1016/S0092-8674(00)81677-3; Calleja M, 1996, SCIENCE, V274, P252, DOI 10.1126/science.274.5285.252; CAPDEVILA J, 1994, EMBO J, V13, P71, DOI 10.1002/j.1460-2075.1994.tb06236.x; Chen CH, 1999, CELL, V98, P305, DOI 10.1016/S0092-8674(00)81960-1; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; Chen Y, 1998, DEVELOPMENT, V125, P4943; DIAZBENJUMEA FJ, 1994, NATURE, V372, P175, DOI 10.1038/372175a0; Dominguez M, 1996, SCIENCE, V272, P1621, DOI 10.1126/science.272.5268.1621; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hepker J, 1997, DEVELOPMENT, V124, P549; Incardona JP, 2000, CURR OPIN CELL BIOL, V12, P193, DOI 10.1016/S0955-0674(99)00076-9; INGHAM PW, 1995, CURR OPIN GENET DEV, V5, P492, DOI 10.1016/0959-437X(95)90054-K; INGHAM PW, 1991, NATURE, V353, P184, DOI 10.1038/353184a0; Jiang J, 1996, CELL, V86, P401, DOI 10.1016/S0092-8674(00)80113-0; KORNEZOS A, 1992, MOL GEN GENET, V235, P397, DOI 10.1007/BF00279386; Lecuit T, 1996, NATURE, V381, P387, DOI 10.1038/381387a0; Lecuit T, 1997, NATURE, V388, P139, DOI 10.1038/40563; LEE JJ, 1992, CELL, V71, P33, DOI 10.1016/0092-8674(92)90264-D; LI W, 1995, CELL, V80, P553, DOI 10.1016/0092-8674(95)90509-X; MA CY, 1993, CELL, V75, P927, DOI 10.1016/0092-8674(93)90536-Y; Marigo V, 1996, NATURE, V384, P176, DOI 10.1038/384176a0; Methot N, 1999, CELL, V96, P819, DOI 10.1016/S0092-8674(00)80592-9; Monnier V, 1998, CURR BIOL, V8, P583, DOI 10.1016/S0960-9822(98)70227-1; MOTZNY CK, 1995, MECH DEVELOP, V52, P137, DOI 10.1016/0925-4773(95)00397-J; Mullor JL, 1997, DEVELOPMENT, V124, P1227; Murone M, 1999, CURR BIOL, V9, P76, DOI 10.1016/S0960-9822(99)80018-9; Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9; Neufeld EB, 1999, J BIOL CHEM, V274, P9627, DOI 10.1074/jbc.274.14.9627; Ohlmeyer JT, 1998, NATURE, V396, P749, DOI 10.1038/25533; PATEL NH, 1989, CELL, V58, P955, DOI 10.1016/0092-8674(89)90947-1; Pignoni F, 1997, DEVELOPMENT, V124, P271; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rorth P, 1998, DEVELOPMENT, V125, P1049; SCHWARTZ C, 1995, DEVELOPMENT, V121, P1625; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Strigini M, 1997, DEVELOPMENT, V124, P4697; TABATA T, 1994, CELL, V76, P89, DOI 10.1016/0092-8674(94)90175-9; TABATA T, 1992, GENE DEV, V6, P2635, DOI 10.1101/gad.6.12b.2635; Therond PP, 1999, DEVELOPMENT, V126, P4039; Therond PP, 1996, P NATL ACAD SCI USA, V93, P4224, DOI 10.1073/pnas.93.9.4224; vandenHeuvel M, 1996, NATURE, V382, P547, DOI 10.1038/382547a0; VANLEEUWEN F, 1994, NATURE, V368, P342, DOI 10.1038/368342a0; Wang QT, 1999, DEVELOPMENT, V126, P5097; ZECCA M, 1995, DEVELOPMENT, V121, P2265	52	420	436	1	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 18	2000	102	4					521	531		10.1016/S0092-8674(00)00056-8	http://dx.doi.org/10.1016/S0092-8674(00)00056-8			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	347BX	10966113	Bronze			2022-12-28	WOS:000088908000013
J	Gavaghan, H				Gavaghan, H			European industry turns to the academics to secure its future	NATURE			English	Article																			0	4	4	0	1	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 17	2000	406	6797					809	811		10.1038/35021184	http://dx.doi.org/10.1038/35021184			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	344PH	10963613				2022-12-28	WOS:000088767700061
J	Kohno, M; Koizumi, Y				Kohno, M; Koizumi, Y			Tokaimura accident - Neutron dose estimates from 5-yen coins	NATURE			English	Article									Kyoto Univ, Dept Nucl Engn, Sakyo Ku, Kyoto 6068501, Japan; Univ Tokyo, Isotope Ctr, Bunkyo Ku, Tokyo 1130032, Japan	Kyoto University; University of Tokyo	Kohno, M (corresponding author), Kyoto Univ, Dept Nucl Engn, Sakyo Ku, Kyoto 6068501, Japan.							IMANAKA T, 1999, GIJUTSU TO NIGEN, V28, P56; Komura K, 2000, J ENVIRON RADIOACTIV, V50, P1; *SCI TECHN AG JAP, 1999, DOS EST ENV NEIGHB J	3	1	1	0	4	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 17	2000	406	6797					693	693		10.1038/35021138	http://dx.doi.org/10.1038/35021138			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	344PH	10963586				2022-12-28	WOS:000088767700033
J	Cheng, AK; Rubin, HR; Powe, NR; Mellon, NK; Francis, HW; Niparko, JK				Cheng, AK; Rubin, HR; Powe, NR; Mellon, NK; Francis, HW; Niparko, JK			Cost-utility analysis of the cochlear implant in children	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PROFOUNDLY DEAF; HEALTH-STATUS; TECHNOLOGY; LIFE	Context Barriers to the use of cochlear implants in children with profound deafness include device costs, difficulty assessing benefit, and lack of data to compare the implant with other medical interventions. Objective To determine the quality of life and cost consequences for deaf children who receive a cochlear implant. Design Cost-utility analysis using preintervention, postintervention, and cross-sectional surveys conducted from July 1998 to May 2000, Setting Hearing clinic at a US academic medical center. Participants Parents of 78 profoundly deaf children (average age, 7.5 years) who received cochlear implants. Main Outcome Measures Direct and total cost to society per quality-adjusted life-year (QALY) using the time-trade-off (TTO), visual analog scale (VAS), and Health Utilities Index-Mark III (HUI), discounting costs and benefits 3% annually. Parents rated their child's health state at the time of the survey and immediately before and 1 year before implantation, Results Recipients had an average of 1.9 years of implant use. Mean VAS scores increased by 0.27, from 0.59 before implantation to 0.86 at survey, In a subset of participants, TTO scores increased by 0.22, from 0.75 to 0.97 (n=40) and HUI scores increased by 0.39, from 0.25 to 0.64 (n=22). Quality-of-life scores were no different 1 year before and immediately before implantation. Discounted direct costs were $60 228, yielding $9029 per QALY using the TTO, $7500 per QALY using the VAS, and $5197 per QALY using the HUI, Including indirect costs such as reduced educational expenses, the cochlear implant provided a savings of $53 198 per child. Conclusions Cochlear implants in profoundly deaf children have a positive effect on quality of life at reasonable direct costs and appear to result in a net savings to society.	Johns Hopkins Univ, Dept Otolaryngol Head & Neck Surg, Baltimore, MD USA; Johns Hopkins Univ, Dept Med, Baltimore, MD USA; Johns Hopkins Univ, Dept Hlth Policy & Management, Baltimore, MD USA; Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Niparko, JK (corresponding author), Johns Hopkins Univ, Dept Otolaryngol, Div Otol Neurotol, 601 N Carolina St, Baltimore, MD 21287 USA.	jnipark@jhmi.edu						ACHENBACH TM, 1987, PSYCHOL BULL, V101, P213, DOI 10.1037/0033-2909.101.2.213; *AM MED ASS, 2000, HLTH CAR FIN ADM COM; Azimi NA, 1998, J GEN INTERN MED, V13, P664, DOI 10.1046/j.1525-1497.1998.00201.x; Blanchfield B. B., 1999, SEVERELY PROFOUNDLY; *BUR CENS, 2000, INC 1998; *BUR CENS, 1992, STAT ABSTR US; *BUR LAB STAT, 2000, CONS PRIC IND ALL UR; Carter R, 1999, INT J TECHNOL ASSESS, V15, P520, DOI 10.1017/S0266462399015378; Cheng AK, 1999, ARCH OTOLARYNGOL, V125, P1214, DOI 10.1001/archotol.125.11.1214; DREWETT RF, 1992, ANN ROY COLL SURG, V74, P286; FEENY D, 1992, J CLIN ONCOL, V10, P923, DOI 10.1200/JCO.1992.10.6.923; Francis HW, 1999, ARCH OTOLARYNGOL, V125, P499, DOI 10.1001/archotol.125.5.499; *GALL RES I, 1999, 1997 98 ANN SURV DEA; GATES GA, 1995, JAMA-J AM MED ASSOC, V274, P1955, DOI 10.1001/jama.1995.03530240065043; Gold MR, 1996, COST EFFECTIVENESS H; Gudex C, 1994, TIME TRADE OFF USER; HUTTON J, 1995, ADV OTO-RHINO-LARYNG, V50, P201; KIND P, 1994, J EPIDEMIOL COMMUN H, V48, P86, DOI 10.1136/jech.48.1.86; Lane H, 1998, OTOLARYNG HEAD NECK, V119, P297, DOI 10.1016/S0194-5998(98)70070-1; LARSEN GC, 1992, J AM COLL CARDIOL, V19, P1323, DOI 10.1016/0735-1097(92)90341-J; LEA AR, 1995, MED PROG TECHNOL, V21, P47; LEA AR, 1991, HLTH CARE TECHNOLOGY, V6; LOOMES G, 1988, DISPARITIES HLTH STA; MOHR P, IN PRESS INT J TECH; O'Neill C, 2000, LARYNGOSCOPE, V110, P156, DOI 10.1097/00005537-200001000-00028; Palmer CS, 1999, ARCH OTOLARYNGOL, V125, P1221, DOI 10.1001/archotol.125.11.1221; REIS R, 1994, VITAL HLTH STAT, V10, P1; SMITH SL, 1999, MEDICARE RBRVS PHYSI; Steiner CA, 1996, J GEN INTERN MED, V11, P294, DOI 10.1007/BF02598272; Stiggelbout AM, 1996, INT J TECHNOL ASSESS, V12, P291, DOI 10.1017/S0266462300009648; Summerfield A, 1995, COCHLEAR IMPLANTATIO; Summerfield AQ, 1997, AM J OTOL, V18, pS166; Theunissen NCM, 1998, QUAL LIFE RES, V7, P387, DOI 10.1023/A:1008801802877; Torrance G W, 1972, Health Serv Res, V7, P118; TORRANCE GW, 1976, HEALTH SERV RES, V11, P349; *US DEP TREAS, 1999, UMR EMPL BUS EXP; Wyatt JR, 1996, LARYNGOSCOPE, V106, P816, DOI 10.1097/00005537-199607000-00006; Wyatt JR, 1995, OTOLOARYNGOL HEAD NE, P112; 2000, HEALTHCARE SALARY DA	39	170	174	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 16	2000	284	7					850	856		10.1001/jama.284.7.850	http://dx.doi.org/10.1001/jama.284.7.850			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	342PM	10938174	Bronze			2022-12-28	WOS:000088654400027
J	Govindarajan, R; Heaton, KM; Broadwater, R; Zeitlin, A; Lang, NP; Hauer-Jensen, M				Govindarajan, R; Heaton, KM; Broadwater, R; Zeitlin, A; Lang, NP; Hauer-Jensen, M			Effect of thalidomide on gastrointestinal toxic effects of irinotecan	LANCET			English	Article								Irinotecan is the only accepted second-line treatment for colorectal cancer in the USA. Doses are, however, frequently limited by associated late-onset diarrhoea. Thalidomide has antiangiogenic and immunomodulatory properties and is being investigated as an antineoplastic. We did a pilot study of combination therapy with thalidomide and irinotecan for metastatic colorectal cancer. In an interim analysis of nine patients, thalidomide had almost eliminated the dose-limiting gastrointestinal toxic effects of irinotecan, especially diarrhoea and nausea (each p<0.0001), and eight of nine patients were able to complete the chemotherapy course.	Univ Arkansas Med Sci, Little Rock, AR 72205 USA; Celgene Corp, Warren, NJ USA	University of Arkansas System; University of Arkansas Medical Sciences; Bristol-Myers Squibb; Celgene Corporation	Govindarajan, R (corresponding author), Univ Arkansas Med Sci, 4301 W Markham, Little Rock, AR 72205 USA.							Cunningham D, 1998, LANCET, V352, P1413, DOI 10.1016/S0140-6736(98)02309-5; DAMATO RJ, 1994, P NATL ACAD SCI USA, V91, P4082, DOI 10.1073/pnas.91.9.4082; Hecht JR, 1998, ONCOLOGY-NY, V12, P72; Marriott JB, 1999, IMMUNOL TODAY, V20, P538, DOI 10.1016/S0167-5699(99)01531-5; SCHMITZ H, 1996, AM J PHYSIOL, V271, P669	5	72	81	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 12	2000	356	9229					566	567		10.1016/S0140-6736(00)02586-1	http://dx.doi.org/10.1016/S0140-6736(00)02586-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	345MY	10950238				2022-12-28	WOS:000088820800018
J	Bollmann, JH; Sakmann, B; Gerard, J; Borst, G				Bollmann, JH; Sakmann, B; Gerard, J; Borst, G			Calcium sensitivity of glutamate release in a calyx-type terminal	SCIENCE			English	Article							BOVINE CHROMAFFIN CELLS; TRANSMITTER RELEASE; DM-NITROPHEN; NERVE-TERMINALS; DEPENDENT EXOCYTOSIS; FLASH-PHOTOLYSIS; TIME-COURSE; SYNAPSE; CA2+; DEPRESSION	Synaptic efficacy critically depends on the presynaptic intracellular calcium concentration ([Ca2+](i)). We measured the calcium sensitivity of glutamate release in a rat auditory brainstem synapse by Laser photolysis of caged calcium. A rise in [Ca2+](i) to 1 micromolar readily evoked release. An increase to >30 micromolar depleted the releasable vesicle pool in <0.5 millisecond. A comparison with action potential-evoked release suggested that a brief increase of [Ca2+](i) to similar to 10 micromolar would be sufficient to reproduce the physiological release pattern. Thus, the calcium sensitivity of release at this synapse is high, and the distinction between phasic and delayed release is Less pronounced than previously thought.	Max Planck Inst Med Res, Dept Cell Physiol, D-69120 Heidelberg, Germany; Univ Amsterdam, Swammerdam Inst Life Sci, NL-1098 SM Amsterdam, Netherlands	Max Planck Society; University of Amsterdam	Bollmann, JH (corresponding author), Max Planck Inst Med Res, Dept Cell Physiol, Jahnstr 29, D-69120 Heidelberg, Germany.	jbollman@mpimf-heidelberg.mpg.de						AUGUSTINE GJ, 1991, ANN NY ACAD SCI, V635, P365, DOI 10.1111/j.1749-6632.1991.tb36505.x; Borst JGG, 1995, J PHYSIOL-LONDON, V489, P825, DOI 10.1113/jphysiol.1995.sp021095; Borst JGG, 1998, J PHYSIOL-LONDON, V506, P143, DOI 10.1111/j.1469-7793.1998.143bx.x; Borst JGG, 1996, NATURE, V383, P431, DOI 10.1038/383431a0; Burgoyne RD, 1998, CELL CALCIUM, V24, P367, DOI 10.1016/S0143-4160(98)90060-4; Chen CF, 1999, J NEUROSCI, V19, P6257; CHOW RH, 1994, P NATL ACAD SCI USA, V91, P12765, DOI 10.1073/pnas.91.26.12765; Cummings DD, 1996, J NEUROSCI, V16, P5312; DELANEY KR, 1990, J PHYSIOL-LONDON, V426, P473, DOI 10.1113/jphysiol.1990.sp018150; DiGregorio DA, 1999, J NEUROSCI, V19, P7846; EllisDavies GCR, 1996, BIOPHYS J, V70, P1006, DOI 10.1016/S0006-3495(96)79644-3; Escobar AL, 1997, PFLUG ARCH EUR J PHY, V434, P615, DOI 10.1007/s004240050444; Hazard AL, 1998, PROTEIN SCI, V7, P2451, DOI 10.1002/pro.5560071123; Heidelberger R, 1998, J GEN PHYSIOL, V111, P225, DOI 10.1085/jgp.111.2.225; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; HEINEMANN C, 1994, BIOPHYS J, V67, P2546, DOI 10.1016/S0006-3495(94)80744-1; Helmchen F, 1997, BIOPHYS J, V72, P1458, DOI 10.1016/S0006-3495(97)78792-7; Hsu SF, 1996, NEURON, V17, P501, DOI 10.1016/S0896-6273(00)80182-8; KAPLAN JH, 1988, P NATL ACAD SCI USA, V85, P6571, DOI 10.1073/pnas.85.17.6571; Kasai H, 1999, TRENDS NEUROSCI, V22, P88, DOI 10.1016/S0166-2236(98)01293-4; Naraghi M, 1997, CELL CALCIUM, V22, P255, DOI 10.1016/S0143-4160(97)90064-6; NEHER E, 1993, NEURON, V10, P21, DOI 10.1016/0896-6273(93)90238-M; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Ohana O, 1998, J PHYSIOL-LONDON, V513, P135, DOI 10.1111/j.1469-7793.1998.135by.x; Proks P, 1996, J PHYSIOL-LONDON, V496, P255, DOI 10.1113/jphysiol.1996.sp021682; Ravin R, 1999, J NEUROPHYSIOL, V81, P634, DOI 10.1152/jn.1999.81.2.634; ROBITAILLE R, 1993, NEURON, V11, P645, DOI 10.1016/0896-6273(93)90076-4; ROSENBOOM H, 1994, P NATL ACAD SCI USA, V91, P5267, DOI 10.1073/pnas.91.12.5267; Schneggenburger R, 1999, NEURON, V23, P399, DOI 10.1016/S0896-6273(00)80789-8; Sudhof TC, 1996, NEURON, V17, P379, DOI 10.1016/S0896-6273(00)80171-3; Tandon A, 1998, NEURON, V21, P147, DOI 10.1016/S0896-6273(00)80522-X; THOMAS P, 1993, NEURON, V11, P93, DOI 10.1016/0896-6273(93)90274-U; Traynelis SF, 1998, J NEUROSCI METH, V86, P25, DOI 10.1016/S0165-0270(98)00140-X; vonGersdorff H, 1997, J NEUROSCI, V17, P8137; Wu LG, 1999, NEURON, V23, P821, DOI 10.1016/S0896-6273(01)80039-8; YAMADA WM, 1992, BIOPHYS J, V61, P671, DOI 10.1016/S0006-3495(92)81872-6; ZUCKER RS, 1993, CELL CALCIUM, V14, P87, DOI 10.1016/0143-4160(93)90079-L; Zucker RS, 1999, CURR OPIN NEUROBIOL, V9, P305, DOI 10.1016/S0959-4388(99)80045-2	38	371	375	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 11	2000	289	5481					953	957		10.1126/science.289.5481.953	http://dx.doi.org/10.1126/science.289.5481.953			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	343KH	10937999				2022-12-28	WOS:000088701200033
J	Horton, JC				Horton, JC			Boundary disputes - The brain still resists researchers' attempts to divide it into neat parcels.	NATURE			English	Editorial Material									Univ Calif San Francisco, Beckman Vis Ctr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Horton, JC (corresponding author), Univ Calif San Francisco, Beckman Vis Ctr, San Francisco, CA 94143 USA.			Horton, Jonathan/0000-0002-3952-435X					0	4	4	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 10	2000	406	6796					565	565		10.1038/35020648	http://dx.doi.org/10.1038/35020648			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	342PF	10949277				2022-12-28	WOS:000088653800021
J	Bourne, HR; Meng, EC				Bourne, HR; Meng, EC			Structure - Rhodopsin sees the light	SCIENCE			English	Editorial Material							TRANSMEMBRANE HELICES; G-PROTEIN; ARRANGEMENT; ACTIVATION		Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Bourne, HR (corresponding author), Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA.	bourne@cmp.ucsf.edu; meng@cgl.ucsf.edu						Baldwin JM, 1997, J MOL BIOL, V272, P144, DOI 10.1006/jmbi.1997.1240; Borhan B, 2000, SCIENCE, V288, P2209, DOI 10.1126/science.288.5474.2209; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Herzyk P, 1998, J MOL BIOL, V281, P741, DOI 10.1006/jmbi.1998.1981; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Pecheur EI, 2000, J BIOL CHEM, V275, P3936, DOI 10.1074/jbc.275.6.3936; PHILLIPS WJ, 1992, J BIOL CHEM, V267, P17032; Pogozheva ID, 1997, BIOPHYS J, V72, P1963, DOI 10.1016/S0006-3495(97)78842-8; Sheikh SP, 1999, J BIOL CHEM, V274, P17033, DOI 10.1074/jbc.274.24.17033; Unger VM, 1997, NATURE, V389, P203, DOI 10.1038/38316	11	59	61	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 4	2000	289	5480					733	734		10.1126/science.289.5480.733	http://dx.doi.org/10.1126/science.289.5480.733			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	341FZ	10950717				2022-12-28	WOS:000088581500025
J	Bruckner, K; Perez, L; Clausen, H; Cohen, S				Bruckner, K; Perez, L; Clausen, H; Cohen, S			Glycosyltransferase activity of fringe modulates notch-delta interactions	NATURE			English	Article							DORSAL-VENTRAL BOUNDARY; WING IMAGINAL DISC; O-LINKED FUCOSE; SIGNALING MOLECULE; GOLGI-APPARATUS; LUNATIC FRINGE; DROSOPHILA; FAMILY; ACTIVATION; SERRATE	Ligands that are capable of activating Notch family receptors are broadly expressed in animal development, but their activity is tightly regulated to allow formation of tissue boundaries(1). Members of the fringe gene family have been implicated in limiting Notch activation during boundary formation(2-8), but the mechanism of Fringe function has not been determined. Here we present evidence that Fringe acts in the Golgi as a glycosyltransferase enzyme that modifies the epidermal growth factor (EGF) modules of Notch and alters the ability of Notch to bind its ligand Delta. Fringe catalyses the addition of N-acetylglucosamine to fucose, which is consistent with a role in the elongation of O-linked fucose O-glycosylation that is associated with EGF repeats. We suggest that cell-type-specific modification of glycosylation may provide a general mechanism to regulate ligand-receptor interactions in vivo.	European Mol Biol Lab, D-69117 Heidelberg, Germany; Univ Copenhagen, Sch Dent, DK-2200 Copenhagen N, Denmark	European Molecular Biology Laboratory (EMBL); University of Copenhagen	Cohen, S (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.		clausen, henrik/AAD-8016-2021; Cohen, Stephen M/G-9930-2011; Perez, Lidia/F-7695-2016	Cohen, Stephen M/0000-0003-2858-9163; Perez, Lidia/0000-0002-8821-1202; Clausen, Henrik/0000-0002-0915-5055				Amado M, 1999, BBA-GEN SUBJECTS, V1473, P35, DOI 10.1016/S0304-4165(99)00168-3; Amado M, 1998, J BIOL CHEM, V273, P12770, DOI 10.1074/jbc.273.21.12770; BERGEMANN AD, 1995, MOL CELL BIOL, V15, P4921; Blaumueller CM, 1997, CELL, V90, P281, DOI 10.1016/S0092-8674(00)80336-0; Breton C, 1999, CURR OPIN STRUC BIOL, V9, P563, DOI 10.1016/S0959-440X(99)00006-8; Bruckner K, 1999, NEURON, V22, P511, DOI 10.1016/S0896-6273(00)80706-0; deCelis JF, 1996, DEVELOPMENT, V122, P359; DiazBenjumea FJ, 1995, DEVELOPMENT, V121, P4215; Doherty D, 1996, GENE DEV, V10, P421, DOI 10.1101/gad.10.4.421; Evrard YA, 1998, NATURE, V394, P377, DOI 10.1038/28632; Fleming RJ, 1997, DEVELOPMENT, V124, P2973; Gastinel LN, 1999, EMBO J, V18, P3546, DOI 10.1093/emboj/18.13.3546; Goode S, 1997, COLD SPRING HARB SYM, V62, P177; HARRIS RJ, 1993, GLYCOBIOLOGY, V3, P219, DOI 10.1093/glycob/3.3.219; Irvine KD, 1999, CURR OPIN GENET DEV, V9, P434, DOI 10.1016/S0959-437X(99)80066-5; IRVINE KD, 1994, CELL, V79, P595, DOI 10.1016/0092-8674(94)90545-2; Johnston SH, 1997, DEVELOPMENT, V124, P2245; KIM J, 1995, CELL, V82, P795, DOI 10.1016/0092-8674(95)90476-X; Laufer E, 1997, NATURE, V386, P366, DOI 10.1038/386366a0; Logeat F, 1998, P NATL ACAD SCI USA, V95, P8108, DOI 10.1073/pnas.95.14.8108; Moloney DJ, 1999, GLYCOBIOLOGY, V9, P679, DOI 10.1093/glycob/9.7.679; NILSSON T, 1994, CURR OPIN CELL BIOL, V6, P517, DOI 10.1016/0955-0674(94)90070-1; Panin VM, 1997, NATURE, V387, P908, DOI 10.1038/43191; RodriguezEsteban C, 1997, NATURE, V386, P360, DOI 10.1038/386360a0; Rottger S, 1998, J CELL SCI, V111, P45; RULIFSON EJ, 1995, DEVELOPMENT, V121, P2813; Stanley H, 1997, P NATL ACAD SCI USA, V94, P14467, DOI 10.1073/pnas.94.26.14467; Wu JY, 1996, SCIENCE, V273, P355, DOI 10.1126/science.273.5273.355; Yuan YP, 1997, CELL, V88, P9, DOI 10.1016/S0092-8674(00)81852-8; Zhang NA, 1998, NATURE, V394, P374, DOI 10.1038/28625	30	574	596	0	27	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 27	2000	406	6794					411	415		10.1038/35019075	http://dx.doi.org/10.1038/35019075			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	337WC	10935637				2022-12-28	WOS:000088383800047
J	Kania, A; Johnson, RL; Jessell, TM				Kania, A; Johnson, RL; Jessell, TM			Coordinate roles for LIM homeobox genes in directing the dorsoventral trajectory of motor axons in the vertebrate limb	CELL			English	Article							SUBTYPE IDENTITY; CHICK HINDLIMB; SPINAL-CORD; NEURON; EXPRESSION; INNERVATION; OUTGROWTH; REQUIREMENT; PATHWAY; CELLS	Motor neurons extend axons along specific trajectories, but the molecules that control their pathfinding remain poorly defined. We show that two LIM homeodomain transcription factors, Lim1 and Lmx1b, control the initial trajectory of motor axons in the developing mammalian limb. The expression of Lim1 by a lateral set of lateral motor column (LMC) neurons ensures that their axons select a dorsal trajectory in the limb. In a complementary manner, the expression of Lmx1b by dorsal limb mesenchymal cells controls the dorsal and ventral axonal trajectories of medial and lateral LMC neurons. In the absence of these two proteins, motor axons appear to select dorsal and ventral trajectories at random. Thus, LIM homeodomain proteins act within motor neurons and cells that guide motor axons to establish the fidelity of a binary choice in axonal trajectory.	Columbia Univ, Dept Biochem & Mol Biophys, Howard Hughes Med Inst, New York, NY 10032 USA; Univ Texas, MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA	Columbia University; Howard Hughes Medical Institute; University of Texas System; UTMD Anderson Cancer Center	Jessell, TM (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, Howard Hughes Med Inst, 630 W 168th St, New York, NY 10032 USA.			Kania, Artur/0000-0002-5209-2520				Araujo M, 1998, DEVELOPMENT, V125, P4195; Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; BEDDINGTON RSP, 1989, DEVELOPMENT, V105, P733; Caton A, 2000, DEVELOPMENT, V127, P1751; Chen H, 1998, NAT GENET, V19, P51, DOI 10.1038/ng0598-51; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; Crossley PH, 1996, CELL, V84, P127, DOI 10.1016/S0092-8674(00)80999-X; Dou CL, 1997, NEURON, V18, P539, DOI 10.1016/S0896-6273(00)80296-2; Ebens A, 1996, NEURON, V17, P1157, DOI 10.1016/S0896-6273(00)80247-0; Ensini M, 1998, DEVELOPMENT, V125, P969; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Feng GP, 2000, NEURON, V25, P295, DOI 10.1016/S0896-6273(00)80895-8; FERGUSON BA, 1983, J NEUROSCI, V3, P1760; FernandezTeran M, 1997, DEV BIOL, V189, P246, DOI 10.1006/dbio.1997.8680; HAMBURGER V, 1977, NEUROSCI RES PROG B, V15, P1; Hobert O, 2000, TRENDS GENET, V16, P75, DOI 10.1016/S0168-9525(99)01883-1; LANDMESSER L, 1978, J PHYSIOL-LONDON, V284, P391, DOI 10.1113/jphysiol.1978.sp012546; LANDMESSER L, 1994, PROG BRAIN RES, V103, P67; Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; MORTENSEN RM, 1992, MOL CELL BIOL, V12, P2391, DOI 10.1128/MCB.12.5.2391; Nohno T, 1997, BIOCHEM BIOPH RES CO, V238, P506, DOI 10.1006/bbrc.1997.7320; Ohuchi H, 1997, DEVELOPMENT, V124, P2235; PARR BA, 1995, NATURE, V374, P350, DOI 10.1038/374350a0; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; Pierani A, 1999, CELL, V97, P903, DOI 10.1016/S0092-8674(00)80802-8; RIDDLE RD, 1995, CELL, V83, P631, DOI 10.1016/0092-8674(95)90103-5; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Sharma K, 1998, CELL, V95, P817, DOI 10.1016/S0092-8674(00)81704-3; Shawlot W, 1999, DEVELOPMENT, V126, P4925; SHAWLOT W, 1995, NATURE, V374, P425, DOI 10.1038/374425a0; Sockanathan S, 1998, CELL, V94, P503, DOI 10.1016/S0092-8674(00)81591-3; STEPHENS TD, 1993, PROG CLIN BIOL RES, V383, P317; SUMMERBELL D, 1981, J EMBRYOL EXP MORPH, V61, P233; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Thor S, 1999, NATURE, V397, P76, DOI 10.1038/16275; Thor S, 1997, NEURON, V18, P397, DOI 10.1016/S0896-6273(00)81241-6; TOSNEY KW, 1985, DEV BIOL, V109, P193, DOI 10.1016/0012-1606(85)90360-4; TOSNEY KW, 1985, J NEUROSCI, V5, P2345; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; VarelaEchavarria A, 1997, NEURON, V18, P193, DOI 10.1016/S0896-6273(00)80261-5; VOGEL A, 1995, NATURE, V378, P716, DOI 10.1038/378716a0; Wang HU, 1997, NEURON, V18, P383, DOI 10.1016/S0896-6273(00)81240-4; WHITELAW V, 1983, J NEUROSCI, V3, P1226; Wilkinson DG, 2000, INT REV CYTOL, V196, P177; Zhao D, 1996, EUR J BIOCHEM, V240, P15, DOI 10.1111/j.1432-1033.1996.0015h.x	46	232	233	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 21	2000	102	2					161	173		10.1016/S0092-8674(00)00022-2	http://dx.doi.org/10.1016/S0092-8674(00)00022-2			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	337NA	10943837	Bronze			2022-12-28	WOS:000088366800007
J	Kivelson, MG; Khurana, KK; Russell, CT; Volwerk, M; Walker, RJ; Zimmer, C				Kivelson, MG; Khurana, KK; Russell, CT; Volwerk, M; Walker, RJ; Zimmer, C			Galileo magnetometer measurements: A stronger case for a subsurface ocean at Europa	SCIENCE			English	Article							JOVIAN MAGNETOSPHERE; PLASMA ENVIRONMENT; CALLISTO; FIELDS; IO	On 3 January 2000, the Galileo spacecraft passed close to Europa when it was located far south of Jupiter's magnetic equator in a region where the radial component of the magnetospheric magnetic field points inward toward Jupiter, This pass with a previously unexamined orientation of the external forcing field distinguished between an induced and a permanent magnetic dipole moment model of Europa's internal field. The Galileo magnetometer measured changes in the magnetic field predicted if a current-carrying outer shell, such as a planet-scale liquid ocean, is present beneath the icy surface. The evidence that Europa's field varies temporally strengthens the argument that a liquid ocean exists beneath the present-day surface.	Univ Calif Los Angeles, Inst Geophys & Planetary Phys, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Kivelson, MG (corresponding author), Univ Calif Los Angeles, Inst Geophys & Planetary Phys, Los Angeles, CA 90095 USA.		Kivelson, Margaret G/I-9019-2012; Russell, Christopher T/E-7745-2012	Kivelson, Margaret G/0000-0003-3859-8581; Russell, Christopher T/0000-0003-1639-8298; Khurana, Krishan/0000-0002-2856-1171				COLBURN DS, 1985, ICARUS, V63, P39, DOI 10.1016/0019-1035(85)90019-3; Greeley R, 1998, ICARUS, V135, P25, DOI 10.1006/icar.1998.5977; Greenberg R, 1999, ICARUS, V141, P263, DOI 10.1006/icar.1999.6187; Hall DT, 1998, ASTROPHYS J, V499, P475, DOI 10.1086/305604; Hoppa GV, 1999, SCIENCE, V285, P1899, DOI 10.1126/science.285.5435.1899; Khurana KK, 1998, NATURE, V395, P777, DOI 10.1038/27394; Kivelson MG, 1997, SCIENCE, V276, P1239, DOI 10.1126/science.276.5316.1239; Kivelson MG, 1999, J GEOPHYS RES-SPACE, V104, P4609, DOI 10.1029/1998JA900095; Kliore AJ, 1997, SCIENCE, V277, P355, DOI 10.1126/science.277.5324.355; MONTGOMERY RB, 1963, AM I PHYSICS HDB, P125; NEUBAUER FM, 1980, J GEOPHYS RES-SPACE, V85, P1171, DOI 10.1029/JA085iA03p01171; Neubauer FM, 1999, J GEOPHYS RES-SPACE, V104, P28671, DOI 10.1029/1999JA900217; Neubauer FM, 1998, J GEOPHYS RES-PLANET, V103, P19843, DOI 10.1029/97JE03370; Pappalardo RT, 1999, SCI AM, V281, P54, DOI 10.1038/scientificamerican1099-54; PARKINSON WD, 1983, INTRO GEOMAGNETISM, P313; Saur J, 1998, J GEOPHYS RES-PLANET, V103, P19947, DOI 10.1029/97JE03556; SOUTHWOOD DJ, 1980, J GEOPHYS RES-SPACE, V85, P5959, DOI 10.1029/JA085iA11p05959; ZIMMER C, IN PRESS ICARUS	18	389	403	4	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 25	2000	289	5483					1340	1343		10.1126/science.289.5483.1340	http://dx.doi.org/10.1126/science.289.5483.1340			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347RF	10958778				2022-12-28	WOS:000088942400035
J	Yusuf, HR; Daniels, D; Smith, P; Coronado, V; Rodewald, L				Yusuf, HR; Daniels, D; Smith, P; Coronado, V; Rodewald, L			Association between administration of hepatitis B vaccine at birth and completion of the hepatitis B and 4 : 3 : 1 : 3 vaccine series	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RISK-FACTORS; DELAYED IMMUNIZATION; VIRUS-INFECTION; CHILDREN; COVERAGE; INFANTS	Context The association between infant age at initiation of hepatitis B vaccination and completion of the 3-dose hepatitis B vaccination series is unclear. Objective To assess the association between administration of the first dose of hepatitis B vaccine within 7 days of birth and completion of the hepatitis B vaccine series and the 4:3:1:3 vaccine series (4 doses of diphtheria-tetanus-pertussis vaccine, 3 doses of polio vaccine, 1 dose of measles-containing vaccine, and 3 doses of Haemophilus influenzae type b vaccine). Design, Setting, and Participants Analysis of data from the 1998 National Immunization Survey, a random-digit-dialing telephone survey (n=34480 completed interviews) of parents of children aged 19 to 35 months from 50 states and 28 selected urban areas in the United States that included a provider record check mail survey. Main Outcome Measures Percentage of infants who received at least 3 doses of hepatitis B vaccine and percentage who received the 4:3:1:3 vaccine series, by age at receipt of the first dose of hepatitis B vaccine. Results Overall, 86.9% of children 19 to 35 months of age in 1998 received 3 or more doses of hepatitis B vaccine, and 79.9% completed the 4:3:1:3 vaccine series. Multivariate analysis indicated that, compared with children who received the first hepatitis B vaccine dose within 7 days of birth, odds ratios (ORs) for not completing the 3-dose hepatitis B vaccine series among children who received the first dose at 8 to 41 days, 42 to 91 days, 92 to 182 days, 183 to 273 days, and 274 or more days of age were 2.4 (95% confidence interval [CI], 2.0-3.0), 7.8 (95% CI, 6.5-9.3), 9.6 (95% ci, 7.0-13.3), 18.3 (95% CI, 12.0-28.0), and 46.6 (95% CI, 33.7-64.5), respectively; ORs for not completing the 4:3:1:3 vaccine series among these same groups were 1.0 (95% CI, 0.8-1.1), 1.0 (95% CI, 0.8-1.1), 1.7 (95% CI, 1.3-2.3), 3.8 (95% CI, 2.6-5.6), and 4.0 (95% CI, 2.9-5.5), respectively. Conclusion Administration of the first dose of hepatitis 3 vaccine at birth is associated with increased likelihood of completion of the hepatitis 8 vaccination series.	Ctr Dis Control & Prevent, Immunizat Serv Div, Natl Immunizat Program, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Data Management Div, Natl Immunizat Program, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Yusuf, HR (corresponding author), Ctr Dis Control & Prevent, Immunizat Serv Div, Natl Immunizat Program, 1600 Clifton Rd,Mailstop E52, Atlanta, GA 30333 USA.			Rodewald, Lance/0000-0003-2593-542X				*AM AC FAM PHYS, 1993, REC HEP B PREEXP VAC; [Anonymous], 1994, MMWR Recomm Rep, V43, P1; BATES AS, 1994, JAMA-J AM MED ASSOC, V272, P1105, DOI 10.1001/jama.272.14.1105; BOBO JK, 1993, PEDIATRICS, V91, P308; Centers for Disease Control and Prevention, 1991, MMWR MORB MORTAL WKL, V40; Freed GL, 1996, J FAM PRACTICE, V42, P587; FREED GL, 1994, PEDIATRICS, V93, P747; GUYER B, 1994, PEDIATRICS, V94, P53; HALL CB, 1992, PEDIATRICS, V89, P795; HYAMS KC, 1995, CLIN INFECT DIS, V20, P992, DOI 10.1093/clinids/20.4.992; Lauderdale DS, 1999, JAMA-J AM MED ASSOC, V282, P1725, DOI 10.1001/jama.282.18.1725; Madlon-Kay D J, 1994, Arch Fam Med, V3, P610, DOI 10.1001/archfami.3.7.610; MAHONEY FJ, 1993, AM FAM PHYSICIAN, V47, P865; MAHONEY FJ, 1996, PRINCIPLES PRACTICE, P1194; MARGOLIS HS, 1991, SEMIN LIVER DIS, V11, P84, DOI 10.1055/s-2008-1040427; MILLER LA, 1994, PEDIATRICS, V94, P213; Ross A, 1998, PEDIATRICS, V101, P970, DOI 10.1542/peds.101.6.970; Shah BV, 1997, SUDAAN USERS MANUAL; SMITH PJ, IN PRESS VITAL HLTH, V2; USA National Vaccine Advisory Committee, 1999, JAMA, Journal of the American Medical Association, V282, P363, DOI 10.1001/jama.282.4.363; WOOD D, 1995, PEDIATRICS, V96, P295; Woodruff BA, 1996, PEDIATRICS, V97, P798; Zell ER, 2000, PUBLIC HEALTH REP, V115, P65, DOI 10.1093/phr/115.1.65	23	57	59	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 23	2000	284	8					978	983		10.1001/jama.284.8.978	http://dx.doi.org/10.1001/jama.284.8.978			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	344PX	10944643	Bronze			2022-12-28	WOS:000088769000024
J	Ralph, D; McNicholas, T				Ralph, D; McNicholas, T			UK management guidelines for erectile dysfunction	BRITISH MEDICAL JOURNAL			English	Article							TRANSURETHRAL ALPROSTADIL; ORAL SILDENAFIL; THERAPY; PROSTAGLANDIN-E1; SAFETY; MEN		Inst Urol, London W1P 7PN, England; Lister Hosp, Stevenage SG1 4AB, Herts, England	Lister Hospital	Ralph, D (corresponding author), Patten Commun, Surrey KT21 2BT, England.		McNicholas, Tom A/C-2268-2014	McNicholas, Tom A/0000-0001-9971-8765				Chew KK, 1997, INT J IMPOT RES, V9, P225, DOI 10.1038/sj.ijir.3900296; Eardley I, 1998, BRIT J UROL, V81, P122; *ER DYSF ALL, 1999, UK MAN GUID ER DYSF; Evans C, 1998, BRIT J UROL, V81, P591; Ghazi SA, 1998, INT J IMPOT RES S3, V10, P13; GODSCHALK MF, 1994, J UROLOGY, V151, P1530, DOI 10.1016/S0022-5347(17)35293-X; Goldstein I, 1998, NEW ENGL J MED, V338, P1397, DOI 10.1056/NEJM199805143382001; Govier FE, 1996, J UROLOGY, V156, P405, DOI 10.1016/S0022-5347(01)65861-0; GRAHAM P, 1998, INT J IMPOT RES S3, V10, pS6; Hartman U, 1998, INT J IMPOT RES S3, V10, pS23; HELLSTROM WJG, 1998, INT J IMPOT RES S3, V10, pS49; Lewis RW, 1997, WORLD J UROL, V15, P78, DOI 10.1007/BF01275162; Linet OI, 1996, NEW ENGL J MED, V334, P873, DOI 10.1056/NEJM199604043341401; Morales A, 1998, INT J IMPOT RES, V10, P69, DOI 10.1038/sj.ijir.3900354; PadmaNathan H, 1997, NEW ENGL J MED, V336, P1, DOI 10.1056/NEJM199701023360101; Porst H, 1997, INT J IMPOT RES, V9, P187, DOI 10.1038/sj.ijir.3900318; Soderdahl DW, 1997, BRIT J UROL, V79, P952, DOI 10.1046/j.1464-410X.1997.00147.x; *UK CENTR COUNC NU, 1992, SCOP PROF PRACT; United States Department of Health and Human Services Agency for Health Care Policy and Research, 1993, AHCPR PUBL, V1, P107	19	57	63	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	AUG 19	2000	321	7259					499	503		10.1136/bmj.321.7259.499	http://dx.doi.org/10.1136/bmj.321.7259.499			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	347MC	10948037	Green Published			2022-12-28	WOS:000088932800026
J	Burgmann, R; Schmidt, D; Nadeau, RM; d'Alessio, M; Fielding, E; Manaker, D; McEvilly, TV; Murray, MH				Burgmann, R; Schmidt, D; Nadeau, RM; d'Alessio, M; Fielding, E; Manaker, D; McEvilly, TV; Murray, MH			Earthquake potential along the northern Hayward fault, California	SCIENCE			English	Article							SAN-ANDREAS FAULT; SURFACE DEFORMATION; SLIP; DEPTH; CREEP; INTERFEROMETRY; PARKFIELD; SPACE; RATES	The Hayward fault slips in large earthquakes and by aseismic creep observed along its surface trace. Dislocation models of the surface deformation adjacent to the Hayward fault measured with the global positioning system and interferometric synthetic aperture radar favor creep at similar to 7 millimeters per year to the bottom of the seismogenic zone along a similar to 20-kilometer-long northern fault segment, Microearthquakes with the same waveform repeatedly occur at 4- to 10-kilometer depths and indicate deep creep at 5 to 7 millimeters per year. The difference between current creep rates and the long-term slip rate of similar to 10 millimeters per year can be reconciled in a mechanical model of a freely slipping northern Hayward fault adjacent to the locked 1868 earthquake rupture, which brake the southern 40 to 50 kilometers of the fault. The potential for a major independent earthquake of the northern Hayward fault might be Less than previously thought.	Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; Univ Calif Berkeley, Berkeley Seismol Lab, Berkeley, CA 94720 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Univ Calif Davis, Dept Geol, Davis, CA 95616 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of California System; University of California Davis	Burgmann, R (corresponding author), Univ Calif Berkeley, Dept Earth & Planetary Sci, 307 McCone Hall, Berkeley, CA 94720 USA.		Fielding, Eric Jameson/A-1288-2007; Burgmann, Roland/AAE-5138-2022; Fielding, Eric/L-8187-2019; Nadeau, Robert/G-1884-2017	Fielding, Eric Jameson/0000-0002-6648-8067; Fielding, Eric/0000-0002-6648-8067; Nadeau, Robert/0000-0003-1255-0643; Burgmann, Roland/0000-0002-3560-044X				ARGUS DF, 1991, GEOLOGY, V19, P1085, DOI 10.1130/0091-7613(1991)019<1085:CSNNAM>2.3.CO;2; Burgmann R, 2000, ANNU REV EARTH PL SC, V28, P169, DOI 10.1146/annurev.earth.28.1.169; Burgmann R, 1998, GEOLOGY, V26, P559, DOI 10.1130/0091-7613(1998)026<0559:SATHFC>2.3.CO;2; HARRIS RA, 1987, J GEOPHYS RES-SOLID, V92, P7945, DOI 10.1029/JB092iB08p07945; Lienkaemper JJ, 1997, SCIENCE, V276, P2014, DOI 10.1126/science.276.5321.2014; LIENKAEMPER JJ, 1991, J GEOPHYS RES-SOL EA, V96, P18261, DOI 10.1029/91JB01589; LIENKAEMPER JJ, 1999, 99318 US GEOL SURV, P1; MATTHEWS MV, 1993, J GEOPHYS RES-SOL EA, V98, P12153, DOI 10.1029/93JB00440; Nadeau RM, 1999, SCIENCE, V285, P718, DOI 10.1126/science.285.5428.718; Nadeau RM, 1998, B SEISMOL SOC AM, V88, P790; OKADA Y, 1985, B SEISMOL SOC AM, V75, P1135; PRESCOTT WH, 1983, TECTONOPHYSICS, V97, P41, DOI 10.1016/0040-1951(83)90124-5; SAVAGE JC, 1993, J GEOPHYS RES-SOL EA, V98, P787, DOI 10.1029/92JB01871; Simpson RV, UNPUB; Thomas A. L., 1993, THESIS STANFORD U ST; Toppozada TR, 1998, B SEISMOL SOC AM, V88, P140; Waldhauser F, 1999, GEOPHYS RES LETT, V26, P3525, DOI 10.1029/1999GL010462; *WORK GROUP CA EAR, 1999, 99517 US GEOL SURV W; Yu E, 1996, J GEOPHYS RES-SOL EA, V101, P16101, DOI 10.1029/96JB00806	19	158	163	2	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 18	2000	289	5482					1178	1182		10.1126/science.289.5482.1178	http://dx.doi.org/10.1126/science.289.5482.1178			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	346JE	10947982				2022-12-28	WOS:000088866600038
J	Onishi, A; Iwamoto, M; Akita, T; Mikawa, S; Takeda, K; Awata, T; Hanada, H; Perry, ACF				Onishi, A; Iwamoto, M; Akita, T; Mikawa, S; Takeda, K; Awata, T; Hanada, H; Perry, ACF			Pig cloning by microinjection of fetal fibroblast nuclei	SCIENCE			English	Article							CLONED TRANSGENIC CALVES; SEX IDENTIFICATION; PORCINE EMBRYOS; SHEEP; CELLS; ADULT; TRANSPLANTATION; GOATS; MICE	Pig cloning will have a marked impact on the optimization of meat production and xenotransplantation. To clone pigs from differentiated cells, we microinjected the nuclei of porcine (Sus scrofa) fetal fibroblasts into enucleated oocytes, and development was induced by electroactivation. The transfer of 110 cloned embryos to four surrogate mothers produced an apparently normal female piglet. The clonal provenance of the piglet was indicated by her coat color and confirmed by DNA microsatellite analysis.	Natl Inst Anim Ind, Dept Anim Breeding & Genet, Tsukuba Norin Danchi, Ibaraki 3050901, Japan; Prima Meatpackers, Basic Res Div, Tsuchiura, Ibaraki 3000841, Japan; Rockefeller Univ, Dev Biol Lab, New York, NY 10021 USA	National Agriculture & Food Research Organization - Japan; Rockefeller University	Onishi, A (corresponding author), Natl Inst Anim Ind, Dept Anim Breeding & Genet, Tsukuba Norin Danchi, Ibaraki 3050901, Japan.	onishi@niai.affrc.go.jp		Perry, Tony/0000-0003-3136-5355				AASEN E, 1990, BIO-TECHNOL, V8, P1279, DOI 10.1038/nbt1290-1279; Baguisi A, 1999, NAT BIOTECHNOL, V17, P456, DOI 10.1038/8632; Campbell K H, 1996, Rev Reprod, V1, P40, DOI 10.1530/ror.0.0010040; Campbell KHS, 1996, NATURE, V380, P64, DOI 10.1038/380064a0; Cibelli JB, 1998, SCIENCE, V280, P1256, DOI 10.1126/science.280.5367.1256; Dobrinsky JR, 1996, BIOL REPROD, V55, P1069, DOI 10.1095/biolreprod55.5.1069; Funahashi H, 1997, THERIOGENOLOGY, V47, P679, DOI 10.1016/S0093-691X(97)00026-5; Hill JR, 1999, THERIOGENOLOGY, V51, P1451, DOI 10.1016/S0093-691X(99)00089-8; Kato Y, 1998, SCIENCE, V282, P2095, DOI 10.1126/science.282.5396.2095; Machaty Z, 1998, BIOL REPROD, V59, P451, DOI 10.1095/biolreprod59.2.451; Martin MJ, 2000, BIOL REPROD, V63, P109, DOI 10.1095/biolreprod63.1.109; McCreath KJ, 2000, NATURE, V405, P1066, DOI 10.1038/35016604; ONISHI A, UNPUB; PETTERS RM, 1993, J REPROD FERTIL, P61; Platt JL, 1998, NATURE, V392, P11; POMP D, 1995, J ANIM SCI, V73, P1408; PRATHER RS, 1989, BIOL REPROD, V41, P123, DOI 10.1095/biolreprod41.1.123; Rohrer GA, 1996, GENOME RES, V6, P371, DOI 10.1101/gr.6.5.371; Schnieke AE, 1997, SCIENCE, V278, P2130, DOI 10.1126/science.278.5346.2130; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wakayama T, 1999, NAT GENET, V22, P127, DOI 10.1038/9632; WAKAYAMA T, COMMUNICATION; Wells DN, 1999, BIOL REPROD, V60, P996, DOI 10.1095/biolreprod60.4.996; WILLADSEN SM, 1986, NATURE, V320, P63, DOI 10.1038/320063a0; YOUNGS CR, 1993, J ANIM SCI, V71, P1561, DOI 10.2527/1993.7161561x	25	650	787	1	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 18	2000	289	5482					1188	1190		10.1126/science.289.5482.1188	http://dx.doi.org/10.1126/science.289.5482.1188			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	346JE	10947985				2022-12-28	WOS:000088866600041
J	Yoo, YK; Duewer, F; Yang, HT; Yi, D; Li, JW; Xiang, XD				Yoo, YK; Duewer, F; Yang, HT; Yi, D; Li, JW; Xiang, XD			Room-temperature electronic phase transitions in the continuous phase diagrams of perovskite manganites	NATURE			English	Article							CHARGE-ORDERED STRIPES; MANGANESE OXIDES; SPIN FLUCTUATIONS; SUPERCONDUCTORS; MAGNETORESISTANCE; INSULATOR; LA1-XCAXMNO3; SEPARATION; STATE	Highly correlated electronic systems-such as transition-metal oxides that are doped Mott insulators-are complex systems which exhibit puzzling phenomena, including high-temperature superconductivity and colossal magnetoresistivity. Recent studies(1-3) suggest that in such systems collective electronic phenomena are important, arising from long-range Coulomb interactions and magnetic effects. The qualitative behaviour of these systems is strongly dependent on charge filling (the level of doping) and the lattice constant. Here we report a time-efficient and systematic experimental approach for studying the phase diagrams of condensed-matter systems. It involves the continuous mapping of the physical properties of epitaxial thin films of perovskite manganites (a class of doped Mott insulator) as their composition is varied. We discover evidence that suggests the presence of phase boundaries of electronic origin at room temperature.	Univ Calif Berkeley, Lawrence Berkeley Lab, Environm Energy Technol Div, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Xiang, XD (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Environm Energy Technol Div, Berkeley, CA 94720 USA.		Xiang, Xiaodong/A-9445-2012; Xiang, Xiaodong/Q-7727-2018; Xiang, Xiaodong/A-5936-2017	Xiang, X.-D./0000-0002-6155-7713				Aeppli G, 1997, SCIENCE, V278, P1432, DOI 10.1126/science.278.5342.1432; BIRGENEAU RJ, 1989, PHYSICAL PROPERTIES, V1, P152; Chen CH, 1997, J APPL PHYS, V81, P4326, DOI 10.1063/1.364758; Chen CH, 1996, PHYS REV LETT, V76, P4042, DOI 10.1103/PhysRevLett.76.4042; Emery VJ, 1996, PHYSICA C, V263, P44, DOI 10.1016/0921-4534(96)00071-8; EMERY VJ, 1994, PHYSICA C, V235, P189, DOI 10.1016/0921-4534(94)91345-5; Gao C, 1998, REV SCI INSTRUM, V69, P3846, DOI 10.1063/1.1149189; HANAK JJ, 1970, J MATER SCI, V5, P964, DOI 10.1007/BF00558177; Kivelson SA, 1998, NATURE, V393, P550, DOI 10.1038/31177; Kuwahara H, 1996, SCIENCE, V272, P80, DOI 10.1126/science.272.5258.80; LIDE DR, 1997, CRC HDB CHEM PHYSICS, pCH12; Lu YL, 1997, SCIENCE, V276, P2004, DOI 10.1126/science.276.5321.2004; Maezono R, 1998, PHYS REV B, V58, P11583, DOI 10.1103/PhysRevB.58.11583; Mook HA, 1998, NATURE, V395, P580, DOI 10.1038/26931; Moreo A, 1999, SCIENCE, V283, P2034, DOI 10.1126/science.283.5410.2034; Mori S, 1998, NATURE, V392, P473, DOI 10.1038/33105; Sachdev S, 2000, SCIENCE, V288, P475, DOI 10.1126/science.288.5465.475; Salkola MI, 1996, PHYS REV LETT, V77, P155, DOI 10.1103/PhysRevLett.77.155; SAWATZKY E, 1969, IBM J RES DEV, V13, P696, DOI 10.1147/rd.136.0696; SCHIFFER P, 1995, PHYS REV LETT, V75, P3336, DOI 10.1103/PhysRevLett.75.3336; Tokura Y, 2000, SCIENCE, V288, P462, DOI 10.1126/science.288.5465.462; Tomioka Y, 1996, PHYS REV B, V53, pR1689, DOI 10.1103/PhysRevB.53.R1689; Tranquada JM, 1997, PHYS REV LETT, V78, P338, DOI 10.1103/PhysRevLett.78.338; TRANQUADA JM, 1995, NATURE, V375, P561, DOI 10.1038/375561a0; URUSHIBARA A, 1995, PHYS REV B, V51, P14103, DOI 10.1103/PhysRevB.51.14103; van Dover RB, 1998, NATURE, V392, P162, DOI 10.1038/32381; Wells BO, 1997, SCIENCE, V277, P1067, DOI 10.1126/science.277.5329.1067; YOO YK, UNPUB APPL PHYS LETT; Zhang SC, 1997, SCIENCE, V275, P1089, DOI 10.1126/science.275.5303.1089	30	66	70	2	63	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 17	2000	406	6797					704	708		10.1038/35021018	http://dx.doi.org/10.1038/35021018			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	344PH	10963590				2022-12-28	WOS:000088767700037
J	[Anonymous]				[Anonymous]			Emerging fields of basic chemistry in Europe	NATURE			English	Article																			0	1	1	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 17	2000	406	6797					811	812		10.1038/35021191	http://dx.doi.org/10.1038/35021191			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	344PH	10963614				2022-12-28	WOS:000088767700062
J	Sen, K; Bonita, R				Sen, K; Bonita, R			Global health status: two steps forward, one step back	LANCET			English	Article							LIFE EXPECTANCY; UNITED-STATES; MORTALITY; DISEASE; BURDEN; IMPACT; DALYS; MEN	Impressive improvements have occurred in global health status in the past century. Unfortunately, these improvements have not been shared equally and health in equalities within and among countries are entrenched. The fragility of health gains has been seen in response to economic, political, and social changes changes, and civil disruption. The limitations of health-status measure hinder our ability to map health trends except in the simplest way. There is an urgent need for better regional and national health surveillance systems to underpin efforts to address the complex mixture of old and new health concerns.	Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge CB2 SR, England; WHO, Noncommunicable Dis & Mental Hlth Cluster, CH-1211 Geneva 27, Switzerland	University of Cambridge; World Health Organization	Sen, K (corresponding author), Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge CB2 SR, England.	ks231@medschl.cam.ac.uk						[Anonymous], 1993, Lancet, V342, P63; [Anonymous], 1999, 10 90 REP HLTH RES 1; [Anonymous], 1999, WORLD HLTH REPORT 19; [Anonymous], BURDEN DIS GLOBAL PO; Barendregt JJ, 1996, B WORLD HEALTH ORGAN, V74, P439; Barker C, 1996, HEALTH POLICY PLANN, V11, P179, DOI 10.1093/heapol/11.2.179; BOWLING A, 1996, EPIDEMOLOGY OLD AGE; BRUNDTLAND GH, 2000, 53 WORLD HLTH ASS MA; CHAKRAVORTY L, 2000, IN PRESS PUBLIC HLTH; CHANDRAMOHAN D, 1994, INT J EPIDEMIOL, V8, P314; Cooper RS, 1998, LANCET, V351, P208, DOI 10.1016/S0140-6736(97)06512-4; CRIMMINS EM, 1989, POPUL DEV REV, V15, P235, DOI 10.2307/1973704; Drever F., 1997, HLTH INEQUALITIES DE; Font F, 2000, INT J EPIDEMIOL, V29, P107, DOI 10.1093/ije/29.1.107; Gwatkin DR, 1999, LANCET, V354, P586, DOI 10.1016/S0140-6736(99)02108-X; Hoj L, 1999, INT J EPIDEMIOL, V28, P70, DOI 10.1093/ije/28.1.70; Kuulasmaa K, 2000, LANCET, V355, P675, DOI 10.1016/S0140-6736(99)11180-2; Lai DJ, 1999, INT J EPIDEMIOL, V28, P894, DOI 10.1093/ije/28.5.894; Leon DA, 1997, LANCET, V350, P383, DOI 10.1016/S0140-6736(97)03360-6; Lopez AD, 1998, BRIT MED J, V317, P1399, DOI 10.1136/bmj.317.7170.1399; MANTON K, 1998, CHRONIC DIS MODELING; Manton KG, 1997, P NATL ACAD SCI USA, V94, P2593, DOI 10.1073/pnas.94.6.2593; MORRIS L, 1996, DEMOGRAPHIC EVALUATI, P75; Murray C. J. L., 1996, GLOBAL BURDEN DIS; MURRAY CJL, 1994, US PATTERNS MORTALIT; MURRAY CJL, 1994, GLOBAL COMP ASSESSME, P3; Qadeer I, 1998, J PUBLIC HEALTH MED, V20, P93, DOI 10.1093/oxfordjournals.pubmed.a024726; *REVES, 1998, 318 REVES INSERM; Rodgers A, 1998, LANCET, V352, P1801; Sen K, 1998, INT J HEALTH PLAN M, V13, P199; SHORT C, 2000, INT HERALD TRIB 0415; Stamler J, 1999, JAMA-J AM MED ASSOC, V282, P2012, DOI 10.1001/jama.282.21.2012; Tuchsen F, 1999, INT J EPIDEMIOL, V28, P640, DOI 10.1093/ije/28.4.640; Turshen M., 1999, PRIVATIZING HLTH SER; *UN, 1998, REV WORLD POP EST PR; *UN, 2000, OV HUM POV POV REP 2; *UN, 1998, WORLD POP PROSP 1998; UNDP, 1999, HUM DEV REP 1999; Vartiainen E, 2000, INT J EPIDEMIOL, V29, P49, DOI 10.1093/ije/29.1.49; WALLIS W, 2000, FINANCIAL TIMES 0425; WILLIAMS A, 1998, HEALTH ECON, V8, P1; WNUKLIPINSKI E, 1990, SOC SCI MED, V31, P879, DOI 10.1016/0277-9536(90)90024-M; World Health Organization, 2000, WORLD HLTH REP 2000; 2000, LANCET, V355, P1379; 2000, GUARDIAN        0409	45	64	65	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 12	2000	356	9229					577	582		10.1016/S0140-6736(00)02590-3	http://dx.doi.org/10.1016/S0140-6736(00)02590-3			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	345MY	10950247				2022-12-28	WOS:000088820800038
J	Artandi, SE; Chang, S; Lee, SL; Alson, S; Gottlieb, GJ; Chin, L; DePinho, RA				Artandi, SE; Chang, S; Lee, SL; Alson, S; Gottlieb, GJ; Chin, L; DePinho, RA			Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice	NATURE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; CARCINOMA IN-SITU; MOUSE TELOMERASE; V(D)J RECOMBINATION; P53-DEFICIENT MICE; HUMAN FIBROBLASTS; EXPRESSION; CELLS; BREAST; METASTASES	Aged humans sustain a high rate of epithelial cancers such as carcinomas of the breast and colon, whereas mice carrying common tumour suppressor gene mutations typically develop soft tissue sarcomas and lymphomas. Among the many factors that may contribute to this species variance are differences in telomere length and regulation. Telomeres comprise the nucleoprotein complexes that cap the ends of eukaryotic chromosomes and are maintained by the reverse transcriptase, telomerase(1). In human cells, insufficient levels of telomerase lead to telomere attrition with cell division in culture(2) and possibly with ageing and tumorigenesis in vivo(3-5). In contrast, critical reduction in telomere length is not observed in the mouse owing to promiscuous telomerase expression and long telomeres(6-10). Here we provide evidence that telomere attrition in ageing telomerase-deficient p53 mutant mice promotes the development of epithelial cancers by a process of fusion-bridge breakage that leads to the formation of complex non-reciprocal translocations-a classical cytogenetic feature of human carcinomas. Our data suggest a model in which telomere dysfunction brought about by continual epithelial renewal during life generates the massive ploidy changes associated with the development of epithelial cancers.	Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; CPI Ameripath Lab, Beachwood, OH 44122 USA; Ackerman Acad Dermatopathol, New York, NY 10016 USA; Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	DePinho, RA (corresponding author), Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA.			DePinho, Ronald/0000-0002-5625-577X	NIA NIH HHS [K08 AG001019] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [K08AG001019] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Al-Mulla F, 1999, GENE CHROMOSOME CANC, V24, P306, DOI 10.1002/(SICI)1098-2264(199904)24:4<306::AID-GCC3>3.0.CO;2-5; ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114; ATKIN NB, 1986, CANCER GENET CYTOGEN, V21, P275, DOI 10.1016/0165-4608(86)90009-9; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Broccoli D, 1996, MOL CELL BIOL, V16, P3765; Buerger H, 1999, J PATHOL, V187, P396, DOI 10.1002/(SICI)1096-9896(199903)187:4<396::AID-PATH286>3.0.CO;2-L; CHADENEAU C, 1995, CANCER RES, V55, P2533; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; Greenberg RA, 1998, ONCOGENE, V16, P1723, DOI 10.1038/sj.onc.1201933; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HARVEY M, 1993, NAT GENET, V5, P225, DOI 10.1038/ng1193-225; HASTIE ND, 1990, NATURE, V346, P866, DOI 10.1038/346866a0; HEIM S, 1995, CANC CYTOGENETICS, P369; Hilgenfeld E, 1999, CURR TOP MICROBIOL, V246, P169; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; KIPLING D, 1990, NATURE, V347, P400, DOI 10.1038/347400a0; Kirk KE, 1997, SCIENCE, V275, P1478, DOI 10.1126/science.275.5305.1478; Kolquist KA, 1998, NAT GENET, V19, P182, DOI 10.1038/554; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Liao MJ, 1998, MOL CELL BIOL, V18, P3495, DOI 10.1128/MCB.18.6.3495; Liyanage M, 1996, NAT GENET, V14, P312, DOI 10.1038/ng1196-312; Martin-Rivera L, 1998, P NATL ACAD SCI USA, V95, P10471, DOI 10.1073/pnas.95.18.10471; McClintock B, 1941, GENETICS, V26, P234; Nacht M, 1998, CELL GROWTH DIFFER, V9, P131; Nishizaki T, 1997, GENE CHROMOSOME CANC, V19, P267, DOI 10.1002/(SICI)1098-2264(199708)19:4<267::AID-GCC9>3.0.CO;2-V; PROWSE KR, 1995, P NATL ACAD SCI USA, V92, P4818, DOI 10.1073/pnas.92.11.4818; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Sedivy JM, 1998, P NATL ACAD SCI USA, V95, P9078, DOI 10.1073/pnas.95.16.9078; Shpitz B, 1999, BREAST CANCER RES TR, V58, P65, DOI 10.1023/A:1006394209922; TSUKAMOTO AS, 1988, CELL, V55, P619, DOI 10.1016/0092-8674(88)90220-6; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0	32	883	916	0	55	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 10	2000	406	6796					641	645		10.1038/35020592	http://dx.doi.org/10.1038/35020592			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	342PF	10949306				2022-12-28	WOS:000088653800051
J	Boltwood, CM; Spitze, T				Boltwood, CM; Spitze, T			A life-threatening coronary-artery stenosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Valley Heart Associates Med Grp, Modesto, CA 95350 USA; Sierra Internal Med, Sonora, CA 95370 USA		Boltwood, CM (corresponding author), Valley Heart Associates Med Grp, Modesto, CA 95350 USA.								0	0	0	1	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 10	2000	343	6					403	403		10.1056/NEJM200008103430605	http://dx.doi.org/10.1056/NEJM200008103430605			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	342DT	10939895				2022-12-28	WOS:000088630500005
J	Bromfield, EB; Vonsattel, JP; Gonzalez, RG; Cole, AJ; Hoch, DB				Bromfield, EB; Vonsattel, JP; Gonzalez, RG; Cole, AJ; Hoch, DB			A 23-year-old man with seizures and a lesion in the left temporal lobe - Neurocysticercosis, left temporal lobe end-stage with calcification. Epilepsy.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CEREBRAL CYSTICERCOSIS; CLASSIFICATION; CHILDREN		Brigham & Womens Hosp, Electroencephalog Lab, Boston, MA 02115 USA; Brigham & Womens Hosp, Epilepsy Program, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Bromfield, EB (corresponding author), Brigham & Womens Hosp, Electroencephalog Lab, 75 Francis St, Boston, MA 02115 USA.			Hoch, Daniel/0000-0002-4294-024X				ABAYOMI O, 1990, J NATL MED ASSOC, V82, P833; ADAMOLEKUM B, 1994, EPILEPSIA, V35, P89; BROMFIELD EB, 1991, SEMIN NEUROL, V11, P91, DOI 10.1055/s-2008-1041210; CARPIO A, 1994, CAN J NEUROL SCI, V21, P43, DOI 10.1017/S0317167100048757; Carpio A, 1998, EPILEPSIA, V39, P1025, DOI 10.1111/j.1528-1157.1998.tb01287.x; *CAS REC MASS GEN, 1997, NEW ENGL J MED, V336, P1373; Chung C K, 1998, J Korean Med Sci, V13, P445; DAVIS LE, 1991, EUR NEUROL, V31, P229, DOI 10.1159/000116683; deBittencourt PRM, 1996, EPILEPSIA, V37, P1128; Dumas JL, 1997, NEURORADIOLOGY, V39, P12, DOI 10.1007/s002340050358; Engel J, 1996, NEW ENGL J MED, V334, P647, DOI 10.1056/NEJM199603073341008; FANDINO J, 1989, REV NEUROL-FRANCE, V145, P389; FISCHER W, 1955, ERKRANKUNGEN ZENSTRA, V3, P387; FRAZER CK, 1995, CLIN RADIOL, V50, P802, DOI 10.1016/S0009-9260(05)83226-X; FRIED I, 1994, NEUROSURGERY, V34, P815, DOI 10.1227/00006123-199405000-00005; Fried Itzhak, 1993, P501; FRIEDLAND RJ, 1996, NEUROIMAGING EPILEPS, P29; HAUSER WA, 1998, EPILEPSY COMPREHENSI, P47; JACKSON JH, 1958, SELECTED WRITINGS JH, V1, P276; KERNAN JC, 1993, NEUROLOGY, V43, P1308, DOI 10.1212/WNL.43.7.1308; MCCORMICK GF, 1982, ARCH NEUROL-CHICAGO, V39, P534, DOI 10.1001/archneur.1982.00510210004002; Mitchell WG, 1997, EUR NEUROL, V37, P126; OBRIEN TJ, 1998, EPILEPSY COMPREHENSI, V3, P2433; Penfield W, 1954, EPILEPSY FUNCTIONAL; Pittella JEH, 1997, BRAIN PATHOL, V7, P681, DOI 10.1111/j.1750-3639.1997.tb01083.x; Quesney L. Felipe, 1993, P173; RAJSHEKHAR V, 1993, J NEUROSURG, V78, P402, DOI 10.3171/jns.1993.78.3.0402; Raymond AA, 1996, LUPUS, V5, P123, DOI 10.1177/096120339600500207; ROBINSON JR, 1991, J NEUROSURG, V75, P709, DOI 10.3171/jns.1991.75.5.0709; SHADY JA, 1994, PEDIATR NEUROSURG, V21, P23, DOI 10.1159/000120810; SOTELO J, 1985, ARCH INTERN MED, V145, P442, DOI 10.1001/archinte.145.3.442; TAMURA M, 1995, CHILD NERV SYST, V11, P141, DOI 10.1007/BF00570254; TEITELBAUM GP, 1989, AM J ROENTGENOL, V153, P857, DOI 10.2214/ajr.153.4.857; THEODORE WH, 1996, NEUROIMAGING EPILEPS, P165; VAZQUEZ V, 1992, NEW ENGL J MED, V327, P696, DOI 10.1056/NEJM199209033271005; WHELAN MA, 1981, RADIOLOGY, V138, P75, DOI 10.1148/radiology.138.1.7455100; WHITE JC, 1957, NEW ENGL J MED, V256, P479, DOI 10.1056/NEJM195703142561101; Wieser Heinz-Gregor, 1993, P161; Wieser Heinz-Gregor, 1993, P49	39	11	11	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 10	2000	343	6					420	427		10.1056/NEJM200008103430608	http://dx.doi.org/10.1056/NEJM200008103430608			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	342DT	10933742				2022-12-28	WOS:000088630500008
J	Cumings, J; Collins, PG; Zettl, A				Cumings, J; Collins, PG; Zettl, A			Materials - Peeling and sharpening multiwall nanotubes	NATURE			English	Article							WALLED CARBON NANOTUBES		Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Cumings, J (corresponding author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.	azettl@physics.berkeley.edu	Cumings, John/A-3595-2012; Zettl, Alex K/O-4925-2016	Zettl, Alex K/0000-0001-6330-136X				Bachtold A, 1999, NATURE, V397, P673, DOI 10.1038/17755; Britto PJ, 1996, BIOELECTROCH BIOENER, V41, P121, DOI 10.1016/0302-4598(96)05078-7; Collins PG, 1997, SCIENCE, V278, P100, DOI 10.1126/science.278.5335.100; Dai HJ, 1996, NATURE, V384, P147, DOI 10.1038/384147a0; Dillon AC, 1997, NATURE, V386, P377, DOI 10.1038/386377a0; Frank S, 1998, SCIENCE, V280, P1744, DOI 10.1126/science.280.5370.1744; Iijima S, 1998, MICRO ELECTRO MECHANICAL SYSTEMS - IEEE ELEVENTH ANNUAL INTERNATIONAL WORKSHOP PROCEEDINGS, P520, DOI 10.1109/MEMSYS.1998.659812; Kong J, 1998, NATURE, V395, P878, DOI 10.1038/27632; RINZLER AG, 1995, SCIENCE, V269, P1550, DOI 10.1126/science.269.5230.1550; TSANG SC, 1994, NATURE, V372, P159, DOI 10.1038/372159a0	10	138	145	3	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 10	2000	406	6796					586	586		10.1038/35020698	http://dx.doi.org/10.1038/35020698			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	342PF	10949291				2022-12-28	WOS:000088653800036
J	Gravenor, MB; Cox, DR; Hoinville, LJ; Hoek, A; McLean, AR				Gravenor, MB; Cox, DR; Hoinville, LJ; Hoek, A; McLean, AR			Encephalopathies - Scrapie in Britain during the BSE years	NATURE			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; VARIANT CJD; SHEEP; AGENT		Inst Anim Hlth, Compton RG20 7NN, Berks, England; Univ Oxford, Dept Stat, Oxford OX1 3TG, England; Vet Labs Agcy, Dept Epidemiol, Addelestone KT15 3NB, Surrey, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; University of Oxford	Gravenor, MB (corresponding author), Inst Anim Hlth, Compton RG20 7NN, Berks, England.							Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; Butler D, 1998, NATURE, V395, P6, DOI 10.1038/25573; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; FOSTER JD, 1993, VET REC, V133, P339, DOI 10.1136/vr.133.14.339; GOLDMANN W, 1994, J GEN VIROL, V75, P989, DOI 10.1099/0022-1317-75-5-989; GRAVENOR MB, UNPUB P R SOC LOND B; Hill AF, 1998, NEUROSCI LETT, V255, P159, DOI 10.1016/S0304-3940(98)00736-8; Hoinville L, 1999, VET REC, V145, P405, DOI 10.1136/vr.145.14.405; KIRKWOOD JK, 1994, VET REC, V135, P296, DOI 10.1136/vr.135.13.296; McLean AR, 1999, P ROY SOC B-BIOL SCI, V266, P2531, DOI 10.1098/rspb.1999.0956	10	20	22	0	2	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 10	2000	406	6796					584	585		10.1038/35020692	http://dx.doi.org/10.1038/35020692			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	342PF	10949289				2022-12-28	WOS:000088653800034
J	Swaddle, JP; Biewener, AA				Swaddle, JP; Biewener, AA			Physiology - Exercise and reduced muscle mass in starlings	NATURE			English	Article							BODY-MASS; PECTORALIS-MUSCLE; FLIGHT-MUSCLE; ADAPTATIONS; HYPERTROPHY		Univ Bristol, Sch Biol Sci, Ctr Behav Biol, Bristol BS8 1UG, Avon, England; Harvard Univ, MCZ, Concord Field Stn, Bedford, MA 01730 USA	University of Bristol; Harvard University	Swaddle, JP (corresponding author), Univ Bristol, Sch Biol Sci, Ctr Behav Biol, Bristol BS8 1UG, Avon, England.		Biewener, Andrew/O-2989-2016	Biewener, Andrew/0000-0003-3303-8737				AUSTIN JE, 1987, AUK, V104, P694, DOI 10.1093/auk/104.4.694; BIEWENER AA, 1992, J EXP BIOL, V164, P1; Brown RE, 1998, CAN J ZOOL, V76, P26, DOI 10.1139/cjz-76-1-26; DRIEDZIC WR, 1993, CAN J ZOOL, V71, P1602, DOI 10.1139/z93-226; GAUNT AS, 1990, AUK, V107, P649, DOI 10.2307/4087994; Helms C. W., 1960, BIRDBANDING, V31, P1, DOI [DOI 10.2307/4510793, 10.2307/4510793]; HOLLOSZY JO, 1984, J APPL PHYSIOL, V56, P831, DOI 10.1152/jappl.1984.56.4.831; MARSH RL, 1984, PHYSIOL ZOOL, V57, P105, DOI 10.1086/physzool.57.1.30155973; OCONNOR TP, 1995, J COMP PHYSIOL B, V165, P298, DOI 10.1007/BF00367313; ROSSER BWC, 1986, CAN J ZOOL, V64, P1174, DOI 10.1139/z86-176; Swaddle JP, 1997, CAN J ZOOL, V75, P1135, DOI 10.1139/z97-136; WITTER MS, 1993, PHILOS T R SOC B, V340, P73, DOI 10.1098/rstb.1993.0050	12	29	31	0	11	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 10	2000	406	6796					585	586		10.1038/35020695	http://dx.doi.org/10.1038/35020695			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	342PF	10949290				2022-12-28	WOS:000088653800035
J	Wood, NS; Marlow, N; Costeloe, K; Gibson, AT; Wilkinson, AR				Wood, NS; Marlow, N; Costeloe, K; Gibson, AT; Wilkinson, AR		EPICure Study Grp	Neurologic and developmental disability after extremely preterm birth	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GESTATIONAL-AGE INFANT; WEIGHT CHILDREN; OUTCOMES; NETHERLANDS; DISORDERS; PREMATURE; DEFICIT; LIFE; BORN	Background Small studies show that many children born as extremely preterm infants have logic and developmental disabilities. We evaluated all children who were born at 25 or fewer completed weeks of gestation in the United Kingdom and Ireland from March through December 1995 at the time when they reached a median age of 30 months. Methods Each child underwent a formal ment by an independent examiner. Development was evaluated with use of the Bayley Scales of Infant Development, and neurologic function was assessed by a standardized examination. Disability and severe were defined by predetermined criteria. Results At a median age of 30 months, corrected for gestational age, 283 (92 percent) of the 308 surviving children were formally assessed. The mean (+/- SD) scores on the Bayley Mental and Psychomotor Developmental Indexes, referenced to a population mean of 100, were 84 +/- 12 and 87 +/- 13, respectively. Fifty-three children (19 percent) had severely delayed development (with scores more than 3 SD below the mean), and a further 32 children (11 percent) had scores from 2 SD to 3 SD below the mean. eight children (10 percent) had severe neuromotor disability, 7 (2 percent) were blind or perceived light only, and 8 (3 percent) had hearing loss that was uncorrectable or required hearing aids. Overall, 138 children had disability (49 percent; 95 percent confidence 43 to 55 percent), including 64 who met the criteria for severe disability (23 percent; 95 percent confidence interval, 18 to 28 percent). When data from 17 assessments by local pediatricians were included, 155 of the 314 infants discharged (49 percent) had no disability. Conclusions Severe disability is common among children born as extremely preterm infants and remains a major challenge in this group of children. (N Engl J Med 2000; 343:378-84.) (C) 2000, Massachusetts Medical Society.	Univ Nottingham, Sch Human Dev, Nottingham NG7 2RD, England; Univ London, Univ London Queen Mary & Westfield Coll, St Bartholomews & Royal London Sch Med & Dent, London E1 4NS, England; Univ Sheffield, Jessop Hosp Women, Sheffield S3 7RE, S Yorkshire, England; Univ Oxford, Dept Paediat, Oxford, England	University of Nottingham; University of London; Queen Mary University London; University of Sheffield; University of Oxford	Marlow, N (corresponding author), Queens Med Ctr, Acad Div Child Hlth, Level E East Block, Nottingham NG7 2UH, England.		Marlow, Neil/D-2918-2009	Marlow, Neil/0000-0001-5890-2953				AMIELTISON C, 1989, ARCH DIS CHILD-FETAL, V64, P496, DOI 10.1136/adc.64.4_Spec_No.496; ARNOLD CC, 1991, AM J EPIDEMIOL, V134, P604, DOI 10.1093/oxfordjournals.aje.a116133; Botting N, 1998, DEV MED CHILD NEUROL, V40, P652; Botting N, 1997, J CHILD PSYCHOL PSYC, V38, P931, DOI 10.1111/j.1469-7610.1997.tb01612.x; COSTELOE K, IN PRESS PEDIATRICS; Doyle LW, 1997, J PAEDIATR CHILD H, V33, P161; ELLIMAN AM, 1991, ACTA PAEDIATR SCAND, V80, P316, DOI 10.1111/j.1651-2227.1991.tb11855.x; EVANS P, 1989, DEV MED CHILD NEUROL, V31, P119; GRIFFITHS R, 1957, ABILITIES YOUNG CHIL; Hack M, 1999, EARLY HUM DEV, V53, P193, DOI 10.1016/S0378-3782(98)00052-8; HACK M, 1994, NEW ENGL J MED, V331, P753, DOI 10.1056/NEJM199409223311201; *INF HLTH DEV PROG, 1997, HELP LOW BIRTH WEIGH; JOHNSON A, 1993, BRIT MED J, V306, P1715, DOI 10.1136/bmj.306.6894.1715; McCarton CM, 1996, PEDIATRICS, V98, P1167; MILLIGAN JE, 1984, AM J OBSTET GYNECOL, V148, P499, DOI 10.1016/0002-9378(84)90734-8; *NAT PER EP UN, 1995, REP 2 WORK GROUPS DI; NELSON KB, 1982, PEDIATRICS, V69, P529; PENA IC, 1988, J PEDIATR-US, V113, P1066, DOI 10.1016/S0022-3476(88)80584-5; PHAROAH POD, 1994, ARCH DIS CHILD, V70, P271, DOI 10.1136/adc.70.4.271; POWLS A, 1995, ARCH DIS CHILD, V72, pF62; Robinson M, 1998, ARCH DIS CHILD-FETAL, V79, pF4; Ross G, 1997, J DEV BEHAV PEDIATR, V18, P109, DOI 10.1097/00004703-199704000-00007; SANLEY FJ, 1987, 2 NAT HLTH MED RES C; Tin W, 1997, BMJ-BRIT MED J, V314, P107, DOI 10.1136/bmj.314.7074.107; VANZEBENVANDERAA TM, 1989, LANCET, V1, P253; VERLOOVEVANHORICK SP, 1986, LANCET, V1, P55; WIGGLESWORTH JS, 1978, EARLY HUM DEV, V2, P179, DOI 10.1016/0378-3782(78)90010-5; Yi S.H., 1993, MANUAL BAYLEY SCALES	28	929	956	1	56	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 10	2000	343	6					378	384		10.1056/NEJM200008103430601	http://dx.doi.org/10.1056/NEJM200008103430601			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	342DT	10933736				2022-12-28	WOS:000088630500001
J	Bochar, DA; Wang, L; Beniya, H; Kinev, A; Xue, YT; Lane, WS; Wang, WD; Kashanchi, F; Shiekhattar, R				Bochar, DA; Wang, L; Beniya, H; Kinev, A; Xue, YT; Lane, WS; Wang, WD; Kashanchi, F; Shiekhattar, R			BRCA1 is associated with a human SWI/SNF-related complex: Linking chromatin remodeling to breast cancer	CELL			English	Article							POLYMERASE-II HOLOENZYME; TRANSCRIPTIONAL ACTIVATION; MEIOTIC CELLS; DNA-DAMAGE; EXPRESSION; PROTEIN; REPAIR; DOMAIN; GROWTH; BINDS	Germline mutations in the tumor suppressor gene, BRCA1, predispose individuals to breast and ovarian cancers. Using a combination of affinity- and conventional chromatographic techniques, we have isolated a predominant form of a multiprotein BRCA1-containing complex from human cells displaying chromatin-remodeling activity. Mass spectrometric sequencing of components of this complex indicated that BRCA1 is associated with a SWI/SNF-related complex. We show that BRCA1 can directly interact with the BRG1 subunit of the SWI/SNF complex. Moreover, p53-mediated stimulation of transcription by BRCA1 was completely abrogated by either a dominant-negative mutant of BRG1 or the cancer-causing deletion in exon 11 of BRCA1. These findings reveal a direct function for BRCA1 in transcriptional control through modulation of chromatin structure.	Wistar Inst, Philadelphia, PA 19104 USA; Harvard Univ, Harvard Microchem Facil, Cambridge, MA 02138 USA; NIA, Genet Lab, NIH, Gerontol Res Ctr, Baltimore, MD 21224 USA; Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Biochem & Mol Biol, Newark, NJ 07103 USA	The Wistar Institute; Harvard University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Rutgers State University New Brunswick; Rutgers State University Medical Center	Shiekhattar, R (corresponding author), Wistar Inst, 3601 Spruce St, Philadelphia, PA 19104 USA.		Kinev, Alexander V/K-3970-2013; Bochar, Daniel A/A-9224-2009; Wang, Weidong/AAV-2446-2021	Wang, Weidong/0000-0002-0658-7928				Anderson SE, 1998, NAT GENET, V19, P254, DOI 10.1038/930; Bochar DA, 1999, J BIOL CHEM, V274, P13162, DOI 10.1074/jbc.274.19.13162; Bochar DA, 2000, P NATL ACAD SCI USA, V97, P1038, DOI 10.1073/pnas.97.3.1038; Chapman MS, 1996, NATURE, V382, P678, DOI 10.1038/382678a0; Chen JJ, 1998, MOL CELL, V2, P317, DOI 10.1016/S1097-2765(00)80276-2; Chittum HS, 1998, BIOCHEMISTRY-US, V37, P10866, DOI 10.1021/bi981042r; COTE J, 1994, SCIENCE, V265, P53, DOI 10.1126/science.8016655; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Gowen LC, 1998, SCIENCE, V281, P1009, DOI 10.1126/science.281.5379.1009; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; Harkin DP, 1999, CELL, V97, P575, DOI 10.1016/S0092-8674(00)80769-2; Harlow E., 1988, ANTIBODIES LAB MANUA; Hu YF, 1999, GENE DEV, V13, P637, DOI 10.1101/gad.13.6.637; Jensen DE, 1998, ONCOGENE, V16, P1097, DOI 10.1038/sj.onc.1201861; KASHANCHI F, 1992, NUCLEIC ACIDS RES, V20, P4673, DOI 10.1093/nar/20.17.4673; KHAVARI PA, 1993, NATURE, V366, P170, DOI 10.1038/366170a0; MacLachlan TK, 2000, J BIOL CHEM, V275, P2777, DOI 10.1074/jbc.275.4.2777; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; MONTEIRO AN, 1996, P NATL ACAD SCI USA, V26, P13595; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Muralidhar S, 1996, J VIROL, V70, P8691, DOI 10.1128/JVI.70.12.8691-8700.1996; Ouchi T, 1998, P NATL ACAD SCI USA, V95, P2302, DOI 10.1073/pnas.95.5.2302; OwenHughes T, 1996, SCIENCE, V273, P513, DOI 10.1126/science.273.5274.513; Pao GM, 2000, P NATL ACAD SCI USA, V97, P1020, DOI 10.1073/pnas.97.3.1020; Phelan ML, 1999, MOL CELL, V3, P247, DOI 10.1016/S1097-2765(00)80315-9; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Scully R, 1999, MOL CELL, V4, P1093, DOI 10.1016/S1097-2765(00)80238-5; Scully R, 1997, P NATL ACAD SCI USA, V94, P5605, DOI 10.1073/pnas.94.11.5605; Sif S, 1998, GENE DEV, V12, P2842, DOI 10.1101/gad.12.18.2842; Somasundaram K, 1997, NATURE, V389, P187, DOI 10.1038/38291; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; Wang WD, 1996, EMBO J, V15, P5370, DOI 10.1002/j.1460-2075.1996.tb00921.x; Wang WD, 1996, GENE DEV, V10, P2117, DOI 10.1101/gad.10.17.2117; WOLFFE AP, 1999, SCI MED, V6, P28; Xu XL, 1999, MOL CELL, V3, P389, DOI 10.1016/S1097-2765(00)80466-9; Zhong Q, 1999, SCIENCE, V285, P747, DOI 10.1126/science.285.5428.747	36	425	441	2	23	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 21	2000	102	2					257	265		10.1016/S0092-8674(00)00030-1	http://dx.doi.org/10.1016/S0092-8674(00)00030-1			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	337NA	10943845	Bronze			2022-12-28	WOS:000088366800015
J	Jones, NL; Killian, KJ				Jones, NL; Killian, KJ			Mechanisms of disease: Exercise limitation in health and disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							CHRONIC HEART-FAILURE; SKELETAL-MUSCLE; LACTIC-ACID; GROUP-III; FATIGUE; PERFORMANCE; CAPACITY; LACTATE; DYSPNEA; CONTRACTION		McMaster Univ, Hlth Sci Ctr, Dept Med, Hamilton, ON L8S 3Z5, Canada	McMaster University; University of Manitoba; Children's Hospital Research Institute of Manitoba	Jones, NL (corresponding author), McMaster Univ, Hlth Sci Ctr, Dept Med, Rm 3U26,1200 Main St W, Hamilton, ON L8S 3Z5, Canada.							BERGSTROM J, 1967, ACTA PHYSIOL SCAND, V71, P140, DOI 10.1111/j.1748-1716.1967.tb03720.x; BIGLANDRITCHIE B, 1979, EXP NEUROL, V64, P414, DOI 10.1016/0014-4886(79)90280-2; BLOMSTRAND E, 1986, J PHYSIOL-LONDON, V381, P111, DOI 10.1113/jphysiol.1986.sp016316; BORG G, 1985, EUR J APPL PHYSIOL O, V54, P343, DOI 10.1007/BF02337176; Borg G., 1986, PERCEPTION EXERTION, P3; BROWN SE, 1985, J APPL PHYSIOL, V58, P1340, DOI 10.1152/jappl.1985.58.4.1340; BURDON JGW, 1983, THORAX, V38, P778, DOI 10.1136/thx.38.10.778; CHASIOTIS D, 1982, J APPL PHYSIOL, V53, P708, DOI 10.1152/jappl.1982.53.3.708; CHUA TP, 1995, BRIT HEART J, V74, P381; CONNETT RJ, 1984, AM J PHYSIOL, V246, pH120, DOI 10.1152/ajpheart.1984.246.1.H120; CONNETT RJ, 1990, J APPL PHYSIOL, V68, P833, DOI 10.1152/jappl.1990.68.3.833; DEMPSEY JA, 1984, J PHYSIOL-LONDON, V355, P161, DOI 10.1113/jphysiol.1984.sp015412; DICKSTEIN K, 1995, J AM COLL CARDIOL, V26, P438, DOI 10.1016/0735-1097(95)80020-H; Douglas CG, 1927, LANCET, V2, P213; DYCK DJ, 1993, AM J PHYSIOL, V265, pE852, DOI 10.1152/ajpendo.1993.265.6.E852; Edwards HT, 1936, AM J PHYSIOL, V116, P367, DOI 10.1152/ajplegacy.1936.116.2.367; ENOKA RM, 1992, J APPL PHYSIOL, V72, P1631, DOI 10.1152/jappl.1992.72.5.1631; FITTS RH, 1994, PHYSIOL REV, V74, P49, DOI 10.1152/physrev.1994.74.1.49; FITTS RH, 1992, PERSPECTIVES EXERCIS, V5, P53; FRANCIOSA JA, 1981, AM J CARDIOL, V47, P33, DOI 10.1016/0002-9149(81)90286-1; FREEDMAN S, 1970, RESP PHYSIOL, V8, P230, DOI 10.1016/0034-5687(70)90017-4; GANDEVIA SC, 1993, J PHYSIOL-LONDON, V470, P85, DOI 10.1113/jphysiol.1993.sp019849; Gandevia SC, 1998, ACTA PHYSIOL SCAND, V163, P305, DOI 10.1046/j.1365-201x.1998.00305.x; Gandevia SC, 1998, ACTA PHYSIOL SCAND, V162, P275, DOI 10.1046/j.1365-201X.1998.0299f.x; GORDON A, 1995, CARDIOVASC RES, V30, P413, DOI 10.1016/0008-6363(95)00062-3; GRAHAM TE, 1989, J APPL PHYSIOL, V66, P561, DOI 10.1152/jappl.1989.66.2.561; HALLER RG, 1983, NEUROLOGY, V33, P1283, DOI 10.1212/WNL.33.10.1283; HAMILTON AL, 1995, AM J RESP CRIT CARE, V152, P2021, DOI 10.1164/ajrccm.152.6.8520771; Hamilton AL, 1996, J APPL PHYSIOL, V81, P1156, DOI 10.1152/jappl.1996.81.3.1156; HARRIS RC, 1977, J APPL PHYSIOL, V43, P852, DOI 10.1152/jappl.1977.43.5.852; Hill AV, 1923, Q J MED, V16, P135, DOI 10.1093/qjmed/os-16.62.135; HULTMAN E, 1996, BIOCH EXERCISE, V9, P157; JANICKI JS, 1984, AM REV RESPIR DIS, V129, pS93, DOI 10.1164/arrd.1984.129.2P2.S93; JONES NL, 1971, AM REV RESPIR DIS, V103, P477; JONES NL, 1975, NEW ENGL J MED, V293, P647; Jones NL, 1996, CLIN SCI, V90, P323, DOI 10.1042/cs0900323; JONES NL, 1985, AM REV RESPIR DIS, V131, P700; JONES NL, 1966, CLIN SCI, V31, P39; Jones NL, 1991, CHRONIC OBSTRUCTIVE, P196; JONES NL, 1997, CLIN EXERCISE TESTIN; KATZ A, 1988, J APPL PHYSIOL, V65, P509, DOI 10.1152/jappl.1988.65.2.509; KEARON MC, 1991, EUR RESPIR J, V4, P917; KEARON MC, 1991, J PHYSIOL-LONDON, V442, P477, DOI 10.1113/jphysiol.1991.sp018804; KILLIAN KJ, 1992, AM REV RESPIR DIS, V145, P1339, DOI 10.1164/ajrccm/145.6.1339; KILLIAN KJ, 1995, THORAX B, P1355; Killian KJ, 1992, BREATHLESSNESS, P132; KILLIAN KJ, 1996, RESP SENSATION, P181; KNIFFKI KD, 1978, EXP BRAIN RES, V31, P511; KOWALCHUK JM, 1988, J APPL PHYSIOL, V65, P2080, DOI 10.1152/jappl.1988.65.5.2080; LEBLANC P, 1986, AM REV RESPIR DIS, V133, P21, DOI 10.1164/arrd.1986.133.1.21; LEBLANC P, 1988, J APPL PHYSIOL, V64, P2482, DOI 10.1152/jappl.1988.64.6.2482; LINDERHOLM H, 1969, ACTA MED SCAND, V185, P153; MAKRIDES L, 1985, CLIN SCI, V69, P197, DOI 10.1042/cs0690197; Maltais F, 1996, AM J RESP CRIT CARE, V154, P442, DOI 10.1164/ajrccm.154.2.8756820; Maltais F, 1998, J APPL PHYSIOL, V84, P1573, DOI 10.1152/jappl.1998.84.5.1573; Maltais F, 1996, AM J RESP CRIT CARE, V153, P288, DOI 10.1164/ajrccm.153.1.8542131; MANCINI DM, 1990, AM J CARDIOL, V65, P1121, DOI 10.1016/0002-9149(90)90325-U; MANNING HL, 1995, NEW ENGL J MED, V333, P1547, DOI 10.1056/NEJM199512073332307; MCCARTNEY N, 1983, J APPL PHYSIOL, V55, P218, DOI 10.1152/jappl.1983.55.1.218; MCCLOSKEY DI, 1978, PHYSIOL REV, V58, P763, DOI 10.1152/physrev.1978.58.4.763; MCKELVIE RS, 1995, J AM COLL CARDIOL, V25, P789, DOI 10.1016/0735-1097(94)00428-S; MCPARLAND C, 1992, AM REV RESPIR DIS, V146, P467, DOI 10.1164/ajrccm/146.2.467; Newsholme EA, 1973, REGULATION METABOLIS; ROTTO DM, 1988, J APPL PHYSIOL, V64, P2306, DOI 10.1152/jappl.1988.64.6.2306; Rowell L, 1993, HUMAN CARDIOVASCULAR; SAHLIN K, 1975, BIOCHEM J, V152, P173, DOI 10.1042/bj1520173; SINOWAY LI, 1993, J NEUROPHYSIOL, V69, P1053, DOI 10.1152/jn.1993.69.4.1053; Sliwinski P, 1996, J APPL PHYSIOL, V80, P1270, DOI 10.1152/jappl.1996.80.4.1270; STEPHENS TW, 1983, BIOCHEM J, V212, P521, DOI 10.1042/bj2120521; STEVENS SS, 1958, PSYCHOL BULL, V55, P177, DOI 10.1037/h0044251; STEVENS SS, 1957, PSYCHOL REV, V64, P153, DOI 10.1037/h0046162; Stevens SS, 1975, PSYCHOPHYSICS INTRO, pxiv; SUGDEN MC, 1994, FASEB J, V8, P54, DOI 10.1096/fasebj.8.1.8299890; SULLIVAN MJ, 1990, CIRCULATION, V81, P518, DOI 10.1161/01.CIR.81.2.518; SULLIVAN MJ, 1995, PROG CARDIOVASC DIS, V38, P1, DOI 10.1016/S0033-0620(05)80011-8; SULLIVAN MJ, 1989, CIRCULATION, V79, P324, DOI 10.1161/01.CIR.79.2.324; SULLIVAN MJ, 1991, CIRCULATION, V84, P1597, DOI 10.1161/01.CIR.84.4.1597; SULLIVAN MJ, 1989, CIRCULATION, V80, P769, DOI 10.1161/01.CIR.80.4.769; SYLVEN C, 1991, MED SCI SPORT EXER, V23, P1050; Vidruk E H, 1980, Exerc Sport Sci Rev, V8, P129; Wasserman K., 1987, PRINCIPLES EXERCISE; WILKIE DR, 1986, HUMAN MUSCLE POWER, P3; WILSON JR, 1995, CIRCULATION, V91, P559, DOI 10.1161/01.CIR.91.2.559; WILSON JR, 1988, J APPL PHYSIOL, V64, P2333, DOI 10.1152/jappl.1988.64.6.2333; WILSON JR, 1993, J AM COLL CARDIOL, V22, pA93, DOI 10.1016/0735-1097(93)90469-H; WILSON JR, 1989, CIRCULATION, V80, P1668, DOI 10.1161/01.CIR.80.6.1668; WOODS JJ, 1987, J NEUROPHYSIOL, V58, P125, DOI 10.1152/jn.1987.58.1.125	87	148	152	1	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 31	2000	343	9					632	641		10.1056/NEJM200008313430907	http://dx.doi.org/10.1056/NEJM200008313430907			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	348RE	10965011				2022-12-28	WOS:000088999600007
J	Hu, FB; Stampfer, MJ; Manson, JE; Grodstein, F; Colditz, GA; Speizer, FE; Willett, WC				Hu, FB; Stampfer, MJ; Manson, JE; Grodstein, F; Colditz, GA; Speizer, FE; Willett, WC			Trends in the incidence of coronary heart disease and changes in diet and lifestyle in women	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; RISK-FACTORS; ADIPOSE-TISSUE; SURVIVAL RATES; GLYCEMIC LOAD; FATTY-ACIDS; MORTALITY; PREVENTION; POPULATION; FIBER	Background: Previous studies have found concurrent declines in blood pressure, serum cholesterol levels, and the incidence of and mortality from coronary disease. However, the effects of changes in diet and lifestyle on trends in coronary disease are largely unknown. Methods: We followed 85,941 women who were 34 to 59 years old and had no previously diagnosed cardiovascular disease or cancer from 1980 to 1994 in the Nurses' Health Study. Diet and lifestyle variables were assessed at base line and updated during follow-up. Results: After adjustment for the effect of age, the incidence of coronary disease declined by 31 percent from the two-year period 1980-1982 to the two-year period 1992-1994. From 1980 to 1992, the proportion of participants currently smoking declined by 41 percent, the proportion of postmenopausal women using hormone therapy increased by 175 percent, and the prevalence of overweight, defined as a body-mass index (the weight in kilograms divided by the square of the height in meters) of 25 or more, increased by 38 percent. During the study period, diet improved substantially. Statistically, changes in these variables - when considered simultaneously - explained a 21 percent decline in the incidence of coronary disease, representing 68 percent of the overall decline from 1980-1982 to 1992-1994. Taken individually, the reduction in smoking explained a 13 percent decline in the incidence of coronary disease; improvement in diet explained a 16 percent decline; and increase in postmenopausal hormone use explained a 9 percent decline. On the other hand, the increase in body-mass index explained an 8 percent increase in the incidence of coronary disease. Conclusions: Reduction in smoking, improvement in diet, and an increase in postmenopausal hormone use accounted for much of the decline in the incidence of coronary disease in this group of women. An increasing prevalence of obesity, however, appears to have slowed the decline in the incidence of coronary disease. (N Engl J Med 2000;343:530-7.) (C)2000, Massachusetts Medical Society.	Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; Brigham & Womens Hosp, Dept Med, Div Prevent Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Hu, FB (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, 665 Huntington Ave, Boston, MA 02115 USA.	frank.hu@channing.harvard.edu	Colditz, Graham/A-3963-2009; Hu, Frank/C-1919-2013	Colditz, Graham/0000-0002-7307-0291; 	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034594, R01HL060712] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL34594, HL60712, HL24074] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		CARACCIOLO EA, 1995, CIRCULATION, V91, P2325, DOI 10.1161/01.CIR.91.9.2325; DAGOSTINO RB, 1990, STAT MED, V9, P1501, DOI 10.1002/sim.4780091214; FISHER L, 1984, NEW ENGL J MED, V310, P750; Garland M, 1998, AM J CLIN NUTR, V67, P25, DOI 10.1093/ajcn/67.1.25; GOLDBERG RJ, 1986, JAMA-J AM MED ASSOC, V255, P2774, DOI 10.1001/jama.255.20.2774; GOLDBERG RJ, 1993, CIRCULATION, V87, P1947, DOI 10.1161/01.CIR.87.6.1947; GRODSTEIN F, 1996, REPROD ENDOCRINOLOGY, V2, P1852; Hu FB, 1999, AM J CLIN NUTR, V70, P1001; Hu FB, 1997, NEW ENGL J MED, V337, P1491, DOI 10.1056/NEJM199711203372102; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Hunink MGM, 1997, JAMA-J AM MED ASSOC, V277, P535, DOI 10.1001/jama.277.7.535; HUNTER DJ, 1992, AM J EPIDEMIOL, V135, P418, DOI 10.1093/oxfordjournals.aje.a116302; KUCZMARSKI RJ, 1994, JAMA-J AM MED ASSOC, V272, P205, DOI 10.1001/jama.272.3.205; Liu SM, 2000, AM J CLIN NUTR, V71, P1455; LONDON SJ, 1991, AM J CLIN NUTR, V54, P340, DOI 10.1093/ajcn/54.2.340; Ludwig DS, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.3.e26; Manson JE, 1999, NEW ENGL J MED, V341, P650, DOI 10.1056/NEJM199908263410904; McGovern PG, 1996, NEW ENGL J MED, V334, P884, DOI 10.1056/NEJM199604043341403; Mosterd A, 1999, NEW ENGL J MED, V340, P1221, DOI 10.1056/NEJM199904223401601; *NAT CTR HLTH STAT, 1997, DHHS PUBL PHS, P183; *NUTR MON TID, 1990, AGR HDB USDA, V813; PELL S, 1985, NEW ENGL J MED, V312, P1005, DOI 10.1056/NEJM198504183121601; Pietinen P, 1996, PREV MED, V25, P243, DOI 10.1006/pmed.1996.0053; PISUNYER FX, 1993, ANN INTERN MED, V119, P655, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00006; RICHEDWARDS JW, 1995, NEW ENGL J MED, V332, P1758, DOI 10.1056/NEJM199506293322607; Rimm EB, 1998, JAMA-J AM MED ASSOC, V279, P359, DOI 10.1001/jama.279.5.359; Rosamond WD, 1998, NEW ENGL J MED, V339, P861, DOI 10.1056/NEJM199809243391301; Rose GA, 1982, WHO MONOGRAPH SERIES, V56; Salmeron J, 1997, JAMA-J AM MED ASSOC, V277, P472, DOI 10.1001/jama.277.6.472; Salmeron J, 1997, DIABETES CARE, V20, P545, DOI 10.2337/diacare.20.4.545; SELHUB J, 1993, JAMA-J AM MED ASSOC, V270, P2693, DOI 10.1001/jama.270.22.2693; STAMPFER MJ, 1984, AM J EPIDEMIOL, V119, P837, DOI 10.1093/oxfordjournals.aje.a113804; SYTKOWSKI PA, 1990, NEW ENGL J MED, V322, P1635, DOI 10.1056/NEJM199006073222304; *US BUR CENS, 1994, STAT ABSTR US 1994; WILLETT W, 1983, AM J EPIDEMIOL, V117, P651, DOI 10.1093/oxfordjournals.aje.a113598; WILLETT WC, 1987, NEW ENGL J MED, V317, P1303, DOI 10.1056/NEJM198711193172102; WILLETT WC, 1993, LANCET, V341, P581, DOI 10.1016/0140-6736(93)90350-P; Willett WC, 1998, OXFORD SCHOLARSHIP O; Wolk A, 1999, JAMA-J AM MED ASSOC, V281, P1998, DOI 10.1001/jama.281.21.1998	39	289	296	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 24	2000	343	8					530	537		10.1056/NEJM200008243430802	http://dx.doi.org/10.1056/NEJM200008243430802			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	346QM	10954760				2022-12-28	WOS:000088882600002
J	Armstrong, D				Armstrong, D			Long-term safety and efficacy of omeprazole in gastro-oesophageal reflux disease	LANCET			English	Editorial Material							EXPERIENCE; THERAPY; TRIAL; RISK; ACID		McMaster Univ, Med Ctr, Div Gastroenterol, Hamilton, ON L8N 3Z5, Canada	McMaster University	Armstrong, D (corresponding author), McMaster Univ, Med Ctr, Div Gastroenterol, Hamilton, ON L8N 3Z5, Canada.							Choudhry U, 1998, AM J CLIN PATHOL, V110, P615, DOI 10.1093/ajcp/110.5.615; Freston JW, 1999, DRUG SAFETY, V20, P195, DOI 10.2165/00002018-199920020-00008; HAVU N, 1986, DIGESTION, V35, P42, DOI 10.1159/000199381; JOELSON S, 1992, DIGESTION, V51, P93, DOI 10.1159/000200922; Klinkenberg-Knol EC, 2000, GASTROENTEROLOGY, V118, P661, DOI 10.1016/S0016-5085(00)70135-1; Kuipers EJ, 2000, GASTROENTEROLOGY, V118, P795, DOI 10.1016/S0016-5085(00)70149-1; KUIPERS EJ, 1996, N ENGL J MED, V334; Lagergren J, 1999, NEW ENGL J MED, V340, P825, DOI 10.1056/NEJM199903183401101; Laine L, 2000, ALIMENT PHARM THER, V14, P651; Lind T, 1999, ALIMENT PHARM THERAP, V13, P907; Lundell L, 1998, GASTROENTEROLOGY, V114, pA207, DOI 10.1016/S0016-5085(98)80841-X; Lundell L, 1999, GASTROENTEROLOGY, V117, P319, DOI 10.1053/gast.1999.0029900319; Rodriguez LAG, 1997, EPIDEMIOLOGY, V8, P571; Stolte M, 2000, PATHOL RES PRACT, V196, P9; Viani F, 2000, EUR J GASTROEN HEPAT, V12, P165, DOI 10.1097/00042737-200012020-00006	15	10	10	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 19	2000	356	9230					610	612		10.1016/S0140-6736(00)02598-8	http://dx.doi.org/10.1016/S0140-6736(00)02598-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	346RD	10968429				2022-12-28	WOS:000088884100004
J	Kmietowicz, Z				Kmietowicz, Z			Breastfeeding programmes "should be targeted"	BRITISH MEDICAL JOURNAL			English	News Item																		2000, EFFECTIVE HLTH CARE, V6, P2	1	4	4	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	AUG 19	2000	321	7259					467	467						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	347MC	10948015				2022-12-28	WOS:000088932800008
J	Antonio, C; Ferby, I; Wilhelm, H; Jones, M; Karsenti, E; Nebreda, AR; Vernos, I				Antonio, C; Ferby, I; Wilhelm, H; Jones, M; Karsenti, E; Nebreda, AR; Vernos, I			Xkid, a chromokinesin required for chromosome alignment on the metaphase plate	CELL			English	Article							KINESIN-LIKE PROTEIN; XENOPUS EGG EXTRACTS; NEWT LUNG-CELLS; MITOTIC SPINDLE; CENP-E; DNA-BINDING; DIRECTIONAL INSTABILITY; DIFFERENTIAL DISPLAY; MICROTUBULE FLUX; DROSOPHILA	Metaphase chromosome alignment is a key step of animal cell mitosis. The molecular mechanism leading to this equatorial positioning is still not fully understood. Forces exerted at kinetochores and on chromosome arms drive chromosome movements that culminate in their alignment on the metaphase plate. In this paper, we show that Xkid, a kinesin-like protein localized on chromosome arms, plays an essential role in metaphase chromosome alignment and in its maintenance. We propose that Xkid is responsible for the polar ejection forces acting on chromosome arms. Our results show that these forces are essential to ensure that kinetochores and chromosome arms align on a narrow equatorial plate during metaphase, a prerequisite for proper chromosome segregation.	European Mol Biol Lab, Cell Biol & Biophys Program, D-69117 Heidelberg, Germany; European Mol Biol Lab, Dev Biol Program, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL)	Vernos, I (corresponding author), European Mol Biol Lab, Cell Biol & Biophys Program, D-69117 Heidelberg, Germany.		Vernos, Isabelle/C-1687-2015; Nebreda, Angel Rodriguez/R-9594-2019; Ferby, Ingvar/B-7895-2008	Vernos, Isabelle/0000-0003-1469-9214; Ferby, Ingvar/0000-0002-3435-1728				AFSHAR K, 1995, CELL, V81, P129, DOI 10.1016/0092-8674(95)90377-1; CASSIMERIS L, 1994, J CELL SCI, V107, P285; Cooke CA, 1997, CHROMOSOMA, V106, P446, DOI 10.1007/s004120050266; Desai A, 1998, J CELL BIOL, V141, P703, DOI 10.1083/jcb.141.3.703; Desai A, 1999, METHOD CELL BIOL, V61, P385; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; Ferby I, 1999, GENE DEV, V13, P2177, DOI 10.1101/gad.13.16.2177; Funabiki H, 2000, CELL, V102, P411, DOI 10.1016/S0092-8674(00)00047-7; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gorbsky GJ, 1998, J CELL BIOL, V141, P1193, DOI 10.1083/jcb.141.5.1193; HAYDEN JH, 1990, J CELL BIOL, V111, P1039, DOI 10.1083/jcb.111.3.1039; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; Inoue S., 1981, Journal of Cell Biology, V91, P131; KOBEL HR, 1986, TRENDS GENET, V2, P310, DOI 10.1016/0168-9525(86)90286-6; Le Bot N, 1998, J CELL BIOL, V143, P1559, DOI 10.1083/jcb.143.6.1559; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; LINSKENS MHK, 1995, NUCLEIC ACIDS RES, V23, P3244, DOI 10.1093/nar/23.16.3244; LOMBILLO VA, 1995, J CELL BIOL, V128, P107, DOI 10.1083/jcb.128.1.107; Makkerh JPS, 1996, CURR BIOL, V6, P1025, DOI 10.1016/S0960-9822(02)00648-6; MILLER L, 1977, IN VITRO CELL DEV B, V13, P557; MINSHULL J, 1994, CELL, V79, P475, DOI 10.1016/0092-8674(94)90256-9; Molina I, 1997, J CELL BIOL, V139, P1361, DOI 10.1083/jcb.139.6.1361; MURPHY TD, 1995, CELL, V81, P139, DOI 10.1016/0092-8674(95)90378-X; MURRAY AW, 1991, XENOPUS LAEVIS PRACT, P581; Ohkura H, 1997, J CELL SCI, V110, P945; RAFFERTY KA, 1969, CYTOGENETICS, V8, P427; RATTNER JB, 1989, J CELL BIOL, V108, P1209, DOI 10.1083/jcb.108.4.1209; RIEDER CL, 1982, INT REV CYTOL, V79, P1, DOI 10.1016/S0074-7696(08)61672-1; RIEDER CL, 1990, J CELL BIOL, V110, P81, DOI 10.1083/jcb.110.1.81; RIEDER CL, 1994, J CELL BIOL, V124, P223, DOI 10.1083/jcb.124.3.223; RIEDER CL, 1986, J CELL BIOL, V103, P581, DOI 10.1083/jcb.103.2.581; Ruden DM, 1997, DEV BIOL, V191, P284, DOI 10.1006/dbio.1997.8726; SAWIN KE, 1991, J CELL BIOL, V112, P941, DOI 10.1083/jcb.112.5.941; SAWIN KE, 1991, J CELL BIOL, V112, P925, DOI 10.1083/jcb.112.5.925; Schaar BT, 1997, J CELL BIOL, V139, P1373, DOI 10.1083/jcb.139.6.1373; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; SKIBBENS RV, 1993, J CELL BIOL, V122, P859, DOI 10.1083/jcb.122.4.859; THEURKAUF WE, 1992, J CELL BIOL, V116, P1167, DOI 10.1083/jcb.116.5.1167; Tokai N, 1996, EMBO J, V15, P457, DOI 10.1002/j.1460-2075.1996.tb00378.x; VERNOS I, 1995, CELL, V81, P117, DOI 10.1016/0092-8674(95)90376-3; Walczak CE, 1998, CURR BIOL, V8, P903, DOI 10.1016/S0960-9822(07)00370-3; WANG SZ, 1995, J CELL BIOL, V128, P761, DOI 10.1083/jcb.128.5.761; Wilhelm H, 1997, METHOD ENZYMOL, V283, P12; Wood KW, 1997, CELL, V91, P357, DOI 10.1016/S0092-8674(00)80419-5; Yao XB, 1997, J CELL BIOL, V139, P435, DOI 10.1083/jcb.139.2.435; ZHANG P, 1990, CELL, V62, P1053, DOI 10.1016/0092-8674(90)90383-P	46	186	190	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 18	2000	102	4					425	435		10.1016/S0092-8674(00)00048-9	http://dx.doi.org/10.1016/S0092-8674(00)00048-9			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	347BX	10966105	Bronze			2022-12-28	WOS:000088908000005
J	Pei, ZM; Murata, Y; Benning, G; Thomine, S; Klusener, B; Allen, GJ; Grill, E; Schroeder, JI				Pei, ZM; Murata, Y; Benning, G; Thomine, S; Klusener, B; Allen, GJ; Grill, E; Schroeder, JI			Calcium channels activated by hydrogen peroxide mediate abscisic acid signalling in guard cells	NATURE			English	Article							INDUCED STOMATAL CLOSURE; CYTOSOLIC-FREE CALCIUM; CYTOPLASMIC CALCIUM; PLASMA-MEMBRANE; COMMELINA-COMMUNIS; ANION CHANNELS; CA-2+; TRANSDUCTION; ELICITORS; INCREASES	Drought is a major threat to agricultural production. Plants synthesize the hormone abscisic acid (ABA) in response to drought, triggering a signalling cascade in guard cells that results in stomatal closure, thus reducing water loss(1). ABA triggers an increase in cytosolic calcium in guard cells ([Ca2+](cyt))(2-6) that has been proposed to include Ca2+ influx across the plasma membrane(3,5,7-9). However, direct recordings of Ca2+ currents have been limited(3) and the upstream activation mechanisms of plasma membrane Ca2+ channels remain unknown. Here we report activation of Ca2+-permeable channels in the plasma membrane of Arabidopsis guard cells by hydrogen peroxide. The H2O2-activated Ca2+ channels mediate both influx of Ca2+ in protoplasts and increases in [Ca2+](cyt) in intact guard cells. ABA induces the production of H2O2 in guard cells. If H2O2 production is blocked, ABA-induced closure of stomata is inhibited. Moreover, activation of Ca2+ channels by H2O2 and ABA- and H2O2-induced stomatal closing are disrupted in the recessive ABA-insensitive mutant gca2. These data indicate that ABA-induced H2O2 production and the H2O2-activated Ca2+ channels are important mechanisms for ABA-induced stomatal closing.	Univ Calif San Diego, Div Biol Cell & Dev Biol, La Jolla, CA 92093 USA; Univ Calif San Diego, Ctr Mol Genet, La Jolla, CA 92093 USA; Tech Univ Munich, Lehrstuhl Bot, D-85350 Freising, Germany	University of California System; University of California San Diego; University of California System; University of California San Diego; Technical University of Munich	Schroeder, JI (corresponding author), Univ Calif San Diego, Div Biol Cell & Dev Biol, La Jolla, CA 92093 USA.		Thomine, Sébastien/V-9029-2019; Barickman, Thomas/I-6993-2012; Murata, Yoshiyuki/B-2098-2011					Allen GJ, 1999, PLANT CELL, V11, P1785, DOI 10.1105/tpc.11.9.1785; Allen GJ, 1999, PLANT J, V19, P735, DOI 10.1046/j.1365-313x.1999.00574.x; Alvarez ME, 1998, CELL, V92, P773, DOI 10.1016/S0092-8674(00)81405-1; DESILVA DLR, 1985, NEW PHYTOL, V101, P555, DOI 10.1111/j.1469-8137.1985.tb02861.x; Frachisse JM, 1999, PLANT PHYSIOL, V121, P253, DOI 10.1104/pp.121.1.253; Gelli A, 1997, PLANT PHYSIOL, V113, P269, DOI 10.1104/pp.113.1.269; GILROY S, 1991, PLANT CELL, V3, P333, DOI 10.1105/tpc.3.4.333; Grabov A, 1998, P NATL ACAD SCI USA, V95, P4778, DOI 10.1073/pnas.95.8.4778; Hamilton DWA, 2000, P NATL ACAD SCI USA, V97, P4967, DOI 10.1073/pnas.080068897; HEDRICH R, 1990, EMBO J, V9, P3889, DOI 10.1002/j.1460-2075.1990.tb07608.x; Himmelbach A, 1998, PHILOS T R SOC B, V353, P1439, DOI 10.1098/rstb.1998.0299; Jacob T, 1999, P NATL ACAD SCI USA, V96, P12192, DOI 10.1073/pnas.96.21.12192; Kiegle E, 2000, PLANT J, V21, P225, DOI 10.1046/j.1365-313x.2000.00659.x; KNIGHT MR, 1991, NATURE, V352, P524, DOI 10.1038/352524a0; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; Leckie CP, 1998, P NATL ACAD SCI USA, V95, P15837, DOI 10.1073/pnas.95.26.15837; Lee S, 1999, PLANT PHYSIOL, V121, P147, DOI 10.1104/pp.121.1.147; MacRobbie EAC, 1998, PHILOS T ROY SOC B, V353, P1475, DOI 10.1098/rstb.1998.0303; MARSHALL J, 1994, PLANT J, V5, P683, DOI 10.1111/j.1365-313X.1994.00683.x; McAinsh MR, 1996, PLANT PHYSIOL, V111, P1031, DOI 10.1104/pp.111.4.1031; MCAINSH MR, 1990, NATURE, V343, P186, DOI 10.1038/343186a0; MCAINSH MR, 1991, P ROY SOC B-BIOL SCI, V243, P195, DOI 10.1098/rspb.1991.0031; Orozco-Cardenas M, 1999, P NATL ACAD SCI USA, V96, P6553, DOI 10.1073/pnas.96.11.6553; Pei ZM, 1997, PLANT CELL, V9, P409, DOI 10.1105/tpc.9.3.409; PINEROS M, 1995, PLANTA, V195, P478, DOI 10.1007/BF00195704; PRICE AH, 1994, PLANT CELL, V6, P1301, DOI 10.1105/tpc.6.9.1301; Sanders D, 1999, PLANT CELL, V11, P691, DOI 10.1105/tpc.11.4.691; SCHROEDER JI, 1990, P NATL ACAD SCI USA, V87, P9305, DOI 10.1073/pnas.87.23.9305; SCHWARTZ A, 1985, PLANT PHYSIOL, V79, P1003, DOI 10.1104/pp.79.4.1003; Staxen I, 1999, P NATL ACAD SCI USA, V96, P1779, DOI 10.1073/pnas.96.4.1779; Zimmermann S, 1997, P NATL ACAD SCI USA, V94, P2751, DOI 10.1073/pnas.94.6.2751	31	1522	1740	33	434	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 17	2000	406	6797					731	734		10.1038/35021067	http://dx.doi.org/10.1038/35021067			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	344PH	10963598				2022-12-28	WOS:000088767700045
J	Ducor, P				Ducor, P			Intellectual property - Coauthorship and coinventorship	SCIENCE			English	Article							AUTHORSHIP		Univ Geneva, Sch Law, CH-1211 Geneva 12, Switzerland; BMG Avocats, CH-1211 Geneva, Switzerland	University of Geneva	Ducor, P (corresponding author), Univ Geneva, Sch Law, CH-1211 Geneva 12, Switzerland.							BARNEY J, 1998, INTELLECTUAL PRO DEC; BROAD WJ, 1981, SCIENCE, V211, P1137, DOI 10.1126/science.7008199; Clever LH, 1997, ANN INTERN MED, V126, P36, DOI 10.7326/0003-4819-126-1-199701010-00006; Hoen WP, 1998, JAMA-J AM MED ASSOC, V280, P217, DOI 10.1001/jama.280.3.217; Marshall E, 2000, SCIENCE, V287, P2399, DOI 10.1126/science.287.5462.2399; Rennie D, 1997, JAMA-J AM MED ASSOC, V278, P579, DOI 10.1001/jama.278.7.579; 2000, NATURE BIOTECHNOL, V18, P103	7	48	50	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 11	2000	289	5481					873	+		10.1126/science.289.5481.873	http://dx.doi.org/10.1126/science.289.5481.873			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	343KH	10960318	Green Published			2022-12-28	WOS:000088701200015
J	Nissen, P; Hansen, J; Ban, N; Moore, PB; Steitz, TA				Nissen, P; Hansen, J; Ban, N; Moore, PB; Steitz, TA			The structural basis of ribosome activity in peptide bond synthesis	SCIENCE			English	Article							TRANSFER-RNA; COLI RIBOSOME; A-SITE; PROTEIN; SUBUNIT; TRANSLATION; RECOGNITION; MICROSCOPY; LOCATION; RIBOZYME	Using the atomic structures of the large ribosomal subunit from Haloarcula marismortui and its complexes with two substrate analogs, we establish that the ribosome is a ribozyme and address the catalytic properties of its all-RNA active site. Both substrate analogs are contacted exclusively by conserved ribosomal RNA (rRNA) residues from domain V of 23S rRNA; there are no protein side-chain atoms closer than about 18 angstroms to the peptide bond being synthesized. The mechanism of peptide band synthesis appears to resemble the reverse of the acylation step in serine proteases, with the base of A2486 (A2451 in Escherichia coti) playing the same general base role as histidine-57 in chymotrypsin. The unusual pK(a) (where K-a is the acid dissociation constant) required for A2486 to perform this function may derive in part from its hydrogen bonding to G2482 (G2447 in E. coli), which also interacts with a buried phosphate that could stabilize unusual tautomers of these two bases. The polypeptide exit tunnel is largely formed by RNA but has significant contributions from proteins L4, L22, and L39e, and its exit is encircled by proteins L19, L22, L23, L24, L29, and L31e.	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Yale Univ, Dept Chem, New Haven, CT 06520 USA; Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Yale University; Howard Hughes Medical Institute	Nissen, P (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA.		Steitz, Thomas A./C-6559-2009; Nissen, Poul/D-5774-2014	Nissen, Poul/0000-0003-0948-6628	NIGMS NIH HHS [GM54216, GM22778] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; BARTA A, 1984, P NATL ACAD SCI-BIOL, V81, P3607, DOI 10.1073/pnas.81.12.3607; Beckmann R, 1997, SCIENCE, V278, P2123, DOI 10.1126/science.278.5346.2123; BENNETT WS, 1978, P NATL ACAD SCI USA, V75, P4848, DOI 10.1073/pnas.75.10.4848; BERNABEU C, 1982, P NATL ACAD SCI-BIOL, V79, P3111, DOI 10.1073/pnas.79.10.3111; BLOBEL G, 1970, J CELL BIOL, V45, P130, DOI 10.1083/jcb.45.1.130; BLOW DM, 1969, NATURE, V221, P337, DOI 10.1038/221337a0; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; Cate JH, 1999, SCIENCE, V285, P2095, DOI 10.1126/science.285.5436.2095; CHOTHIA C, 1975, NATURE, V256, P705, DOI 10.1038/256705a0; COOPERMAN BS, 1980, RIBOSOMES STRUCTURE, P531; CRICK FHC, 1968, J MOL BIOL, V38, P367, DOI 10.1016/0022-2836(68)90392-6; DOBBERSTEIN B, COMMUNICATION; Ferre-D'Amare AR, 1998, NATURE, V395, P567, DOI 10.1038/26912; FRANCESCHI FJ, 1990, J BIOL CHEM, V265, P16676; Frank J, 1995, BIOCHEM CELL BIOL, V73, P757, DOI 10.1139/o95-084; FRANK J, 1995, NATURE, V376, P441, DOI 10.1038/376441a0; Garrett R. A., 1996, RIBOSOMAL RNA STRUCT, P327; Green R, 1998, SCIENCE, V280, P286, DOI 10.1126/science.280.5361.286; Green R, 1997, ANNU REV BIOCHEM, V66, P679, DOI 10.1146/annurev.biochem.66.1.679; GUERRIERTAKADA C, 1983, CELL, V35, P849, DOI 10.1016/0092-8674(83)90117-4; GUTELL RR, UNPUB; Khaitovich P, 1999, P NATL ACAD SCI USA, V96, P85, DOI 10.1073/pnas.96.1.85; Khaitovich P, 1999, RNA, V5, P605, DOI 10.1017/S1355838299990295; Kim DF, 1999, MOL CELL, V4, P859, DOI 10.1016/S1097-2765(00)80395-0; KOSHLAND DE, 1963, COLD SPRING HARB SYM, V28, P473, DOI 10.1101/SQB.1963.028.01.063; KRUGER K, 1982, CELL, V31, P147, DOI 10.1016/0092-8674(82)90414-7; MADEN BEH, 1968, J MOL BIOL, V35, P333, DOI 10.1016/S0022-2836(68)80028-2; MILLIGAN RA, 1986, NATURE, V319, P693, DOI 10.1038/319693a0; MOAZED D, 1991, P NATL ACAD SCI USA, V88, P3725, DOI 10.1073/pnas.88.9.3725; MOAZED D, 1989, NATURE, V342, P142, DOI 10.1038/342142a0; MOAZED D, 1989, CELL, V57, P585, DOI 10.1016/0092-8674(89)90128-1; MONRO RE, 1967, J MOL BIOL, V26, P147, DOI 10.1016/0022-2836(67)90271-9; MONRO RE, 1969, NATURE, V222, P356, DOI 10.1038/222356a0; MOORE PB, 1996, RIBOSOMAL RNA STRUCT, P199; Muth GW, 2000, SCIENCE, V289, P947, DOI 10.1126/science.289.5481.947; Nakano S, 2000, SCIENCE, V287, P1493, DOI 10.1126/science.287.5457.1493; Nissen P, 1996, BIOCHIMIE, V78, P921, DOI 10.1016/S0300-9084(97)86714-4; Nitta I, 1998, RNA, V4, P257; Nitta I, 1998, SCIENCE, V281, P666, DOI 10.1126/science.281.5377.666; NOLLER HF, 1984, ANNU REV BIOCHEM, V53, P119, DOI 10.1146/annurev.bi.53.070184.001003; NOLLER HF, 1992, SCIENCE, V256, P1416, DOI 10.1126/science.1604315; NOLLER HF, 1991, ANNU REV BIOCHEM, V60, P191, DOI 10.1146/annurev.biochem.60.1.191; OFENGAND J, 1980, RIBOSOMES STRUCTURE, P497; Perrotta AT, 1999, SCIENCE, V286, P123, DOI 10.1126/science.286.5437.123; PICKING WD, 1992, BIOCHEMISTRY-US, V31, P2368, DOI 10.1021/bi00123a023; Prinz A, 2000, EMBO J, V19, P1900, DOI 10.1093/emboj/19.8.1900; RYABOVA LA, 1988, FEBS LETT, V226, P255, DOI 10.1016/0014-5793(88)81434-0; RYCHLIK I, 1966, BIOCHIM BIOPHYS ACTA, V114, P425, DOI 10.1016/0005-2787(66)90327-3; Saenger W., 1984, PRINCIPLES NUCL ACID; SAMAHA RR, 1995, NATURE, V377, P309, DOI 10.1038/377309a0; Stark H, 1997, CELL, V88, P19, DOI 10.1016/S0092-8674(00)81854-1; STARK H, 1995, STRUCTURE, V3, P815, DOI 10.1016/S0969-2126(01)00216-7; STEITZ TA, 1982, ANNU REV BIOPHYS BIO, V11, P419, DOI 10.1146/annurev.bb.11.060182.002223; TRAUT RR, 1964, J MOL BIOL, V10, P63, DOI 10.1016/S0022-2836(64)80028-0; VESTER B, 1988, EMBO J, V7, P3577, DOI 10.1002/j.1460-2075.1988.tb03235.x; WELCH M, 1995, BIOCHEMISTRY-US, V34, P385, DOI 10.1021/bi00002a001; Welch M, 1997, BIOCHEMISTRY-US, V36, P6614, DOI 10.1021/bi963135j; WITTMANNLIEBOLD B, 1990, RIBOSOME, P598; Xu ZH, 1998, J STRUCT BIOL, V124, P129, DOI 10.1006/jsbi.1998.4060; YONATH A, 1987, SCIENCE, V236, P813, DOI 10.1126/science.3576200; ZHAUG B, 1998, CHEM BIOL, V5, P539	62	1630	1719	7	274	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 11	2000	289	5481					920	930		10.1126/science.289.5481.920	http://dx.doi.org/10.1126/science.289.5481.920			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	343KH	10937990				2022-12-28	WOS:000088701200024
J	Shinjo, T; Okuno, T; Hassdorf, R; Shigeto, K; Ono, T				Shinjo, T; Okuno, T; Hassdorf, R; Shigeto, K; Ono, T			Magnetic vortex core observation in circular dots of permalloy	SCIENCE			English	Article								Spin structures of nanoscale magnetic dots are the subject of increasing scientific effort, as the confinement of spins imposed by the geometrical restrictions makes these structures comparable to some internal characteristic Length scales of the magnet. For a vortex (a ferromagnetic dot with a curling magnetic structure), a spot of perpendicular magnetization has been theoretically predicted to exist at the center of the vortex. Experimental evidence for this magnetization spot is provided by magnetic force microscopy imaging of circular dots of permalloy (Ni80Fe20) 0.3 to 1 micrometer in diameter and 50 nanometers thick.	Kyoto Univ, Chem Res Inst, Uji, Kyoto 6110011, Japan; Keio Univ, Fac Sci & Technol, Yokohama, Kanagawa 2238522, Japan	Kyoto University; Keio University	Shinjo, T (corresponding author), Kyoto Univ, Chem Res Inst, Uji, Kyoto 6110011, Japan.		Ono, Teruo/AAR-1164-2020					Cowburn RP, 1999, PHYS REV LETT, V83, P1042, DOI 10.1103/PhysRevLett.83.1042; Hubert A, 1998, MAGNETIC DOMAINS; MATSUBARA F, UNPUB; OHSHIMA M, UNPUB; Sasaki J, 1997, J PHYS SOC JPN, V66, P2138, DOI 10.1143/JPSJ.66.2138	5	1146	1158	8	251	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 11	2000	289	5481					930	932		10.1126/science.289.5481.930	http://dx.doi.org/10.1126/science.289.5481.930			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	343KH	10937991				2022-12-28	WOS:000088701200025
J	Bermudez, V; Capron, N; Gase, T; Gatti, FG; Kajzar, F; Leigh, DA; Zerbetto, F; Zhang, SW				Bermudez, V; Capron, N; Gase, T; Gatti, FG; Kajzar, F; Leigh, DA; Zerbetto, F; Zhang, SW			Influencing intramolecular motion with an alternating electric field	NATURE			English	Article							MOLECULAR SHUTTLE; BIREFRINGENCE; MECHANICS; ROTAXANES; MACHINES; DYNAMICS; WATER	Analogues of mechanical devices that operate on the molecular level(1-5), such as shuttles(6-10), brakes(11), ratchets(12,13), turnstiles(14) and unidirectional spinning motors(15,16), are current targets of both synthetic chemistry and nanotechnology. These structures are designed to restrict the degrees of freedom of submolecular components such that they can only move with respect to each other in a predetermined manner, ideally under the influence of some external stimuli. Alternating-current (a.c.) electric fields are commonly used to probe electronic structure, but can also change the orientation of molecules(17-19) (a phenomenon exploited in liquid crystal displays), or interact with large-scale molecular motions, such as the backbone fluctuations of semi-rigid polymers(20,21). Here we show that modest a.c. fields can be used to monitor and influence the relative motion within certain rotaxanes(22), molecules comprising a ring that rotates around a linear 'thread' carrying bulky 'stoppers' at each end. We observe strong birefringence at frequencies that correspond to the rate at which the molecular ring pirouettes about the thread, with the frequency of maximum birefringence, and by inference also the rate of ring pirouetting giving rise to it, changing as the electric field strength is varied. Computer simulations and nuclear magnetic resonance spectroscopy show the ring rotation to be the only dynamic process occurring on a timescale corresponding to the frequency of maximum birefringence, thus confirming that mechanical motion within the rotaxanes can be addressed, and to some extent controlled, by oscillating electric fields.	Univ Warwick, Dept Chem, Ctr Supramol & Macromol Chem, Coventry CV4 7AL, W Midlands, England; Ctr Etud Saclay, LETI, CEA Technol Avancees, DEIN,SPE GCO, F-91191 Gif Sur Yvette, France; Univ Bologna, Dipartimento Chim G Ciamician, I-40126 Bologna, Italy	University of Warwick; CEA; University of Bologna	Leigh, DA (corresponding author), Univ Warwick, Dept Chem, Ctr Supramol & Macromol Chem, Coventry CV4 7AL, W Midlands, England.		Gatti, Francesco G/G-9315-2012; Zerbetto, Francesco/D-2503-2014; Leigh, David/K-5965-2015	Gatti, Francesco G/0000-0003-0837-4616; Zerbetto, Francesco/0000-0002-2419-057X; Leigh, David/0000-0002-1202-4507; , Bermudez/0000-0002-4380-3853				ALLINGER NL, 1989, J AM CHEM SOC, V111, P8551, DOI 10.1021/ja00205a001; ANELLI PL, 1991, J AM CHEM SOC, V113, P5131, DOI 10.1021/ja00013a096; Balzani V, 1998, ACCOUNTS CHEM RES, V31, P405, DOI 10.1021/ar970340y; BARTHEL J, 1990, CHEM PHYS LETT, V165, P369, DOI 10.1016/0009-2614(90)87204-5; BEDARD TC, 1995, J AM CHEM SOC, V117, P10662, DOI 10.1021/ja00148a008; BISSELL RA, 1994, NATURE, V369, P133, DOI 10.1038/369133a0; BUCKINGHAM AD, 1976, MOL ELECTROOPTICS, P7; CASTNER EW, 1995, J CHEM PHYS, V102, P653, DOI 10.1063/1.469177; Collin JP, 1997, NEW J CHEM, V21, P525; Cook DJ, 1999, CHEM PHYS LETT, V309, P221, DOI 10.1016/S0009-2614(99)00668-5; DAHLQUIST FW, 1975, J MAGN RESON, V17, P406, DOI 10.1016/0022-2364(75)90210-3; Davis AP, 1998, ANGEW CHEM INT EDIT, V37, P909, DOI 10.1002/(SICI)1521-3773(19980420)37:7<909::AID-ANIE909>3.0.CO;2-X; Feynman R.P, 1961, MINATURIZATION, P282, DOI DOI 10.1201/9781315217178; Gimzewski J, 1998, PHYS WORLD, V11, P29; KAPITULNIK A, 1984, PHYS REV LETT, V53, P469, DOI 10.1103/PhysRevLett.53.469; Kelly TR, 1999, NATURE, V401, P150, DOI 10.1038/43639; Kelly TR, 1997, ANGEW CHEM INT EDIT, V36, P1866, DOI 10.1002/anie.199718661; KELLY TR, 1994, J AM CHEM SOC, V116, P3657, DOI 10.1021/ja00087a085; Kippelen B, 1996, APPL PHYS LETT, V68, P1748, DOI 10.1063/1.116653; Koumura N, 1999, NATURE, V401, P152, DOI 10.1038/43646; Lane AS, 1997, J AM CHEM SOC, V119, P11092, DOI 10.1021/ja971224t; Leigh DA, 1997, ANGEW CHEM INT EDIT, V36, P728, DOI 10.1002/anie.199707281; Leigh DA, 1998, J AM CHEM SOC, V120, P6458, DOI 10.1021/ja974065m; LIM KC, 1985, J CHEM PHYS, V82, P516, DOI 10.1063/1.448773; Mislow K, 1988, CHEMTRACTS ORG CHEM, V2, P151; Murakami H, 1997, J AM CHEM SOC, V119, P7605, DOI 10.1021/ja971438a; PONDER JW, 1987, J COMPUT CHEM, V8, P1016, DOI 10.1002/jcc.540080710; Sandstrom J., 1982, DYNAMIC NMR SPECTROS; Sauvage, 1999, MOL CATENANES ROTAXA; Sauvage JP, 1998, ACCOUNTS CHEM RES, V31, P611, DOI 10.1021/ar960263r	30	200	206	1	79	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 10	2000	406	6796					608	611		10.1038/35020531	http://dx.doi.org/10.1038/35020531			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	342PF	10949297				2022-12-28	WOS:000088653800042
J	Brook, RJ				Brook, RJ			W. David Kingery (1926-2000) - Obituary	NATURE			English	Biographical-Item									Engn & Phys Sci Res Council, Swindon SN2 1ET, Wilts, England	UK Research & Innovation (UKRI); Engineering & Physical Sciences Research Council (EPSRC)	Brook, RJ (corresponding author), Engn & Phys Sci Res Council, Polaris House,N Star Ave, Swindon SN2 1ET, Wilts, England.								0	0	0	0	2	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 10	2000	406	6796					582	582		10.1038/35020685	http://dx.doi.org/10.1038/35020685			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	342PF	10949287				2022-12-28	WOS:000088653800032
J	Macilwain, C				Macilwain, C			Emissions targets 'unrealistic' says US climate change body	NATURE			English	News Item																			0	1	1	0	1	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 27	2000	406	6794					333	334		10.1038/35019194	http://dx.doi.org/10.1038/35019194			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	337WC	10935601	Bronze			2022-12-28	WOS:000088383800002
J	Sibilia, M; Fleischmann, A; Behrens, A; Stingl, L; Carroll, J; Watt, FM; Schlessinger, J; Wagner, EF				Sibilia, M; Fleischmann, A; Behrens, A; Stingl, L; Carroll, J; Watt, FM; Schlessinger, J; Wagner, EF			The EGF receptor provides an essential survival signal for SOS-dependent skin tumor development	CELL			English	Article							GROWTH-FACTOR RECEPTOR; KINASE-C-DELTA; BCL-X-L; HAIR FOLLICLE; MICE LACKING; TGF-ALPHA; TYROSINE PHOSPHORYLATION; TARGETED DISRUPTION; SQUAMOUS PAPILLOMAS; HUMAN KERATINOCYTES	The EGF receptor (EGFR) is required for skin development and is implicated in epithelial tumor formation. Transgenic mice expressing a dominant form of Son of Sevenless (SOS-F) in basal keratinocytes develop skin papillomas with 100% penetrance. However, tumor formation is inhibited in a hypomorphic (wa2) and null EGFR background. Similarly, EGFR-deficient fibroblasts are resistant to transformation by SOS-F and rasV12, however, tumorigenicity is restored by expression of the anti-apoptotic bcl-2 gene. The K5-SOS-F papillomas and primary keratinocytes from wa2 mice display increased apoptosis, reduced Akt phosphorylation and grafting experiments imply a cell-autonomous requirement for EGFR in keratinocytes. Therefore, EGFR functions as a survival factor in oncogenic transformation and provides a valuable target for therapeutic intervention in a broader range of tumors than anticipated.	Res Inst Mol Pathol, A-1030 Vienna, Austria; Imperial Canc Res Fund, London WC2A 3PX, England; NYU Med Ctr, Dept Pharmacol, New York, NY 10016 USA	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Cancer Research UK; New York University	Sibilia, M (corresponding author), Univ Vienna, Sch Med, VIRCC, Dept Dermatol,DIAID, Brunnerstr 59, A-1235 Vienna, Austria.		Watt, Fiona/AHB-0226-2022	Watt, Fiona/0000-0001-9151-5154; Sibilia, Maria/0000-0001-6129-5613; Behrens, Axel/0000-0002-1557-1143; Wagner, Erwin F/0000-0001-7872-0196				ARONHEIM A, 1994, CELL, V78, P949, DOI 10.1016/0092-8674(94)90271-2; BAILLEUL B, 1990, CELL, V62, P697, DOI 10.1016/0092-8674(90)90115-U; BARBACID M, 1990, EUR J CLIN INVEST, V20, P225, DOI 10.1111/j.1365-2362.1990.tb01848.x; Bergmann A, 1998, CELL, V95, P331, DOI 10.1016/S0092-8674(00)81765-1; Brown K, 1998, CURR BIOL, V8, P516, DOI 10.1016/S0960-9822(98)70203-9; BROWN K, 1986, CELL, V46, P447, DOI 10.1016/0092-8674(86)90665-3; CARROLL JM, 1995, CELL, V83, P957, DOI 10.1016/0092-8674(95)90211-2; DENNING MF, 1993, J BIOL CHEM, V268, P26079; Denning MF, 1996, J BIOL CHEM, V271, P5325, DOI 10.1074/jbc.271.10.5325; DERYNCK R, 1992, ADV CANCER RES, V58, P27, DOI 10.1016/S0065-230X(08)60289-4; Dlugosz AA, 1997, CANCER RES, V57, P3180; DLUGOSZ AA, 1994, CANCER RES, V54, P6413; DOMINEY AM, 1993, CELL GROWTH DIFFER, V4, P1071; Downward J, 1998, CURR OPIN GENET DEV, V8, P49, DOI 10.1016/S0959-437X(98)80061-0; EARP HS, 1995, BREAST CANCER RES TR, V35, P115, DOI 10.1007/BF00694752; FOWLER KJ, 1995, P NATL ACAD SCI USA, V92, P1465, DOI 10.1073/pnas.92.5.1465; FUCHS E, 1992, J INVEST DERMATOL, V99, P671, DOI 10.1111/1523-1747.ep12613737; FUCHS E, 1990, J CELL BIOL, V111, P2807, DOI 10.1083/jcb.111.6.2807; Gandarillas A, 1999, EXP DERMATOL, V8, P71, DOI 10.1111/j.1600-0625.1999.tb00350.x; Gangarosa LM, 1997, J BIOL CHEM, V272, P18926, DOI 10.1074/jbc.272.30.18926; Hansen LA, 1997, AM J PATHOL, V150, P1959; JONES PH, 1993, CELL, V73, P713, DOI 10.1016/0092-8674(93)90251-K; KauffmanZeh A, 1997, NATURE, V385, P544, DOI 10.1038/385544a0; KING LE, 1990, J INVEST DERMATOL, V94, P164; Kurada P, 1998, CELL, V95, P319, DOI 10.1016/S0092-8674(00)81764-X; LEMMON MA, 1994, TRENDS BIOCHEM SCI, V19, P459, DOI 10.1016/0968-0004(94)90130-9; LIBERMANN TA, 1985, NATURE, V313, P144, DOI 10.1038/313144a0; LUETTEKE NC, 1993, CELL, V73, P263, DOI 10.1016/0092-8674(93)90228-I; LUETTEKE NC, 1994, GENE DEV, V8, P399, DOI 10.1101/gad.8.4.399; MANN GB, 1993, CELL, V73, P249, DOI 10.1016/0092-8674(93)90227-H; MCCARTHY SA, 1995, GENE DEV, V9, P1953, DOI 10.1101/gad.9.16.1953; MIETTINEN PJ, 1995, NATURE, V376, P337, DOI 10.1038/376337a0; MURILLAS R, 1995, EMBO J, V14, P5216, DOI 10.1002/j.1460-2075.1995.tb00206.x; Nagane M, 1998, P NATL ACAD SCI USA, V95, P5724, DOI 10.1073/pnas.95.10.5724; PRIGENT S A, 1992, Progress in Growth Factor Research, V4, P1, DOI 10.1016/0955-2235(92)90002-Y; RAMIREZ A, 1994, DIFFERENTIATION, V58, P53, DOI 10.1007/s002580050065; REDEMANN N, 1992, MOL CELL BIOL, V12, P491, DOI 10.1128/MCB.12.2.491; REICHMANN E, 1994, SEMIN CANCER BIOL, V5, P157; Rodeck U, 1997, P NATL ACAD SCI USA, V94, P5067, DOI 10.1073/pnas.94.10.5067; Rodeck U, 1997, J CELL SCI, V110, P113; ROOP DR, 1986, NATURE, V323, P822, DOI 10.1038/323822a0; SCHLESSINGER J, 1994, CURR OPIN GENET DEV, V4, P25, DOI 10.1016/0959-437X(94)90087-6; Sibilia M, 1998, EMBO J, V17, P719, DOI 10.1093/emboj/17.3.719; SIBILIA M, 1995, SCIENCE, V269, P234, DOI 10.1126/science.7618085; Stoll SW, 1998, ONCOGENE, V16, P1493, DOI 10.1038/sj.onc.1201657; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084; TODARO GJ, 1965, J CELL COMPAR PHYSL, V66, P325, DOI 10.1002/jcp.1030660310; VARDY DA, 1995, J CELL PHYSIOL, V163, P257, DOI 10.1002/jcp.1041630206; VASSAR R, 1991, GENE DEV, V5, P714, DOI 10.1101/gad.5.5.714; WANG W, 1995, NAT GENET, V10, P294, DOI 10.1038/ng0795-294; Weiss FU, 1997, CURR OPIN GENET DEV, V7, P80, DOI 10.1016/S0959-437X(97)80113-X	51	252	259	0	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 21	2000	102	2					211	220		10.1016/S0092-8674(00)00026-X	http://dx.doi.org/10.1016/S0092-8674(00)00026-X			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	337NA	10943841	Bronze			2022-12-28	WOS:000088366800011
J	Hughes, TR; Marton, MJ; Jones, AR; Roberts, CJ; Stoughton, R; Armour, CD; Bennett, HA; Coffey, E; Dai, HY; He, YDD; Kidd, MJ; King, AM; Meyer, MR; Slade, D; Lum, PY; Stepaniants, SB; Shoemaker, DD; Gachotte, D; Chakraburtty, K; Simon, J; Bard, M; Friend, SH				Hughes, TR; Marton, MJ; Jones, AR; Roberts, CJ; Stoughton, R; Armour, CD; Bennett, HA; Coffey, E; Dai, HY; He, YDD; Kidd, MJ; King, AM; Meyer, MR; Slade, D; Lum, PY; Stepaniants, SB; Shoemaker, DD; Gachotte, D; Chakraburtty, K; Simon, J; Bard, M; Friend, SH			Functional discovery via a compendium of expression profiles	CELL			English	Article							STEROL C-8-C-7 ISOMERASE; VACUOLAR H+-ATPASE; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; COPPER DETOXIFICATION; CALCOFLUOR WHITE; HIGH-AFFINITY; YEAST GENOME; BINDING-SITE; CELL-CYCLE	Ascertaining the impact of uncharacterized perturbations on the cell is a fundamental problem in biology. Here, we describe how a single assay can be used to monitor hundreds of different cellular functions simultaneously. We constructed a reference database or "compendium" of expression profiles corresponding to 300 diverse mutations and chemical treatments in S. cerevisiae, and we show that the cellular pathways affected can be determined by pattern matching, even among very subtle profiles. The utility of this approach is validated by examining profiles caused by deletions of uncharacterized genes: we identify and experimentally confirm that eight uncharacterized open reading frames encode proteins required for sterol metabolism, cell wall function, mitochondrial respiration, or protein synthesis. We also show that the compendium can be used to characterize pharmacological perturbations by identifying a novel target of the commonly used drug dyclonine.	Rosetta Inpharmat Inc, Kirkland, WA 98034 USA; Indiana Univ Purdue Univ, Dept Biol, Indianapolis, IN 46202 USA; Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Medical College of Wisconsin; Fred Hutchinson Cancer Center	Friend, SH (corresponding author), Rosetta Inpharmat Inc, 12040 115th Ave NE, Kirkland, WA 98034 USA.				NATIONAL CANCER INSTITUTE [R01CA078746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI038598] Funding Source: NIH RePORTER; NCI NIH HHS [CA78746] Funding Source: Medline; NIAID NIH HHS [AI38598] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALBERTS AW, 1980, P NATL ACAD SCI-BIOL, V77, P3957, DOI 10.1073/pnas.77.7.3957; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; BARD M, 1972, Journal of Bacteriology, V111, P649; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Daum G, 1998, YEAST, V14, P1471, DOI 10.1002/(SICI)1097-0061(199812)14:16<1471::AID-YEA353>3.0.CO;2-Y; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; EIDE DJ, 1993, MOL GEN GENET, V241, P447, DOI 10.1007/BF00284699; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Galitski T, 1999, SCIENCE, V285, P251, DOI 10.1126/science.285.5425.251; Gari E, 1997, YEAST, V13, P837, DOI 10.1002/(SICI)1097-0061(199707)13:9<837::AID-YEA145>3.0.CO;2-T; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Gray NS, 1998, SCIENCE, V281, P533, DOI 10.1126/science.281.5376.533; Hanner M, 1996, P NATL ACAD SCI USA, V93, P8072, DOI 10.1073/pnas.93.15.8072; Hartigan J., 1975, CLUSTERING ALGORITHM; Heller RA, 1997, P NATL ACAD SCI USA, V94, P2150, DOI 10.1073/pnas.94.6.2150; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; HUGHES TR, 2000, IN PRESS NAT GENET; JUNGMANN J, 1993, EMBO J, V12, P5051, DOI 10.1002/j.1460-2075.1993.tb06198.x; Kekuda R, 1996, BIOCHEM BIOPH RES CO, V229, P553, DOI 10.1006/bbrc.1996.1842; KELEHER CA, 1992, CELL, V68, P709, DOI 10.1016/0092-8674(92)90146-4; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; LIPKE PN, 1976, J BACTERIOL, V127, P610, DOI 10.1128/JB.127.1.610-618.1976; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Lussier M, 1997, GENETICS, V147, P435; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; Marton MJ, 1998, NAT MED, V4, P1293, DOI 10.1038/3282; Mewes HW, 1997, NUCLEIC ACIDS RES, V25, P28, DOI 10.1093/nar/25.1.28; Moebius FF, 1996, BIOCHEMISTRY-US, V35, P16871, DOI 10.1021/bi961996m; Moebius FF, 1997, BRIT J PHARMACOL, V121, P1, DOI 10.1038/sj.bjp.0701079; MOLZAHN SW, 1972, J GEN MICROBIOL, V72, P339, DOI 10.1099/00221287-72-2-339; Nakajima H, 1998, EXP CELL RES, V241, P126, DOI 10.1006/excr.1998.4027; NELSON H, 1995, P NATL ACAD SCI USA, V92, P497, DOI 10.1073/pnas.92.2.497; Nguyen VH, 1998, EUR J PHARMACOL, V361, P157, DOI 10.1016/S0014-2999(98)00706-7; OHYA Y, 1991, J BIOL CHEM, V266, P13971; Ovalle R, 1998, YEAST, V14, P1159, DOI 10.1002/(SICI)1097-0061(19980930)14:13<1159::AID-YEA317>3.0.CO;2-3; PARKS LW, 1995, LIPIDS, V30, P227, DOI 10.1007/BF02537825; Pennisi E, 1998, SCIENCE, V282, P1972, DOI 10.1126/science.282.5396.1972; Perou CM, 1999, P NATL ACAD SCI USA, V96, P9212, DOI 10.1073/pnas.96.16.9212; RAGUZZI F, 1988, FEBS LETT, V231, P253, DOI 10.1016/0014-5793(88)80742-7; RAM AFJ, 1994, YEAST, V10, P1019, DOI 10.1002/yea.320100804; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; RONCERO C, 1988, J BACTERIOL, V170, P1950, DOI 10.1128/jb.170.4.1950-1954.1988; Ross-Macdonald P, 1999, NATURE, V402, P413, DOI 10.1038/46558; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Shoemaker DD, 1996, NAT GENET, V14, P450, DOI 10.1038/ng1296-450; Smith V, 1996, SCIENCE, V274, P2069, DOI 10.1126/science.274.5295.2069; Somerville C, 1999, SCIENCE, V285, P380, DOI 10.1126/science.285.5426.380; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Spradling AC, 1999, GENETICS, V153, P135; Szczypka MS, 1997, YEAST, V13, P1423, DOI 10.1002/(SICI)1097-0061(199712)13:15<1423::AID-YEA190>3.3.CO;2-3; Tsukiyama T, 1999, GENE DEV, V13, P686, DOI 10.1101/gad.13.6.686; Veitia RA, 1999, CYTOGENET CELL GENET, V85, P217, DOI 10.1159/000015296; Velculescu VE, 1997, CELL, V88, P243, DOI 10.1016/S0092-8674(00)81845-0; Wilke RA, 1999, J PHYSIOL-LONDON, V517, P391, DOI 10.1111/j.1469-7793.1999.00391.x; WILLIAMS FE, 1991, MOL CELL BIOL, V11, P3307, DOI 10.1128/MCB.11.6.3307; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wittes J, 1999, J NATL CANCER I, V91, P400, DOI 10.1093/jnci/91.5.400; ZHOU Z, 1992, GENETICS, V131, P851	59	1918	2009	0	90	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 7	2000	102	1					109	126		10.1016/S0092-8674(00)00015-5	http://dx.doi.org/10.1016/S0092-8674(00)00015-5			18	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	332UL	10929718	Bronze			2022-12-28	WOS:000088091700013
J	Abbott, RJ; Smith, LC; Milne, RI; Crawford, RMM; Wolff, K; Balfour, J				Abbott, RJ; Smith, LC; Milne, RI; Crawford, RMM; Wolff, K; Balfour, J			Molecular analysis of plant migration and refugia in the Arctic	SCIENCE			English	Article							SAXIFRAGA-OPPOSITIFOLIA; PHYLOGEOGRAPHY; DIVERSITY; EVOLUTION	The arctic flora is thought to have originated during the Late Tertiary, approximately 3 million years ago. Plant migration routes during colonization of the Arctic are currently unknown, and uncertainty remains over where arctic plants survived Pleistocene glaciations. A phylogenetic analysis of chloroplast DNA variation in the purple saxifrage (Saxifraga oppositifolia) indicates that this plant first occurred in the Arctic in western Beringia before it migrated east and west to achieve a circumpolar distribution. The geographical distribution of chloroplast DNA variation in the species supports the hypothesis that, during Pleistocene glaciations, some plant refugia were Located in the Arctic as well as at more southern Latitudes.	Univ St Andrews, Sch Biol, Div Environm & Evolutionary Biol, St Andrews KY16 9TH, Fife, Scotland; Newcastle Univ, Dept Agr & Environm Sci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	University of St Andrews; Newcastle University - UK	Abbott, RJ (corresponding author), Univ St Andrews, Sch Biol, Div Environm & Evolutionary Biol, Harold Mitchell Bldg, St Andrews KY16 9TH, Fife, Scotland.	rja@st-and.ac.uk	Wolff, Kirsten/E-7961-2012	Wolff, Kirsten/0000-0002-6050-8493				ABBOTT RJ, 1995, MOL ECOL, V4, P199, DOI 10.1111/j.1365-294X.1995.tb00209.x; [Anonymous], 1937, OUTLINE HIST ARCTIC; [Anonymous], 1967, BERING LAND BRIDGE; BENNIKE O, 1990, ARCTIC, V43, P331; Birks HH, 1994, DISS BOT, V234, P129; Comes HP, 1998, TRENDS PLANT SCI, V3, P432, DOI 10.1016/S1360-1385(98)01327-2; CWYNAR LC, 1982, ECOL MONOGR, V52, P1, DOI 10.2307/2937342; FRENZEL B, 1968, SCIENCE, V161, P637, DOI 10.1126/science.161.3842.637; Gabrielsen TM, 1997, MOL ECOL, V6, P831; GORNALL RJ, UNPUB; HEDBERG KO, 1992, BOT J LINN SOC, V109, P377, DOI 10.1111/j.1095-8339.1992.tb00280.x; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; HULTEN E, 1973, BOT NOTISER, V126, P459; Hulten E., 1986, ATLAS N EUROPEAN VAS, V1-3; MATTHEWS JV, 1990, ARCTIC, V43, P324; McIver EE, 1999, ANN MO BOT GARD, V86, P523, DOI 10.2307/2666184; Milne RI, 1999, AM J BOT, V86, P1776, DOI 10.2307/2656674; MURRAY D. F., 1981, EVOLUTION TODAY, P11; MURRAY DF, 1995, ECOL STU AN, V113, P21; PONS O, 1995, THEOR APPL GENET, V90, P462, DOI 10.1007/BF00221991; RITCHIE J C, 1992, Acta Botanica Fennica, V144, P81; SOLTIS DE, 1990, J HERED, V81, P168; STENSTROM M, 1992, ARCTIC ALPINE RES, V24, P337, DOI 10.2307/1551289; Svendsen JI, 1999, BOREAS, V28, P234, DOI 10.1111/j.1502-3885.1999.tb00217.x; Swofford D. L., 1998, PAUP PHYLOGENETIC AN; Tremblay NO, 1999, MOL ECOL, V8, P1187, DOI 10.1046/j.1365-294x.1999.00680.x; Webb DA., 1989, SAXIFRAGES EUROPE NO; Willis KJ, 2000, SCIENCE, V287, P1406, DOI 10.1126/science.287.5457.1406	28	328	347	2	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 25	2000	289	5483					1343	1346		10.1126/science.289.5483.1343	http://dx.doi.org/10.1126/science.289.5483.1343			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347RF	10958779				2022-12-28	WOS:000088942400036
J	Osby, U; Correia, N; Brandt, L; Ekbom, A; Sparen, P				Osby, U; Correia, N; Brandt, L; Ekbom, A; Sparen, P			Time trends in schizophrenia mortality in Stockholm County, Sweden: cohort study	BRITISH MEDICAL JOURNAL			English	Article									Karolinska Inst, Dept Clin Neurosci, S-17176 Stockholm, Sweden; Karolinska Inst, Dept Med Epidemiol, S-10401 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Osby, U (corresponding author), Karolinska Inst, Dept Clin Neurosci, S-17176 Stockholm, Sweden.			Sparen, Par/0000-0002-5184-8971				Brown S, 1999, PSYCHOL MED, V29, P697, DOI 10.1017/S0033291798008186; Brown S, 1997, BRIT J PSYCHIAT, V171, P502, DOI 10.1192/bjp.171.6.502; Kristjansson E, 1987, NORD PSYKIATR TIDSSK, V41, P229, DOI DOI 10.3109/08039488709103182; MORTENSEN PB, 1993, BRIT J PSYCHIAT, V163, P183, DOI 10.1192/bjp.163.2.183; OSBY U, 2000, IN PRESS SCHIZOPHR R	5	172	172	0	9	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	AUG 19	2000	321	7259					483	484		10.1136/bmj.321.7259.483	http://dx.doi.org/10.1136/bmj.321.7259.483			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	347MC	10948028	Bronze, Green Published			2022-12-28	WOS:000088932800021
J	Hoffman, GR; Cerione, RA				Hoffman, GR; Cerione, RA			Flipping the switch: The structural basis for signaling through the CRIB motif	CELL			English	Review							ALDRICH-SYNDROME PROTEIN; GTPASE-BINDING DOMAIN; TYROSINE KINASE; CDC42; BRAIN; WASP		Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA	Cornell University; Cornell University	Cerione, RA (corresponding author), Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA.							Abdul-Manan N, 1999, NATURE, V399, P379, DOI 10.1038/20726; Bagrodia S, 1999, TRENDS CELL BIOL, V9, P350, DOI 10.1016/S0962-8924(99)01618-9; Bi EF, 1999, CURR BIOL, V9, pR160, DOI 10.1016/S0960-9822(99)80102-X; BURBELO PD, 1995, J BIOL CHEM, V270, P29071, DOI 10.1074/jbc.270.49.29071; Frost JA, 1996, MOL CELL BIOL, V16, P3707, DOI 10.1128/mcb.16.7.3707; Gizachew D, 2000, BIOCHEMISTRY-US, V39, P3963, DOI 10.1021/bi992646d; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Kim AS, 2000, NATURE, V404, P151, DOI 10.1038/35004513; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; MANSER E, 1993, NATURE, V363, P364, DOI 10.1038/363364a0; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Miki H, 1998, NATURE, V391, P93, DOI 10.1038/34208; Morreale A, 2000, NAT STRUCT BIOL, V7, P384; Mott HR, 1999, NATURE, V399, P384, DOI 10.1038/20732; Owen D, 2000, BIOCHEMISTRY-US, V39, P1243, DOI 10.1021/bi991567z; Rudolph MG, 1998, J BIOL CHEM, V273, P18067, DOI 10.1074/jbc.273.29.18067; Symons M, 1996, CELL, V84, P723, DOI 10.1016/S0092-8674(00)81050-8; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Yang WN, 1997, J BIOL CHEM, V272, P24819, DOI 10.1074/jbc.272.40.24819	19	58	58	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 18	2000	102	4					403	406		10.1016/S0092-8674(00)00045-3	http://dx.doi.org/10.1016/S0092-8674(00)00045-3			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	347BX	10966102	Bronze			2022-12-28	WOS:000088908000002
J	Dickson, D				Dickson, D			Chemist tipped for top UK science post	NATURE			English	News Item																			0	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 17	2000	406	6797					667	667		10.1038/35021282	http://dx.doi.org/10.1038/35021282			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	344PH	10963568	Bronze			2022-12-28	WOS:000088767700011
J	Donnenberg, MS				Donnenberg, MS			Pathogenic strategies of enteric bacteria	NATURE			English	Review							ENTEROPATHOGENIC ESCHERICHIA-COLI; ACTIN-BASED MOTILITY; PROTEIN-SECRETION SYSTEM; SHIGELLA-FLEXNERI; SALMONELLA-TYPHIMURIUM; EPITHELIAL-CELLS; MAMMALIAN-CELLS; YERSINIA-PSEUDOTUBERCULOSIS; FOCAL ADHESIONS; BINDING PROTEIN	Enteric bacteria use a limited array of macromolecular systems to implement diverse pathogenic strategies. The cellular targets of several enteric virulence factors have recently been identified. The themes that have emerged from these studies include the exploitation of molecules that regulate the actin cytoskeleton and the activation of apoptotic pathways to serve the pathogen.	Univ Maryland, Dept Med, Div Infect Dis, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Donnenberg, MS (corresponding author), Univ Maryland, Dept Med, Div Infect Dis, 10 S Pine St, Baltimore, MD 21201 USA.			Donnenberg, Michael/0000-0002-8818-3184				Achtman M, 1999, P NATL ACAD SCI USA, V96, P14043, DOI 10.1073/pnas.96.24.14043; Anantha RP, 1998, INFECT IMMUN, V66, P122, DOI 10.1128/IAI.66.1.122-131.1998; Anantha TP, 2000, J BACTERIOL, V182, P2498, DOI 10.1128/JB.182.9.2498-2506.2000; Ben-Ami G, 1998, INFECT IMMUN, V66, P1755, DOI 10.1128/IAI.66.4.1755-1758.1998; Bieber D, 1998, SCIENCE, V280, P2114, DOI 10.1126/science.280.5372.2114; Black DS, 1997, EMBO J, V16, P2730, DOI 10.1093/emboj/16.10.2730; Blocker A, 1999, J CELL BIOL, V147, P683, DOI 10.1083/jcb.147.3.683; Bourdet-Sicard R, 1999, EMBO J, V18, P5853, DOI 10.1093/emboj/18.21.5853; Cornelis GR, 1997, MOL MICROBIOL, V23, P861, DOI 10.1046/j.1365-2958.1997.2731623.x; CUDMORE S, 1995, NATURE, V378, P636, DOI 10.1038/378636a0; Davis BM, 2000, SCIENCE, V288, P333, DOI 10.1126/science.288.5464.333; Donnenberg MS, 1997, TRENDS MICROBIOL, V5, P109, DOI 10.1016/S0966-842X(97)01000-7; Egile C, 1999, J CELL BIOL, V146, P1319, DOI 10.1083/jcb.146.6.1319; Fu YX, 1999, NATURE, V401, P293, DOI 10.1038/45829; Hamburger ZA, 1999, SCIENCE, V286, P291, DOI 10.1126/science.286.5438.291; Hardt WD, 1998, CELL, V93, P815, DOI 10.1016/S0092-8674(00)81442-7; Hayward RD, 1999, EMBO J, V18, P4926, DOI 10.1093/emboj/18.18.4926; HENSEL M, 1995, SCIENCE, V269, P400, DOI 10.1126/science.7618105; Hersh D, 1999, P NATL ACAD SCI USA, V96, P2396, DOI 10.1073/pnas.96.5.2396; Jensen VB, 1998, INFECT IMMUN, V66, P3758, DOI 10.1128/IAI.66.8.3758-3766.1998; Kalman D, 1999, NAT CELL BIOL, V1, P389, DOI 10.1038/14087; Karaolis DKR, 1999, NATURE, V399, P375, DOI 10.1038/20715; Kenny B, 1997, CELL, V91, P511, DOI 10.1016/S0092-8674(00)80437-7; Knutton S, 1999, MOL MICROBIOL, V33, P499, DOI 10.1046/j.1365-2958.1999.01495.x; Knutton S, 1998, EMBO J, V17, P2166, DOI 10.1093/emboj/17.8.2166; Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602; Lawrence JG, 1998, P NATL ACAD SCI USA, V95, P9413, DOI 10.1073/pnas.95.16.9413; Loisel TP, 1999, NATURE, V401, P613, DOI 10.1038/44183; Marciano DK, 1999, SCIENCE, V284, P1516, DOI 10.1126/science.284.5419.1516; Menard R, 1996, P NATL ACAD SCI USA, V93, P1254, DOI 10.1073/pnas.93.3.1254; Mirold S, 1999, P NATL ACAD SCI USA, V96, P9845, DOI 10.1073/pnas.96.17.9845; Monack DM, 1998, J EXP MED, V188, P2127, DOI 10.1084/jem.188.11.2127; Palmer LE, 1998, MOL MICROBIOL, V27, P953, DOI 10.1046/j.1365-2958.1998.00740.x; Perna NT, 1998, INFECT IMMUN, V66, P3810, DOI 10.1128/IAI.66.8.3810-3817.1998; Persson C, 1999, MOL MICROBIOL, V33, P828, DOI 10.1046/j.1365-2958.1999.01529.x; Persson C, 1997, EMBO J, V16, P2307, DOI 10.1093/emboj/16.9.2307; Russel M, 1998, J MOL BIOL, V279, P485, DOI 10.1006/jmbi.1998.1791; Sanger JM, 1996, CELL MOTIL CYTOSKEL, V34, P279; SANSONETTI PJ, 1995, J CLIN INVEST, V96, P884, DOI 10.1172/JCI118135; Sansonetti PJ, 1999, CLIN INFECT DIS, V28, P466, DOI 10.1086/515150; Schesser K, 1998, MOL MICROBIOL, V28, P1067, DOI 10.1046/j.1365-2958.1998.00851.x; Tardy F, 1999, EMBO J, V18, P6793, DOI 10.1093/emboj/18.23.6793; Thanassi DG, 1998, CURR OPIN MICROBIOL, V1, P223, DOI 10.1016/S1369-5274(98)80015-5; Tran Van Nhieu G., 1997, EMBO J, V16, P2717; Uchiya K, 1999, EMBO J, V18, P3924, DOI 10.1093/emboj/18.14.3924; Van Nhieu GT, 1999, EMBO J, V18, P3249, DOI 10.1093/emboj/18.12.3249; Vazquez-Torres A, 2000, SCIENCE, V287, P1655, DOI 10.1126/science.287.5458.1655; Waldor MK, 1996, SCIENCE, V272, P1910, DOI 10.1126/science.272.5270.1910; WHITTAM TS, 1996, ESCHERICHIA COLI SAL, P2708; Yoshida T, 1999, J BACTERIOL, V181, P2038, DOI 10.1128/JB.181.7.2038-2043.1999; Young GM, 1999, P NATL ACAD SCI USA, V96, P6456, DOI 10.1073/pnas.96.11.6456; Yu L, 2000, NATURE, V405, P1073, DOI 10.1038/35016618; Zhou DG, 1999, P NATL ACAD SCI USA, V96, P10176, DOI 10.1073/pnas.96.18.10176; Zumbihl R, 1999, J BIOL CHEM, V274, P29289, DOI 10.1074/jbc.274.41.29289	54	100	106	2	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 17	2000	406	6797					768	774		10.1038/35021212	http://dx.doi.org/10.1038/35021212			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	344PH	10963606				2022-12-28	WOS:000088767700053
J	Berger, A				Berger, A			Science commentary: Th1 and Th2 responses: what are they?	BRITISH MEDICAL JOURNAL			English	Editorial Material																		Gereda JE, 2000, LANCET, V355, P1680, DOI 10.1016/S0140-6736(00)02239-X; Jones CA, 2000, ALLERGY, V55, P2, DOI 10.1034/j.1398-9995.2000.00109.x	2	281	300	1	22	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	AUG 12	2000	321	7258					424	424		10.1136/bmj.321.7258.424	http://dx.doi.org/10.1136/bmj.321.7258.424			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	344QC	10938051	Green Published, Bronze			2022-12-28	WOS:000088769500022
J	Lennard, AL; Jackson, GH				Lennard, AL; Jackson, GH			Science, medicine, and the future - Stem cell transplantation	BRITISH MEDICAL JOURNAL			English	Review							BONE-MARROW TRANSPLANTATION; BLOOD PROGENITOR CELLS; MULTIPLE-MYELOMA; LEUKEMIA; DISEASES; CYCLOPHOSPHAMIDE; CHEMOTHERAPY; LYMPHOMA; THERAPY; TRIAL		Royal Victoria Infirm, Dept Haematol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England	Newcastle University - UK	Lennard, AL (corresponding author), Royal Victoria Infirm, Dept Haematol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.		Jackson, Graham/GMW-7638-2022	Jackson, Graham/0000-0003-0756-969X				Attal M, 1996, NEW ENGL J MED, V335, P91, DOI 10.1056/NEJM199607113350204; Burnett AK, 1998, LANCET, V351, P700, DOI 10.1016/S0140-6736(97)09214-3; de Marie S, 2000, HAEMATOLOGICA, V85, P88; Duncan N, 1996, BONE MARROW TRANSPL, V18, P1175; Ganser Arnold, 1996, Current Opinion in Oncology, V8, P265; Gluckman E, 1999, BEST PRACT RES CL HA, V12, P279, DOI 10.1053/beha.1999.0023; Goldman JM, 1998, BONE MARROW TRANSPL, V21, P1, DOI 10.1038/sj.bmt.1701089; Goldschmidt H, 1996, BONE MARROW TRANSPL, V17, P691; Gratwohl A, 1998, LANCET, V352, P1087, DOI 10.1016/S0140-6736(98)03030-X; Hebart H, 1998, Curr Opin Hematol, V5, P483, DOI 10.1097/00062752-199811000-00022; Hortobagyi GN, 2000, JNCI-J NATL CANCER I, V92, P225, DOI 10.1093/jnci/92.3.225; HOWS J, 1996, RECENT ADV HAEMATOLO, V8, P191; Kolb HJ, 1998, VOX SANG, V74, P321, DOI 10.1111/j.1423-0410.1998.tb05438.x; Laurence ADJ, 1999, SEMIN HEMATOL, V36, P303; Lemoli RM, 1999, BEST PRACT RES CL HA, V12, P57, DOI 10.1053/beha.1999.0007; Lennard AL, 1998, LEUKEMIA, V12, P746, DOI 10.1038/sj.leu.2400993; LUCARELLI G, 1990, NEW ENGL J MED, V322, P417, DOI 10.1056/NEJM199002153220701; Matthews DC, 1999, BLOOD, V94, P1237, DOI 10.1182/blood.V94.4.1237.416k34_1237_1247; MCELWAIN TJ, 1979, EXP HEMATOL, V7, P360; Perry AR, 1996, BLOOD REV, V10, P237, DOI 10.1016/S0268-960X(96)90007-7; PROCTOR SJ, 1999, ANN ONCOL S3, V10, P238; Romano G, 2000, STEM CELLS, V18, P19, DOI 10.1634/stemcells.18-1-19; Slavin S, 1998, BLOOD, V91, P756, DOI 10.1182/blood.V91.3.756.756_756_763; Snowden JA, 1997, BRIT J HAEMATOL, V99, P9, DOI 10.1046/j.1365-2141.1997.3273144.x; STEVENSON FK, 1995, IMMUNOL REV, V145, P211, DOI 10.1111/j.1600-065X.1995.tb00083.x; Vile RG, 2000, GENE THER, V7, P2, DOI 10.1038/sj.gt.3301084	26	43	46	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	AUG 12	2000	321	7258					433	437		10.1136/bmj.321.7258.433	http://dx.doi.org/10.1136/bmj.321.7258.433			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	344QC	10938056	Green Published			2022-12-28	WOS:000088769500028
J	Rotenberg, E; Theis, W; Horn, K; Gille, P				Rotenberg, E; Theis, W; Horn, K; Gille, P			Quasicrystalline valence bands in decagonal AlNiCo	NATURE			English	Article							QUASI-CRYSTALS; LOCALIZATION; DISPERSION; ELECTRONS	Quasicrystals are metallic alloys that possess perfect long-range structural order, in spite of the fact that their rotational symmetries are incompatible with long-range periodicity. The exotic structural properties of this class of materials(1) are accompanied by physical properties that are unexpected for metallic alloys. Considerable progress in resolving the geometric structures of quasicrystals has been made using X-ray and neutron diffraction, and concepts such as the quasi-unit-cell model(2) have provided theoretical insights. But the basic properties of the valence electronic states-whether they are extended as in periodic crystals or localized as in amorphous materials-are still largely unresolved(3). Here we investigate the electronic bandstructure of quasicrystals through angle-resolved photoemission experiments on decagonal Al71.8Ni14.8Co13.4. We rnd that the s-p and d states exhibit band-like behaviour with the symmetry of the quasiperiodic lattice, and that the Fermi level is crossed by dispersing d-bands. The observation of free-electron-like bands, distributed in momentum space according to the surface diffraction pattern, suggests that the electronic states are not dominated by localization.	Univ Calif Berkeley, Lawrence Berkeley Lab, Adv Light Source, Berkeley, CA 94720 USA; Free Univ Berlin, Inst Expt Phys, D-14195 Berlin, Germany; Max Planck Gesell, Fritz Haber Inst, D-14195 Berlin, Germany; Univ Munich, Inst Kristallog & Angew Mineral, D-80333 Munich, Germany	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Free University of Berlin; Max Planck Society; Fritz Haber Institute of the Max Planck Society; University of Munich	Rotenberg, E (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Adv Light Source, MS2-400, Berkeley, CA 94720 USA.		Rotenberg, Eli/B-3700-2009; Theis, Wolfgang/AAA-3195-2022	Rotenberg, Eli/0000-0002-3979-8844; Theis, Wolfgang/0000-0002-4074-8318				deLaissardiere GT, 1997, PHYS REV B, V55, P2890, DOI 10.1103/PhysRevB.55.2890; FUJIWARA T, 1989, PHYS REV B, V40, P7413, DOI 10.1103/PhysRevB.40.7413; Gardner M., 1977, SCI AM, V236, P110, DOI DOI 10.1038/SCIENTIFICAMERICAN0177-110; Gille P, 1999, J CRYST GROWTH, V207, P95, DOI 10.1016/S0022-0248(99)00348-6; HAFNER J, 1999, PHYSICAL PROPERTIES; JANOT C, 1997, QUASICRYSTALS PRIMER, P359; Kevan S. D., 1992, ANGLE RESOLVED PHOTO; NIIZEKI K, 1990, J PHYS-CONDENS MAT, V2, P2759, DOI 10.1088/0953-8984/2/12/001; OSTERWALDER J, 1990, PHYS REV LETT, V64, P2683, DOI 10.1103/PhysRevLett.64.2683; Rapp O., 1999, Physical properties of quasicrystals, P127; Roche S, 1998, PHYS REV B, V58, P11338, DOI 10.1103/PhysRevB.58.11338; Rotenberg E, 1998, PHYS REV LETT, V80, P2905, DOI 10.1103/PhysRevLett.80.2905; SENECHAL M., 1995, QUASICRYSTALS GEOMET; SMITH AP, 1987, PHYS REV LETT, V59, P1365, DOI 10.1103/PhysRevLett.59.1365; Steinhardt PJ, 1998, NATURE, V396, P55, DOI 10.1038/23902; STEURER W, 1993, ACTA CRYSTALLOGR B, V49, P661, DOI 10.1107/S0108768193003143; WU X, 1995, PHYS REV LETT, V75, P4540, DOI 10.1103/PhysRevLett.75.4540; Zurkirch M, 1998, PHYS REV B, V58, P14113, DOI 10.1103/PhysRevB.58.14113; [No title captured]	19	87	88	3	47	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 10	2000	406	6796					602	605		10.1038/35020519	http://dx.doi.org/10.1038/35020519			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	342PF	10949295				2022-12-28	WOS:000088653800040
J	Smith, R				Smith, R			An end to violence - "I should only make myself ridiculous in my own eyes if I clung to life."	NATURE			English	Article									John Hunter Hosp, Hunter, NSW 2310, Australia	John Hunter Hospital	Smith, R (corresponding author), John Hunter Hosp, Locked Bag 1, Hunter, NSW 2310, Australia.			Smith, Roger/0000-0003-4720-0280					0	0	0	0	2	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 10	2000	406	6796					567	567		10.1038/35020651	http://dx.doi.org/10.1038/35020651			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	342PF	10949278	Bronze			2022-12-28	WOS:000088653800022
J	Bethlem, HL; Berden, G; Crompvoets, FMH; Jongma, RT; van Roij, AJA; Meijer, G				Bethlem, HL; Berden, G; Crompvoets, FMH; Jongma, RT; van Roij, AJA; Meijer, G			Electrostatic trapping of ammonia molecules	NATURE			English	Article							CHEMICAL PHYSICS; NEUTRAL ATOMS; STATE; PHOTOASSOCIATION	The ability to cool and slow atoms with light for subsequent trapping(1-3) allows investigations of the properties and interactions of the trapped atoms in unprecedented detail. By contrast, the complex structure of molecules prohibits this type of manipulation, but magnetic trapping of calcium hydride molecules thermalized in ultra-cold buffer gas(4) and optical trapping of caesium dimers(5) generated from ultra-cold caesium atoms have been reported. However, these methods depend on the target molecules being paramagnetic or able to form through the association of atoms amenable to laser cooling(6-8), respectively, thus restricting the range of species that can be studied. Here we describe the slowing of an adiabatically cooled beam of deuterated ammonia molecules by time-varying inhomogeneous electric fields(9,10) and subsequent loading into an electrostatic trap. We are able to trap state-selected ammonia molecules with a density of 10(6) cm(-3) in a volume of 0.25 cm(3) at temperatures below 0.35 K. We observe pronounced density oscillations caused by the rapid switching of the electric fields during loading of the trap. Our findings illustrate that polar molecules can be efficiently cooled and trapped, thus providing an opportunity to study collisions and collective quantum effects in a wide range of ultra-cold molecular systems(11-14).	EURATOM, FOM, Inst Plasma Phys Rijnhuizen, NL-3430 BE Nieuwegein, Netherlands; Catholic Univ Nijmegen, Dept Mol & Laser Phys, NL-6525 ED Nijmegen, Netherlands	Euratom; Radboud University Nijmegen	Meijer, G (corresponding author), EURATOM, FOM, Inst Plasma Phys Rijnhuizen, POB 1207, NL-3430 BE Nieuwegein, Netherlands.		Meijer, Gerard/D-2141-2009; Jongma, Rienk/D-4506-2012; Bethlem, Hendrick Lucas/B-2831-2008; Berden, Giel/F-9690-2015	Meijer, Gerard/0000-0001-9669-8340; Bethlem, Hendrick Lucas/0000-0003-4575-8512; 				ASHFOLD MNR, 1988, J CHEM PHYS, V89, P1754, DOI 10.1063/1.455715; Bahns JT, 2000, ADV ATOM MOL OPT PHY, V42, P171, DOI 10.1016/S1049-250X(08)60187-1; BAND YB, 1995, PHYS REV A, V51, pR4317, DOI 10.1103/PhysRevA.51.R4317; Bethlem HL, 2000, PHYS REV LETT, V84, P5744, DOI 10.1103/PhysRevLett.84.5744; Bethlem HL, 1999, PHYS REV LETT, V83, P1558, DOI 10.1103/PhysRevLett.83.1558; Chu S, 1998, REV MOD PHYS, V70, P685, DOI 10.1103/RevModPhys.70.685; Cohen-Tannoudji CN, 1998, REV MOD PHYS, V70, P707, DOI 10.1103/RevModPhys.70.707; Doyle JM, 1999, NATURE, V401, P749, DOI 10.1038/44479; Fioretti A, 1998, PHYS REV LETT, V80, P4402, DOI 10.1103/PhysRevLett.80.4402; Friedrich B, 1998, J CHEM SOC FARADAY T, V94, P1783, DOI 10.1039/a708859k; Friedrich B, 2000, PHYS REV A, V61, DOI 10.1103/PhysRevA.61.025403; GANDHI SR, 1987, J CHEM PHYS, V87, P6457, DOI 10.1063/1.453427; Gupta M, 1999, J PHYS CHEM A, V103, P10670, DOI 10.1021/jp993560x; Herschbach D, 1999, REV MOD PHYS, V71, pS411, DOI 10.1103/RevModPhys.71.S411; Maddi JA, 1999, PHYS REV A, V60, P3882, DOI 10.1103/PhysRevA.60.3882; Nikolov AN, 1999, PHYS REV LETT, V82, P703, DOI 10.1103/PhysRevLett.82.703; Phillips WD, 1998, REV MOD PHYS, V70, P721, DOI 10.1103/RevModPhys.70.721; Takekoshi T, 1998, PHYS REV LETT, V81, P5105, DOI 10.1103/PhysRevLett.81.5105; Weinstein JD, 1998, NATURE, V395, P148, DOI 10.1038/25949; Williams CJ, 2000, SCIENCE, V287, P986, DOI 10.1126/science.287.5455.986; WING WH, 1980, PHYS REV LETT, V45, P631, DOI 10.1103/PhysRevLett.45.631; Wynar R, 2000, SCIENCE, V287, P1016, DOI 10.1126/science.287.5455.1016	22	427	435	1	47	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 3	2000	406	6795					491	494		10.1038/35020030	http://dx.doi.org/10.1038/35020030			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	340ML	10952305				2022-12-28	WOS:000088538000039
J	Kerssemakers, JWJ; van der Molen, SJ; Koeman, NJ; Gunther, R; Griessen, R				Kerssemakers, JWJ; van der Molen, SJ; Koeman, NJ; Gunther, R; Griessen, R			Pixel switching of epitaxial Pd/YHx/CaF2 switchable mirrors	NATURE			English	Article							OPTICAL-TRANSMISSION; HYDRIDE MIRRORS; FILMS; YTTRIUM; SPECTROSCOPY; TRANSITION; HYDROGEN	Exposure of rare-earth films to hydrogen can induce a metal-insulator transition, accompanied by pronounced optical changes. This 'switchable mirror' effect(1) has received considerable attention from theoretical(2-4), experimental(5) and technological(6) points of view. Most systems use polycrystalline films, but the synthesis of yttrium-based epitaxial switchable mirrors(7) has also been reported. The latter form an extended self-organized ridge network during initial hydrogen loading(7), which results in the creation of micrometre-sized triangular domains. Here we observe homogeneous and essentially independent optical switching of individual domains in epitaxial switchable mirrors during hydrogen absorption. The optical switching is accompanied by topographical changes as the domains sequentially expand and contract; the ridges block lateral hydrogen diffusion and serve as a microscopic lubricant for the domain oscillations. We observe the correlated changes in topology and optical properties using in situ atomic force and optical microscopy. Single-domain phase switching is not observed in polycrystalline films, which are optically homogeneous(8). The ability to generate a tunable, dense pattern of switchable pixels is of technological relevance for solid-state displays based on switchable mirrors.	Vrije Univ Amsterdam, Fac Sci, Div Phys & Astron, NL-1081 HV Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Gunther, R (corresponding author), Vrije Univ Amsterdam, Fac Sci, Div Phys & Astron, Boelelaan 1081, NL-1081 HV Amsterdam, Netherlands.		van der Molen, Sense J/F-3035-2014	Kerssemakers, Jacob Willem Jozef/0000-0002-6184-7913				Armitage R, 1999, APPL PHYS LETT, V75, P1863, DOI 10.1063/1.124853; den Broeder FJA, 1998, NATURE, V394, P656, DOI 10.1038/29250; Eder R, 1997, PHYS REV B, V56, P10115, DOI 10.1103/PhysRevB.56.10115; Grier EJ, 2000, J PHYS D APPL PHYS, V33, P894, DOI 10.1088/0022-3727/33/8/302; Hayoz J, 1998, PHYS REV B, V58, pR4270, DOI 10.1103/PhysRevB.58.R4270; HU MS, 1989, ACTA METALL, V37, P7; Huiberts JN, 1996, J ALLOY COMPD, V239, P158, DOI 10.1016/0925-8388(96)02286-4; Huiberts JN, 1996, NATURE, V380, P231, DOI 10.1038/380231a0; Kelly PJ, 1997, PHYS REV LETT, V78, P1315, DOI 10.1103/PhysRevLett.78.1315; Kooij ES, 1999, J ELECTROCHEM SOC, V146, P2990, DOI 10.1149/1.1392040; Kremers M, 1998, PHYS REV B, V57, P4943, DOI 10.1103/PhysRevB.57.4943; Nagengast DG, 1999, APPL PHYS LETT, V75, P1724, DOI 10.1063/1.124800; Ng KK, 1999, PHYS REV B, V59, P5398, DOI 10.1103/PhysRevB.59.5398; Remhof A, 1999, PHYS REV B, V59, P6689, DOI 10.1103/PhysRevB.59.6689; REMHOF A, IN PRESS PHYS REV B; Vajda P, 1995, HDB PHYS CHEM RARE E, V20, P207; van der Molen SJ, 1999, J APPL PHYS, V86, P6107, DOI 10.1063/1.371660; van Gogh ATM, 1999, PHYS REV LETT, V83, P4614, DOI 10.1103/PhysRevLett.83.4614; vanderSluis P, 1997, APPL PHYS LETT, V70, P3356, DOI 10.1063/1.119169	19	66	66	0	23	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 3	2000	406	6795					489	491		10.1038/35020024	http://dx.doi.org/10.1038/35020024			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	340ML	10952304				2022-12-28	WOS:000088538000038
J	Macilwain, C				Macilwain, C			Ocean researchers dive to deep-sea stations	NATURE			English	News Item																			0	2	2	1	1	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 3	2000	406	6795					449	449		10.1038/35020238	http://dx.doi.org/10.1038/35020238			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	340ML	10952283	Bronze			2022-12-28	WOS:000088538000011
J	Khakh, BS; Zhou, XP; Sydes, J; Galligan, JJ; Lester, HA				Khakh, BS; Zhou, XP; Sydes, J; Galligan, JJ; Lester, HA			State-dependent cross-inhibition between transmitter-gated cation channels	NATURE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; PARASYMPATHETIC CARDIAC GANGLIA; GUINEA-PIG; ION CHANNELS; SYMPATHETIC NEURONS; EVOKED CURRENTS; MICE LACKING; ATP; DYSFUNCTION; ADENOSINE	Transmitter-gated cation channels are detectors of excitatory chemical signals at synapses in the nervous system(1). Here we show that structurally distinct alpha 3 beta 4 nicotinic and P2X(2) channels influence each other when co-activated. The activation of one channel type affects distinct kinetic and conductance states of the other, and co-activation results in non-additive responses owing to inhibition of both channel types. State-dependent inhibition of nicotinic channels is revealed most clearly with mutant P2X(2) channels, and inhibition is decreased at lower densities of channel expression. In synaptically coupled myenteric neurons, nicotinic fast excitatory postsynaptic currents are occluded during activation of endogenously co-expressed P2X channels. Our data provide a molecular basis and a synaptic context for cross-inhibition between transmitter-gated channels.	CALTECH, Div Biol, Pasadena, CA 91125 USA; Michigan State Univ, Dept Pharmacol & Toxicol, E Lansing, MI 48824 USA; Michigan State Univ, Program Neurosci, E Lansing, MI 48824 USA	California Institute of Technology; Michigan State University; Michigan State University	Khakh, BS (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.							Barajas-Lopez C, 1998, J PHYSIOL-LONDON, V513, P671, DOI 10.1111/j.1469-7793.1998.671ba.x; Boue-Grabot E, 2000, J BIOL CHEM, V275, P10190, DOI 10.1074/jbc.275.14.10190; BRAKE AJ, 1994, NATURE, V371, P519, DOI 10.1038/371519a0; Bueno L, 1999, Can J Gastroenterol, V13 Suppl A, p42A; Collo G, 1996, J NEUROSCI, V16, P2495; Duke TAJ, 1999, P NATL ACAD SCI USA, V96, P10104, DOI 10.1073/pnas.96.18.10104; Evans RJ, 1996, J PHYSIOL-LONDON, V497, P413, DOI 10.1113/jphysiol.1996.sp021777; FIEBER LA, 1991, J PHYSIOL-LONDON, V434, P239, DOI 10.1113/jphysiol.1991.sp018467; FIEBER LA, 1991, J PHYSIOL-LONDON, V434, P215, DOI 10.1113/jphysiol.1991.sp018466; Figl A, 1996, J GEN PHYSIOL, V107, P369, DOI 10.1085/jgp.107.3.369; Green T, 1998, NEURON, V20, P427, DOI 10.1016/S0896-6273(00)80986-1; HONORE E, 1992, EMBO J, V11, P2465, DOI 10.1002/j.1460-2075.1992.tb05311.x; Khakh BS, 1999, NAT NEUROSCI, V2, P322, DOI 10.1038/7233; LABARCA C, 1995, NATURE, V376, P514, DOI 10.1038/376514a0; Liu F, 2000, NATURE, V403, P274, DOI 10.1038/35002014; Lutz PL, 1997, BRAIN RES, V769, P281, DOI 10.1016/S0006-8993(97)00719-1; Miyazawa A, 1999, J MOL BIOL, V288, P765, DOI 10.1006/jmbi.1999.2721; NAKAZAWA K, 1994, J NEUROSCI, V14, P740; North RA, 1996, CURR OPIN CELL BIOL, V8, P474, DOI 10.1016/S0955-0674(96)80023-8; Rogers M, 1997, J NEUROPHYSIOL, V77, P1407, DOI 10.1152/jn.1997.77.3.1407; Searl TJ, 1998, J PHYSIOL-LONDON, V510, P783, DOI 10.1111/j.1469-7793.1998.783bj.x; TALEB O, 1994, EMBO J, V13, P1318, DOI 10.1002/j.1460-2075.1994.tb06384.x; Virginio C, 1999, NAT NEUROSCI, V2, P315, DOI 10.1038/7225; Xu W, 1999, P NATL ACAD SCI USA, V96, P5746, DOI 10.1073/pnas.96.10.5746; Xu W, 1999, J NEUROSCI, V19, P9298; Zhou XP, 1996, J PHYSIOL-LONDON, V496, P719, DOI 10.1113/jphysiol.1996.sp021722; Zhou XP, 1998, J PHYSIOL-LONDON, V513, P685, DOI 10.1111/j.1469-7793.1998.685ba.x	27	148	155	0	6	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 27	2000	406	6794					405	410		10.1038/35019066	http://dx.doi.org/10.1038/35019066			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	337WC	10935636				2022-12-28	WOS:000088383800046
J	Agarwal, S; Roeder, GS				Agarwal, S; Roeder, GS			Zip3 provides a link between recombination enzymes and synaptonemal complex proteins	CELL			English	Article							HOMOLOGOUS CHROMOSOME SYNAPSIS; SACCHAROMYCES-CEREVISIAE; MEIOTIC RECOMBINATION; BUDDING YEAST; MUTS HOMOLOG; MEIOSIS; PHOSPHORYLATION; INTERACT; EXCHANGE; NODULES	In budding yeast, absence of the meiosis-specific Zip3 protein (also known as Cst9) causes synaptonemal complex formation to be delayed and incomplete. The Zip3 protein colocalizes with Zip2 at discrete foci on meiotic chromosomes, corresponding to the sites where synapsis initiates. Observations suggest that Zip3 promotes synapsis by recruiting the Zip2 protein to chromosomes and/or stabilizing the association of Zip2 with chromosomes. Zip3 interacts with a number of gene products involved in meiotic recombination, including proteins that act at both early (Mre11, Rad51, and Rad57) and late (Msh4 and Msh5) steps in the exchange process. We speculate that Zip3 is a component of recombination nodules and serves to link the initiation of synapsis to meiotic recombination.	Yale Univ, Howard Hughes Med Inst, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Yale Univ, Howard Hughes Med Inst, Dept Genet, New Haven, CT 06520 USA	Howard Hughes Medical Institute; Yale University; Howard Hughes Medical Institute; Yale University	Roeder, GS (corresponding author), Yale Univ, Howard Hughes Med Inst, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028904] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM28904] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson LK, 1997, P NATL ACAD SCI USA, V94, P6868, DOI 10.1073/pnas.94.13.6868; Bailis JM, 2000, CELL, V101, P211, DOI 10.1016/S0092-8674(00)80831-4; Bailis JM, 1998, GENE DEV, V12, P3551, DOI 10.1101/gad.12.22.3551; BISHOP DK, 1994, CELL, V79, P1081, DOI 10.1016/0092-8674(94)90038-8; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Chua PR, 1998, CELL, V93, P349, DOI 10.1016/S0092-8674(00)81164-2; Dernburg AF, 1998, CELL, V94, P387, DOI 10.1016/S0092-8674(00)81481-6; Dong HJ, 2000, J CELL BIOL, V148, P417, DOI 10.1083/jcb.148.3.417; GAME JC, 1989, GENETICS, V123, P695; Gasior SL, 1998, GENE DEV, V12, P2208, DOI 10.1101/gad.12.14.2208; GOLDWAY M, 1993, GENETICS, V133, P159; Haber JE, 1998, CELL, V95, P583, DOI 10.1016/S0092-8674(00)81626-8; HAWLEY RS, 1980, GENETICS, V94, P625; HOLLINGSWORTH NM, 1995, GENE DEV, V9, P1728, DOI 10.1101/gad.9.14.1728; KELLOGG DR, 1995, J CELL BIOL, V130, P661, DOI 10.1083/jcb.130.3.661; MALONE RE, 1983, MOL GEN GENET, V189, P405, DOI 10.1007/BF00325902; McKim KS, 1998, SCIENCE, V279, P876, DOI 10.1126/science.279.5352.876; MITCHELL AP, 1994, MICROBIOL REV, V58, P56, DOI 10.1128/MMBR.58.1.56-70.1994; Nelms BE, 1998, SCIENCE, V280, P590, DOI 10.1126/science.280.5363.590; Ouspenski II, 1999, NUCLEIC ACIDS RES, V27, P3001, DOI 10.1093/nar/27.15.3001; PAQUES F, 1999, MOL BIO REV, V63, P319; Pochart P, 1997, J BIOL CHEM, V272, P30345, DOI 10.1074/jbc.272.48.30345; ROCKMILL B, 1990, GENETICS, V126, P563; Rockmill B, 1998, GENE DEV, V12, P2574, DOI 10.1101/gad.12.16.2574; Roeder GS, 1997, GENE DEV, V11, P2600, DOI 10.1101/gad.11.20.2600; Ross-Macdonald P, 1999, NATURE, V402, P413, DOI 10.1038/46558; ROSSMACDONALD P, 1994, CELL, V79, P1069, DOI 10.1016/0092-8674(94)90037-X; Schmekel K, 1998, CHROMOSOME RES, V6, P155, DOI 10.1023/A:1009295115033; Seedorf M, 1999, MOL CELL BIOL, V19, P1547; Sung P, 1997, GENE DEV, V11, P1111, DOI 10.1101/gad.11.9.1111; SYM M, 1995, J CELL BIOL, V128, P455, DOI 10.1083/jcb.128.4.455; SYM M, 1994, CELL, V79, P283, DOI 10.1016/0092-8674(94)90197-X; TYERS M, 1992, EMBO J, V11, P1773, DOI 10.1002/j.1460-2075.1992.tb05229.x; Usui T, 1998, CELL, V95, P705, DOI 10.1016/S0092-8674(00)81640-2; XU LZ, 1995, MOL CELL BIOL, V15, P6572; Yoshida K, 1998, MOL CELL, V1, P707, DOI 10.1016/S1097-2765(00)80070-2; Zeng XM, 1999, J CELL BIOL, V146, P415, DOI 10.1083/jcb.146.2.415; ZETKA M, 1995, TRENDS GENET, V11, P27, DOI 10.1016/S0168-9525(00)88983-0	39	206	212	0	18	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 21	2000	102	2					245	255		10.1016/S0092-8674(00)00029-5	http://dx.doi.org/10.1016/S0092-8674(00)00029-5			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	337NA	10943844	Bronze			2022-12-28	WOS:000088366800014
J	Ruiz-Gomez, M; Coutts, N; Price, A; Taylor, MV; Bate, M				Ruiz-Gomez, M; Coutts, N; Price, A; Taylor, MV; Bate, M			Drosophila dumbfounded: A myoblast attractant essential for fusion	CELL			English	Article							MAMMALIAN SKELETAL-MUSCLES; SECONDARY MYOTUBES; GENE-EXPRESSION; HOMEOBOX GENE; CELL FATES; EMBRYOGENESIS; PROTEIN; WINGLESS; EMBRYOS; FIBER	Aggregation and fusion of myoblasts to form myotubes is essential for myogenesis in many organisms. In Drosophila the formation of syncytial myotubes is seeded by founder myoblasts. Founders fuse with clusters of fusion-competent myoblasts. Here we identify the gene dumbfounded (duf) and show that it is required for myoblast aggregation and fusion. duf encodes a member of the immunoglobulin superfamily of proteins that is an attractant for fusion-competent myoblasts. It is expressed by founder cells and serves to attract clusters of myoblasts from which myotubes form by fusion.	Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	University of Cambridge	Ruiz-Gomez, M (corresponding author), Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain.		Ruiz-Gómez, Mar/K-9266-2014; Taylor, Michael/A-8204-2010; Price, Alivia/AAX-4614-2021	Ruiz-Gómez, Mar/0000-0002-9024-1400; Taylor, Michael/0000-0003-1351-939X; Price, Alivia/0000-0002-0890-4667				ALTSCHUL SF, 1990, P NATL ACAD SCI USA, V87, P5509, DOI 10.1073/pnas.87.14.5509; Bate Michael, 1993, P1013; Baylies MK, 1996, SCIENCE, V272, P1481, DOI 10.1126/science.272.5267.1481; Baylies MK, 1998, CELL, V93, P921, DOI 10.1016/S0092-8674(00)81198-8; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brook WJ, 1996, SCIENCE, V273, P1373, DOI 10.1126/science.273.5280.1373; BROWN NH, 1988, J MOL BIOL, V203, P425, DOI 10.1016/0022-2836(88)90010-1; Calleja M, 1996, SCIENCE, V274, P252, DOI 10.1126/science.274.5285.252; CARMENA A, 1995, GENE DEV, V9, P2373, DOI 10.1101/gad.9.19.2373; CAVENER DR, 1991, NUCLEIC ACIDS RES, V19, P3185, DOI 10.1093/nar/19.12.3185; CHIBA A, 1993, J NEUROSCI, V13, P714; COHEN B, 1991, MECH DEVELOP, V33, P229, DOI 10.1016/0925-4773(91)90030-A; Doberstein SK, 1997, J CELL BIOL, V136, P1249, DOI 10.1083/jcb.136.6.1249; DOHRMANN C, 1990, GENE DEV, V4, P2098, DOI 10.1101/gad.4.12a.2098; DUXSON MJ, 1989, DEVELOPMENT, V107, P243; DUXSON MJ, 1989, DEVELOPMENT, V107, P743; Frasch M, 1999, CURR OPIN GENET DEV, V9, P522, DOI 10.1016/S0959-437X(99)00014-3; Gelbart WM, 1999, NUCLEIC ACIDS RES, V27, P85, DOI 10.1093/nar/27.1.85; Glise B, 1997, GENE DEV, V11, P1738, DOI 10.1101/gad.11.13.1738; GONZALEZ F, 1991, MECH DEVELOP, V35, P43, DOI 10.1016/0925-4773(91)90040-D; HARRIS AJ, 1981, PHILOS T ROY SOC B, V293, P257, DOI 10.1098/rstb.1981.0076; HARRIS AJ, 1989, DEVELOPMENT, V107, P771; HO RK, 1983, NATURE, V301, P66, DOI 10.1038/301066a0; Hughes SM, 1999, CURR OPIN NEUROBIOL, V9, P54, DOI 10.1016/S0959-4388(99)80007-5; JELLIES J, 1990, TRENDS NEUROSCI, V13, P126, DOI 10.1016/0166-2236(90)90003-S; Kardon G, 1998, DEVELOPMENT, V125, P4019; Keller CA, 1998, DEV BIOL, V202, P157, DOI 10.1006/dbio.1998.9009; KIEHART DP, 1986, J CELL BIOL, V103, P1517, DOI 10.1083/jcb.103.4.1517; Knirr S, 1999, DEVELOPMENT, V126, P4525; Kosman D, 1998, DEV GENES EVOL, V208, P290, DOI 10.1007/s004270050184; LAWRENCE PA, 1982, NATURE, V295, P55, DOI 10.1038/295055a0; Maeland Anne D., 1996, Molecular Biology of the Cell, V7, p39A; MLODZIK M, 1990, CELL, V60, P211, DOI 10.1016/0092-8674(90)90737-Y; Nose A, 1998, DEVELOPMENT, V125, P215; NOSE A, 1992, CELL, V70, P553, DOI 10.1016/0092-8674(92)90426-D; Paululat A, 1999, MECH DEVELOP, V83, P17, DOI 10.1016/S0925-4773(99)00029-5; Ramirez-Weber FA, 1999, CELL, V97, P599, DOI 10.1016/S0092-8674(00)80771-0; RAMOS RGP, 1989, GENETICS, V123, P337; RAMOS RGP, 1993, GENE DEV, V7, P2533, DOI 10.1101/gad.7.12b.2533; Rizki T.M., 1978, P397; RuizGomez M, 1997, DEVELOPMENT, V124, P3407; RUSHTON E, 1995, DEVELOPMENT, V121, P1979; Simpson P, 1997, CURR OPIN GENET DEV, V7, P537, DOI 10.1016/S0959-437X(97)80083-4; Taylor MV, 2000, DEV BIOL, V220, P37, DOI 10.1006/dbio.2000.9608; VANDENHEUVEL M, 1989, CELL, V59, P739, DOI 10.1016/0092-8674(89)90020-2; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5	46	248	251	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 21	2000	102	2					189	198		10.1016/S0092-8674(00)00024-6	http://dx.doi.org/10.1016/S0092-8674(00)00024-6			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	337NA	10943839	Bronze			2022-12-28	WOS:000088366800009
J	Le Souef, PN; Goldblatt, J; Lynch, NR				Le Souef, PN; Goldblatt, J; Lynch, NR			Evolutionary adaptation of inflammatory immune responses in human beings	LANCET			English	Article							EPSILON-RI-BETA; BETA(2)-ADRENORECEPTOR GENE; ETHNIC-DIFFERENCES; ASTHMA; PREVALENCE; CHILDREN; POLYMORPHISMS; ASSOCIATION; RATES; RACE	Modern man's ancestors lived in an environment where Infectious, tropical diseases would have been endemic. We postulate that this relatively hostile environment would have caused genetic selection for Increased proinflammatory immune responses. On migrating to temperate regions, pronounced proinflammatory responses would have been less important and selected against due to increased mortality from overly vigorous responses to harmless environmental agents. This hypothesis is supported by the observation that proinflammatory alleles In several genes involved in Inflammation are more prevalent in populations with long-term tropical ancestry than those with long-term residence in temperate regions. In addition, when the former populations relocate from a tropical to a temperate region, they have a higher incidence of allergic inflammatory diseases than the latter populations. These observations suggest that there may be general patterns of recent evolutionary adaptation of the human immune system to particular regions and that these adaptations can produce differences in disease susceptibility.	Univ Western Australia, Princess Margaret Hosp Children, Dept Paediat, Perth, WA 6001, Australia; Cent Univ Venezuela, Inst Biomed, Caracas, Venezuela	University of Western Australia; University of Central Venezuela	Le Souef, PN (corresponding author), Univ Western Australia, Princess Margaret Hosp Children, Dept Paediat, GPO Box D184, Perth, WA 6001, Australia.		Le Souef, Peter N/H-5256-2014; Lynch, Natalie/GSI-7336-2022	Le Souef, Peter/0000-0003-0930-1654				Beasley R, 1998, LANCET, V351, P1225, DOI 10.1016/S0140-6736(97)07302-9; Burchard EG, 1999, AM J RESP CRIT CARE, V160, P919, DOI 10.1164/ajrccm.160.3.9812024; Burchard EG, 1999, AM J RESP CRIT CARE, V159, pA645; Diamond J, 1998, GUNS GERMS STEEL; DIECHMANN K, 1997, BIOCHEM BIOPH RES CO, V231, P696; DOWSE GK, 1985, J ALLERGY CLIN IMMUN, V75, P75, DOI 10.1016/0091-6749(85)90016-8; Eber E., 1998, European Respiratory Journal, V12, p443S; GILLAM SJ, 1989, BRIT MED J, V299, P953, DOI 10.1136/bmj.299.6705.953; Gilthorpe MS, 1998, RESP MED, V92, P642, DOI 10.1016/S0954-6111(98)90511-X; GOLD DR, 1993, AM REV RESPIR DIS, V148, P10, DOI 10.1164/ajrccm/148.1.10; Green SL, 1998, AM J RESP CRIT CARE, V158, P1487, DOI 10.1164/ajrccm.158.5.9707099; HAYDEN CM, IN PRESS EUR RESP J; Hill MR, 1996, HUM MOL GENET, V5, P959, DOI 10.1093/hmg/5.7.959; Laing IA, 1998, J MED GENET, V35, P463, DOI 10.1136/jmg.35.6.463; Laing IA, 2000, AM J RESP CRIT CARE, V161, P124, DOI 10.1164/ajrccm.161.1.9904073; Leakey MG, 1998, NATURE, V393, P62, DOI 10.1038/29972; Leakey R., 1993, ORIGINS RECONSIDERED; Litonjua AA, 1999, PEDIATR PULM, V28, P394, DOI 10.1002/(SICI)1099-0496(199912)28:6<394::AID-PPUL2>3.0.CO;2-6; Lynch NR, 1999, THORAX, V54, P659, DOI 10.1136/thx.54.8.659; Lynch NR, 1998, J ALLERGY CLIN IMMUN, V101, P217, DOI 10.1016/S0091-6749(98)70386-0; Miller JE, 2000, AM J PUBLIC HEALTH, V90, P428, DOI 10.2105/AJPH.90.3.428; MILLER LH, 1976, NEW ENGL J MED, V295, P302, DOI 10.1056/NEJM197608052950602; MYERS P, 1992, RESP MED, V86, P297, DOI 10.1016/S0954-6111(06)80027-2; Nelson DA, 1997, ANN ALLERG ASTHMA IM, V78, P21, DOI 10.1016/S1081-1206(10)63365-0; Nickel R, 1999, J ALLERGY CLIN IMMUN, V103, pS174; Nickel R, 1999, J ALLERGY CLIN IMMUN, V104, P723, DOI 10.1016/S0091-6749(99)70281-2; PILLARI A, 1999, AM J RESP CRIT CARE, V159, pA645; Ramsay CE, 1999, CLIN EXP ALLERGY, V29, P1195; Ramsay CE, 1999, HUM GENET, V104, P269, DOI 10.1007/s004390050947; REISHAUS E, 1993, AM J RESPIR CELL MOL, V8, P334; ROSSENWASSER LJ, 1995, CLIN EXP ALLERGY S2, V25, P74; Sarpong SB, 1996, J ALLERGY CLIN IMMUN, V97, P1393, DOI 10.1016/S0091-6749(96)70209-9; STRINGER CB, 1997, AFRICAN EXODUS ORIGI; Stromberg BE, 1997, VET PARASITOL, V72, P247, DOI 10.1016/S0304-4017(97)00100-3; Von Behren J, 1999, J ASTHMA, V36, P575, DOI 10.3109/02770909909087294	35	76	80	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 15	2000	356	9225					242	244						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	334GQ	10963213				2022-12-28	WOS:000088179100038
J	Katona, C; Livingston, G				Katona, C; Livingston, G			Impact of screening old people with physical illness for depression?	LANCET			English	Editorial Material							COMMUNITY; ISLINGTON; SCALE; LIFE		UCL Royal Free & Univ Coll Med Sch, Dept Psychiat & Behav Sci, London W1N 8AA, England	University of London; University College London; UCL Medical School	Katona, C (corresponding author), UCL Royal Free & Univ Coll Med Sch, Dept Psychiat & Behav Sci, London W1N 8AA, England.			Katona, Cornelius/0000-0001-7451-0167; Livingston, Gill/0000-0001-6741-5516				ADSHEAD F, 1992, BRIT MED J, V305, P397, DOI 10.1136/bmj.305.6850.397; Beekman ATF, 1999, BRIT J PSYCHIAT, V174, P307, DOI 10.1192/bjp.174.4.307; Hoyl MT, 1999, J AM GERIATR SOC, V47, P873, DOI 10.1111/j.1532-5415.1999.tb03848.x; ILIFFE S, 1991, BRIT J GEN PRACT, V41, P13; KATONA C, 1997, COMORBID DEPRESSION; Katona CLE, 1997, AGING MENT HEALTH, V1, P57, DOI 10.1080/13607869757380; KODER DA, 1996, INT J GERIATR PSYCH, V11, P57; Livingston G, 1997, BRIT J PSYCHIAT, V171, P56, DOI 10.1192/bjp.171.1.56; Livingston G, 1997, J AFFECT DISORDERS, V46, P255, DOI 10.1016/S0165-0327(97)00155-9; Mittmann N, 1997, J AFFECT DISORDERS, V46, P191, DOI 10.1016/S0165-0327(97)00107-9; MULLANE MR, 1994, INVEST NEW DRUG, V12, P267, DOI 10.1007/BF00873971; Schein RL, 1997, INT J GERIATR PSYCH, V12, P436; WELLS KB, 1989, JAMA-J AM MED ASSOC, V262, P914, DOI 10.1001/jama.262.7.914; WILLIAMS EI, 1993, OCCASIONAL PAPER ROY, V59, P1	14	25	26	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 8	2000	356	9224					91	92		10.1016/S0140-6736(00)02466-1	http://dx.doi.org/10.1016/S0140-6736(00)02466-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	331UG	10963242				2022-12-28	WOS:000088036600006
J	Bayliss, R; Littlewood, T; Stewart, M				Bayliss, R; Littlewood, T; Stewart, M			Structural basis for the interaction between FxFG nucleoporin repeats and importin-beta in nuclear trafficking	CELL			English	Article							TRANSPORT FACTOR-2 NTF2; PORE COMPLEX PROTEINS; BINDING-SITES; GDP-RAN; DOMAIN; PATHWAYS; EXPORT; IDENTIFICATION; NUP153; P62	We describe the crystal structure of a complex between importin-beta residues 1-442 (Ib442) and five FxFG nucleoporin repeats from Nsp1p. Nucleoporin FxFG cores bind on the convex face of Ib442 to a primary site between the A helices of HEAT repeats 5 and 6, and to a secondary site between HEAT repeats 6 and 7. Mutations at importin-beta IIe178 in the primary FxFG binding site reduce both binding and nuclear protein import, providing direct evidence for the functional significance of the importin-beta-FxFG interaction. The FxFG binding sites on importin-beta do not overlap with the RanGTP binding site. Instead, RanGTP may release importin-beta from FxFG nucleoporins by generating a conformational change that alters the structure of the FxFG binding site.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Stewart, M (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	ms@mrc-lmb.cam.ac.uk		Bayliss, Richard/0000-0003-0604-2773				Adam SA, 1999, CURR OPIN CELL BIOL, V11, P402, DOI 10.1016/S0955-0674(99)80056-8; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bayliss R, 1999, J MOL BIOL, V293, P579, DOI 10.1006/jmbi.1999.3166; Bonifaci N, 1997, P NATL ACAD SCI USA, V94, P5055, DOI 10.1073/pnas.94.10.5055; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BUSS F, 1995, J CELL BIOL, V128, P251, DOI 10.1083/jcb.128.3.251; Chi NC, 1997, MOL BIOL CELL, V8, P945, DOI 10.1091/mbc.8.6.945; Chook YM, 1999, NATURE, V399, P230, DOI 10.1038/20375; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Clarkson WD, 1997, J MOL BIOL, V272, P716, DOI 10.1006/jmbi.1997.1255; Clarkson WD, 1996, J MOL BIOL, V263, P517, DOI 10.1006/jmbi.1996.0594; Damelin M, 2000, MOL CELL, V5, P133, DOI 10.1016/S1097-2765(00)80409-8; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; FELDHERR CM, 1984, J CELL BIOL, V99, P2216, DOI 10.1083/jcb.99.6.2216; FINLAY DR, 1990, CELL, V60, P17, DOI 10.1016/0092-8674(90)90712-N; Gorlich D, 1998, EMBO J, V17, P2721, DOI 10.1093/emboj/17.10.2721; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Gorlich D, 1996, EMBO J, V15, P5584, DOI 10.1002/j.1460-2075.1996.tb00943.x; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; GROTE M, 1995, J CELL SCI, V108, P2963; Hu TH, 1996, J CELL BIOL, V134, P589, DOI 10.1083/jcb.134.3.589; Iovine MK, 1995, J CELL BIOL, V131, P1699, DOI 10.1083/jcb.131.6.1699; Iovine MK, 1997, J CELL BIOL, V137, P797, DOI 10.1083/jcb.137.4.797; Kehlenbach RH, 1999, J CELL BIOL, V145, P645, DOI 10.1083/jcb.145.4.645; Kose S, 1999, J BIOL CHEM, V274, P3946, DOI 10.1074/jbc.274.7.3946; Kutay U, 1997, EMBO J, V16, P1153, DOI 10.1093/emboj/16.6.1153; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Melchior F, 1998, TRENDS CELL BIOL, V8, P175, DOI 10.1016/S0962-8924(98)01252-5; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Nakielny S, 1999, CELL, V99, P677, DOI 10.1016/S0092-8674(00)81666-9; Nakielny S, 1999, EMBO J, V18, P1982, DOI 10.1093/emboj/18.7.1982; NEHRBASS U, 1990, CELL, V61, P979, DOI 10.1016/0092-8674(90)90063-K; PASCHAL BM, 1995, J CELL BIOL, V129, P925, DOI 10.1083/jcb.129.4.925; Pemberton LF, 1998, CURR OPIN CELL BIOL, V10, P392, DOI 10.1016/S0955-0674(98)80016-1; Percipalle P, 1997, J MOL BIOL, V266, P722, DOI 10.1006/jmbi.1996.0801; Powers MA, 1997, J CELL BIOL, V136, P241, DOI 10.1083/jcb.136.2.241; RADU A, 1995, CELL, V81, P215, DOI 10.1016/0092-8674(95)90331-3; RADU A, 1995, P NATL ACAD SCI USA, V92, P1769, DOI 10.1073/pnas.92.5.1769; REXACH M, 1995, CELL, V83, P683, DOI 10.1016/0092-8674(95)90181-7; Rout Michael P., 1994, Trends in Cell Biology, V4, P357, DOI 10.1016/0962-8924(94)90085-X; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Seedorf M, 1999, MOL CELL BIOL, V19, P1547; Shah S, 1998, J CELL BIOL, V141, P31, DOI 10.1083/jcb.141.1.31; Shah S, 1998, CURR BIOL, V8, P1376, DOI 10.1016/S0960-9822(98)00018-9; Stewart M, 1999, NAT STRUCT BIOL, V6, P301, DOI 10.1038/7529; Stoffler D, 1999, CURR OPIN CELL BIOL, V11, P391, DOI 10.1016/S0955-0674(99)80055-6; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Talcott B, 1999, TRENDS CELL BIOL, V9, P312, DOI 10.1016/S0962-8924(99)01608-6; Vetter IR, 1999, CELL, V97, P635, DOI 10.1016/S0092-8674(00)80774-6; Yaseen NR, 1999, J BIOL CHEM, V274, P26493, DOI 10.1074/jbc.274.37.26493; Yokoya F, 1999, MOL BIOL CELL, V10, P1119, DOI 10.1091/mbc.10.4.1119	53	376	386	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 7	2000	102	1					99	108		10.1016/S0092-8674(00)00014-3	http://dx.doi.org/10.1016/S0092-8674(00)00014-3			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	332UL	10929717	Bronze			2022-12-28	WOS:000088091700012
J	Du, CY; Fang, M; Li, YC; Li, L; Wang, XD				Du, CY; Fang, M; Li, YC; Li, L; Wang, XD			Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition	CELL			English	Article							PROGRAMMED CELL-DEATH; APOPTOSIS PROTEINS; DROSOPHILA; BCL-2; GENE; RELEASE; COMPLEX; FAMILY; GRIM; PROCASPASE-9	We report here the identification of a novel protein, Smac, which promotes caspase activation in the cytochrome c/Apaf-1/caspase-9 pathway. Smac promotes caspase-9 activation by binding to inhibitor of apoptosis proteins, IAPs, and removing their inhibitory activity. Smac is normally a mitochondrial protein but is released into the cytosol when cells undergo apoptosis. Mitochondrial import and cleavage of its signal peptide are required for Smac to gain its apoptotic activity. Overexpression of Smac increases cells' sensitivity to apoptotic stimuli. Smac is the second mitochondrial protein, along with cytochrome c, that promotes apoptosis by activating caspases.	Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75235 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75235 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Wang, XD (corresponding author), Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75235 USA.			Wang, Xiaodong/0000-0001-9885-356X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057158] Funding Source: NIH RePORTER; NIGMS NIH HHS [GMRO1-57158] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Brodsky MH, 2000, CELL, V101, P103, DOI 10.1016/S0092-8674(00)80627-3; Chen P, 1996, GENE DEV, V10, P1773, DOI 10.1101/gad.10.14.1773; CROOK NE, 1993, J VIROL, V67, P2168, DOI 10.1128/JVI.67.4.2168-2174.1993; Deshmukh M, 1998, NEURON, V21, P695, DOI 10.1016/S0896-6273(00)80587-5; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Deveraux QL, 1998, EMBO J, V17, P2215, DOI 10.1093/emboj/17.8.2215; Goyal L, 2000, EMBO J, V19, P589, DOI 10.1093/emboj/19.4.589; GRETHER ME, 1995, GENE DEV, V9, P1694, DOI 10.1101/gad.9.14.1694; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Haining WN, 1999, P NATL ACAD SCI USA, V96, P4936, DOI 10.1073/pnas.96.9.4936; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Li F, 1997, J BIOL CHEM, V272, P30299, DOI 10.1074/jbc.272.48.30299; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; MacFarlane M, 1997, J CELL BIOL, V137, P469, DOI 10.1083/jcb.137.2.469; McCarthy JV, 1998, J BIOL CHEM, V273, P24009, DOI 10.1074/jbc.273.37.24009; Purring C, 1999, J AM CHEM SOC, V121, P7435, DOI 10.1021/ja991235h; Reed JC, 1997, CELL, V91, P559, DOI 10.1016/S0092-8674(00)80442-0; Rothe M, 1995, CELL, V83, P1243, DOI 10.1016/0092-8674(95)90149-3; Sambrook J., 2002, MOL CLONING LAB MANU; Schatz G, 1996, SCIENCE, V271, P1519, DOI 10.1126/science.271.5255.1519; Srinivasula SM, 1998, MOL CELL, V1, P949, DOI 10.1016/S1097-2765(00)80095-7; Takahashi R, 1998, J BIOL CHEM, V273, P7787, DOI 10.1074/jbc.273.14.7787; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; UREN AG, 1996, P NATL ACAD SCI USA, V93, P4947; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Vucic D, 1998, MOL CELL BIOL, V18, P3300, DOI 10.1128/MCB.18.6.3300; WHITE K, 1994, SCIENCE, V264, P677, DOI 10.1126/science.8171319; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; YUAN JY, 1992, DEVELOPMENT, V116, P309; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	33	2680	2899	16	166	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 7	2000	102	1					33	42		10.1016/S0092-8674(00)00008-8	http://dx.doi.org/10.1016/S0092-8674(00)00008-8			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	332UL	10929711	Bronze			2022-12-28	WOS:000088091700006
J	Ball, TM; Castro-Rodriguez, JA; Griffith, KA; Holberg, CJ; Martinez, FD; Wright, AL				Ball, TM; Castro-Rodriguez, JA; Griffith, KA; Holberg, CJ; Martinez, FD; Wright, AL			Siblings, day-care attendance, and the risk of asthma and wheezing during childhood	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	39th Annual Meeting of the Ambulatory-Pediatric-Association	MAY 01-04, 1999	SAN FRANCISCO, CA	Ambulatory Pediat Assoc			RESPIRATORY-TRACT ILLNESS; HAY-FEVER; 1ST YEAR; CHILDREN; ALLERGEN; ATOPY; LIFE; SENSITIZATION; RESPONSES; DISEASE	Background: Young children with older siblings and those who attend day care are at increased risk for infections, which in turn may protect against the development of allergic diseases, including asthma. However, the results of studies examining the relation between exposure to other children and the subsequent development of asthma have been conflicting. Methods: In a study involving 1035 children followed since birth as part of the Tucson Children's Respiratory Study, we determined the incidence of asthma (defined as at least one episode of asthma diagnosed by a physician when the child was 6 to 13 years old) and the prevalence of frequent wheezing (more than three wheezing episodes during the preceding year) in relation to the number of siblings at home and in relation to attendance at day care during infancy. Results: The presence of one or more older siblings at home protected against the development of asthma (adjusted relative risk for each additional older sibling, 0.8; 95 percent confidence interval, 0.7 to 1.0; P = 0.04), as did attendance at day care during the first six months of life (adjusted relative risk, 0.4; 95 percent confidence interval, 0.2 to 1.0; P = 0.04). Children with more exposure to other children at home or at day care were more likely to have frequent wheezing at the age of 2 years than children with little or no exposure (adjusted relative risk, 1.4; 95 percent confidence interval, 1.1 to 1.8; P = 0.01) but were less likely to have frequent wheezing from the age of 6 (adjusted relative risk, 0.8; 95 percent confidence interval, 0.6 to 1.0; P = 0.03) through the age of 13 (adjusted relative risk, 0.3; 95 percent confidence interval, 0.2 to 0.5; P<0.001). Conclusions: Exposure of young children to older children at home or to other children at day care protects against the development of asthma and frequent wheezing later in childhood. (N Engl J Med 2000;343:538-43.) (C)2000, Massachusetts Medical Society.	Univ Arizona, Coll Med, Resp Sci Ctr, Tucson, AZ 85724 USA; Univ Arizona, Coll Med, Dept Pediat, Tucson, AZ 85724 USA	University of Arizona; University of Arizona	Wright, AL (corresponding author), Univ Arizona, Coll Med, Resp Sci Ctr, 1501 N Campbell Ave,POB 245073, Tucson, AZ 85724 USA.	awright@resp-sci.arizona.edu	Castro-Rodriguez, Jose A./ABA-2760-2021; Castro-Rodriguez, Jose A./ABA-6591-2021	Castro-Rodriguez, Jose A./0000-0002-0708-4281	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056177, P50HL014136] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 03154, HL 14136, HL 56177] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ADAMS PF, 1995, VITAL HLTH STAT 10, V193; BACKMAN A, 1984, ALLERGY, V39, P309, DOI 10.1111/j.1398-9995.1984.tb00867.x; Halonen M, 1997, AM J RESP CRIT CARE, V155, P1356, DOI 10.1164/ajrccm.155.4.9105079; HOLBERG CJ, 1993, PEDIATRICS, V91, P885; KJELLMAN NIM, 1976, CLIN ALLERGY, V6, P51, DOI 10.1111/j.1365-2222.1976.tb01411.x; Kramer U, 1999, LANCET, V353, P450, DOI 10.1016/S0140-6736(98)06329-6; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Lombardi E, 1997, AM J RESP CRIT CARE, V156, P1863, DOI 10.1164/ajrccm.156.6.9612066; Mannino D M, 1998, MMWR CDC Surveill Summ, V47, P1; Marbury MC, 1997, AM J RESP CRIT CARE, V155, P156, DOI 10.1164/ajrccm.155.1.9001305; Martinez FD, 1999, J ALLERGY CLIN IMMUN, V103, P355, DOI 10.1016/S0091-6749(99)70456-2; Matricardi PM, 1997, BRIT MED J, V314, P999, DOI 10.1136/bmj.314.7086.999; Nafstad P, 1999, PEDIATRICS, V103, P753, DOI 10.1542/peds.103.4.753; OSTERHOLM MT, 1994, PEDIATRICS, V94, P987; Ponsonby AL, 1998, ARCH DIS CHILD, V79, P328, DOI 10.1136/adc.79.4.328; Prescott SL, 1999, LANCET, V353, P196, DOI 10.1016/S0140-6736(98)05104-6; Rona RJ, 1997, J ALLERGY CLIN IMMUN, V99, P454, DOI 10.1016/S0091-6749(97)70070-8; Shaheen SO, 1996, LANCET, V347, P1792, DOI 10.1016/S0140-6736(96)91617-7; Shirakawa T, 1997, SCIENCE, V275, P77, DOI 10.1126/science.275.5296.77; SILVERMAN M, 1993, THORAX, V48, P1200, DOI 10.1136/thx.48.12.1200; SPORIK R, 1990, NEW ENGL J MED, V323, P502, DOI 10.1056/NEJM199008233230802; Stein RT, 1997, THORAX, V52, P946, DOI 10.1136/thx.52.11.946; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Strachan DP, 1997, J ALLERGY CLIN IMMUN, V99, P6, DOI 10.1016/S0091-6749(97)81038-X; Strachan DP, 1996, ARCH DIS CHILD, V74, P422, DOI 10.1136/adc.74.5.422; TAUSSIG LM, 1989, AM J EPIDEMIOL, V129, P1219, DOI 10.1093/oxfordjournals.aje.a115242; TAUSSIG LM, 1995, AM J RESP CRIT CARE, V151, pS32, DOI 10.1164/ajrccm/151.2_Pt_2.S32; *US BUR CENS, 1998, CURR POP REP P20, V515; *US BUR CENS, 1976, CURR POP REP P20, V291, P4; VONMUTIUS E, 1994, BRIT MED J, V308, P692, DOI 10.1136/bmj.308.6930.692; WEST J, 1995, DHEW PUBL NCES; WISSOW LS, 1988, AM J PUBLIC HEALTH, V78, P777, DOI 10.2105/AJPH.78.7.777; WRIGHT AL, 1989, BRIT MED J, V299, P946, DOI 10.1136/bmj.299.6705.946; WRIGHT AL, 1989, AM J EPIDEMIOL, V129, P1232, DOI 10.1093/oxfordjournals.aje.a115243; YUNGINGER JW, 1992, AM REV RESPIR DIS, V146, P888, DOI 10.1164/ajrccm/146.4.888	35	656	680	0	30	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 24	2000	343	8					538	543		10.1056/NEJM200008243430803	http://dx.doi.org/10.1056/NEJM200008243430803			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	346QM	10954761				2022-12-28	WOS:000088882600003
J	[Anonymous]				[Anonymous]			Mergers and acquisitions rock UK chemical industry infrastructure	NATURE			English	Article																			0	0	0	2	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 17	2000	406	6797					812	812		10.1038/35021195	http://dx.doi.org/10.1038/35021195			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	344PH	10963615				2022-12-28	WOS:000088767700063
J	Isaacs, D; Fitzgerald, D				Isaacs, D; Fitzgerald, D			Ten e-pistles for the e-fficient trimillennial physician	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 16	2000	284	7					806	806		10.1001/jama.284.7.806	http://dx.doi.org/10.1001/jama.284.7.806			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	342PM	10938151				2022-12-28	WOS:000088654400001
J	Kramer, MS; Demissie, K; Yang, H; Platt, RW; Sauve, R; Liston, R				Kramer, MS; Demissie, K; Yang, H; Platt, RW; Sauve, R; Liston, R		Fetal Infant Hlth Study Grp Canadi	The contribution of mild and moderate preterm birth to infant mortality	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NEONATAL MORBIDITY; WEIGHT INFANTS; OUTCOMES; CHILDREN; DELIVERY; COHORT; DEATH; RISK; BORN; CARE	Context The World Health Organization defines preterm birth as birth at less than 37 completed gestational weeks, but most studies have focused on very preterm infants (birth at <32 weeks) because of their high risk of mortality and serious morbidity. However, infants born at 32 through 36 weeks are more common and their public health impact has not been well studied. Objective To assess the quantitative contribution of mild (birth at 34-36 gestational weeks) and moderate (birth at 32-33 gestational weeks) preterm birth to infant mortality. Design, Setting, and Participants Population-based cohort study using linked singleton live birth-infant death cohort files for US birth cohorts for 1985 and 1995 and Canadian birth cohorts (excluding Ontario) for 1985-1987 and 1992-1994. Main Outcome Measures Relative risks (RRs) and etiologic fractions (EFs) for overall and cause-specific early neonatal (age 0-6 days), late neonatal (age 7-27 days), postneonatal (age 28-364 days), and total infant death among mild and moderate preterm births vs term births (at greater than or equal to 37 gestational weeks). Results Relative risks for infant death from ail causes among singletons born at 32 through 33 gestational weeks were 6.6 (95% confidence interval [CI], 6.1-7.0) in the United States in 1995 and 15.2 (95% CI, 13.2-17.5) in Canada in 1992-1994; among singletons born at 34 through 36 gestational weeks, the RRs were 2.9 (95% CI, 2.8-3.0) and 4.5 (95% CI, 4.0-5.0), respectively. Corresponding EFs were 3.2% and 4.8%, respectively, at 32 through 33 gestational weeks and 6.3% and 8.0%, respectively, at 34 through 36 gestational weeks; the sum of the EFs for births at 32 through 33 and 34 through 36 gestational weeks exceeded those for births at 28 through 31 gestational weeks. Substantial RRs were observed overall for the neonatal (eg, for early neonatal deaths, 14.6 and 33.0 for US and Canadian infants, respectively, born at 32-33 gestational weeks; EFs, 3.6% and and 6.2% for US and Canadian infants, respectively) and postneonatal (RRs, 2.1-3.8 and 3.0-7.0 for US and Canadian infants, respectively, born at 32-36 gestational weeks; EFs, 2.7%-5.8% and 3.0%-7.0% for the same groups, respectively) periods and for death due to asphyxia, infection, sudden infant death syndrome, and external causes. Except for a reduction in the RR and EF for neonatal mortality due to infection, the patterns have changed little since 1985 in either country. Conclusions Mild- and moderate-preterm birth infants are at high RR for death during infancy and are responsible for an important fraction of infant deaths.	McGill Univ, Fac Med, Dept Pediat, Montreal, PQ, Canada; McGill Univ, Fac Med, Dept Epidemiol & Biostat, Montreal, PQ, Canada; Hlth Canada, Vur Reprod & Child Hlth, Lab Ctr Dis Control, Ottawa, ON, Canada; Univ Med & Dent New Jersey, Dept Environm & Community Med, Piscataway, NJ 08854 USA; Univ Calgary, Fac Med, Dept Pediat, Calgary, AB, Canada; Univ Calgary, Fac Med, Dept Community Med, Calgary, AB, Canada; Univ British Columbia, Dept Obstet & Gynecol, Vancouver, BC V5Z 1M9, Canada	McGill University; McGill University; Health Canada; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Calgary; University of Calgary; University of British Columbia	Kramer, MS (corresponding author), 1020 Pine Ave W, Montreal, PQ H3A 1A2, Canada.	mkrame@po-box.mcgill.ca		Platt, Robert/0000-0002-5981-8443				[Anonymous], 1985, PREV LOW BIRTHW; COLE S, 1989, ACTA OBSTET GYN SCAN, V68, P113, DOI 10.3109/00016348909009897; DOLLFUS C, 1990, PEDIATRICS, V86, P176; Doyle LW, 1999, MED J AUSTRALIA, V170, P528, DOI 10.5694/j.1326-5377.1999.tb127877.x; Goldenberg RL, 1998, NEW ENGL J MED, V339, P313, DOI 10.1056/NEJM199807303390506; Gould JB, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.3.e37; HACK M, 1994, NEW ENGL J MED, V331, P753, DOI 10.1056/NEJM199409223311201; Kalter HD, 1998, AM J PUBLIC HEALTH, V88, P816, DOI 10.2105/AJPH.88.5.816; Kimberlin DF, 1999, AM J OBSTET GYNECOL, V180, P683, DOI 10.1016/S0002-9378(99)70273-5; LEE K, 1995, AM J EPIDEMIOL, V141, P1188, DOI 10.1093/oxfordjournals.aje.a117392; MCCORMICK MC, 1985, NEW ENGL J MED, V312, P82, DOI 10.1056/NEJM198501103120204; MIETTINE.OS, 1974, AM J EPIDEMIOL, V99, P325, DOI 10.1093/oxfordjournals.aje.a121617; MORRISON JC, 1990, OBSTET GYNECOL, V76, pS5; O'Shea TM, 1998, PEDIATRICS, V101, P642, DOI 10.1542/peds.101.4.642; Platt RW, 1999, AM J EPIDEMIOL, V149, pS50; Richardson DK, 1998, PEDIATRICS, V102, P893, DOI 10.1542/peds.102.4.893; ROBERTSON PA, 1992, AM J OBSTET GYNECOL, V166, P1629, DOI 10.1016/0002-9378(92)91551-K; RUSH RW, 1976, BRIT MED J, V2, P965, DOI 10.1136/bmj.2.6042.965; Saigal S, 1996, JAMA-J AM MED ASSOC, V276, P453, DOI 10.1001/jama.276.6.453; Schendel DE, 1997, AM J EPIDEMIOL, V146, P740; Sutton L, 1999, PAEDIATR PERINAT EP, V13, P288; *WHO, 1970, WHO TECHN REP SER, V457; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	23	480	500	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 16	2000	284	7					843	849		10.1001/jama.284.7.843	http://dx.doi.org/10.1001/jama.284.7.843			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	342PM	10938173	Bronze			2022-12-28	WOS:000088654400026
J	Ghani, AC; Ferguson, NM; Donnelly, CA; Anderson, RM				Ghani, AC; Ferguson, NM; Donnelly, CA; Anderson, RM			Predicted vCJD mortality in Great Britain - Modelling the latest data puts a ceiling on the likely number of vCJD cases.	NATURE			English	Article									Univ Oxford, Wellcome Trust Ctr Epidemiol Infect Dis, Oxford OX1 3FY, England	University of Oxford	Ghani, AC (corresponding author), Univ Oxford, Wellcome Trust Ctr Epidemiol Infect Dis, Oxford OX1 3FY, England.		Ghani, Azra/B-8560-2009; Ferguson, Neil/B-8578-2008	Ferguson, Neil/0000-0002-1154-8093; Ghani, Azra/0000-0002-0007-4910; Donnelly, Christl/0000-0002-0195-2463; Anderson, Roy/0000-0002-9528-3175				Anderson RM, 1996, NATURE, V382, P779, DOI 10.1038/382779a0; *EUR UN SCI STEER, 1999, OP SCI STEER COMM HU; Ferguson NM, 1997, PHILOS T R SOC B, V352, P803, DOI 10.1098/rstb.1997.0063; Ghani AC, 2000, P ROY SOC B-BIOL SCI, V267, P23, DOI 10.1098/rspb.2000.0961; Ghani AC, 1998, P ROY SOC B-BIOL SCI, V265, P2443, DOI 10.1098/rspb.1998.0596; Ironside JW, 2000, LANCET, V355, P1693, DOI 10.1016/S0140-6736(00)02243-1	6	157	161	0	11	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 10	2000	406	6796					583	584		10.1038/35020688	http://dx.doi.org/10.1038/35020688			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	342PF	10949288				2022-12-28	WOS:000088653800033
J	Kaupp, UB; Weyand, I				Kaupp, UB; Weyand, I			Cell biology - A universal bicarbonate sensor	SCIENCE			English	Editorial Material							HYPERPOLARIZATION-ACTIVATED CHANNEL; ADENYLATE-CYCLASE; SPERM; SPERMATOZOA; PHOSPHORYLATION; MOTILITY; RAP1		Forschungszentrum Julich, Inst Biol Informat Verarbeitung, Julich, Germany	Helmholtz Association; Research Center Julich	Kaupp, UB (corresponding author), Forschungszentrum Julich, Inst Biol Informat Verarbeitung, Julich, Germany.	a.eckert@fz.juelich.de; i.weyand@fz-juelich.de						Buck J, 1999, P NATL ACAD SCI USA, V96, P79, DOI 10.1073/pnas.96.1.79; Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625; Darszon A, 1999, PHYSIOL REV, V79, P481, DOI 10.1152/physrev.1999.79.2.481; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Eisenbach M, 1999, BIOESSAYS, V21, P203, DOI 10.1002/(SICI)1521-1878(199903)21:3<203::AID-BIES4>3.0.CO;2-T; GARTY NB, 1987, FEBS LETT, V218, P148, DOI 10.1016/0014-5793(87)81036-0; Gauss R, 1998, NATURE, V393, P583, DOI 10.1038/31248; GAUSS R, IN PRESS CHRONOBIOL; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; LEVINE N, 1971, J PHYSIOL-LONDON, V213, P557, DOI 10.1113/jphysiol.1971.sp009400; OKAMURA N, 1991, J BIOL CHEM, V266, P17754; OKAMURA N, 1985, J BIOL CHEM, V260, P9699; Seifert R, 1999, P NATL ACAD SCI USA, V96, P9391, DOI 10.1073/pnas.96.16.9391; TASH JS, 1989, CELL MOTIL CYTOSKEL, V14, P332, DOI 10.1002/cm.970140303; VISCONTI PE, 1995, DEVELOPMENT, V121, P1139; WARD CR, 1993, DEV BIOL, V158, P9, DOI 10.1006/dbio.1993.1165	16	19	20	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 28	2000	289	5479					559	560		10.1126/science.289.5479.559	http://dx.doi.org/10.1126/science.289.5479.559			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	338XD	10939966				2022-12-28	WOS:000088447800030
J	Heinrich, SU; Mothes, W; Brunner, J; Rapoport, TA				Heinrich, SU; Mothes, W; Brunner, J; Rapoport, TA			The Sec61p complex mediates the integration of a membrane protein by allowing lipid partitioning of the transmembrane domain	CELL			English	Article							ENDOPLASMIC-RETICULUM MEMBRANE; SIGNAL SEQUENCE RECOGNITION; POSITIVELY CHARGED RESIDUES; CONDUCTING CHANNEL; ANCHOR PROTEINS; TRANSLOCATION; INSERTION; TOPOLOGY; ORIENTATION; BIOGENESIS	We have investigated how the transmembrane (TM) domain of a membrane protein is cotranslationally integrated into the endoplasmic reticulum. We demonstrate that the Sec61p channel allows the TM domain to bypass the barrier posed by the polar head groups of the lipid bilayer and come into contact with the hydrophobic interior of the membrane. Together with the TRAM protein, Sec61p provides a site in the membrane, at the interface of channel and lipid, through which a TM domain can dynamically equilibrate between the lipid and aqueous phases, depending on the hydrophobicity of the TM domain and the length of the polypeptide segment tethering it to the ribosome. Our results suggest a unifying, lipid-partitioning model which can explain the general behavior of hydrophobic topogenic sequences.	Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; ETH Zurich, Biochem Lab, CH-8092 Zurich, Switzerland	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Swiss Federal Institutes of Technology Domain; ETH Zurich	Rapoport, TA (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA.				NIGMS NIH HHS [GM52586] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052586] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Borel AC, 1996, CELL, V85, P379, DOI 10.1016/S0092-8674(00)81116-2; BRUNNER J, 1980, J BIOL CHEM, V255, P3313; Denzer AJ, 1995, EMBO J, V14, P6311, DOI 10.1002/j.1460-2075.1995.tb00321.x; Do H, 1996, CELL, V85, P369, DOI 10.1016/S0092-8674(00)81115-0; GORLICH D, 1992, NATURE, V357, P47, DOI 10.1038/357047a0; GORLICH D, 1993, CELL, V75, P615, DOI 10.1016/0092-8674(93)90483-7; HARTMANN E, 1989, P NATL ACAD SCI USA, V86, P5786, DOI 10.1073/pnas.86.15.5786; Hegde RS, 1997, CELL, V91, P575, DOI 10.1016/S0092-8674(00)80445-6; HIGH S, 1993, J CELL BIOL, V121, P743, DOI 10.1083/jcb.121.4.743; JUNGNICKEL B, 1995, CELL, V82, P261, DOI 10.1016/0092-8674(95)90313-5; Kopito RR, 1997, CELL, V88, P427, DOI 10.1016/S0092-8674(00)81881-4; MARTOGLIO B, 1995, CELL, V81, P207, DOI 10.1016/0092-8674(95)90330-5; Matlack KES, 1998, CELL, V92, P381, DOI 10.1016/S0092-8674(00)80930-7; Mothes W, 1998, J CELL BIOL, V142, P355, DOI 10.1083/jcb.142.2.355; Mothes W, 1997, CELL, V89, P523, DOI 10.1016/S0092-8674(00)80234-2; PARKS GD, 1991, CELL, V64, P777, DOI 10.1016/0092-8674(91)90507-U; Plath K, 1998, CELL, V94, P795, DOI 10.1016/S0092-8674(00)81738-9; RAPOPORT TA, 1985, FEBS LETT, V187, P1, DOI 10.1016/0014-5793(85)81202-3; SAKAGUCHI M, 1987, EMBO J, V6, P2425, DOI 10.1002/j.1460-2075.1987.tb02521.x; SIMON SM, 1991, CELL, V65, P371, DOI 10.1016/0092-8674(91)90455-8; SINGER SJ, 1987, P NATL ACAD SCI USA, V84, P1960, DOI 10.1073/pnas.84.7.1960; Voigt S, 1996, J CELL BIOL, V134, P25, DOI 10.1083/jcb.134.1.25; VONHEIJNE G, 1986, EMBO J, V5, P3021, DOI 10.1002/j.1460-2075.1986.tb04601.x; VONHEIJNE G, 1989, NATURE, V341, P456, DOI 10.1038/341456a0; WALTER P, 1994, ANNU REV CELL BIOL, V10, P87, DOI 10.1146/annurev.cb.10.110194.000511	25	209	213	0	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 21	2000	102	2					233	244		10.1016/S0092-8674(00)00028-3	http://dx.doi.org/10.1016/S0092-8674(00)00028-3			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	337NA	10943843	Bronze			2022-12-28	WOS:000088366800013
J	Bounameaux, H				Bounameaux, H			Factor V Leiden paradox: risk of deep-vein thrombosis but not of pulmonary embolism	LANCET			English	Editorial Material							ACTIVATED PROTEIN-C; MUTATION; POPULATION; RESISTANCE		Univ Hosp Geneva, Div Angiol & Haemostasis, CH-1211 Geneva 14, Switzerland	University of Geneva	Bounameaux, H (corresponding author), Univ Hosp Geneva, Div Angiol & Haemostasis, CH-1211 Geneva 14, Switzerland.							Baglin TP, 1997, THROMB HAEMOSTASIS, V77, P1219; Bajzar L, 1996, J BIOL CHEM, V271, P22949, DOI 10.1074/jbc.271.38.22949; BERTINA RM, 1994, NATURE, V369, P64, DOI 10.1038/369064a0; Bjorgell O, 2000, THROMB HAEMOSTASIS, V83, P648; Dahlback B, 2000, LANCET, V355, P1627, DOI 10.1016/S0140-6736(00)02225-X; DAHLBACK B, 1993, P NATL ACAD SCI USA, V90, P1004, DOI 10.1073/pnas.90.3.1004; DEMOERLOOSE P, IN PRESS BR J HAEMAT; Desmarais S, 1996, LANCET, V347, P1374, DOI 10.1016/S0140-6736(96)91013-2; Ehrenforth S., 2000, Haemostasis, V30, P36; Manten B, 1996, THROMB HAEMOSTASIS, V76, P510; Marinelli I, 1997, THROMB HAEMOSTASIS, V77, P440; MEYER G, IN PRESS AM J MED; Turkstra F, 1999, THROMB HAEMOSTASIS, V81, P345; vantVeer C, 1997, J BIOL CHEM, V272, P20721, DOI 10.1074/jbc.272.33.20721	14	93	95	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 15	2000	356	9225					182	183		10.1016/S0140-6736(00)02476-4	http://dx.doi.org/10.1016/S0140-6736(00)02476-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	334GQ	10963193				2022-12-28	WOS:000088179100006
J	Deng, J; Newton, NM; Hall-Craggs, MA; Shirley, RA; Linney, AD; Lees, WR; Rodeck, CH; McGrouther, DA				Deng, J; Newton, NM; Hall-Craggs, MA; Shirley, RA; Linney, AD; Lees, WR; Rodeck, CH; McGrouther, DA			Novel technique for three-dimensional visualisation and quantification of deformable, moving soft-tissue body parts	LANCET			English	Article							ECHOCARDIOGRAPHY; SURGERY; MRI	Background Three-dimensional (3D) imaging of delicate, moving soft-tissue body parts is very difficult. Our understanding of the muscles that control lip movements is based largely on histological and cadaveric studies, which provide scant information about dynamic morphology. Our aim was to develop an innovative scanning technique for the imaging and reconstruction of dynamic orofacial morphology by use of 3D and four-dimensional (4D, ie, 3D plus time) ultrasonography. Methods Four volunteers (including one patient) underwent ultrasonography with 3D/4D imaging systems. To avoid deformation of the delicate orofacial structures, a water bath with an acoustic window was devised. The orofacial part was immersed in the bath throughout scanning, and a timer was used to synchronise lip movements with the 4D scan. Findings 4D views showed the functional differences in superficial and deep muscle groups of the lips, and clearly showed the changes occurring with movement of the lips and mouth. In the patient, a pathological layer and its extension corresponding to surface malformation were clearly identified. Interpretation We have developed a prototype device that has made possible 3D and 40 examination of orofacial anatomy and function. With further refinement of the device and improvement in 4D acquisition timing, this technique may offer a new way of dynamically imaging and quantifying many soft-tissue parts in 3D without deforming structure or disturbing function.	UCL, Dept Med Phys, London WC1E 6JA, England; UCL, Dept Obstet & Gynaecol, London WC1E 6JA, England; UCL, Dept Plast & Reconstruct Surg, London WC1E 6JA, England; UCL, Dept Med Imaging, London WC1E 6JA, England	University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London	Deng, J (corresponding author), UCL, Dept Med Phys, 1st Floor Shropshire House,11-20 Capper St, London WC1E 6JA, England.	jdeng@medphys.ucl.ac.uk; n.newton@ucl.ac.uk	Deng, J/S-9428-2019	Hall-Craggs, Margaret/0000-0001-8734-4065; Deng, Jing/0000-0002-1736-1801				Bell Charles, 1984, ESSAYS ANATOMY EXPRE; Cacou C, 1997, PLAST RECONSTR SURG, V99, P982, DOI 10.1097/00006534-199704000-00008; Chen Q, 1999, EUR J RADIOL, V29, P90, DOI 10.1016/S0720-048X(98)00172-7; Chikui T, 1997, ORAL SURG ORAL MED O, V84, P88, DOI 10.1016/S1079-2104(97)90302-4; Clark MPA, 1998, PLAST RECONSTR SURG, V101, P1945, DOI 10.1097/00006534-199806000-00027; Deng J, 1996, ULTRASOUND MED BIOL, V22, P979, DOI 10.1016/S0301-5629(96)00119-6; DENT J, 2000, IN PRESS ULTRASOUND; HELL B, 1993, INT J ORAL MAX SURG, V22, P173, DOI 10.1016/S0901-5027(05)80247-4; HOWRY DH, 1952, J LAB CLIN MED, V40, P579; LATHAM RA, 1976, J ANAT, V121, P151; LEE S T, 1988, Annals Academy of Medicine Singapore, V17, P328; Light ED, 1998, ULTRASONIC IMAGING, V20, P1; Lightoller GHS, 1925, J ANAT, V60, P1; McAlister RW, 1998, EUR J ORTHODONT, V20, P713, DOI 10.1093/ejo/20.6.713; McGrouther DA, 1997, BRIT MED J, V314, P991, DOI 10.1136/bmj.314.7086.991; MERZ E, 1995, ULTRASOUND OBST GYN, V5, P222, DOI 10.1046/j.1469-0705.1995.05040222.x; NEWTON NM, 1999, P BRIT ASS PLAST SUR, P78; Rasheed S A, 1996, J Clin Pediatr Dent, V20, P305; SALMON S, 1995, GRAYS ANATOMY ANATOM, P798; SCHWARTZ SL, 1994, AM J CARDIOL, V73, P501, DOI 10.1016/0002-9149(94)90682-3; VINKKAPUHAKKA H, 1989, J ANAT, V166, P121; Welzel J, 1997, J AM ACAD DERMATOL, V37, P958, DOI 10.1016/S0190-9622(97)70072-0	22	25	27	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 8	2000	356	9224					127	131		10.1016/S0140-6736(00)02449-1	http://dx.doi.org/10.1016/S0140-6736(00)02449-1			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	331UG	10963249				2022-12-28	WOS:000088036600013
J	Soll, R				Soll, R			Patient-triggered ventilation of the newborn	LANCET			English	Editorial Material									Univ Vermont, Coll Med, Dept Pediat, Burlington, VT 05405 USA	University of Vermont	Soll, R (corresponding author), Univ Vermont, Coll Med, Dept Pediat, Burlington, VT 05405 USA.							Baumer JH, 2000, ARCH DIS CHILD-FETAL, V82, pF5, DOI 10.1136/fn.82.1.F5; Beresford MW, 2000, ARCH DIS CHILD-FETAL, V82, pF14, DOI 10.1136/fn.82.1.F14; GREENOUGH A, 1991, J PERINAT MED, V19, P471, DOI 10.1515/jpme.1991.19.6.471; GREENOUGH A, 1985, BRIT MED J, V290, P597, DOI 10.1136/bmj.290.6468.597; GREENOUGH A, 1992, ARCH DIS CHILD-FETAL, V67, P69, DOI 10.1136/adc.67.1_Spec_No.69; GREENOUGH A, 1999, COCHRANE LIB; LIPSCOMB AP, 1981, LANCET, V1, P414; NORTHWAY WH, 1967, NEW ENGL J MED, V276, P357, DOI 10.1056/NEJM196702162760701	8	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 8	2000	356	9224					90	91		10.1016/S0140-6736(00)02465-X	http://dx.doi.org/10.1016/S0140-6736(00)02465-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	331UG	10963241				2022-12-28	WOS:000088036600005
J	Brown, A; Yates, PA; Burrola, P; Ortuno, D; Vaidya, A; Jessell, TM; Pfaff, SL; O'Leary, DDM; Lemke, G				Brown, A; Yates, PA; Burrola, P; Ortuno, D; Vaidya, A; Jessell, TM; Pfaff, SL; O'Leary, DDM; Lemke, G			Topographic mapping from the retina to the midbrain is controlled by relative but not absolute levels of EphA receptor signaling	CELL			English	Article							GANGLION-CELL AXONS; MAMMALIAN RETINOCOLLICULAR PROJECTION; FLUORESCENT LATEX MICROSPHERES; CHICK VISUAL-SYSTEM; NEURAL DEVELOPMENT; TYROSINE KINASES; MOUSE RETINA; IN-VITRO; GUIDANCE; EXPRESSION	Topographic maps are a fundamental feature of sensory representations in nervous systems. The formation of one such map, defined by the connection of ganglion cells in the retina to their targets in the superior colliculus of the midbrain, is thought to depend upon an interaction between complementary gradients of retinal EphA receptors and collicular ephrin-a ligands. We have tested this hypothesis by using gene targeting to elevate EphA receptor expression in a subset of mouse ganglion cells, thereby producing two intermingled ganglion cell populations that express distinct EphA receptor gradients. We find that these two populations form separate maps in the colliculus, which can be predicted as a function of the net EphA receptor level that a given ganglion cell expresses relative to its neighbors.	Univ Western Ontario, John P Robarts Res Inst, London, ON N6A 5K8, Canada; Univ Western Ontario, Dept Physiol, London, ON N6A 5K8, Canada; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Western University (University of Western Ontario); Western University (University of Western Ontario); University of California System; University of California San Diego; Columbia University; Howard Hughes Medical Institute	Lemke, G (corresponding author), Univ Western Ontario, John P Robarts Res Inst, London, ON N6A 5K8, Canada.		Brown, Arthur/K-8328-2013	Brown, Arthur/0000-0002-8725-3195				BAIER H, 1992, SCIENCE, V255, P472, DOI 10.1126/science.1734526; BASTMEYER M, 1995, J CELL BIOL, V130, P969, DOI 10.1083/jcb.130.4.969; CHEN G, 1994, BIOL CONTROL, V4, P157, DOI 10.1006/bcon.1994.1025; CHENG HJ, 1995, CELL, V82, P371, DOI 10.1016/0092-8674(95)90426-3; Connor RJ, 1998, DEV BIOL, V193, P21, DOI 10.1006/dbio.1997.8786; COX EC, 1990, NEURON, V4, P31, DOI 10.1016/0896-6273(90)90441-H; DAVIS S, 1994, SCIENCE, V266, P816, DOI 10.1126/science.7973638; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; Feldheim DA, 1998, NEURON, V21, P1303, DOI 10.1016/S0896-6273(00)80650-9; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Flanagan JG, 1997, CELL, V90, P403; FRASER SE, 1980, ANNU REV NEUROSCI, V3, P319, DOI 10.1146/annurev.ne.03.030180.001535; Frisen J, 1998, NEURON, V20, P235, DOI 10.1016/S0896-6273(00)80452-3; Gale NW, 1996, NEURON, V17, P9, DOI 10.1016/S0896-6273(00)80276-7; Gao PP, 1998, P NATL ACAD SCI USA, V95, P5329, DOI 10.1073/pnas.95.9.5329; Gao PP, 1996, P NATL ACAD SCI USA, V93, P11161, DOI 10.1073/pnas.93.20.11161; GAZE RM, 1972, NATURE, V237, P375, DOI 10.1038/237375a0; Goodhill GJ, 1999, TRENDS NEUROSCI, V22, P529, DOI 10.1016/S0166-2236(99)01469-1; Hornberger MR, 1999, NEURON, V22, P731, DOI 10.1016/S0896-6273(00)80732-1; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Kaas JH, 1997, BRAIN RES BULL, V44, P107, DOI 10.1016/S0361-9230(97)00094-4; KATZ LC, 1990, NEUROSCIENCE, V34, P511, DOI 10.1016/0306-4522(90)90159-2; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; KATZ LC, 1984, NATURE, V310, P498, DOI 10.1038/310498a0; Mackarehtschian K, 1999, CEREB CORTEX, V9, P601, DOI 10.1093/cercor/9.6.601; Marcus RC, 1996, DEV BIOL, V180, P786, DOI 10.1006/dbio.1996.0347; McLaughlin T, 1999, NEURON, V22, P636, DOI 10.1016/S0896-6273(00)80718-7; Miskevich F, 1998, MOL CELL NEUROSCI, V12, P240, DOI 10.1006/mcne.1998.0718; Monschau B, 1997, EMBO J, V16, P1258, DOI 10.1093/emboj/16.6.1258; Nakamoto M, 1996, CELL, V86, P755, DOI 10.1016/S0092-8674(00)80150-6; O'Leary DDM, 1999, CELL, V96, P255, DOI 10.1016/S0092-8674(00)80565-6; O'Leary DDM, 1999, CURR OPIN NEUROBIOL, V9, P65, DOI 10.1016/S0959-4388(99)80008-7; Orioli D, 1997, TRENDS GENET, V13, P354, DOI 10.1016/S0168-9525(97)01220-1; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; SIMON DK, 1992, J NEUROSCI, V12, P1212; SIMON DK, 1992, P NATL ACAD SCI USA, V89, P10593, DOI 10.1073/pnas.89.22.10593; SIMON DK, 1994, DEV BIOL, V162, P384, DOI 10.1006/dbio.1994.1095; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; STAHL B, 1990, NEURON, V5, P735, DOI 10.1016/0896-6273(90)90227-7; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; YEN LS, 1995, J NEUROSCI, V15, P4712; Zhang JH, 1996, J NEUROSCI, V16, P7182; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665	44	263	265	0	18	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 7	2000	102	1					77	88		10.1016/S0092-8674(00)00012-X	http://dx.doi.org/10.1016/S0092-8674(00)00012-X			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	332UL	10929715	Bronze			2022-12-28	WOS:000088091700010
J	Guan, YB; Huss, GR; MacPherson, GJ; Wasserburg, GJ				Guan, YB; Huss, GR; MacPherson, GJ; Wasserburg, GJ			Calcium-aluminum-rich inclusions from enstatite chondrites: Indigenous or foreign?	SCIENCE			English	Article							EARLY SOLAR-SYSTEM; AL-26; METEORITES; ABUNDANCES; ALLENDE; OXYGEN	The primary mineral assemblages and initial Al-26/Al-27 ratios of rare calcium-aluminum-rich inclusions (CAIs) from enstatite (E) chondrites are similar to those of CAIs from other chondrite classes. CAIs from all chondrite classes formed under oxidizing conditions that are much different from the reducing conditions under which the E chondrites formed. Either CAIs formed at an earlier, more oxidizing epoch in the region where E chondrites ultimately formed, or they formed at a different place in the solar nebula and were transported into the E chondrite formation region.	Smithsonian Inst, Natl Museum Nat Hist, Dept Mineral Sci, Washington, DC 20560 USA; CALTECH, Div Geol & Planetary Sci 170 25, Lunat Asylum, Pasadena, CA 91125 USA; Arizona State Univ, Ctr Meteorite Studies, Tempe, AZ 85287 USA; Arizona State Univ, Dept Geol, Tempe, AZ 85287 USA	Smithsonian Institution; Smithsonian National Museum of Natural History; California Institute of Technology; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Guan, YB (corresponding author), Smithsonian Inst, Natl Museum Nat Hist, Dept Mineral Sci, Washington, DC 20560 USA.		WASSERBURG, GERALD J/F-6247-2011	Huss, Gary/0000-0003-4281-7839				Bischoff A., 1985, CHEM ERDE-GEOCHEM, V44, P97; Brearly A.J., 1998, REV MINER, V36; FAHEY AJ, 1987, GEOCHIM COSMOCHIM AC, V51, P329, DOI 10.1016/0016-7037(87)90245-6; FAHEY AJ, 1988, THESIS WASHINGTON U; GROSSMAN JN, 1993, METEORITICS, V28, P358; HUNEKE JC, 1983, GEOCHIM COSMOCHIM AC, V47, P1635, DOI 10.1016/0016-7037(83)90190-4; IRELAND TR, 1991, GEOCHIM COSMOCHIM AC, V55, P367, DOI 10.1016/0016-7037(91)90424-4; KEIL K, 1989, METEORITICS, V24, P195, DOI 10.1111/j.1945-5100.1989.tb00694.x; LARIMER JW, 1979, GEOCHIM COSMOCHIM AC, V43, P1455, DOI 10.1016/0016-7037(79)90140-6; LEE T, 1976, GEOPHYS RES LETT, V3, P109, DOI 10.1029/GL003i002p00109; LEE T, 1977, ASTROPHYS J, V211, pL107, DOI 10.1086/182351; LIN Y, 1996, LUNAR PLANET SCI, V57, P755; LUSBY D, 1987, J GEOPHYS RES-SOLID, V92, pE679, DOI 10.1029/JB092iB04p0E679; MacPherson G.J., 1988, METEORITES EARLY SOL, P746; MACPHERSON GJ, 1995, METEORITICS, V30, P365, DOI 10.1111/j.1945-5100.1995.tb01141.x; McKeegan KD, 1998, SCIENCE, V280, P414, DOI 10.1126/science.280.5362.414; Russell SS, 1996, SCIENCE, V273, P757, DOI 10.1126/science.273.5276.757; Russell SS, 1998, GEOCHIM COSMOCHIM AC, V62, P689, DOI 10.1016/S0016-7037(97)00374-8; Simon SB, 1998, METEORIT PLANET SCI, V33, P411, DOI 10.1111/j.1945-5100.1998.tb01646.x; WARK DA, 1977, P LUNAR PLANET SCI, V8, P95	21	58	64	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 25	2000	289	5483					1330	1333		10.1126/science.289.5483.1330	http://dx.doi.org/10.1126/science.289.5483.1330			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347RF	10958775				2022-12-28	WOS:000088942400032
J	McKeegan, KD; Chaussidon, M; Robert, F				McKeegan, KD; Chaussidon, M; Robert, F			Incorporation of short-lived Be-10 in a calcium-aluminum-rich inclusion from the Allende meteorite	SCIENCE			English	Article							YOUNG STELLAR OBJECTS; EARLY SOLAR-SYSTEM; COSMIC-RAYS; REFRACTORY INCLUSIONS; GAMMA-RAYS; BORON; BERYLLIUM; AL-26; CHONDRITES; CHONDRULES	Enrichments in boron-10/boron-11 in a calcium-aluminum-rich inclusion from the Allende carbonaceous chondrite are correlated with beryllium/boron in a manner indicative of the in situ decay of short-lived beryllium-10. Because this radionuclide is produced only by nuclear spallation reactions, its existence in early solar system materials attests to intense irradiation processes in the solar nebula. The particle fluence inferred from the initial beryllium-10/beryllium-9 is sufficient to produce other short-lived nuclides, calcium-41 and manganese-53, found in meteorites, but the high canonical abundance of aluminum-26 may still require seeding of the solar system by radioactive stellar debris.	Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA; Ctr Rech Petrog & Geochim, CNRS, F-54501 Vandoeuvre Nancy, France; Museum Natl Hist Nat, F-75015 Paris, France	University of California System; University of California Los Angeles; Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine; Museum National d'Histoire Naturelle (MNHN)	McKeegan, KD (corresponding author), Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA.		Chaussidon, Marc/E-7067-2017; McKeegan, Kevin D/A-4107-2008	McKeegan, Kevin D/0000-0002-1827-729X				BECKETT JR, 1990, GEOCHIM COSMOCHIM AC, V54, P1755, DOI 10.1016/0016-7037(90)90406-B; Bloemen H, 1999, ASTROPHYS J, V521, pL137, DOI 10.1086/312185; CAMERON AGW, 1995, ASTROPHYS J, V447, pL53, DOI 10.1086/309554; Chaussidon M, 1998, EARTH PLANET SC LETT, V164, P577, DOI 10.1016/S0012-821X(98)00250-7; Chaussidon M, 1997, GEOSTANDARD NEWSLETT, V21, P7, DOI 10.1111/j.1751-908X.1997.tb00527.x; CHAUSSIDON M, 1995, NATURE, V374, P337, DOI 10.1038/374337a0; CLAYTON DD, 1995, ASTROPHYS J, V451, P681, DOI 10.1086/176254; CLAYTON DD, 1995, ASTROPHYS J, V451, pL87, DOI 10.1086/309684; EPSTEIN RI, 1977, ASTROPHYS J, V212, P595, DOI 10.1086/155080; Feigelson ED, 1999, ANNU REV ASTRON ASTR, V37, P363, DOI 10.1146/annurev.astro.37.1.363; HUTCHEON ID, 1982, ACS SYM SER, V176, P95; Igea J, 1999, ASTROPHYS J, V518, P848, DOI 10.1086/307302; Lauretta DS, 1997, EARTH PLANET SC LETT, V146, P315, DOI 10.1016/S0012-821X(96)00208-7; Lee T, 1998, ASTROPHYS J, V506, P898, DOI 10.1086/306284; LEE T, 1976, GEOPHYS RES LETT, V3, P109, DOI 10.1029/GL003i002p00109; LUKASIAK A, 1994, ASTROPHYS J, V423, P426, DOI 10.1086/173818; MacPherson G.J., 1988, METEORITES EARLY SOL, P746; MACPHERSON GJ, 1995, METEORITICS, V30, P365, DOI 10.1111/j.1945-5100.1995.tb01141.x; Marhas KK, 2000, CURR SCI INDIA, V78, P78; Montmerle T., 1999, Astronomy with Radioactivities. International Workshop. Proceedings, P225; PHINNEY D, 1979, P LUNAR PLANET SCI C, V10, P885; PODOSEK FA, 1991, GEOCHIM COSMOCHIM AC, V55, P1083, DOI 10.1016/0016-7037(91)90165-2; PRANTZOS N, 1993, ORIGIN EVOLUTION ELE, P156; Ramaty R, 1996, ASTROPHYS J, V456, P525, DOI 10.1086/176677; REEVES H, 1970, NATURE, V226, P727, DOI 10.1038/226727a0; REEVES H, 1993, ORIGIN EVOLUTION ELE, V93, P168; Sahijpal S, 1998, NATURE, V391, P559, DOI 10.1038/35325; SIMON SB, 1991, GEOCHIM COSMOCHIM AC, V55, P2635, DOI 10.1016/0016-7037(91)90379-J; SISTERSON JM, 1997, LUNAR PLANET SCI, V28, P1327; SPIVACK AJ, 1987, LUNAR PLANET SCI, V18, P938; Zhai MZ, 1996, GEOCHIM COSMOCHIM AC, V60, P4877, DOI 10.1016/S0016-7037(96)00338-9	32	256	260	1	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 25	2000	289	5483					1334	1337		10.1126/science.289.5483.1334	http://dx.doi.org/10.1126/science.289.5483.1334			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347RF	10958776				2022-12-28	WOS:000088942400033
J	Messerli, FH; Nussberger, J				Messerli, FH; Nussberger, J			Vasopeptidase inhibition and angio-oedema	LANCET			English	Editorial Material							CONVERTING-ENZYME-INHIBITION; ANGIOTENSIN; EDEMA; THERAPY		Alton Ochsner Med Fdn & Ochsner Clin, New Orleans, LA 70121 USA; Univ Lausanne Hosp, Dept Internal Med, Lausanne, Switzerland	Ochsner Health System; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Messerli, FH (corresponding author), Alton Ochsner Med Fdn & Ochsner Clin, 1516 Jefferson Highway, New Orleans, LA 70121 USA.		Messerli, Franz/AAR-4783-2021					ACKER CG, 1995, NEW ENGL J MED, V333, P1572, DOI 10.1056/NEJM199512073332316; Agostoni A, 1999, IMMUNOPHARMACOLOGY, V44, P21, DOI 10.1016/S0162-3109(99)00107-1; FRANK MM, 1976, ANN INTERN MED, V84, P580, DOI 10.7326/0003-4819-84-5-580; Grossman E, 2000, ARCH INTERN MED, V160, P1905, DOI 10.1001/archinte.160.13.1905; ISRAILI ZH, 1992, ANN INTERN MED, V117, P234, DOI 10.7326/0003-4819-117-3-234; Nussberger J, 1998, LANCET, V351, P1693, DOI 10.1016/S0140-6736(97)09137-X; Osler W, 1888, AM J MED SCI, V95, P362; PELLACANI A, 1994, CLIN SCI, V87, P567, DOI 10.1042/cs0870567; SLATER EE, 1988, JAMA-J AM MED ASSOC, V260, P967, DOI 10.1001/jama.260.7.967; WEINER JM, 1995, AUST NZ J MED, V25, P241, DOI 10.1111/j.1445-5994.1995.tb01532.x; Willenheimer R, 2000, LANCET, V355, P2012, DOI 10.1016/S0140-6736(00)02344-8; Yusuf S, 2000, NEW ENGL J MED, V342, P145	12	170	171	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 19	2000	356	9230					608	609		10.1016/S0140-6736(00)02596-4	http://dx.doi.org/10.1016/S0140-6736(00)02596-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	346RD	10968427				2022-12-28	WOS:000088884100002
J	Hellemans, A				Hellemans, A			Through the looking glass	NATURE			English	Article							PENNING TRAP; ANTIHYDROGEN; ANTIPROTONS; ELECTRON											Baur G, 1996, PHYS LETT B, V368, P251, DOI 10.1016/0370-2693(96)00005-6; Blanford G, 1998, PHYS REV LETT, V80, P3037, DOI 10.1103/PhysRevLett.80.3037; BROWN LS, 1986, REV MOD PHYS, V58, P233, DOI 10.1103/RevModPhys.58.233; Eikema KSE, 1999, PHYS REV LETT, V83, P3828, DOI 10.1103/PhysRevLett.83.3828; Estrada J, 2000, PHYS REV LETT, V84, P859, DOI 10.1103/PhysRevLett.84.859; GABRIELSE G, 1988, PHYS LETT A, V129, P38, DOI 10.1016/0375-9601(88)90470-7; Gabrielse G, 1999, PHYS LETT B, V455, P311, DOI 10.1016/S0370-2693(99)00453-0; Hall DS, 1996, PHYS REV LETT, V77, P1962, DOI 10.1103/PhysRevLett.77.1962; Holzscheiter MH, 1996, PHYS LETT A, V214, P279, DOI 10.1016/0375-9601(96)00189-2; Torii HA, 1999, PHYS REV A, V59, P223, DOI 10.1103/PhysRevA.59.223; Wesdorp C, 2000, PHYS REV LETT, V84, P3799, DOI 10.1103/PhysRevLett.84.3799	11	7	7	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 10	2000	406	6796					556	558		10.1038/35020740	http://dx.doi.org/10.1038/35020740			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	342PF	10949272				2022-12-28	WOS:000088653800012
J	Rea, S; Eisenhaber, F; O'Carroll, N; Strahl, BD; Sun, ZW; Schmid, M; Opravil, S; Mechtler, K; Ponting, CP; Allis, CD; Jenuwein, T				Rea, S; Eisenhaber, F; O'Carroll, N; Strahl, BD; Sun, ZW; Schmid, M; Opravil, S; Mechtler, K; Ponting, CP; Allis, CD; Jenuwein, T			Regulation of chromatin structure by site-specific histone H3 methyltransferases	NATURE			English	Article							POSITION-EFFECT VARIEGATION; HETEROCHROMATIN-ASSOCIATED PROTEIN; GROUP GENE ENHANCER; FISSION YEAST; DROSOPHILA HETEROCHROMATIN; CHROMOSOME CONDENSATION; MAMMALIAN HOMOLOGS; DOMAIN; CENTROMERE; MUTATIONS	The organization of chromatin into higher-order structures influences chromosome function and epigenetic gene regulation. Higher-order chromatin has been proposed to be nucleated by the covalent modification of histone tails and the subsequent establishment of chromosomal subdomains by non-histone modifier factors. Here we show that human SUV39H1 and murine Suv39h1-mammalian homologues of Drosophila Su(var)3-9 and of Schizosaccharomyces pombe cir4-encode histone H3-specific methyltransferases that selectively methylate lysine 9 of the amino terminus of histone H3 in vitro. We mapped the catalytic motif to the evolutionarily conserved SET domain, which requires adjacent cysteine-rich regions to confer histone methyltransferase activity. Methylation of lysine 9 interferes with phosphorylation of serine 10, but is also influenced by preexisting modifications in the amino terminus of H3. In vivo, deregulated SUV39H1 or disrupted Suv39h activity modulate H3 serine 10 phosphorylation in native chromatin and induce aberrant mitotic divisions. Our data reveal a functional interdependence of site-specific H3 tail modifications and suggest a dynamic mechanism for the regulation of higher-order chromatin.	Vienna Bioctr, Res Inst Mol Pathol, A-1030 Vienna, Austria; Univ Virginia, Hlth Sci Ctr, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; Univ Oxford, Dept Human Anat & Genet, MRC, Funct Genet Unit, Oxford OX1 3QX, England	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); University of Virginia; University of Oxford	Jenuwein, T (corresponding author), Vienna Bioctr, Res Inst Mol Pathol, Dr Bohrgasse 7, A-1030 Vienna, Austria.	jenuwein@nt.imp.univie.ac.at	Mechtler, Karl/AAF-2717-2019; Schmid, Manfred/E-6725-2012; Strahl, Brian/C-7601-2012; Ponting, Chris/AAV-2621-2021	Mechtler, Karl/0000-0002-3392-9946; Schmid, Manfred/0000-0003-0516-3055; Strahl, Brian/0000-0002-4947-6259; Rea, Stephen/0000-0001-5797-5157; O'Carroll, Donal/0000-0002-8626-2217; Ponting, Chris/0000-0003-0202-7816				Aagaard L, 1999, EMBO J, V18, P1923, DOI 10.1093/emboj/18.7.1923; AASLAND R, 1995, NUCLEIC ACIDS RES, V23, P3168; ALLSHIRE RC, 1995, GENE DEV, V9, P218, DOI 10.1101/gad.9.2.218; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BAKSA K, 1993, GENETICS, V135, P117; Ball LJ, 1997, EMBO J, V16, P2473, DOI 10.1093/emboj/16.9.2473; Birney E, 1996, NUCLEIC ACIDS RES, V24, P2730, DOI 10.1093/nar/24.14.2730; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Cleard F, 1997, EMBO J, V16, P5280, DOI 10.1093/emboj/16.17.5280; Cui XM, 1998, NAT GENET, V18, P331, DOI 10.1038/ng0498-331; DeRubertis F, 1996, NATURE, V384, P589; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; EISSENBERG JC, 1992, GENETICS, V131, P345; Ekwall K, 1996, J CELL SCI, V109, P2637; Firestein R, 2000, MOL CELL BIOL, V20, P4900, DOI 10.1128/MCB.20.13.4900-4909.2000; Frishman D, 1997, PROTEINS, V27, P329, DOI 10.1002/(SICI)1097-0134(199703)27:3<329::AID-PROT1>3.0.CO;2-8; Grewal SIS, 1998, GENETICS, V150, P563; Grunstein M, 1998, CELL, V93, P325, DOI 10.1016/S0092-8674(00)81160-5; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; HENIKOFF S, 1996, EPIGENETIC MECH GENE, P319; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; Ivanova AV, 1998, NAT GENET, V19, P192, DOI 10.1038/566; Jenuwein T, 1998, CELL MOL LIFE SCI, V54, P80, DOI 10.1007/s000180050127; JONES RS, 1993, MOL CELL BIOL, V13, P6357, DOI 10.1128/MCB.13.10.6357; Karpen GH, 1997, TRENDS GENET, V13, P489, DOI 10.1016/S0168-9525(97)01298-5; KLEIN RR, 1995, PLANT MOL BIOL, V27, P249, DOI 10.1007/BF00020181; KOONIN EV, 1995, NUCLEIC ACIDS RES, V23, P4229, DOI 10.1093/nar/23.21.4229; Laible G, 1997, EMBO J, V16, P3219, DOI 10.1093/emboj/16.11.3219; Larsson J, 1996, GENETICS, V143, P887; Martzen MR, 1999, SCIENCE, V286, P1153, DOI 10.1126/science.286.5442.1153; Melcher M, 2000, MOL CELL BIOL, V20, P3728, DOI 10.1128/MCB.20.10.3728-3741.2000; Murzina N, 1999, MOL CELL, V4, P529, DOI 10.1016/S1097-2765(00)80204-X; PEHRSON JR, 1992, SCIENCE, V257, P1398; PLATERO JS, 1995, EMBO J, V14, P3977, DOI 10.1002/j.1460-2075.1995.tb00069.x; REUTER G, 1992, BIOESSAYS, V14, P605, DOI 10.1002/bies.950140907; Sassone-Corsi P, 1999, SCIENCE, V285, P886, DOI 10.1126/science.285.5429.886; Schotta G, 2000, MOL GEN GENET, V262, P916, DOI 10.1007/PL00008659; Schultz J, 2000, NUCLEIC ACIDS RES, V28, P231, DOI 10.1093/nar/28.1.231; STASSEN MJ, 1995, MECH DEVELOP, V52, P209, DOI 10.1016/0925-4773(95)00402-M; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Strahl BD, 1999, P NATL ACAD SCI USA, V96, P14967, DOI 10.1073/pnas.96.26.14967; SULLIVAN KF, 1994, J CELL BIOL, V127, P581, DOI 10.1083/jcb.127.3.581; TKACHUK DC, 1992, CELL, V71, P691, DOI 10.1016/0092-8674(92)90602-9; TSCHIERSCH B, 1994, EMBO J, V13, P3822, DOI 10.1002/j.1460-2075.1994.tb06693.x; Turner BM, 1998, CELL MOL LIFE SCI, V54, P21, DOI 10.1007/s000180050122; Wallrath L, 1998, CURR OPIN GENET DEV, V8, P147, DOI 10.1016/S0959-437X(98)80135-4; Wei Y, 1999, CELL, V97, P99, DOI 10.1016/S0092-8674(00)80718-7; Xu XL, 1999, MOL CELL, V3, P389, DOI 10.1016/S1097-2765(00)80466-9; Zheng Q, 1998, PROTEIN EXPRES PURIF, V14, P104, DOI 10.1006/prep.1998.0936	49	2054	2134	6	244	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 10	2000	406	6796					593	599		10.1038/35020506	http://dx.doi.org/10.1038/35020506			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	342PF	10949293				2022-12-28	WOS:000088653800038
J	Hofstra, L; Liem, IH; Dumont, EA; Boersma, HH; van Heerde, WL; Doevendans, PA; DeMuinck, E; Wellens, HJJ; Kemerink, GJ; Reutelingsperger, CPM; Heidendal, GA				Hofstra, L; Liem, IH; Dumont, EA; Boersma, HH; van Heerde, WL; Doevendans, PA; DeMuinck, E; Wellens, HJJ; Kemerink, GJ; Reutelingsperger, CPM; Heidendal, GA			Visualisation of cell death in vivo in patients with acute myocardial infarction	LANCET			English	Article							APOPTOSIS	Background In-vivo visualisation and quantification of the extent and time-frame of cell death after acute myocardial infarction would be of great interest. We studied in-vivo cell death in the hearts of patients with an acute myocardial infarction using imaging with technetium-99m-labelled annexin-V-a protein that binds to cells undergoing annexin-V-a apoptosis. Methods Seven patients with an acute myocardial infarction and one control were studied. All patients were treated by percutaneous transluminal coronary angioplasty (six primary and one rescue), resulting in thrombolysis in myocardial infarction (TIMI) III flow of the infarct-related artery. 2 h after reperfusion, 1 mg annexin-V labelled with 584 MBq Tc-99m was injected intravenously. Early (mean 3.4 h) and late (mean 20.5 h) single-photon-emission computed tomo graphic (SPECT) images of the heart were obtained. Routine myocardial resting-perfusion imaging was also done to verify infarct localisation. Findings In six of the seven patients, increased uptake of Tc-99m-labelled annexin-V was seen in the infarct area of the heart on early and late SPECT images. No increased uptake was seen in the heart outside the infarct area. All patients with increased Tc99m-labelled annexin-V uptake in the infarct area showed a matching perfusion defect, in a control individual, no increased uptake in the heart was seen. Interpretation Increased uptake of Tc-99m-labelled annexin-V is present in the infarct area of patients with an acute myocardial infarction, suggesting that programmed cell death occurs in that area. The annexin-V imaging protocol might allow us to study the dynamics of reperfusion-induced cell death in the area at risk and may help to assess interventions that inhibit cell death in patients with an acute myocardial infarction.	Univ Hosp Maastricht, Dept Cardiol, Maastricht, Netherlands; Univ Hosp Maastricht, Dept Nucl Med, Maastricht, Netherlands; Univ Hosp Maastricht, Dept Biochem, Maastricht, Netherlands; Univ Hosp Maastricht, Dept Clin Pharm, Maastricht, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC)	Reutelingsperger, CPM (corresponding author), Univ Limburg, Cardiovasc Res Inst Maastricht, Dept Biochem, POB 616, NL-6200 MD Maastricht, Netherlands.		Boersma, Hendrikus/AAF-8139-2020; van Heerde, Waander/L-4357-2015	Boersma, Hendrikus/0000-0003-1892-9830; van Heerde, Waander/0000-0001-7101-8775				Barinaga M, 1998, SCIENCE, V281, P1302, DOI 10.1126/science.281.5381.1302; Blankenberg FG, 1998, P NATL ACAD SCI USA, V95, P6349, DOI 10.1073/pnas.95.11.6349; DUMONT E, 1999, LANCET S3, V353, pS27; FADOK VA, 1992, J IMMUNOL, V149, P4029; Fliss H, 1996, CIRC RES, V79, P949, DOI 10.1161/01.RES.79.5.949; Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029; GOTTLIEB RA, 1994, J CLIN INVEST, V94, P1621, DOI 10.1172/JCI117504; Kajstura J, 1996, LAB INVEST, V74, P86; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; KOOPMAN G, 1994, BLOOD, V84, P5; Martin SJ, 1996, J BIOL CHEM, V271, P28753, DOI 10.1074/jbc.271.46.28753; Ohno M, 1998, CIRCULATION, V98, P1422, DOI 10.1161/01.CIR.98.14.1422; Saraste A, 1997, CIRCULATION, V95, P320; Schwaiger M, 1999, LANCET, V354, P661, DOI 10.1016/S0140-6736(99)06057-2; van Heerde WL, 2000, CARDIOVASC RES, V45, P549, DOI 10.1016/S0008-6363(99)00396-X; vandenEijnde SM, 1997, CYTOMETRY, V29, P313, DOI 10.1002/(SICI)1097-0320(19971201)29:4<313::AID-CYTO8>3.0.CO;2-A; Veinot JP, 1997, HUM PATHOL, V28, P485, DOI 10.1016/S0046-8177(97)90039-3; VERMES I, 1995, J IMMUNOL METHODS, V184, P144; YEH ET, 1997, CIRCULATION, V97, P782	19	336	351	0	12	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 15	2000	356	9225					209	212		10.1016/S0140-6736(00)02482-X	http://dx.doi.org/10.1016/S0140-6736(00)02482-X			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	334GQ	10963199				2022-12-28	WOS:000088179100012
J	Rampton, DS; Neurath, MF; Almer, S; D'Haens, G; Petritsch, W; Stange, EF				Rampton, DS; Neurath, MF; Almer, S; D'Haens, G; Petritsch, W; Stange, EF			Mycophenolate mofetil in Crohn's disease	LANCET			English	Letter									Barts & London NHS Trust, Dept Gastroenterol, London E1 1BB, England; Univ Clin, Mainz, Germany; Linkoping Univ Hosp, S-58185 Linkoping, Sweden; Univ Ziekenhuizen, Louvain, Belgium; Univ Klinikum Graz, Landeskrankenhaus, Graz, Austria; Med Univ Lubeck, Lubeck, Germany	Barts Health NHS Trust; Linkoping University; University of Lubeck	Rampton, DS (corresponding author), Barts & London NHS Trust, Dept Gastroenterol, London E1 1BB, England.		Rampton, David/AHD-0789-2022	Almer, Sven/0000-0001-9334-1821				Fellermann K, 2000, ALIMENT PHARM THER, V14, P171; Fickert P, 1998, AM J GASTROENTEROL, V93, P2529, DOI 10.1016/S0002-9270(98)00487-0; Hassard PV, 2000, INFLAMM BOWEL DIS, V6, P16, DOI 10.1097/00054725-200002000-00003; Lowry PW, 1999, LANCET, V354, P3, DOI 10.1016/S0140-6736(99)00152-X; Neurath MF, 1999, GUT, V44, P625, DOI 10.1136/gut.44.5.625	5	6	7	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 8	2000	356	9224					163	164		10.1016/S0140-6736(05)73176-7	http://dx.doi.org/10.1016/S0140-6736(05)73176-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	331UG	10963270	Bronze			2022-12-28	WOS:000088036600047
J	Sweat, M; Gregorich, S; Sangiwa, G; Furlonge, C; Balmer, D; Kamenga, C; Grinstead, O; Coates, T				Sweat, M; Gregorich, S; Sangiwa, G; Furlonge, C; Balmer, D; Kamenga, C; Grinstead, O; Coates, T			Cost-effectiveness of voluntary HIV-1 counselling and testing in reducing sexual transmission of HIV-1 in Kenya and Tanzania	LANCET			English	Article							DEVELOPING-COUNTRIES; NEVIRAPINE; AFRICA; UGANDA; AIDS	Background Access to HIV-1 voluntary counselling and testing (VCT) is severely limited in less-developed countries. We undertook a multisite trial of HIV-1 VCT to assess its impact, cost, and cost-effectiveness in less-developed country settings. Methods The cost-effectiveness of HIV-1 VCT was estimated for a hypothetical cohort of 10 000 people seeking VCT in urban east Africa. Outcomes were modelled based on results from a randomised controlled trial of HIV-1 VCT in Tanzania and Kenya. Our main outcome measures included programme cost, number of HIV-1 infections averted, cost per HIV-1 infection averted, and cost per disability-adjusted life-year (DALY) saved. We also modelled the impact of targeting VCT by HIV-1 prevalence of the client population, and the proportion of clients who receive VCT as a couple compared with as individuals. Sensitivity analysis was done on all model parameters. Findings HIV-1 VCT was estimated to avert 1104 HIV-1 infections in Kenya and 895 in Tanzania during the subsequent year, The cost per HIV-1 infection averted was US$249 and $346, respectively, and the cost per DALY saved was $12.77 and $17.78. The intervention was most cost-effective for HIV-1-infected people and those who received VCT as a couple. The cost-effectiveness of VCT was robust, with a range for the average cost per DALY saved of $5.16-27.36 in Kenya, and $6.58-45.03 in Tanzania. Analysis of targeting showed that increasing the proportion of couples to 70% reduces the cost per DALY saved to $10.71 in Kenya and $13.39 in Tanzania, and that targeting a population with HIV-1 prevalence of 45% decreased the cost per DALY saved to $8.36 in Kenya and $11.74 in Tanzania. Interpretation HIV-1 VCT is highly cost-effective in urban east African settings, but slightly less so than interventions such as improvement of sexually transmitted disease services and universal provision of nevirapine to pregnant women in high-prevalence settings. With the targeting of VCT to populations with high HIV-1 prevalence and couples the cost-effectiveness of VCT is improved significantly.	Johns Hopkins Univ, Sch Hyg & Publ Hlth, Baltimore, MD 21205 USA; Univ Calif San Francisco, Ctr AIDS Prevent Studies, San Francisco, CA 94143 USA; Univ Dar Es Salaam, Muhimbili Med Coll, Dar Es Salaam, Tanzania; Queens Pk Counseling Ctr, Port Of Spain, Trinidad Tobago; Kenya Assoc Profess Counselors, Nairobi, Kenya; Univ Calgary, Calgary, AB, Canada; Family Hlth Int, AIDSCAP, Arlington, VA USA	Johns Hopkins University; University of California System; University of California San Francisco; University of Dar es Salaam; University of Calgary	Sweat, M (corresponding author), Johns Hopkins Univ, Sch Hyg & Publ Hlth, 615 N Wolfe St,Room E7140, Baltimore, MD 21205 USA.	MSWEAT@JHSPH.EDU			NIMH NIH HHS [5R29MH57217-03, MH42459] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH042459, R29MH057217] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ALLEN S, 1992, JAMA-J AM MED ASSOC, V268, P3338, DOI 10.1001/jama.268.23.3338; *CDC, 1998, JAMA-J AM MED ASSOC, V279, P1061; COATES T, 1998, 12 INT C AIDS GEN JU; Coates TJ, 2000, LANCET, V356, P103, DOI 10.1016/S0140-6736(00)02446-6; De Zoysa I, 1995, AIDS, V9 Suppl A, pS95; Gilson L, 1997, LANCET, V350, P1805, DOI 10.1016/S0140-6736(97)08222-6; Grinberg L, 1997, AIDS Treat News, P6; Guay LA, 1999, LANCET, V354, P795, DOI 10.1016/S0140-6736(99)80008-7; HENDRIKS JC, 1996, 11 INT C AIDS VANC J; HIGGINS DL, 1990, 6 INT C AIDS SAN FR; JAMISON DT, 1991, AM J PUBLIC HEALTH, V81, P15, DOI 10.2105/AJPH.81.1.15; Joint United Nations Programme on HIV/AIDS (UNAIDS), 1998, EP FACT SHEET HIV AI; Marseille E, 1999, LANCET, V354, P803, DOI 10.1016/S0140-6736(99)80009-9; MARUM E, 1994, 10 INT C AIDS YOK AU; Mertens TE, 1996, B WORLD HEALTH ORGAN, V74, P121; Mugerwa RD, 1996, E AFR MED J, V73, P20; Murray C. J. L., 1996, GLOBAL BURDEN DIS; Prescott N, 1997, IMPLICATIONS OF ANTIRETROVIRAL TREATMENTS, P57; Rehle TM, 1998, AIDS, V12, pS27; Renault B, 1999, NAT MED, V5, P1093, DOI 10.1038/13387; Rothenberg K H, 1995, J Am Med Womens Assoc (1972), V50, P87; SWEAT M, 1998, 12 INT C AIDS GEN JU; TEMMERMAN M, 1995, LANCET, V345, P969, DOI 10.1016/S0140-6736(95)90707-6; THOMAS J, 1998, AIDS ANAL ASIA, V4, P1; *UNAIDS, 1999, AIDS EP UPD; *US BUR CENS, 1999, LIF TABL; WEINSTEIN M, 1989, COST EFFECTIVENESS A; WILKINSON D, 1998, AIDS, V12, P1571; Wolitski RJ, 1997, AIDS EDUC PREV, V9, P52; World Bank, 1993, WORLD DEV REP INV HL; 1998, NATURE, V392, P118	31	273	279	0	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 8	2000	356	9224					113	121		10.1016/S0140-6736(00)02447-8	http://dx.doi.org/10.1016/S0140-6736(00)02447-8			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	331UG	10963247				2022-12-28	WOS:000088036600011
J	Christie, B				Christie, B			Premature babies have high death and disability rate	BRITISH MEDICAL JOURNAL			English	News Item																		2000, EFFECTIVE HLTH CARE, V6, P2	1	3	3	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	AUG 19	2000	321	7259					467	467		10.1136/bmj.321.7259.467	http://dx.doi.org/10.1136/bmj.321.7259.467			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	347MC	10948014	Green Published			2022-12-28	WOS:000088932800007
J	Jones, J				Jones, J			Risk of vCJD lower than expected	BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	AUG 19	2000	321	7259					469	469						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	347MC	10948021				2022-12-28	WOS:000088932800013
J	Bloom, BR				Bloom, BR			On the particularity of pathogens	NATURE			English	Article								In the elemental struggle between pathogenic microbes and the immune system of the host, each strives for a unique advantage and thus each exploits its own unique particularities in pathogenesis and protection. And each presumably selects for the diversity that generally characterizes the wide range of successful host-pathogen interactions.	Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Bloom, BR (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.								0	14	14	0	2	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 17	2000	406	6797					760	761		10.1038/35021204	http://dx.doi.org/10.1038/35021204			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	344PH	10963604				2022-12-28	WOS:000088767700051
J	Bookheimer, SY; Strojwas, MH; Cohen, MS; Saunders, AM; Pericak-Vance, MA; Mazziotta, JC; Small, GW				Bookheimer, SY; Strojwas, MH; Cohen, MS; Saunders, AM; Pericak-Vance, MA; Mazziotta, JC; Small, GW			Patterns of brain activation in people at risk for Alzheimer's disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CEREBRAL BLOOD-FLOW; E TYPE-4 ALLELE; APOLIPOPROTEIN-E; SENSORY STIMULATION; EPSILON-4 ALLELE; TEMPORAL-LOBE; MEMORY; PERFORMANCE; ASSOCIATION; METABOLISM	Background: The epsilon 4 allele of the apolipoprotein E gene (APOE) is the chief known genetic risk factor for Alzheimer's disease, the most common cause of dementia late in life. To determine the relation between brain responses to tasks requiring memory and the genetic risk of Alzheimer's disease, we performed APOE genotyping and functional magnetic resonance imaging (MRI) of the brain in older persons with intact cognition. Methods: We studied 30 subjects (age, 47 to 82 years) who were neurologically normal, of whom 16 were carriers of the APOE epsilon 4 allele and 14 were homozygous for the APOE epsilon 3 allele. The mean age and level of education were similar in the two groups. Patterns of brain activation during functional MRI scanning were determined while subjects memorized and recalled unrelated pairs of words and while subjects rested between such periods. Memory was reassessed in 14 subjects two years later. Results: Both the magnitude and the extent of brain activation during memory-activation tasks in regions affected by Alzheimer's disease, including the left hippocampal, parietal, and prefrontal regions, were greater among the carriers of the APOE epsilon 4 allele than among the carriers of the APOE epsilon 3 allele. During periods of recall, the carriers of the APOE epsilon 4 allele had a greater average increase in signal intensity in the hippocampal region (1.03 percent vs. 0.62 percent, P<0.001) and a greater mean (+/-SD) number of activated regions throughout the brain (15.9+/-6.2 vs. 9.4+/-5.5, P = 0.005) than did carriers of the APOE epsilon 3 allele. Longitudinal assessment after two years indicated that the degree of base-line brain activation correlated with degree of decline in memory. Conclusions: Patterns of brain activation during tasks requiring memory differ depending on the genetic risk of Alzheimer's disease and may predict a subsequent decline in memory. (N Engl J Med 2000;343:450-6.) (C)2000, Massachusetts Medical Society.	Univ Calif Los Angeles, Inst Neuropsychiat, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Dept Radiol, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Dept Mol & Mol Pharmacol, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Brain Mapping Ctr, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Alzheimers Dis Res Ctr, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Ctr Aging, Los Angeles, CA 90024 USA; Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Small, GW (corresponding author), Univ Calif Los Angeles, Inst Neuropsychiat, Dept Psychiat & Biobehav Sci, 88-201,760 Westwood Plaza, Los Angeles, CA 90024 USA.		Cohen, Mark S/C-6610-2011	Cohen, Mark S/0000-0001-6731-4053; Bookheimer, Susan/0000-0002-3417-5891	NIA NIH HHS [P30 AG010123-03, U24 AG021886, P30 AG010123, P60 AG011268-07, P50 AG005128, R01 AG013308, P50 AG005128-21, R01 AG013308-13, P60 AG011268, AG13308] Funding Source: Medline; NIMH NIH HHS [MH52453, R01 MH052453-05, R01 MH052453] Funding Source: Medline; NINDS NIH HHS [R01 NS031153, R01 NS031153-14, P01 NS026630] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH052453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS026630, R01NS031153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013308, P60AG011268, U24AG021886, P50AG005128, P30AG010123] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Backman L, 1999, NEUROLOGY, V52, P1861, DOI 10.1212/WNL.52.9.1861; Benton A, 1978, PSYCHOL ASSESSMENT R; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; BUSCHKE H, 1974, NEUROLOGY, V24, P1019, DOI 10.1212/WNL.24.11.1019; Cohen J D, 1994, Hum Brain Mapp, V1, P293, DOI 10.1002/hbm.460010407; Cohen MS, 1999, JMRI-J MAGN RESON IM, V10, P33, DOI 10.1002/(SICI)1522-2586(199907)10:1<33::AID-JMRI5>3.0.CO;2-N; Cohen MS, 1997, NEUROIMAGE, V6, P93, DOI 10.1006/nimg.1997.0278; COHEN MS, 1994, TRENDS NEUROSCI, V17, P268, DOI 10.1016/0166-2236(94)90055-8; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Damasio H, 1989, LESION ANAL NEUROPSY; FOX PT, 1986, P NATL ACAD SCI USA, V83, P1140, DOI 10.1073/pnas.83.4.1140; Gabrieli JDE, 1997, SCIENCE, V276, P264, DOI 10.1126/science.276.5310.264; Golomb J, 1996, NEUROLOGY, V47, P810, DOI 10.1212/WNL.47.3.810; GRADY CL, 1994, J NEUROSCI, V14, P1450, DOI 10.1523/JNEUROSCI.14-03-01450.1994; GRADY CL, 1993, NEUROBIOL AGING, V14, P35, DOI 10.1016/0197-4580(93)90018-7; Just MA, 1996, SCIENCE, V274, P114, DOI 10.1126/science.274.5284.114; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; Mega MS, 1998, NEUROLOGY, V50, P145, DOI 10.1212/WNL.50.1.145; Mentis MJ, 1996, AM J PSYCHIAT, V153, P32; O'Hara R, 1998, J AM GERIATR SOC, V46, P1493, DOI 10.1111/j.1532-5415.1998.tb01532.x; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; Price JL, 1999, ANN NEUROL, V45, P358, DOI 10.1002/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X; RAICHLE ME, 1994, CEREB CORTEX, V4, P8, DOI 10.1093/cercor/4.1.8; RAUSCH R, 1993, ARCH NEUROL-CHICAGO, V50, P812, DOI 10.1001/archneur.1993.00540080023008; Reiman EM, 1996, NEW ENGL J MED, V334, P752, DOI 10.1056/NEJM199603213341202; Relkin NR, 1996, LANCET, V347, P1091, DOI 10.1016/S0140-6736(96)90284-6; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Small GW, 1997, JAMA-J AM MED ASSOC, V278, P1363, DOI 10.1001/jama.278.16.1363; SMALL GW, 1995, JAMA-J AM MED ASSOC, V273, P942, DOI 10.1001/jama.273.12.942; Song AW, 1996, MAGNET RESON MED, V35, P155, DOI 10.1002/mrm.1910350204; Talairach J., 1988, COPLANAR STEREOTAXIC; Wechsler D, 1945, J PSYCHOL, V19, P87, DOI 10.1080/00223980.1945.9917223; Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P153, DOI 10.1097/00004728-199801000-00028	34	979	1006	0	72	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 17	2000	343	7					450	456		10.1056/NEJM200008173430701	http://dx.doi.org/10.1056/NEJM200008173430701			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	344FC	10944562	Green Accepted			2022-12-28	WOS:000088747700001
J	Cohen, ML				Cohen, ML			Changing patterns of infectious disease	NATURE			English	Review							UNITED-STATES; TUBERCULOSIS; RESISTANCE; EPIDEMIC; OUTBREAK	Despite a century of often successful prevention and control efforts, infectious diseases remain an important global problem in public health, causing over 13 million deaths each year. Changes in society, technology and the microorganisms themselves are contributing to the emergence of new diseases, the re-emergence of diseases once controlled, and to the development of antimicrobial resistance. Two areas of special concern in the twenty-first century are food-borne disease and antimicrobial resistance. The effective control of infectious diseases in the new millennium will require effective public health infrastructures that will rapidly recognize and respond to them and will prevent emerging problems.	Ctr Dis Control & Prevent, Div Bacterial & Mycot Dis C09, Natl Ctr Infect Dis, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Cohen, ML (corresponding author), Ctr Dis Control & Prevent, Div Bacterial & Mycot Dis C09, Natl Ctr Infect Dis, 1600 Clifton Rd, Atlanta, GA 30333 USA.		Garza-González, Elvira/B-7569-2009					Ackerknecht EH, 1965, HIST GEOGRAPHY MOST; Altekruse SF, 1997, EMERG INFECT DIS, V3, P285, DOI 10.3201/eid0303.970304; *AM CANC SOC, 1996, CANC FACTS FIG 1996; Ampel NM, 1998, CLIN INFECT DIS, V27, P1528, DOI 10.1086/515044; Armstrong GL, 1999, JAMA-J AM MED ASSOC, V281, P61, DOI 10.1001/jama.281.1.61; Bax RP, 1997, CLIN INFECT DIS, V24, pS151, DOI 10.1093/clinids/24.Supplement_1.S151; BLOOM BR, 1992, SCIENCE, V257, P1055, DOI 10.1126/science.257.5073.1055; Cantwell MF, 1996, TUBERCLE LUNG DIS, V77, P220, DOI 10.1016/S0962-8479(96)90004-0; *CDC, 1982, POL SURV SUMM 1980 8; *CDCP, 1999, NAT ANT RES MON SYST; *CDCP, 1995, NAT PREV DIAB US DIA; *CDCP, 1994, 1994 FACT BOOK, V7; *CDCP, 1998, PEV EM INF DIS STRAT; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P845; Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V48, P1165; Centers for Disease Control Prevention, 1999, MMWR-MORBID MORTAL W, V48, P545; COHEN ML, 1992, SCIENCE, V257, P1050, DOI 10.1126/science.257.5073.1050; CULOTTA E, 1994, SCIENCE, V264, P362, DOI 10.1126/science.8153617; Daniels NA, 2000, J INFECT DIS, V181, P1661, DOI 10.1086/315459; Dixon DM, 1996, PUBLIC HEALTH REP, V111, P226; Ezzell C, 2000, SCI AM, V282, P96, DOI 10.1038/scientificamerican0500-96; FISHERHOCH SP, 1995, CLIN INFECT DIS, V21, P897, DOI 10.1093/clinids/21.4.897; Forum on Emerging Infections Institute of Medicine, 1998, ANT RES ISS OPT; GARRETT L, 1993, COMING PLAGUE NEWLY; Garrett Laurie, 1992, P825; GARROD LP, 1973, ANTIBIOTIC CHEMOTHER, V4; Gerberding J, 1999, AM J INFECT CONTROL, V27, P520; Hennessy TW, 1996, NEW ENGL J MED, V334, P1281, DOI 10.1056/NEJM199605163342001; Herwaldt BL, 1997, NEW ENGL J MED, V336, P1548, DOI 10.1056/NEJM199705293362202; Hjelle B, 2000, J INFECT DIS, V181, P1569, DOI 10.1086/315467; Institute of Medicine, 1992, EM INF MICR THREATS; LEE LA, 1994, J INFECT DIS, V170, P128, DOI 10.1093/infdis/170.1.128; MARX R, 1991, SEX TRANSM DIS, V18, P92, DOI 10.1097/00007435-199118020-00008; MCCRAIG LF, 1995, JAMA-J AM MED ASSOC, V273, P214; Mckeown T, 1966, INTRO SOCIAL MED; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; *NAT CTR HLTH STAT, 1999, HLTH US 1999; *NAT CTR HLTH STAT, 1989, VIT HLTH STAT, V3; Nuorti JP, 2000, NEW ENGL J MED, V342, P681, DOI 10.1056/NEJM200003093421002; RIES AA, 1994, J INFECT DIS, V169, P1035, DOI 10.1093/infdis/169.5.1035; SIGERIST HE, 1971, GREAT DOCTORS, P372; *US BUR CENS, 1990, CENS POP GEN POP CHA; WHITTAM TS, 1993, INFECT IMMUN, V61, P1619, DOI 10.1128/IAI.61.5.1619-1629.1993; World Health Organization, 1999, REM OBST HLTH DEV	45	560	603	0	108	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 17	2000	406	6797					762	767		10.1038/35021206	http://dx.doi.org/10.1038/35021206			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	344PH	10963605				2022-12-28	WOS:000088767700052
J	Coopman, PJP; Do, MTH; Barth, M; Bowden, ET; Hayes, AJ; Basyuk, E; Blancato, JK; Vezza, PR; McLeskey, SW; Mangeat, PH; Mueller, SC				Coopman, PJP; Do, MTH; Barth, M; Bowden, ET; Hayes, AJ; Basyuk, E; Blancato, JK; Vezza, PR; McLeskey, SW; Mangeat, PH; Mueller, SC			The Syk tyrosine kinase suppresses malignant growth of human breast cancer cells	NATURE			English	Article							ANTIGEN RECEPTOR; PROTEIN; PHAGOCYTOSIS; EXPRESSION; HYBRIDIZATION; TRANSCRIPTS; METASTASIS; INTERACTS; P72(SYK); CLONING	Syk is a protein tyrosine kinase that is widely expressed in haematopoietic cells. It is involved in coupling activated immunoreceptors to downstream signalling events that mediate diverse cellular responses including proliferation, differentiation and phagocytosis(1-4). Syk expression has been reported in cell lines of epithelial origin(5), but its function in these cells remains unknown. Here we show that Syk is commonly expressed in normal human breast tissue, benign breast lesions and low-tumorigenic breast cancer cell lines. Syk messenger RNA and protein, however, are low or undetectable in invasive breast carcinoma tissue and cell lines. Transfection of wild-type Syk into a Syk-negative breast cancer cell line markedly inhibited its tumour growth and metastasis formation in athymic mice. Conversely, overexpression of a kinase-deficient Syk in a Syk-positive breast cancer cell line significantly increased its tumour incidence and growth. Suppression of tumour growth by the reintroduction of Syk appeared to be the result of aberrant mitosis and cytokinesis. We propose that Syk is a potent modulator of epithelial cell growth and a potential tumour suppressor in human breast carcinomas.	Georgetown Univ, Sch Med, Dept Cell Biol, Washington, DC 20007 USA; Georgetown Univ, Sch Med, Dept Oncol, Washington, DC 20007 USA; Georgetown Univ, Sch Med, Dept Pathol, Washington, DC 20007 USA; Georgetown Univ, Sch Med, Dept Pharmacol, Washington, DC 20007 USA; Georgetown Univ, Sch Med, Sch Nursing, Washington, DC 20007 USA; Georgetown Univ, Sch Med, Inst Mol & Human Genet, Washington, DC 20007 USA; Georgetown Univ, Sch Med, Vincent T Lombardi Canc Res Ctr, Washington, DC 20007 USA; CNRS, UPR 9023, F-34095 Montpellier, France; CNRS, UMR 5539, F-34095 Montpellier, France	Georgetown University; Georgetown University; Georgetown University; Georgetown University; Georgetown University; Georgetown University; Georgetown University; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS)	Mueller, SC (corresponding author), Georgetown Univ, Sch Med, Dept Cell Biol, Washington, DC 20007 USA.		Coopman, Peter/G-7416-2019; H, Michael Tri/A-5917-2009	Coopman, Peter/0000-0003-3720-523X; H, Michael Tri/0000-0001-6418-0977; Basyuk, Eugenia/0000-0001-9768-4557				BRUNNER N, 1992, EUR J CANCER, V28A, P1989, DOI 10.1016/0959-8049(92)90245-W; Cheng AM, 1997, CURR OPIN IMMUNOL, V9, P528, DOI 10.1016/S0952-7915(97)80106-9; CHENG AM, 1995, NATURE, V378, P303, DOI 10.1038/378303a0; Chu DH, 1998, IMMUNOL REV, V165, P167, DOI 10.1111/j.1600-065X.1998.tb01238.x; Coopman PJ, 1998, CLIN CANCER RES, V4, P507; Coopman PJ, 1996, MOL BIOL CELL, V7, P1789, DOI 10.1091/mbc.7.11.1789; Deckert M, 1996, IMMUNITY, V5, P591, DOI 10.1016/S1074-7613(00)80273-3; EmmertBuck MR, 1996, SCIENCE, V274, P998, DOI 10.1126/science.274.5289.998; FANG WJ, 1992, J BIOL CHEM, V267, P25889; FARGNOLI J, 1995, J BIOL CHEM, V270, P26533, DOI 10.1074/jbc.270.44.26533; FLUCK M, 1995, BIOCHEM BIOPH RES CO, V213, P273, DOI 10.1006/bbrc.1995.2126; INDIK ZK, 1995, BLOOD, V85, P1175, DOI 10.1182/blood.V85.5.1175.bloodjournal8551175; KUREBAYASHI J, 1993, CANCER RES, V53, P2178; Kurosaki T, 1997, CURR OPIN IMMUNOL, V9, P309, DOI 10.1016/S0952-7915(97)80075-1; Law CL, 1996, MOL CELL BIOL, V16, P1305; LAW CL, 1994, J BIOL CHEM, V269, P12310; Lingle WL, 1999, AM J PATHOL, V155, P1941, DOI 10.1016/S0002-9440(10)65513-7; Minobe K, 1998, JPN J CANCER RES, V89, P916, DOI 10.1111/j.1349-7006.1998.tb00649.x; Miranti CK, 1998, CURR BIOL, V8, P1289, DOI 10.1016/S0960-9822(07)00559-3; Murphy MA, 1998, MOL CELL BIOL, V18, P4872, DOI 10.1128/MCB.18.8.4872; NAGAI K, 1994, J BIOCHEM-TOKYO, V116, P1176, DOI 10.1093/oxfordjournals.jbchem.a124646; Peters JD, 1996, J BIOL CHEM, V271, P4755; PINKEL D, 1986, COLD SPRING HARB SYM, V51, P151, DOI 10.1101/SQB.1986.051.01.018; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; TAKATA M, 1994, EMBO J, V13, P1341, DOI 10.1002/j.1460-2075.1994.tb06387.x; THOMPSON EW, 1992, J CELL PHYSIOL, V150, P534, DOI 10.1002/jcp.1041500314; TURNER M, 1995, NATURE, V378, P298, DOI 10.1038/378298a0; WILLIAMS RJ, 1984, ADV PLANT PATHOL, V2, P1; YAGI S, 1994, BIOCHEM BIOPH RES CO, V200, P28, DOI 10.1006/bbrc.1994.1409	29	264	326	0	14	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 17	2000	406	6797					742	747		10.1038/35021086	http://dx.doi.org/10.1038/35021086			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	344PH	10963601				2022-12-28	WOS:000088767700048
J	Schon, JH; Kloc, C; Batlogg, B				Schon, JH; Kloc, C; Batlogg, B			RETRACTED: Superconductivity in molecular crystals induced by charge injection (Retracted article. See vol 422 pg 93 2003)	NATURE			English	Article; Retracted Publication							FIELD; TRANSISTORS; POLYACENE; FILMS	Progress in the field of superconductivity is often linked to the discovery of new classes of materials, with the layered copper oxides(1) being a particularly impressive example. The superconductors known today include a wide spectrum of materials, ranging in complexity from simple elemental metals, to alloys and binary compounds of metals, to multi-component compounds of metals and chalcogens or metalloids, doped fullerenes and organic charge-transfer salts. Here we present a new class of superconductors: insulating organic molecular crystals that are made metallic through charge injection. The first examples are pentacene, tetracene and anthracene, the last having the highest transition temperature, at 4 K. We anticipate that many other organic molecular crystals can also be made superconducting by this method, which will lead to surprising findings in the vast composition space of molecular crystals.	Bell Labs, Lucent Technol, Murray Hill, NJ 07974 USA	Alcatel-Lucent; Lucent Technologies; AT&T	Batlogg, B (corresponding author), Bell Labs, Lucent Technol, 600 Mt Ave, Murray Hill, NJ 07974 USA.	batlogg@bell-labs.com	Kloc, Christian/A-2255-2011					Ahn CH, 1999, SCIENCE, V284, P1152, DOI 10.1126/science.284.5417.1152; BEDNORZ JG, 1986, Z PHYS B CON MAT, V64, P189, DOI 10.1007/BF01303701; Devos A, 1998, PHYS REV B, V58, P8236, DOI 10.1103/PhysRevB.58.8236; DODABALAPUR A, 1995, SCIENCE, V268, P270, DOI 10.1126/science.268.5208.270; GINZBURG VL, 1968, CONTEMP PHYS, V9, P355, DOI 10.1080/00107516808220090; GLOVER RE, 1960, PHYS REV LETT, V5, P248, DOI 10.1103/PhysRevLett.5.248; Ishiguro T., 1998, ORGANIC SUPERCONDUCT, V2nd; Jerome D., 1980, J PHYS LETT, V41, P95, DOI DOI 10.1051/JPHYSLET:0198000410409500; KIVELSON S, 1983, PHYS REV B, V28, P7236, DOI 10.1103/PhysRevB.28.7236; Kloc C, 1997, J CRYST GROWTH, V182, P416, DOI 10.1016/S0022-0248(97)00370-9; Konsin P, 1998, PHYS REV B, V58, P5795, DOI 10.1103/PhysRevB.58.5795; MANNHART J, 1993, APPL PHYS LETT, V62, P630, DOI 10.1063/1.108877; MISHIMA A, 1985, SYNTHETIC MET, V11, P75, DOI 10.1016/0379-6779(85)90176-6; Schon JH, 2000, SCIENCE, V288, P656, DOI 10.1126/science.288.5466.656; Schon JH, 2000, SCIENCE, V288, P2338, DOI 10.1126/science.288.5475.2338; Schon JH, 2000, SCIENCE, V287, P1022, DOI 10.1126/science.287.5455.1022; Silinsh E. A., 1994, ORGANIC MOL CRYSTALS; WARTA W, 1985, PHYS REV B, V32, P1172, DOI 10.1103/PhysRevB.32.1172; WARTA W, 1985, APPL PHYS A-MATER, V36, P163, DOI 10.1007/BF00624938	19	182	184	0	56	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 17	2000	406	6797					702	704		10.1038/35021011	http://dx.doi.org/10.1038/35021011			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	344PH	10963589				2022-12-28	WOS:000088767700036
J	Wallace, K; Hardy, G; Serabyn, E				Wallace, K; Hardy, G; Serabyn, E			Deep and stable interferometric nulling of broadband light with implications for observing planets around nearby stars	NATURE			English	Article							SOLAR	The number of indirectly detected planetary systems around nearby stars has grown tremendously since their initial discovery five years ago(1). But the direct observation of light reflected from these systems remains a formidable task, because of the high contrast ratios between them and their parent stars, and because of the tiny angular separations. Theoretically(2), these difficulties can be overcome by using a dual-aperture stellar interferometer in which the starlight is cancelled, or 'nulled', by broadband destructive interference, leaving the planet's light visible. Although the basic requirement of equal and oppositely directed electric fields is easy to state, an experimental demonstration of deep broadband nulling has been lacking, owing to difficulties engendered by the needs for extreme symmetry and stability, and low dispersion in the optical system. Here we report the deep (10(-4)) and stable nulling of broadband (18% bandwidth) thermal light. These results validate the physical principles underlying future planet-searching interferometers, and our laboratory instrument will serve as a prototype for the nulling instrument to be implemented on the Keck interferometer in 2001.	CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Wallace, K (corresponding author), CALTECH, Jet Prop Lab, MS 171-113,4800 Oak Grove Dr, Pasadena, CA 91109 USA.			Wallace, James/0000-0001-5299-6899				Angel J. R. P., 1990, NEXT GENERATION SPAC, P81; ANGEL JRP, 1996, P SOC PHOTO-OPT INS, V2871, P516; BADOUZ P, 1998, P SOC PHOTO-OPT INS, V3353, P455; BEICHMAN A, 1999, JPL PUBLICATION, V993; BRACEWELL RN, 1978, NATURE, V274, P780, DOI 10.1038/274780a0; BRACEWELL RN, 1979, ICARUS, V38, P136, DOI 10.1016/0019-1035(79)90093-9; Colavita MM, 1998, P SOC PHOTO-OPT INS, V3350, P776, DOI 10.1117/12.317145; DANNER R, 1999, SPACE INTERFEROMETRY, P103; Diner D. J., 1991, Journal of the British Interplanetary Society, V44, P505; DINER DJ, 1990, NEXT GENERATION SPAC, P133; Gay J, 1996, CR ACAD SCI II B, V322, P265; Hinz PM, 1998, NATURE, V395, P251, DOI 10.1038/26172; Leger A, 1996, ICARUS, V123, P249, DOI 10.1006/icar.1996.0155; Ollivier M, 1997, APPL OPTICS, V36, P5340, DOI 10.1364/AO.36.005340; Serabyn E, 1999, ASTR SOC P, V194, P437; Serabyn E, 1999, APPL OPTICS, V38, P7128, DOI 10.1364/AO.38.007128; Serabyn E, 1999, APPL OPTICS, V38, P4213, DOI 10.1364/AO.38.004213; SHAO M, 1991, P SOC PHOTO-OPT INS, V1494, P347, DOI 10.1117/12.46735; SHAO M, 1990, NEXT GENERATION SPAC, P160	20	57	58	0	6	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 17	2000	406	6797					700	702		10.1038/35021007	http://dx.doi.org/10.1038/35021007			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	344PH	10963588				2022-12-28	WOS:000088767700035
J	Leonard, JV; Morris, AAM				Leonard, JV; Morris, AAM			Inborn errors of metabolism around time of birth	LANCET			English	Review							SYRUP URINE DISEASE; DEFICIENT GLYCOPROTEIN SYNDROME; HYDROPS-FETALIS; LIVER-FAILURE; MANAGEMENT; MYOPATHY; ACIDOSIS	Inborn errors of metabolism commonly present around the time of birth. Although most affected babies are born healthy and subsequently deteriorate, some disorders may present at (or shortly after) birth and a few may be detected by antenatal ultrosonography. In many cases, it is important that the diagnosis is made quickly and a strategy to identify those at high risk is proposed. Treatment should not be delayed for a definitive diagnosis.	Inst Child Hlth, Biochem Endocrinol & Metab Unit, London WC1 1EH, England; Royal Victoria Infirm, Dept Child Hlth, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England	University of London; University College London; Newcastle University - UK	Leonard, JV (corresponding author), Inst Child Hlth, Biochem Endocrinol & Metab Unit, London WC1 1EH, England.							Alegria A, 1999, J INHERIT METAB DIS, V22, P330, DOI 10.1023/A:1005568507267; Barth PG, 1999, J INHERIT METAB DIS, V22, P555, DOI 10.1023/A:1005568609936; BERRY GT, 1991, NEW ENGL J MED, V324, P175, DOI 10.1056/NEJM199101173240307; CLAYTON PT, 1992, J INHERIT METAB DIS, V15, P857, DOI 10.1007/BF01800221; CLOW CL, 1981, PEDIATRICS, V68, P856; COOKE RJ, 1983, CLIN CHEM, V29, P1563; CormierDaire V, 1996, AM J MED GENET, V66, P457, DOI 10.1002/(SICI)1096-8628(19961230)66:4<457::AID-AJMG15>3.0.CO;2-T; de Koning TJ, 1998, J INHERIT METAB DIS, V21, P681, DOI 10.1023/A:1005496920435; FAYON M, 1992, GASTROENTEROLOGY, V103, P1332, DOI 10.1016/0016-5085(92)91525-9; Holme E, 1998, J INHERIT METAB DIS, V21, P507, DOI 10.1023/A:1005410820201; Morris AAM, 1998, J HEPATOL, V28, P556, DOI 10.1016/S0168-8278(98)80278-X; Papadopoulou LC, 1999, NAT GENET, V23, P333; Saudubray JM, 1999, J INHERIT METAB DIS, V22, P488; Schaefer F, 1999, NEPHROL DIAL TRANSPL, V14, P910, DOI 10.1093/ndt/14.4.910; VANEKEREN GJ, 1993, EUR J PEDIATR, V152, P255, DOI 10.1007/BF01956157; WALTER JH, 1995, ARCH DIS CHILD-FETAL, V72, pF197, DOI 10.1136/fn.72.3.F197; Webster M, 1999, J INHERIT METAB D S1, V22, P80; WENDEL U, 1982, EUR J PEDIATR, V139, P172, DOI 10.1007/BF01377350; WILCKEN B, 1993, LANCET, V341, P407, DOI 10.1016/0140-6736(93)92993-4	19	40	42	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 12	2000	356	9229					583	587		10.1016/S0140-6736(00)02591-5	http://dx.doi.org/10.1016/S0140-6736(00)02591-5			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	345MY	10950248				2022-12-28	WOS:000088820800039
J	Laabi, Y; Strasser, A				Laabi, Y; Strasser, A			Immunology - Lymphocyte survival - Ignorance is BLys	SCIENCE			English	Editorial Material							TUMOR-NECROSIS-FACTOR; FACTOR FAMILY; RECEPTOR SUPERFAMILY; CELL GROWTH; B-CELLS; DEATH; BCL-2; MICE; ACTIVATION; APOPTOSIS		Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia	Walter & Eliza Hall Institute	Laabi, Y (corresponding author), Walter & Eliza Hall Inst Med Res, PO Royal Melbourne Hosp, Melbourne, Vic 3050, Australia.	laabi@wehi.edu.au; strasser@wehi.edu.au	Strasser, Andreas/C-7581-2013	Strasser, Andreas/0000-0002-5020-4891				ANDERSON PN, 1969, NATURE, V222, P994, DOI 10.1038/222994a0; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Baker SJ, 1998, ONCOGENE, V17, P3261, DOI 10.1038/sj.onc.1202568; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Grell M, 1999, EMBO J, V18, P3034, DOI 10.1093/emboj/18.11.3034; Gross JA, 2000, NATURE, V404, P995, DOI 10.1038/35010115; Grumont RJ, 1998, J EXP MED, V187, P663, DOI 10.1084/jem.187.5.663; Hahne M, 1998, J EXP MED, V188, P1185, DOI 10.1084/jem.188.6.1185; Hatzoglou A, 2000, J IMMUNOL, V165, P1322, DOI 10.4049/jimmunol.165.3.1322; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Khare SD, 2000, P NATL ACAD SCI USA, V97, P3370, DOI 10.1073/pnas.050580697; LAABI Y, 1992, EMBO J, V11, P3897, DOI 10.1002/j.1460-2075.1992.tb05482.x; LAABI Y, 1994, NUCLEIC ACIDS RES, V22, P1147, DOI 10.1093/nar/22.7.1147; Levens JM, 2000, CELL DEATH DIFFER, V7, P59, DOI 10.1038/sj.cdd.4400636; Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697; MacLennan ICM, 1998, CURR OPIN IMMUNOL, V10, P220, DOI 10.1016/S0952-7915(98)80252-5; Marsters SA, 2000, CURR BIOL, V10, P785, DOI 10.1016/S0960-9822(00)00566-2; McLaughlin Peter, 1999, Current Opinion in Oncology, V11, P333, DOI 10.1097/00001622-199909000-00003; Moore PA, 1999, SCIENCE, V285, P260, DOI 10.1126/science.285.5425.260; Mukhopadhyay A, 1999, J BIOL CHEM, V274, P15978, DOI 10.1074/jbc.274.23.15978; Newton K, 2000, EMBO J, V19, P931, DOI 10.1093/emboj/19.5.931; Newton K, 1998, EMBO J, V17, P706, DOI 10.1093/emboj/17.3.706; RATHMELL JC, 1995, NATURE, V376, P181, DOI 10.1038/376181a0; Schneider P, 1999, J EXP MED, V189, P1747, DOI 10.1084/jem.189.11.1747; Shu HB, 2000, P NATL ACAD SCI USA, V97, P9156, DOI 10.1073/pnas.160213497; Shu HB, 1999, J LEUKOCYTE BIOL, V65, P680, DOI 10.1002/jlb.65.5.680; STRASSER A, 1991, P NATL ACAD SCI USA, V88, P8661, DOI 10.1073/pnas.88.19.8661; STRASSER A, 1990, NATURE, V348, P331, DOI 10.1038/348331a0; Strasser A, 1995, EMBO J, V14, P6136, DOI 10.1002/j.1460-2075.1995.tb00304.x; Thompson JS, 2000, J EXP MED, V192, P129, DOI 10.1084/jem.192.1.129; TSUJIMOTO Y, 1985, SCIENCE, V228, P1440, DOI 10.1126/science.3874430; vonBulow GU, 1997, SCIENCE, V278, P138, DOI 10.1126/science.278.5335.138; Wang J, 2000, EUR J IMMUNOL, V30, P155, DOI 10.1002/1521-4141(200001)30:1<155::AID-IMMU155>3.3.CO;2-O; Xia XZ, 2000, J EXP MED, V192, P137, DOI 10.1084/jem.192.1.137; Yamada Y, 1997, P NATL ACAD SCI USA, V94, P1441, DOI 10.1073/pnas.94.4.1441; Yan MH, 2000, NAT IMMUNOL, V1, P37, DOI 10.1038/76889; Yoshida T, 2000, INT IMMUNOL, V12, P517, DOI 10.1093/intimm/12.4.517; Zhang JK, 1998, NATURE, V392, P296, DOI 10.1038/32681	38	43	58	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 11	2000	289	5481					883	884		10.1126/science.289.5481.883	http://dx.doi.org/10.1126/science.289.5481.883			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	343KH	10960320				2022-12-28	WOS:000088701200021
J	Rensberger, JM; Watabe, M				Rensberger, JM; Watabe, M			Fine structure of bone in dinosaurs, birds and mammals	NATURE			English	Article							COMPACT-BONE; COLLAGEN	After observation of detailed structural evidence for the origin of birds from dinosaurs(1), and in light of evidence that dinosaur bone tissue resembles the histology in mammals(2), the histology of bone has become one of the focal points in discussions of the physiology of dinosaurs and Mesozoic birds(3-10). Most of this microstructural information has focused on features related to the vascular organization and the amount of remodelled bone around vascular canals. However, the finer structures have received less attention, although differences in such structures have been observed among modern vertebrates(10,11). Here we present evidence that canaliculi-the submicrometre-sized channels that interconnect bone cells and vascular canals-and the collagen fibre bundles in bone are differently organized among certain dinosaur lineages. Ornithomimid dinosaurs(12) are more like birds than mammals in these features. In canalicular structure, and to some extent in fibre bundle arrangement, ornithischian dinosaurs are more like mammals. These differences in both canalicular and lamellar structure are probably linked to differences in the process and rate(13) of bone formation.	Univ Washington, Burke Museum Nat Hist & Culture, Seattle, WA 98195 USA; Univ Washington, Dept Geol Sci, Seattle, WA 98195 USA; Hayashibara Museum Nat Sci, Okayama 7000907, Japan	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Rensberger, JM (corresponding author), Univ Washington, Burke Museum Nat Hist & Culture, Seattle, WA 98195 USA.							Amprino R., 1947, ARCH BIOL SCI, V58, P315; AMPRINO RODOLFO, 1947, COMMENTATIONES PONTIFICIA ACAD SCI, V11, P329; [Anonymous], 1980, COLD LOOK WARM BLOOD; BAKKER RT, 1972, NATURE, V238, P81, DOI 10.1038/238081a0; Boyde A., 1972, BIOCH PHYSL BONE, V1, P259; Castanet J, 1996, CR ACAD SCI III-VIE, V319, P301; CHINSAMY A, 1990, Palaeontologia Africana, V27, P77; Crawford GNC, 1940, J ANAT, V74, P284; Currey J. D., 1962, Palaeontology, V5, P238; Currey JD., 1984, MECH ADAPTATIONS BON; CURTIS TA, 1985, ANAT RECORD, V212, P336, DOI 10.1002/ar.1092120403; DERICQLES A, 1975, ANN PALEONTOL, V61, P51; Enlow D. H., 1957, Texas Journal of Science, V9, P186; GAUTHIER JA, 1986, MEM CALIF ACAD SCI, V8, P1; GEBHARDT W, 1906, ARCH ENTW MECH ORG, V20, P187; GIRAUDGUILLE MM, 1988, CALCIFIED TISSUE INT, V42, P167, DOI 10.1007/BF02556330; HOLTZ TR, 1994, J PALEONTOL, V68, P1100, DOI 10.1017/S0022336000026706; MARTIN RB, 1989, STRUCTURE FUNCTION A; MCMAHON JM, 1995, ANAT RECORD, V242, P147, DOI 10.1002/ar.1092420203; OSTROM JH, 1973, NATURE, V242, P136, DOI 10.1038/242136a0; PAWLICKI R, 1966, NATURE, V211, P655, DOI 10.1038/211655a0; PAWLICKI R, 1984, FOLIA HISTOCHEM CYTO, V22, P91; Raspanti M, 1996, ACTA ANAT, V155, P249; REID REH, 1985, J PALEONTOL, V59, P140; REID REH, 1984, S ZOOLOGICAL SOC LON, V52, P629; Ricqles A., 1991, BONE BONE MATRIX BON, V3, P1, DOI DOI 10.1111/J.0021-8782.2004.00275.X; Rimblot-Baly Frederique, 1995, Annales de Paleontologie, V81, P49; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; Varricchio David J., 1993, Journal of Vertebrate Paleontology, V13, P99; Xu X, 1999, NATURE, V399, P350, DOI 10.1038/20670	30	36	57	0	21	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 10	2000	406	6796					619	622		10.1038/35020550	http://dx.doi.org/10.1038/35020550			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	342PF	10949300				2022-12-28	WOS:000088653800045
J	Richmond, CR				Richmond, CR			How neptunium led to the birth of plutonium	NATURE			English	Letter									Oak Ridge Natl Lab, Oak Ridge, TN 37830 USA	United States Department of Energy (DOE); Oak Ridge National Laboratory	Richmond, CR (corresponding author), Oak Ridge Natl Lab, POB 2008, Oak Ridge, TN 37830 USA.							SEABORG GS, 1972, RADIOBIOLOGY PLUTONI; 2000, NATURE, V405, P131	2	1	1	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 3	2000	406	6795					455	455		10.1038/35020248	http://dx.doi.org/10.1038/35020248			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	340ML	10952287				2022-12-28	WOS:000088538000015
J	Stairs, IH; Lyne, AG; Shemar, SL				Stairs, IH; Lyne, AG; Shemar, SL			Evidence for free precession in a pulsar	NATURE			English	Article							NEUTRON-STARS; PLANETARY SYSTEM; SPIN-DOWN; PSR1257+12	Pulsars are rotating neutron stars that produce lighthouse-like beams of radio emission from their magnetic poles. The observed pulse of emission enables their rotation rates to be measured with great precision. For some young pulsars, this provides a means of studying the interior structure of neutron stars. Most pulsars have stable pulse shapes, and slow down steadily (for example, see ref. 20). Here we report the discovery of long-term, highly periodic and correlated variations in both the pulse shape and the rate of slow-down of the pulsar PSR B1828-11. The variations are best described as harmonically related sinusoids, with periods of approximately 1,000, 500 and 250 days, probably resulting from precession of the spin axis caused by an asymmetry in the shape of the pulsar. This is difficult to understand theoretically, because torque-free precession of a solitary pulsar should be damped out by the vortices in its superfluid interior(1,2).	Univ Manchester, Jodrell Bank Observ, Macclesfield SK11 9DL, Cheshire, England	University of Manchester; Jodrell Bank Centre for Astrophysics	Lyne, AG (corresponding author), Univ Manchester, Jodrell Bank Observ, Macclesfield SK11 9DL, Cheshire, England.	agl@jb.man.ac.uk		Shemar, Setnam/0000-0003-0308-3000				ALPAR MA, 1984, ASTROPHYS J, V276, P325, DOI 10.1086/161616; Arzoumanian Z, 1995, THESIS PRINCETON U; BAILES M, 1993, ASTR SOC P, V36, P19; CORDES JM, 1993, ASTR SOC P, V36, P43; D'Alessandro F, 1997, MON NOT R ASTRON SOC, V292, P879, DOI 10.1093/mnras/292.4.879; GOLDSTEIN H, 1980, CLASSICAL MECHANICS, P205; KENNEL CF, 1979, SOLAR SYSTEM PLASMA, V2, P105; LYNE AG, 1996, P IAU C, V160, P73; LYNE AG, 1998, PULSAR ASTRONOMY, P14; Melatos A, 1999, ASTROPHYS J, V519, pL77, DOI 10.1086/312104; MEREGHETTI S, 1995, ASTROPHYS J, V455, P598, DOI 10.1086/176607; RASIO FA, 1992, NATURE, V355, P325, DOI 10.1038/355325a0; ROBERTS DH, 1987, ASTRON J, V93, P968, DOI 10.1086/114383; Sedrakian A, 1999, ASTROPHYS J, V524, P341, DOI 10.1086/307777; SHAHAM J, 1977, ASTROPHYS J, V214, P251, DOI 10.1086/155249; Suleymanova S. A, 1994, APJ, V422, P17; TKACHENKO VK, 1966, ZH EKSP TEOR FIZ, V23, P1049; WEISBERG JM, 1989, ASTROPHYS J, V347, P1030, DOI 10.1086/168193; WOLSZCZAN A, 1994, SCIENCE, V264, P538, DOI 10.1126/science.264.5158.538; WOLSZCZAN A, 1992, NATURE, V355, P145, DOI 10.1038/355145a0	20	188	193	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 3	2000	406	6795					484	486		10.1038/35020010	http://dx.doi.org/10.1038/35020010			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	340ML	10952302				2022-12-28	WOS:000088538000036
J	Coles, P; Chiang, LY				Coles, P; Chiang, LY			Characterizing the nonlinear growth of large-scale structure in the Universe	NATURE			English	Article							SELF-SIMILAR EVOLUTION; DENSITY FIELDS; PHASE; BISPECTRUM	The local Universe displays a rich hierarchical pattern of galaxy clusters and superclusters(1,2). The early Universe, however, was almost smooth, with only slight 'ripples', as seen in the cosmic microwave background radiation(3). Models of the evolution of cosmic structure link these observations through the effect of gravity, because the small initially overdense fluctuations are predicted to attract additional mass as the Universe expands(4). During the early stages of this expansion, the ripples evolve independently, like linear waves on the surface of deep water. As the structures grow in mass, they interact with each other in nonlinear ways, more like waves breaking in shallow water. We have recently shown(5) how cosmic structure can be characterized by phase correlations associated with these nonlinear interactions, but it was not clear how to use that information to obtain quantitative insights into the growth of structures. Here we report a method of revealing phase information, and show quantitatively how this relates to the formation of filaments, sheets and clusters of galaxies by nonlinear collapse. We develop a statistical method based on information entropy to separate linear from nonlinear effects, and thereby are able to disentangle those aspects of galaxy clustering that arise from initial conditions (the ripples) from the subsequent dynamical evolution.	Univ Nottingham, Sch Phys & Astron, Nottingham NG7 2RD, England; Univ London Queen Mary & Westfield Coll, Sch Math Sci, Astron Unit, London E1 4NS, England	University of Nottingham; University of London; Queen Mary University London	Coles, P (corresponding author), Univ Nottingham, Sch Phys & Astron, Univ Pk, Nottingham NG7 2RD, England.		蔣龍毅, Lung-Yih Chiang/ABC-3083-2020	蔣龍毅, Lung-Yih Chiang/0000-0002-6564-9391; Coles, Peter/0000-0002-5535-2850				BARDEEN JM, 1986, ASTROPHYS J, V304, P15, DOI 10.1086/164143; BEACOM JF, 1991, ASTROPHYS J, V372, P351, DOI 10.1086/169983; Bromley BC, 1999, ASTROPHYS J, V524, pL79, DOI 10.1086/312304; Chiang LY, 2000, MON NOT R ASTRON SOC, V311, P809, DOI 10.1046/j.1365-8711.2000.03086.x; Ferreira PG, 1998, ASTROPHYS J, V503, pL1, DOI 10.1086/311514; Foley J. D., 1982, FUNDAMENTALS INTERAC, P2; GUTH AH, 1982, PHYS REV LETT, V49, P1110, DOI 10.1103/PhysRevLett.49.1110; Jain B, 1996, ASTROPHYS J, V456, P43, DOI 10.1086/176625; Jain B, 1998, ASTROPHYS J, V509, P517, DOI 10.1086/306538; Matarrese S, 1997, MON NOT R ASTRON SOC, V290, P651, DOI 10.1093/mnras/290.4.651; MELOTT AL, 1990, NATURE, V346, P633, DOI 10.1038/346633a0; OPPENHEIM AV, 1981, P IEEE, V69, P529, DOI 10.1109/PROC.1981.12022; Pando J, 1998, PHYS REV LETT, V81, P4568, DOI 10.1103/PhysRevLett.81.4568; Peebles P. J., 1980, LARGE SCALE STRUCTUR; POLYGIANNAKIS JM, 1995, SOL PHYS, V158, P159, DOI 10.1007/BF00680840; RYDEN BS, 1991, ASTROPHYS J, V383, pL33, DOI 10.1086/186234; SAUNDERS W, 1991, NATURE, V349, P32, DOI 10.1038/349032a0; SCHERRER RJ, 1991, ASTROPHYS J, V377, P29, DOI 10.1086/170333; Scoccimarro R, 1999, ASTROPHYS J, V517, P531, DOI 10.1086/307220; SHANDARIN SF, 1989, REV MOD PHYS, V61, P185, DOI 10.1103/RevModPhys.61.185; Shectman SA, 1996, ASTROPHYS J, V470, P172, DOI 10.1086/177858; Smoot G.F., 1992, APJ, V396, pL1; SODA J, 1992, ASTROPHYS J, V396, P379, DOI 10.1086/171726; Stirling AJ, 1996, MON NOT R ASTRON SOC, V283, pL99, DOI 10.1093/mnras/283.4.L99; THORNTON AL, 1998, THESIS U READING; Verde L, 2000, MON NOT R ASTRON SOC, V313, P141, DOI 10.1046/j.1365-8711.2000.03191.x	26	60	60	1	6	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 27	2000	406	6794					376	378		10.1038/35019009	http://dx.doi.org/10.1038/35019009			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	337WC	10935627				2022-12-28	WOS:000088383800037
J	Frasch, M; Leptin, M				Frasch, M; Leptin, M			Mergers and acquisitions: Unequal partnerships in Drosophila myoblast fusion	CELL			English	Review							MUSCLES; EMBRYOGENESIS; GENE; CELLS; CITY		CUNY Mt Sinai Sch Med, Dept Biochem & Mol Biol, New York, NY 10029 USA; Univ Cologne, Inst Genet, D-50931 Cologne, Germany	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; University of Cologne	Frasch, M (corresponding author), CUNY Mt Sinai Sch Med, Dept Biochem & Mol Biol, 1 Gustave L Levy Pl, New York, NY 10029 USA.		Jani, Arpit/B-5376-2017; Frasch, Manfred/H-7002-2013; Verma, Anshul/L-2903-2018	Frasch, Manfred/0000-0003-1373-9798; Verma, Anshul/0000-0002-4266-9701				BATE M, 1990, DEVELOPMENT, V110, P791; Baylies MK, 1998, CELL, V93, P921, DOI 10.1016/S0092-8674(00)81198-8; Bour BA, 2000, GENE DEV, V14, P1498; BRUMMENDORF T, 1994, PROTEIN PROFILE, V1, P951; Doberstein SK, 1997, J CELL BIOL, V136, P1249, DOI 10.1083/jcb.136.6.1249; DOHRMANN C, 1990, GENE DEV, V4, P2098, DOI 10.1101/gad.4.12a.2098; Erickson MRS, 1997, J CELL BIOL, V138, P589, DOI 10.1083/jcb.138.3.589; Frasch M, 1999, CURR OPIN GENET DEV, V9, P522, DOI 10.1016/S0959-437X(99)00014-3; HO RK, 1983, NATURE, V301, P66, DOI 10.1038/301066a0; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Paululat A, 1999, MECH DEVELOP, V83, P17, DOI 10.1016/S0925-4773(99)00029-5; PAULULAT A, 1995, DEVELOPMENT, V121, P2611; Ruiz-Gomez M, 2000, CELL, V102, P189, DOI 10.1016/S0092-8674(00)00024-6; RUSHTON E, 1995, DEVELOPMENT, V121, P1979; Rutishauser U, 2000, J CELL BIOL, V149, P757, DOI 10.1083/jcb.149.4.757	15	19	19	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 21	2000	102	2					127	129		10.1016/S0092-8674(00)00016-7	http://dx.doi.org/10.1016/S0092-8674(00)00016-7			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	337NA	10943831	Bronze			2022-12-28	WOS:000088366800001
J	Tomassetti, P; Migliori, M; Caletti, GC; Fusaroli, P; Corinaldesi, R; Gullo, L				Tomassetti, P; Migliori, M; Caletti, GC; Fusaroli, P; Corinaldesi, R; Gullo, L			Treatment of type II gastric carcinoid tumors with somatostatin analogues	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ENTEROCHROMAFFIN-LIKE CELLS; IDENTIFICATION; OCTREOTIDE; SUBTYPES; GENE		Univ Bologna, Dept Internal Med & Gastroenterol, Bologna, Italy	University of Bologna	Gullo, L (corresponding author), S Orsola Hosp, Dept Internal Med & Gastroenterol, Via Massarenti 9, I-40138 Bologna, Italy.		Fusaroli, Pietro/AAC-2182-2020	Fusaroli, Pietro/0000-0002-4397-9314				CADIOT G, 1993, GASTROENTEROLOGY, V105, P579, DOI 10.1016/0016-5085(93)90736-V; Caplin ME, 1998, AM J GASTROENTEROL, V93, P1945; Debelenko LV, 1997, GASTROENTEROLOGY, V113, P773, DOI 10.1016/S0016-5085(97)70171-9; Ferraro G, 1996, J CLIN ENDOCR METAB, V81, P677, DOI 10.1210/jc.81.2.677; GILLIGAN CJ, 1995, AM J GASTROENTEROL, V90, P338; HIRSCHOWITZ BI, 1992, GASTROENTEROLOGY, V102, P1409; Jensen RT, 1999, 7 INT WORKSH MULT NE, P67; KUBOTA A, 1994, J CLIN INVEST, V93, P1321, DOI 10.1172/JCI117090; MODLIN IM, 1993, ITAL J GASTROENTE S2, V31, pS117; PRINZ C, 1994, GASTROENTEROLOGY, V107, P1067, DOI 10.1016/0016-5085(94)90231-3; REUBI JC, 1992, ENDOCRINOLOGY, V131, P166, DOI 10.1210/en.131.1.166; RINDI G, 1993, GASTROENTEROLOGY, V104, P994, DOI 10.1016/0016-5085(93)90266-F; Rindi G, 1999, GASTROENTEROLOGY, V116, P532, DOI 10.1016/S0016-5085(99)70174-5; Rubin J, 1999, J CLIN ONCOL, V17, P600, DOI 10.1200/JCO.1999.17.2.600; RUSZNIEWSKI P, 1988, PANCREAS, V3, P145, DOI 10.1097/00006676-198804000-00006; Tomassetti P, 1998, AM J GASTROENTEROL, V93, P1468, DOI 10.1111/j.1572-0241.1998.465_q.x; Tomassetti P, 2000, ALIMENT PHARM THERAP, V14, P557	17	103	105	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 24	2000	343	8					551	554		10.1056/NEJM200008243430805	http://dx.doi.org/10.1056/NEJM200008243430805			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	346QM	10954763				2022-12-28	WOS:000088882600005
J	Moran, GJ; Talan, DA; Mower, W; Newdow, M; Ong, S; Nakase, JY; Pinner, RW; Childs, JE				Moran, GJ; Talan, DA; Mower, W; Newdow, M; Ong, S; Nakase, JY; Pinner, RW; Childs, JE		Emergency ID Net Study Grp	Appropriateness of rabies postexposure prophylaxis treatment for animal exposures	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							UNITED-STATES; EPIDEMIOLOGY	Context Rabies postexposure prophylaxis (RPEP) treatments and associated costs have increased in the United States. The extent to which RPEP use is consistent with guidelines is not well understood. Objective To characterize animal contacts and determine the frequency and factors associated with inappropriate RPEP use. Design, Setting, and Patients Prospective case series study of patients presenting with an animal exposure-related complaint from July 1996 to September 1998 at 11 university-affiliated, urban emergency departments (the Emergency ID Net). Main Outcome Measures Exposure type, circumstances, and RPEP use (appropriateness defined by local public health departments). Results Of 2030 exposures, 1635 (81%) were to dogs; 268 (13%) to cats; 88 (4%) to rodents/rabbits; 70 (0.5%) to raccoons; 5 (0.2%) to bats; and 24 (1.2%) to other animals. Among those exposed, 136 (6.7%) received RPEP after dog (95), cat (21), raccoon (8), bat (4), or other animal (8) exposures. Use of RPEP varied by site (range, 0%-27.7% of exposures), with most frequent use reported at sites in the eastern United States, Management was considered appropriate in 1857 exposures (91.5%), Use of RPEP was considered inappropriate in 54 cases (40% of those in which it was given), owing to factors including animal availability for observation and exposure in a low-endemicity area. Rabies postexposure prophylaxis was considered inappropriately withheld from 119 cases (6.3% of those not receiving RPEP), often because a domestic animal was unavailable for observation or testing. Conclusion These results suggest that use of RPEP is often inappropriate. Greater compliance with current guidelines would increase RPEP use. Physician education, improved coordination with public health officials, and clarification of RPEP guidelines could optimize use of this expensive resource.	Olive View UCLA Med Ctr, Dept Emergency Med, Sylmar, CA 91342 USA; Univ Calif Los Angeles, Sch Med, Los Angeles, CA USA; Ctr Dis Control & Prevent, Natl Ctr Infect Dis, Atlanta, GA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Centers for Disease Control & Prevention - USA	Moran, GJ (corresponding author), Olive View UCLA Med Ctr, Dept Emergency Med, 14445 Olive View Dr,N Annex, Sylmar, CA 91342 USA.	gmoran@ucla.edu	Childs, James E/B-4002-2012	Chiang, William/0000-0003-3562-8896	PHS HHS [U50/CCU912342] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		[Anonymous], 1999, MMWR Recomm Rep, V48, P1; [Anonymous], 1991, MMWR Recomm Rep, V40, P1; Auslander M, 1997, EMERG INFECT DIS, V3, P199, DOI 10.3201/eid0302.970216; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V45, P1117; CIESLAK PR, 1998, INT C EM INF DIS MAR; Harrigan Richard A., 1996, Journal of Emergency Medicine, V14, P287, DOI 10.1016/0736-4679(96)00023-6; HELMICK CG, 1983, JAMA-J AM MED ASSOC, V250, P1990, DOI 10.1001/jama.250.15.1990; Krebs J W, 1998, J Public Health Manag Pract, V4, P56; Krebs JW, 1998, J AM VET MED ASSOC, V213, P1713; Meltzer MI, 1998, PHARMACOECONOMICS, V14, P365, DOI 10.2165/00019053-199814040-00004; Noah DL, 1998, ANN INTERN MED, V128, P922, DOI 10.7326/0003-4819-128-11-199806010-00012; Talan DA, 1998, ANN EMERG MED, V32, P703, DOI 10.1016/S0196-0644(98)70071-X; U.S. Department of Health and Human Services, 1991, DHHS PUBL; Weiss HB, 1998, JAMA-J AM MED ASSOC, V279, P51, DOI 10.1001/jama.279.1.51; 1998, JAMA, V30, P1525	15	81	82	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 23	2000	284	8					1001	1007		10.1001/jama.284.8.1001	http://dx.doi.org/10.1001/jama.284.8.1001			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	344PX	10944646	Bronze			2022-12-28	WOS:000088769000027
J	Palladino, MJ; Keegan, LP; O'Connell, MA; Reenan, RA				Palladino, MJ; Keegan, LP; O'Connell, MA; Reenan, RA			A-to-I pre-mRNA editing in Drosophila is primarily involved in adult nervous system function and integrity	CELL			English	Article							DOUBLE-STRANDED-RNA; GLUTAMATE-RECEPTOR CHANNELS; SUBUNIT GLUR-B; MESSENGER-RNAS; ADENOSINE-DEAMINASE; ION FLOW; GENE; INOSINE; HYPERMUTATION; PURIFICATION	Specific A-to-I RNA editing, like that seen in mammals, has been reported for several Drosophila ion channel genes. Drosophila possesses a candidate editing enzyme, dADAR. Here, we describe dADAR deletion mutants that lack ADAR activity in extracts. Correspondingly, all known Drosophila site-specific RNA editing (25 sites in three ion channel transcripts) is abolished. Adults lacking dADAR are morphologically wild-type but exhibit extreme behavioral deficits including temperature-sensitive paralysis, locomotor uncoordination, and tremors which increase in severity with age. Neurodegeneration accompanies the increase in phenotypic severity. Surprisingly, dADAR mutants are not short-lived. Thus, A-to-I editing of pre-mRNAs in Drosophila acts predominantly through nervous system targets to affect adult nervous system function, integrity, and behavior.	Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, Farmington, CT 06030 USA; Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland	University of Connecticut; University of Edinburgh	Reenan, RA (corresponding author), Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, 263 Farmington Ave, Farmington, CT 06030 USA.	rreenan@neuron.uchc.edu	Keegan, Liam P/F-1106-2017; OConnell, Mary Anne/G-4740-2015; Keegan, Liam P./AAL-3753-2021; O'Connell, Mary Anne/U-7693-2019	Keegan, Liam P/0000-0001-7915-5790; OConnell, Mary Anne/0000-0003-3844-6174; Keegan, Liam P./0000-0001-7915-5790; O'Connell, Mary Anne/0000-0003-3844-6174				AUFFRAY C, 1980, EUR J BIOCHEM, V107, P303; Auxilien S, 1996, J MOL BIOL, V262, P437, DOI 10.1006/jmbi.1996.0527; BALLINGER DG, 1989, P NATL ACAD SCI USA, V86, P9402, DOI 10.1073/pnas.86.23.9402; BASILIO C, 1962, P NATL ACAD SCI USA, V48, P613, DOI 10.1073/pnas.48.4.613; BASS BL, 1988, CELL, V55, P1089, DOI 10.1016/0092-8674(88)90253-X; Bass BL, 1997, TRENDS BIOCHEM SCI, V22, P157, DOI 10.1016/S0968-0004(97)01035-9; BASS BL, 1989, CELL, V56, P331, DOI 10.1016/0092-8674(89)90234-1; BENNE R, 1986, CELL, V46, P819, DOI 10.1016/0092-8674(86)90063-2; BRUSA R, 1995, SCIENCE, V270, P1677, DOI 10.1126/science.270.5242.1677; Burns CM, 1997, NATURE, V387, P303, DOI 10.1038/387303a0; CASEY JL, 1995, J VIROL, V69, P7593, DOI 10.1128/JVI.69.12.7593-7600.1995; Chan L, 1997, BBA-LIPID LIPID MET, V1345, P11, DOI 10.1016/S0005-2760(96)00156-7; Cleland TA, 1996, MOL NEUROBIOL, V13, P97, DOI 10.1007/BF02740637; Cully DF, 1996, J BIOL CHEM, V271, P20187, DOI 10.1074/jbc.271.33.20187; DELGADO R, 1989, FEBS LETT, V243, P337, DOI 10.1016/0014-5793(89)80157-7; Feldmeyer D, 1999, NAT NEUROSCI, V2, P57, DOI 10.1038/4561; Feyereisen R, 1995, TOXICOL LETT, V82-3, P83, DOI 10.1016/0378-4274(95)03470-6; Gerber A, 1998, EMBO J, V17, P4780, DOI 10.1093/emboj/17.16.4780; Gerber AP, 1999, SCIENCE, V286, P1146, DOI 10.1126/science.286.5442.1146; Hanrahan CJ, 2000, GENETICS, V155, P1149; Herb A, 1996, P NATL ACAD SCI USA, V93, P1875, DOI 10.1073/pnas.93.5.1875; HIGUCHI M, 1993, CELL, V75, P1361, DOI 10.1016/0092-8674(93)90622-W; Hough RF, 1999, NUCLEIC ACIDS RES, V27, P3424, DOI 10.1093/nar/27.17.3424; Keegan LP, 2000, MOL CELL BIOL, V20, P825, DOI 10.1128/MCB.20.3.825-833.2000; Keller W, 1999, FEBS LETT, V452, P71, DOI 10.1016/S0014-5793(99)00590-6; KOHLER M, 1993, NEURON, V10, P491, DOI 10.1016/0896-6273(93)90336-P; Kumar M, 1997, P NATL ACAD SCI USA, V94, P3542, DOI 10.1073/pnas.94.8.3542; LILLY M, 1994, GENETICS, V136, P1087; Littleton JT, 1999, INT REV NEUROBIOL, V43, P139, DOI 10.1016/S0074-7742(08)60544-9; LOUGHNEY K, 1989, CELL, V58, P1143, DOI 10.1016/0092-8674(89)90512-6; Maas S, 1997, CURR OPIN CELL BIOL, V9, P343, DOI 10.1016/S0955-0674(97)80006-3; Morse DP, 1999, P NATL ACAD SCI USA, V96, P6048, DOI 10.1073/pnas.96.11.6048; Niswender CM, 1999, J BIOL CHEM, V274, P9472, DOI 10.1074/jbc.274.14.9472; OConnell MA, 1997, CURR BIOL, V7, pR437, DOI 10.1016/S0960-9822(06)00212-0; OCONNELL MA, 1994, P NATL ACAD SCI USA, V91, P10596, DOI 10.1073/pnas.91.22.10596; Palladino MJ, 2000, RNA, V6, P1004, DOI 10.1017/S1355838200000248; Patton DE, 1997, NEURON, V19, P711, DOI 10.1016/S0896-6273(00)80383-9; Paul MS, 1998, EMBO J, V17, P1120, DOI 10.1093/emboj/17.4.1120; Peixoto AA, 1997, GENETICS, V145, P1003; Peixoto AA, 1998, GENETICS, V148, P827; Pittendrigh B, 1997, MOL GEN GENET, V256, P602, DOI 10.1007/s004380050608; RAJENDRA S, 1995, TRENDS NEUROSCI, V18, P80; Reenan RA, 2000, NEURON, V25, P139, DOI 10.1016/S0896-6273(00)80878-8; Rueter SM, 1999, NATURE, V399, P75, DOI 10.1038/19992; RUETER SM, 1998, MODIFICATION EDITING; Seeburg PH, 2000, NEURON, V25, P261, DOI 10.1016/S0896-6273(00)80891-0; Seeburg PH, 1998, BRAIN RES REV, V26, P217, DOI 10.1016/S0165-0173(97)00062-3; Semenov EP, 1999, J NEUROCHEM, V72, P66, DOI 10.1046/j.1471-4159.1999.0720066.x; SIMPSON L, 1999, RNA WORLD; Smith L A, 1998, J Neurogenet, V12, P227; Smith LA, 1998, GENETICS, V149, P1407; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; STERN M, 1990, GENETICS, V124, P133; VERDOORN TA, 1991, SCIENCE, V252, P1715, DOI 10.1126/science.1710829; WAGNER RW, 1990, MOL CELL BIOL, V10, P5586, DOI 10.1128/MCB.10.10.5586; Wu C F, 1992, Ion Channels, V3, P261	56	296	318	1	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 18	2000	102	4					437	449		10.1016/S0092-8674(00)00049-0	http://dx.doi.org/10.1016/S0092-8674(00)00049-0			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	347BX	10966106	Bronze, Green Published			2022-12-28	WOS:000088908000006
J	Nadis, S				Nadis, S			The sky's the limit as radio telescope array is approved	NATURE			English	News Item																		ALLEN P, 2000, NATURE, V406, P551	1	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 17	2000	406	6797					665	666		10.1038/35021272	http://dx.doi.org/10.1038/35021272			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	344PH	10963565	Bronze			2022-12-28	WOS:000088767700008
J	Adler, AI; Stratton, IM; Neil, HAW; Yudkin, JS; Matthews, DR; Cull, CA; Wright, AD; Turner, RC; Holman, RR				Adler, AI; Stratton, IM; Neil, HAW; Yudkin, JS; Matthews, DR; Cull, CA; Wright, AD; Turner, RC; Holman, RR		UK Prospective Diabetes Study Grp	Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY HEART-DISEASE; MIDDLE-AGED PATIENTS; RISK-FACTORS; CARDIOVASCULAR MORTALITY; FOLLOW-UP; MYOCARDIAL-INFARCTION; STROKE; MEN; HYPERTENSION; MELLITUS	Objective To determine the relation between systolic blood pressure over time and the risk of macrovascular or microvascular complications in patients dth type 2 diabetes. Design Prospective observational study. Setting 23 hospital based clinics in England, Scotland and Northern Ireland Participants 4801 white, Asian Indian, and Afro-Caribbean UKPDS patients, whether randomised or not to treatment, were included in analyses of incidence; of these, 3642 were included in analyses of relative risk, Outcome measures Primary predefined aggregate clinical outcomes: any complications or deaths related to diabetes and all cause mortality. Secondary aggregate outcomes: myocardial infarction, stroke, lower extremity amputation (including death from peripheral vascular disease), and microvascular disease (predominantly retinal photocoagulation). Single end points: non-fatal heart failure and cataract extraction Risk reduction associated with a 10 mm Hg decrease in updated mean systolic blood pressure adjusted for specific confounders Results The incidence of clinical complications was significantly associated with systolic blood pressure, except for cataract extraction. Each 10 mm Hg decrease in updated mean systolic blood pressure was associated with reductions in risk of 12% for any complication related to diabetes (95%, confidence interval 10% to 14%, P < 0.0001), 15% for deaths related to diabetes (12% to 18%, P< 0.0001), 11% for myocardial infarction (7% to 14%, P< 0.0001), and 13% for microvascular complications (10% to 16%, P< 0.0001). No threshold of risk was observed for any end point. Conclusions In patients with type 2 diabetes the risk of diabetic complications was strongly associated with raised blood pressure. Any reduction in blood pressure is likely to reduce the risk of complications, with the lowest risk being in those with systolic blood pressure less than 120 mm Hg.	Univ Oxford, Radcliffe Infirm, Oxford Ctr Diabet Endocrinol & Metab, Diabet Trial Unit, Oxford OX2 6HE, England; Univ Oxford, Inst Hlth Sci, Div Publ Hlth & Primary Care, Oxford OX3 7LF, England; UCL, Sch Med, Whittington Hosp, London N19 3UA, England; Selly Oak Hosp, Birmingham B29 6JD, W Midlands, England; Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Diabet Res Labs, Oxford OX2 6HE, England	Radcliffe Infirmary; University of Oxford; University of Oxford; University of London; University College London; UCL Medical School; University of Oxford	Adler, AI (corresponding author), Univ Oxford, Radcliffe Infirm, Oxford Ctr Diabet Endocrinol & Metab, Diabet Trial Unit, Oxford OX2 6HE, England.	amanda.adler@dtu.ox.ac.uk	Yudkin, John S/C-1988-2008; stratton, irene/AAZ-3627-2020	stratton, irene/0000-0003-1172-7865				[Anonymous], 1994, Diabet Med, V11, P773; [Anonymous], 1995, Diabetes, V44, P1249; [Anonymous], 1997, ARCH INTERN MED, V157, P2413; BARRETTCONNOR E, 1988, AM J EPIDEMIOL, V128, P116, DOI 10.1093/oxfordjournals.aje.a114934; BARRETTCONNOR EL, 1991, JAMA-J AM MED ASSOC, V265, P627, DOI 10.1001/jama.265.5.627; Birke JA, 1998, DIABETES CARE, V21, P23, DOI 10.2337/diacare.21.1.23; Borghi C, 1998, J CARDIOVASC PHARM, V32, pS24, DOI 10.1097/00005344-199800004-00005; Bruno G, 1999, DIABETOLOGIA, V42, P297, DOI 10.1007/s001250051154; COLLINS R, 1990, LANCET, V335, P827, DOI 10.1016/0140-6736(90)90944-Z; COWIE CC, 1995, DIABETES AM; Curb JD, 1996, JAMA-J AM MED ASSOC, V276, P1886, DOI 10.1001/jama.276.23.1886; Cutler JA, 1996, J HYPERTENS        S, V14, P3; Doughty RN, 1997, EUR HEART J, V18, P560; EASTON DF, 1991, STAT MED, V10, P1025, DOI 10.1002/sim.4780100703; Eriksson J, 1999, DIABETOLOGIA, V42, P793, DOI 10.1007/s001250051229; Ferrari R, 1998, EUR HEART J, V19, pJ30; Freemantle N, 1999, BMJ-BRIT MED J, V318, P1730, DOI 10.1136/bmj.318.7200.1730; Gerstein HC, 2000, LANCET, V355, P253; GOODKIN G, 1975, J OCCUP ENVIRON MED, V17, P716; Hanefeld M, 1996, DIABETOLOGIA, V39, P1577, DOI 10.1007/s001250050617; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; KANNEL WB, 1979, JAMA-J AM MED ASSOC, V241, P2035, DOI 10.1001/jama.241.19.2035; KEIL JE, 1993, NEW ENGL J MED, V329, P73, DOI 10.1056/NEJM199307083290201; KLEIN R, 1995, DIABETES CARE, V18, P258, DOI 10.2337/diacare.18.2.258; KUUSISTO J, 1994, DIABETES, V43, P960, DOI 10.2337/diabetes.43.8.960; Lehto S, 1997, DIABETES, V46, P1354, DOI 10.2337/diabetes.46.8.1354; Lehto S, 1996, STROKE, V27, P63, DOI 10.1161/01.STR.27.1.63; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; MANLEY SE, 1994, DIABETIC MED, V11, P534; MANSON JE, 1991, ARCH INTERN MED, V151, P1141, DOI 10.1001/archinte.151.6.1141; Meltzer S, 1998, CAN MED ASSOC J, V159, pS1; Palumbo P J, 1978, Adv Neurol, V19, P593; Psaty BM, 1997, JAMA-J AM MED ASSOC, V277, P739, DOI 10.1001/jama.277.9.739; Rodby RA, 1996, DIABETES CARE, V19, P1051, DOI 10.2337/diacare.19.10.1051; ROSE G, 1981, BMJ-BRIT MED J, V282, P1847, DOI 10.1136/bmj.282.6279.1847; ROSENGREN A, 1989, BRIT MED J, V299, P1127, DOI 10.1136/bmj.299.6708.1127; *SAS I, 1990, SAS VERS 6; STAMLER J, 1993, DIABETES CARE, V16, P434, DOI 10.2337/diacare.16.2.434; Standl E, 1996, DIABETOLOGIA, V39, P1540, DOI 10.1007/s001250050612; Stearne MR, 1998, BMJ-BRIT MED J, V317, P720; Stearne MR, 1998, BRIT MED J, V317, P713; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Svetkey LP, 1999, ARCH INTERN MED, V159, P285, DOI 10.1001/archinte.159.3.285; Taggart DP, 1998, HEART, V80, P1; TATE RB, 1995, AM J EPIDEMIOL, V142, P946, DOI 10.1093/oxfordjournals.aje.a117742; Tuomilehto J, 1999, NEW ENGL J MED, V340, P677, DOI 10.1056/NEJM199903043400902; TURNER RC, 1993, J HYPERTENS, V11, P309; TURNER RC, 1991, DIABETOLOGIA, V34, P877; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; UUSITUPA MIJ, 1993, DIABETOLOGIA, V36, P1175, DOI 10.1007/BF00401063; van den Hoogen PCW, 2000, NEW ENGL J MED, V342, P1, DOI 10.1056/NEJM200001063420101; VATTEN LJ, 1995, EPIDEMIOLOGY, V6, P70, DOI 10.1097/00001648-199501000-00014; Wei M, 1998, DIABETES CARE, V21, P1167, DOI 10.2337/diacare.21.7.1167; Yusuf S, 2000, NEW ENGL J MED, V342, P145	56	1417	1493	1	50	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 12	2000	321	7258					412	419		10.1136/bmj.321.7258.412	http://dx.doi.org/10.1136/bmj.321.7258.412			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	344QC	10938049	Green Published, Bronze			2022-12-28	WOS:000088769500020
J	Muth, GW; Ortoleva-Donnelly, L; Strobel, SA				Muth, GW; Ortoleva-Donnelly, L; Strobel, SA			A single adenosine with a neutral pK(a) in the ribosomal peptidyl transferase center	SCIENCE			English	Article							TRANSFER-RNA; SERINE PROTEASES; ESCHERICHIA-COLI; A-SITES; P-SITES; CHLORAMPHENICOL; ERYTHROMYCIN; RESISTANCE; CATALYSIS; RIBOZYME	Biochemical and crystallographic evidence suggests that 23S ribosomal RNA (rRNA) is the catalyst of peptide bond formation. To explore the mechanism of this reaction, we screened for nucleotides in Escherichia coli 23S rRNA that may have a perturbed pK(a) (where K-a is the acid constant) based on the pH dependence of dimethylsulfate modification. A single universally conserved A (number 2451) within the central loop of domain V has a near neutral pK(a) of 7.6 +/- 0.2, which is about the same as that reported for the peptidyl transferase reaction. In vivo mutational analysis of this nucleotide indicates that it has an essential role in ribosomal function. These results are consistent with a mechanism wherein the nucleotide base of A2451 serves as a general acid base during peptide bond formation.	Yale Univ, Dept Chem, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University	Strobel, SA (corresponding author), Yale Univ, Dept Chem, Dept Mol Biophys & Biochem, 260 Whitney Ave, New Haven, CT 06520 USA.	strobel@csb.yale.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054839] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM54839] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; CONNELL GJ, 1994, SCIENCE, V264, P1137, DOI 10.1126/science.7513905; DOUTHWAITE S, 1989, J MOL BIOL, V209, P655, DOI 10.1016/0022-2836(89)93000-3; Fasman G. D., 1975, HDB BIOCH MOL BIOL, V1; Ferre-D'Amare AR, 1998, NATURE, V395, P567, DOI 10.1038/26912; Fersht A., 1985, ENZYME STRUCTURE MEC; Green R, 1997, ANNU REV BIOCHEM, V66, P679, DOI 10.1146/annurev.biochem.66.1.679; GUTELL RR, 1994, MICROBIOL REV, V58, P10, DOI 10.1128/MMBR.58.1.10-26.1994; KEARSEY SE, 1981, NATURE, V290, P607, DOI 10.1038/290607a0; KRAUT J, 1977, ANNU REV BIOCHEM, V46, P331, DOI 10.1146/annurev.bi.46.070177.001555; LAWLEY PD, 1963, BIOCHEM J, V89, P127, DOI 10.1042/bj0890127; MADEN BEH, 1968, EUR J BIOCHEM, V6, P309, DOI 10.1111/j.1432-1033.1968.tb00450.x; MADEN BEH, 1968, J MOL BIOL, V35, P333, DOI 10.1016/S0022-2836(68)80028-2; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; Minakawa N, 1999, J ORG CHEM, V64, P7158, DOI 10.1021/jo990638x; MOAZED D, 1991, P NATL ACAD SCI USA, V88, P3725, DOI 10.1073/pnas.88.9.3725; MOAZED D, 1989, CELL, V57, P585, DOI 10.1016/0092-8674(89)90128-1; MOAZED D, 1987, BIOCHIMIE, V69, P879, DOI 10.1016/0300-9084(87)90215-X; Nakano S, 2000, SCIENCE, V287, P1493, DOI 10.1126/science.287.5457.1493; Narlikar GJ, 1997, ANNU REV BIOCHEM, V66, P19, DOI 10.1146/annurev.biochem.66.1.19; Perrotta AT, 1999, SCIENCE, V286, P123, DOI 10.1126/science.286.5437.123; PESTKA S, 1972, P NATL ACAD SCI USA, V69, P624, DOI 10.1073/pnas.69.3.624; RHEINBERGER HJ, 1988, METHOD ENZYMOL, V164, P658; Saenger W., 1984, PRINCIPLES NUCL ACID; SAITO T, 1979, J CHEM SOC CHEM COMM, P135, DOI 10.1039/c39790000135; STEINER G, 1988, EMBO J, V7, P3949, DOI 10.1002/j.1460-2075.1988.tb03281.x; STEITZ TA, 1982, ANNU REV BIOPHYS BIO, V11, P419, DOI 10.1146/annurev.bb.11.060182.002223; STERN S, 1988, METHOD ENZYMOL, V164, P481; VANNUFFEL P, 1994, NUCLEIC ACIDS RES, V22, P4449, DOI 10.1093/nar/22.21.4449	30	238	244	1	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 11	2000	289	5481					947	950		10.1126/science.289.5481.947	http://dx.doi.org/10.1126/science.289.5481.947			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	343KH	10937997				2022-12-28	WOS:000088701200031
J	Yu, LH; Babzien, M; Ben-Zvi, I; DiMauro, LF; Doyuran, A; Graves, W; Johnson, E; Krinsky, S; Malone, R; Pogorelsky, I; Skaritka, J; Rakowsky, G; Solomon, L; Wang, XJ; Woodle, M; Yakimenko, V; Biedron, SG; Galayda, JN; Gluskin, E; Jagger, J; Sajaev, V; Vasserman, I				Yu, LH; Babzien, M; Ben-Zvi, I; DiMauro, LF; Doyuran, A; Graves, W; Johnson, E; Krinsky, S; Malone, R; Pogorelsky, I; Skaritka, J; Rakowsky, G; Solomon, L; Wang, XJ; Woodle, M; Yakimenko, V; Biedron, SG; Galayda, JN; Gluskin, E; Jagger, J; Sajaev, V; Vasserman, I			High-gain harmonic-generation free-electron laser	SCIENCE			English	Article							AMPLIFIED SPONTANEOUS EMISSION; TRANSIENT ANALYSIS; OUTPUT POWER; AMPLIFICATION; FEL; RADIATION; BUNCH	A high-gain harmonic-generation free-electron laser is demonstrated. Our approach uses a laser-seeded free-electron laser to produce amplified, longitudinally coherent, Fourier transform-limited output at a harmonic of the seed laser. A seed carbon dioxide laser at a wavelength of 10.6 micrometers produced saturated, amplified free-electron Laser output at the second-harmonic wavelength, 5.3 micrometers. The experiment verifies the theoretical foundation for the technique and prepares the way for the application of this technique in the vacuum ultraviolet region of the spectrum, with the ultimate goal of extending the approach to provide an intense, highly coherent source of hard x-rays.	Argonne Natl Lab, Adv Photon Source, Argonne, IL 60439 USA; Brookhaven Natl Lab, Upton, NY 11973 USA	United States Department of Energy (DOE); Argonne National Laboratory; United States Department of Energy (DOE); Brookhaven National Laboratory	Yu, LH (corresponding author), Brookhaven Natl Lab, Upton, NY 11973 USA.		Biedron, Sandra/AAA-2420-2020					BENZVI I, 1992, NUCL INSTRUM METH A, V318, P208, DOI 10.1016/0168-9002(92)91052-B; BENZVI I, 1997, P 18 INT FREE EL LAS, P10; BENZVI I, 1991, NUCL INSTRUM METH A, V304, P151; BONIFACIO R, 1994, PHYS REV LETT, V73, P70, DOI 10.1103/PhysRevLett.73.70; BONIFACIO R, 1990, NUCL INSTRUM METH A, V296, P787, DOI 10.1016/0168-9002(90)91307-W; BONIFACIO R, 1984, OPT COMMUN, V50, P373, DOI 10.1016/0030-4018(84)90105-6; BOSCOLO I, 1982, NUCL INSTRUM METHODS, V198, P483, DOI 10.1016/0167-5087(82)90291-5; DEBENEV YS, 1982, METHODS PHYS RES A, V193, P415; EDER DC, 1996, XRAY LASERS 1996, V151, P136; Jaroszynski DA, 1996, NUCL INSTRUM METH A, V375, P456, DOI 10.1016/0168-9002(95)01475-6; KIEFFER JC, 1993, PHYS FLUIDS B-PLASMA, V5, P2676, DOI 10.1063/1.860705; KIM KJ, 1986, NUCL INSTRUM METH A, V250, P396, DOI 10.1016/0168-9002(86)90916-2; KIM KJ, 1986, PHYS REV LETT, V57, P1871, DOI 10.1103/PhysRevLett.57.1871; KRINSKY S, 1987, PHYS REV A, V35, P3406, DOI 10.1103/PhysRevA.35.3406; Krinsky S, 1999, PHYS REV E, V59, P1171, DOI 10.1103/PhysRevE.59.1171; *LCLS DES STUD GRO, 1998, SLACR521 LCLS; LEONE S, 1999, REPORT BESAC PANEL N; McNeil BWJ, 1999, OPT COMMUN, V165, P65, DOI 10.1016/S0030-4018(99)00222-9; Neil GR, 2000, PHYS REV LETT, V84, P662, DOI 10.1103/PhysRevLett.84.662; PRAZERES R, 1991, NUCL INSTRUM METH A, V304, P72, DOI 10.1016/0168-9002(91)90823-9; Qiu X, 1996, PHYS REV LETT, V76, P3723, DOI 10.1103/PhysRevLett.76.3723; ROSSBACH J, UNPUB; ROUSSE A, 1994, PHYS REV E, V50, P2200, DOI 10.1103/PhysRevE.50.2200; Salieres P., 1999, ADV ATOM MOL OPT PHY, V41, P83; WANG JM, 1986, NUCL INSTRUM METH A, V250, P484, DOI 10.1016/0168-9002(86)90928-9; YU LH, 1990, PHYS REV LETT, V64, P3011, DOI 10.1103/PhysRevLett.64.3011; YU LH, 1991, PHYS REV A, V44, P5178, DOI 10.1103/PhysRevA.44.5178; YU LH, 1992, PHYS REV A, V45, P1163, DOI 10.1103/PhysRevA.45.1163; YU LH, 1994, PHYS REV E, V49, P4480, DOI 10.1103/PhysRevE.49.4480; Yu LH, 1998, PHYS REV E, V58, P4991, DOI 10.1103/PhysRevE.58.4991; Yu LH, 1997, NUCL INSTRUM METH A, V393, P96, DOI 10.1016/S0168-9002(97)00435-X; YU LH, 1999, P ICFA 17 ADV BEAM D; YU LH, 1999, 21 FREE EL LAS C HAM	33	367	395	0	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 11	2000	289	5481					932	934		10.1126/science.289.5481.932	http://dx.doi.org/10.1126/science.289.5481.932			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	343KH	10937992				2022-12-28	WOS:000088701200026
J	Jarvis, ED; Ribeiro, S; da Silva, ML; Ventura, D; Vielliard, J; Mello, CV				Jarvis, ED; Ribeiro, S; da Silva, ML; Ventura, D; Vielliard, J; Mello, CV			Behaviourally driven gene expression reveals song nuclei in hummingbird brain	NATURE			English	Article							SYSTEM; FOREBRAIN; PATHWAYS; CANARY; BIRDS	Hummingbirds have developed a wealth of intriguing features, such as backwards flight, ultraviolet vision, extremely high metabolic rates, nocturnal hibernation, high brain-to-body size ratio and a remarkable species-specific diversity of vocalizations(1-4). Like humans, they have also developed the rare trait of vocal learning, this being the ability to acquire vocalizations through imitation rather than instinct(5,6). Here we show, using behaviourally driven gene expression in freely ranging tropical animals, that the forebrain of hummingbirds contains seven discrete structures that are active during singing, providing the first anatomical and functional demonstration of vocal nuclei in hummingbirds. These structures are strikingly similar to seven forebrain regions that are involved in vocal learning and production in songbirds and parrots(7-13)-the only other avian orders known to be vocal learners(5). This similarity is surprising, as songbirds, parrots and hummingbirds are thought to have evolved vocal learning and associated brain structures independently(5,14), and it indicates that strong constraints may influence the evolution of forebrain vocal nuclei.	Rockefeller Univ, Lab Anim Behav, New York, NY 10021 USA; Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; Univ Sao Paulo, PG Neurociencias & Comportamento, BR-09500900 Sao Paulo, Brazil; Univ Estadual Campinas, Dept Zool, BR-13083970 Campinas, SP, Brazil; Univ Sao Paulo, Dept Psicol Expt, BR-09500900 Sao Paulo, Brazil	Rockefeller University; Duke University; Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade de Sao Paulo	Jarvis, ED (corresponding author), Rockefeller Univ, Lab Anim Behav, 1230 York Ave, New York, NY 10021 USA.	jarvis@neuro.duke.edu; mello@rockvax.rockefeller.edu	Jarvis, Erich D/A-2319-2008; Ventura, Dora F/B-9071-2012; Ribeiro, Sidarta/C-5794-2016	Jarvis, Erich D/0000-0001-8931-5049; Ventura, Dora F/0000-0002-7616-4031; Mello, Claudio/0000-0002-9826-8421; Ribeiro, Sidarta/0000-0001-9325-9545	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R29DC002853] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BAPTISTA LF, 1990, ETHOLOGY, V84, P15; Brenowitz EA, 1997, J NEUROBIOL, V33, P517, DOI 10.1002/(SICI)1097-4695(19971105)33:5<517::AID-NEU3>3.0.CO;2-7; Chaudhuri A, 1997, NEUROREPORT, V8, pR5; Durand SE, 1997, J COMP NEUROL, V377, P179, DOI 10.1002/(SICI)1096-9861(19970113)377:2<179::AID-CNE3>3.0.CO;2-0; Ellis DH, 1998, BEHAV PROCESS, V43, P125, DOI 10.1016/S0376-6357(98)00008-4; ESSER KH, 1994, NEUROREPORT, V5, P1718, DOI 10.1097/00001756-199409080-00007; FEDUCCIA A, 1995, SCIENCE, V267, P637, DOI 10.1126/science.267.5198.637; GUINEE LN, 1988, ETHOLOGY, V79, P295; Hessler NA, 1999, J NEUROSCI, V19, P10461; Jarvis ED, 1997, NEUROREPORT, V8, P2073, DOI 10.1097/00001756-199705260-00052; Jarvis ED, 1998, NEURON, V21, P775, DOI 10.1016/S0896-6273(00)80594-2; Jarvis ED, 2000, J COMP NEUROL, V419, P1, DOI 10.1002/(SICI)1096-9861(20000327)419:1<1::AID-CNE1>3.0.CO;2-M; KROODSMA DE, 1991, ANIM BEHAV, V42, P477, DOI 10.1016/S0003-3472(05)80047-8; LIDSKY TI, 1985, BRAIN RES REV, V9, P133, DOI 10.1016/0165-0173(85)90010-4; MELLO CV, 1994, J NEUROSCI, V14, P6652; Miller Edward H., 1996, P241; NOTTEBOHM F, 1976, J COMP NEUROL, V165, P457, DOI 10.1002/cne.901650405; NOTTEBOHM F, 1972, AM NAT, V106, P116, DOI 10.1086/282756; NOTTEBOHM F, 1982, J COMP NEUROL, V207, P344, DOI 10.1002/cne.902070406; Payne R.B., 1986, Current Ornithology, V3, P87; REHKAMPER G, 1991, BRAIN BEHAV EVOLUT, V37, P85, DOI 10.1159/000114349; Ruschi A, 1982, HUMMINGBIRDS STATE E; SCHARFF C, 1991, J NEUROSCI, V11, P2896; Schuchmann K.-L., 1999, HDB BIRDS WORLD, P468; Sibley C.G., 1990, PHYLOGENY CLASSIFICA; VENTURA DF, 1994, INVEST OPHTH VIS SCI, V35, P2168; Wild JM, 1997, J COMP NEUROL, V377, P392, DOI 10.1002/(SICI)1096-9861(19970120)377:3<392::AID-CNE7>3.0.CO;2-Y; Yu AC, 1996, SCIENCE, V273, P1871, DOI 10.1126/science.273.5283.1871; [No title captured]; [No title captured]	30	174	181	1	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 10	2000	406	6796					628	632		10.1038/35020570	http://dx.doi.org/10.1038/35020570			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	342PF	10949303	Green Accepted, Green Published			2022-12-28	WOS:000088653800048
J	Arimura, G; Ozawa, R; Shimoda, T; Nishioka, T; Boland, W; Takabayashi, J				Arimura, G; Ozawa, R; Shimoda, T; Nishioka, T; Boland, W; Takabayashi, J			Herbivory-induced volatiles elicit defence genes in lima bean leaves	NATURE			English	Article							PREDATOR-PREY INTERACTIONS; ACQUIRED-RESISTANCE; PHASEOLUS-VULGARIS; JASMONIC ACID; SPIDER-MITES; PLANT; IDENTIFICATION; LIPOXYGENASE; ACCUMULATION; ARABIDOPSIS	In response to herbivore damage, several plant species emit volatiles that attract natural predators of the attacking herbivores(1-5). Using spider mites (Tetranychus urticae) and predatory mites (Phytoseiulus persimilis)(1-4), it has been shown that not only the attacked plant but also neighbouring plants are affected, becoming more attractive to predatory mites(3,6) and less susceptible to spider mites(6). The mechanism involved in such interactions, however, remains elusive. Here we show that uninfested lima bean leaves activate five separate defence genes when exposed to volatiles from conspecific leaves infested with T. urticae, but not when exposed to volatiles from artificially wounded leaves. The expression pattern of these genes is similar to that produced by exposure to jasmonic acid. At least three terpenoids in the volatiles are responsible for this gene activation; they are released in response to herbivory but not artificial wounding. Expression of these genes requires calcium influx and protein phosphorylation/dephosphorylation.	Kyoto Univ, Grad Sch Agr, Lab Ecol Informat, Kyoto 6068502, Japan; Biooriented Technol Res Advancement Inst, Tokyo 1050001, Japan; Kyoto Univ, Grad Sch Agr, Lab Insect Physiol, Kyoto 6068502, Japan; Max Planck Inst Chem Ecol, D-07745 Jena, Germany	Kyoto University; National Agriculture & Food Research Organization - Japan; Kyoto University; Max Planck Society	Takabayashi, J (corresponding author), Kyoto Univ, Grad Sch Agr, Lab Ecol Informat, Kyoto 6068502, Japan.	junji@kais.kyoto-u.ac.jp	Takabayashi, Junji/G-2212-2010; Boland, Wilhelm/K-7762-2012	Takabayashi, Junji/0000-0002-3575-9952; Boland, Wilhelm/0000-0001-6784-2534				Bate NJ, 1998, PLANT J, V16, P561, DOI 10.1046/j.1365-313x.1998.00324.x; BELL E, 1995, P NATL ACAD SCI USA, V92, P8675, DOI 10.1073/pnas.92.19.8675; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREDERODE FT, 1991, PLANT MOL BIOL, V17, P1117, DOI 10.1007/BF00028729; BROGLIE KE, 1986, P NATL ACAD SCI USA, V83, P6820, DOI 10.1073/pnas.83.18.6820; BRUIN J, 1992, EXPERIENTIA, V48, P525, DOI 10.1007/BF01928181; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; De Moraes CM, 1998, NATURE, V393, P570, DOI 10.1038/31219; DICKE M, 1990, J CHEM ECOL, V16, P3091, DOI 10.1007/BF00979614; DICKE M, 1990, J CHEM ECOL, V16, P381, DOI 10.1007/BF01021772; Dicke M, 1999, J CHEM ECOL, V25, P1907, DOI 10.1023/A:1020942102181; EDINGTON BV, 1991, PLANT MOL BIOL, V16, P81, DOI 10.1007/BF00017919; EDWARDS K, 1985, P NATL ACAD SCI USA, V82, P6731, DOI 10.1073/pnas.82.20.6731; FARMER EE, 1990, P NATL ACAD SCI USA, V87, P7713, DOI 10.1073/pnas.87.19.7713; HILDEBRAND DF, 1986, J ECON ENTOMOL, V79, P1459, DOI 10.1093/jee/79.6.1459; Kahl J, 2000, PLANTA, V210, P336, DOI 10.1007/PL00008142; Li CP, 1996, GENE, V171, P193, DOI 10.1016/0378-1119(95)00880-2; MacKinney G, 1941, J BIOL CHEM, V140, P315; MARGISPINHEIRO M, 1991, PLANT MOL BIOL, V17, P243, DOI 10.1007/BF00039499; McConn M, 1997, P NATL ACAD SCI USA, V94, P5473, DOI 10.1073/pnas.94.10.5473; MEIER BM, 1993, MOL PLANT MICROBE IN, V6, P453, DOI 10.1094/MPMI-6-453; Ozawa R, 2000, PLANT CELL PHYSIOL, V41, P391, DOI 10.1093/pcp/41.4.391; Ryals JA, 1996, PLANT CELL, V8, P1809, DOI 10.1105/tpc.8.10.1809; Shulaev V, 1997, NATURE, V385, P718, DOI 10.1038/385718a0; Takabayashi J, 1996, TRENDS PLANT SCI, V1, P109, DOI 10.1016/S1360-1385(96)90004-7	25	505	576	10	206	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 3	2000	406	6795					512	515		10.1038/35020072	http://dx.doi.org/10.1038/35020072			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	340ML	10952311				2022-12-28	WOS:000088538000045
J	Clark, EA; Golub, TR; Lander, ES; Hynes, RO				Clark, EA; Golub, TR; Lander, ES; Hynes, RO			Genomic analysis of metastasis reveals an essential role for RhoC	NATURE			English	Article							MELANOMA-CELLS; CANCER; PROGRESSION; EXPRESSION; PROTEIN; GROWTH; GENES; OVEREXPRESSION; TUMORIGENICITY; FIBRONECTIN	The most damaging change during cancer progression is the switch from a locally growing tumour to a metastatic killer. This switch is believed to involve numerous alterations that allow tumour cells to complete the complex series of events needed for metastasis(1). Relatively few genes have been implicated in these events(2-5.) Here we use an in vivo selection scheme to select highly metastatic melanoma cells. By analysing these cells on DNA arrays, we define a pattern of gene expression that correlates with progression to a metastatic phenotype. In particular, we show enhanced expression of several genes involved in extracellular matrix assembly and of a second set of genes that regulate, either directly or indirectly, the actin-based cytoskeleton. One of these, the small GTPase RhoC, enhances metastasis when overexpressed, whereas a dominant-negative Rho inhibits metastasis. Analysis of the phenotype of cells expressing dominant-negative Rho or RhoC indicates that RhoC is important in tumour cell invasion. The genomic approach allows us to identify families of genes involved in a process, not just single genes, and can indicate which molecular and cellular events might be important in complex biological processes such as metastasis.	MIT, Ctr Canc Res, Howard Hughes Med Inst, Cambridge, MA 02139 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Whitehead Inst MIT Ctr Genome Res, Cambridge, MA 02142 USA; Dana Farber Canc Inst, Boston, MA 02115 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Dana-Farber Cancer Institute	Hynes, RO (corresponding author), MIT, Ctr Canc Res, Howard Hughes Med Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA.							ALBELDA SM, 1990, CANCER RES, V50, P6757; Bao LR, 1996, NAT MED, V2, P1322, DOI 10.1038/nm1296-1322; Chambers AF, 1997, J NATL CANCER I, V89, P1260, DOI 10.1093/jnci/89.17.1260; CHEN L, 1990, ONCOGENE, V5, P1391; Clark EA, 1998, J CELL BIOL, V142, P573, DOI 10.1083/jcb.142.2.573; Fambrough D, 1999, CELL, V97, P727, DOI 10.1016/S0092-8674(00)80785-0; FEIG LA, 1988, MOL CELL BIOL, V8, P3235, DOI 10.1128/MCB.8.8.3235; Fidler IJ, 1996, J NATL CANCER I, V88, P1700, DOI 10.1093/jnci/88.23.1700; FIDLER IJ, 1973, NATURE-NEW BIOL, V242, P148, DOI 10.1038/newbio242148a0; HABETS GGM, 1994, CELL, V77, P537, DOI 10.1016/0092-8674(94)90216-X; HALL AK, 1991, INT J CANCER, V48, P672, DOI 10.1002/ijc.2910480507; HUMPHRIES MJ, 1986, SCIENCE, V233, P467, DOI 10.1126/science.3726541; Jeffers M, 1996, MOL CELL BIOL, V16, P1115; KOZLOWSKI JM, 1984, J NATL CANCER I, V72, P913; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Liu XD, 1997, P NATL ACAD SCI USA, V94, P10669, DOI 10.1073/pnas.94.20.10669; Maniotis AJ, 1999, AM J PATHOL, V155, P739, DOI 10.1016/S0002-9440(10)65173-5; QUILLIAM LA, 1995, BIOESSAYS, V17, P395, DOI 10.1002/bies.950170507; Roberts DD, 1996, FASEB J, V10, P1183, DOI 10.1096/fasebj.10.10.8751720; Ruoslahti E, 1999, ADV CANCER RES, V76, P1, DOI 10.1016/S0065-230X(08)60772-1; SCHONHERR E, 1995, J BIOL CHEM, V270, P2776, DOI 10.1074/jbc.270.6.2776; Suwa H, 1998, BRIT J CANCER, V77, P147, DOI 10.1038/bjc.1998.23; Svensson L, 1999, J BIOL CHEM, V274, P9636, DOI 10.1074/jbc.274.14.9636; Van Noorden CJF, 1998, AM SCI, V86, P130; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; WELCH DR, 1994, ONCOGENE, V9, P255; WETERMAN MAJ, 1993, INT J CANCER, V53, P278, DOI 10.1002/ijc.2910530218; Yebra M, 1996, J BIOL CHEM, V271, P29393, DOI 10.1074/jbc.271.46.29393; Zhang L, 1997, SCIENCE, V276, P1268, DOI 10.1126/science.276.5316.1268	29	1218	1321	0	74	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 3	2000	406	6795					532	535		10.1038/35020106	http://dx.doi.org/10.1038/35020106			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	340ML	10952316				2022-12-28	WOS:000088538000050
J	Heidelberg, JF; Eisen, JA; Nelson, WC; Clayton, RA; Gwinn, ML; Dodson, RJ; Haft, DH; Hickey, EK; Peterson, JD; Umayam, L; Gill, SR; Nelson, KE; Read, TD; Tettelin, H; Richardson, D; Ermolaeva, MD; Vamathevan, J; Bass, S; Qin, HY; Dragoi, I; Sellers, P; McDonald, L; Utterback, T; Fleishmann, RD; Nierman, WC; White, O; Salzberg, SL; Smith, HO; Colwell, RR; Mekalanos, JJ; Venter, JC; Fraser, CM				Heidelberg, JF; Eisen, JA; Nelson, WC; Clayton, RA; Gwinn, ML; Dodson, RJ; Haft, DH; Hickey, EK; Peterson, JD; Umayam, L; Gill, SR; Nelson, KE; Read, TD; Tettelin, H; Richardson, D; Ermolaeva, MD; Vamathevan, J; Bass, S; Qin, HY; Dragoi, I; Sellers, P; McDonald, L; Utterback, T; Fleishmann, RD; Nierman, WC; White, O; Salzberg, SL; Smith, HO; Colwell, RR; Mekalanos, JJ; Venter, JC; Fraser, CM			DNA sequence of both chromosomes of the cholera pathogen Vibrio cholerae	NATURE			English	Article							MANNOSE-SENSITIVE HEMAGGLUTININ; O1 EL-TOR; NUCLEOTIDE-SEQUENCE; GENE-CLUSTER; BIOFILM FORMATION; TOXIN; PILUS; IDENTIFICATION; VIRULENCE; BACTERIA	Here we determine the complete genomic sequence of the Gram negative, gamma-Proteobacterium Vibrio cholerae El Tor N16961 to be 4,033,460 base pairs (bp). The genome consists of two circular chromosomes of 2,961,146 bp and 1,072,314 bp that together encode 3,885 open reading frames. The vast majority of recognizable genes for essential cell functions (such as DNA replication, transcription, translation and cell-wall biosynthesis) and pathogenicity (for example, toxins, surface antigens and adhesins) are located on the large chromosome. In contrast, the small chromosome contains a larger fraction (59%) of hypothetical genes compared with the large chromosome (42%), and also contains many more genes that appear to have origins other than the g-Proteobacteria. The small chromosome also carries a gene capture system (the integron island) and host 'addiction' genes that are typically found on plasmids; thus, the small chromosome may have originally been a megaplasmid that was captured by an ancestral Vibrio species. The V. cholerae genomic sequence provides a starting point for understanding how a free-living, environmental organism emerged to become a significant human bacterial pathogen.	Inst Genom Res, Rockville, MD 20850 USA; Univ Maryland, Ctr Marine Biotechnol, Inst Biotechnol, Baltimore, MD 21202 USA; Univ Maryland, Dept Cell & Mol Biol, College Pk, MD 20742 USA; Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	J. Craig Venter Institute; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland College Park; Harvard University; Harvard Medical School	Fraser, CM (corresponding author), Inst Genom Res, 9712 Med Ctr Dr, Rockville, MD 20850 USA.	gvc@tigr.org	Read, Timothy/E-6240-2011; Nelson, William C/E-9263-2016; Salzberg, Steven L/F-6162-2011; Salzberg, Steven/Q-6514-2019; Eisen, Jonathan A./H-2706-2019	Nelson, William C/0000-0002-1873-3929; Salzberg, Steven L/0000-0002-8859-7432; Salzberg, Steven/0000-0002-8859-7432; Eisen, Jonathan A./0000-0002-0159-2197; Vamathevan, Jessica/0000-0003-2016-9754; Fraser, Claire/0000-0003-1462-2428; Heidelberg, John/0000-0003-0673-3224; Read, Timothy/0000-0001-8966-9680				ALM RA, 1988, MOL MICROBIOL, V2, P481; Attridge SR, 1996, INFECT IMMUN, V64, P3369, DOI 10.1128/IAI.64.8.3369-3373.1996; BASSLER BL, 1991, J BIOL CHEM, V266, P24276; Bassler BL, 1997, J BACTERIOL, V179, P4043, DOI 10.1128/jb.179.12.4043-4045.1997; Bateman A, 1999, NUCLEIC ACIDS RES, V27, P260, DOI 10.1093/nar/27.1.260; BIK EM, 1995, EMBO J, V14, P209, DOI 10.1002/j.1460-2075.1995.tb06993.x; BROWN RC, 1995, MOL MICROBIOL, V16, P425, DOI 10.1111/j.1365-2958.1995.tb02408.x; Colwell Rita R., 1992, P107; COLWELL RR, 1994, ANN NY ACAD SCI, V740, P44, DOI 10.1111/j.1749-6632.1994.tb19852.x; Colwell RR, 1996, SCIENCE, V274, P2025, DOI 10.1126/science.274.5295.2025; Davis BM, 1999, J BACTERIOL, V181, P6779, DOI 10.1128/JB.181.21.6779-6787.1999; Eisen JA, 1999, MUTAT RES-DNA REPAIR, V435, P171, DOI 10.1016/S0921-8777(99)00050-6; Faruque SM, 1998, MICROBIOL MOL BIOL R, V62, P1301, DOI 10.1128/MMBR.62.4.1301-1314.1998; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Fullner KJ, 1999, INFECT IMMUN, V67, P1393, DOI 10.1128/IAI.67.3.1393-1404.1999; HALL RM, 1991, MOL MICROBIOL, V5, P1941, DOI 10.1111/j.1365-2958.1991.tb00817.x; Hochhut B, 1999, MOL MICROBIOL, V32, P99, DOI 10.1046/j.1365-2958.1999.01330.x; HUQ A, 1983, APPL ENVIRON MICROB, V45, P275, DOI 10.1128/AEM.45.1.275-283.1983; JONSON G, 1991, MICROB PATHOGENESIS, V11, P433, DOI 10.1016/0882-4010(91)90039-D; JONSON G, 1994, MOL MICROBIOL, V13, P109, DOI 10.1111/j.1365-2958.1994.tb00406.x; Karaolis DKR, 1999, NATURE, V399, P375, DOI 10.1038/20715; Karaolis DKR, 1998, P NATL ACAD SCI USA, V95, P3134, DOI 10.1073/pnas.95.6.3134; Kovach ME, 1996, MICROBIOL-SGM, V142, P2165, DOI 10.1099/13500872-142-8-2165; Lee SH, 1999, CELL, V99, P625, DOI 10.1016/S0092-8674(00)81551-2; Lin W, 1999, P NATL ACAD SCI USA, V96, P1071, DOI 10.1073/pnas.96.3.1071; Lobitz B, 2000, P NATL ACAD SCI USA, V97, P1438, DOI 10.1073/pnas.97.4.1438; Lobry JR, 1996, MOL BIOL EVOL, V13, P660, DOI 10.1093/oxfordjournals.molbev.a025626; Manning PA, 1997, GENE, V192, P63, DOI 10.1016/S0378-1119(97)00036-X; Marsh JW, 1998, MOL MICROBIOL, V29, P1481, DOI 10.1046/j.1365-2958.1998.01031.x; Mazel D, 1998, SCIENCE, V280, P605, DOI 10.1126/science.280.5363.605; Mekalanos JJ, 1997, FEMS IMMUNOL MED MIC, V18, P241, DOI 10.1016/S0928-8244(97)00054-0; MEKALANOS JJ, 1983, CELL, V35, P253, DOI 10.1016/0092-8674(83)90228-3; OBRIEN AD, 1984, LANCET, V1, P77; OGAWA A, 1990, INFECT IMMUN, V58, P3325, DOI 10.1128/IAI.58.10.3325-3329.1990; ROSZAK DB, 1987, MICROBIOL REV, V51, P365, DOI 10.1128/MMBR.51.3.365-379.1987; Rowe-Magnus DA, 1999, RES MICROBIOL, V150, P641, DOI 10.1016/S0923-2508(99)00127-8; Salzberg SL, 1998, NUCLEIC ACIDS RES, V26, P544, DOI 10.1093/nar/26.2.544; Tacket CO, 1998, INFECT IMMUN, V66, P692, DOI 10.1128/IAI.66.2.692-695.1998; Thelin KH, 1996, INFECT IMMUN, V64, P2853, DOI 10.1128/IAI.64.7.2853-2856.1996; Trucksis M, 1998, P NATL ACAD SCI USA, V95, P14464, DOI 10.1073/pnas.95.24.14464; Wachmuth Kaye, 1994, P357; WALDOR MK, 1994, P NATL ACAD SCI USA, V91, P11388, DOI 10.1073/pnas.91.24.11388; Waldor MK, 1996, SCIENCE, V272, P1910, DOI 10.1126/science.272.5270.1910; Watnick PI, 1999, MOL MICROBIOL, V34, P586, DOI 10.1046/j.1365-2958.1999.01624.x; Watnick PI, 1999, J BACTERIOL, V181, P3606, DOI 10.1128/JB.181.11.3606-3609.1999; WILLIAMS SG, 1993, MOL MICROBIOL, V9, P751, DOI 10.1111/j.1365-2958.1993.tb01735.x; Wu ZY, 1996, MICROB PATHOGENESIS, V21, P111, DOI 10.1006/mpat.1996.0047; Yamaichi Y, 1999, MOL MICROBIOL, V31, P1513, DOI 10.1046/j.1365-2958.1999.01296.x; Yildiz FH, 1999, P NATL ACAD SCI USA, V96, P4028, DOI 10.1073/pnas.96.7.4028; Yildiz FH, 1998, J BACTERIOL, V180, P773, DOI 10.1128/JB.180.4.773-784.1998	50	1383	2470	6	177	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 3	2000	406	6795					477	483		10.1038/35020000	http://dx.doi.org/10.1038/35020000			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	340ML	10952301	Green Published, hybrid			2022-12-28	WOS:000088538000035
J	Hochstrasser, M				Hochstrasser, M			Biochemistry - All in the ubiquitin family	SCIENCE			English	Editorial Material							MODIFIERS		Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University	Hochstrasser, M (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, 266 Whitney Ave, New Haven, CT 06520 USA.			Hochstrasser, Mark/0000-0002-1131-5484				Bhaskar V, 2000, J BIOL CHEM, V275, P4033, DOI 10.1074/jbc.275.6.4033; Buschmann T, 2000, CELL, V101, P753, DOI 10.1016/S0092-8674(00)80887-9; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Epps JL, 1998, CURR BIOL, V8, P1277, DOI 10.1016/S0960-9822(07)00538-6; Furukawa K, 2000, J BIOL CHEM, V275, P7462, DOI 10.1074/jbc.275.11.7462; Hochstrasser M, 1998, GENE DEV, V12, P901, DOI 10.1101/gad.12.7.901; Kamura T, 1999, GENE DEV, V13, P2928, DOI 10.1101/gad.13.22.2928; Klionsky DT, 1999, ANNU REV CELL DEV BI, V15, P1, DOI 10.1146/annurev.cellbio.15.1.1; Kretz-Remy C, 1999, BIOCHEM CELL BIOL, V77, P299, DOI 10.1139/bcb-77-4-299; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Muller S, 2000, J BIOL CHEM, V275, P13321, DOI 10.1074/jbc.275.18.13321; Read MA, 2000, MOL CELL BIOL, V20, P2326, DOI 10.1128/MCB.20.7.2326-2333.2000; Vierstra RD, 1999, PLANT MOL BIOL, V41, P435, DOI 10.1023/A:1006323317890	13	95	100	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 28	2000	289	5479					563	564		10.1126/science.289.5479.563	http://dx.doi.org/10.1126/science.289.5479.563			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	338XD	10939967				2022-12-28	WOS:000088447800033
J	Schiermeier, Q				Schiermeier, Q			Review panel assails Brussels research bureaucracy	NATURE			English	News Item																		2000, NATURE, V404, P695	1	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 27	2000	406	6794					336	336		10.1038/35019213	http://dx.doi.org/10.1038/35019213			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	337WC	10935608	Bronze			2022-12-28	WOS:000088383800009
J	Shyu, AB; Wilkinson, MF				Shyu, AB; Wilkinson, MF			The double lives of shuttling mRNA binding proteins	CELL			English	Review							MESSENGER-RNA; CYTOPLASMIC TRANSPORT; RICH ELEMENTS; TRANSLATION; LOCALIZATION; TRAFFICKING; DECAY		Univ Texas, Sch Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA	University of Texas System; University of Texas System; UTMD Anderson Cancer Center	Shyu, AB (corresponding author), Univ Texas, Sch Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046454] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ainger K, 1997, J CELL BIOL, V138, P1077, DOI 10.1083/jcb.138.5.1077; Caceres JF, 1998, GENE DEV, V12, P55, DOI 10.1101/gad.12.1.55; Carter MS, 1996, EMBO J, V15, P5965, DOI 10.1002/j.1460-2075.1996.tb00983.x; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; DeMaria CT, 1997, J BIOL CHEM, V272, P27635, DOI 10.1074/jbc.272.44.27635; Gonzalez CI, 2000, MOL CELL, V5, P489, DOI 10.1016/S1097-2765(00)80443-8; Gray NK, 1998, ANNU REV CELL DEV BI, V14, P399, DOI 10.1146/annurev.cellbio.14.1.399; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; Hoek KS, 1998, BIOCHEMISTRY-US, V37, P7021, DOI 10.1021/bi9800247; Krecic AM, 1999, CURR OPIN CELL BIOL, V11, P363, DOI 10.1016/S0955-0674(99)80051-9; Kwon S, 1999, J CELL BIOL, V147, P247, DOI 10.1083/jcb.147.2.247; Lall S, 1999, CELL, V98, P171, DOI 10.1016/S0092-8674(00)81012-0; Laroia G, 1999, SCIENCE, V284, P499, DOI 10.1126/science.284.5413.499; Le Hir H, 2000, GENE DEV, V14, P1098; Loflin P, 1999, GENE DEV, V13, P1884, DOI 10.1101/gad.13.14.1884; MAQUAT LE, 1995, RNA, V1, P453; Matsumoto K, 1998, EMBO J, V17, P2107, DOI 10.1093/emboj/17.7.2107; Munro TP, 1999, J BIOL CHEM, V274, P34389, DOI 10.1074/jbc.274.48.34389; Ostareck DH, 1997, CELL, V89, P597, DOI 10.1016/S0092-8674(00)80241-X; van Oordt WV, 2000, J CELL BIOL, V149, P307, DOI 10.1083/jcb.149.2.307	20	188	191	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 21	2000	102	2					135	138		10.1016/S0092-8674(00)00018-0	http://dx.doi.org/10.1016/S0092-8674(00)00018-0			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	337NA	10943833	Bronze			2022-12-28	WOS:000088366800003
J	Halloran, PF				Halloran, PF			Sirolimus and ciclosporin for renal transplantation	LANCET			English	Editorial Material							RAPAMYCIN AY-22,989; ANTIFUNGAL		Univ Alberta, Div Nephrol & Immunol, Edmonton, AB T6G 2S2, Canada	University of Alberta	Halloran, PF (corresponding author), Univ Alberta, Div Nephrol & Immunol, Edmonton, AB T6G 2S2, Canada.		Halloran, Philip F/J-1390-2012	Halloran, Philip F/0000-0003-1371-1947				BOREL JF, 1976, AGENTS ACTIONS, V6, P468, DOI 10.1007/BF01973261; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; GREGORY CR, 1993, TRANSPLANTATION, V55, P1409, DOI 10.1097/00007890-199306000-00037; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; Li YS, 1999, NAT MED, V5, P1298, DOI 10.1038/15256; McAlister VC, 2000, LANCET, V355, P376, DOI 10.1016/S0140-6736(99)03882-9; MURPHY PM, 1994, ANNU REV IMMUNOL, V12, P593, DOI 10.1146/annurev.iy.12.040194.003113; Peterson RT, 1999, P NATL ACAD SCI USA, V96, P4438, DOI 10.1073/pnas.96.8.4438; Raught B, 2000, EMBO J, V19, P434, DOI 10.1093/emboj/19.3.434; SEHGAL SN, 1975, J ANTIBIOT, V28, P727, DOI 10.7164/antibiotics.28.727; SHAPIRO AMJ, IN PRESS N ENGL J ME; VEZINA C, 1975, J ANTIBIOT, V28, P721, DOI 10.7164/antibiotics.28.721	12	43	43	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 15	2000	356	9225					179	180		10.1016/S0140-6736(00)02473-9	http://dx.doi.org/10.1016/S0140-6736(00)02473-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	334GQ	10963190				2022-12-28	WOS:000088179100003
J	Marshall, AT; Bedford, A				Marshall, AT; Bedford, A			Pseudomembranous colitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									N Shore Univ Hosp, Manhasset, NY 11030 USA; Hosp St Raphael, New Haven, CT 06511 USA	Northwell Health; North Shore University Hospital; Hospital Saint Raphael	Marshall, AT (corresponding author), N Shore Univ Hosp, Manhasset, NY 11030 USA.								0	0	0	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 24	2000	343	8					555	555		10.1056/NEJM200008243430806	http://dx.doi.org/10.1056/NEJM200008243430806			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	346QM	10954764				2022-12-28	WOS:000088882600006
J	Barnes, J; Kroll, L; Burke, O; Lee, J; Jones, A; Stein, A				Barnes, J; Kroll, L; Burke, O; Lee, J; Jones, A; Stein, A			Qualitative interview study of communication between parents and children about maternal breast cancer	BRITISH MEDICAL JOURNAL			English	Article							ADJUSTMENT; ILLNESS	Objective To examine parents' communication with their children about die diagnosis and initial treatment of breast cancer in the mother. Design Qualitative interview study within cross sectional cohort. Setting Two breast cancer treatment centres. Participants 32 women with stage I or stage II breast cancer with a total of 56 school aged children. Main outcome measures Semistructured interview regarding timing and extent of communication with children about the diagnosis and initial treatment of the mother's illness, reasons for talking to children or witholding information, and help available and requested from health professionals. Results Women were most likely to begin talking to their children after their diagnosis had been confirmed by biopsy, but a minority waited until after surgery or said nothing at all. Family discussion did not necessarily include mention of cancer. There was considerable consistency in die reasons given for either discussing or not discussing the diagnosis. The most common reason for not communicating was avoidance of children's questions and particularly those about death, While most mothers experienced helpful discussion with a doctor concerning their illness, few were offered help with talking to children; many would have liked help, particularly the opportunity for both parents to talk to a health professional with experience in understanding and talking to children. Conclusions Parents diagnosed with cancer or other serious illnesses should be offered help to think about whether, what, and how to tell their children and about what children can understand, especially as they may well be struggling themselves to come to terms with their illness.	UCL Royal Free & Univ Coll Med Sch, Dept Paediat & Child Hlth, Leopold Muller Ctr Child & Family Mental Hlth, London NW3 2PF, England; Tavistock & Portman NHS Trust, London NW3 5BA, England; UCL Royal Free Hampstead NHS Trust, London NW3 2QG, England	University of London; University College London; UCL Medical School; University of London; University College London	Barnes, J (corresponding author), UCL Royal Free & Univ Coll Med Sch, Dept Paediat & Child Hlth, Leopold Muller Ctr Child & Family Mental Hlth, London NW3 2PF, England.	j.barnes@rfc.ucl.ac.uk		Stein, Alan/0000-0001-8207-2822				Banister P., 1994, QUALITATIVE METHODS; BRITTEN N, 1995, BRIT MED J, V311, P251, DOI 10.1136/bmj.311.6999.251; Buckman R, 1996, BRIT MED J, V313, P699; *CANC RES CAMP, 1996, FACT SHEET, V6; FALLOWFIELD LJ, 1994, BRIT MED J, V309, P148; Hetherington EM, 1999, J CHILD PSYCHOL PSYC, V40, P129, DOI 10.1111/1469-7610.00427; Kroll L, 1998, BRIT MED J, V316, P880, DOI 10.1136/bmj.316.7135.880; Lichtman RR, 1984, J PSYCHOSOC ONCOL, V2, P1; Nelson E, 1994, J Cancer Educ, V9, P30; Rushforth H, 1999, J CHILD PSYCHOL PSYC, V40, P683, DOI 10.1017/S0021963099003996; Welch AS, 1996, CANCER, V77, P1409, DOI 10.1002/(SICI)1097-0142(19960401)77:7<1409::AID-CNCR28>3.0.CO;2-4; WOOLLEY H, 1989, BRIT MED J, V298, P1623, DOI 10.1136/bmj.298.6688.1623	12	96	96	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 19	2000	321	7259					479	482		10.1136/bmj.321.7259.479	http://dx.doi.org/10.1136/bmj.321.7259.479			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	347MC	10948027	Green Published, Bronze			2022-12-28	WOS:000088932800020
J	Gottlieb, S				Gottlieb, S			Toys can turn hospital cots into "reservoirs of bacteria"	BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	AUG 19	2000	321	7259					470	470						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	347MC	10948024				2022-12-28	WOS:000088932800016
J	Kyrle, PA; Minar, E; Hirschl, M; Bialonczyk, C; Stain, M; Schneider, B; Weltermann, A; Speiser, W; Lechner, K; Eichinger, S				Kyrle, PA; Minar, E; Hirschl, M; Bialonczyk, C; Stain, M; Schneider, B; Weltermann, A; Speiser, W; Lechner, K; Eichinger, S			High plasma levels of factor VIII and the risk of recurrent venous thromboembolism.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ORAL ANTICOAGULANT-THERAPY; FACTOR-V-LEIDEN; PROTHROMBIN GENE; FIRST EPISODE; PROTEIN-C; THROMBOSIS; THROMBOPHILIA; FIBRINOGEN; PREVALENCE; MUTATION	Background: A high plasma level of factor VIII is a risk factor for venous thromboembolism. We evaluated the risk of a recurrence of thrombosis after an initial episode of spontaneous venous thromboembolism among patients with high plasma levels of factor VIII. Methods: We studied 360 patients for an average follow-up period of 30 months after a first episode of venous thromboembolism and discontinuation of oral anticoagulants. Patients who had recurrent or secondary venous thromboembolism, a congenital deficiency of an anticoagulant, the lupus anticoagulant, hyperhomocysteinemia, cancer, or a requirement for long-term treatment with antithrombotic drugs or who were pregnant were excluded. The end point was objectively documented, symptomatic recurrent venous thromboembolism. Results: Recurrent venous thromboembolism developed in 38 of the 360 patients (10.6 percent). Patients with recurrence had higher mean (+/-SD) plasma levels of factor VIII than those without recurrence (182+/-66 vs. 157+/-54 IU per deciliter, P=0.009). The relative risk of recurrent venous thrombosis was 1.08 (95 percent confidence interval, 1.04 to 1.12; P<0.001) for each increase of 10 IU per deciliter in the plasma level of factor VIII. Among patients with a factor VIII level above the 90th percentile of the values in the study population, the likelihood of recurrence at two years was 37 percent, as compared with a 5 percent likelihood among patients with lower levels (P<0.001). Among patients with plasma factor VIII levels above the 90th percentile, as compared with those with lower levels, the overall relative risk of recurrence was 6.7 (95 percent confidence interval, 3.0 to 14.8) after adjustment for age, sex, the presence or absence of factor V Leiden or the G20210A prothrombin mutation, and the duration of oral anticoagulation. Conclusions: Patients with a high plasma level of factor VIII have an increased risk of recurrent venous thromboembolism. (N Engl J Med 2000;343:457-62.) (C)2000, Massachusetts Medical Society.	Univ Hosp Vienna, Dept Internal Med 1, Div Hematol & Hemostasis, Vienna, Austria; Univ Hosp Vienna, Dept Internal Med 2, Div Angiol, Vienna, Austria; Univ Hosp Vienna, Dept Med Stat, Vienna, Austria; Univ Hosp Vienna, Clin Inst Med & Chem Lab Diagnost, Vienna, Austria; Hanuschkrankenhaus, Vienna, Austria; Wilhelminenspital Stadt Wien, Vienna, Austria	University Hospital Vienna; University Hospital Vienna; University Hospital Vienna; University Hospital Vienna; WGKK - Hanusch Hospital; Wilhelminenspital	Kyrle, PA (corresponding author), Allgemeines Krankenhaus Wien, Innere Med Klin 1, Abt Hamatol & Hamostaseol, Wahringer Gurtel 18-20, A-1090 Vienna, Austria.	paul.kyrle@akh-wien.ac.at						BALLEISEN L, 1985, THROMB HAEMOSTASIS, V54, P475; BERTINA RM, 1994, NATURE, V369, P64, DOI 10.1038/369064a0; BRANDT JT, 1995, THROMB HAEMOSTASIS, V74, P1185; De Stefano V, 1999, NEW ENGL J MED, V341, P801, DOI 10.1056/NEJM199909093411104; Douketis JD, 1998, JAMA-J AM MED ASSOC, V279, P458, DOI 10.1001/jama.279.6.458; Eichinger S, 1997, THROMB HAEMOSTASIS, V77, P624; Eichinger S, 1999, THROMB HAEMOSTASIS, V81, P14; Eichinger S, 1998, THROMB HAEMOSTASIS, V80, P566; Kalbfleisch D., 1980, STAT ANAL FAILURE TI; Kamphuisen PW, 1999, THROMB HAEMOSTASIS, V81, P680, DOI 10.1055/s-0037-1614553; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kearon C, 1999, NEW ENGL J MED, V341, P298; Kearon C, 1999, NEW ENGL J MED, V340, P901, DOI 10.1056/NEJM199903253401201; KHAMASHTA MA, 1995, NEW ENGL J MED, V332, P993, DOI 10.1056/NEJM199504133321504; KOSTER T, 1995, LANCET, V345, P152, DOI 10.1016/S0140-6736(95)90166-3; Kraaijenhagen RA, 2000, THROMB HAEMOSTASIS, V83, P5; Levine MN, 1998, CHEST, V114, p511S, DOI 10.1378/chest.114.5_Supplement.511S; Lindmarker P, 1999, THROMB HAEMOSTASIS, V81, P684; O'Donnell J, 2000, THROMB HAEMOSTASIS, V83, P10; ODonnell J, 1997, THROMB HAEMOSTASIS, V77, P825; PABINGER I, 1992, BLOOD COAGUL FIBRIN, V3, P547, DOI 10.1097/00001721-199210000-00005; Palareti G, 1996, LANCET, V348, P423, DOI 10.1016/S0140-6736(96)01109-9; Poort SR, 1996, BLOOD, V88, P3698, DOI 10.1182/blood.V88.10.3698.bloodjournal88103698; Prandoni P, 1996, ANN INTERN MED, V125, P1, DOI 10.7326/0003-4819-125-1-199607010-00001; Schulman S, 1997, NEW ENGL J MED, V336, P393, DOI 10.1056/NEJM199702063360601; SCHULMAN S, 1995, NEW ENGL J MED, V332, P1661, DOI 10.1056/NEJM199506223322501; vandenBelt AGM, 1997, ARCH INTERN MED, V157, P2227, DOI 10.1001/archinte.157.19.2227; vanderMeer FJM, 1996, THROMB HAEMOSTASIS, V76, P12; VREIM CE, 1990, JAMA-J AM MED ASSOC, V263, P2753	29	555	567	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 17	2000	343	7					457	462		10.1056/NEJM200008173430702	http://dx.doi.org/10.1056/NEJM200008173430702			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	344FC	10950667				2022-12-28	WOS:000088747700002
J	Phillips, P				Phillips, P			Organic materials - From insulator to superconductor	NATURE			English	Editorial Material									Univ Illinois, Loomis Lab Phys, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Phillips, P (corresponding author), Univ Illinois, Loomis Lab Phys, 1110 W Green St, Urbana, IL 61801 USA.							Belitz D, 1998, PHYS REV B, V58, P8214, DOI 10.1103/PhysRevB.58.8214; CHIANG CK, 1977, PHYS REV LETT, V39, P1098, DOI 10.1103/PhysRevLett.39.1098; Devos A, 1998, PHYS REV B, V58, P8236, DOI 10.1103/PhysRevB.58.8236; Gunnarsson O, 1997, REV MOD PHYS, V69, P575, DOI 10.1103/RevModPhys.69.575; Laughlin RB, 2000, P NATL ACAD SCI USA, V97, P28, DOI 10.1073/pnas.97.1.28; LAUGHLIN RB, 1983, PHYS REV LETT, V50, P873; LITTLE WA, 1983, J PHYS-PARIS, V44, P819, DOI 10.1051/jphyscol/1983008; Mason N, 1999, PHYS REV LETT, V82, P5341, DOI 10.1103/PhysRevLett.82.5341; Phillips P, 1998, NATURE, V395, P253, DOI 10.1038/26179; Sarachik MP, 1999, P NATL ACAD SCI USA, V96, P5900, DOI 10.1073/pnas.96.11.5900; Schon JH, 2000, NATURE, V406, P702, DOI 10.1038/35021011; Schon JH, 2000, SCIENCE, V288, P656, DOI 10.1126/science.288.5466.656; Schon JH, 2000, SCIENCE, V288, P2338, DOI 10.1126/science.288.5475.2338	13	14	14	3	7	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 17	2000	406	6797					687	688		10.1038/35021170	http://dx.doi.org/10.1038/35021170			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	344PH	10963581	Green Submitted			2022-12-28	WOS:000088767700028
J	Blythe, J				Blythe, J			Study questions ethics of covert medication	BRITISH MEDICAL JOURNAL			English	News Item																			0	3	3	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	AUG 12	2000	321	7258					402	402		10.1136/bmj.321.7258.402	http://dx.doi.org/10.1136/bmj.321.7258.402			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	344QC	10938041	Green Published			2022-12-28	WOS:000088769500012
J	Brutsche, MH; Brutsche, IC; Munavvar, M; Langley, SJ; Masterson, CM; Daley-Yates, PT; Brown, R; Custovic, A; Woodcock, A				Brutsche, MH; Brutsche, IC; Munavvar, M; Langley, SJ; Masterson, CM; Daley-Yates, PT; Brown, R; Custovic, A; Woodcock, A			Comparison of pharmacokinetics and systemic effects of inhaled fluticasone propionate in patients with asthma and healthy volunteers: a randomised crossover study	LANCET			English	Article							ADRENAL SUPPRESSION; BUDESONIDE; CORTICOSTEROIDS; BECLOMETHASONE; TURBUHALER; DEPOSITION; DISKHALER; PLASMA; GROWTH; SINGLE	Background Inhaled corticosteroids are currently the cornerstone of asthma treatment. Some studies of high-dose fluticasone propionate in patients with no or mild asthma have, however, suggested substantial systemic absorption. We investigated the pharmacokinetics of fluticasone propionate in patients with asthma receiving appropriate doses for severity. Methods We did a double-blind, randomised, crossover study in 11 patients with asthma and 13 matched healthy controls (age 20-65 years; asthma patients forced expiratory volume in 1 s <75% and stable on high-dose inhaled corticosteroids), Patients received one 1000 mu g intravenous dose or 1000 mu g daily for 7 days inhaled (via spacer device) fluticasone propionate, In the 12 h after dosing, we monitored plasma fluticasone propionate and cortisol concentrations by mass spectrometry and competitive immunoassay with use of direct chemiluminescence. Analysis was by intention to treat. Findings After inhalation, geometric mean values were significantly lower in the asthma group than in controls for fluticasone propionate plasma area under curve (1082 [95% CI 850-1451] vs 2815 pg mL(-1) h(-1) [2262-3949], -62% difference [45-72]; p<0.001), maximum concentrations (117 [91-159] vs 383 pg/mL [302-546], -68% [-50 to -81]; p<0.001), and systemic bioavailability (10.1 [7.9-14.0] vs 21.4% [15.4-32 2], -54% [-27 to -70]; p=0.001). Intravenous-dose clearance, volume of distribution at steady state, plasma half-life, and mean residence time, were similar in the two groups. Less suppression of plasma cortisol concentrations was seen in the asthma group than in controls 4-12 h after inhaled fluticasone propionate. Interpretation Systemic availability of fluticasone propionate is substantially less in patients with moderate to severe asthma than in healthy controls. Inhaled corticosteroids that are absorbed through the lungs need to be assessed in patients who are receiving doses appropriate for disease severity, and not in normal volunteers.	Wythenshawe Hosp, NW Lung Ctr, Manchester M23 9LT, Lancs, England; Glaxo Wellcome Res & Dev Ltd, Uxbridge, Middx, England; Glaxo Wellcome Res & Dev Ltd, Clin Pharmacol, Greenford, Middx, England	Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; GlaxoSmithKline; GlaxoSmithKline	Woodcock, A (corresponding author), Wythenshawe Hosp, NW Lung Ctr, Manchester M23 9LT, Lancs, England.		Custovic, Adnan/A-2435-2012	Custovic, Adnan/0000-0001-5218-7071; Brutsche, Martin/0000-0002-1612-3609; Woodcock, Ashley/0000-0002-5428-8578				Agertoft L, 1997, J ALLERGY CLIN IMMUN, V99, P773, DOI 10.1016/S0091-6749(97)80011-5; AYRES JG, 1995, EUR RESPIR J, V8, P579; BARNES PJ, 1993, AM REV RESPIR DIS, V148, P1; Boorsma M, 1996, EUR RESPIR J, V9, P1427, DOI 10.1183/09031936.96.09071427; BORGSTROM L, 1993, COMPREHENSIVE SUMMAR, P105; Callejas SL, 1998, J CHROMATOGR B, V718, P243, DOI 10.1016/S0378-4347(98)00374-0; Clark DJ, 1997, THORAX, V52, P55, DOI 10.1136/thx.52.1.55; Clark DJ, 1996, THORAX, V51, P262, DOI 10.1136/thx.51.3.262; Derendorf H, 1997, RESP MED, V91, P22, DOI 10.1016/S0954-6111(97)90102-5; DEROM E, 1997, AM J RESP CRIT CARE, V155, pA355; Efthimiou J, 1998, EUR RESPIR J, V11, P1167, DOI 10.1183/09031936.98.11051167; Egan JJ, 1999, EUR RESPIR J, V13, P1267, DOI 10.1183/09031936.99.13612769; FABBRI L, 1993, THORAX, V48, P817, DOI 10.1136/thx.48.8.817; FALCOZ C, 1996, BR J CLIN PHARM, V41, P459; GIBALDI M, 1991, BIOPHARMACEUTICS CLI; Grahnen A, 1997, EUR J CLIN PHARMACOL, V52, P261, DOI 10.1007/s002280050287; GRAHNEN A, 1994, BRIT J CLIN PHARMACO, V38, P521, DOI 10.1111/j.1365-2125.1994.tb04393.x; Hallett C, 1999, RESP MED, V93, P292, DOI 10.1016/S0954-6111(99)90030-6; HARDING SM, 1990, RESP MED, V84, P25, DOI 10.1016/S0954-6111(08)80004-2; HODSMAN AB, 1991, J CLIN ENDOCR METAB, V72, P530, DOI 10.1210/jcem-72-3-530; LIPWORTH BJ, 1996, CLIN PHARM, V42, P697; Lonnebo A, 1996, EUR J CLIN PHARMACOL, V49, P459; MELCHOR R, 1993, THORAX, V48, P506, DOI 10.1136/thx.48.5.506; Mollmann H, 1998, EUR J CLIN PHARMACOL, V53, P459, DOI 10.1007/s002280050407; PACKE GE, 1992, THORAX, V47, P415; STEAD R J, 1990, Thorax, V45, P792; Thorsson L, 1997, BRIT J CLIN PHARMACO, V43, P155, DOI 10.1046/j.1365-2125.1997.d01-1425.x; Wolthers OD, 1997, PEDIATR RES, V41, P44, DOI 10.1203/00006450-199701000-00007; Yanai M, 1998, EUR RESPIR J, V11, P1342, DOI 10.1183/09031936.98.11061342; Yiallouros PK, 1997, ARCH DIS CHILD, V76, P405, DOI 10.1136/adc.76.5.405	30	182	187	0	8	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 12	2000	356	9229					556	561		10.1016/S0140-6736(00)02581-2	http://dx.doi.org/10.1016/S0140-6736(00)02581-2			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	345MY	10950233				2022-12-28	WOS:000088820800013
J	Goren-Inbar, N; Feibel, CS; Verosub, KL; Melamed, Y; Kislev, ME; Tchernov, E; Saragusti, I				Goren-Inbar, N; Feibel, CS; Verosub, KL; Melamed, Y; Kislev, ME; Tchernov, E; Saragusti, I			Pleistocene milestones on the out-of-Africa corridor at Gesher Benot Ya'aqov, Israel	SCIENCE			English	Article							SITE; AGE	The Acheulean site of Gesher Benot Ya'aqov in the Dead Sea Rift of Israel documents hominin movements and technological development on a corridor between Africa and Eurasia. New age data place the site at 780,000 years ago (oxygen isotope stage 19), considerably older than previous estimates. The archaeological data from the site portray strong affinities with African stone tool traditions. The findings also reflect adroit technical skills and in-depth planning abilities. more advanced and complex than those of earlier archaeological occurrences in the Levant.	Hebrew Univ Jerusalem, Archaeol Inst, IL-91905 Jerusalem, Israel; Rutgers State Univ, Dept Anthropol, New Brunswick, NJ 08901 USA; Univ Calif Davis, Dept Geol, Davis, CA 95616 USA; Bar Ilan Univ, Dept Life Sci, IL-52900 Ramat Gan, Israel; Hebrew Univ Jerusalem, Dept Evolut Systemat & Ecol, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem; Rutgers State University New Brunswick; University of California System; University of California Davis; Bar Ilan University; Hebrew University of Jerusalem	Goren-Inbar, N (corresponding author), Hebrew Univ Jerusalem, Archaeol Inst, Mt Scopus, IL-91905 Jerusalem, Israel.							Balout L, 1967, ANTHROPOLOGIE, V71, P217; Bar-Yosef O, 1993, LITHIC ASSEMBLAGES U; BASSINOT FC, 1994, EARTH PLANET SC LETT, V126, P91, DOI 10.1016/0012-821X(94)90244-5; BELFERCOHEN A, 1994, WORLD ARCHAEOL, V26, P144, DOI 10.1080/00438243.1994.9980269; Callow P., 1994, OLDUVAI GORGE, V5, P235; CHALINE J, 1990, BOREAS, V19, P69; CLARK D, 1968, ANAL ARCHAEOLOGY; Clark J. D., 1975, AUSTRALOPITHECINES, P605; CLARK JD, 1966, AM ANTHROPOL, V8, P202; GERAADS D, 1983, ANTHROPOLOGIE, V87, P138; GERAADS D, 1986, QUATERNARY RES, V25, P380, DOI 10.1016/0033-5894(86)90008-6; Goren-Inbar N., 1992, Geoarchaeology, V7, P27, DOI 10.1002/gea.3340070103; Goren-Inbar N., 1994, PALEORIENT, V20, P99, DOI DOI 10.3406/PALEO.1994.4604; GorenInbar N, 1996, J FIELD ARCHAEOL, V23, P15, DOI 10.1179/009346996791974007; GORENINBAR N, 1989, QUATERNARY RES, V31, P371, DOI 10.1016/0033-5894(89)90043-4; GORENINBAR N, 1992, QUATERNARY RES, V38, P117, DOI 10.1016/0033-5894(92)90034-G; HOROWITZ A, 1973, ISRAEL J EARTH SCI, V22, P107; Isaac G.L., 1986, STONE AGE PREHISTORY, P221; Isaac GL, 1977, OLORGESAILIE ARCHAEO; Jones P.R., 1994, OLDUVAI GORGE, P254; Kleindienst MR, 1961, S AFRICAN ARCHAEOLOG, V16, P35, DOI DOI 10.2307/3886868; Leakey MD, 1994, OLDUVAI GORGE EXCAVA; MELAMED Y, 1998, THESIS BAR ILAN U; POTTS R, 1989, J HUM EVOL, V18, P477, DOI 10.1016/0047-2484(89)90076-6; Roche H., 1988, AFR ARCHAEOL REV, V6, P27, DOI [DOI 10.1007/BF01117111, DOI 10.1007/BF01117111)]; Roche H., 1995, EVOLUTION ECOLOGY HO, P153; ROE DA, 1994, OLDUVAI GORGE EXCAVA, P146; ROEBROEKS W, 1995, EARLIEST OCCUPATION, P297; SANTONJA M, 1990, J WORLD PREHIST, V4, P45, DOI 10.1007/BF00974819; STEKELIS M., 1960, BULL RES COUNC ISRAEL SECT G GEO SCI, V9G, P61; TCHERNOV E, 1994, QUATERNARY RES, V42, P328, DOI 10.1006/qres.1994.1083; Tchernov E., 1992, COURIER FORSCHUNGSIN, V153, P103; Texier P.-J., 1996, VIE PREHISTORIQUES, P58; von Koenigswald W., 1999, KAUPIA, V9, P53; VONKOENIGSWALD W, 1992, NEUES JB GEOLOGIE PA, V184, P1	35	257	261	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 11	2000	289	5481					944	947		10.1126/science.289.5481.944	http://dx.doi.org/10.1126/science.289.5481.944			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	343KH	10937996				2022-12-28	WOS:000088701200030
J	Gridelli, B; Remuzzi, G				Gridelli, B; Remuzzi, G			Strategies for making more organs available for transplantation	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							ORTHOTOPIC LIVER-TRANSPLANTATION; SINGLE-LUNG TRANSPLANTATION; ONE DONOR LIVER; LIVING DONOR; HEPATIC TRANSPLANTATION; KIDNEY-TRANSPLANTS; OFFICIAL REPORT; 2 RECIPIENTS; FOLLOW-UP; PULMONARY-HYPERTENSION		Osped Riuniti Bergamo, Mario Negri Inst Pharmacol Res, Dept Immunol & Clin Organ Transplantat, I-24100 Bergamo, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Ospedali Riuniti di Bergamo	Remuzzi, G (corresponding author), Mario Negri Inst Pharmacol Res, Via Gavazzeni 11, I-24125 Bergamo, Italy.		Remuzzi, Giuseppe/V-9766-2017	Remuzzi, Giuseppe/0000-0002-6194-3446				ADAM R, 1993, TRANSPLANT P, V25, P1556; ALEXANDER JW, 1991, TRANSPLANTATION, V51, P135, DOI 10.1097/00007890-199101000-00021; Alfrey EJ, 1997, TRANSPLANTATION, V64, P1142, DOI 10.1097/00007890-199710270-00011; ANDERSON RG, 1991, J UROLOGY, V145, P11, DOI 10.1016/S0022-5347(17)38232-0; Andres A, 2000, TRANSPLANTATION, V69, P2060, DOI 10.1097/00007890-200005270-00015; Arcasoy SM, 1999, NEW ENGL J MED, V340, P1081, DOI 10.1056/NEJM199904083401406; Azoulay D, 2000, LIVER TRANSPLANT, V6, P239, DOI 10.1016/S1527-6465(00)80018-0; Azuma H, 1997, TRANSPLANTATION, V64, P190, DOI 10.1097/00007890-199707270-00002; Barr M. L., 1998, Transplantation Proceedings, V30, P2261, DOI 10.1016/S0041-1345(98)00612-5; BISMUTH H, 1989, BRIT J SURG, V76, P722, DOI 10.1002/bjs.1800760723; BRENNER BM, 1992, J AM SOC NEPHROL, V3, P1038; BROELSCH CE, 1990, SURG GYNECOL OBSTET, V171, P353; Busuttil RW, 1999, ANN SURG, V229, P313, DOI 10.1097/00000658-199903000-00003; Cecka J M, 1997, Clin Transpl, P1; CECKA JM, 1996, CLIN TRANSPLANTS 199; CECKA JM, 1997, CLIN TRANSPLANT, P25; Colledan M, 1999, LANCET, V353, P1763, DOI 10.1016/S0140-6736(99)00661-3; Council o f The Transplantation Society, 1985, LANCET, V2, P715; Drews D, 1997, TRANSPL P, V29, P421, DOI 10.1016/S0041-1345(96)00161-3; EMOND JC, 1989, HEPATOLOGY, V10, P867, DOI 10.1002/hep.1840100520; EMOND JC, 1993, TRANSPLANTATION, V55, P835, DOI 10.1097/00007890-199304000-00029; Emre S, 1996, TRANSPLANTATION, V62, P62, DOI 10.1097/00007890-199607150-00013; ESQUIVEL CO, 1991, ARCH SURG-CHICAGO, V126, P1278; EVANS RW, 1995, LANCET, V346, P1169; FEDUSKA NJ, 1993, CLIN TRANSPLANT, V351, P205; Flowers JL, 1997, ANN SURG, V226, P483, DOI 10.1097/00000658-199710000-00009; GOLDSMITH MF, 1990, JAMA-J AM MED ASSOC, V264, P2724, DOI 10.1001/jama.1990.03450210014003; Goss JA, 1997, TRANSPLANTATION, V64, P871, DOI 10.1097/00007890-199709270-00014; Grover FL, 1997, AM J SURG, V173, P523, DOI 10.1016/S0002-9610(97)00004-4; HAKIM RM, 1984, KIDNEY INT, V25, P930, DOI 10.1038/ki.1984.112; Hariharan S, 2000, NEW ENGL J MED, V342, P605, DOI 10.1056/NEJM200003023420901; HARPER AM, 1997, CLIN TRANSPLANTS 199, P69; HOLMGREN G, 1993, LANCET, V341, P1113, DOI 10.1016/0140-6736(93)93127-M; HOSENPUD JD, 1994, J HEART LUNG TRANSPL, V13, P561; Hosenpud JD, 1999, J HEART LUNG TRANSPL, V18, P611, DOI 10.1016/S1053-2498(99)00037-6; HOUSSIN D, 1993, BRIT J SURG, V80, P75, DOI 10.1002/bjs.1800800126; Jacobbi LM, 1995, TRANSPLANTATION, V60, P1491, DOI 10.1097/00007890-199560120-00021; JAKOBSEN A, 1996, TRANSPLANT P, V28, P35; JONES J, 1993, TRANSPLANT REV, V7, P115; Karatzas T, 1997, TRANSPLANT P, V29, P2830, DOI 10.1016/S0041-1345(97)00695-7; KAYE MP, 1993, J HEART LUNG TRANSPL, V12, P541; KRAMER MR, 1994, AM J CARDIOL, V73, P494, DOI 10.1016/0002-9149(94)90681-5; LADEFOGED J, 1992, LANCET, V339, P124, DOI 10.1016/0140-6736(92)91034-6; LAND W, 1989, TRANSPLANT INT, V2, P168, DOI 10.1111/j.1432-2277.1989.tb01861.x; LEVINE SM, 1990, CHEST, V98, P1107, DOI 10.1378/chest.98.5.1107; LLOYDSTILL JD, 1985, AM J DIS CHILD, V139, P381, DOI 10.1001/archpedi.1985.02140060063030; Lo CM, 1999, TRANSPLANTATION, V68, P1112, DOI 10.1097/00007890-199910270-00009; Lu AD, 2000, TRANSPLANTATION, V69, P281, DOI 10.1097/00007890-200001270-00014; Lu CY, 1999, KIDNEY INT, V55, P2157, DOI 10.1046/j.1523-1755.1999.00491.x; MALATACK JJ, 1987, J PEDIATR-US, V111, P479, DOI 10.1016/S0022-3476(87)80105-1; Marcos A, 1999, TRANSPLANTATION, V68, P798, DOI 10.1097/00007890-199909270-00012; Marcos A, 2000, LIVER TRANSPLANT, V6, P3, DOI 10.1002/lt.500060117; MCCARTHY PM, 1990, J THORAC CARDIOV SUR, V99, P54; Melchor JL, 1998, TRANSPLANT P, V30, P2869, DOI 10.1016/S0041-1345(98)00847-1; Melendez HV, 1999, TRANSPLANTATION, V68, P469, DOI 10.1097/00007890-199908270-00003; Mercer P, 1998, Transpl Int, V11 Suppl 1, pS424, DOI 10.1007/s001470050514; Merrill John P, 1955, SURG FORUM, V6, P432; MODAN B, 1995, LANCET, V346, P660, DOI 10.1016/S0140-6736(95)92279-2; NAJARIAN JS, 1992, LANCET, V340, P807, DOI 10.1016/0140-6736(92)92683-7; NAJARIAN JS, 1994, TRANSPLANTATION, V57, P812, DOI 10.1097/00007890-199403270-00007; Philosophe B, 1999, TRANSPLANTATION, V68, P497, DOI 10.1097/00007890-199908270-00009; PICHLMAYR R, 1988, LANGENBECK ARCH CHIR, V373, P127, DOI 10.1007/BF01262776; Potapov EV, 1999, TRANSPLANTATION, V68, P1834, DOI 10.1097/00007890-199912270-00002; RAIA S, 1989, LANCET, V2, P497; Ratner LE, 1997, TRANSPLANTATION, V63, P229, DOI 10.1097/00007890-199701270-00009; Remuzzi G, 1998, J AM SOC NEPHROL, V9, P1321; Remuzzi G, 2000, TRANSPLANTATION, V69, P2000, DOI 10.1097/00007890-200005270-00002; Remuzzi G, 1999, J AM SOC NEPHROL, V10, P2591; Revillon Y, 1999, J PEDIATR SURG, V34, P851, DOI 10.1016/S0022-3468(99)90386-X; ROBERTS J, 1977, VITAL HLTH STAT, V11; ROGIERS X, 1995, TRANSPLANTATION, V59, P1081, DOI 10.1097/00007890-199504270-00001; Rogiers X, 1996, ANN SURG, V224, P331, DOI 10.1097/00000658-199609000-00009; Romero CJ, 1999, TRANSPLANTATION, V68, P572, DOI 10.1097/00007890-199908270-00021; Schmidt HHJ, 1999, J HEPATOL, V30, P293, DOI 10.1016/S0168-8278(99)80076-2; SINGER PA, 1989, NEW ENGL J MED, V321, P620, DOI 10.1056/NEJM198908313210919; SMITH MD, 1986, AM J KIDNEY DIS, V8, P223, DOI 10.1016/S0272-6386(86)80030-0; Sommacale D, 2000, TRANSPLANTATION, V69, P1005; STARNES VA, 1992, J THORAC CARDIOV SUR, V104, P1060; Strasberg SM, 1999, LIVER TRANSPLANT SUR, V5, P437, DOI 10.1002/lt.500050508; STRONG RW, 1990, NEW ENGL J MED, V322, P1505, DOI 10.1056/NEJM199005243222106; Strong RW, 1999, LIVER TRANSPLANT SUR, V5, P536, DOI 10.1002/lt.500050613; Takayama J, 1998, TRANSPLANT P, V30, P3504, DOI 10.1016/S0041-1345(98)01115-4; Tenderich G, 1998, TRANSPLANTATION, V66, P1109, DOI 10.1097/00007890-199810270-00025; TERASAKI PI, 1995, NEW ENGL J MED, V333, P333, DOI 10.1056/NEJM199508103330601; TERWEE PM, 1990, J INTERN MED, V228, P393; Testa G, 1998, TRANSPLANTATION, V65, P925, DOI 10.1097/00007890-199804150-00011; THEODORE J, 1990, NEW ENGL J MED, V322, P772, DOI 10.1056/NEJM199003153221110; *UN NETW ORG SHAR, 1999, ANN REP 1999 UNOS RE; Vargas HE, 1999, GASTROENTEROLOGY, V117, P149, DOI 10.1016/S0016-5085(99)70561-5; WILLIAMS SL, 1986, ANN INTERN MED, V105, P1, DOI 10.7326/0003-4819-105-1-1; YAMAOKA Y, 1994, TRANSPLANTATION, V57, P1127, DOI 10.1097/00007890-199404150-00024	91	223	228	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 10	2000	343	6					404	410		10.1056/NEJM200008103430606	http://dx.doi.org/10.1056/NEJM200008103430606			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	342DT	10933740				2022-12-28	WOS:000088630500006
J	Camba, R				Camba, R			Start making sense - Scientists must stop isolating themselves behind walls of jargon.	NATURE			English	Article									Univ Oxford, Inorgan Chem Lab, Oxford OX1 3QR, England	University of Oxford	Camba, R (corresponding author), Univ Oxford, Inorgan Chem Lab, S Parks Rd, Oxford OX1 3QR, England.								0	5	5	0	4	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 3	2000	406	6795					461	461		10.1038/35020154	http://dx.doi.org/10.1038/35020154			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	340ML	10952288				2022-12-28	WOS:000088538000021
J	Gao, SS; Silver, PG; Linde, AT; Sacks, IS				Gao, SS; Silver, PG; Linde, AT; Sacks, IS			Annual modulation of triggered seismicity following the 1992 Landers earthquake in California	NATURE			English	Article								The mechanism responsible for the triggering of earthquakes remains one of the least-understood aspects of the earthquake process. The magnitude-7.3 Landers, California earthquake of 28 June 1992 was followed for several weeks by triggered seismic activity over a large area, encompassing much of the western United States(1). Here we show that this triggered seismicity marked the beginning of a five-year trend, consisting of an elevated microearthquake rate that was modulated by an annual cycle, decaying with time. The annual cycle is mainly associated with several hydrothermal or volcanic regions where short-term triggering was also observed. These data indicate that the Landers earthquake produced long-term physical changes in these areas, and that an environmental source of stress-plausibly barometric pressure-might be responsible for the annual variation.	Carnegie Inst Washington, Dept Terr Magnetism, Washington, DC 20015 USA	Carnegie Institution for Science	Gao, SS (corresponding author), Kansas State Univ, Dept Geol, Manhattan, KS 66506 USA.		Gao, Stephen/F-1395-2011	Gao, Stephen/0000-0001-7530-7128				ANDERSON JG, 1994, B SEISMOL SOC AM, V84, P863; GOMBERG J, 1994, B SEISMOL SOC AM, V84, P844; Gomberg J, 1996, J GEOPHYS RES-SOL EA, V101, P733, DOI 10.1029/95JB03250; Gomberg J, 1998, J GEOPHYS RES-SOL EA, V103, P24411, DOI 10.1029/98JB01125; HILL DP, 1993, SCIENCE, V260, P1617, DOI 10.1126/science.260.5114.1617; HILL DP, 1995, J GEOPHYS RES-SOL EA, V100, P12985, DOI 10.1029/95JB00860; KING GCP, 1994, B SEISMOL SOC AM, V84, P935; LINDE AT, 1994, NATURE, V371, P408, DOI 10.1038/371408a0; REASENBERG P, 1985, J GEOPHYS RES-SOLID, V90, P5479, DOI 10.1029/JB090iB07p05479; REASENBERG PA, 1992, SCIENCE, V255, P1686; Roeloffs E, 1996, ADV GEOPHYS, V37, P135, DOI 10.1016/S0065-2687(08)60270-8; STEIN RS, 1983, J GEOPHYS RES, V88, P6477, DOI 10.1029/JB088iB08p06477; Sturtevant B, 1996, J GEOPHYS RES-SOL EA, V101, P25269, DOI 10.1029/96JB02654	13	47	49	0	10	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 3	2000	406	6795					500	504		10.1038/35020045	http://dx.doi.org/10.1038/35020045			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	340ML	10952308				2022-12-28	WOS:000088538000042
J	Albert, R; Jeong, H; Barabasi, AL				Albert, R; Jeong, H; Barabasi, AL			Error and attack tolerance of complex networks	NATURE			English	Article							SMALL-WORLD NETWORKS; WIDE-WEB; INTERNET; DYNAMICS	Many complex systems display a surprising degree of tolerance against errors. For example, relatively simple organisms grow, persist and reproduce despite drastic pharmaceutical or environmental interventions, an error tolerance attributed to the robustness of the underlying metabolic network(1). Complex communication networks(2) display a surprising degree of robustness: although key components regularly malfunction, local failures rarely lead to the loss of the global information-carrying ability of the network. The stability of these and other complex systems is often attributed to the redundant wiring of the functional web defined by the systems' components. Here we demonstrate that error tolerance is not shared by all redundant systems: it is displayed only by a class of inhomogeneously wired networks, called scale-free networks, which include the World-Wide Web(3-5), the Internet(6), social networks(7) and cells(8). We find that such networks display an unexpected degree of robustness, the ability of their nodes to communicate being unaffected even by unrealistically high failure rates. However, error tolerance comes at a high price in that these networks are extremely vulnerable to attacks (that is, to the selection and removal of a few nodes that play a vital role in maintaining the network's connectivity). Such error tolerance and attack vulnerability are generic properties of communication networks.	Univ Notre Dame, Dept Phys, Notre Dame, IN 46556 USA	University of Notre Dame	Barabasi, AL (corresponding author), Univ Notre Dame, Dept Phys, 225 Nieuwland Sci Hall, Notre Dame, IN 46556 USA.	alb@nd.edu	Jeong, Hawoong/AAR-2524-2021; Albert, Reka/E-2195-2011; Jeong, Hawoong/C-1587-2011; Barabasi, Albert-Laszlo/S-6474-2017; Jeong, Hawoong/A-2469-2009; Naji, PARISA/CAF-0160-2022	Jeong, Hawoong/0000-0002-2491-8620; Albert, Reka/0000-0002-9485-0828; Jeong, Hawoong/0000-0002-2491-8620; Barabasi, Albert/0000-0002-4028-3522				Adamic LA, 1999, LECT NOTES COMPUT SC, V1696, P443; Albert R, 1999, NATURE, V401, P130, DOI 10.1038/43601; Banavar JR, 1999, NATURE, V399, P130, DOI 10.1038/20144; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barthelemy M, 1999, PHYS REV LETT, V82, P3180, DOI 10.1103/PhysRevLett.82.3180; Bollobas B., 1985, RANDOM GRAPHS; Bunde A., 1996, FRACTALS DISORDERED; CLAFFY K, 1999, NATURE WEB MATTERS; ERDOS P, 1960, B INT STATIST INST, V38, P343; Faloutsos M, 1999, COMP COMM R, V29, P251, DOI 10.1145/316194.316229; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Huberman BA, 1999, NATURE, V401, P131, DOI 10.1038/43604; JEONG H, IN PRESS NATURE; Kumar R., 2000, P 19 ACM SIGMOD SIGA, P1; Lawrence S, 1999, NATURE, V400, P107, DOI 10.1038/21987; Maritan A, 1996, SCIENCE, V272, P984, DOI 10.1126/science.272.5264.984; MILGRAM S, 1967, PSYCHOL TODAY, V1, P61; Paxson V, 1997, IEEE ACM T NETWORK, V5, P601, DOI 10.1109/90.649563; Redner S, 1998, EUR PHYS J B, V4, P131, DOI 10.1007/s100510050359; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Williams RJ, 2000, NATURE, V404, P180, DOI 10.1038/35004572; Zegura EW, 1997, IEEE ACM T NETWORK, V5, P770, DOI 10.1109/90.650138	23	5528	5961	73	964	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 27	2000	406	6794					378	382		10.1038/35019019	http://dx.doi.org/10.1038/35019019			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	337WC	10935628	Green Submitted			2022-12-28	WOS:000088383800038
J	Macilwain, C				Macilwain, C			Physicists celebrate detection of elusive 'final' particle	NATURE			English	News Item																			0	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 27	2000	406	6794					334	334		10.1038/35019200	http://dx.doi.org/10.1038/35019200			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	337WC	10935604	Bronze			2022-12-28	WOS:000088383800004
J	Stevenson, IR; Bryant, DM				Stevenson, IR; Bryant, DM			Avian phenology - Climate change and constraints on breeding	NATURE			English	Article							EGG-LAYING TRENDS; GREAT TITS; TEMPERATURE		Univ Stirling, Inst Biol Sci, Stirling FK9 4LA, Scotland	University of Stirling	Stevenson, IR (corresponding author), Univ Stirling, Inst Biol Sci, Stirling FK9 4LA, Scotland.							Both C, 1999, P ROY SOC B-BIOL SCI, V266, P465, DOI 10.1098/rspb.1999.0660; Cramp S., 1977, HDB BIRDS EUROPE MID; Crick HQP, 1999, NATURE, V399, P423, DOI 10.1038/20839; DRENT RH, 1980, ARDEA, V68, P225; Forchhammer MC, 1998, NATURE, V391, P29, DOI 10.1038/34070; HASHIM RB, 1996, THESIS U STIRLING; McCleery RH, 1998, NATURE, V391, P30, DOI 10.1038/34073; PATTERSON HD, 1971, BIOMETRIKA, V58, P545, DOI 10.1093/biomet/58.3.545; Perrins CM, 1996, IBIS, V138, P2, DOI 10.1111/j.1474-919X.1996.tb04308.x; Reiss M.J., 1989, ALLOMETRY GROWTH REP; Speakman J.R., 1997, DOUBLY LABELLED WATE; Tinbergen JM, 2000, J ANIM ECOL, V69, P323, DOI 10.1046/j.1365-2656.2000.00395.x; VANNOORDWIJK AJ, 1995, J ANIM ECOL, V64, P451, DOI 10.2307/5648; Visser ME, 1998, P ROY SOC B-BIOL SCI, V265, P1867, DOI 10.1098/rspb.1998.0514	14	180	183	1	87	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 27	2000	406	6794					366	367		10.1038/35019151	http://dx.doi.org/10.1038/35019151			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	337WC	10935624				2022-12-28	WOS:000088383800031
J	Walker, RJ				Walker, RJ			Earth science - The extraterrestrial wedding ring	NATURE			English	Editorial Material							DIFFERENTIATION		Univ Maryland, Dept Geol, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Walker, RJ (corresponding author), Univ Maryland, Dept Geol, College Pk, MD 20742 USA.		Walker, Richard/K-6869-2016	Walker, Richard/0000-0003-0348-2407				Chou CL, 1983, J GEOPHYS RES A, V88, P507; CHOU CL, 1978, P 9 LUN PLAN SCI C, P219; Drake MJ, 2000, GEOCHIM COSMOCHIM AC, V64, P2363, DOI 10.1016/S0016-7037(00)00372-0; Holzheid A, 2000, NATURE, V406, P396, DOI 10.1038/35019050; JONES JH, 1986, NATURE, V322, P221, DOI 10.1038/322221a0; Li J, 1996, NATURE, V381, P686, DOI 10.1038/381686a0; MORGAN JW, 1986, J GEOPHYS RES-SOLID, V91, P2375, DOI 10.1029/JB091iB12p12375; MURTHY VR, 1991, SCIENCE, V253, P303, DOI 10.1126/science.253.5017.303; Righter K, 1997, EARTH PLANET SC LETT, V146, P541, DOI 10.1016/S0012-821X(96)00243-9	9	0	0	0	3	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 27	2000	406	6794					359	360						2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	337WC	10935621				2022-12-28	WOS:000088383800028
J	van Basten, JPA; van Driel, MF; Hoekstra, HJH; Sleijfer, DT				van Basten, JPA; van Driel, MF; Hoekstra, HJH; Sleijfer, DT			Erectile dysfunction with chemotherapy	LANCET			English	Letter							TESTICULAR CANCER		Isala Clin, Dept Urol, Zwolle, Netherlands; Univ Groningen Hosp, Dept Urol, Groningen, Netherlands; Univ Groningen Hosp, Dept Surg Oncol, Groningen, Netherlands; Univ Groningen Hosp, Dept Clin Oncol, Groningen, Netherlands	Isala Clinics; University of Groningen; University of Groningen; University of Groningen	van Basten, JPA (corresponding author), Isala Clin, Dept Urol, Zwolle, Netherlands.		hoekstra, harald/AAR-3263-2021					Chatterjee R, 2000, LANCET, V355, P1335, DOI 10.1016/S0140-6736(00)02121-8; Van Basten JPA, 1999, BJU INT, V84, P671; vanBasten JPA, 1997, J CLIN ONCOL, V15, P2442, DOI 10.1200/JCO.1997.15.6.2442	3	6	6	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 8	2000	356	9224					169	169		10.1016/S0140-6736(05)73187-1	http://dx.doi.org/10.1016/S0140-6736(05)73187-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	331UG	10963279				2022-12-28	WOS:000088036600058
J	Nakagawa, J				Nakagawa, J			Images in clinical medicine - Hepatodiaphragmatic interposition of the colon	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Nakagawa Naika Clin, Kyoto 6101146, Japan		Nakagawa, J (corresponding author), Nakagawa Naika Clin, Kyoto 6101146, Japan.								0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 31	2000	343	9					631	631		10.1056/NEJM200008313430906	http://dx.doi.org/10.1056/NEJM200008313430906			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	348RE	10965010				2022-12-28	WOS:000088999600006
J	Janik, VM				Janik, VM			Whistle matching in wild bottlenose dolphins (Tursiops truncatus)	SCIENCE			English	Article							SIGNATURE WHISTLES; NOSED DOLPHINS; PATTERNS; MIMICRY	Dolphin communication is suspected to be complex, on the basis of their call repertoires, cognitive abilities, and ability to modify signals through vocal Learning. Because of the difficulties involved in observing and recording individual cetaceans, very Little is known about how they use their calls. This report shows that wild, unrestrained bottlenose dolphins use their Learned whistles in matching interactions, in which an individual responds to a whistle of a conspecific by emitting the same whistle type. Vocal matching occurred over distances of up to 580 meters and is indicative of animals addressing each other individually.	Univ Aberdeen, Lighthouse Field Stn, Cromarty IV11 8YJ, Rossshire, Scotland; Univ St Andrews, Sch Biol, St Andrews KY16 9TS, Fife, Scotland	University of Aberdeen; University of St Andrews	Janik, VM (corresponding author), Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA.							CALDWELL M C, 1969, Mammalia, V33, P505, DOI 10.1515/mamm.1969.33.3.505; Caldwell M.C., 1990, P199; Catchpole CK, 1995, BIRD SONG BIOL THEME; Dabelsteen T, 1997, ANIM BEHAV, V53, P249, DOI 10.1006/anbe.1996.0369; Dabelsteen T, 1996, J AVIAN BIOL, V27, P189, DOI 10.2307/3677221; HERMAN LM, 1993, COMPAR COGN, P403; Janik VM, 1997, ADV STUD BEHAV, V26, P59, DOI 10.1016/S0065-3454(08)60377-0; Janik VM, 1996, MAR MAMMAL SCI, V12, P597, DOI 10.1111/j.1748-7692.1996.tb00073.x; JANIK VM, 1994, BEHAV ECOL SOCIOBIOL, V35, P243, DOI 10.1007/s002650050094; Janik VM, 1999, ANIM BEHAV, V57, P133, DOI 10.1006/anbe.1998.0923; Janik VM, 1998, ANIM BEHAV, V56, P829, DOI 10.1006/anbe.1998.0881; Janik VM, 2000, MAR MAMMAL SCI, V16, P437, DOI 10.1111/j.1748-7692.2000.tb00935.x; LANG TG, 1966, SCIENCE, V151, P588, DOI 10.1126/science.151.3710.588; Manly BFJ., 2017, RANDOMIZATION MONTE, DOI 10.1201/9781315273075; RICHARDS DG, 1984, J COMP PSYCHOL, V98, P10, DOI 10.1037/0735-7036.98.1.10; SAYIGH LS, 1990, BEHAV ECOL SOCIOBIOL, V26, P247; TERRACE HS, 1985, AM PSYCHOL, V40, P1011, DOI 10.1037/0003-066X.40.9.1011; TODT D, 1981, Z TIERPSYCHOL, V57, P73; TYACK P, 1986, BEHAV ECOL SOCIOBIOL, V18, P251, DOI 10.1007/BF00300001; Tyack Peter L., 1997, Bioacoustics, V8, P21; WILKINS WK, 1995, BEHAV BRAIN SCI, V18, P161, DOI 10.1017/S0140525X00037924; Wilson B, 1997, J APPL ECOL, V34, P1365, DOI 10.2307/2405254	22	249	260	3	143	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 25	2000	289	5483					1355	+		10.1126/science.289.5483.1355	http://dx.doi.org/10.1126/science.289.5483.1355			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347RF	10958783				2022-12-28	WOS:000088942400040
J	Mariner, WK				Mariner, WK			What recourse? Liability for managed-care decisions and the Employee Retirement Income Security Act	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PATIENTS RIGHTS		Boston Univ, Sch Publ Hlth, Hlth Law Dept, Boston, MA 02118 USA	Boston University	Mariner, WK (corresponding author), Boston Univ, Sch Publ Hlth, Hlth Law Dept, Boston, MA 02118 USA.			Mariner, Wendy/0000-0001-5176-5917				Angell M, 2000, NEW ENGL J MED, V342, P1663, DOI 10.1056/NEJM200006013422209; Annas GJ, 1998, NEW ENGL J MED, V338, P695, DOI 10.1056/NEJM199803053381020; Annas GJ, 1997, NEW ENGL J MED, V337, P210, DOI 10.1056/NEJM199707173370323; Keeton W., 1984, PROSSER KEETON LAW T; Mariner WK, 1996, AM J PUBLIC HEALTH, V86, P863, DOI 10.2105/AJPH.86.6.863; Mariner WK, 1996, NEW ENGL J MED, V335, P1986, DOI 10.1056/NEJM199612263352610; Rodwin MA, 1999, J HEALTH POLIT POLIC, V24, P1115; RODWIN MA, 1999, U MICH LAW REV, V32, P1041	8	18	18	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 24	2000	343	8					592	596		10.1056/NEJM200008243430823	http://dx.doi.org/10.1056/NEJM200008243430823			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	346QM	10954770				2022-12-28	WOS:000088882600033
J	Heald, R				Heald, R			Motor function in the mitotic spindle	CELL			English	Review							CELL-DIVISION; MITOSIS; CHROMOSOMES; ROLES		Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Heald, R (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.			Heald, Rebecca/0000-0001-6671-6528				Antonio C, 2000, CELL, V102, P425, DOI 10.1016/S0092-8674(00)00048-9; Compton DA, 1998, J CELL SCI, V111, P1477; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Desai A, 1998, J CELL BIOL, V141, P703, DOI 10.1083/jcb.141.3.703; FUNABIKI H, 2000, CELL, V203, P522; Goldstein LSB, 1999, ANNU REV CELL DEV BI, V15, P141, DOI 10.1146/annurev.cellbio.15.1.141; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; INOUE S, 1995, MOL BIOL CELL, V6, P1619, DOI 10.1091/mbc.6.12.1619; Karki S, 1999, CURR OPIN CELL BIOL, V11, P45, DOI 10.1016/S0955-0674(99)80006-4; Kreis T., 1999, GUIDEBOOK CYTOSKELET, V2nd; Mallavarapu A, 1999, CURR BIOL, V9, P1423, DOI 10.1016/S0960-9822(00)80090-1; Maney T, 2000, INT REV CYTOL, V194, P67; MCKIM KS, 1995, SCIENCE, V270, P1595, DOI 10.1126/science.270.5242.1595; Merdes A, 2000, J CELL BIOL, V149, P851, DOI 10.1083/jcb.149.4.851; Morgan DO, 1999, NAT CELL BIOL, V1, pE47, DOI 10.1038/10039; RIEDER CL, 1994, J CELL BIOL, V124, P223, DOI 10.1083/jcb.124.3.223; Rieder CL, 1998, TRENDS CELL BIOL, V8, P310, DOI 10.1016/S0962-8924(98)01299-9; Walczak CE, 1998, CURR BIOL, V8, P903, DOI 10.1016/S0960-9822(07)00370-3; WATERS JC, 1995, BIOESSAYS, V17, P911, DOI 10.1002/bies.950171102	19	110	114	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 18	2000	102	4					399	402		10.1016/S0092-8674(00)00044-1	http://dx.doi.org/10.1016/S0092-8674(00)00044-1			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	347BX	10966101	Bronze			2022-12-28	WOS:000088908000001
J	St Croix, B; Rago, C; Velculescu, V; Traverso, G; Romans, KE; Montgomery, E; Lal, A; Riggins, GJ; Lengauer, C; Vogelstein, B; Kinzler, KW				St Croix, B; Rago, C; Velculescu, V; Traverso, G; Romans, KE; Montgomery, E; Lal, A; Riggins, GJ; Lengauer, C; Vogelstein, B; Kinzler, KW			Genes expressed in human tumor endothelium	SCIENCE			English	Article							ANGIOGENESIS INVITRO; SERIAL ANALYSIS; GROWTH-FACTOR; CELLS; TISSUE; MODULATION; PROTEINS; ANTIGEN; CULTURE; STROMA	To gain a molecular understanding of tumor angiogenesis, we compared gene expression patterns of endothelial cells derived from blood vessels of normal and malignant colorectal tissues. Of over 170 transcripts predominantly expressed in the endothelium, 79 were differentially expressed, including 46 that were specifically elevated in tumor-associated endothelium. Several of these genes encode extracellular matrix proteins, but most are of unknown function. Most of these tumor endothelial markers were expressed in a wide range of tumor types, as well as in normal vessels associated with wound healing and corpus Luteum formation. These studies demonstrate that tumor and normal endothelium are distinct at the molecular Level, a finding that may have significant implications for the development of anti-angiogenic therapies.	Johns Hopkins Univ, Sch Med, Johns Hopkins Oncol Ctr, Baltimore, MD 21231 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21231 USA; Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21231 USA; Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA	Johns Hopkins University; Johns Hopkins Medicine; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Duke University	Kinzler, KW (corresponding author), Johns Hopkins Univ, Sch Med, Johns Hopkins Oncol Ctr, Baltimore, MD 21231 USA.		Velculescu, Victor/ABF-4846-2020; Traverso, Carlo Giovanni/ABC-9065-2020	Velculescu, Victor/0000-0003-1195-438X; Traverso, Carlo Giovanni/0000-0001-7851-4077	NCI NIH HHS [CA62924, CA57345] Funding Source: Medline; PHS HHS [CGAP S98-146A] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA057345, P50CA062924, R37CA057345] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Akaogi K, 1996, P NATL ACAD SCI USA, V93, P8384, DOI 10.1073/pnas.93.16.8384; Bardin N, 1996, TISSUE ANTIGENS, V48, P531, DOI 10.1111/j.1399-0039.1996.tb02666.x; BRADHAM DM, 1991, J CELL BIOL, V114, P1285, DOI 10.1083/jcb.114.6.1285; Datson NA, 1999, NUCLEIC ACIDS RES, V27, P1300, DOI 10.1093/nar/27.5.1300; Dong QG, 1997, ARTERIOSCL THROM VAS, V17, P1599, DOI 10.1161/01.ATV.17.8.1599; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; FOLKMAN J, 1997, CANC MED, P181; FOUSER L, 1991, J BIOL CHEM, V266, P18345; Girard JP, 1999, AM J PATHOL, V155, P2043, DOI 10.1016/S0002-9440(10)65523-X; GIRARD JP, 1995, IMMUNITY, V2, P113, DOI 10.1016/1074-7613(95)90083-7; HARALDSEN G, 1995, GUT, V37, P225, DOI 10.1136/gut.37.2.225; Hewett PW, 1996, IN VITRO CELL DEV-AN, V32, P462, DOI 10.1007/BF02723047; Hull MA, 1996, GASTROENTEROLOGY, V111, P1230, DOI 10.1053/gast.1996.v111.pm8898637; IRUELAARISPE ML, 1991, ARTERIOSCLER THROMB, V11, P805, DOI 10.1161/01.ATV.11.4.805; IRUELAARISPE ML, 1991, LAB INVEST, V64, P174; IURIARO M, 1999, EUR J CLIN INVEST, V29, P793; JAFFE EA, 1989, J IMMUNOL, V143, P3961; Jendraschak E, 1996, SEMIN CANCER BIOL, V7, P139, DOI 10.1006/scbi.1996.0019; Kerbel RS, 2000, CARCINOGENESIS, V21, P505, DOI 10.1093/carcin/21.3.505; Lee WS, 1998, CIRC RES, V82, P845; MURAGAKI Y, 1995, P NATL ACAD SCI USA, V92, P8763, DOI 10.1073/pnas.92.19.8763; Niquet J, 1996, DEV BRAIN RES, V95, P227, DOI 10.1016/S0165-3806(96)00089-2; OHTANI H, 1987, J ELECTRON MICROSC, V36, P204; OONO T, 1993, J INVEST DERMATOL, V100, P329, DOI 10.1111/1523-1747.ep12470022; Sheikh H, 2000, J CELL SCI, V113, P1021; Solovey A, 1997, NEW ENGL J MED, V337, P1584, DOI 10.1056/NEJM199711273372203; Tucci M, 1998, J ENDOCRINOL, V157, P13, DOI 10.1677/joe.0.1570013; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; Velculescu VE, 1999, NAT GENET, V23, P387, DOI 10.1038/70487; Virlon B, 1999, P NATL ACAD SCI USA, V96, P15286, DOI 10.1073/pnas.96.26.15286; Zhang L, 1997, SCIENCE, V276, P1268, DOI 10.1126/science.276.5316.1268	32	1500	1683	1	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 18	2000	289	5482					1197	1202						6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	346JE	10947988				2022-12-28	WOS:000088866600044
J	Fraser, CM; Eisen, JA; Salzberg, SL				Fraser, CM; Eisen, JA; Salzberg, SL			Microbial genome sequencing	NATURE			English	Article							PATHOGEN HELICOBACTER-PYLORI; BACTERIAL HYPERTHERMOPHILES; MYCOPLASMA-GENITALIUM; ANTIMALARIAL-DRUGS; UNIVERSAL TREE; GENE EXCHANGE; DNA; SPIROCHETE; ARCHAEAL; PROTEIN	Complete genome sequences of 30 microbial species have been determined during the past five years, and work in progress indicates that the complete sequences of more than 100 further microbial species will be available in the next two to four years. These results have revealed a tremendous amount of information on the physiology and evolution of microbial species, and should provide novel approaches to the diagnosis and treatment of infectious disease.	Inst Genome Res, Rockville, MD 20850 USA	J. Craig Venter Institute	Fraser, CM (corresponding author), Inst Genome Res, 9712 Med Ctr Dr, Rockville, MD 20850 USA.		Salzberg, Steven L/F-6162-2011; Salzberg, Steven/Q-6514-2019; Eisen, Jonathan A./H-2706-2019	Salzberg, Steven L/0000-0002-8859-7432; Salzberg, Steven/0000-0002-8859-7432; Eisen, Jonathan A./0000-0002-0159-2197; Fraser, Claire/0000-0003-1462-2428				Alm RA, 1999, NATURE, V397, P176, DOI 10.1038/16495; Aravind L, 1998, TRENDS GENET, V14, P442, DOI 10.1016/S0168-9525(98)01553-4; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Davidoff AJ, 1996, INT J TECHNOL ASSESS, V12, P9, DOI 10.1017/S026646230000934X; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Doolittle WF, 1999, SCIENCE, V284, P2124, DOI 10.1126/science.284.5423.2124; Eisen JA, 1995, J MOL EVOL, V41, P1105; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Fraser CM, 1998, SCIENCE, V281, P375, DOI 10.1126/science.281.5375.375; Gardner MJ, 1998, SCIENCE, V282, P1126, DOI 10.1126/science.282.5391.1126; GATESY J, 1993, MOL PHYLOGENET EVOL, V2, P152, DOI 10.1006/mpev.1993.1015; Graham DE, 2000, P NATL ACAD SCI USA, V97, P3304, DOI 10.1073/pnas.050564797; Himmelreich R, 1996, NUCLEIC ACIDS RES, V24, P4420, DOI 10.1093/nar/24.22.4420; Jain R, 1999, P NATL ACAD SCI USA, V96, P3801, DOI 10.1073/pnas.96.7.3801; Jomaa H, 1999, SCIENCE, V285, P1573, DOI 10.1126/science.285.5433.1573; Kyrpides NC, 1999, TRENDS GENET, V15, P298, DOI 10.1016/S0168-9525(99)01811-9; Lafay B, 1999, NUCLEIC ACIDS RES, V27, P1642, DOI 10.1093/nar/27.7.1642; Lawrence JG, 1998, P NATL ACAD SCI USA, V95, P9413, DOI 10.1073/pnas.95.16.9413; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Makarova KS, 1999, GENOME RES, V9, P608; Martin W, 1999, BIOESSAYS, V21, P99, DOI 10.1002/(SICI)1521-1878(199902)21:2<99::AID-BIES3>3.3.CO;2-2; Nelson KE, 1999, NATURE, V399, P323, DOI 10.1038/20601; PETERSON SN, 1995, P NATL ACAD SCI USA, V92, P11829, DOI 10.1073/pnas.92.25.11829; Philippe H, 1999, J MOL EVOL, V49, P509, DOI 10.1007/PL00006573; Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816; Read TD, 2000, NUCLEIC ACIDS RES, V28, P1397, DOI 10.1093/nar/28.6.1397; Ridley RG, 1999, SCIENCE, V285, P1502, DOI 10.1126/science.285.5433.1502; SANGER F, 1982, J MOL BIOL, V162, P729, DOI 10.1016/0022-2836(82)90546-0; Snel B, 1999, NAT GENET, V21, P108, DOI 10.1038/5052; Staley J. T., 1997, MICROBIAL WORLD FDN; Sutton G. G., 1995, GENOME SCI TECHNOL, V1, P9, DOI [10.1089/gst.1995.1.9, DOI 10.1089/GST.1995.1.9]; Tettelin H, 2000, SCIENCE, V287, P1809, DOI 10.1126/science.287.5459.1809; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088	37	106	118	1	6	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 17	2000	406	6797					799	803		10.1038/35021244	http://dx.doi.org/10.1038/35021244			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	344PH	10963611	hybrid, Green Published			2022-12-28	WOS:000088767700058
J	McKinney, JD; zu Bentrup, KH; Munoz-Elias, EJ; Miczak, A; Chen, B; Chan, WT; Swenson, D; Sacchettini, JC; Jacobs, WR; Russell, DG				McKinney, JD; zu Bentrup, KH; Munoz-Elias, EJ; Miczak, A; Chen, B; Chan, WT; Swenson, D; Sacchettini, JC; Jacobs, WR; Russell, DG			Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase	NATURE			English	Article							ALLELIC EXCHANGE; EXPRESSION; MATURATION; SMEGMATIS; SURVIVAL; MUTANTS; AVIUM; CELLS	Mycobacterium tuberculosis claims more human lives each year than any other bacterial pathogen. Infection is maintained in spite of acquired immunity and resists eradication by antimicrobials(1,2). Despite an urgent need for new therapies targeting persistent bacteria, our knowledge of bacterial metabolism throughout the course of infection remains rudimentary. Here we report that persistence of M. tuberculosis in mice is facilitated by isocitrate lyase (ICL), an enzyme essential for the metabolism of fatty acids(3,4). Disruption of the icl gene attenuated bacterial persistence and virulence in immune-competent mice without affecting bacterial growth during the acute phase of infection. A link between the requirement for ICL and the immune status of the host was established by the restored virulence of Delta icl bacteria in interferon-gamma knockout mice. This link was apparent at the level of the infected macrophage: Activation of infected macrophages increased expression of ICL, and the Delta icl mutant was markedly attenuated for survival in activated but not resting macrophages. These data suggest that the metabolism of M. tuberculosis in vivo is profoundly influenced by the host response to infection, an observation with important implications for the treatment of chronic tuberculosis.	Yeshiva Univ Albert Einstein Coll Med, Howard Hughes Med Inst, Bronx, NY 10461 USA; Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; Rockefeller Univ, New York, NY 10021 USA; Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA	Howard Hughes Medical Institute; Yeshiva University; Albert Einstein College of Medicine; Washington University (WUSTL); Rockefeller University; Texas A&M University System; Texas A&M University College Station	Russell, DG (corresponding author), Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14853 USA.	dgr8@cornell.edu	Russell, David G/N-5280-2019; Russell, David G/D-4533-2009	Russell, David G/0000-0002-9748-750X; Russell, David G/0000-0002-9748-750X; Jacobs, William/0000-0003-3321-3080				Bentrup KHZ, 1999, J BACTERIOL, V181, P7161; Clark D. P., 1996, ESCHERICHIA COLI SAL, P343; Clemens DL, 1996, J EXP MED, V184, P1349, DOI 10.1084/jem.184.4.1349; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Cronan JE, 1996, ESCHERICHIA COLI SAL, V1, P206; Farewell A, 1996, J BACTERIOL, V178, P6443, DOI 10.1128/jb.178.22.6443-6450.1996; GIRLING DJ, 1989, BIOL MYCOBACTERIA, V3, P285; Graham JE, 1999, P NATL ACAD SCI USA, V96, P11554, DOI 10.1073/pnas.96.20.11554; HART PD, 1975, NATURE, V256, P47, DOI 10.1038/256047a0; JAMES PE, 1995, J CELL PHYSIOL, V163, P241, DOI 10.1002/jcp.1041630204; McKinney JD, 1998, BIOMED RES REP, P51; MITCHISON DA, 1980, J ROY COLL PHYS LOND, V14, P91; MURTHY PS, 1973, AM REV RESPIR DIS, V108, P689; Parrish NM, 1998, TRENDS MICROBIOL, V6, P107, DOI 10.1016/S0966-842X(98)01216-5; Pavelka MS, 1999, J BACTERIOL, V181, P4780, DOI 10.1128/JB.181.16.4780-4789.1999; Pelicic V, 1997, P NATL ACAD SCI USA, V94, P10955, DOI 10.1073/pnas.94.20.10955; REES RJ, 1961, BRIT J EXP PATHOL, V42, P83; RUSSOMARIE F, 1993, P NATL ACAD SCI USA, V90, P8194, DOI 10.1073/pnas.90.17.8194; Schaible UE, 1998, J IMMUNOL, V160, P1290; Sega W., 1984, MYCOBACTERIA SOURCEB, P547; SHARMA V, IN PRESS NATURE STRU; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Spector MP, 1999, MICROBIOL-SGM, V145, P15, DOI 10.1099/13500872-145-1-15; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Sturgill-Koszycki S, 1997, ELECTROPHORESIS, V18, P2558, DOI 10.1002/elps.1150181411; STURGILLKOSZYCKI S, 1994, SCIENCE, V263, P678, DOI 10.1126/science.8303277; SturgillKoszycki S, 1996, EMBO J, V15, P6960, DOI 10.1002/j.1460-2075.1996.tb01088.x; Via LE, 1998, J CELL SCI, V111, P897; WALLACE JG, 1961, AM REV RESPIR DIS, V83, P866; WAYNE LG, 1982, INFECT IMMUN, V37, P1042, DOI 10.1128/IAI.37.3.1042-1049.1982; Wheeler Paul R., 1994, P353	31	1045	1116	3	107	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 17	2000	406	6797					735	738		10.1038/35021074	http://dx.doi.org/10.1038/35021074			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	344PH	10963599				2022-12-28	WOS:000088767700046
J	Cassel, CK				Cassel, CK			In defense of a department of geriatrics	ANNALS OF INTERNAL MEDICINE			English	Article							FUNCTIONAL OUTCOMES; OLDER PATIENTS; HOSPITALIZATION; TRIAL	Departmental status for geriatrics offers many advantages, all of which are related to strengthening academic and clinical programs in aging. The training programs and the content of medical school curriculum in geriatrics remain inadequate under the current structures. A department of geriatrics can provide a stronger faculty base and allow effective interaction with other departments (including but not limited to internal medicine) that need geriatric training. A department of geriatrics also focuses on a model of care that involves working closely with other disciplines, such as nursing and social work. This interdisciplinary model helps expert providers work efficiently throughout the spectrum of care, strengthening continuity. The department can include other medical specialists, such as family practitioners, psychiatrists, and physiatrists, who work with caregivers and patients throughout a course of treatment to manage chronic illness and help maintain and enhance function and independence as long as possible. Comprehensive care and proper care management also substantially benefit institutions by expanding the patient population, reducing length of stay, and avoiding unnecessary hospitalization of older patients through effective discharge planning and transitional care. This requires strong relationships with long-term care providers, a characteristic strength of geriatricians. Although not all research in aging needs to be housed in a department of geriatric medicine, the presence of a critical mass of basic and clinical researchers creates an environment that can stimulate new initiatives and attract external funding. Additional research bridging basic translational and clinical phases relevant to the elderly population is best encouraged by maintaining relationships with other basic science and clinical departments.	Mt Sinai Sch Med, New York, NY USA; Vet Affairs Med Ctr, Bronx, NY USA	Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Cassel, CK (corresponding author), Mt Sinai NYU Med Ctr, Dept Geriatr & Adult Dev, 1 Gustave L Levy Pl,Box 1070, New York, NY 10029 USA.							Alliance for Aging Research, 1996, WILL YOU STILL TREAT; CREDITOR MC, 1993, ANN INTERN MED, V118, P219, DOI 10.7326/0003-4819-118-3-199302010-00011; HAZZARD WR, 1991, ANN INTERN MED, V115, P229, DOI 10.7326/0003-4819-115-3-229; Hutchins LF, 1999, NEW ENGL J MED, V341, P2061, DOI 10.1056/NEJM199912303412706; LANDEFELD CS, 1995, NEW ENGL J MED, V332, P1338, DOI 10.1056/NEJM199505183322006; NAYLOR M, 1994, ANN INTERN MED, V120, P999, DOI 10.7326/0003-4819-120-12-199406150-00005; NAYLOR M, 1991, CRITICAL CARE NURSIN, P331; RUBENSTEIN LZ, 1996, GENERATIONS      WIN, P47; Sager MA, 1996, ARCH INTERN MED, V156, P645, DOI 10.1001/archinte.156.6.645; SINGAL BM, 1992, ANN EMERG MED, V21, P802, DOI 10.1016/S0196-0644(05)81025-X; TRIMBLE EL, 1994, CANCER, V74, P2208, DOI 10.1002/1097-0142(19941001)74:7+<2208::AID-CNCR2820741737>3.0.CO;2-#; *US CENS BUR, 1996, 1996 POP PROJ US AG; WENNBERG JE, 1999, DARTMOUTH ATLAS HLTH, P105	13	14	15	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 15	2000	133	4					297	301		10.7326/0003-4819-133-4-200008150-00015	http://dx.doi.org/10.7326/0003-4819-133-4-200008150-00015			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	346NG	10929172				2022-12-28	WOS:000088877500008
J	Mudur, G				Mudur, G			Research finds high hepatitis B rate in Indian island tribes	BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	AUG 12	2000	321	7258					404	404						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	344QC	10938047				2022-12-28	WOS:000088769500018
J	Koop, T; Luo, BP; Tsias, A; Peter, T				Koop, T; Luo, BP; Tsias, A; Peter, T			Water activity as the determinant for homogeneous ice nucleation in aqueous solutions	NATURE			English	Article							PHASE-TRANSITIONS; SUPERCOOLED WATER; PRESSURE; TEMPERATURES; AEROSOLS; GLASSY	The unique properties of water in the supercooled (metastable) state are not fully understood(1). In particular, the effects of solutes and mechanical pressure on the kinetics of the liquid-to-solid phase transition of supercooled water and aqueous solutions to ice have remained unresolved. Here we show from experimental data that the homogeneous nucleation of ice from supercooled aqueous solutions is independent of the nature of the solute, but depends only on the water activity of the solution-that is, the ratio between the water vapour pressures of the solution and of pure water under the same conditions. In addition, we show that the presence of solutes and the application of pressure have a very similar effect on ice nucleation. We present a thermodynamic theory for homogeneous ice nucleation, which expresses the nucleation rate coefficient as a function of water activity and pressure. Recent observations from clouds containing ice are in good agreement with our theory and our results should help to overcome one of the main weaknesses of numerical models of the atmosphere, the formulation of cloud processes.	ETH Honggerberg, Swiss Fed Inst Technol, Inst Atmospher Sci, CH-8093 Zurich, Switzerland; Max Planck Inst Chem, Nachwuchsgrp, D-55020 Mainz, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; Max Planck Society	Koop, T (corresponding author), ETH Honggerberg, Swiss Fed Inst Technol, Inst Atmospher Sci, CH-8093 Zurich, Switzerland.		Peter, Thomas/B-2529-2018; Koop, Thomas/B-7861-2008	Peter, Thomas/0000-0002-7218-7156; Koop, Thomas/0000-0002-7571-3684				ANGELL CA, 1981, J PHYS CHEM-US, V85, P1461, DOI 10.1021/j150611a001; Baker MB, 1997, SCIENCE, V276, P1072, DOI 10.1126/science.276.5315.1072; Bertram AK, 2000, J PHYS CHEM A, V104, P584, DOI 10.1021/jp9931197; Carslaw KS, 1998, J GEOPHYS RES-ATMOS, V103, P5785, DOI 10.1029/97JD03626; Chang HYA, 1999, J PHYS CHEM A, V103, P2673, DOI 10.1021/jp9841034; Clegg SL, 1998, J PHYS CHEM A, V102, P2137, DOI 10.1021/jp973042r; Dantl G., 1969, PHYS ICE P INT S PHY, P223; GAGNON RE, 1988, J CHEM PHYS, V89, P4522, DOI 10.1063/1.454792; HARE DE, 1987, J CHEM PHYS, V87, P4840, DOI 10.1063/1.453710; Heymsfield AJ, 1998, GEOPHYS RES LETT, V25, P1343, DOI 10.1029/98GL01089; JOHARI GP, 1994, J PHYS CHEM-US, V98, P4719, DOI 10.1021/j100068a038; KANNO H, 1977, J PHYS CHEM-US, V81, P2639, DOI 10.1021/j100541a013; KANNO H, 1975, SCIENCE, V189, P880, DOI 10.1126/science.189.4206.880; Koop T, 1999, J PHYS CHEM A, V103, P9042, DOI 10.1021/jp992033a; Koop T, 1998, J PHYS CHEM A, V102, P8924, DOI 10.1021/jp9828078; KRAMER B, 1998, THESIS FREE U BERLIN; LEBERMAN R, 1995, NATURE, V378, P364, DOI 10.1038/378364a0; MACFARLANE DR, 1983, J CHEM PHYS, V79, P3921, DOI 10.1063/1.446260; Mishima O, 1996, NATURE, V384, P546, DOI 10.1038/384546a0; Mishima O, 1998, NATURE, V396, P329, DOI 10.1038/24540; MISHIMA O, 1985, NATURE, V314, P76, DOI 10.1038/314076a0; Murphy DM, 1998, SCIENCE, V282, P1664, DOI 10.1126/science.282.5394.1664; OGUNI M, 1980, J CHEM PHYS, V73, P1948, DOI 10.1063/1.440303; Pruppacher H. R., 1997, MICROPHYSICS CLOUDS, p[79, 205]; Rasmussen D.H., 1972, WATER STRUCTURE WATE, P126; RASMUSSEN DH, 1982, J CRYST GROWTH, V56, P56, DOI 10.1016/0022-0248(82)90012-4; SASSEN K, 1988, J ATMOS SCI, V45, P1357, DOI 10.1175/1520-0469(1988)045<1357:HNRFHS>2.0.CO;2; SCHAFER K, 1962, LANDOLDTBORNSTEIN 2B; Speedy RJ, 1996, J CHEM PHYS, V105, P240, DOI 10.1063/1.471869; WEAST RC, 1966, HDB CHEM PHYSICS, pD139	30	899	912	17	368	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 10	2000	406	6796					611	614		10.1038/35020537	http://dx.doi.org/10.1038/35020537			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	342PF	10949298				2022-12-28	WOS:000088653800043
J	Benford, G				Benford, G			Taking control - Great moments in megaengineering.	NATURE			English	Article									Univ Calif Irvine, Irvine, CA 92717 USA	University of California System; University of California Irvine	Benford, G (corresponding author), Univ Calif Irvine, Irvine, CA 92717 USA.								0	0	0	0	3	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 3	2000	406	6795					462	462		10.1038/35020157	http://dx.doi.org/10.1038/35020157			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	340ML	10952289	Bronze			2022-12-28	WOS:000088538000022
J	Shen, XT; Mizuguchi, G; Hamiche, A; Wu, C				Shen, XT; Mizuguchi, G; Hamiche, A; Wu, C			A chromatin remodelling complex involved in transcription and DNA processing	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; NUCLEOSOME; BINDING; PROTEIN; SWI/SNF; RUVB; RECOMBINATION; HELICASE; SUBUNIT; FAMILY	The packaging of the eukaryotic genome in chromatin presents barriers that restrict the access of enzymes that process DNA(1,2). To overcome these barriers, cells possess a number of multi-protein, ATP-dependent chromatin remodelling complexes, each containing an ATPase subunit from the SNF2/SWI2 superfamily(3,4). Chromatin remodelling complexes function by increasing nucleosome mobility and are clearly implicated in transcription(5-7). Here we have analysed SNF2/SWI2- and ISWI-related proteins to identify remodelling complexes that potentially assist other DNA transactions. We purified a complex from Saccharomyces cerevisiae that contains the Ino80 ATPase(8). The INO80 complex contains about 12 polypeptides including two proteins related to the bacterial RuvB DNA helicase(9-11), which catalyses branch migration of Holliday junctions. The purified complex remodels chromatin, facilitates transcription in vitro and displays 3' to 5' DNA helicase activity. Mutants of ino80 show hypersensitivity to agents that cause DNA damage, in addition to defects in transcription(8). These results indicate that chromatin remodelling driven by the Ino80 ATPase may be connected to transcription as well as DNA damage repair.	NCI, Mol Cell Biol Lab, NIH, Bethesda, MD 20892 USA; Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068502, Japan	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Kyoto University	Wu, C (corresponding author), NCI, Mol Cell Biol Lab, NIH, Bethesda, MD 20892 USA.			Shen, Xuetong/0000-0002-4267-5298				Armstrong JA, 1998, CURR OPIN GENET DEV, V8, P165, DOI 10.1016/S0959-437X(98)80137-8; Cairns BR, 1998, MOL CELL, V2, P639, DOI 10.1016/S1097-2765(00)80162-8; Cairns BR, 1996, CELL, V87, P1249, DOI 10.1016/S0092-8674(00)81820-6; COTE J, 1994, SCIENCE, V265, P53, DOI 10.1126/science.8016655; Ebbert R, 1999, MOL MICROBIOL, V32, P741, DOI 10.1046/j.1365-2958.1999.01390.x; EISEN JA, 1995, NUCLEIC ACIDS RES, V23, P2715, DOI 10.1093/nar/23.14.2715; Galarneau L, 2000, MOL CELL, V5, P927, DOI 10.1016/S1097-2765(00)80258-0; Gdula DA, 1998, GENE DEV, V12, P3206, DOI 10.1101/gad.12.20.3206; Haber JE, 1999, TRENDS BIOCHEM SCI, V24, P271, DOI 10.1016/S0968-0004(99)01413-9; HANSEN SK, 1995, CELL, V82, P565, DOI 10.1016/0092-8674(95)90029-2; Huang MX, 1997, MOL CELL BIOL, V17, P6105, DOI 10.1128/MCB.17.10.6105; IKURA T, UNPUT NATURE; Kadonaga JT, 1998, CELL, V92, P307, DOI 10.1016/S0092-8674(00)80924-1; Kanemaki M, 1997, BIOCHEM BIOPH RES CO, V235, P64, DOI 10.1006/bbrc.1997.6729; Kanemaki M, 1999, J BIOL CHEM, V274, P22437, DOI 10.1074/jbc.274.32.22437; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Luger K, 1998, CURR OPIN STRUC BIOL, V8, P33, DOI 10.1016/S0959-440X(98)80007-9; Mizuguchi G, 1997, MOL CELL, V1, P141, DOI 10.1016/S1097-2765(00)80015-5; Park JS, 1997, J BIOL CHEM, V272, P18910, DOI 10.1074/jbc.272.30.18910; Peterson CL, 1996, CURR OPIN GENET DEV, V6, P171, DOI 10.1016/S0959-437X(96)80047-5; Qiu XB, 1998, J BIOL CHEM, V273, P27786, DOI 10.1074/jbc.273.43.27786; Seigneur M, 1998, CELL, V95, P419, DOI 10.1016/S0092-8674(00)81772-9; TSUKIYAMA T, 1995, CELL, V83, P1011, DOI 10.1016/0092-8674(95)90216-3; Tsukiyama T, 1999, GENE DEV, V13, P686, DOI 10.1101/gad.13.6.686; TSUKIYAMA T, 1995, CELL, V83, P1021, DOI 10.1016/0092-8674(95)90217-1; WEINERT TA, 1990, MOL CELL BIOL, V10, P6554, DOI 10.1128/MCB.10.12.6554; West SC, 1997, ANNU REV GENET, V31, P213, DOI 10.1146/annurev.genet.31.1.213; Wood MA, 2000, MOL CELL, V5, P321, DOI 10.1016/S1097-2765(00)80427-X; Workman JL, 1998, ANNU REV BIOCHEM, V67, P545, DOI 10.1146/annurev.biochem.67.1.545; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5	30	621	640	1	53	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 3	2000	406	6795					541	544		10.1038/35020123	http://dx.doi.org/10.1038/35020123			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	340ML	10952318				2022-12-28	WOS:000088538000052
J	Tanabe, T; Kuwabara, T; Warashina, M; Tani, K; Taira, K; Asano, S				Tanabe, T; Kuwabara, T; Warashina, M; Tani, K; Taira, K; Asano, S			Oncogene inactivation in a mouse model - Tissue invasion by leukaemic cells is stalled by loading them with a designer ribozyme.	NATURE			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; PHILADELPHIA-CHROMOSOME; MARROW TRANSPLANTATION; BONE-MARROW; CLEAVAGE; GENE		Univ Tokyo, Inst Med Sci, Dept Hematol Oncol, Minato Ku, Tokyo 1088539, Japan; Natl Inst Adv Interdisciplinary Res, Tsukuba Sci City, Ibaraki 3058562, Japan; Univ Tsukuba, Inst Appl Biochem, Tsukuba Sci City, Ibaraki 3058572, Japan; Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Tokyo 1138656, Japan	University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST); University of Tsukuba; University of Tokyo	Tanabe, T (corresponding author), Univ Tokyo, Inst Med Sci, Dept Hematol Oncol, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088539, Japan.							Amontov SV, 1996, J AM CHEM SOC, V118, P1624, DOI 10.1021/ja9517734; BARTRAM CR, 1983, NATURE, V306, P277, DOI 10.1038/306277a0; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; DEISSEROTH AB, 1994, BLOOD, V83, P3068, DOI 10.1182/blood.V83.10.3068.3068; GISHIZKY ML, 1992, SCIENCE, V256, P836, DOI 10.1126/science.1375394; KONOPKA JB, 1984, CELL, V37, P1035, DOI 10.1016/0092-8674(84)90438-0; Kuwabara T, 1999, P NATL ACAD SCI USA, V96, P1886, DOI 10.1073/pnas.96.5.1886; Kuwabara T, 1998, NAT BIOTECHNOL, V16, P961, DOI 10.1038/nbt1098-961; Kuwabara T, 1998, MOL CELL, V2, P617, DOI 10.1016/S1097-2765(00)80160-4; MCGLAVE P, 1993, BLOOD, V81, P543; Onishi M, 1996, EXP HEMATOL, V24, P324; SNYDER DS, 1990, HEMATOL ONCOL CLIN N, V4, P535, DOI 10.1016/S0889-8588(18)30477-5; Tanabe T, 2000, BIOMACROMOLECULES, V1, P108, DOI 10.1021/bm990009x	13	67	74	0	4	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 3	2000	406	6795					473	474		10.1038/35020190	http://dx.doi.org/10.1038/35020190			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	340ML	10952298				2022-12-28	WOS:000088538000032
J	Tuite, MF				Tuite, MF			Cell biology - Sowing the protein seeds of prion propagation	SCIENCE			English	Editorial Material							SACCHAROMYCES-CEREVISIAE		Univ Kent, Dept Biosci, Canterbury CT2 7NJ, Kent, England	University of Kent	Tuite, MF (corresponding author), Univ Kent, Dept Biosci, Canterbury CT2 7NJ, Kent, England.	m.f.tuite@ukc.ac.uk	Tuite, Mick/ABC-7909-2020	Tuite, Mick/0000-0002-5214-540X				DePace AH, 1998, CELL, V93, P1241, DOI 10.1016/S0092-8674(00)81467-1; Eaglestone SS, 2000, P NATL ACAD SCI USA, V97, P240, DOI 10.1073/pnas.97.1.240; Glover JR, 1997, CELL, V89, P811, DOI 10.1016/S0092-8674(00)80264-0; Hill AF, 1999, J GEN VIROL, V80, P11, DOI 10.1099/0022-1317-80-1-11; KOCISKO DA, 1994, NATURE, V370, P471, DOI 10.1038/370471a0; Sondheimer N, 2000, MOL CELL, V5, P163, DOI 10.1016/S1097-2765(00)80412-8; Sparrer HE, 2000, SCIENCE, V289, P595, DOI 10.1126/science.289.5479.595; Thual C, 1999, J BIOL CHEM, V274, P13666, DOI 10.1074/jbc.274.19.13666; Tuite MF, 2000, CELL, V100, P289, DOI 10.1016/S0092-8674(00)80663-7; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Wickner RB, 1999, COLD SPRING HARBOR M, V38, P229	11	6	8	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 28	2000	289	5479					556	557		10.1126/science.289.5479.556	http://dx.doi.org/10.1126/science.289.5479.556			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	338XD	10939965				2022-12-28	WOS:000088447800028
J	Vosshall, LB; Wong, AM; Axel, R				Vosshall, LB; Wong, AM; Axel, R			An olfactory sensory map in the fly brain	CELL			English	Article							ODORANT RECEPTOR EXPRESSION; MITRAL TUFTED CELLS; ANTENNAL LOBE; DROSOPHILA-MELANOGASTER; NEURONAL-ACTIVITY; GENE-EXPRESSION; BULB; ORGANIZATION; RESPONSES; PROTEIN	We have isolated the "complete" repertoire of genes encoding the odorant receptors in Drosophila and employ these genes to provide a molecular description of the organization of the peripheral olfactory system. The repertoire of Drosophila odorant receptors is encoded by 57 genes. Individual sensory neurons are likely to express only a single receptor gene. Neurons expressing a given gene project axons to one or two spatially invariant glomeruli in the antennal robe. The insect brain therefore retains a two-dimensional map of receptor activation such that the quality of an odor may be encoded by different spatial patterns of activity in the antennal lobe.	Columbia Univ Coll Phys & Surg, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute	Axel, R (corresponding author), Columbia Univ Coll Phys & Surg, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA.	ra27@columbia.edu		Axel, Richard/0000-0002-3141-4076; Vosshall, Leslie/0000-0002-6060-8099	NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH050733] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS029832] Funding Source: NIH RePORTER; NIMH NIH HHS [5P50 MH50733-06] Funding Source: Medline; NINDS NIH HHS [NS29832-08] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; BENARIE N, 1994, HUM MOL GENET, V3, P229, DOI 10.1093/hmg/3.2.229; BRAND AH, 1993, DEVELOPMENT, V118, P401; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Carlson JR, 1996, TRENDS GENET, V12, P175, DOI 10.1016/0168-9525(96)10015-9; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Clyne PJ, 1999, NEURON, V22, P339, DOI 10.1016/S0896-6273(00)81094-6; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Cobb M, 1999, BIOL REV, V74, P425, DOI 10.1017/S0006323199005393; COLBERT HA, 1995, NEURON, V14, P803, DOI 10.1016/0896-6273(95)90224-4; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Elliott G, 1997, CELL, V88, P223, DOI 10.1016/S0092-8674(00)81843-7; Estes PS, 2000, J NEUROGENET, V13, P233, DOI 10.3109/01677060009084496; Friedrich RW, 1997, NEURON, V18, P737, DOI 10.1016/S0896-6273(00)80314-1; Galizia CG, 1999, NAT NEUROSCI, V2, P473, DOI 10.1038/8144; Gao Q, 1999, GENOMICS, V60, P31, DOI 10.1006/geno.1999.5894; Goulding SE, 2000, NEURON, V25, P69, DOI 10.1016/S0896-6273(00)80872-7; HANSSON BS, 1992, SCIENCE, V256, P1313, DOI 10.1126/science.1598574; HAY BA, 1994, DEVELOPMENT, V120, P2121; HIGA I, 1993, GENETICA, V88, P129, DOI 10.1007/BF02424469; HILDEBRAND JG, 1995, P NATL ACAD SCI USA, V92, P67, DOI 10.1073/pnas.92.1.67; HOLLDOBLER B, 1995, P NATL ACAD SCI USA, V92, P19, DOI 10.1073/pnas.92.1.19; Holldobler B., 1990, pi; IMAMURA K, 1992, J NEUROPHYSIOL, V68, P1986, DOI 10.1152/jn.1992.68.6.1986; ISINGRINI M, 1985, P NATL ACAD SCI USA, V82, P8545, DOI 10.1073/pnas.82.24.8545; Ito K, 1998, LEARN MEMORY, V5, P52; Joerges J, 1997, NATURE, V387, P285, DOI 10.1038/387285a0; Jones KA, 1998, NATURE, V396, P674, DOI 10.1038/25348; KATOH K, 1993, J NEUROPHYSIOL, V70, P2161, DOI 10.1152/jn.1993.70.5.2161; KAUER JS, 1987, BRAIN RES, V418, P255, DOI 10.1016/0006-8993(87)90093-X; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Laissue PP, 1999, J COMP NEUROL, V405, P543; LANCET D, 1982, P NATL ACAD SCI-BIOL, V79, P670, DOI 10.1073/pnas.79.2.670; Leibovici M, 1996, DEV BIOL, V175, P118, DOI 10.1006/dbio.1996.0100; LEVY NS, 1991, J STEROID BIOCHEM, V39, P633, DOI 10.1016/0960-0760(91)90262-4; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; MARTIN KA, 1995, NEURON, V14, P229, DOI 10.1016/0896-6273(95)90281-3; Menzel R, 1996, ANNU REV NEUROSCI, V19, P379, DOI 10.1146/annurev.ne.19.030196.002115; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; MORI K, 1992, J NEUROPHYSIOL, V67, P786, DOI 10.1152/jn.1992.67.3.786; Nef S, 1996, MECH DEVELOP, V55, P65, DOI 10.1016/0925-4773(95)00491-2; NGAI J, 1993, CELL, V72, P657, DOI 10.1016/0092-8674(93)90396-8; Qasba P, 1998, J NEUROSCI, V18, P227; RAY K, 1995, DEV BIOL, V167, P426, DOI 10.1006/dbio.1995.1039; Reddy GV, 1997, DEVELOPMENT, V124, P703; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; Robertson HM, 1998, GENOME RES, V8, P449, DOI 10.1101/gr.8.5.449; ROBINOW S, 1988, DEV BIOL, V126, P294, DOI 10.1016/0012-1606(88)90139-X; RODRIGUES V, 1984, BRAIN RES, V324, P374, DOI 10.1016/0006-8993(84)90053-2; RODRIGUES V, 1988, BRAIN RES, V453, P299, DOI 10.1016/0006-8993(88)90170-9; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Sachse S, 1999, EUR J NEUROSCI, V11, P3970, DOI 10.1046/j.1460-9568.1999.00826.x; Sengupta P, 1996, CELL, V84, P899, DOI 10.1016/S0092-8674(00)81068-5; SIDDIQI O, 1987, TRENDS GENET, V3, P137, DOI 10.1016/0168-9525(87)90204-6; SIMON MA, 1991, CELL, V67, P701, DOI 10.1016/0092-8674(91)90065-7; STEWART WB, 1979, J COMP NEUROL, V185, P715, DOI 10.1002/cne.901850407; STOCKER RF, 1983, CELL TISSUE RES, V232, P237, DOI 10.1007/BF00213783; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; STOCKER RF, 1990, CELL TISSUE RES, V262, P9, DOI 10.1007/BF00327741; Troemel ER, 1999, CELL, V99, P387, DOI 10.1016/S0092-8674(00)81525-1; Troemel ER, 1997, CELL, V91, P161, DOI 10.1016/S0092-8674(00)80399-2; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Warr CG, 2000, CELL, V102, P145; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354	72	763	837	7	101	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 21	2000	102	2					147	159		10.1016/S0092-8674(00)00021-0	http://dx.doi.org/10.1016/S0092-8674(00)00021-0			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	337NA	10943836	Bronze			2022-12-28	WOS:000088366800006
J	Isaacson, PG				Isaacson, PG			Relation between cryptic intestinal lymphoma and refractory sprue	LANCET			English	Editorial Material							T-CELL LYMPHOMA; INTRAEPITHELIAL LYMPHOCYTES; MALIGNANT HISTIOCYTOSIS; ULCERATIVE JEJUNITIS; ENTEROPATHY; CLONALITY		UCL, Royal Free & Univ Coll Med Sch, London WC1E 6JJ, England	University of London; University College London	Isaacson, PG (corresponding author), UCL, Royal Free & Univ Coll Med Sch, Torrington Pl, London WC1E 6JJ, England.							AshtonKey M, 1997, AM J PATHOL, V151, P493; Bagdi E, 1999, BLOOD, V94, P260, DOI 10.1182/blood.V94.1.260.413k40_260_264; Cellier C, 1998, GASTROENTEROLOGY, V114, P471, DOI 10.1016/S0016-5085(98)70530-X; FAIRLIE NH, 1937, BRIT MED J, V1, P379; GOUGH KR, 1962, GUT, V3, P232, DOI 10.1136/gut.3.3.232; ISAACSON P, 1978, LANCET, V1, P67; ISAACSON PG, 1985, LANCET, V2, P688; MACDONALD TT, 1988, J EXP MED, V167, P1341, DOI 10.1084/jem.167.4.1341; MURRAY A, 1995, AM J PATHOL, V146, P509; SPENCER J, 1988, AM J PATHOL, V132, P1	10	20	21	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 15	2000	356	9225					178	179		10.1016/S0140-6736(00)02472-7	http://dx.doi.org/10.1016/S0140-6736(00)02472-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	334GQ	10963189				2022-12-28	WOS:000088179100002
J	Baigent, C; Burbury, K; Wheeler, D				Baigent, C; Burbury, K; Wheeler, D			Premature cardiovascular disease in chronic renal failure	LANCET			English	Review							ISCHEMIC-HEART-DISEASE; SERUM-CHOLESTEROL CONCENTRATION; THERAPEUTIC IMPLICATIONS; HEMODIALYSIS-PATIENTS; DIABETES-MELLITUS; BLOOD-PRESSURE; RISK; MICROALBUMINURIA; MORTALITY; HYPERTENSION	There is a remarkable lack of reliable information about the determinants of risk of cardiovascular disease (CVD) among patients with chronic renal failure. Indeed, such patients have often been deliberately excluded from randomised trials of treatments of CVD, perhaps because of concerns about drug safety. But the absolute risk of CVD among them may be large, so the potential absolute benefits of treatments may also be large, and may well exceed any increased hazards. Hence, as well as further investigation of the underlying mechanisms of cardiac disease, it would be helpful to have some large-scale randomised trials in a wide range of renal patients of interventions (such as cholesterol-lowering drugs, antihypertensives, aspirin, B-vitamins, and antioxidant vitamins) that are of proven or suspected benefit in other settings. If safe and effective treatments can be identified, and started early in the natural history of renal failure, the exceptionally high risk of CVD experienced by these patients could be decreased before and after end-stage renal failure has occurred.	Radcliffe Infirm, Clin Trial Serv Unit, Oxford OX2 6HE, England; Radcliffe Infirm, Epidemiol Studies Unit, Oxford OX2 6HE, England; Univ Hosp Birmingham NHS Trust, Dept Nephrol, Queen Elizabeth Med Ctr, Birmingham, W Midlands, England	Radcliffe Infirmary; University of Oxford; Radcliffe Infirmary; University of Oxford; Birmingham City University; University of Birmingham	Baigent, C (corresponding author), Radcliffe Infirm, Clin Trial Serv Unit, Oxford OX2 6HE, England.							Arnadottir M, 1996, SCAND J CLIN LAB INV, V56, P41, DOI 10.3109/00365519609088586; BAIGENT C, 2000, IN PRESS NEPHROL DIA; BAIGENT C, 1999, P R COLL PHYSICIA S5, V29, P10; Besarab A, 1998, NEW ENGL J MED, V339, P584, DOI 10.1056/NEJM199808273390903; Bianchi S, 1999, AM J KIDNEY DIS, V34, P973, DOI 10.1016/S0272-6386(99)70002-8; Buckalew VM, 1996, AM J KIDNEY DIS, V28, P811, DOI 10.1016/S0272-6386(96)90380-7; CHAUVEAU P, 1993, KIDNEY INT       S41, V43, P72; Clarke R, 1999, AM J EPIDEMIOL, V150, P341; Corti MC, 1997, ANN INTERN MED, V126, P753, DOI 10.7326/0003-4819-126-10-199705150-00001; Danesh J, 1998, J Cardiovasc Risk, V5, P229, DOI 10.1097/00043798-199808000-00004; Danesh J, 1998, JAMA-J AM MED ASSOC, V279, P1477, DOI 10.1001/jama.279.18.1477; DANESH J, 2000, IN PRESS CIRCULATION; DEGOULET P, 1982, NEPHRON, V31, P103, DOI 10.1159/000182627; Dinneen SF, 1997, ARCH INTERN MED, V157, P1413, DOI 10.1001/archinte.157.13.1413; EDMUNDS ME, 1994, TXB HYPERTENSION, P798; Fliser D, 1998, KIDNEY INT, V53, P1343, DOI 10.1046/j.1523-1755.1998.00898.x; Foley RN, 1996, AM J KIDNEY DIS, V28, P53, DOI 10.1016/S0272-6386(96)90130-4; Foley RN, 1998, AM J KIDNEY DIS, V32, pS112, DOI 10.1053/ajkd.1998.v32.pm9820470; FOLEY RN, 1995, KIDNEY INT, V47, P186, DOI 10.1038/ki.1995.22; Foley RN, 1996, KIDNEY INT, V49, P1379, DOI 10.1038/ki.1996.194; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; GILBERT RE, 1994, DIABETIC MED, V11, P636, DOI 10.1111/j.1464-5491.1994.tb00325.x; GORDON DJ, 1989, CIRCULATION, V79, P8, DOI 10.1161/01.CIR.79.1.8; GRUTZMACHER P, 1988, NEPHRON, V50, P103, DOI 10.1159/000185138; Irish A, 1998, ATHEROSCLEROSIS, V137, P133, DOI 10.1016/S0021-9150(97)00273-6; JENSEN JS, 1995, CLIN SCI, V88, P629, DOI 10.1042/cs0880629; Jones CA, 1998, AM J KIDNEY DIS, V32, P992, DOI 10.1016/S0272-6386(98)70074-5; KRONENBERG F, 1994, ARTERIOSCLER THROMB, V14, P1399, DOI 10.1161/01.ATV.14.9.1399; Kronenberg F, 1996, AM J KIDNEY DIS, V27, P1, DOI 10.1016/S0272-6386(96)90026-8; LAW MR, 1994, BMJ-BRIT MED J, V308, P367, DOI 10.1136/bmj.308.6925.367; LAW MR, 1994, BMJ-BRIT MED J, V308, P363, DOI 10.1136/bmj.308.6925.363; Levin A, 1999, AM J KIDNEY DIS, V34, P125, DOI 10.1016/S0272-6386(99)70118-6; Levy D, 1996, JAMA-J AM MED ASSOC, V275, P1557, DOI 10.1001/jama.275.20.1557; LONDON GM, 1993, KIDNEY INT, V43, pS42; LOWRIE EG, 1990, AM J KIDNEY DIS, V15, P458, DOI 10.1016/S0272-6386(12)70364-5; MACMAHON S, 1994, TXB HYPERTENSION, P46; Oda H, 1998, NEPHROL DIAL TRANSPL, V13, P45, DOI 10.1093/ndt/13.suppl_1.45; PASCUAL J, 1991, CLIN NEPHROL, V35, P280; PERNEGER TV, 1993, AM J PUBLIC HEALTH, V83, P1735, DOI 10.2105/AJPH.83.12.1735; Qizilbash N, 1995, LANCET, V346, P1647; Rajman I, 1998, NEPHROL DIAL TRANSPL, V13, P2281, DOI 10.1093/ndt/13.9.2281; ROSTAND SG, 1984, KIDNEY INT, V25, P653, DOI 10.1038/ki.1984.70; SCARABIN PY, 1993, ARTERIOSCLER THROMB, V13, P886, DOI 10.1161/01.ATV.13.6.886; Schwarz U, 2000, NEPHROL DIAL TRANSPL, V15, P218, DOI 10.1093/ndt/15.2.218; Sechi LA, 1998, ANN INTERN MED, V129, P457, DOI 10.7326/0003-4819-129-6-199809150-00006; *US REN DAT SYST, 1999, ANN DAT REP; van Guldener C, 1998, NETH J MED, V52, P58, DOI 10.1016/S0300-2977(97)00069-7; Wannamethee SG, 1997, STROKE, V28, P557, DOI 10.1161/01.STR.28.3.557; WARWICK GL, 1993, NEPHROL DIAL TRANSPL, V8, P385; YUDKIN JS, 1988, LANCET, V2, P530; Zager PG, 1998, KIDNEY INT, V54, P561, DOI 10.1046/j.1523-1755.1998.00005.x	51	435	458	0	12	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 8	2000	356	9224					147	152		10.1016/S0140-6736(00)02456-9	http://dx.doi.org/10.1016/S0140-6736(00)02456-9			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	331UG	10963260				2022-12-28	WOS:000088036600036
J	Biswas, AC; Molla, MAM; Al-Moslem, K				Biswas, AC; Molla, MAM; Al-Moslem, K			A baby with bulging anterior fontanelle	LANCET			English	Article									Al Yamamah Hosp, Dept Paediat, Riyadh 11484, Saudi Arabia		Biswas, AC (corresponding author), POB 1878, Riyadh 11342, Saudi Arabia.							BARRY W, 1989, ARCH DIS CHILD, V64, P635, DOI 10.1136/adc.64.4.635-a; Biswas AC, 1999, ANN SAUDI MED, V19, P345, DOI 10.5144/0256-4947.1999.345; BISWAS AC, 1975, THESIS U CALCUTTA; GROSS TP, 1989, J PEDIATR-US, V114, P423, DOI 10.1016/S0022-3476(89)80562-1; HASLAM RHA, 1996, NELSON TXB PEDIAT, P1735	5	4	4	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 8	2000	356	9224					132	132		10.1016/S0140-6736(00)02450-8	http://dx.doi.org/10.1016/S0140-6736(00)02450-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	331UG	10963250				2022-12-28	WOS:000088036600014
J	Tyler-Smith, C; Floridia, G				Tyler-Smith, C; Floridia, G		CRC Chromosome Mol Biol Grp	Many paths to the top of the mountain: Diverse evolutionary solutions to centromere structure	CELL			English	Review							KINETOCHORE		Univ Oxford, Dept Biochem, CRC Dept Chromosome Mol Biol Grp, Oxford OX1 3QU, England; Ist Super Sanita, Ultrastrutture Lab, I-00161 Rome, Italy	University of Oxford; Istituto Superiore di Sanita (ISS)	Tyler-Smith, C (corresponding author), Univ Oxford, Dept Biochem, CRC Dept Chromosome Mol Biol Grp, S Parks Rd, Oxford OX1 3QU, England.		FLORIDIA, GIOVANNA/A-6640-2015	FLORIDIA, GIOVANNA/0000-0003-4187-8816				Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Agudo M, 2000, CHROMOSOMA, V109, P190, DOI 10.1007/s004120050427; Brown WRA, 2000, TRENDS BIOTECHNOL, V18, P218, DOI 10.1016/S0167-7799(00)01438-4; Choo KHA, 2000, TRENDS CELL BIOL, V10, P182, DOI 10.1016/S0962-8924(00)01739-6; Copenhaver GP, 1999, SCIENCE, V286, P2468, DOI 10.1126/science.286.5449.2468; Dawe RK, 1999, PLANT CELL, V11, P1227, DOI 10.1105/tpc.11.7.1227; Dobie KW, 1999, CURR OPIN GENET DEV, V9, P206, DOI 10.1016/S0959-437X(99)80031-8; Henikoff S, 2000, P NATL ACAD SCI USA, V97, P716, DOI 10.1073/pnas.97.2.716; Karpen GH, 1997, TRENDS GENET, V13, P489, DOI 10.1016/S0168-9525(97)01298-5; Koonin EV, 2000, CELL, V101, P573, DOI 10.1016/S0092-8674(00)80867-3; Pidoux AL, 2000, CURR OPIN CELL BIOL, V12, P308, DOI 10.1016/S0955-0674(00)00094-6; Platero JS, 1999, MOL CELL, V4, P995, DOI 10.1016/S1097-2765(00)80228-2; Saffery R, 2000, HUM MOL GENET, V9, P175, DOI 10.1093/hmg/9.2.175; Sugata N, 1999, J BIOL CHEM, V274, P27343, DOI 10.1074/jbc.274.39.27343; Tyler-Smith C, 1999, AM J HUM GENET, V64, P1440, DOI 10.1086/302380; Warburton PE, 2000, AM J HUM GENET, V66, P1794, DOI 10.1086/302924; Weiler KS, 1995, ANNU REV GENET, V29, P577, DOI 10.1146/annurev.ge.29.120195.003045	17	36	37	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 7	2000	102	1					5	8		10.1016/S0092-8674(00)00004-0	http://dx.doi.org/10.1016/S0092-8674(00)00004-0			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	332UL	10929707	Bronze			2022-12-28	WOS:000088091700002
J	Rosenhek, R; Binder, T; Porenta, G; Lang, I; Christ, G; Schemper, M; Maurer, G; Baumgartner, H				Rosenhek, R; Binder, T; Porenta, G; Lang, I; Christ, G; Schemper, M; Maurer, G; Baumgartner, H			Predictors of outcome in severe, asymptomatic aortic stenosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEART-VALVE REPLACEMENT; NATURAL-HISTORY; DISEASE; ADULTS; SURVIVAL; PATIENT	Background Whether to perform valve ment in patients with asymptomatic but severe aortic stenosis is controversial. Therefore, we studied the natural history of this condition to identify predictors of outcome. Methods During 1994, we identified 128 consecutive patients with asymptomatic, severe aortic (59 women and 69 men; mean [+/- SD] age, 60 +/- 18 years; aortic-jet velocity, 5.0 +/- 0.6 m per second). The patients were prospectively followed until 1998. Results Follow-up information was available for 126 patients (98 percent) for a mean of 22 +/- 18 months. Event-free survival, with the end point defined as death (8 patients) or valve replacement necessitated by the development of symptoms ( 59 patients), was 67 +/- 5 percent at one year, 56 +/- 5 percent at two years, and 33 +/- 5 percent at four years. Five of the six deaths from cardiac disease were preceded by symptoms. According to multivariate analysis, only the extent of aortic-valve calcification was an independent tor of outcome, whereas age, sex, and the presence or absence of coronary artery disease, hypertension, diabetes, and hypercholesterolemia were not. survival for patients with no or mild valvular calcification was 92 +/- 5 percent at one year, 84 +/- 8 percent at two years, and 75 +/- 9 percent at four years, as compared with 60 +/- 6 percent, 47 +/- 6 percent, and 20 +/- 5 respectively, for those with moderate or severe calcification. The rate of progression of stenosis, as reflected by the aortic-jet velocity, was significantly higher in patients who had cardiac events (0.45 +/- 0.38 m per second per year) than those who did not have cardiac events (0.14 +/- 0.18 m per second year, P<0.001), and the rate of progression of stenosis provided useful prognostic information. Of the patients with moderately or severely calcified aortic valves whose aortic-jet velocity increased by 0.3 m per second or more within one year, 79 percent surgery or died within two years of the observed increase. Conclusions In asymptomatic patients with aortic stenosis, it appears to be relatively safe to delay surgery until symptoms develop. However, outcomes vary widely. The presence of moderate or severe valvular calcification, together with a raid increase in aortic-jet velocity, identifies patients with a ver poor prognosis. These patients should be considered for early valve replacement rather than have surgery delayed until symptoms develop. (N Engl J Med 2000; 343:611-7.) (C) 2000, Massachusetts Medical Society.	Univ Vienna, Vienna Gen Hosp, Dept Cardiol, A-1090 Vienna, Austria; Univ Vienna, Ludwig Boltzmann Inst Cardiovasc Res, A-1090 Vienna, Austria; Univ Vienna, Dept Med Comp Sci, A-1090 Vienna, Austria	University of Vienna; Ludwig Boltzmann Institute; University of Vienna; University of Vienna	Baumgartner, H (corresponding author), Univ Vienna, Vienna Gen Hosp, Dept Cardiol, Wahringer Gurtel 18-20, A-1090 Vienna, Austria.		Winter, Max P/E-8456-2011	Lang, Irene/0000-0003-0485-2692; Maurer, Gerald/0000-0002-9043-7657				AKINS CW, 1991, ANN THORAC SURG, V52, P161, DOI 10.1016/0003-4975(91)91453-3; BLOOMFIELD P, 1991, NEW ENGL J MED, V324, P573, DOI 10.1056/NEJM199102283240901; Bonow RO, 1998, J AM COLL CARDIOL, V32, P1486, DOI 10.1016/S0735-1097(98)00454-9; Carabello BA, 1997, CIRCULATION, V95, P2241, DOI 10.1161/01.CIR.95.9.2241; CHIZNER MA, 1980, AM HEART J, V99, P419, DOI 10.1016/0002-8703(80)90375-0; Connolly HM, 1997, CIRCULATION, V95, P2395, DOI 10.1161/01.CIR.95.10.2395; ENGELSTEIN ED, 1998, HURSTS HEART ARTERIE, V1, P1081; FAGGIANO P, 1992, AM J CARDIOL, V70, P229, DOI 10.1016/0002-9149(92)91280-H; FRANK S, 1973, BRIT HEART J, V35, P41; HAMMERMEISTER KE, 1993, NEW ENGL J MED, V328, P1289, DOI 10.1056/NEJM199305063281801; HORSTKOTTE D, 1988, EUR HEART J, V9, P57, DOI 10.1093/eurheartj/9.suppl_E.57; Iivanainen AM, 1996, AM J CARDIOL, V78, P97, DOI 10.1016/S0002-9149(96)00235-4; KELLY TA, 1988, AM J CARDIOL, V61, P123, DOI 10.1016/0002-9149(88)91317-3; KOUCHOUKOS NT, 1994, NEW ENGL J MED, V330, P1, DOI 10.1056/NEJM199401063300101; LINDBLOM D, 1990, J AM COLL CARDIOL, V15, P566, DOI 10.1016/0735-1097(90)90627-2; Lund O, 1996, THORAC CARDIOV SURG, V44, P289, DOI 10.1055/s-2007-1012039; LUND O, 1990, CIRCULATION, V82, P124, DOI 10.1161/01.CIR.82.1.124; LUND O, 1989, SCAND J THORAC CARD, V23, P263, DOI 10.3109/14017438909106006; MURPHY ES, 1981, CIRCULATION, V64, P184; OBRIEN MF, 1995, ANN THORAC SURG, V60, pS65, DOI 10.1016/0003-4975(95)00223-8; OTTO CM, 1997, CIRCULATION, V95, P222; PELLIKKA PA, 1990, J AM COLL CARDIOL, V15, P1012, DOI 10.1016/0735-1097(90)90234-G; RAPAPORT E, 1975, AM J CARDIOL, V35, P221, DOI 10.1016/0002-9149(75)90005-3; Ross J Jr, 1968, Circulation, V38, P61; SCHWARZ F, 1982, CIRCULATION, V66, P1105, DOI 10.1161/01.CIR.66.5.1105; SMITH N, 1978, CIRCULATION, V58, P255, DOI 10.1161/01.CIR.58.2.255; SPRIGINGS DC, 1995, BRIT HEART J, V74, P481; *STS NAT DAT, 2000, STS US CARD SURG DAT; TURINA J, 1987, EUR HEART J, V8, P471, DOI 10.1093/oxfordjournals.eurheartj.a062307; Vongpatanasin W, 1996, NEW ENGL J MED, V335, P407, DOI 10.1056/NEJM199608083350607; WOOD P, 1958, AM J CARDIOL, V1, P553, DOI 10.1016/0002-9149(58)90138-3; YACOUB M, 1995, J THORAC CARDIOV SUR, V110, P186, DOI 10.1016/S0022-5223(05)80025-X	32	940	969	0	39	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 31	2000	343	9					611	617		10.1056/NEJM200008313430903	http://dx.doi.org/10.1056/NEJM200008313430903			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	348RE	10965007	Bronze			2022-12-28	WOS:000088999600003
J	Bard, J; Zhelkovsky, AM; Helmling, S; Earnest, TN; Moore, CL; Bohm, A				Bard, J; Zhelkovsky, AM; Helmling, S; Earnest, TN; Moore, CL; Bohm, A			Structure of yeast poly(A) polymerase alone and in complex with 3 '-dATP	SCIENCE			English	Article							DNA-POLYMERASE; CRYSTAL-STRUCTURES; MESSENGER-RNA; BINDING; MECHANISM; DOMAIN; BETA; NUCLEOTIDYLTRANSFERASE; EUKARYOTES; FRAGMENT	Polyadenylate [poly(A)] polymerase (PAP) catalyzes the addition of a polyadenosine tail to almost all eukaryotic messenger RNAs (mRNAs). The crystal structure of the PAP from Saccharomyces cerevisiae (Pap1) has been solved to 2.6 angstroms, both alone and in complex with 3'-deoxyadenosine triphosphate (3'-dATP). Like other nucleic acid polymerases, Pap1 is composed of three domains that encircle the active site. The arrangement of these domains, however, is quite different from that seen in polymerases that use a template to select and position their incoming nucleotides. The first two domains are functionally analogous to polymerase palm and fingers domains. The third domain is attached to the fingers domain and is' known to interact with the single-stranded RNA primer. In the nucleotide complex, two molecules of 3'-dATP are bound to Pap1, One occupies the position of the incoming base, prior to its addition to the mRNA chain. The other is believed to occupy the position of the 3' end of the mRNA primer.	Boston Biomed Res Inst, Watertown, MA 02472 USA; Tufts Univ, Sch Med, Dept Mol Microbiol, Boston, MA 02111 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Phys Sci, Macromol Crystallog Facil Adv Light Source, Berkeley, CA 94720 USA; Tufts Univ, Sch Med, Dept Biochem, Boston, MA 02111 USA	Boston Biomedical Research Institute; Tufts University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Tufts University	Bohm, A (corresponding author), Boston Biomed Res Inst, 64 Grove St, Watertown, MA 02472 USA.				NIGMS NIH HHS [R01 GM57218-01A2] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057218] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agalarov SC, 2000, SCIENCE, V288, P107, DOI 10.1126/science.288.5463.107; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; BEESE LS, 1993, BIOCHEMISTRY-US, V32, P14095, DOI 10.1021/bi00214a004; Brautigam CA, 1998, CURR OPIN STRUC BIOL, V8, P54, DOI 10.1016/S0959-440X(98)80010-9; Bricogne G, 1997, METHOD ENZYMOL, V276, P361, DOI 10.1016/S0076-6879(97)76069-5; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carpousis AJ, 1999, TRENDS GENET, V15, P24, DOI 10.1016/S0168-9525(98)01627-8; Coburn GA, 1999, PROG NUCLEIC ACID RE, V62, P55; Conte MR, 2000, EMBO J, V19, P3132, DOI 10.1093/emboj/19.12.3132; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Doublie S, 1998, CURR OPIN STRUC BIOL, V8, P704, DOI 10.1016/S0959-440X(98)80089-4; Doublie S, 1999, STRUCTURE, V7, pR31, DOI 10.1016/S0969-2126(99)80017-3; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P345, DOI 10.1016/S0968-0004(00)89071-4; Huang YQ, 1996, MOL CELL BIOL, V16, P1534; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Martin G, 1996, EMBO J, V15, P2593, DOI 10.1002/j.1460-2075.1996.tb00617.x; MARTIN G, IN PRESS EMBO J; Ohnacker M, 1996, NUCLEIC ACIDS RES, V24, P2585, DOI 10.1093/nar/24.13.2585; OLLIS DL, 1985, NATURE, V313, P762, DOI 10.1038/313762a0; PEDERSEN LC, 1995, BIOCHEMISTRY-US, V34, P13305, DOI 10.1021/bi00041a005; PELLETIER H, 1994, SCIENCE, V264, P1891, DOI 10.1126/science.7516580; Sachs AB, 1997, CELL, V89, P831, DOI 10.1016/S0092-8674(00)80268-8; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P11205, DOI 10.1021/bi9703812; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999; Zhelkovsky A, 1998, MOL CELL BIOL, V18, P5942, DOI 10.1128/MCB.18.10.5942; ZHELKOVSKY AM, 1995, J BIOL CHEM, V270, P26715, DOI 10.1074/jbc.270.44.26715; ZHELKOVSKY AM, UNPUB; [No title captured]	32	94	96	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 25	2000	289	5483					1346	1349		10.1126/science.289.5483.1346	http://dx.doi.org/10.1126/science.289.5483.1346			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347RF	10958780				2022-12-28	WOS:000088942400037
J	Yu, J; Hu, DH; Barbara, PF				Yu, J; Hu, DH; Barbara, PF			Unmasking electronic energy transfer of conjugated polymers by suppression of O-2 quenching	SCIENCE			English	Article							TIME-RESOLVED PHOTOLUMINESCENCE; FLUORESCENCE SPECTROSCOPY; SINGLE MOLECULES; EXCITATIONS; FILMS; DERIVATIVES; HOMOPOLYMER; OLIGOMERS; VINYLENE); DYNAMICS	The photochemistry of poly[2-methoxy, 5-(2'-ethyl-hexyloxy)-p-phenylene-vinylene] (MEH-PPV) has been found to be highly dependent on the presence of O-2, which increases singlet exciton quenching dramatically, Spectroscopy on isolated single molecules of MEH-PPV in polycarbonate films that exclude O-2 reveals two distinct polymer conformations with fluorescence maxima near 555 and 580 nanometers wavelength, respectively. Time-resolved single-molecule data demonstrate that the 580-nanometer conformation exhibits a "landscape" for intramolecular electronic energy relaxation with a "funnel" that contains a 580-nanometer singlet exciton trap at the bottom. The exciton traps can be converted to exciton quenchers by reaction with O-2. Conformationally induced, directed-energy transfer is arguably a critical dynamical process that is responsible for many of the distinctive photophysical properties of conjugated polymers.	Univ Texas, Dept Chem & Biochem, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Barbara, PF (corresponding author), Univ Texas, Dept Chem & Biochem, Austin, TX 78712 USA.	p.barbara@mail.utexas.edu	Hu, Dehong/B-4650-2010	Hu, Dehong/0000-0002-3974-2963				Basche T., 1996, SINGLE MOL OPTICAL D; Bassler H, 1999, ACCOUNTS CHEM RES, V32, P173, DOI 10.1021/ar960228k; Bazan GC, 1998, J AM CHEM SOC, V120, P9188, DOI 10.1021/ja973816h; Blatchford JW, 1996, PHYS REV B, V54, pR3683, DOI 10.1103/PhysRevB.54.R3683; Czlikkely V, 1970, CHEM PHYS LETT, V6, P11, DOI 10.1016/0009-2614(70)80062-8; Friend RH, 1999, NATURE, V397, P121, DOI 10.1038/16393; GETTINGER CL, 1994, J CHEM PHYS, V101, P1673, DOI 10.1063/1.468438; Grosberg A. Yu., 1979, Biophysics, V24, P30; Hale GD, 1997, PHYS REV B, V55, P16069, DOI 10.1103/PhysRevB.55.R16069; Hide F, 1997, ACCOUNTS CHEM RES, V30, P430, DOI 10.1021/ar950191o; Hu DH, 1999, J AM CHEM SOC, V121, P6936, DOI 10.1021/ja990139d; Hu DH, 2000, NATURE, V405, P1030, DOI 10.1038/35016520; Jakubiak R, 1999, J PHYS CHEM A, V103, P2394, DOI 10.1021/jp9839450; Kohler A, 1998, NATURE, V392, P903, DOI 10.1038/31901; Kuznetsov YA, 1999, J CHEM PHYS, V111, P3744, DOI 10.1063/1.479655; Meier H, 1997, ACTA POLYM, V48, P379, DOI 10.1002/actp.1997.010480905; Moerner WE, 1999, SCIENCE, V283, P1670, DOI 10.1126/science.283.5408.1670; Mukamel S, 1997, SCIENCE, V277, P781, DOI 10.1126/science.277.5327.781; Nguyen TQ, 1999, J CHEM PHYS, V110, P4068, DOI 10.1063/1.478288; Noguchi H, 1998, J CHEM PHYS, V109, P5070, DOI 10.1063/1.477121; Osterbacka R, 2000, SCIENCE, V287, P839, DOI 10.1126/science.287.5454.839; Osterbacka R., 1999, PHYS REV B, V60, pR11253, DOI DOI 10.1103/PHYSREVB.60; Padmanaban G, 2000, J AM CHEM SOC, V122, P2244, DOI 10.1021/ja9932481; RIGLER R, 1995, J BIOTECHNOL, V41, P177, DOI 10.1016/0168-1656(95)00054-T; Samuel IDW, 1997, SYNTHETIC MET, V84, P497, DOI 10.1016/S0379-6779(97)80837-5; SETH J, 1994, J AM CHEM SOC, V116, P10578, DOI 10.1021/ja00102a027; Sirringhaus H, 1999, NATURE, V401, P685, DOI 10.1038/44359; SMILOWITZ L, 1993, J CHEM PHYS, V98, P6504, DOI 10.1063/1.464790; Swager TM, 1998, ACCOUNTS CHEM RES, V31, P201, DOI 10.1021/ar9600502; VandenBout DA, 1997, SCIENCE, V277, P1074, DOI 10.1126/science.277.5329.1074; Weiss S, 1999, SCIENCE, V283, P1676, DOI 10.1126/science.283.5408.1676; Xie XS, 1998, ANNU REV PHYS CHEM, V49, P441, DOI 10.1146/annurev.physchem.49.1.441; YAN M, 1995, PHYS REV LETT, V75, P1992, DOI 10.1103/PhysRevLett.75.1992; Yang CY, 1998, POLYMER, V39, P2299, DOI 10.1016/S0032-3861(97)00509-0; Zhou YQ, 1997, J CHEM PHYS, V107, P10691, DOI 10.1063/1.474186	35	357	360	0	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 25	2000	289	5483					1327	1330		10.1126/science.289.5483.1327	http://dx.doi.org/10.1126/science.289.5483.1327			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347RF	10958774				2022-12-28	WOS:000088942400031
J	Day, SJ; Altman, DG				Day, SJ; Altman, DG			Statistics Notes - Blinding in clinical trials and other studies	BRITISH MEDICAL JOURNAL			English	Article							EMPIRICAL-EVIDENCE; BIAS		Leo Pharmaceut, Princes Risborough HP27 9RR, Bucks, England; Inst Hlth Sci, ICRF Med Stat Grp, Oxford OX3 7LF, England	University of Oxford	Day, SJ (corresponding author), Leo Pharmaceut, Princes Risborough HP27 9RR, Bucks, England.							Barry D, 1996, STAT MED, V15, P2603; deCraen AJM, 1996, BRIT MED J, V313, P1624, DOI 10.1136/bmj.313.7072.1624; Lijmer JG, 1999, JAMA-J AM MED ASSOC, V282, P1061, DOI 10.1001/jama.282.11.1061; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408	4	262	272	2	17	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	AUG 19	2000	321	7259					504	504		10.1136/bmj.321.7259.504	http://dx.doi.org/10.1136/bmj.321.7259.504			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	347MC	10948038	Green Published, Bronze			2022-12-28	WOS:000088932800027
J	Gracias, DH; Tien, J; Breen, TL; Hsu, C; Whitesides, GM				Gracias, DH; Tien, J; Breen, TL; Hsu, C; Whitesides, GM			Forming electrical networks in three dimensions by self-assembly	SCIENCE			English	Article							SYSTEMS	Self-assembly of millimeter-scale polyhedra, with surfaces patterned with solder dots, wires, and light-emitting diodes, generated electrically functional, three-dimensional networks. The patterns of dots and wires controlled the structure of the networks formed; both parallel and serial connections were generated.	Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA	Harvard University	Whitesides, GM (corresponding author), Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA.		Gracias, David/A-1942-2010	Gracias, David/0000-0003-2735-4725; Carmichael, Tricia/0000-0002-0847-437X				Bowden N, 1997, SCIENCE, V276, P233, DOI 10.1126/science.276.5310.233; Breen TL, 1999, SCIENCE, V284, P948, DOI 10.1126/science.284.5416.948; CAMPBELL SA, 1996, SCI ENG MICROELECTRI; Choi IS, 1999, ANGEW CHEM INT EDIT, V38, P3078, DOI 10.1002/(SICI)1521-3773(19991018)38:20<3078::AID-ANIE3078>3.0.CO;2-3; Fung C. D., 1985, MICROMACHINING MICRO; GANDHI SK, 1994, VLSI FABRICATION PRI; Harsh KF, 1999, SENSOR ACTUAT A-PHYS, V77, P237, DOI 10.1016/S0924-4247(99)00220-4; Hassoun MH., 1995, FUNDAMENTALS ARTIFIC, DOI 10.1109/JPROC.1996.503146; Heath JR, 1998, SCIENCE, V280, P1716, DOI 10.1126/science.280.5370.1716; HOPFIELD JJ, 1986, SCIENCE, V233, P625, DOI 10.1126/science.3755256; ISHIKAWA A, 2000, Patent No. 6069682; MALY W, 1987, ATLAS IC TECHNOLOGIE; MEAD C, 1990, P IEEE, V78, P1629, DOI 10.1109/5.58356; MILLER LF, 1969, IBM J RES DEV, V13, P239, DOI 10.1147/rd.133.0239; Rothemund PWK, 2000, P NATL ACAD SCI USA, V97, P984, DOI 10.1073/pnas.97.3.984; SLIWA JW, 1991, Patent No. 5075253; SYMS RRA, 1993, ELECTRON LETT, V29, P662, DOI 10.1049/el:19930444; Syms RRA, 1999, J MICROELECTROMECH S, V8, P448, DOI 10.1109/84.809060; TIEN JF, UNPUB; TOUGAW PD, 1994, J APPL PHYS, V75, P1818, DOI 10.1063/1.356375; YEH HJJ, 1994, IEEE PHOTONIC TECH L, V6, P706, DOI 10.1109/68.300169; YIN Y, IN PRESS ADV MAT; ZAVRACKY PM, 1999, Patent No. 5976953	23	413	440	4	103	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 18	2000	289	5482					1170	1172		10.1126/science.289.5482.1170	http://dx.doi.org/10.1126/science.289.5482.1170			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	346JE	10947979				2022-12-28	WOS:000088866600035
J	Cohen, JI				Cohen, JI			Epstein-Barr virus infection.	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE; HUMAN-IMMUNODEFICIENCY-VIRUS; CENTRAL-NERVOUS-SYSTEM; NON-HODGKINS-LYMPHOMA; ORGAN TRANSPLANT RECIPIENTS; ORAL HAIRY LEUKOPLAKIA; CYTOTOXIC T-CELLS; NASOPHARYNGEAL CARCINOMA; EPITHELIAL-CELLS; ACQUIRED IMMUNODEFICIENCY		NIAID, Med Virol Sect, Clin Invest Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Cohen, JI (corresponding author), NIAID, Med Virol Sect, Clin Invest Lab, NIH, Bldg 10,Rm 11N214,10 Ctr Dr, Bethesda, MD 20892 USA.	jcohen@niaid.nih.gov			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000710] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALLDAY MJ, 1988, LANCET, V1, P855; ANAGNOSTOPOULOS I, 1995, BLOOD, V85, P744, DOI 10.1182/blood.V85.3.744.bloodjournal853744; ANDIMAN WA, 1985, LANCET, V2, P1390; Antinori A, 1997, NEUROLOGY, V48, P687, DOI 10.1212/WNL.48.3.687; Babcock GJ, 1998, IMMUNITY, V9, P395, DOI 10.1016/S1074-7613(00)80622-6; Benkerrou M, 1998, BLOOD, V92, P3137, DOI 10.1182/blood.V92.9.3137.421k28_3137_3147; BIRX DL, 1986, NEW ENGL J MED, V314, P874, DOI 10.1056/NEJM198604033141403; Caldwell RG, 1998, IMMUNITY, V9, P405, DOI 10.1016/S1074-7613(00)80623-8; Callan MFC, 1998, J EXP MED, V187, P1395, DOI 10.1084/jem.187.9.1395; COHEN JI, 1991, MEDICINE, V70, P137, DOI 10.1097/00005792-199103000-00005; Cohen JI, 1999, J VIROL, V73, P7627, DOI 10.1128/JVI.73.9.7627-7632.1999; Cohen JI, 1997, JAMA-J AM MED ASSOC, V278, P510, DOI 10.1001/jama.278.6.510; Cook RC, 1999, LANCET, V354, P1698, DOI 10.1016/S0140-6736(99)02058-9; Darenkov IA, 1997, TRANSPLANTATION, V64, P848, DOI 10.1097/00007890-199709270-00010; Davis CL, 1998, TRANSPLANTATION, V66, P1770, DOI 10.1097/00007890-199812270-00035; DETHE G, 1978, NATURE, V274, P756, DOI 10.1038/274756a0; DETHE G, 1986, EPSTEINBARR VIRUS RE, P237; Emanuel DJ, 1997, TRANSPLANTATION, V63, P1691, DOI 10.1097/00007890-199706150-00027; EPSTEIN MA, 1985, NATURE, V318, P287, DOI 10.1038/318287a0; EPSTEIN MA, 1964, LANCET, V1, P702, DOI 10.1016/s0140-6736(64)91524-7; Faulkner GC, 1999, J VIROL, V73, P1555, DOI 10.1128/JVI.73.2.1555-1564.1999; FINGEROTH JD, 1984, P NATL ACAD SCI-BIOL, V81, P4510, DOI 10.1073/pnas.81.14.4510; Glaser SL, 1997, INT J CANCER, V70, P375, DOI 10.1002/(SICI)1097-0215(19970207)70:4&lt;375::AID-IJC1&gt;3.0.CO;2-T; GRATAMA JW, 1988, P NATL ACAD SCI USA, V85, P8693, DOI 10.1073/pnas.85.22.8693; Green M, 1997, CLIN INFECT DIS, V25, P1344, DOI 10.1086/516139; GREENSPAN JS, 1985, NEW ENGL J MED, V313, P1564, DOI 10.1056/NEJM198512193132502; GRIERSON H, 1987, ANN INTERN MED, V106, P538, DOI 10.7326/0003-4819-106-4-538; GU SY, 1995, DEV BIOL STAND, V84, P171; Hale G, 1998, BLOOD, V91, P3079, DOI 10.1182/blood.V91.8.3079.3079_3079_3083; HALPRIN J, 1986, ANN INTERN MED, V104, P331, DOI 10.7326/0003-4819-104-3-331; HAMILTONDUTOIT SJ, 1991, AM J PATHOL, V138, P149; HENDERSON S, 1993, P NATL ACAD SCI USA, V90, P8479, DOI 10.1073/pnas.90.18.8479; HENKE CE, 1973, AM J EPIDEMIOL, V98, P483, DOI 10.1093/oxfordjournals.aje.a121577; HENLE G, 1968, P NATL ACAD SCI USA, V59, P94, DOI 10.1073/pnas.59.1.94; HOCHBERG FH, 1983, NEW ENGL J MED, V309, P745, DOI 10.1056/NEJM198309293091301; HSU DH, 1990, SCIENCE, V250, P830, DOI 10.1126/science.2173142; IMAI S, 1994, P NATL ACAD SCI USA, V91, P9131, DOI 10.1073/pnas.91.19.9131; INGHIRAMI G, 1990, SCIENCE, V250, P682, DOI 10.1126/science.2237417; Jackman WT, 1999, VACCINE, V17, P660, DOI 10.1016/S0264-410X(98)00248-5; Jenson H, 1999, J INFECT DIS, V179, P1395, DOI 10.1086/314764; JOHANNSEN E, 1995, J VIROL, V69, P253, DOI 10.1128/JVI.69.1.253-262.1995; JONES JF, 1988, NEW ENGL J MED, V318, P733, DOI 10.1056/NEJM198803243181203; KERR BM, 1992, VIROLOGY, V187, P189, DOI 10.1016/0042-6822(92)90307-B; Kersten MJ, 1997, J CLIN INVEST, V99, P1525, DOI 10.1172/JCI119315; Khanna R, 1999, IMMUNOL REV, V170, P49, DOI 10.1111/j.1600-065X.1999.tb01328.x; Khanna R, 1999, P NATL ACAD SCI USA, V96, P10391, DOI 10.1073/pnas.96.18.10391; Kieff E., 1996, FIELDS VIROLOGY, V2, P2343; Komano J, 1999, J VIROL, V73, P9827, DOI 10.1128/JVI.73.12.9827-9831.1999; Kulwichit W, 1998, P NATL ACAD SCI USA, V95, P11963, DOI 10.1073/pnas.95.20.11963; LEE ES, 1995, NEW ENGL J MED, V332, P19, DOI 10.1056/NEJM199501053320104; Levitskaya J, 1997, P NATL ACAD SCI USA, V94, P12616, DOI 10.1073/pnas.94.23.12616; Li QX, 1997, J VIROL, V71, P4657, DOI 10.1128/JVI.71.6.4657-4662.1997; Liebowitz D, 1998, NEW ENGL J MED, V338, P1413, DOI 10.1056/NEJM199805143382003; MACMAHON EME, 1991, LANCET, V338, P969, DOI 10.1016/0140-6736(91)91837-K; MCCLAIN KL, 1995, NEW ENGL J MED, V332, P12, DOI 10.1056/NEJM199501053320103; McDiarmid SV, 1998, TRANSPLANTATION, V66, P1604, DOI 10.1097/00007890-199812270-00006; McDiarmid SV, 1999, TRANSPLANTATION, V68, P909; MILLER CL, 1995, IMMUNITY, V2, P155, DOI 10.1016/S1074-7613(95)80040-9; MILPIED N, 1999, ANN ONCOL, V10, P5; Moghaddam A, 1997, SCIENCE, V276, P2030, DOI 10.1126/science.276.5321.2030; MOORE KW, 1990, SCIENCE, V250, P494, DOI 10.1126/science.250.4980.494-a; MOSIALOS G, 1995, CELL, V80, P389, DOI 10.1016/0092-8674(95)90489-1; MUELLER N, 1989, NEW ENGL J MED, V320, P689, DOI 10.1056/NEJM198903163201103; Nalesnik MA, 1997, TRANSPLANTATION, V63, P1200, DOI 10.1097/00007890-199705150-00002; Niedobitek G, 1997, J PATHOL, V182, P151, DOI 10.1002/(SICI)1096-9896(199706)182:2<151::AID-PATH824>3.0.CO;2-3; OReilly RJ, 1997, IMMUNOL REV, V157, P195, DOI 10.1111/j.1600-065X.1997.tb00983.x; PALLESEN G, 1993, ADV CANCER RES, V62, P179, DOI 10.1016/S0065-230X(08)60319-X; PATHMANATHAN R, 1995, NEW ENGL J MED, V333, P693, DOI 10.1056/NEJM199509143331103; Paya CV, 1999, TRANSPLANTATION, V68, P1517, DOI 10.1097/00007890-199911270-00015; Pedneault L, 1998, J INFECT DIS, V177, P1087, DOI 10.1086/517401; RANDHAWA PS, 1992, NEW ENGL J MED, V327, P1710, DOI 10.1056/NEJM199212103272403; RESNICK L, 1988, JAMA-J AM MED ASSOC, V259, P384, DOI 10.1001/jama.259.3.384; Rickinson AB, 1997, ANNU REV IMMUNOL, V15, P405, DOI 10.1146/annurev.immunol.15.1.405; RIDDLER SA, 1994, BLOOD, V84, P972; Rooney C M, 1998, J Natl Cancer Inst Monogr, P89; Rooney CM, 1998, BLOOD, V92, P1549, DOI 10.1182/blood.V92.5.1549.417k32_1549_1555; Roskrow MA, 1998, BLOOD, V91, P2925, DOI 10.1182/blood.V91.8.2925.2925_2925_2934; Sayos J, 1998, NATURE, V395, P462, DOI 10.1038/26683; SHIBATA D, 1991, BLOOD, V77, P1527; SHIBATA D, 1993, BLOOD, V81, P2102; SIXBEY JW, 1983, NATURE, V306, P480, DOI 10.1038/306480a0; SIXBEY JW, 1984, NEW ENGL J MED, V310, P1225, DOI 10.1056/NEJM198405103101905; STARZL TE, 1984, LANCET, V1, P583; STRAUS SE, 1988, J INFECT DIS, V157, P405, DOI 10.1093/infdis/157.3.405; STRAUS SE, 1993, ANN INTERN MED, V118, P45, DOI 10.7326/0003-4819-118-1-199301010-00009; SWINNEN LJ, 1995, BLOOD, V86, P3333, DOI 10.1182/blood.V86.9.3333.bloodjournal8693333; Tan LC, 1999, J IMMUNOL, V162, P1827; Tangye SG, 1999, J IMMUNOL, V162, P6981; TIERNEY RJ, 1994, J VIROL, V68, P7374, DOI 10.1128/JVI.68.11.7374-7385.1994; TOSATO G, 1993, J CLIN INVEST, V91, P2806, DOI 10.1172/JCI116523; Triantos D, 1997, CLIN INFECT DIS, V25, P1392, DOI 10.1086/516131; Tynell E, 1996, J INFECT DIS, V174, P324, DOI 10.1093/infdis/174.2.324; Uchida J, 1999, SCIENCE, V286, P300, DOI 10.1126/science.286.5438.300; VANDERHORST C, 1991, J INFECT DIS, V164, P788, DOI 10.1093/infdis/164.4.788; WANG D, 1985, CELL, V43, P831, DOI 10.1016/0092-8674(85)90256-9; WANG F, 1990, J VIROL, V64, P2309, DOI 10.1128/JVI.64.5.2309-2318.1990; WEISS LM, 1989, NEW ENGL J MED, V320, P502, DOI 10.1056/NEJM198902233200806; YAO QY, 1989, INT J CANCER, V43, P67, DOI 10.1002/ijc.2910430115; YAO QY, 1985, INT J CANCER, V35, P35, DOI 10.1002/ijc.2910350107; YATES J, 1984, P NATL ACAD SCI-BIOL, V81, P3806, DOI 10.1073/pnas.81.12.3806; ZENG Y, 1982, INT J CANCER, V29, P139, DOI 10.1002/ijc.2910290204; ZIEGLER JL, 1982, LANCET, V2, P631; ZURHAUSE.H, 1970, NATURE, V228, P1056, DOI 10.1038/2281056a0	103	1094	1160	6	111	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 17	2000	343	7					481	492		10.1056/NEJM200008173430707	http://dx.doi.org/10.1056/NEJM200008173430707			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	344FC	10944566				2022-12-28	WOS:000088747700007
J	Hosli, P; Schapira, M				Hosli, P; Schapira, M			Spontaneous duodenal hematoma during oral anticoagulation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									CHU Vaudois, CH-1011 Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Hosli, P (corresponding author), CHU Vaudois, CH-1011 Lausanne, Switzerland.								0	3	3	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 17	2000	343	7					474	474		10.1056/NEJM200008173430705	http://dx.doi.org/10.1056/NEJM200008173430705			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	344FC	10944564	Green Published			2022-12-28	WOS:000088747700005
J	Mandel, J; Mark, EJ; McLoud, TC; Hales, CA				Mandel, J; Mark, EJ; McLoud, TC; Hales, CA			A 69-year-old woman with pleuritic pain and pulmonary arterial obstruction - Sarcoma of the intima of the pulmonary artery.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CHRONIC THROMBOEMBOLIC DISEASE; GIANT-CELL ARTERITIS; TAKAYASU-ARTERITIS; HYPERTENSION; INVOLVEMENT; DIAGNOSIS; EMBOLISM; CT		Beth Israel Deaconess Med Ctr, Pulm Hypertens Unit, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Mandel, J (corresponding author), Beth Israel Deaconess Med Ctr, Pulm Hypertens Unit, Boston, MA 02215 USA.							ANDERSON MB, 1995, ANN THORAC SURG, V59, P1487, DOI 10.1016/0003-4975(95)00149-F; AUGER WR, 1995, AM J MED, V99, P392, DOI 10.1016/S0002-9343(99)80187-9; AUGER WR, 1992, RADIOLOGY, V182, P393, DOI 10.1148/radiology.182.2.1732955; BAKER PB, 1985, ARCH PATHOL LAB MED, V109, P35; Bassiri AG, 1997, AM J RESP CRIT CARE, V155, P2089, DOI 10.1164/ajrccm.155.6.9196119; Bergin CJ, 1997, RADIOLOGY, V204, P695, DOI 10.1148/radiology.204.3.9280245; Brooks RC, 1997, ARCH INTERN MED, V157, P162, DOI 10.1001/archinte.157.2.162; BURKE AP, 1993, CANCER, V71, P1761, DOI 10.1002/1097-0142(19930301)71:5<1761::AID-CNCR2820710510>3.0.CO;2-7; DAIL DH, 1994, PULMONARY PATHOLOGY, P1387; DAUERMAN HL, 1999, UPTODATE CARDIOLOGY; DAVEY RJ, 1978, TRANSFUSION, V18, P738, DOI 10.1046/j.1537-2995.1978.18679077959.x; FITZMAURICE RJ, 1990, HISTOPATHOLOGY, V17, P457, DOI 10.1111/j.1365-2559.1990.tb00768.x; FRASER RS, 1999, FRASER PARES DIAGNOS, V2, P1332; HIROSHIMA K, 1992, ACTA PATHOL JAPON, V42, P755; Iwamoto M, 1999, ARTHRITIS RHEUM, V42, P1549; JOHANSSON L, 1994, VIRCHOWS ARCH, V424, P217; KAUCZOR HU, 1994, CARDIOVASC INTER RAD, V17, P185, DOI 10.1007/BF00571532; KELLY RJ, 1994, P NATL ACAD SCI USA, V91, P5843, DOI 10.1073/pnas.91.13.5843; KERR KM, 1995, AM J RESP CRIT CARE, V152, P367, DOI 10.1164/ajrccm.152.1.7599847; King MA, 1998, AM J ROENTGENOL, V170, P955, DOI 10.2214/ajr.170.4.9530043; LADANYI M, 1987, ARCH PATHOL LAB MED, V111, P1178; MCGLENNEN RC, 1989, MODERN PATHOL, V2, P486; MCINTYRE KM, 1974, CHEST, V65, P534, DOI 10.1378/chest.65.5.534; MCINTYRE KM, 1971, AM J CARDIOL, V28, P288, DOI 10.1016/0002-9149(71)90116-0; MOSER KM, 1993, CHEST, V103, P685, DOI 10.1378/chest.103.3.685; MOSER KM, 1992, EUR RESPIR J, V5, P334; NASU T, 1975, PATHOL MICROBIOL, V43, P140, DOI 10.1159/000162809; *PROSP INV PULM EM, 1990, JAMA-J AM MED ASSOC, V623, P2753; REDMOND ML, 1990, CHEST, V98, P752, DOI 10.1378/chest.98.3.752; Sakane T, 1999, NEW ENGL J MED, V341, P1284, DOI 10.1056/NEJM199910213411707; SHARMA S, 1990, CLIN RADIOL, V42, P177, DOI 10.1016/S0009-9260(05)81929-4; SHURE D, 1985, ANN INTERN MED, V103, P844, DOI 10.7326/0003-4819-103-6-844; WAGENAAR SSC, 1981, THORAX, V36, P876, DOI 10.1136/thx.36.11.876; WEINREB JC, 1990, J COMPUT ASSIST TOMO, V14, P647, DOI 10.1097/00004728-199007000-00025; YAMADA I, 1993, RADIOLOGY, V188, P89, DOI 10.1148/radiology.188.1.8099751; Yamada N, 1998, CHEST, V113, P555, DOI 10.1378/chest.113.2.555; YAMATO M, 1986, RADIOLOGY, V161, P329, DOI 10.1148/radiology.161.2.2876459	37	5	6	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 17	2000	343	7					493	500		10.1056/NEJM200008173430708	http://dx.doi.org/10.1056/NEJM200008173430708			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	344FC	10944567				2022-12-28	WOS:000088747700008
J	Werlen, G; Hausmann, B; Palmer, E				Werlen, G; Hausmann, B; Palmer, E			A motif in the alpha beta T-cell receptor controls positive selection by modulating ERK activity	NATURE			English	Article							MAP KINASE ACTIVATION; NEGATIVE SELECTION; DIFFERENTIATION; LYMPHOCYTES; THYMOCYTES; APOPTOSIS; PATHWAYS; SIGNAL; MICE; JNK2	Positive selection allows thymocytes that recognize an individual's own major histocompatibility complex (self-MHC) molecules to survive and differentiate, whereas negative selection removes overtly self-reactive thymocytes(1). Although both forms of thymic selection are mediated by the alpha beta T-cell receptor (TCR) and require self-MHC recognition, an important question is whether they are controlled by distinct signalling cascades(2). We have shown that mutation of an essential motif within the TCR alpha-chain-connecting peptide domain (alpha-CPM) profoundly affects positive but not negative selection(3). Using transgenic mice expressing a mutant alpha-CPM TCR we examined the contribution of several mitogen-activated protein kinase (MAPK) cascades to thymic selection. Here we show that in thymocytes expressing a mutant alpha-CPM receptor, a positively selecting peptide failed to activate the extracellular signal-regulated kinase (ERK), although other MAPK cascades were induced normally. The defect in ERK activation was associated with impaired recruitment of the activated tyrosine kinases Lck and ZAP-70, phosphorylated forms of the TCR component CD3 zeta and the adaptor protein LAT to detergent-insoluble glycolipid-enriched microdomains (DIGs). Therefore, an intact DIG-associated signalosome is essential for sustained ERK activation, which leads to positive selection.	Basel Inst Immunol, CH-4005 Basel, Switzerland		Werlen, G (corresponding author), Basel Inst Immunol, Grenzacherstr 487, CH-4005 Basel, Switzerland.							AlberolaIla J, 1996, J EXP MED, V184, P9, DOI 10.1084/jem.184.1.9; ALBEROLAILA J, 1995, NATURE, V373, P620, DOI 10.1038/373620a0; ALEXANDER J, 1989, IMMUNOGENETICS, V29, P380, DOI 10.1007/BF00375866; Backstrom BT, 1998, SCIENCE, V281, P835, DOI 10.1126/science.281.5378.835; Backstrom BT, 1996, IMMUNITY, V5, P437, DOI 10.1016/S1074-7613(00)80500-2; Dave VP, 1997, EMBO J, V16, P1360, DOI 10.1093/emboj/16.6.1360; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; Dong C, 2000, NATURE, V405, P91, DOI 10.1038/35011091; Finco TS, 1998, IMMUNITY, V9, P617, DOI 10.1016/S1074-7613(00)80659-7; HOGQUIST KA, 1995, IMMUNITY, V3, P79, DOI 10.1016/1074-7613(95)90160-4; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Jacinto E, 1998, IMMUNITY, V8, P31, DOI 10.1016/S1074-7613(00)80456-2; Mariathasan S, 1999, SEMIN IMMUNOL, V11, P263, DOI 10.1006/smim.1999.0182; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Montixi C, 1998, EMBO J, V17, P5334, DOI 10.1093/emboj/17.18.5334; OShea CC, 1996, EUR J IMMUNOL, V26, P2350, DOI 10.1002/eji.1830261012; Pages G, 1999, SCIENCE, V286, P1374, DOI 10.1126/science.286.5443.1374; Sabapathy K, 1999, CURR BIOL, V9, P116, DOI 10.1016/S0960-9822(99)80065-7; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Stotz SH, 1999, J EXP MED, V189, P253, DOI 10.1084/jem.189.2.253; Sugawara T, 1998, IMMUNITY, V9, P565, DOI 10.1016/S1074-7613(00)80639-1; SWAN KA, 1995, EMBO J, V14, P276, DOI 10.1002/j.1460-2075.1995.tb07001.x; SWAT W, 1991, NATURE, V351, P150, DOI 10.1038/351150a0; VONBOEHMER H, 1989, IMMUNOL TODAY, V10, P57, DOI 10.1016/0167-5699(89)90307-1; Werlen G, 1998, EMBO J, V17, P3101, DOI 10.1093/emboj/17.11.3101; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yang DD, 1998, IMMUNITY, V9, P575, DOI 10.1016/S1074-7613(00)80640-8; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8; ZIJLSTRA M, 1990, NATURE, V344, P742, DOI 10.1038/344742a0	30	161	164	0	6	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 27	2000	406	6794					422	426		10.1038/35019094	http://dx.doi.org/10.1038/35019094			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	337WC	10935640				2022-12-28	WOS:000088383800050
J	Coates, TJ; Grinstead, OA; Gregorich, SE; Heilbron, DC; Wolf, WP; Choi, KH; Schachter, J; Scheirer, P; van der Straten, A; Kamenga, MC; Sweat, MD; De Zoysa, I; Dallabetta, G; O'Reilly, KR; van Praag, E; Miller, D; Ruiz, M; Kalibala, S; Nkowane, B; Balmer, D; Kihuho, F; Moses, S; Plummer, F; Sangiwa, G; Hogan, M; Killewo, J; Mwakigile, D; Furlonge, C				Coates, TJ; Grinstead, OA; Gregorich, SE; Heilbron, DC; Wolf, WP; Choi, KH; Schachter, J; Scheirer, P; van der Straten, A; Kamenga, MC; Sweat, MD; De Zoysa, I; Dallabetta, G; O'Reilly, KR; van Praag, E; Miller, D; Ruiz, M; Kalibala, S; Nkowane, B; Balmer, D; Kihuho, F; Moses, S; Plummer, F; Sangiwa, G; Hogan, M; Killewo, J; Mwakigile, D; Furlonge, C		Voluntary HIV1 Counseling Testing	Efficacy of voluntary HIV-1 counselling and testing in individuals and couples in Kenya, Tanzania, and Trinidad: a randomised trial	LANCET			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; LIGASE CHAIN-REACTION; SEXUAL-BEHAVIOR; RISK-REDUCTION; SEROCONVERSION; GENDER	Background Our aim was to determine the efficacy of HIV-1 voluntary counselling and testing (VCT) in reducing unprotected intercourse among individuals and sex-partner couples in Nairobi (Kenya), Dar es Salaam (Tanzania), and Port of Spain (Trinidad). Methods Individual or couple participants were randomly assigned HIV-1 VCT or basic health information. At first follow-up (mean 7.3 months after baseline) health-information participants were offered VCT and all VCT participants were offered retesting. Sexually transmitted infections were diagnosed and treated at first follow-up. The second follow-up (mean 139 months after baseline) involved only behavioural assessment, and all participants were again offered VCT. Findings 3120 individuals and 586 couples were enrolled. The proportion of individuals reporting unprotected intercourse with non-primary partners declined significantly more for those receiving VCT than those receiving health information (men, 35% reduction with VCT vs 13% reduction with health information; women, 39% reduction with VCT vs 17% reduction with health information), and these results were maintained at the second follow-up. Individual HIV-1-infected men were more likely than uninfected men to reduce unprotected intercourse with primary and non-primary partners, whereas HIV-1-infected women were more likely than uninfected women to reduce unprotected intercourse with primary partners. Couples assigned VCT reduced unprotected intercourse with their enrolment partners significantly more than couples assigned health information, but no differences were found in unprotected intercourse with non-enrolment partners. Couples in which one or both members were diagnosed with HIV-1 were more likely to reduce unprotected intercourse with each other than couples in which both members were uninfected. These changes were replicated by those in the health-information group diagnosed with HIV-1 at first follow-up. Interpretation These data support the efficacy of HIV-1 VCT in promoting behaviour change.	Univ Calif San Francisco, Ctr AIDS Prevent Studies, AIDS Res Inst, San Francisco, CA 94105 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94105 USA; Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94105 USA; Family Hlth Int, AIDSCAP, Arlington, VA USA; WHO, Global Programme AIDS, CH-1211 Geneva, Switzerland; UNAIDS, CH-1211 Geneva, Switzerland; Kenya Assoc Profess Counselors, Nairobi, Kenya; Univ Calgary, Calgary, AB, Canada; Univ Dar Es Salaam, Muhimbili Med Coll, Dar Es Salaam, Tanzania; Queens Pk Counseling Ctr, Port Of Spain, Trinidad Tobago	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; World Health Organization; UNAIDS; University of Calgary; University of Dar es Salaam	Coates, TJ (corresponding author), Univ Calif San Francisco, Ctr AIDS Prevent Studies, AIDS Res Inst, 74 New Montgomery 600, San Francisco, CA 94105 USA.	tcoates@psg.ucsf.edu		van der Straten, Ariane/0000-0001-8536-648X	NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH042459] Funding Source: NIH RePORTER; NIMH NIH HHS [MH42459] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ALLEN S, 1992, BRIT MED J, V304, P1605, DOI 10.1136/bmj.304.6842.1605; BEARDSELL S, 1994, AIDS CARE, V6, P5, DOI 10.1080/09540129408258020; BIRKENMEYER L, 1992, J CLIN MICROBIOL, V30, P3089, DOI 10.1128/JCM.30.12.3089-3094.1992; CATANIA JA, 1990, PSYCHOL BULL, V108, P339, DOI 10.1037/0033-2909.108.3.339; Catania JA, 1996, PUBLIC OPIN QUART, V60, P345, DOI 10.1086/297758; *CDC, 1993, HIV PREV COUNS TRAIN; Celentano DD, 1998, SCIENCE, V280, P1889, DOI 10.1126/science.280.5371.1889; De Zoysa I, 1995, AIDS, V9 Suppl A, pS95; Diggle PJ, 1994, ANAL LONGITUDINAL DA; DILLE BJ, 1993, J CLIN MICROBIOL, V31, P729, DOI 10.1128/JCM.31.3.729-731.1993; FURLONGE C, 2000, AIDS BEHAV, V4, P49; GRINSTEAD O, IN PRESS AIDS CARE; GRINSTEAD O, 1998, 12 WORLD AIDS C GEN; HIGGINS DL, 1991, JAMA-J AM MED ASSOC, V266, P2419, DOI 10.1001/jama.266.17.2419; HOLTGRAVE DR, 1993, ARCH INTERN MED, V153, P1225, DOI 10.1001/archinte.153.10.1225; Kamb ML, 1998, JAMA-J AM MED ASSOC, V280, P1161, DOI 10.1001/jama.280.13.1161; KAMENGA M, 1991, AIDS, V5, P61, DOI 10.1097/00002030-199101000-00009; KARIM QA, 1995, AM J PUBLIC HEALTH, V85, P1521, DOI 10.2105/AJPH.85.11.1521; KEOGH P, 1994, SOC SCI MED, V38, P1047, DOI 10.1016/0277-9536(94)90221-6; KILLEWO J, 1998, 12 WORLD AIDS C GEN; PHILLIPS KA, 1995, AIDS CARE, V7, P115, DOI 10.1080/09540129550126623; QUINN TC, 2000, 7 C RETR OPP INF SAN; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; Shain RN, 1999, NEW ENGL J MED, V340, P93, DOI 10.1056/NEJM199901143400203; Sweat M, 2000, LANCET, V356, P113, DOI 10.1016/S0140-6736(00)02447-8; SWEAT M, 1998, 12 WORLD AIDS C GEN; The Voluntary HIV-1 Counseling and Testing Efficacy Study Group, 2000, AIDS BEHAV, V4, P5; VANDERSTRATEN A, 1995, AIDS, V9, P935, DOI 10.1097/00002030-199508000-00016; Weinhardt LS, 1999, AM J PUBLIC HEALTH, V89, P1397, DOI 10.2105/AJPH.89.9.1397; Wolitski RJ, 1997, AIDS EDUC PREV, V9, P52; [No title captured]	31	463	469	0	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 8	2000	356	9224					103	112						10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	331UG	10963246				2022-12-28	WOS:000088036600010
J	Cruess, RL; Cruess, SR; Johnston, SE				Cruess, RL; Cruess, SR; Johnston, SE			Professionalism: an ideas to be sustained	LANCET			English	Editorial Material							MEDICAL PROFESSIONALISM		McGill Univ, Ctr Med Educ, Montreal, PQ H3A 1A3, Canada	McGill University	Cruess, RL (corresponding author), McGill Univ, Ctr Med Educ, 1110 Pine Ave W, Montreal, PQ H3A 1A3, Canada.							[Anonymous], 1989, OXFORD ENGLISH DICT; BRAODBENT J, 1997, END PROFESSIONS RECO, P34; Carr-Saunders A.M., 1933, PROFESSIONS; Cruess RL, 1997, ACAD MED, V72, P941, DOI 10.1097/00001888-199711000-00009; Cruess RL, 1999, ACAD MED, V74, P878, DOI 10.1097/00001888-199908000-00010; DUNNING AJ, 1999, LANCET S4, V354; EMMANUEL EJ, 1996, ANN INTERN MED, V124, P229; Flexner A, 1915, SCHOOL SOC, V1, P901; Freidson E., 1994, PROFESSIONALISM REBO; Goode William J., 1969, SEMIPROFESSIONS THEI, P266; Haug Marie R., 1972, SOCIOL REV MONOGR, V20, P195, DOI 10.1111/j.1467-954X.1972.tb03217.x; Ihara CK, 1988, PROFESSIONAL IDEALS, P56; Irvine D, 1999, LANCET, V353, P1174, DOI 10.1016/S0140-6736(99)91160-1; Johnson Terrence, 1972, PROFESSIONS POWER; Kassirer JP, 1998, NEW ENGL J MED, V339, P1543, DOI 10.1056/NEJM199811193392109; Krause Elliott, 1996, DEATH GUILDS PROFESS; Kultgen John H., 1988, ETHICS PROFESSIONALI; Larson, 1979, RISE PROFESSIONALISM, V233; MCKINLAY JB, 1982, PROFESSIONALS WORKER, P37; Mechanic D, 1996, MILBANK Q, V74, P171, DOI 10.2307/3350245; Moran M., 1993, STATES REGULATION ME; Parsons T, 1939, SOC FORCES, V17, P457, DOI 10.2307/2570695; PELLEGRINO E, 1999, JAMA-J AM MED ASSOC, V282, P954; Perkin H., 1996, 3 REVOLUTION PROFESS; Smith R, 1999, ANN INTERN MED, V130, P143, DOI 10.7326/0003-4819-130-2-199901190-00009; Sohl P, 1980, SOC SCI MED, V22, P1175; STACEY M, 1997, FED B, V84, P17; Starr Paul., 1984, SOCIAL TRANSFORMATIO; Sullivan W., 1995, WORK INTEGRITY CRISI; Tanenbaum SJ, 1999, ACAD MED, V74, P757, DOI 10.1097/00001888-199907000-00008; WEBB S, 1917, NEW STATESMAN SOC, V9, P7; Wynia MK, 1999, NEW ENGL J MED, V341, P1612, DOI 10.1056/NEJM199911183412112; [No title captured]	33	96	99	0	9	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 8	2000	356	9224					156	159		10.1016/S0140-6736(00)02458-2	http://dx.doi.org/10.1016/S0140-6736(00)02458-2			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	331UG	10963262				2022-12-28	WOS:000088036600038
J	Robinson, RG				Robinson, RG			Treatment of poststroke depression - Reply	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									Univ Iowa Hlth Care, Iowa City, IA USA	University of Iowa	Robinson, RG (corresponding author), Univ Iowa Hlth Care, Iowa City, IA USA.		Robinson, Robert/AAF-6191-2021						0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 23	2000	284	8					959	959						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	344PX	10944636				2022-12-28	WOS:000088769000033
J	Johansson, J; Balsalobre, C; Wang, SY; Urbonaviciene, J; Jin, DJ; Sonden, B; Uhlin, BE				Johansson, J; Balsalobre, C; Wang, SY; Urbonaviciene, J; Jin, DJ; Sonden, B; Uhlin, BE			Nucleoid proteins stimulate stringently controlled bacterial promoters: A link between the cAMP-CRP and the (p)ppGpp regulons in Escherichia coli	CELL			English	Article							HISTONE-LIKE PROTEINS; GUANOSINE 5'-DIPHOSPHATE 3'-DIPHOSPHATE; H-NS; STATIONARY PHASE; GENE-EXPRESSION; PPGPP SYNTHESIS; RNA-POLYMERASE; DNA TOPOLOGY; INVITRO; COMPLEXES	We report that the H-NS nucleoid protein plays a positive role in the expression of stringently regulated genes in Escherichia coli. Bacteria lacking both H-NS and the paralog StpA show reduced growth rate. Colonies displaying an increased growth rate were isolated, and mapping of a suppressor mutation revealed a base pair substitution in the spoT gene. The spoT(A404E) mutant showed low ppGpp synthesizing ability. The crp gene, which encodes the global regulator CRP, was subject to negative stringent regulation. The stable RNA/protein ratio in an hns, stpA strain was decreased, whereas it was restored in the suppressor strain. Our findings provide evidence of a direct link between the cAMP-CRP modulon and the stringent response.	Umea Univ, Dept Microbiol, S-90187 Umea, Sweden; NCI, NIH, Mol Biol Lab, Bethesda, MD 20892 USA	Umea University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Uhlin, BE (corresponding author), Umea Univ, Dept Microbiol, S-90187 Umea, Sweden.	bernt.eric.uhlin@micro.umu.se	Uhlin, Bernt Eric/AAO-6292-2021; Balsalobre, Carlos/E-4213-2016	Uhlin, Bernt Eric/0000-0002-2991-8072; Balsalobre, Carlos/0000-0002-4147-219X; Johansson, Jorgen/0000-0002-0904-497X				AIBA H, 1982, NUCLEIC ACIDS RES, V10, P1345, DOI 10.1093/nar/10.4.1345; ARNQVIST A, 1992, MOL MICROBIOL, V6, P2443; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; BOLIVAR F, 1977, GENE, V2, P95, DOI 10.1016/0378-1119(77)90000-2; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; CASHEL M, 1969, J BIOL CHEM, V244, P3133; Cashel M., 1996, ESCHERICHIA COLI SAL, P1458; DRLICA K, 1987, MICROBIOL REV, V51, P301, DOI 10.1128/MMBR.51.3.301-319.1987; FALCONI M, 1993, MOL MICROBIOL, V10, P273, DOI 10.1111/j.1365-2958.1993.tb01953.x; Figueroa-Bossi N, 1998, EMBO J, V17, P2359, DOI 10.1093/emboj/17.8.2359; Gentry DR, 1996, MOL MICROBIOL, V19, P1373, DOI 10.1111/j.1365-2958.1996.tb02480.x; Gonzalez-Gil G, 1998, EMBO J, V17, P2877, DOI 10.1093/emboj/17.10.2877; GORANSSON M, 1989, MOL MICROBIOL, V3, P1557, DOI 10.1111/j.1365-2958.1989.tb00141.x; GORANSSON M, 1990, NATURE, V344, P682, DOI 10.1038/344682a0; GUYER MS, 1980, COLD SPRING HARB SYM, V45, P135, DOI 10.1101/SQB.1981.045.01.022; HAGER DA, 1990, BIOCHEMISTRY-US, V29, P7890, DOI 10.1021/bi00486a016; HEINEMEYER EA, 1978, P NATL ACAD SCI USA, V75, P4180, DOI 10.1073/pnas.75.9.4180; Johansson J, 1998, J BACTERIOL, V180, P6117; Keener J, 1996, ESCHERICHIA COLI SAL, V2, P1417; KLECKNER N, 1991, METHOD ENZYMOL, V204, P139; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Kvint K, 2000, MOL MICROBIOL, V35, P435, DOI 10.1046/j.1365-2958.2000.01714.x; LAGOSKY PA, 1980, J BACTERIOL, V144, P499, DOI 10.1128/JB.144.2.499-508.1980; LAZZARINI RA, 1971, J BIOL CHEM, V246, P4381; LINN T, 1992, J BIOL CHEM, V267, P1449; METZGER S, 1989, J BIOL CHEM, V264, P21146; Murray KD, 1996, J MOL BIOL, V259, P41; NEIDHARDT FC, 1977, J BACTERIOL, V129, P378, DOI 10.1128/JB.129.1.378-387.1977; NINNEMANN O, 1992, EMBO J, V11, P1075, DOI 10.1002/j.1460-2075.1992.tb05146.x; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; OHLSEN KL, 1992, J BIOL CHEM, V267, P19813; OHLSEN KL, 1992, MOL MICROBIOL, V6, P2243, DOI 10.1111/j.1365-2958.1992.tb01400.x; OWENHUGHES TA, 1992, CELL, V71, P255, DOI 10.1016/0092-8674(92)90354-F; Pettijohn D.E., 1996, ESCHERICHIA COLI SAL, P158; Raghavan A, 1998, BIOPHYS CHEM, V75, P7, DOI 10.1016/S0301-4622(98)00185-9; ROSS W, 1990, EMBO J, V9, P3733, DOI 10.1002/j.1460-2075.1990.tb07586.x; ROSS W, 1989, J BACTERIOL, V171, P4009, DOI 10.1128/jb.171.7.4009-4018.1989; SCHMID MB, 1990, CELL, V63, P451, DOI 10.1016/0092-8674(90)90438-K; SCHNEIDER WC, 1945, J BIOL CHEM, V161, P293; Sonden B, 1996, EMBO J, V15, P4970, DOI 10.1002/j.1460-2075.1996.tb00877.x; SPASSKY A, 1984, NUCLEIC ACIDS RES, V12, P5321, DOI 10.1093/nar/12.13.5321; Tao H, 1999, J BACTERIOL, V181, P6425, DOI 10.1128/JB.181.20.6425-6440.1999; TUPPER AE, 1994, EMBO J, V13, P258, DOI 10.1002/j.1460-2075.1994.tb06256.x; VANBOGELEN RA, 1992, ELECTROPHORESIS, V13, P1014, DOI 10.1002/elps.11501301203; VONGABAIN A, 1983, P NATL ACAD SCI-BIOL, V80, P653; Williams RM, 1997, FEMS MICROBIOL LETT, V156, P175, DOI 10.1016/S0378-1097(97)00397-2; XIAO H, 1991, J BIOL CHEM, V266, P5980; YAMASHINO T, 1995, EMBO J, V14, P594, DOI 10.1002/j.1460-2075.1995.tb07035.x; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; ZHANG AX, 1992, NUCLEIC ACIDS RES, V20, P6735, DOI 10.1093/nar/20.24.6735; Zhang AX, 1996, EMBO J, V15, P1340, DOI 10.1002/j.1460-2075.1996.tb00476.x; Zhou YN, 1998, P NATL ACAD SCI USA, V95, P2908, DOI 10.1073/pnas.95.6.2908	53	75	76	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 18	2000	102	4					475	485		10.1016/S0092-8674(00)00052-0	http://dx.doi.org/10.1016/S0092-8674(00)00052-0			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	347BX	10966109	Bronze			2022-12-28	WOS:000088908000009
J	Abbott, A; Gitschel, U				Abbott, A; Gitschel, U			German scientists left in the cold as Berlin rejects rescue plan	NATURE			English	News Item																		Abbott A, 1996, NATURE, V380, P278, DOI 10.1038/380278a0; 1995, NATURE, V378, P656	2	1	1	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 17	2000	406	6797					663	664		10.1038/35021257	http://dx.doi.org/10.1038/35021257			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	344PH	10963560	Bronze			2022-12-28	WOS:000088767700003
J	Pearson, PN; Palmer, MR				Pearson, PN; Palmer, MR			Atmospheric carbon dioxide concentrations over the past 60 million years	NATURE			English	Article							BORON ISOTOPIC COMPOSITION; EQUATORIAL PACIFIC; OCEAN PH; EOCENE; CO2; FORAMINIFERA; CLIMATE; PHOTOSYNTHESIS; DISSOCIATION; TEMPERATURES	Knowledge of the evolution of atmospheric carbon dioxide concentrations throughout the Earth's history is important for a reconstruction of the links between climate and radiative forcing of the Earth's surface temperatures. Although atmospheric carbon dioxide concentrations in the early Cenozoic era (about 60 Myr ago) are widely believed to have been higher than at present, there is disagreement regarding the exact carbon dioxide levels, the timing of the decline and the mechanisms that are most important for the control of CO2 concentrations over geological timescales. Here we use the boron-isotope ratios of ancient planktonic foraminifer shells to estimate the pH of surface-layer sea water throughout the past 60 million years, which can be used to reconstruct atmospheric CO2 concentrations. We estimate CO2 concentrations of more than 2,000 p.p.m. for the late Palaeocene and earliest Eocene periods (from about 60 to 52 Myr ago), and rnd an erratic decline between 55 and 40 Myr ago that may have been caused by reduced CO2 outgassing from ocean ridges, volcanoes and metamorphic belts and increased carbon burial. Since the early Miocene (about 24 Myr ago), atmospheric CO2 concentrations appear to have remained below 500 p.p.m. and were more stable than before, although transient intervals of CO2 reduction may have occurred during periods of rapid cooling approximately 15 and 3 Myr ago.	Univ Bristol, Dept Earth Sci, Bristol BS8 1RJ, Avon, England; Univ London Imperial Coll Sci Technol & Med, TH Huxley Sch, London SW7 2BP, England	University of Bristol; Imperial College London	Pearson, PN (corresponding author), Univ Bristol, Dept Earth Sci, Queens Rd, Bristol BS8 1RJ, Avon, England.	Paul.Pearson@Bristol.ac.uk	Palmer, Martin R/I-6765-2012; Pearson, Paul N/B-2276-2009	Palmer, Martin R/0000-0003-1660-3714; Pearson, Paul N/0000-0003-4628-9818				Arrhenius S., 1896, LOND EDINB DUBLIN PH, V41, P237, DOI [10.1080/14786449608620846, DOI 10.1080/14786449608620846]; Beck RA, 1998, LATE PALEOCENE-EARLY EOCENE CLIMATIC AND BIOTIC EVENTS IN THE MARINE AND TERRESTRIAL RECORDS, P103; BERGER WH, 1986, GEOL RUNDSCH, V75, P249, DOI 10.1007/BF01770192; Berggren W. A., 1995, GEOCHRONOLOGY TIME S, P129, DOI DOI 10.2110/PEC.95.04.0129; BERNER RA, 1983, AM J SCI, V283, P641, DOI 10.2475/ajs.283.7.641; BRADY PV, 1991, J GEOPHYS RES-SOL EA, V96, P18101, DOI 10.1029/91JB01898; BRALOWER TJ, 1995, PALEOCEANOGRAPHY, V10, P841, DOI 10.1029/95PA01143; Broecker WS, 1998, GLOBAL BIOGEOCHEM CY, V12, P403, DOI 10.1029/98GB01927; Chamberlin T.C., 1899, J GEOL, V7, P545, DOI [10.1086/, 10.1086/608449, DOI 10.1086/608449]; Coxall HK, 2000, GEOLOGY, V28, P87, DOI 10.1130/0091-7613(2000)028<0087:HDAAEL>2.3.CO;2; CROWLEY TJ, 2000, WARM CLIMATES EARTH, P425; DICKENS GR, 1995, PALEOCEANOGRAPHY, V10, P965, DOI 10.1029/95PA02087; Frakes L. A, 1992, CLIMATE MODES PHANER; Hemming NG, 1998, GLOBAL BIOGEOCHEM CY, V12, P581, DOI 10.1029/98GB02337; HEMMING NG, 1992, GEOCHIM COSMOCHIM AC, V56, P537, DOI 10.1016/0016-7037(92)90151-8; HEMMING NG, 1995, GEOCHIM COSMOCHIM AC, V59, P371, DOI 10.1016/0016-7037(95)00288-B; ISRAELSON C, 1995, P ODP SCI RES, V144, P737; JORGENSEN BB, 1985, LIMNOL OCEANOGR, V30, P1253, DOI 10.4319/lo.1985.30.6.1253; KAKIHANA H, 1977, B CHEM SOC JPN, V50, P158, DOI 10.1246/bcsj.50.158; Kerrick DM, 1998, CHEM GEOL, V145, P213, DOI 10.1016/S0009-2541(97)00144-7; KIEHL JT, 1987, J GEOPHYS RES-ATMOS, V92, P2991, DOI 10.1029/JD092iD03p02991; MCGOWRAN B, 1989, GEOLOGY, V17, P857, DOI 10.1130/0091-7613(1989)017<0857:SBITEO>2.3.CO;2; Miller KG, 1987, PALEOCEANOGRAPHY, V2, P1, DOI 10.1029/PA002i001p00001; MILLERO FJ, 1995, GEOCHIM COSMOCHIM AC, V59, P661, DOI 10.1016/0016-7037(94)00354-O; Opdyke Bradley N., 1995, Proceedings of the Ocean Drilling Program Scientific Results, V144, P993; OWEN RM, 1985, SCIENCE, V227, P166, DOI 10.1126/science.11536555; Pagani M, 1999, PALEOCEANOGRAPHY, V14, P273, DOI 10.1029/1999PA900006; Palmer MR, 1998, SCIENCE, V282, P1468, DOI 10.1126/science.282.5393.1468; Paytan A, 1998, SCIENCE, V282, P1459, DOI 10.1126/science.282.5393.1459; Pearson Paul N., 1995, Proceedings of the Ocean Drilling Program Scientific Results, V144, P401; Pearson Paul N., 1995, Proceedings of the Ocean Drilling Program Scientific Results, V144, P21, DOI 10.2973/odp.proc.sr.144.013.1995; Pearson PN, 1999, SCIENCE, V284, P1824, DOI 10.1126/science.284.5421.1824; RAYMO ME, 1992, NATURE, V359, P117, DOI 10.1038/359117a0; Rink S, 1998, MAR BIOL, V131, P583, DOI 10.1007/s002270050350; RITCHIE JD, 1996, GEOLOGICAL SOC SPECI, V101, P63; Sanyal A, 1997, GLOBAL BIOGEOCHEM CY, V11, P125, DOI 10.1029/97GB00223; Sanyal A, 1996, PALEOCEANOGRAPHY, V11, P513, DOI 10.1029/96PA01858; SANYAL A, 1995, NATURE, V373, P234, DOI 10.1038/373234a0; Scotese C.R., 1994, PANGEA PALEOCLIMATE, V288, P57, DOI DOI 10.1130/SPE288-P57; SHACKLETON NJ, 1986, PALAEOGEOGR PALAEOCL, V57, P91, DOI 10.1016/0031-0182(86)90008-8; SLOAN LC, 1992, NATURE, V357, P320, DOI 10.1038/357320a0; SPIVACK AJ, 1993, NATURE, V363, P149, DOI 10.1038/363149a0; Taylor S.R., 1985, CONTINENTAL CRUST IT; Thomas Ellen, 2000, P132; VANANDEL TH, 1975, EARTH PLANET SC LETT, V26, P187, DOI 10.1016/0012-821X(75)90086-2; Wanninkhof R, 1999, MAR CHEM, V65, P291, DOI 10.1016/S0304-4203(99)00021-3; Wing S.L., 2000, WARM CLIMATES EARTH, P197; Wright JD, 1992, PALEOCEANOGRAPHY, V7, P357, DOI 10.1029/92PA00760; ZACHOS JC, 1993, J GEOL, V101, P191, DOI 10.1086/648216; ZACHOS JC, 1994, PALEOCEANOGRAPHY, V9, P353, DOI 10.1029/93PA03266	50	1028	1111	10	609	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 17	2000	406	6797					695	699		10.1038/35021000	http://dx.doi.org/10.1038/35021000			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	344PH	10963587				2022-12-28	WOS:000088767700034
J	Bartlett, JG				Bartlett, JG			Update in infectious diseases	ANNALS OF INTERNAL MEDICINE			English	Review							UNITED-STATES; STREPTOCOCCUS-PNEUMONIAE; ANTIRETROVIRAL THERAPY; ENCEPHALITIS; TRANSMISSION; RESISTANCE; PREVENTION; HIV-1		Div Infect Dis, Baltimore, MD 21205 USA		Bartlett, JG (corresponding author), Div Infect Dis, 1830 Monument St,Room 437, Baltimore, MD 21205 USA.							ALTMAN LK, 1999, NY TIMES        0615, pD1; [Anonymous], 1997, MMWR-MORBID MORTAL W, V46, P813; Bozzette SA, 1998, NEW ENGL J MED, V339, P1897, DOI 10.1056/NEJM199812243392606; Briese T, 1999, LANCET, V354, P1261, DOI 10.1016/S0140-6736(99)04576-6; Carpenter CCJ, 2000, JAMA-J AM MED ASSOC, V283, P381, DOI 10.1001/jama.283.3.381; Chen DK, 1999, NEW ENGL J MED, V341, P233, DOI 10.1056/NEJM199907223410403; Doern GV, 1999, EMERG INFECT DIS, V5, P757, DOI 10.3201/eid0506.990603; Doern GV, 1996, ANTIMICROB AGENTS CH, V40, P1208, DOI 10.1128/AAC.40.5.1208; Edmond MB, 1999, CLIN INFECT DIS, V29, P239, DOI 10.1086/520192; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; GERBERDING J, 2000, INTERNAL MED NE 0515, P44; Gleason PP, 1999, ARCH INTERN MED, V159, P2562, DOI 10.1001/archinte.159.21.2562; Guay LA, 1999, LANCET, V354, P795, DOI 10.1016/S0140-6736(99)80008-7; GWALTNEY JM, 1994, NEW ENGL J MED, V330, P25, DOI 10.1056/NEJM199401063300105; Hayden FG, 1999, JAMA-J AM MED ASSOC, V282, P1240, DOI 10.1001/jama.282.13.1240; Hecht FM, 1998, NEW ENGL J MED, V339, P307, DOI 10.1056/NEJM199807303390504; Lanciotti RS, 1999, SCIENCE, V286, P2333, DOI 10.1126/science.286.5448.2333; Liang T. Jake, 2000, Annals of Internal Medicine, V132, P296; Lisziewicz J, 1999, NEW ENGL J MED, V340, P1683, DOI 10.1056/NEJM199905273402114; Marrie TJ, 2000, JAMA-J AM MED ASSOC, V283, P749, DOI 10.1001/jama.283.6.749; *NEW ENGL MED CTR, 2000, DIAGN TREATM AC BACT; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Seeff LB, 2000, ANN INTERN MED, V132, P105, DOI 10.7326/0003-4819-132-2-200001180-00003; Seltzer EG, 2000, JAMA-J AM MED ASSOC, V283, P609, DOI 10.1001/jama.283.5.609; Smith TL, 1999, NEW ENGL J MED, V340, P493, DOI 10.1056/NEJM199902183400701; Zhanel GG, 1999, ANTIMICROB AGENTS CH, V43, P2504, DOI 10.1128/AAC.43.10.2504; Zhang H, 1998, NEW ENGL J MED, V339, P1803, DOI 10.1056/NEJM199812173392502; 2000, MMWR MORB MORTAL WKL, V49, P173	28	6	7	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 15	2000	133	4					285	292		10.7326/0003-4819-133-4-200008150-00013	http://dx.doi.org/10.7326/0003-4819-133-4-200008150-00013			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	346NG	10929170				2022-12-28	WOS:000088877500006
J	Chaillous, L; Lefevre, H; Thivolet, C; Boitard, C; Lahlou, N; Atlan-Gepner, C; Bouhanick, B; Mogenet, A; Nicolino, M; Carel, JC; Lecomte, P; Marechaud, R; Bougneres, P; Charbonnel, B; Sai, P				Chaillous, L; Lefevre, H; Thivolet, C; Boitard, C; Lahlou, N; Atlan-Gepner, C; Bouhanick, B; Mogenet, A; Nicolino, M; Carel, JC; Lecomte, P; Marechaud, R; Bougneres, P; Charbonnel, B; Sai, P		Diabete Insuline Orale grp	Oral insulin administration and residual beta-cell function in recent-onset type 1 diabetes: a multicentre randomised controlled trial	LANCET			English	Article							NOD MICE; T-CELLS; AUTOIMMUNE-DISEASES; ADOPTIVE TRANSFER; TRANSFER MODEL; B-CHAIN; SUPPRESSION; PREVENTION; TOLERANCE; MOUSE	Background Oral administration of autoantigens can slow the progression of beta-cell destruction in non-obese diabetic mice. We investigated whether oral administration of recombinant human insulin could protect residual beta-cell function in recent-onset type 1 diabetes. Methods We enrolled 131 autoantibody-positive diabetic patients aged 7-40 years within 2 weeks of diagnosis (no ketoacidosis at diagnosis, weight loss <10%, polyuria for <6 weeks). They were randomly assigned 2.5 mg or 7.5 mg oral insulin daily or placebo for 1 year, in addition to subcutaneous insulin therapy, Serum C-peptide concentrations were measured in the fasting state and after stimulation, to assess beta-cell function. Autoantibodies to beta-cell antigens were assayed. Analyses were by intention to treat. Findings Baseline C-peptide and haemoglobin A(1c) concentrations were similar in the three groups. During follow up, there were no differences between the groups assigned 2.5 mg or 7.5 mg oral insulin or placebo in subcutaneous insulin requirements, haemoglobin A(1c) concentrations, or measurements of fasting (mean at 12 months 0.18 [SD 0.17], 0.17 [0.17], and 0.17 [0.12] nmol/L) or stimulated C-peptide concentrations (glucagon-stimulated 0.39 [0.38], 0.37 [0.39], and 0.33 [0.24] nmol/L; meal-stimulated 0.72 [0.60], 0.49 [0.49], and 0.57 [0.51 nmol/L]. Neither age nor C-peptide concentration at entry influenced treatment effects. No differences were seen in the time-course or titres of antibodies to insulin, glutamic acid decarboxylase, or islet antigen 2, Interpretation At the doses used in this trial, oral administration of insulin initiated at clinical onset of type 1 diabetes did not prevent the deterioration of beta-cell function.	CHU Nantes, F-44035 Nantes 01, France; CHU St Vincent de Paul, Paris, France; CHU Lyon, Lyon, France; CHU Necker, Paris, France; CHU Marseille, Marseille, France; CHU Angers, Angers, France; CHU Tours, Tours, France; CHU Poitiers, Poitiers, France	Nantes Universite; CHU de Nantes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; CHU Lyon; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; CHU Tours; CHU Poitiers; Universite de Poitiers	Chaillous, L (corresponding author), Hop Hotel Dieu, Pl Alexis Ricordeau, F-44093 Nantes 01, France.	lucy.chaillous@wanadoo.fr	Carel, Jean-Claude/AAZ-7691-2020	Carel, Jean-Claude/0000-0002-0424-6767; BOITARD, Christian/0000-0003-3985-9405; LEFEVRE, Herve/0000-0002-9850-2337				Bellmann K, 1998, DIABETOLOGIA, V41, P844, DOI 10.1007/s001250050997; BERGEROT I, 1994, J AUTOIMMUN, V7, P655, DOI 10.1006/jaut.1994.1050; Bergerot I, 1999, DIABETES, V48, P1720, DOI 10.2337/diabetes.48.9.1720; Bergerot I, 1996, ANN NY ACAD SCI, V778, P362, DOI 10.1111/j.1749-6632.1996.tb21144.x; Bergerot I, 1997, P NATL ACAD SCI USA, V94, P4610, DOI 10.1073/pnas.94.9.4610; Blanas E, 1996, SCIENCE, V274, P1707, DOI 10.1126/science.274.5293.1707; BOUGNERES PF, 1988, NEW ENGL J MED, V318, P663, DOI 10.1056/NEJM198803173181103; Bowman MA, 1996, DIABETES, V45, P205, DOI 10.2337/diabetes.45.2.205; Carel JC, 1996, J AUTOIMMUN, V9, P739, DOI 10.1006/jaut.1996.0096; CHAILLOUS L, 1994, DIABETOLOGIA, V37, P491, DOI 10.1007/s001250050137; Chaillous L, 1996, DIABETOLOGIA, V39, P523; Coutant R, 1998, DIABETOLOGIA, V41, P1040, DOI 10.1007/s001250051028; Coutant R, 1998, DIABETES, V47, pA97; Daniel D, 1996, P NATL ACAD SCI USA, V93, P956, DOI 10.1073/pnas.93.2.956; FEUTREN G, 1986, LANCET, V2, P119; HANCOCK WW, 1995, AM J PATHOL, V147, P1193; Hartmann B, 1997, DIABETOLOGIA, V40, P902, DOI 10.1007/s001250050766; HUSBY S, 1994, J IMMUNOL, V152, P4663; KELLER RJ, 1993, LANCET, V341, P927, DOI 10.1016/0140-6736(93)91215-8; Matsui M, 1996, ANN NY ACAD SCI, V778, P398, DOI 10.1111/j.1749-6632.1996.tb21156.x; NAQUET P, 1988, J IMMUNOL, V140, P2569; PETERSEN JS, 1994, DIABETES, V43, P459, DOI 10.2337/diabetes.43.3.459; Pitocco D, 1999, DIABETOLOGIA, V42, pA92; Ploix C, 1998, DIABETES, V47, P39, DOI 10.2337/diabetes.47.1.39; Polanski M, 1997, J AUTOIMMUN, V10, P339, DOI 10.1006/jaut.1997.0148; Sai P, 1996, DIABETES METAB, V22, P341; SHAH SC, 1989, NEW ENGL J MED, V320, P550, DOI 10.1056/NEJM198903023200902; Weiner HL, 1997, ANNU REV MED, V48, P341; Yoon JW, 1999, SCIENCE, V284, P1183, DOI 10.1126/science.284.5417.1183; ZHANG ZJ, 1991, P NATL ACAD SCI USA, V88, P10252, DOI 10.1073/pnas.88.22.10252	30	186	192	0	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 12	2000	356	9229					545	549		10.1016/S0140-6736(00)02579-4	http://dx.doi.org/10.1016/S0140-6736(00)02579-4			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	345MY	10950231				2022-12-28	WOS:000088820800011
J	Detrick, RS				Detrick, RS			Seafloor spreading - Portrait of a magma chamber	NATURE			English	Editorial Material							EAST PACIFIC RISE; BENEATH; RIDGE; CREST; MELT		Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA	Woods Hole Oceanographic Institution	Detrick, RS (corresponding author), Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA.							BAZIN S, 2000, THESIS U CALIFORNIA; COLLIER J, 1990, NATURE, V346, P646, DOI 10.1038/346646a0; Dunn RA, 1997, NATURE, V388, P259, DOI 10.1038/40831; HARDING AJ, 1993, J GEOPHYS RES-SOL EA, V98, P13925, DOI 10.1029/93JB00886; Kent GM, 2000, NATURE, V406, P614, DOI 10.1038/35020543; KENT GM, 1993, J GEOPHYS RES-SOL EA, V98, P13971, DOI 10.1029/93JB00706; MACDONALD KC, 1988, NATURE, V335, P217, DOI 10.1038/335217a0; MUTTER J, 1998, NATURE, V336, P156; PARMENTIER EM, 1990, NATURE, V348, P325, DOI 10.1038/348325a0; Singh SC, 1998, NATURE, V394, P874, DOI 10.1038/29740; TOOMEY DR, 1990, NATURE, V347, P639, DOI 10.1038/347639a0; WANG XJ, 1993, J GEOPHYS RES-SOL EA, V98, P19505, DOI 10.1029/93JB01551	12	5	7	0	7	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 10	2000	406	6796					578	579		10.1038/35020671	http://dx.doi.org/10.1038/35020671			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	342PF	10949284				2022-12-28	WOS:000088653800028
J	Takahashi, K; Yanagida, M				Takahashi, K; Yanagida, M			Cell cycle - Replication meets cohesion	SCIENCE			English	Editorial Material							SISTER-CHROMATID COHESION		Kyoto Univ, Grad Sch Biostudies, Dept Gene Mechanisms, Sakyo Ku, Kyoto 6068502, Japan	Kyoto University	Takahashi, K (corresponding author), Kyoto Univ, Grad Sch Biostudies, Dept Gene Mechanisms, Sakyo Ku, Kitashirakawa Oiwakecho, Kyoto 6068502, Japan.							Aravind L, 1999, NUCLEIC ACIDS RES, V27, P1609, DOI 10.1093/nar/27.7.1609; Furuya K, 1998, GENE DEV, V12, P3408, DOI 10.1101/gad.12.21.3408; Hubscher U, 2000, TRENDS BIOCHEM SCI, V25, P143, DOI 10.1016/S0968-0004(99)01523-6; Nasmyth K, 2000, SCIENCE, V288, P1379, DOI 10.1126/science.288.5470.1379; Skibbens RV, 1999, GENE DEV, V13, P307, DOI 10.1101/gad.13.3.307; Tanaka K, 2000, MOL CELL BIOL, V20, P3459, DOI 10.1128/MCB.20.10.3459-3469.2000; Wang SW, 2000, MOL CELL BIOL, V20, P3234, DOI 10.1128/MCB.20.9.3234-3244.2000; Wang ZH, 2000, SCIENCE, V289, P774, DOI 10.1126/science.289.5480.774	8	5	5	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 4	2000	289	5480					735	736		10.1126/science.289.5480.735	http://dx.doi.org/10.1126/science.289.5480.735			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	341FZ	10950718				2022-12-28	WOS:000088581500026
J	Paytan, A				Paytan, A			Global change - Iron uncertainty	NATURE			English	Editorial Material							BIOLOGICAL PRODUCTIVITY; EQUATORIAL PACIFIC		Stanford Univ, Dept Geol & Environm Sci, Stanford, CA 94305 USA	Stanford University	Paytan, A (corresponding author), Stanford Univ, Dept Geol & Environm Sci, Braun Hall 320,207, Stanford, CA 94305 USA.							DELMAS RJ, 1980, NATURE, V284, P155, DOI 10.1038/284155a0; Harrison KG, 2000, PALEOCEANOGRAPHY, V15, P292, DOI 10.1029/1999PA000427; HERGUERA J, IN PRESS MAR MICROPA; HERGUERA JC, 1991, GEOLOGY, V19, P1173, DOI 10.1130/0091-7613(1991)019<1173:PFBFAG>2.3.CO;2; Loubere P, 1999, GLOBAL BIOGEOCHEM CY, V13, P115, DOI 10.1029/1998GB900001; Loubere P, 2000, NATURE, V406, P497, DOI 10.1038/35020041; Loubere P, 1999, MAR MICROPALEONTOL, V37, P173, DOI 10.1016/S0377-8398(99)00013-4; Lyle M, 1988, PALEOCEANOGRAPHY, V3, P39, DOI 10.1029/PA003i001p00039; Martin JH, 1990, PALEOCEANOGRAPHY, V5, P1, DOI 10.1029/PA005i001p00001; Prahl FG, 1989, PALEOCEANOGRAPHY, V4, P495, DOI 10.1029/PA004i005p00495; Treguer P, 2000, NATURE, V406, P358, DOI 10.1038/35019236; YANG Y, 1995, GEOLOGY, V23, P115	12	4	5	0	2	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 3	2000	406	6795					468	469		10.1038/35020176	http://dx.doi.org/10.1038/35020176			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	340ML	10952294				2022-12-28	WOS:000088538000028
J	Carmody, J				Carmody, J			What if ...? Chinese explorers - or Darwin's bulldog - had settled in Australia?	NATURE			English	Article									Univ New S Wales, Fac Med, Sydney, NSW 2052, Australia	University of New South Wales Sydney	Carmody, J (corresponding author), Univ New S Wales, Fac Med, Sydney, NSW 2052, Australia.								0	1	1	0	1	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 27	2000	406	6794					349	349		10.1038/35019180	http://dx.doi.org/10.1038/35019180			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	337WC	10935614				2022-12-28	WOS:000088383800021
J	Weissert, H				Weissert, H			Global change - Deciphering methane's fingerprint	NATURE			English	Editorial Material							STRATIGRAPHY; DELTA-C-13		ETH Zurich, Dept Earth Sci, CH-8092 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Weissert, H (corresponding author), ETH Zurich, Dept Earth Sci, CH-8092 Zurich, Switzerland.							DICKENS GR, 1995, PALEOCEANOGRAPHY, V10, P965, DOI 10.1029/95PA02087; Hesselbo SP, 2000, NATURE, V406, P392, DOI 10.1038/35019044; HSU KJ, 1985, GEOPHYS MONOGR SER, V32, P487; JARHEN AH, 1998, GOEL SOC AM ABSTR PR, V30, P53; LARSON RL, 1991, GEOLOGY, V19, P547, DOI 10.1130/0091-7613(1991)019<0547:LPOEEF>2.3.CO;2; Menegatti AP, 1998, PALEOCEANOGRAPHY, V13, P530, DOI 10.1029/98PA01793; Veizer J, 1999, CHEM GEOL, V161, P59, DOI 10.1016/S0009-2541(99)00081-9; Weissert H, 1998, PALAEOGEOGR PALAEOCL, V137, P189, DOI 10.1016/S0031-0182(97)00109-0	8	33	35	0	11	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 27	2000	406	6794					356	357		10.1038/35019230	http://dx.doi.org/10.1038/35019230			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	337WC	10935618				2022-12-28	WOS:000088383800025
J	Marx, J				Marx, J			Alzheimer's Congress - Drug shows promise for advanced disease	SCIENCE			English	News Item																			0	6	7	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 21	2000	289	5478					375	+						2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	336ME	10939942				2022-12-28	WOS:000088305500008
J	Rayman, MP				Rayman, MP			The importance of selenium to human health	LANCET			English	Review							GLUTATHIONE-PEROXIDASE ACTIVITY; ISCHEMIC-HEART-DISEASE; SERUM SELENIUM; DIETARY SELENIUM; MYOCARDIAL-INFARCTION; CANCER MORTALITY; THYROID-HORMONES; PROSTATE-CANCER; TRACE-ELEMENTS; PLASMA-LEVELS	The essential trace mineral, selenium, is of fundamental importance to human health. As a constituent of selenoproteins, selenium has structural and enzymic roles, in the latter context being best-known as an antioxidant and catalyst for the production of active thyroid hormone. Selenium is needed for the proper functioning of the immune system, and appears to be a key nutrient in counteracting the development of virulence and inhibiting HIV progression to AIDS. It is required for sperm motility and may reduce the risk of miscarriage. Deficiency has been linked to adverse mood states. Findings have been equivocal in linking selenium to cardiovascular disease risk although other conditions involving oxidative stress and inflammation have shown benefits of a higher selenium status. An elevated selenium intake may be associated with reduced cancer risk. Large clinical trials are now planned to confirm or refute this hypothesis. In the context of these health effects, low or diminishing selenium status in some parts of the world, notably in some European countries, is giving cause for concern.	Univ Surrey, Sch Biol Sci, Ctr Nutr & Food Safety, Guildford GU2 7XH, Surrey, England	University of Surrey	Rayman, MP (corresponding author), Univ Surrey, Sch Biol Sci, Ctr Nutr & Food Safety, Guildford GU2 7XH, Surrey, England.		Duarte, Graziela Biude Silva/Q-7728-2016					Allan CB, 1999, ANNU REV NUTR, V19, P1, DOI 10.1146/annurev.nutr.19.1.1; Arteel GE, 1999, FEBS LETT, V445, P226, DOI 10.1016/S0014-5793(99)00073-3; Barrington J. W., 1997, Journal of Obstetrics and Gynaecology (Abingdon), V17, P199; Barrington JW, 1996, BRIT J OBSTET GYNAEC, V103, P130, DOI 10.1111/j.1471-0528.1996.tb09663.x; Baum MK, 1997, J ACQ IMMUN DEF SYND, V15, P370, DOI 10.1097/00042560-199708150-00007; Beck MA, 1998, FASEB J, V12, P1143, DOI 10.1096/fasebj.12.12.1143; BECK MA, 1995, NAT MED, V1, P433, DOI 10.1038/nm0595-433; Behne D, 1997, BIOMED ENVIRON SCI, V10, P340; Behne D, 1996, J REPROD FERTIL, V106, P291, DOI 10.1530/jrf.0.1060291; Behne D, 2000, TRACE ELEMENTS IN MAN AND ANIMALS 10, P29; BENTON D, 1991, BIOL PSYCHIAT, V29, P1092, DOI 10.1016/0006-3223(91)90251-G; BERR C, 2000, IN PRESS J AM GERIAT; Brown KM, 2000, CLIN SCI, V98, P593, DOI 10.1042/CS19990276; Campa A, 1999, J ACQ IMMUN DEF SYND, V20, P508, DOI 10.1097/00042560-199904150-00015; Castano A, 1997, NEUROCHEM INT, V30, P549, DOI 10.1016/S0197-0186(96)00123-4; Clark LC, 1996, JAMA-J AM MED ASSOC, V276, P1957, DOI 10.1001/jama.276.24.1957; CLARK LC, 1991, ARCH ENVIRON HEALTH, V46, P37, DOI 10.1080/00039896.1991.9937427; Combs GF, 1998, PHARMACOL THERAPEUT, V79, P179, DOI 10.1016/S0163-7258(98)00014-X; Committee on Medical Aspects of Food Policy, 1991, REP HLTH SOC SUBJ; DIPLOCK AT, 1994, MOL ASPECTS MED, V15, P293, DOI 10.1016/0098-2997(94)90005-1; Duffield AJ, 1999, AM J CLIN NUTR, V70, P896; Finley JW, 1998, J TRACE ELEM EXP MED, V11, P11; Giovannucci E, 1998, LANCET, V352, P755, DOI 10.1016/S0140-6736(05)60674-5; Guimaraes MJ, 1996, P NATL ACAD SCI USA, V93, P15086, DOI 10.1073/pnas.93.26.15086; Hagmar L, 1998, EUR J CLIN NUTR, V52, P796, DOI 10.1038/sj.ejcn.1600649; HASSELMARK L, 1993, ALLERGY, V48, P30; Hawkes WC, 1996, BIOL PSYCHIAT, V39, P121, DOI 10.1016/0006-3223(95)00085-2; HIDIROGLOU M, 1979, J DAIRY SCI, V62, P1195, DOI 10.3168/jds.S0022-0302(79)83400-1; IWANIER K, 1995, J ANDROL, V16, P441; Jiang C, 1999, MOL CARCINOGEN, V26, P213, DOI 10.1002/(SICI)1098-2744(199912)26:4<213::AID-MC1>3.0.CO;2-Z; Kardinaal AFM, 1997, AM J EPIDEMIOL, V145, P373, DOI 10.1093/oxfordjournals.aje.a009115; KIREMIDJIANSCHUMACHER L, 1994, BIOL TRACE ELEM RES, V41, P115, DOI 10.1007/BF02917222; Knekt P, 1998, AM J EPIDEMIOL, V148, P975, DOI 10.1093/oxfordjournals.aje.a009574; KNEKT P, 2000, IN PRESS EPIDEMIOLOG; KOK FJ, 1987, AM J EPIDEMIOL, V125, P12, DOI 10.1093/oxfordjournals.aje.a114493; KUKLINSKY B, 1996, J NUTR ENV MED, V6, P393; Look MP, 1997, BIOL TRACE ELEM RES, V56, P31, DOI 10.1007/BF02778982; MacPherson A, 1997, TRACE ELEMENTS IN MAN AND ANIMALS - 9, P203; McCloy R, 1998, DIGESTION, V59, P36, DOI 10.1159/000051441; MELTZER HM, 1993, BIOL TRACE ELEM RES, V36, P229, DOI 10.1007/BF02783957; *NAT AC HLTH CAN, 2000, DIET REF INT VIT C V; Neve J, 1996, J Cardiovasc Risk, V3, P42; Neve J, 2000, TRACE ELEMENTS IN MAN AND ANIMALS 10, P317; Nichol C, 1998, CLIN CHEM, V44, P1764; Nicoll AE, 1999, BRIT J OBSTET GYNAEC, V106, P1188, DOI 10.1111/j.1471-0528.1999.tb08146.x; Oldereid NB, 1998, HUM REPROD, V13, P2172, DOI 10.1093/humrep/13.8.2172; OLIVIERI O, 1995, CLIN SCI, V89, P637, DOI 10.1042/cs0890637; PERETZ A, 1992, BRIT J RHEUMATOL, V31, P281; RAMAEKERS VT, 1994, NEUROPEDIATRICS, V25, P217, DOI 10.1055/s-2008-1073025; Rayman MP, 1997, BRIT MED J, V314, P387, DOI 10.1136/bmj.314.7078.387; Rayman MP, 2000, TRACE ELEMENTS IN MAN AND ANIMALS 10, P575; Reilly R., 2006, SELENIUM FOOD HEATH, P173; SALONEN JT, 1988, ATHEROSCLEROSIS, V70, P155, DOI 10.1016/0021-9150(88)90109-8; SALONEN JT, 1982, LANCET, V2, P175; SALVINI S, 1995, AM J CARDIOL, V76, P1218, DOI 10.1016/S0002-9149(99)80344-0; SAPPEY C, 1994, AIDS RES HUM RETROV, V10, P1451, DOI 10.1089/aid.1994.10.1451; SATTLER W, 1994, ARCH BIOCHEM BIOPHYS, V309, P214, DOI 10.1006/abbi.1994.1105; SCHRAUZER GN, 1977, BIOINORG CHEM, V7, P35, DOI 10.1016/S0006-3061(00)80127-1; Scott R, 1998, BRIT J UROL, V82, P76, DOI 10.1046/j.1464-410x.1998.00683.x; Shaheen S.O., 1999, EUR RESPIR J, V14, p141S, DOI [10.1164/ajrccm.164.10.2104061, DOI 10.1164/AJRCCM.164.10.2104061]; SHAW R, 1994, NEW ZEAL MED J, V107, P387; Shisler JL, 1998, SCIENCE, V279, P102, DOI 10.1126/science.279.5347.102; Shortt CT, 1997, EUR J CLIN NUTR, V51, P400, DOI 10.1038/sj.ejcn.1600421; SPALLHOLZ JE, 1990, ANN NY ACAD SCI, V587, P123, DOI 10.1111/j.1749-6632.1990.tb00140.x; STUART LD, 1982, VET HUM TOXICOL, V24, P435; SUADICANI P, 1992, ATHEROSCLEROSIS, V96, P33, DOI 10.1016/0021-9150(92)90035-F; Sunde R. A., 1997, Handbook of nutritionally essential mineral elements., P493; Tanguy S, 1998, J TRACE ELEM MED BIO, V12, P28, DOI 10.1016/S0946-672X(98)80018-7; Taylor EW, 1997, BIOL TRACE ELEM RES, V56, P63, DOI 10.1007/BF02778984; TAYLOR EW, 1999, INFO ONKOLOGI, V2, P7; THOMSON CD, 1993, BRIT J NUTR, V69, P577, DOI 10.1079/BJN19930057; *UK MIN AGR FISH F, 1997, 126 MAFF JOINT FOOD; UNDERWOOD EJ, 1977, TRACE ELEMENTS HUMAN, P303; Ursini F, 1999, SCIENCE, V285, P1393, DOI 10.1126/science.285.5432.1393; VANDERPAS JB, 1990, AM J CLIN NUTR, V52, P1087, DOI 10.1093/ajcn/52.6.1087; VIRTAMO J, 1985, AM J EPIDEMIOL, V122, P276, DOI 10.1093/oxfordjournals.aje.a114099; WEBER GF, 1991, LANCET, V337, P1443, DOI 10.1016/0140-6736(91)93130-2; Whanger P, 1996, ANN CLIN LAB SCI, V26, P99; *WHO FAO, 1996, TRAC EL HUM NUTR HLT; WU SH, 1973, BIOL REPROD, V8, P625, DOI 10.1093/biolreprod/8.5.625; Yoshizawa K, 1998, JNCI-J NATL CANCER I, V90, P1219, DOI 10.1093/jnci/90.16.1219; Yu MW, 1999, AM J EPIDEMIOL, V150, P367, DOI 10.1093/oxfordjournals.aje.a010016; Yu SY, 1997, BIOL TRACE ELEM RES, V56, P117, DOI 10.1007/BF02778987; Zhang W, 1999, BIOL TRACE ELEM RES, V70, P97, DOI 10.1007/BF02783852; Zhao LJ, 2000, P NATL ACAD SCI USA, V97, P6356, DOI 10.1073/pnas.97.12.6356	85	2875	3132	26	812	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 15	2000	356	9225					233	241		10.1016/S0140-6736(00)02490-9	http://dx.doi.org/10.1016/S0140-6736(00)02490-9			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	334GQ	10963212	Green Submitted			2022-12-28	WOS:000088179100037
J	Van Hilten, BJ; Van de Beek, WJT; Hoff, JI; Voormolen, JHC; Delhaas, EM				Van Hilten, BJ; Van de Beek, WJT; Hoff, JI; Voormolen, JHC; Delhaas, EM			Intrathecal baclofen for the treatment of dystonia in patients with reflex sympathetic dystrophy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SPINAL-CORD; PRESYNAPTIC INHIBITION; SEVERE SPASTICITY; MUSCLE-SPINDLE; NEURONS; GABA; PAIN; RAT; RECEPTORS; AFFERENTS	Background Patients with reflex sympathetic dystrophy (also known as the complex regional pain syndrome) may have dystonia, which is often unresponsive to treatment. Some forms of dystonia respond to the intrathecal administration of baclofen, a specific gamma-aminobutyric acid receptor (type B) agonist that sensory input to the neurons of the spinal cord. We evaluated this treatment in seven women who had reflex sympathetic dystrophy with cal or generalized tonic dystonia. Methods We performed a double-blind, randomized, controlled crossover trial of bolus intrathecal injections of 25, 50, and 75 mu g of baclofen and placebo. Changes in the severity of dystonia were assessed by the woman and by an investigator after each injection. In the second phase of the study, six of the women received a subcutaneous pump for continuous intrathecal administration of baclofen and were followed for 0.5 to 3 years. Results In six women, bolus injections of 50 and 75 mu g of baclofen resulted in complete or partial resolution of focal dystonia of the hands but little improvement in dystonia of the legs. During continuous therapy, three women regained normal hand function, and two of these three women regained the ability to walk (one only indoors). In one woman who received continuous therapy, the pain and violent jerks disappeared and the dystonic posturing of the arm decreased. In two women the spasms or restlessness of the legs decreased, without any change in the dystonia. Conclusions In some patients, the dystonia associated wit reflex sympathetic dystrophy responds markedly to intrathecal baclofen. (N Engl J Med 2000; 343:625-30.) (C) 2000, Massachusetts Medical Society.	Leiden Univ, Med Ctr, Dept Neurol, NL-2300 RC Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Neurosurg, NL-2300 RC Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Van Hilten, BJ (corresponding author), Leiden Univ, Med Ctr, Dept Neurol, POB 9600, NL-2300 RC Leiden, Netherlands.			van Hilten, Jacobus/0000-0002-7030-0362; Voormolen, Joan/0000-0002-7685-6847				Becker R, 1997, J NEUROL, V244, P160, DOI 10.1007/s004150050067; BHATIA KP, 1993, BRAIN, V116, P843, DOI 10.1093/brain/116.4.843; BHATTACHARYA SK, 1986, J PHARM PHARMACOL, V38, P144, DOI 10.1111/j.2042-7158.1986.tb04531.x; BOGAN N, 1989, BRAIN RES, V505, P257, DOI 10.1016/0006-8993(89)91452-2; BOYD RE, 1983, AM J MED, V74, P507, DOI 10.1016/0002-9343(83)90999-3; Buritova J, 1996, NEUROSCIENCE, V73, P487, DOI 10.1016/0306-4522(96)00071-1; Chancellor MB, 1996, J UROLOGY, V155, P634, DOI 10.1016/S0022-5347(01)66472-3; CLOUGH JFM, 1968, J PHYSIOL-LONDON, V198, P145, DOI 10.1113/jphysiol.1968.sp008598; DAWSONSAUNDERS B, 1990, BASIC CLIN BIOSTATIS; DELHAAS EM, 1991, INT J CLIN PHARM TH, V29, P274; DOTSON RM, 1993, MUSCLE NERVE, V16, P1049, DOI 10.1002/mus.880161008; ERDINE S, 1995, RAIN REV, V2, P227; GIULIANI S, 1992, NEUROSCIENCE, V48, P217, DOI 10.1016/0306-4522(92)90350-B; JANKOWSKA E, 1992, PROG NEUROBIOL, V38, P335, DOI 10.1016/0301-0082(92)90024-9; KNUTSSON E, 1974, J NEUROL SCI, V23, P473, DOI 10.1016/0022-510X(74)90163-4; LEWIS DI, 1995, J PHYSIOL-LONDON, V486, P483, DOI 10.1113/jphysiol.1995.sp020827; Lin Q, 1996, J NEUROPHYSIOL, V76, P1005, DOI 10.1152/jn.1996.76.2.1005; Malcangio M, 1996, TRENDS PHARMACOL SCI, V17, P457; Merskey H., 1994, CLASSIFICATION CHRON, V2nd ed; Ordia JI, 1996, J NEUROSURG, V85, P452, DOI 10.3171/jns.1996.85.3.0452; PENG YY, 1989, J NEUROSCI, V9, P1502; PENN RD, 1995, MOVEMENT DISORD, V10, P675, DOI 10.1002/mds.870100524; PENN RD, 1989, NEW ENGL J MED, V320, P1517, DOI 10.1056/NEJM198906083202303; RIBBERS G, 1995, INT J REHABIL RES, V18, P277, DOI 10.1097/00004356-199512000-00001; RUDOMIN P, 1990, TRENDS NEUROSCI, V13, P499, DOI 10.1016/0166-2236(90)90084-N; SCHWARTZMAN RJ, 1990, NEUROLOGY, V40, P57, DOI 10.1212/WNL.40.1.57; Sherman SE, 1995, CAN J PHYSIOL PHARM, V73, P1698, DOI 10.1139/y95-733; VELDMAN PHJM, 1993, LANCET, V342, P1012, DOI 10.1016/0140-6736(93)92877-V	28	157	166	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 31	2000	343	9					625	630		10.1056/NEJM200008313430905	http://dx.doi.org/10.1056/NEJM200008313430905			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	348RE	10965009	Bronze			2022-12-28	WOS:000088999600005
J	Cody, GD; Boctor, NZ; Filley, TR; Hazen, RM; Scott, JH; Sharma, A; Yoder, HS				Cody, GD; Boctor, NZ; Filley, TR; Hazen, RM; Scott, JH; Sharma, A; Yoder, HS			Primordial carbonylated iron-sulfur compounds and the synthesis of pyruvate	SCIENCE			English	Article							BIOCHEMISTRY	Experiments exploring the potential catalytic role of iron sulfide at 250 degrees C and elevated pressures (50, 100, and 200 megapascals) revealed a facile, pressure-enhanced synthesis of organometallic phases formed through the reaction of alkyl thiols and carbon monoxide with iron sulfide. A suite of organometallic compounds were characterized with ultraviolet-visible and Raman spectroscopy. The natural synthesis of such compounds is anticipated in present-day and ancient environments wherever reduced hydrothermal fluids pass through iron sulfide-containing crust. Here, pyruvic acid was synthesized in the presence of such organometallic phases. These compounds could have provided the prebiotic Earth with critical biochemical functionality.	Carnegie Inst Washington, Geophys Lab, Washington, DC 20015 USA	Carnegie Institution for Science	Cody, GD (corresponding author), Carnegie Inst Washington, Geophys Lab, 5251 Broad Branch Rd NW, Washington, DC 20015 USA.		Filley, Timothy R/A-9862-2009	Filley, Timothy/0000-0001-7250-5065				Abel E. W., 1967, ORGANOMET CHEM REV, V2, P443; Adams MWW, 1998, SCIENCE, V282, P1842, DOI 10.1126/science.282.5395.1842; Barns SM, 1996, P NATL ACAD SCI USA, V93, P9188, DOI 10.1073/pnas.93.17.9188; Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653; Blau K, 1993, HDB DERIVATIVES CHRO, V1, DOI [10.1016/s0022-328x(00)83288-x, DOI 10.1016/S0022-328X(00)83288-X]; Cammack Richard, 1996, P43; Haggerty J.A., 1992, PROC OCEAN DRILL SCI, V125, P387, DOI [10.2973/odp.proc.sr.125.125.1992, DOI 10.2973/ODP.PROC.SR.125.125.1992]; Heinen W, 1996, ORIGINS LIFE EVOL B, V26, P131, DOI 10.1007/BF01809852; HEKINIAN R, 1973, NATURE, V245, P371, DOI 10.1038/245371a0; Henrici Olive G., 1984, CHEM CATALYTIC HYDRO; Huber C, 1997, SCIENCE, V276, P245, DOI 10.1126/science.276.5310.245; KING RB, 1965, INORG CHEM, V4, P1663, DOI 10.1021/ic50033a031; KULLERUD G, 1971, RES TECHNIQUES HIGH, P289; MAYERLE JJ, 1975, J AM CHEM SOC, V97, P1032, DOI 10.1021/ja00838a015; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; PALMER DA, 1993, EOS, V74, P327; Peters JW, 1998, SCIENCE, V282, P1853, DOI 10.1126/science.282.5395.1853; QIU D, 1994, SCIENCE, V264, P817, DOI 10.1126/science.8171334; Spiro T. G., 1982, IRON SULFUR PROTEINS; WACHTERSHAUSER G, 1992, PROG BIOPHYS MOL BIO, V58, P85, DOI 10.1016/0079-6107(92)90022-X; YODER HS, 1950, T AM GEOPHYS UNION, V31, P821	21	322	334	6	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 25	2000	289	5483					1337	1340		10.1126/science.289.5483.1337	http://dx.doi.org/10.1126/science.289.5483.1337			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347RF	10958777				2022-12-28	WOS:000088942400034
J	Klein, I; Ojamaa, K				Klein, I; Ojamaa, K			Thyroid (neuro)myopathy	LANCET			English	Editorial Material									NYU, N Shore Univ Hosp, Sch Med, Div Endocrinol, Manhasset, NY 11030 USA	New York University; Northwell Health; North Shore University Hospital	Klein, I (corresponding author), NYU, N Shore Univ Hosp, Sch Med, Div Endocrinol, Manhasset, NY 11030 USA.							Caiozzo VJ, 1998, J APPL PHYSIOL, V85, P2237, DOI 10.1152/jappl.1998.85.6.2237; Duyff RF, 2000, J NEUROL NEUROSUR PS, V68, P750, DOI 10.1136/jnnp.68.6.750; KLEIN I, 1994, ANN INTERN MED, V121, P281, DOI 10.7326/0003-4819-121-4-199408150-00010; KLEIN I, IN PRESS N ENGL J ME; Koss KL, 1996, CIRC RES, V79, P1059, DOI 10.1161/01.RES.79.6.1059; MARTIN WH, 1993, ANN THORAC SURG, V56, pS24, DOI 10.1016/0003-4975(93)90551-R; Olson B R, 1991, Thyroid, V1, P137, DOI 10.1089/thy.1991.1.137	7	33	33	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 19	2000	356	9230					614	614						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	346RD	10968432				2022-12-28	WOS:000088884100007
J	Jacob, DE; Viljoen, KS; Grassineau, N; Jagoutz, E				Jacob, DE; Viljoen, KS; Grassineau, N; Jagoutz, E			Remobilization in the cratonic lithosphere recorded in polycrystalline diamond	SCIENCE			English	Article							ECLOGITE XENOLITHS; ELEMENT SIGNATURE; OCEANIC-CRUST; ISOTOPE; MANTLE; METASOMATISM; KIMBERLITES; BOTSWANA; JWANENG	Polycrystalline diamonds (framesites) from the Venetia kimberlite in South Africa contain silicate minerals whose isotopic and trace element characteristics document remobilization of older carbon and silicate components to form the framesites shortly before kimberlite eruption. Chemical variations within the garnets correlate with carbon isotopes in the diamonds, indicating contemporaneous formation. Trace element, radiogenic, and stable isotope variations can be explained by the interaction of eclogites with a carbonatitic melt, derived by remobilization of material that had been stored for a considerable time in the lithosphere, These results indicate more recent formation of diamonds from older materials within the cratonic lithosphere.	Ernst Moritz Arndt Univ Greifswald, Inst Geol Wissensch, D-17487 Greifswald, Germany; DeBeers Geosci Ctr, ZA-2135 Southdale, South Africa; Univ London Royal Holloway & Bedford New Coll, Dept Geol, Egham TW20 0EX, Surrey, England; Max Planck Inst Chem, D-55122 Mainz, Germany	Ernst Moritz Arndt Universitat Greifswald; University of London; Royal Holloway University London; Max Planck Society	Jacob, DE (corresponding author), Ernst Moritz Arndt Univ Greifswald, Inst Geol Wissensch, FL Jahnstr 17A, D-17487 Greifswald, Germany.		Jacob, Dorrit E/F-8617-2010	Jacob, Dorrit E/0000-0003-4744-6627; Grassineau, Nathalie/0000-0001-7958-7104				Allsopp H.L., 1995, S AFR J GEOL, V98, P239; Cartigny P, 1998, SCIENCE, V280, P1421, DOI 10.1126/science.280.5368.1421; CARTIGNY P, 1997, THESIS U PARIS 7; COGHLAN RAN, 1990, THESIS BROWN U PROVI; Deines P, 1997, GEOCHIM COSMOCHIM AC, V61, P3993, DOI 10.1016/S0016-7037(97)00199-3; GURNEY JJ, 1982, YB CARNEGIE I, P267; Haggerty SE, 1999, SCIENCE, V285, P851, DOI 10.1126/science.285.5429.851; Hatton C. J., 1978, THESIS U CAPE TOWN C; IONOV DA, 1993, EARTH PLANET SC LETT, V119, P283, DOI 10.1016/0012-821X(93)90139-Z; JACOB D, 1994, GEOCHIM COSMOCHIM AC, V58, P5191, DOI 10.1016/0016-7037(94)90304-2; JACOB D, 1995, CPRM SPEC PUBL, V1, P304; Jacob DE, 1999, LITHOS, V48, P317, DOI 10.1016/S0024-4937(99)00034-1; Jacob DE, 1998, NEUES JB MINER ABH, V172, P357; JANSE AJA, 1992, RUSS GEOL GEOPHYS, V33, P9; Longerich HP, 1996, J ANAL ATOM SPECTROM, V11, P899, DOI 10.1039/ja9961100899; MACGREGOR ID, 1986, J GEOPHYS RES-SOLID, V91, P14063, DOI 10.1029/JB091iB14p14063; MATTEY D, 1993, CHEM GEOL, V105, P305, DOI 10.1016/0009-2541(93)90133-4; McCandless T.E., 1997, RUSS GEOL GEOPHYS, V38, P394; MCCANDLESS TE, 1989, 28 INT GEOL C WASH; NAVON O, 1999, P 7 INT KIMB C RED R, P584; PEARSON DG, 1995, GEOCHIM COSMOCHIM AC, V59, P959, DOI 10.1016/00167-0379(50)00143-; POLLACK HN, 1977, TECTONOPHYSICS, V38, P279, DOI 10.1016/0040-1951(77)90215-3; RICHARDSON SH, 1990, NATURE, V346, P54, DOI 10.1038/346054a0; RICHARDSON SH, 1984, NATURE, V310, P198, DOI 10.1038/310198a0; SHIMIZU N, 1995, NATURE, V375, P394, DOI 10.1038/375394a0; Simons FJ, 1999, LITHOS, V48, P17, DOI 10.1016/S0024-4937(99)00041-9; SMITH CB, 1989, GEOL SOC AUSTR SPEC, V14, P853; Snyder GA, 1997, J PETROL, V38, P85, DOI 10.1093/petrology/38.1.85; SOBOLEV NV, 1977, PEEP SEATED INCLUSIO; Sun S.-S., 1989, GEOLOGICAL SOC LONDO, V42, P323, DOI [10.1144/GSL.SP.1989.042.01.19, DOI 10.1144/GSL.SP.1989.042.01.19]; Viljoen KS, 1996, CHEM GEOL, V131, P235, DOI 10.1016/0009-2541(96)00018-6; VILJOEN KS, UNPUB; YAXLEY GM, 1994, EARTH PLANET SC LETT, V128, P313, DOI 10.1016/0012-821X(94)90153-8	33	48	50	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 18	2000	289	5482					1182	1185		10.1126/science.289.5482.1182	http://dx.doi.org/10.1126/science.289.5482.1182			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	346JE	10947983				2022-12-28	WOS:000088866600039
J	Da Silva, M; Rajchenbach, J				Da Silva, M; Rajchenbach, J			Stress transmission through a model system of cohesionless elastic grains	NATURE			English	Article							FORCE FLUCTUATIONS; GRANULAR-MATERIALS; BEAD PACKS	Understanding the mechanical properties of granular materials is important for applications in civil and chemical engineering, geophysical sciences and the food industry(1), as well as for the control or prevention of avalanches and landslides(2). Unlike continuous media, granular materials lack cohesion, and cannot resist tensile stresses. Current descriptions of the mechanical properties of collections of cohesionless grains have relied either on elasto-plastic models classically used in civil engineering(3), or on a recent model involving hyperbolic equations(4,5). The former models suggest that collections of elastic grains submitted to a compressive load will behave elastically. Here we present the results of an experiment on a two-dimensional model system-made of discrete square cells submitted to a point load-in which the region in which the stress is confined is photoelastically visualized as a parabola. These results, which can be interpreted within a statistical framework, demonstrate that the collective response of the pile contradicts the standard elastic predictions and supports a diffusive description of stress transmission. We expect that these findings will be applicable to problems in soil mechanics, such as the behaviour of cohesionless soils or sand piles.	Univ Paris 06, CNRS, UMR 7603, Lab Milieux Desordonnes & Heterogenes, F-75252 Paris 05, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Rajchenbach, J (corresponding author), Univ Paris 06, CNRS, UMR 7603, Lab Milieux Desordonnes & Heterogenes, Case 86,4 Pl Jussieu, F-75252 Paris 05, France.							BOUCHAUD JP, 1995, J PHYS I, V5, P639, DOI 10.1051/jp1:1995157; Boussinesq J, 1885, APPL POTENTIELS ETUD; Cates ME, 1998, PHILOS T R SOC A, V356, P2535, DOI 10.1098/rsta.1998.0285; Coppersmith SN, 1996, PHYS REV E, V53, P4673, DOI 10.1103/PhysRevE.53.4673; Ennis BJ, 1997, POWDERS & GRAINS 97, P13; Gray J. M. N. T., 1998, PHYS J, V54, P37, DOI DOI 10.1002/PHBL.19980540110; Landau L.D., 1980, THEORY ELASTICITY; LIU CH, 1995, SCIENCE, V269, P513, DOI 10.1126/science.269.5223.513; Miller B, 1996, PHYS REV LETT, V77, P3110, DOI 10.1103/PhysRevLett.77.3110; Moukarzel CF, 1998, PHYS REV LETT, V81, P1634, DOI 10.1103/PhysRevLett.81.1634; Mueth DM, 1998, PHYS REV E, V57, P3164, DOI 10.1103/PhysRevE.57.3164; Ngadi A, 1998, PHYS REV LETT, V80, P273, DOI 10.1103/PhysRevLett.80.273; PeraltaFabi R, 1997, POWDERS & GRAINS 97, P227; Radjai F, 1996, PHYS REV LETT, V77, P274, DOI 10.1103/PhysRevLett.77.274; Sokolovski V. V., 1965, STATICS GRANULAR MED; Terzaghi K., 1943, THEORETICAL SOIL MEC; Timoshenko S., 1951, THEORY ELASTICITY	17	66	66	3	47	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 17	2000	406	6797					708	710		10.1038/35021023	http://dx.doi.org/10.1038/35021023			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	344PH	10963591				2022-12-28	WOS:000088767700038
J	Park, SH; Bendelac, A				Park, SH; Bendelac, A			CD1-restricted T-cell responses and microbial infection	NATURE			English	Article							NKT CELLS; MOUSE CD1; LIPOGLYCAN ANTIGENS; CUTTING EDGE; RECOGNITION; GLYCOLIPIDS; BINDING; LIGAND; MICE; DIFFERENTIATION	CD1, a conserved family of major histocompatibility (MHC)-like glycoproteins in mammals, specializes in capturing lipid rather than peptide antigen for presentation to T lymphocytes. The principles and mechanisms of this newly discovered immune strategy differ markedly from those governing classical MHC-peptide presentation. They might be exploited for the design of new lipid-based microbial vaccines and adjuvants.	Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University	Park, SH (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.							Almeida IC, 2000, EMBO J, V19, P1476, DOI 10.1093/emboj/19.7.1476; BEEKMAN EM, 1994, NATURE, V372, P691, DOI 10.1038/372691a0; BELDJORD K, 1993, J EXP MED, V178, P121, DOI 10.1084/jem.178.1.121; Bendelac A, 1997, ANNU REV IMMUNOL, V15, P535, DOI 10.1146/annurev.immunol.15.1.535; BENDELAC A, 1995, SCIENCE, V268, P863, DOI 10.1126/science.7538697; Benedict CL, 1999, IMMUNITY, V10, P607, DOI 10.1016/S1074-7613(00)80060-6; Benlagha K, 2000, J EXP MED, V191, P1895, DOI 10.1084/jem.191.11.1895; Besra Gurdyal S., 1994, P285; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; Briken V, 2000, J EXP MED, V192, P281, DOI 10.1084/jem.192.2.281; Burdin N, 1999, EUR J IMMUNOL, V29, P2014, DOI 10.1002/(SICI)1521-4141(199906)29:06<2014::AID-IMMU2014>3.0.CO;2-G; Burdin N, 1998, J IMMUNOL, V161, P3271; CALABI F, 1989, EUR J IMMUNOL, V19, P285, DOI 10.1002/eji.1830190211; Carnaud C, 1999, J IMMUNOL, V163, P4647; CASTANO AR, 1995, SCIENCE, V269, P223, DOI 10.1126/science.7542403; Chiu YH, 1999, J EXP MED, V189, P103, DOI 10.1084/jem.189.1.103; Cui JQ, 1999, J EXP MED, V190, P783, DOI 10.1084/jem.190.6.783; Ernst WA, 1998, IMMUNITY, V8, P331, DOI 10.1016/S1074-7613(00)80538-5; Gumperz JE, 2000, IMMUNITY, V12, P211, DOI 10.1016/S1074-7613(00)80174-0; Hammond KJL, 1998, J EXP MED, V187, P1047, DOI 10.1084/jem.187.7.1047; Jackman RM, 1998, IMMUNITY, V8, P341, DOI 10.1016/S1074-7613(00)80539-7; Joyce S, 1998, SCIENCE, V279, P1541, DOI 10.1126/science.279.5356.1541; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kitamura H, 1999, J EXP MED, V189, P1121, DOI 10.1084/jem.189.7.1121; Lee RE, 1996, CURR TOP MICROBIOL, V215, P1; Lehuen A, 1998, J EXP MED, V188, P1831, DOI 10.1084/jem.188.10.1831; Molano A, 2000, J IMMUNOL, V164, P5005, DOI 10.4049/jimmunol.164.10.5005; Moody DB, 2000, NATURE, V404, P884, DOI 10.1038/35009119; Moody DB, 1997, SCIENCE, V278, P283, DOI 10.1126/science.278.5336.283; Naidenko OV, 1999, J EXP MED, V190, P1069, DOI 10.1084/jem.190.8.1069; NATORI T, 1994, TETRAHEDRON, V50, P2771, DOI 10.1016/S0040-4020(01)86991-X; Park SH, 2000, EUR J IMMUNOL, V30, P620, DOI 10.1002/1521-4141(200002)30:2<620::AID-IMMU620>3.0.CO;2-4; Porcelli SA, 1999, ANNU REV IMMUNOL, V17, P297, DOI 10.1146/annurev.immunol.17.1.297; PORCELLI SA, 1997, CURR BIOL, V7, P508; Schaible UE, 2000, J IMMUNOL, V164, P4843, DOI 10.4049/jimmunol.164.9.4843; Schofield L, 1999, SCIENCE, V283, P225, DOI 10.1126/science.283.5399.225; Shamshiev A, 1999, EUR J IMMUNOL, V29, P1667, DOI 10.1002/(SICI)1521-4141(199905)29:05<1667::AID-IMMU1667>3.0.CO;2-U; Shinkai K, 2000, J EXP MED, V191, P907, DOI 10.1084/jem.191.6.907; Sieling PA, 2000, J IMMUNOL, V164, P4790, DOI 10.4049/jimmunol.164.9.4790; SIELING PA, 1995, SCIENCE, V269, P227, DOI 10.1126/science.7542404; Singh N, 1999, J IMMUNOL, V163, P2373; Smyth MJ, 2000, J EXP MED, V191, P661, DOI 10.1084/jem.191.4.661; Spada FM, 2000, J EXP MED, V191, P937, DOI 10.1084/jem.191.6.937; Stenger S, 1997, SCIENCE, V276, P1684, DOI 10.1126/science.276.5319.1684; Sugita M, 1999, IMMUNITY, V11, P743, DOI 10.1016/S1074-7613(00)80148-X; Tatu C, 1999, J EXP MED, V190, P903, DOI 10.1084/jem.190.7.903; Wilson SB, 1998, NATURE, V391, P177, DOI 10.1038/34419; Zeng ZH, 1997, SCIENCE, V277, P339, DOI 10.1126/science.277.5324.339	48	97	112	0	12	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 17	2000	406	6797					788	792		10.1038/35021233	http://dx.doi.org/10.1038/35021233			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	344PH	10963609				2022-12-28	WOS:000088767700056
J	Syngal, S; Schrag, D; Falchuk, M; Tung, N; Farraye, FA; Chung, D; Wright, M; Whetsell, A; Miller, G; Garber, JE				Syngal, S; Schrag, D; Falchuk, M; Tung, N; Farraye, FA; Chung, D; Wright, M; Whetsell, A; Miller, G; Garber, JE			Phenotypic characteristics associated with the APC gene I1307K mutation in Ashkenazi Jewish patients with colorectal polyps	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OVARIAN-CANCER RISK; FAMILY HISTORY; 11307K ALLELE; BREAST-CANCER; JEWS; POLYMORPHISM; COMMUNITY; VARIANT	Context The I1307K mutation of the APC gene is found in approximately 6% of the Ashkenazi Jewish population and is associated with elevated risk of colorectal cancer. The incidence of the mutation in patients with colorectal adenomas is unknown. Objectives To determine the carrier rate of the I1307K mutation in Ashkenazi Jewish patients with a history of colorectal polyps but without colorectal cancer and to compare phenotypic characteristics and family history of carriers vs noncarriers. Design, Setting, and Patients A total of 231 patients who had at least 1 large bowel polyp diagnosed between January 1, 1992, and January 31, 1999, at 1 of 5 centers in Boston. Mass, were included, of whom 183 were Ashkenazi Jewish. DNA was isolated from cheek swab samples. Main Outcome Measures Presence of the I1307K variant in the APC gene. Results The I1307K variant was identified in 22 (14%) of 161 Ashkenazi Jewish patients with a history of adenomatous polyps and in 1 (5%) of 20 Ashkenazi Jewish patients with hyperplastic polyps. The phenotypic features of adenomas, family history of polyps, colorectal cancer, and other cancers were indistinguishable between I1307K carriers and noncarriers, Conclusions The frequency of the APC I1307K mutation is elevated in Ashkenazi Jewish patients with adenomatous polyps, but not hyperplastic polyps. The I1307K mutation represents a novel paradigm for cancer-predisposing genes, as it is associated with moderately increased risk of neoplasia without other associated distinguishing phenotypic features.	Dana Farber Canc Inst, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Gastroenterol, Boston, MA 02115 USA; Genzyme Corp, Boston, MA USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Beth Israel Deaconess Med Ctr,Gastrointestinal Un, Boston, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Sanofi-Aventis; Genzyme Corporation; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Massachusetts General Hospital	Syngal, S (corresponding author), Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA.	Sapna_Syngal@dfci.harvard.edu		Farraye, Francis/0000-0001-6371-2441				Abrahamson J, 1998, CANCER RES, V58, P2919; CANNONALBRIGHT LA, 1988, NEW ENGL J MED, V319, P533, DOI 10.1056/NEJM198809013190902; Frayling IM, 1998, P NATL ACAD SCI USA, V95, P10722, DOI 10.1073/pnas.95.18.10722; FUCHS CS, 1994, NEW ENGL J MED, V331, P1669, DOI 10.1056/NEJM199412223312501; Gryfe R, 1999, AM J HUM GENET, V64, P378, DOI 10.1086/302262; Gryfe R, 1998, CANCER RES, V58, P4040; Laken SJ, 1997, NAT GENET, V17, P79, DOI 10.1038/ng0997-79; Levin M, 1999, GENET TEST, V3, P207, DOI 10.1089/gte.1999.3.207; Lothe RA, 1998, CANCER RES, V58, P2923; Maresco DL, 1999, AM J HUM GENET, V64, P1228, DOI 10.1086/302345; Petrukhin L, 1997, CANCER RES, V57, P5480; Prior TW, 1999, GASTROENTEROLOGY, V116, P58, DOI 10.1016/S0016-5085(99)70229-5; Redston M, 1998, NAT GENET, V20, P13, DOI 10.1038/1666; Rozen P, 1999, GASTROENTEROLOGY, V116, P54, DOI 10.1016/S0016-5085(99)70228-3; Shields PG, 2000, J CLIN ONCOL, V18, P2309, DOI 10.1200/JCO.2000.18.11.2309; SHUBER AP, 1993, HUM MOL GENET, V2, P153, DOI 10.1093/hmg/2.2.153; Woodage T, 1998, NAT GENET, V20, P62, DOI 10.1038/1722	17	25	25	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 16	2000	284	7					857	860		10.1001/jama.284.7.857	http://dx.doi.org/10.1001/jama.284.7.857			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	342PM	10938175				2022-12-28	WOS:000088654400028
J	Chew, AL; Bashir, SJ; Maibach, HI				Chew, AL; Bashir, SJ; Maibach, HI			Treatment of head lice	LANCET			English	Editorial Material							PERMETHRIN; RESISTANT		Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Bashir, SJ (corresponding author), Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA.							Bainbridge CV, 1998, CLIN PEDIATR, V37, P17, DOI 10.1177/000992289803700103; BURGESS IF, 1995, BRIT MED J, V311, P752, DOI 10.1136/bmj.311.7007.752; Burnier M, 1999, AM J HYPERTENS, V12, p129A; Clore E R, 1993, J Pediatr Health Care, V7, P55, DOI 10.1016/0891-5245(93)90074-R; *DEP HLTH, 1996, PREV TREATM HEAD LIC; DODD CS, 2000, COCHRANE LIBRARY; Downs AMR, 1999, BRIT J DERMATOL, V141, P508, DOI 10.1046/j.1365-2133.1999.03046.x; Mellanby K., 1942, Bulletin of Entomological Research London, V33, P267, DOI 10.1017/S0007485300026584; MELLANBY K, 1985, CUTANEOUS INFESTATIO, V2, P9; PARISH LC, 1985, CUTANEOUS INFESTATIO, P159; SILVERTON N, 1972, BMJ-BRIT MED J, V30, P646; Urquhart R, 2000, CLIN PHARMACOL THER, V67, P331, DOI 10.1067/mcp.2000.105582	12	8	8	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 12	2000	356	9229					523	524		10.1016/S0140-6736(00)02571-X	http://dx.doi.org/10.1016/S0140-6736(00)02571-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	345MY	10950223				2022-12-28	WOS:000088820800003
J	Ely, JW; Osheroff, JA; Gorman, PN; Ebell, MH; Chambliss, ML; Pifer, EA; Stavri, PZ				Ely, JW; Osheroff, JA; Gorman, PN; Ebell, MH; Chambliss, ML; Pifer, EA; Stavri, PZ			A taxonomy of generic clinical questions: classification study	BRITISH MEDICAL JOURNAL			English	Article							INFORMATION NEEDS; PHYSICIANS USE; MEDLINE; CARE	Objective To develop a taxonomy of doctors' questions about patient care that could be used to help answer such questions. Design Use of 295 questions asked by Oregon primary care doctors to modify previously developed taxonomy of 1101 clinical questions asked by Iowa family doctors. Setting Primary care practices in Iowa and Oregon. Participants Random samples of 103 Iowa family doctors and 49 Oregon primary care doctors. Main outcome measures Consensus among seven investigators on a meaningful taxonomy of generic questions; interrater reliability among 11 individuals who used the taxonomy to classify a random sample of 100 questions: 50 from Iowa and 50 from Oregon. Results The revised taxonomy, which comprised 64 generic question types, was used to classify 1396 clinical questions. The three commonest generic types were "What is the drug of choice for condition x?" (150 questions, 11%); "What is the cause of symptom x?"(115 questions, 8%); and "What test is indicated in situation x?"(112 questions, 8%). The mean interrater reliability among 11 coders nas moderate (kappa = 0.53, agreement 55%). Conclusions Clinical questions in primary care can be categorised into a limited number of generic types. A moderate degree of interrater reliability was achieved with the taxonomy developed in this study, The taxonomy may enhance our understanding of doctors' information needs and improve our ability to meet those needs.	Univ Iowa, Coll Med, Dept Family Med, Iowa City, IA 52242 USA; Praxis Press, New York, NY 10010 USA; Oregon Hlth Sci Univ, Div Med Informat & Outcomes Res, Portland, OR 97201 USA; Michigan State Univ, Dept Family Practice, Clin Ctr B101, E Lansing, MI 48824 USA; Moses Cone Family Med Residency, Greensboro, NC USA; Presbyterian Med Ctr, Philadelphia, PA 19104 USA; Univ Arizona, Sch Informat Resources & Lib Sci, Tucson, AZ 85719 USA	University of Iowa; Oregon Health & Science University; Michigan State University; University of Pennsylvania; Pennsylvania Medicine; Pennsylvania Presbyterian Medical Center; University of Arizona	Ely, JW (corresponding author), Univ Iowa, Coll Med, Dept Family Med, 01291-D PFP,200 Hawkins Dr, Iowa City, IA 52242 USA.							Chambliss ML, 1996, J FAM PRACTICE, V43, P140; CIMINO JJ, 1993, B MED LIBR ASSOC, V81, P195; COVELL DG, 1985, ANN INTERN MED, V103, P596, DOI 10.7326/0003-4819-103-4-596; CURLEY SP, 1990, MED DECIS MAKING, V10, P231, DOI 10.1177/0272989X9001000401; Ely JW, 1999, BRIT MED J, V319, P358, DOI 10.1136/bmj.319.7206.358; Fleiss J. L., 1981, STAT METHODS RATES P, V2; FUNK ME, 1983, B MED LIBR ASSOC, V71, P176; GORMAN PN, 1995, MED DECIS MAKING, V15, P113, DOI 10.1177/0272989X9501500203; Graesser AC., 1988, QUEST EXCHANGE, V2, P3; Humphreys BL, 1998, J AM MED INFORM ASSN, V5, P1; HUTH EJ, 1994, ANN INTERN MED, V120, P889, DOI 10.7326/0003-4819-120-10-199405150-00012; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; LINDBERG DAB, 1993, JAMA-J AM MED ASSOC, V269, P3124, DOI 10.1001/jama.269.24.3124; McCray AT, 1998, J AM MED INFORM ASSN, V5, P129, DOI 10.1136/jamia.1998.0050129; NORTHUP DE, 1983, J MED EDUC, V58, P873; OSHEROFF JA, 1993, B MED LIBR ASSOC, V81, P11	16	170	172	0	18	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	AUG 12	2000	321	7258					429	432		10.1136/bmj.321.7258.429	http://dx.doi.org/10.1136/bmj.321.7258.429			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	344QC	10938054	Green Published, Bronze			2022-12-28	WOS:000088769500027
J	Cech, TR				Cech, TR			Structural biology - The ribosome is a ribozyme	SCIENCE			English	Editorial Material							PEPTIDYL-TRANSFERASE; ANGSTROM-RESOLUTION; RNA; PROTEIN; SUBUNIT		Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Howard Hughes Medical Institute	Cech, TR (corresponding author), Howard Hughes Med Inst, 4000 Jones Bridge Rd, Chevy Chase, MD 20815 USA.							Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Ban N, 1999, NATURE, V400, P841, DOI 10.1038/23641; Cate JH, 1999, SCIENCE, V285, P2095, DOI 10.1126/science.285.5436.2095; Clemons WM, 1999, NATURE, V400, P833, DOI 10.1038/23631; Ferre-D'Amare AR, 1998, NATURE, V395, P567, DOI 10.1038/26912; Legault P, 1997, J AM CHEM SOC, V119, P6621, DOI 10.1021/ja9640051; Muth GW, 2000, SCIENCE, V289, P947, DOI 10.1126/science.289.5481.947; Nakano S, 2000, SCIENCE, V287, P1493, DOI 10.1126/science.287.5457.1493; NOLLER HF, 1981, NUCLEIC ACIDS RES, V9, P6167, DOI 10.1093/nar/9.22.6167; NOLLER HF, 1992, SCIENCE, V256, P1416, DOI 10.1126/science.1604315; Perrotta AT, 1999, SCIENCE, V286, P123, DOI 10.1126/science.286.5437.123; WELCH M, 1995, BIOCHEMISTRY-US, V34, P385, DOI 10.1021/bi00002a001; Welch M, 1997, BIOCHEMISTRY-US, V36, P6614, DOI 10.1021/bi963135j; Zhang BL, 1998, CHEM BIOL, V5, P539, DOI 10.1016/S1074-5521(98)90113-2	15	222	228	0	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 11	2000	289	5481					878	879		10.1126/science.289.5481.878	http://dx.doi.org/10.1126/science.289.5481.878			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	343KH	10960319				2022-12-28	WOS:000088701200018
J	Bohossian, HB; Skaletsky, H; Page, DC				Bohossian, HB; Skaletsky, H; Page, DC			Unexpectedly similar rates of nucleotide substitution found in male and female hominids	NATURE			English	Article							MALE-DRIVEN EVOLUTION; MUTATION-RATE; DNA-SEQUENCES; X-CHROMOSOME; INTRON SEQUENCES; RECOMBINATION; TRANSPOSITION; REGIONS	In 1947, it was suggested that, in humans, the mutation rate is dramatically higher in the male germ line than in the female germ line(1). This hypothesis has been supported by the observation that, among primates, Y-linked genes evolved more rapidly than homologous X-linked genes(2-6). Based on these evolutionary studies, the ratio (alpha(m)) of male to female mutation rates in primates was estimated to be about 5. However, selection could have skewed sequence evolution in introns and exons(7-10). In addition, some of the X-Y gene pairs studied lie within chromosomal regions with substantially divergent nucleotide sequences(7,11,12). Here we directly compare human X and Y sequences within a large region with no known genes. Here the two chromosomes are 99% identical, and X-Y divergence began only three or four million years ago, during hominid evolution(13-15). In apes, homologous sequences exist only on the X chromosome. We sequenced and compared 38.6 kb of this region from human X, human Y, chimpanzee X and gorilla X chromosomes. We calculated alpha(m) to be 1.7 (95% confidence interval 1.15-2.87), significantly lower than previous estimates in primates. We infer that, in humans and their immediate ancestors, male and female mutation rates were far more similar than previously supposed.	MIT, Howard Hughes Med Inst, Whitehead Inst, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Page, DC (corresponding author), MIT, Howard Hughes Med Inst, Whitehead Inst, 9 Cambridge Ctr, Cambridge, MA 02142 USA.							Agresti A., 1990, CATEGORICAL DATA ANA, pXV; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Bishop YM., 2007, DISCRETE MULTIVARIAT; BULMER M, 1986, MOL BIOL EVOL, V3, P322; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Chang BHJ, 1996, ZOOL STUD, V35, P36; CHARLESWORTH B, 1994, GENET RES, V63, P213, DOI 10.1017/S0016672300032365; Crow JF, 1997, P NATL ACAD SCI USA, V94, P8380, DOI 10.1073/pnas.94.16.8380; Ellegren H, 1997, NAT GENET, V17, P182, DOI 10.1038/ng1097-182; HALDANE JBS, 1947, ANN EUGENIC, V13, P262; Huang W, 1997, J MOL EVOL, V44, P463, DOI 10.1007/PL00006166; Kaessmann H, 1999, SCIENCE, V286, P1159, DOI 10.1126/science.286.5442.1159; Kaessmann H, 1999, NAT GENET, V22, P78, DOI 10.1038/8785; Li W. H, 1997, MOL EVOLUTION; LI WH, 1989, MOL BIOL EVOL, V6, P424; McVean GT, 1997, NATURE, V386, P388, DOI 10.1038/386388a0; MIYATA T, 1987, COLD SPRING HARB SYM, V52, P863, DOI 10.1101/SQB.1987.052.01.094; Mumm S, 1997, GENOME RES, V7, P307, DOI 10.1101/gr.7.4.307; PAGE DC, 1984, NATURE, V311, P119, DOI 10.1038/311119a0; Rozen S, 1999, BIOINFORMATICS METHO; Schwartz A, 1998, HUM MOL GENET, V7, P1, DOI 10.1093/hmg/7.1.1; SHIMMIN LC, 1994, J MOL EVOL, V39, P569, DOI 10.1007/BF00160402; SHIMMIN LC, 1993, J MOL EVOL, V37, P160, DOI 10.1007/BF02407351; SHIMMIN LC, 1993, NATURE, V362, P745, DOI 10.1038/362745a0; SHIZUYA H, 1992, P NATL ACAD SCI USA, V89, P8794, DOI 10.1073/pnas.89.18.8794; TAJIMA F, 1984, MOL BIOL EVOL, V1, P269; UBERBACHER EC, 1991, P NATL ACAD SCI USA, V88, P11261, DOI 10.1073/pnas.88.24.11261; Vogel F., 1997, HUMAN GENETICS; Wilkin DJ, 1998, AM J HUM GENET, V63, P711, DOI 10.1086/302000; WOLFE KH, 1989, NATURE, V337, P283, DOI 10.1038/337283a0	30	71	74	0	11	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 10	2000	406	6796					622	625		10.1038/35020557	http://dx.doi.org/10.1038/35020557			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	342PF	10949301				2022-12-28	WOS:000088653800046
J	Matas, AJ; Garvey, CA; Jacobs, CL; Kahn, JP				Matas, AJ; Garvey, CA; Jacobs, CL; Kahn, JP			Nondirected donation of kidneys from living donors	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ORGAN DONATION; FOLLOW-UP; TRANSPLANTATION; PROGRAM; ETHICS		Univ Minnesota, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Matas, AJ (corresponding author), Univ Minnesota, Minneapolis, MN 55455 USA.		matas, arthur/ABE-1018-2021	Kahn, Jeffrey/0000-0003-2493-2016	PHS HHS [13083] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		D'Alessandro AM, 1998, SURGERY, V124, P604, DOI 10.1067/msy.1998.91482; ELLIOTT C, 1995, J MED ETHICS, V21, P91, DOI 10.1136/jme.21.2.91; FELLNER CH, 1973, ANN INTERN MED, V79, P589, DOI 10.7326/0003-4819-79-4-589; FELLNER CH, 1971, NEW ENGL J MED, V284, P582, DOI 10.1056/NEJM197103182841105; JACOBS CL, 1998, AM SOC TRANSPL PHYS; Johnson EM, 1997, TRANSPLANTATION, V64, P1124, DOI 10.1097/00007890-199710270-00007; Johnson EM, 1999, TRANSPLANTATION, V67, P717, DOI 10.1097/00007890-199903150-00013; JONES J, 1993, TRANSPLANT REV, V7, P115; KREIS H, 1985, TRANSPL P, V17, P1510; Matas AJ, 1996, CLIN TRANSPLANT, V10, P516; MATAS AJ, IN PRESS ANN SURG; MCGEOWN MG, 1968, AM HEART J, V75, P711, DOI 10.1016/0002-8703(68)90331-1; MICHIELSEN P, 1995, CLIN TRANSPLANTS 199, P344; NAJARIAN JS, 1992, LANCET, V340, P807, DOI 10.1016/0140-6736(92)92683-7; Park K, 1999, TRANSPLANT P, V31, P356, DOI 10.1016/S0041-1345(98)01659-5; PARK K, 1993, CLIN TRANSPLANTS 199, P249; RAPAPORT FT, 1987, TRANSPL P, V19, P169; Ross LF, 1997, NEW ENGL J MED, V336, P1752, DOI 10.1056/NEJM199706123362412; Sells RA, 1997, NEW ENGL J MED, V337, P1392; Simmons RG, 1977, GIFT LIFE SOCIAL PSY; Spital A, 1996, TRANSPLANTATION, V62, P1356, DOI 10.1097/00007890-199611150-00031; Spital A, 1997, CLIN TRANSPLANT, V11, P77; SPITAL A, 1991, CLIN TRANSPLANT, V5, P322; STARZL TE, 1987, TRANSPLANT P, V19, P174; SUTHERLAND DER, 1995, TRANSPLANT P, V27, P102; WOODRUFF MF, 1964, BMJ-BRIT MED J, V1, P1457, DOI 10.1136/bmj.1.5396.1457	26	122	122	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 10	2000	343	6					433	436		10.1056/NEJM200008103430611	http://dx.doi.org/10.1056/NEJM200008103430611			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	342DT	10933745				2022-12-28	WOS:000088630500011
J	Loubere, P				Loubere, P			Marine control of biological production in the eastern equatorial Pacific Ocean	NATURE			English	Article							QUANTITATIVE ESTIMATION; BENTHIC FORAMINIFERA; DEEP-SEA; VARIABILITY; ASSEMBLAGES	The eastern equatorial Pacific Ocean is the site of approximately 20-50% of new biological production in the global oceans(1). This region is also responsible for the greatest efflux of CO2 from oceans to the atmosphere(2). New production, which fixes carbon in response to external inputs of nutrients as opposed to supply from local nutrient recycling, is thought to modulate the CO2 release(3). But what controls new production in this region is less clear. Here we present a quantitative reconstruction of biological production in the surface ocean for this region over the past 130,000 years, which shows that the equatorial Pacific Ocean exhibits higher-frequency variations than the South Equatorial Current. Comparison of these records with palaeotemperature reconstructions indicates that atmospherically driven mechanisms-such as aeolian flux of iron or wind-driven changes in upwelling rate of nutrient-rich waters-are unlikely to have influenced longer-term rates of production in this region. Instead, biological production appears to be governed by changes in ocean circulation and the chemical composition of upwelled water.	No Illinois Univ, Dept Geol & Environm Geosci, De Kalb, IL 60115 USA	Northern Illinois University	Loubere, P (corresponding author), No Illinois Univ, Dept Geol & Environm Geosci, De Kalb, IL 60115 USA.	paul@geol.niu.edu						Antoine D, 1996, GLOBAL BIOGEOCHEM CY, V10, P57, DOI 10.1029/95GB02832; BARBER RT, 1991, LIMNOL OCEANOGR, V36, P1803, DOI 10.4319/lo.1991.36.8.1803; Barber RT, 1996, DEEP-SEA RES PT II, V43, P933, DOI 10.1016/0967-0645(96)00035-5; Berger WH, 1998, DEEP-SEA RES PT II, V45, P1885, DOI 10.1016/S0967-0645(98)80021-0; BERGER WH, 1989, PRODUCTIVITY OCEAN P, P429; Dugdale RC, 1998, NATURE, V391, P270, DOI 10.1038/34630; Fariduddin M, 1997, MAR MICROPALEONTOL, V32, P289, DOI 10.1016/S0377-8398(97)00026-1; FARRELL JW, 1995, NATURE, V377, P514, DOI 10.1038/377514a0; Fitzwater SE, 1996, DEEP-SEA RES PT II, V43, P995, DOI 10.1016/0967-0645(96)00033-1; Francois R, 1997, NATURE, V389, P929, DOI 10.1038/40073; Kutzbach J, 1998, QUATERNARY SCI REV, V17, P473, DOI 10.1016/S0277-3791(98)00009-2; Lampitt RS, 1997, DEEP-SEA RES PT I, V44, P1377, DOI 10.1016/S0967-0637(97)00020-4; Liu Z, 2000, GEOPHYS RES LETT, V27, P105, DOI 10.1029/1999GL002321; Loubere P, 1996, MAR MICROPALEONTOL, V28, P247, DOI 10.1016/0377-8398(96)00004-7; Loubere P, 1999, GLOBAL BIOGEOCHEM CY, V13, P115, DOI 10.1029/1998GB900001; Loubere P, 1999, MAR MICROPALEONTOL, V37, P173, DOI 10.1016/S0377-8398(99)00013-4; LOUBERE P, 1994, PALEOCEANOGRAPHY, V9, P723, DOI 10.1029/94PA01624; Loubere P, 1998, DEEP-SEA RES PT I, V45, P409, DOI 10.1016/S0967-0637(97)00092-7; Lyle M, 1988, PALEOCEANOGRAPHY, V3, P39, DOI 10.1029/PA003i001p00039; Martin JH, 1990, PALEOCEANOGRAPHY, V5, P1, DOI 10.1029/PA005i001p00001; MIX A, 1996, S ATLANTIC PRESENT C; Mix A.C., 1995, Proceedings of the Ocean Drilling Program Scientific Results, V138, P839, DOI 10.2973/odp.proc.sr.138.160.1995; MURRAY JW, 1994, SCIENCE, V266, P58, DOI 10.1126/science.266.5182.58; NINKOVICH D, 1975, EARTH PLANET SC LETT, V27, P20, DOI 10.1016/0012-821X(75)90156-9; Pisias NG, 1997, PALEOCEANOGRAPHY, V12, P381, DOI 10.1029/97PA00583; Pisias NG, 1990, PALEOCEANOGRAPHY, V5, P147, DOI 10.1029/PA005i002p00147; REA DK, 1994, REV GEOPHYS, V32, P159, DOI 10.1029/93RG03257; TANS PP, 1990, SCIENCE, V247, P1431, DOI 10.1126/science.247.4949.1431; TOGGWEILER JR, 1991, J GEOPHYS RES-OCEANS, V96, P20467, DOI 10.1029/91JC02063; Toggweiler JR, 1995, DAHL WS ENV, V18, P337	30	72	76	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 3	2000	406	6795					497	500		10.1038/35020041	http://dx.doi.org/10.1038/35020041			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	340ML	10952307				2022-12-28	WOS:000088538000041
J	Delhase, M; Li, NX; Karin, M				Delhase, M; Li, NX; Karin, M			Signalling pathways - Kinase regulation in inflammatory response	NATURE			English	Article							NF-KAPPA-B; CELL-DEATH; ACTIVATION; PHOSPHORYLATION; SUBUNIT; ALPHA		Univ Calif San Diego, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Delhase, M (corresponding author), Univ Calif San Diego, Lab Gene Regulat & Signal Transduct, 9500 Gilman Dr, La Jolla, CA 92093 USA.		Delhase, Mireille/ABE-5256-2021	Delhase, Mireille/0000-0003-2312-1051				Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; Hemmings BA, 1997, SCIENCE, V275, P628, DOI 10.1126/science.275.5300.628; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Madrid LV, 2000, MOL CELL BIOL, V20, P1626, DOI 10.1128/MCB.20.5.1626-1638.2000; Ozes ON, 1999, NATURE, V401, P82; ROTHWARF DM, 1999, NF KAPPA ACTIVATION; Sizemore N, 1999, MOL CELL BIOL, V19, P4798; Takeda K, 1999, SCIENCE, V284, P313, DOI 10.1126/science.284.5412.313; Tojima Y, 2000, NATURE, V404, P778, DOI 10.1038/35008109	12	108	112	0	5	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 27	2000	406	6794					367	368		10.1038/35019154	http://dx.doi.org/10.1038/35019154			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	337WC	10935625				2022-12-28	WOS:000088383800032
J	Andrews, DW				Andrews, DW			Transport across membranes: A question of navigation	CELL			English	Article							BLUE NATIVE ELECTROPHORESIS; PROTEIN COMPLEXES; IMPORT; RNA		McMaster Univ, Dept Biochem, Hamilton, ON L8N 3Z5, Canada	McMaster University	Andrews, DW (corresponding author), McMaster Univ, Dept Biochem, 1200 Main St W, Hamilton, ON L8N 3Z5, Canada.			Andrews, David/0000-0002-9266-7157				Abe Y, 2000, CELL, V100, P551, DOI 10.1016/S0092-8674(00)80691-1; Braun BC, 1999, NAT CELL BIOL, V1, P221, DOI 10.1038/12043; Chen XJ, 1999, TRENDS CELL BIOL, V9, P222, DOI 10.1016/S0962-8924(99)01554-8; Donzeau M, 2000, CELL, V101, P401, DOI 10.1016/S0092-8674(00)80850-8; Falcone D, 1999, J BIOL CHEM, V274, P33661, DOI 10.1074/jbc.274.47.33661; Kennedy KA, 1999, J BIOL CHEM, V274, P6259, DOI 10.1074/jbc.274.10.6259; LEGATE KR, 2000, IN PRESS J BIOL CHEM; Millman JS, 1997, CELL, V89, P673, DOI 10.1016/S0092-8674(00)80248-2; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Scotti PA, 2000, EMBO J, V19, P542, DOI 10.1093/emboj/19.4.542; Snyder WB, 2000, J CELL BIOL, V149, P1171, DOI 10.1083/jcb.149.6.1171; Watkins JL, 1998, P NATL ACAD SCI USA, V95, P6779, DOI 10.1073/pnas.95.12.6779; Yermovsky-Kammerer AE, 1999, MOL CELL BIOL, V19, P6253	14	3	3	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 21	2000	102	2					139	144		10.1016/S0092-8674(00)00019-2	http://dx.doi.org/10.1016/S0092-8674(00)00019-2			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	337NA	10943834	Bronze			2022-12-28	WOS:000088366800004
J	Li, H; Kolluri, SK; Gu, J; Dawson, MI; Cao, XH; Hobbs, PD; Lin, BZ; Chen, GQ; Lu, LS; Lin, F; Xie, ZH; Fontana, JA; Reed, JC; Zhang, XK				Li, H; Kolluri, SK; Gu, J; Dawson, MI; Cao, XH; Hobbs, PD; Lin, BZ; Chen, GQ; Lu, LS; Lin, F; Xie, ZH; Fontana, JA; Reed, JC; Zhang, XK			Cytochrome c release and apoptosis induced by mitochondrial targeting of nuclear orphan receptor TR3	SCIENCE			English	Article							RETINOID-X-RECEPTOR; THYROID-HORMONE; GROWTH-FACTORS; CELL-DEATH; GENE NUR77; NGFI-B; SUPERFAMILY; BCL-2; HETERODIMERIZATION; REQUIREMENT	TR3, an immediate-early response gene and an orphan member of the steroid-thyroid hormone-retinoid receptor superfamily of transcription factors, regulates apoptosis through an unknown mechanism. In response to apoptotic stimuli, TR3 translocates from the nucleus to mitochondria to induce cytochrome c release and apoptosis. Mitochondrial targeting of TR3, but not its DNA binding and transactivation, is essential for its proapoptotic effect. Our results reveal a mechanism by which a nuclear transcription factor translocates to mitochondria to initiate apoptosis.	Burnham Inst, La Jolla, CA 92037 USA; Mol Med Res Inst, Mt View, CA 94043 USA; SRI Int, Retinoid Program, Menlo Park, CA 94025 USA; Wayne State Univ, Karmanos Canc Inst, Detroit, MI 48201 USA; John D Dingel VA Med Ctr, Detroit, MI 48201 USA	Sanford Burnham Prebys Medical Discovery Institute; SRI International; Barbara Ann Karmanos Cancer Institute; Wayne State University	Zhang, XK (corresponding author), Burnham Inst, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.			Fontana, Joseph/0000-0003-3829-3358				BERNARD BA, 1992, BIOCHEM BIOPH RES CO, V186, P977, DOI 10.1016/0006-291X(92)90842-9; BISSONNETTE RP, 1992, NATURE, V359, P552, DOI 10.1038/359552a0; BODDYWETZEL E, 1997, EMBO J, V16, P1695; CHANG C, 1988, BIOCHEM BIOPH RES CO, V155, P971, DOI 10.1016/S0006-291X(88)80591-6; Cheng LEC, 1997, EMBO J, V16, P1865, DOI 10.1093/emboj/16.8.1865; FANIDI A, 1992, NATURE, V359, P554, DOI 10.1038/359554a0; FORMAN BM, 1995, CELL, V81, P541, DOI 10.1016/0092-8674(95)90075-6; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; HAZEL TG, 1988, P NATL ACAD SCI USA, V85, P8444, DOI 10.1073/pnas.85.22.8444; HERSCHMAN HR, 1991, ANNU REV BIOCHEM, V60, P281, DOI 10.1146/annurev.biochem.60.1.281; KASTNER P, 1995, CELL, V83, P859, DOI 10.1016/0092-8674(95)90202-3; Kolluri SK, 1999, GENE DEV, V13, P1742, DOI 10.1101/gad.13.13.1742; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Labelle Y, 1999, ONCOGENE, V18, P3303, DOI 10.1038/sj.onc.1202675; LEEVERS SJ, 1994, NATURE, V369, P411, DOI 10.1038/369411a0; LI HN, UNPUB; Li Y, 1998, MOL CELL BIOL, V18, P4719, DOI 10.1128/MCB.18.8.4719; LIU ZG, 1994, NATURE, V367, P281, DOI 10.1038/367281a0; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; MILBRANDT J, 1988, NEURON, V1, P183, DOI 10.1016/0896-6273(88)90138-9; NAKAI A, 1990, MOL ENDOCRINOL, V4, P1438, DOI 10.1210/mend-4-10-1438; PERLMANN T, 1995, GENE DEV, V9, P769, DOI 10.1101/gad.9.7.769; Phillips A, 1997, MOL CELL BIOL, V17, P5946, DOI 10.1128/MCB.17.10.5946; Reed JC, 1997, CELL, V91, P559, DOI 10.1016/S0092-8674(00)80442-0; RYSECK RP, 1989, EMBO J, V8, P3327, DOI 10.1002/j.1460-2075.1989.tb08494.x; SOLTYS BJ, 1992, BIOCHEM CELL BIOL, V70, P1174, DOI 10.1139/o92-163; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.bi.63.070194.002315; Uemura H, 1998, ENDOCRINOLOGY, V139, P2329, DOI 10.1210/en.139.5.2329; Weih F, 1996, P NATL ACAD SCI USA, V93, P5533, DOI 10.1073/pnas.93.11.5533; WORONICZ JD, 1994, NATURE, V367, P277, DOI 10.1038/367277a0; Wu Q, 1997, EMBO J, V16, P1656, DOI 10.1093/emboj/16.7.1656; Wu Q, 1997, MOL CELL BIOL, V17, P6598, DOI 10.1128/MCB.17.11.6598; Yoneda Y, 1997, J BIOCHEM, V121, P811; YOON JK, 1993, J BIOL CHEM, V268, P9148; YOUNG CYF, 1994, ONCOL RES, V6, P203; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248; ZHANG XK, 1993, TRENDS ENDOCRIN MET, V4, P156, DOI 10.1016/1043-2760(93)90105-N; ZHANG XK, 1992, NATURE, V355, P441, DOI 10.1038/355441a0; Zhu WJ, 1996, EMBO J, V15, P4130, DOI 10.1002/j.1460-2075.1996.tb00788.x	39	559	604	1	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 18	2000	289	5482					1159	1164		10.1126/science.289.5482.1159	http://dx.doi.org/10.1126/science.289.5482.1159			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	346JE	10947977				2022-12-28	WOS:000088866600033
J	Macaluso, E; Frith, CD; Driver, J				Macaluso, E; Frith, CD; Driver, J			Modulation of human visual cortex by crossmodal spatial attention	SCIENCE			English	Article							CONNECTIONS; MECHANISMS; AREAS; MAPS	A sudden touch on one hand can improve vision near that hand, revealing crossmodal Links in spatial attention. It is often assumed that such Links involve only multimodal neural structures, but unimodal brain areas may also be affected. We tested the effect of simultaneous visuo-tactile stimulation on the activity of the human visual cortex. Tactile stimulation enhanced activity in the visual cortex, but only when it was on the same side as a visual target. Analysis of effective connectivity between brain areas suggests that touch influences unimodal visual cortex via back-projections from multimodal parietal areas. This provides a neural explanation for crossmodal links in spatial attention.	UCL, Inst Cognit Neurosci, London WC1E 6BT, England; Inst Neurol, Wellcome Dept Cognit Neurol, London WC1N 3BG, England	University of London; University College London; University of London; University College London	Macaluso, E (corresponding author), UCL, Inst Cognit Neurosci, London WC1E 6BT, England.	e.macaluso@filion.uclac.uk	Frith, Chris D/A-2171-2009; Macaluso, Emiliano/AAE-9185-2019; Macaluso, Emiliano/H-3139-2017; Driver, Jon/A-4779-2010	Frith, Chris D/0000-0002-8665-0690; Macaluso, Emiliano/0000-0002-1919-5288; Macaluso, Emiliano/0000-0002-1919-5288; 				ANDERSEN RA, 1990, J COMP NEUROL, V296, P65, DOI 10.1002/cne.902960106; BUTTER CM, 1989, NEUROPSYCHOLOGIA, V27, P1231, DOI 10.1016/0028-3932(89)90035-3; COGHILL RC, 1994, J NEUROSCI, V14, P4095; CORBETTA M, 1993, J NEUROSCI, V13, P1202; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; diPellegrino G, 1997, NATURE, V388, P730, DOI 10.1038/41921; Driver J, 1998, TRENDS COGN SCI, V2, P254, DOI 10.1016/S1364-6613(98)01188-7; FARAH MJ, 1989, NEUROPSYCHOLOGIA, V27, P461, DOI 10.1016/0028-3932(89)90051-1; Felleman DJ, 1997, J COMP NEUROL, V379, P21, DOI 10.1002/(SICI)1096-9861(19970303)379:1<21::AID-CNE3>3.0.CO;2-K; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Graziano MSA, 1998, CURR OPIN NEUROBIOL, V8, P195, DOI 10.1016/S0959-4388(98)80140-2; HAENNY PE, 1988, EXP BRAIN RES, V69, P245, DOI 10.1007/BF00247570; Hahnloser R, 1999, NAT NEUROSCI, V2, P746, DOI 10.1038/11219; Henson R.N.A., 1999, NEUROIMAGE, V9, P125, DOI DOI 10.1016/J.NEUROIMAGE.2011.06.078; Hillyard Steven A., 1995, P665; Pashler HE, 1998, PSYCHOL ATTENTION; Passingham RE, 1998, COMP NEUROPSYCHOLOGY, P271; Spence C, 1998, PERCEPT PSYCHOPHYS, V60, P544, DOI 10.3758/BF03206045; WEINTRAUB S, 1987, ARCH NEUROL-CHICAGO, V44, P621, DOI 10.1001/archneur.1987.00520180043014; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; [No title captured]	21	436	441	1	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 18	2000	289	5482					1206	1208		10.1126/science.289.5482.1206	http://dx.doi.org/10.1126/science.289.5482.1206			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	346JE	10947990				2022-12-28	WOS:000088866600046
J	Seder, RA; Hill, AVS				Seder, RA; Hill, AVS			Vaccines against intracellular infections requiring cellular immunity	NATURE			English	Article							MEMORY T-CELLS; IMMUNODEFICIENCY VIRUS-INFECTION; ACTIVE ANTIRETROVIRAL THERAPY; IN-VIVO; PROTECTIVE IMMUNITY; INTERFERON-GAMMA; DNA VACCINATION; CPG MOTIFS; ANTIGEN; LYMPHOCYTES	Vaccines against a variety of infectious diseases represent one of the great triumphs of medicine. The immune correlates of protection induced by most current vaccines seem to be mediated by long-lived humoral immune responses. By contrast, there are no currently available vaccines that are uniformly effective for diseases such as HIV, malaria and tuberculosis, in which the cellular immune response might be crucial in mediating protection. Here we examine the mechanisms by which long-lived cellular immune responses are generated and maintained in vivo. We then discuss current approaches for vaccination against diseases in which cellular immune responses are important for protection.	NIAID, Clin Immunol Sect, Clin Invest Lab, NIH, Bethesda, MD 20892 USA; Univ Oxford, John Radcliffe Hosp, Nuffield Dept Med, Inst Mol Med,Mol Immunol Grp, Oxford OX3 9DU, England	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Oxford	Seder, RA (corresponding author), NIAID, Clin Immunol Sect, Clin Invest Lab, NIH, Bethesda, MD 20892 USA.	rseder@niaid.nih.gov	HILL, Adrian V>S>/C-1306-2008					Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Bachmann MF, 1997, P NATL ACAD SCI USA, V94, P640, DOI 10.1073/pnas.94.2.640; Calarota S, 1998, LANCET, V351, P1320, DOI 10.1016/S0140-6736(97)09440-3; Cho HJ, 2000, NAT BIOTECHNOL, V18, P509, DOI 10.1038/75365; Cowdery J, 1996, J IMMUNOL, V156, P4570; Doolan DL, 1996, J EXP MED, V183, P1739, DOI 10.1084/jem.183.4.1739; Dutton RW, 1998, ANNU REV IMMUNOL, V16, P201, DOI 10.1146/annurev.immunol.16.1.201; Flynn KJ, 1998, IMMUNITY, V8, P683, DOI 10.1016/S1074-7613(00)80573-7; Garcia S, 1999, IMMUNITY, V11, P163, DOI 10.1016/S1074-7613(00)80091-6; GRAY D, 1991, J EXP MED, V174, P969, DOI 10.1084/jem.174.5.969; Guebre-Xabier M, 1999, EUR J IMMUNOL, V29, P3978, DOI 10.1002/(SICI)1521-4141(199912)29:12&lt;3978::AID-IMMU3978&gt;3.0.CO;2-0; Gurunathan S, 1998, NAT MED, V4, P1409, DOI 10.1038/4000; Hanke T, 1999, J VIROL, V73, P7524, DOI 10.1128/JVI.73.9.7524-7532.1999; HOU S, 1994, NATURE, V369, P652, DOI 10.1038/369652a0; Kalams SA, 1999, J VIROL, V73, P6721, DOI 10.1128/JVI.73.8.6721-6728.1999; Kent SJ, 1998, J VIROL, V72, P10180, DOI 10.1128/JVI.72.12.10180-10188.1998; Klinman DM, 1996, P NATL ACAD SCI USA, V93, P2879, DOI 10.1073/pnas.93.7.2879; Krieg AM, 1998, P NATL ACAD SCI USA, V95, P12631, DOI 10.1073/pnas.95.21.12631; Kundig TM, 1996, P NATL ACAD SCI USA, V93, P9716, DOI 10.1073/pnas.93.18.9716; LAU LL, 1994, NATURE, V369, P648, DOI 10.1038/369648a0; Le TP, 2000, VACCINE, V18, P1893, DOI 10.1016/S0264-410X(99)00407-7; Lifson JD, 1997, J VIROL, V71, P9508, DOI 10.1128/JVI.71.12.9508-9514.1997; Matano T, 1998, J VIROL, V72, P164, DOI 10.1128/JVI.72.1.164-169.1998; MCHEYZERWILLIAMS MG, 1995, SCIENCE, V268, P106, DOI 10.1126/science.7535476; MULLBACHER A, 1994, J EXP MED, V179, P317, DOI 10.1084/jem.179.1.317; Murali-Krishna K, 1999, SCIENCE, V286, P1377, DOI 10.1126/science.286.5443.1377; Ochsenbein AF, 1999, P NATL ACAD SCI USA, V96, P9293, DOI 10.1073/pnas.96.16.9293; OEHEN S, 1992, J EXP MED, V176, P1273, DOI 10.1084/jem.176.5.1273; Ogg GS, 1998, SCIENCE, V279, P2103, DOI 10.1126/science.279.5359.2103; Opferman JT, 1999, SCIENCE, V283, P1745, DOI 10.1126/science.283.5408.1745; Ortiz GM, 1999, J CLIN INVEST, V104, pR13, DOI 10.1172/JCI7371; RAZVI ES, 1995, ADV VIRUS RES, V45, P1, DOI 10.1016/S0065-3527(08)60057-3; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sato Y, 1996, SCIENCE, V273, P352, DOI 10.1126/science.273.5273.352; SCHELLER LF, 1995, P NATL ACAD SCI USA, V92, P4066, DOI 10.1073/pnas.92.9.4066; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Schneider J, 1998, NAT MED, V4, P397, DOI 10.1038/nm0498-397; Schneider J, 1999, IMMUNOL REV, V170, P29, DOI 10.1111/j.1600-065X.1999.tb01326.x; Schubach A, 1998, J INFECT DIS, V178, P911, DOI 10.1086/515355; Seder RA, 1999, NEW ENGL J MED, V341, P277, DOI 10.1056/NEJM199907223410410; Stoute JA, 1997, NEW ENGL J MED, V336, P86, DOI 10.1056/NEJM199701093360202; Swain SL, 1999, SCIENCE, V286, P1381, DOI 10.1126/science.286.5443.1381; Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057; ULMER JB, 1993, SCIENCE, V259, P1745, DOI 10.1126/science.8456302; Wang RB, 1998, SCIENCE, V282, P476, DOI 10.1126/science.282.5388.476; Zhang XH, 1998, IMMUNITY, V8, P591, DOI 10.1016/S1074-7613(00)80564-6; Zhang ZQ, 1999, SCIENCE, V286, P1353, DOI 10.1126/science.286.5443.1353	47	296	320	0	15	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 17	2000	406	6797					793	798		10.1038/35021239	http://dx.doi.org/10.1038/35021239			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	344PH	10963610	Bronze			2022-12-28	WOS:000088767700057
J	Brown, JS; Sawaya, G; Thom, DH; Grady, D				Brown, JS; Sawaya, G; Thom, DH; Grady, D			Hysterectomy and urinary incontinence: a systematic review	LANCET			English	Article							TOTAL ABDOMINAL HYSTERECTOMY; VAGINAL HYSTERECTOMY; BLADDER FUNCTION; TRACT FUNCTION; PELVIC FLOOR; WOMEN; PREVALENCE; SYMPTOMS; RISK; AGE	Background Serious complications after hysterectomy are estimated to occur in around six women per 10 000 hysterectomies in the USA. We did a systematic review of evidence that hysterectomy is associated with urinary incontinence. Methods We identified English-language and non-English-language articles registered on MEDLINE from January, 1966, to December, 1997, did manual review of references, and consulted specialists. We identified 45 articles reporting on the association of urinary incontinence and hysterectomy. We selected reports that presented original data on development of incontinence in women who underwent hysterectomy compared with those who did not. Results were abstracted by two independent reviewers and summarised with a random-effects model. Findings: 12 papers met our selection criteria-eight cross-sectional studies, two prospective cohort studies, one case control study, and one randomised controlled trial. The summary estimate was consistent with increased odds for incontinence in women with hysterectomy. Because incontinence might not develop for many years after hysterectomy, we stratified the findings by age at assessment of incontinence. Among women who were 60 years or older, the summary odds ratio for urinary incontinence was increased by 60% (1.6 [95% CI 1.4-1.8]) but odds were not increased for women younger than 60 years. incontinence incontinence. Interpretation: When women are counselled about sequelae of hysterectomy, practitioners should discuss the possibility of an increased likelihood of incontinence in later life.	Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, Womens Continence Ctr, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Stanford Univ, Div Family & Community Med, Stanford, CA 94305 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Stanford University	Brown, JS (corresponding author), Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, Womens Continence Ctr, 2330 Post St,Suite 200, San Francisco, CA 94143 USA.	brownj@obgyn.ucsf.edu			NIA NIH HHS [K08 AG000710] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [K08AG000710] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		AINMELK Y, 1975, UNION MED CAN, V104, P1413; ANDERSEN TF, 1993, ACTA OBSTET GYN SCAN, V72, P570, DOI 10.3109/00016349309058166; Bhattacharya S, 1996, BRIT J OBSTET GYNAEC, V103, P898, DOI 10.1111/j.1471-0528.1996.tb09909.x; BORENSTEIN R, 1992, SURG GYNECOL OBSTET, V175, P551; Brown JS, 1996, OBSTET GYNECOL, V87, P715, DOI 10.1016/0029-7844(96)00013-0; CARLSON KJ, 1994, OBSTET GYNECOL, V83, P556, DOI 10.1097/00006250-199404000-00012; COUGHLAN BM, 1989, IRISH J MED SCI, V158, P215, DOI 10.1007/BF02943615; DELANCEY JOL, 1993, NEW ENGL J MED, V329, P1956, DOI 10.1056/NEJM199312233292610; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DICKER RC, 1982, AM J OBSTET GYNECOL, V144, P841, DOI 10.1016/0002-9378(82)90362-3; DIOKNO AC, 1990, UROLOGY, V36, P129, DOI 10.1016/0090-4295(90)80211-5; FARGHALY SA, 1986, BRIT J UROL, V58, P299, DOI 10.1111/j.1464-410X.1986.tb09059.x; Fleiss J. L., 1981, STAT METHODS RATES P, V2; FOLDSPANG A, 1992, J EPIDEMIOL COMMUN H, V46, P595, DOI 10.1136/jech.46.6.595; Gadonneix P, 1987, Rev Fr Gynecol Obstet, V82, P555; Graves E.J, 1995, VITALHEALTHSTAT, V122, P1; GREENLAND S, 1987, EPIDEMIOL REV, V9, P1; GRIFFITHJONES MD, 1991, BRIT J UROL, V67, P295, DOI 10.1111/j.1464-410X.1991.tb15138.x; Hanley H G, 1969, Br J Urol, V41, P682, DOI 10.1111/j.1464-410X.1969.tb09977.x; HANSEN BM, 1985, UROL INT, V40, P224, DOI 10.1159/000281085; HARRISON GL, 1994, BRIT J GEN PRACT, V44, P149; HASSON HM, 1993, J REPROD MED, V38, P781; HELLSTROM L, 1990, AGE AGEING, V19, P383, DOI 10.1093/ageing/19.6.383; HORDING U, 1986, SCAND J UROL NEPHROL, V20, P183, DOI 10.3109/00365598609024491; IOSIF CS, 1988, INT J GYNECOL OBSTET, V26, P255, DOI 10.1016/0020-7292(88)90270-6; IOSIF S, 1981, ACTA OBSTET GYN SCAN, V60, P71, DOI 10.3109/00016348109154113; JEQUIER AM, 1976, BRIT J UROL, V49, P437, DOI 10.1111/j.1464-410X.1976.tb06676.x; JOLLEYS JV, 1988, BRIT MED J, V296, P1300, DOI 10.1136/bmj.296.6632.1300; KILKKU P, 1985, ACTA OBSTET GYN SCAN, V64, P375, DOI 10.3109/00016348509155151; LALOS O, 1986, EUR J OBSTET GYN R B, V21, P143, DOI 10.1016/0028-2243(86)90028-6; LALOS O, 1985, ARCH GYNECOL S, V223, P140; LANGER R, 1989, OBSTET GYNECOL, V74, P205; Larsen P N, 1983, Ugeskr Laeger, V145, P3402; MCPHERSON K, 1989, HLTH CARE FINANCIN S, P9; Milani R, 1980, Ann Ostet Ginecol Med Perinat, V101, P404; MILSOM I, 1993, J UROLOGY, V149, P1459, DOI 10.1016/S0022-5347(17)36415-7; MOMMSEN S, 1993, BRIT J UROL, V72, P30, DOI 10.1111/j.1464-410X.1993.tb06452.x; Mouritsen L, 1983, Ugeskr Laeger, V145, P1062; Munro MG, 1997, OBSTET GYNECOL, V89, P133; Narushima M, 1993, Hinyokika Kiyo, V39, P797; OXMAN AD, 1994, JAMA-J AM MED ASSOC, V272, P1367, DOI 10.1001/jama.272.17.1367; PARYS BT, 1990, EUR UROL, V17, P129; PARYS BT, 1990, AUST NZ J OBSTET GYN, V30, P161, DOI 10.1111/j.1479-828X.1990.tb03253.x; PARYS BT, 1989, BRIT J UROL, V64, P594, DOI 10.1111/j.1464-410X.1989.tb05316.x; PARYS BT, 1990, INT UROGYNECOL J, V1, P200; Pinotti J A, 1981, AMB Rev Assoc Med Bras, V27, P135; POKRAS R, 1987, VITAL HLTH STAT, V92, P1; QUENU L, 1979, CHIRURGIE, V105, P377; REKERS H, 1992, MATURITAS, V15, P101, DOI 10.1016/0378-5122(92)90244-X; RICHARDS DH, 1974, LANCET, V2, P983; SCHOFIELD MJ, 1991, BRIT J OBSTET GYNAEC, V98, P1129, DOI 10.1111/j.1471-0528.1991.tb15365.x; SKONER MM, 1994, NURS RES, V43, P301; Smith P, 1970, Br J Urol, V42, P3; SNOOKS SJ, 1990, BRIT J SURG, V77, P1358, DOI 10.1002/bjs.1800771213; SNOOKS SJ, 1985, BRIT J UROL, V57, P422, DOI 10.1111/j.1464-410X.1985.tb06302.x; STANTON SL, 1982, BRIT J OBSTET GYNAEC, V89, P459, DOI 10.1111/j.1471-0528.1982.tb03637.x; TAYLOR T, 1990, INT J COLORECTAL DIS, V5, P228, DOI 10.1007/BF00303282; Thom DH, 1997, OBSTET GYNECOL, V90, P983, DOI 10.1016/S0029-7844(97)00537-1; THOMAS TM, 1980, BRIT MED J, V281, P1243, DOI 10.1136/bmj.281.6250.1243; VEHKALAHTI I, 1985, GERONTOLOGY, V31, P391, DOI 10.1159/000212728; VERVEST HAM, 1989, ACTA OBSTET GYN SCAN, V68, P231, DOI 10.3109/00016348909020994; VERVEST HAM, 1988, ACTA OBSTET GYN SCAN, V67, P141, DOI 10.3109/00016348809004187; VESSEY MP, 1992, BRIT J OBSTET GYNAEC, V99, P402, DOI 10.1111/j.1471-0528.1992.tb13758.x; VIKTRUP L, 1992, OBSTET GYNECOL, V79, P945; VIRTANEN H, 1993, BRIT J UROL, V72, P868, DOI 10.1111/j.1464-410X.1993.tb16288.x; WAKE CR, 1980, BRIT J OBSTET GYNAEC, V87, P901, DOI 10.1111/j.1471-0528.1980.tb04445.x; WINGO PA, 1985, AM J OBSTET GYNECOL, V152, P803, DOI 10.1016/S0002-9378(85)80067-3; YARNELL JWG, 1979, AGE AGEING, V8, P81, DOI 10.1093/ageing/8.2.81	68	192	204	0	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 12	2000	356	9229					535	539		10.1016/S0140-6736(00)02577-0	http://dx.doi.org/10.1016/S0140-6736(00)02577-0			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	345MY	10950229				2022-12-28	WOS:000088820800009
J	Prockter, LM; Pappalardo, RT				Prockter, LM; Pappalardo, RT			Folds on Europa: Implications for crustal cycling and accommodation of extension	SCIENCE			English	Article							TIDAL STRESSES; MODELS; SEPARATION; FEATURES; PATTERNS; FRACTURE; FAULT; BAND	Regional-scale undulations with associated small-scale secondary structures are inferred to be folds on Jupiter's moon Europa. Formation is consistent with stresses from tidal deformation, potentially triggering compressional instability of a region of Locally high thermal gradient. Folds may compensate for extension elsewhere on Europa and then relax away over time.	Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; Brown Univ, Dept Geol Sci, Providence, RI 02912 USA	Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; Brown University	Prockter, LM (corresponding author), Johns Hopkins Univ, Appl Phys Lab, MS 7-366,11100 Johns Hopkins Rd, Laurel, MD 20723 USA.	louise.prockter@jhuapl.edu; robert_pappalardo@brown.edu	Pappalardo, Robert/AAP-8953-2021	Pappalardo, Robert/0000-0003-2571-4627				BIOT MA, 1961, GEOL SOC AM BULL, V72, P1595, DOI 10.1130/0016-7606(1961)72[1595:TOFOSV]2.0.CO;2; BIOT MA, 1960, J FRANKLIN I, V270, P190, DOI DOI 10.1016/0016-0032(60)90589-5); BIOT MA, 1959, J FRANKLIN I, V267, P211; FIGUEREDO P, IN PRESS J GEOPHYS R; Goldsby DL, 1997, SCRIPTA MATER, V37, P1399, DOI 10.1016/S1359-6462(97)00246-7; Greenberg R, 1998, ICARUS, V135, P64, DOI 10.1006/icar.1998.5986; HEAD J, 1998, LUNAR PLANET SCI C, V29; HELFENSTEIN P, 1985, ICARUS, V61, P175, DOI 10.1016/0019-1035(85)90099-5; HERRICK DL, 1990, ICARUS, V85, P191, DOI 10.1016/0019-1035(90)90110-U; HILLIER J, 1991, J GEOPHYS RES-PLANET, V96, P15665, DOI 10.1029/91JE01401; Hoppa G, 1999, ICARUS, V141, P287, DOI 10.1006/icar.1999.6185; Hoppa GV, 1999, SCIENCE, V285, P1899, DOI 10.1126/science.285.5435.1899; Leith AC, 1996, ICARUS, V120, P387, DOI 10.1006/icar.1996.0058; MCEWEN AS, 1986, NATURE, V321, P49, DOI 10.1038/321049a0; Mellor M, 1980, PHYSICS MECHANICS IC, P217; MUELLER S, 1988, ICARUS, V76, P437, DOI 10.1016/0019-1035(88)90014-0; PAPPALARDO R, 1999, LUNAR PLANET SCI C, V30; Pappalardo RT, 1996, ICARUS, V123, P557, DOI 10.1006/icar.1996.0178; Pappalardo RT, 1999, J GEOPHYS RES-PLANET, V104, P24015, DOI 10.1029/1998JE000628; PAPPALARDO RT, 1995, J GEOPHYS RES-PLANET, V100, P18985, DOI 10.1029/94JE02638; Prockter LM, 2000, J GEOPHYS RES-PLANET, V105, P9483, DOI 10.1029/1999JE001226; PROCKTER LM, 1999, LUNAR PLANET SCI C, V30; SCHENK PM, 1989, ICARUS, V79, P75, DOI 10.1016/0019-1035(89)90109-7; Schenk PM, 1998, ASTROPHYS SPACE SC L, V227, P551, DOI 10.1007/978-94-011-5252-5_23; SOLOMON SC, 1984, J GEOPHYS RES, V89, P6885, DOI 10.1029/JB089iB08p06885; Squyres S. W., 1986, SATELLITES, P293; Sullivan R, 1998, NATURE, V391, P371, DOI 10.1038/34874; SULLIVAN R, 1997, LUNAR PLANET SCI C, V27, P1343; THOMAS PJ, 1986, J GEOPHYS RES, V91, P453; Tufts BR, 1999, ICARUS, V141, P53, DOI 10.1006/icar.1999.6168	30	62	63	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 11	2000	289	5481					941	943		10.1126/science.289.5481.941	http://dx.doi.org/10.1126/science.289.5481.941			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	343KH	10937995				2022-12-28	WOS:000088701200029
J	Kuo, RK; Baxter, GT; Thompson, SH; Stricker, SA; Patton, C; Bonaventura, J; Epel, D				Kuo, RK; Baxter, GT; Thompson, SH; Stricker, SA; Patton, C; Bonaventura, J; Epel, D			NO is necessary and sufficient for egg activation at fertilization	NATURE			English	Article							NITRIC-OXIDE SYNTHASE; SEA-URCHIN EGGS; ACROSOME REACTION; SPERM; CALCIUM; RELEASE; PATHWAY; FAMILY; ASSAY	The early steps that lead to the rise in calcium and egg activation at fertilization are unknown but of great interest-particularly with the advent of in vitro fertilization techniques for treating male infertility and whole-animal cloning by nuclear transfer. This calcium rise is required for egg activation and the subsequent events of development in eggs of all species(1,2). Injection of intact sperm or sperm extracts can activate eggs, suggesting that sperm-derived factors may be involved. Here we show that nitric oxide synthase is present at high concentration and active in sperm after activation by the acrosome reaction. An increase in nitrosation within eggs is evident seconds after insemination and precedes the calcium pulse of fertilization. Microinjection of nitric oxide donors or recombinant nitric oxide synthase recapitulates events of egg activation, whereas prior injection of oxyhaemoglobin, a physiological nitric oxide scavenger, prevents egg activation after fertilization. We conclude that nitric oxide synthase and nitric-oxide-related bioactivity satisfy the primary criteria of an egg activator: they are present in an appropriate place, active at an appropriate time, and are necessary and sufficient for successful fertilization.	Stanford Univ, Dept Biol Sci, Hopkins Marine Stn, Pacific Grove, CA 93950 USA; Stanford Univ, Program Neurosci, Sch Med, Stanford, CA 94305 USA; Cornell Univ, Knight Lab, Ithaca, NY 14853 USA; Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; Duke Marine Biomed Ctr, Nicholas Sch Environm, Pivers Isl, NC 28516 USA	Stanford University; Stanford University; Cornell University; University of New Mexico; Duke University; Duke University	Epel, D (corresponding author), Stanford Univ, Dept Biol Sci, Hopkins Marine Stn, Pacific Grove, CA 93950 USA.	depel@stanford.edu						Akhand AK, 1999, J BIOL CHEM, V274, P25821, DOI 10.1074/jbc.274.36.25821; Antonini E., 1971, HEMOGLOBIN MYOGLOBIN; Ciapa B, 1996, BIOCHEM BIOPH RES CO, V223, P633, DOI 10.1006/bbrc.1996.0946; CROSSLEY I, 1991, CELL REGUL, V2, P121, DOI 10.1091/mbc.2.2.121; EPEL D, 1997, HDB PHYSIOL 14, P859; Fehsel K, 1996, METHOD ENZYMOL, V269, P426; Giraldez RR, 1998, ANAL BIOCHEM, V261, P29, DOI 10.1006/abio.1998.2721; Giusti AF, 1999, DEV BIOL, V208, P189, DOI 10.1006/dbio.1998.9187; Gross SS, 1999, P NATL ACAD SCI USA, V96, P9967, DOI 10.1073/pnas.96.18.9967; GUERRERO A, 1989, J BIOL CHEM, V264, P19593; HOPE BT, 1991, P NATL ACAD SCI USA, V88, P2811, DOI 10.1073/pnas.88.7.2811; KAO JPY, 1994, PRACTICAL ASPECTS ME; Kojima H, 1998, ANAL CHEM, V70, P2446, DOI 10.1021/ac9801723; KURODA R, IN PRESS ZYGOTE; Lee SJ, 1996, DEV BIOL, V180, P324, DOI 10.1006/dbio.1996.0304; Miller BS, 1999, DEV BIOL, V216, P394, DOI 10.1006/dbio.1999.9513; MISKO TP, 1993, ANAL BIOCHEM, V214, P11, DOI 10.1006/abio.1993.1449; NADAI CD, 1998, DEV GROWTH DIFFER, V40, P669; PODELL SB, 1984, J CELL BIOL, V99, P1598, DOI 10.1083/jcb.99.5.1598; REGULSKI M, 1995, P NATL ACAD SCI USA, V92, P9072, DOI 10.1073/pnas.92.20.9072; Rongish BJ, 1999, DEV BIOL, V215, P147, DOI 10.1006/dbio.1999.9472; Schulz JR, 1997, DEV BIOL, V191, P80, DOI 10.1006/dbio.1997.8712; SEXTON DJ, 1994, PHOTOCHEM PHOTOBIOL, V59, P463, DOI 10.1111/j.1751-1097.1994.tb05065.x; Stamler, 1996, METHODS NITRIC OXIDE, P249; Stricker SA, 1999, DEV BIOL, V211, P157, DOI 10.1006/dbio.1999.9340; TURNER E, 1987, BIOCHEMISTRY-US, V26, P4028, DOI 10.1021/bi00387a043; Willmott N, 1996, J BIOL CHEM, V271, P3699; Xu L, 1998, SCIENCE, V279, P234, DOI 10.1126/science.279.5348.234	28	145	154	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 10	2000	406	6796					633	636		10.1038/35020577	http://dx.doi.org/10.1038/35020577			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	342PF	10949304				2022-12-28	WOS:000088653800049
J	Henney, JE				Henney, JE			Guidance for adverse reactions labeling	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item											Henney, JE (corresponding author), HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	2	3	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 9	2000	284	6					685	685		10.1001/jama.284.6.685	http://dx.doi.org/10.1001/jama.284.6.685			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	341JM	10950660				2022-12-28	WOS:000088587300006
J	Oxtoby, DW				Oxtoby, DW			Phase transitions - Catching crystals at birth	NATURE			English	Editorial Material							NUCLEATION		Univ Chicago, James Franck Inst, Chicago, IL 60637 USA; Univ Chicago, Dept Chem, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Oxtoby, DW (corresponding author), Univ Chicago, James Franck Inst, 5640 S Ellis Ave, Chicago, IL 60637 USA.							KASHCHIEV D, 1982, J CHEM PHYS, V76, P5098, DOI 10.1063/1.442808; MALKIN A, 1994, ACTA CRYSTALLOGR D, V50, P385, DOI 10.1107/S0907444993013319; Talanquer V, 1998, J CHEM PHYS, V109, P223, DOI 10.1063/1.476554; tenWolde PR, 1997, SCIENCE, V277, P1975, DOI 10.1126/science.277.5334.1975; TURNBULL D, 1949, J CHEM PHYS, V17, P71, DOI 10.1063/1.1747055; Yau ST, 2000, NATURE, V406, P494, DOI 10.1038/35020035	6	51	52	1	28	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 3	2000	406	6795					464	465		10.1038/35020163	http://dx.doi.org/10.1038/35020163			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	340ML	10952291				2022-12-28	WOS:000088538000024
J	Paar, J; Oldroyd, BP; Kastberger, G				Paar, J; Oldroyd, BP; Kastberger, G			Entomology - Giant honeybees return to their nest sites	NATURE			English	Article									Univ Sydney, Sch Biol Sci A12, Sydney, NSW 2006, Australia; Graz Univ, Inst Zool, A-8010 Graz, Austria	University of Sydney; University of Graz	Paar, J (corresponding author), Univ Sydney, Sch Biol Sci A12, Sydney, NSW 2006, Australia.	boldroyd@bio.usyd.edu.au	Oldroyd, Benjamin/A-4800-2008	Oldroyd, Benjamin/0000-0001-6831-3677				ESTOUP A, 1994, P ROY SOC B-BIOL SCI, V258, P1, DOI 10.1098/rspb.1994.0133; KOENIGER N, 1980, J APICULT RES, V19, P21, DOI 10.1080/00218839.1980.11099994; Oldroyd BP, 1999, P ROY SOC B-BIOL SCI, V266, P1335, DOI 10.1098/rspb.1999.0784; Oldroyd BP, 2000, INSECT SOC, V47, P94, DOI 10.1007/s000400050015; WEIR BS, 1994, ANNU REV GENET, V28, P597	5	36	40	0	13	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 3	2000	406	6795					475	475		10.1038/35020196	http://dx.doi.org/10.1038/35020196			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	340ML	10952300				2022-12-28	WOS:000088538000034
J	Saint-Ruf, C; Panigada, M; Azogui, O; Debey, P; von Boehmer, H; Grassi, F				Saint-Ruf, C; Panigada, M; Azogui, O; Debey, P; von Boehmer, H; Grassi, F			Different initiation of pre-TCR and gamma delta TCR signalling	NATURE			English	Article							T-CELL-RECEPTOR; PROTEIN-TYROSINE KINASE; ALPHA-BETA; LINEAGE COMMITMENT; ANTIGEN RECEPTOR; LIPID RAFTS; SH2 DOMAINS; ACTIVATION; EXPRESSION; MEMBRANES	Lineage choice is of great interest in developmental biology. In the immune system, the alpha beta and gamma delta lineages of T lymphocytes diverge during the course of the beta-, gamma- and delta-chain rearrangement of T-cell receptor (TCR) genes that takes place within the same precursor cell and which results in the formation of the gamma delta TCR or pre-TCR proteins(1-3). The pre-TCR consists of the TCR beta chain covalently linked to the pre-TCR alpha protein, which is present in immature but not in mature T cells which instead express the TCR alpha chain(4,5). Animals deficient in pre-TCR alpha have few alpha beta lineage cells but an increased number of gamma delta T cells. These gamma delta T cells exhibit more extensive TCR beta rearrangement than gamma delta T cells from wild-type mice(6,7). These observations are consistent with the idea that different signals emanating from the gamma delta TCR and pre-TCR instruct lineage commitment(8). Here we show, by using confocal microscopy and biochemistry to analyse the initiation of signalling, that the pre-TCR but not the gamma delta TCR colocalizes with the p56(lck) Src kinase into glycolipid-enriched membrane domains (rafts) apparently without any need for ligation. This results in the phosphorylation of CD3 epsilon and Zap-70 signal transducing molecules. The results indicate clear differences between pre-TCR and gamma delta TCR signalling.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Fac Med Necker, INSERM, U373, Inst Necker, F-75730 Paris 15, France; Inst Biol Physicochim, Museum Natl Hist Nat, INRA, Unite 806, F-75005 Paris, France; Univ Milan, Dipartimento Biol & Genet Sci Med, I-20133 Milan, Italy	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; INRAE; Museum National d'Histoire Naturelle (MNHN); University of Milan	von Boehmer, H (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, 44 Binney St,Smith 736, Boston, MA 02115 USA.			GRASSI, FABIO/0000-0003-3348-1712				Aifantis L, 1998, IMMUNITY, V9, P649, DOI 10.1016/S1074-7613(00)80662-7; Amirand C, 1998, J CELL SCI, V111, P3551; ANDERSON SJ, 1995, IMMUNOL TODAY, V16, P99, DOI 10.1016/0167-5699(95)80096-4; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; delPorto P, 1995, P NATL ACAD SCI USA, V92, P12105, DOI 10.1073/pnas.92.26.12105; FEHLING HJ, 1995, NATURE, V375, P795, DOI 10.1038/375795a0; GODFREY DI, 1993, J IMMUNOL, V150, P4244; GROETTRUP M, 1993, CELL, V75, P283, DOI 10.1016/0092-8674(93)80070-U; GUNNING P, 1987, P NATL ACAD SCI USA, V84, P4831, DOI 10.1073/pnas.84.14.4831; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; Huby RDJ, 1997, J CELL BIOL, V137, P1639, DOI 10.1083/jcb.137.7.1639; Irving BA, 1998, SCIENCE, V280, P905, DOI 10.1126/science.280.5365.905; Janes PW, 1999, J CELL BIOL, V147, P447, DOI 10.1083/jcb.147.2.447; Lanzavecchia A, 1999, CELL, V96, P1, DOI 10.1016/S0092-8674(00)80952-6; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Montixi C, 1998, EMBO J, V17, P5334, DOI 10.1093/emboj/17.18.5334; RODEWALD HR, 1993, J EXP MED, V177, P1079, DOI 10.1084/jem.177.4.1079; RODGERS W, 1994, MOL CELL BIOL, V14, P5384, DOI 10.1128/MCB.14.8.5384; SAINTRUF C, 1994, SCIENCE, V266, P1208, DOI 10.1126/science.7973703; Sheets ED, 1999, J CELL BIOL, V145, P877, DOI 10.1083/jcb.145.4.877; SHENOYSCARIA AM, 1994, J CELL BIOL, V126, P353, DOI 10.1083/jcb.126.2.353; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; VANOERS NSC, 1995, J EXP MED, V182, P1585, DOI 10.1084/jem.182.5.1585; von Boehmer H, 1998, IMMUNOL REV, V165, P111; vonBoehmer H, 1997, ANNU REV IMMUNOL, V15, P433, DOI 10.1146/annurev.immunol.15.1.433; WANGE RL, 1993, J BIOL CHEM, V268, P19797; Xavier R, 1998, IMMUNITY, V8, P723, DOI 10.1016/S1074-7613(00)80577-4; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8	29	138	139	0	6	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 3	2000	406	6795					524	527		10.1038/35020093	http://dx.doi.org/10.1038/35020093			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	340ML	10952314	Green Published			2022-12-28	WOS:000088538000048
J	Moloney, DJ; Panin, VM; Johnston, SH; Chen, JH; Shao, L; Wilson, R; Wang, Y; Stanley, P; Irvine, KD; Haltiwanger, RS; Vogt, TF				Moloney, DJ; Panin, VM; Johnston, SH; Chen, JH; Shao, L; Wilson, R; Wang, Y; Stanley, P; Irvine, KD; Haltiwanger, RS; Vogt, TF			Fringe is a glycosyltransferase that modifies Notch	NATURE			English	Article							HAMSTER OVARY CELLS; O-LINKED FUCOSE; DROSOPHILA WING DEVELOPMENT; RESISTANT CHO CELLS; GDP-FUCOSE; GLYCOSYLATION PATHWAY; SIGNALING PATHWAY; MOLECULAR-CLONING; SERRATE; DORSAL	Notch receptors function in highly conserved intercellular signalling pathways that direct cell-fate decisions, proliferation and apoptosis in metazoans. Fringe proteins can positively and negatively modulate the ability of Notch ligands to activate the Notch receptor. Here we establish the biochemical mechanism of Fringe action. Drosophila and mammalian Fringe proteins possess a fucose-specific beta 1,3 N-acetylglucosaminyltransferase activity that initiates elongation of O-linked fucose residues attached to epidermal growth factor-like sequence repeats of Notch. We obtained biological evidence that Fringe-dependent elongation of O-linked fucose on Notch modulates Notch signalling by using co-culture assays in mammalian cells and by expression of an enzymatically inactive Fringe mutant in Drosophila. The post-translational modification of Notch by Fringe represents a striking example of modulation of a signalling event by differential receptor glycosylation and identifies a mechanism that is likely to be relevant to other signalling pathways.	SUNY Stony Brook, Dept Biochem & Cell Biol, Inst Cell & Dev Biol, Stony Brook, NY 11794 USA; Rutgers State Univ, Waksman Inst, Piscataway, NJ 08854 USA; Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA; Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; Genentech Inc, Dept Metab & Pharmacokinet, S San Francisco, CA 94080 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Princeton University; Yeshiva University; Albert Einstein College of Medicine; Roche Holding; Genentech	Haltiwanger, RS (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Inst Cell & Dev Biol, Stony Brook, NY 11794 USA.		Panin, Vlad/G-1583-2016	Panin, Vlad/0000-0001-9126-1481; Stanley, Pamela/0000-0001-5704-3747				Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Beyer T A, 1981, Adv Enzymol Relat Areas Mol Biol, V52, P23; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; CHENG HJ, 1995, CELL, V82, P371, DOI 10.1016/0092-8674(95)90426-3; Cohen B, 1997, NAT GENET, V16, P283, DOI 10.1038/ng0797-283; de Celis JF, 2000, DEVELOPMENT, V127, P1291; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; DECELIS JF, 1994, MECH DEVELOP, V46, P109, DOI 10.1016/0925-4773(94)90080-9; Fleming RJ, 1997, DEVELOPMENT, V124, P2973; HARRIS RJ, 1993, GLYCOBIOLOGY, V3, P219, DOI 10.1093/glycob/3.3.219; HICKS C, IN PRESS NATURE CELL; Hirschberg CB, 1998, ANNU REV BIOCHEM, V67, P49, DOI 10.1146/annurev.biochem.67.1.49; Hsieh JJD, 1996, MOL CELL BIOL, V16, P952; Irvine KD, 1999, CURR OPIN GENET DEV, V9, P434, DOI 10.1016/S0959-437X(99)80066-5; IRVINE KD, 1994, CELL, V79, P595, DOI 10.1016/0092-8674(94)90545-2; Irvine KD, 1997, CURR OPIN CELL BIOL, V9, P867, DOI 10.1016/S0955-0674(97)80090-7; Johnston SH, 1997, DEVELOPMENT, V124, P2245; Joutel A, 1998, SEMIN CELL DEV BIOL, V9, P619, DOI 10.1006/scdb.1998.0261; Ju BG, 2000, NATURE, V405, P191, DOI 10.1038/35012090; Kao YH, 1999, BIOCHEMISTRY-US, V38, P7097, DOI 10.1021/bi990234z; KELLEY MR, 1987, CELL, V51, P539, DOI 10.1016/0092-8674(87)90123-1; KIM J, 1995, CELL, V82, P795, DOI 10.1016/0092-8674(95)90476-X; Klein T, 1998, DEVELOPMENT, V125, P2951; Klueg KM, 1999, J CELL SCI, V112, P3289; Kornfeld S, 1998, J CLIN INVEST, V101, P1293, DOI 10.1172/JCI3140; Kotenko SV, 2000, P NATL ACAD SCI USA, V97, P1695, DOI 10.1073/pnas.97.4.1695; LINDSELL CE, 1995, CELL, V80, P909, DOI 10.1016/0092-8674(95)90294-5; Lu FM, 1996, P NATL ACAD SCI USA, V93, P5663, DOI 10.1073/pnas.93.11.5663; Lubke T, 1999, J BIOL CHEM, V274, P25986, DOI 10.1074/jbc.274.37.25986; MACARTHUR CA, 1995, CELL GROWTH DIFFER, V6, P817; Moloney DJ, 1999, GLYCOBIOLOGY, V9, P679, DOI 10.1093/glycob/9.7.679; Moloney DJ, 1997, J BIOL CHEM, V272, P19046, DOI 10.1074/jbc.272.30.19046; Moloney DJ, 2000, J BIOL CHEM, V275, P9604, DOI 10.1074/jbc.275.13.9604; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Ohyama C, 1998, J BIOL CHEM, V273, P14582, DOI 10.1074/jbc.273.23.14582; Panin VM, 1998, SEMIN CELL DEV BIOL, V9, P609, DOI 10.1006/scdb.1998.0263; Panin VM, 1997, NATURE, V387, P908, DOI 10.1038/43191; Perrimon N, 2000, NATURE, V404, P725, DOI 10.1038/35008000; REBAY I, 1991, CELL, V67, P687, DOI 10.1016/0092-8674(91)90064-6; REBAY I, 1993, CELL, V74, P319, DOI 10.1016/0092-8674(93)90423-N; RIPKA J, 1986, ARCH BIOCHEM BIOPHYS, V249, P533, DOI 10.1016/0003-9861(86)90031-7; RIPKA J, 1986, SOMAT CELL MOLEC GEN, V12, P51, DOI 10.1007/BF01560727; ROBERTSON MA, 1978, CELL, V13, P515, DOI 10.1016/0092-8674(78)90325-2; STANLEY P, 1975, P NATL ACAD SCI USA, V72, P3323, DOI 10.1073/pnas.72.9.3323; Sullivan FX, 1998, J BIOL CHEM, V273, P8193, DOI 10.1074/jbc.273.14.8193; Wiggins CAR, 1998, P NATL ACAD SCI USA, V95, P7945, DOI 10.1073/pnas.95.14.7945; Yuan YP, 1997, CELL, V88, P9, DOI 10.1016/S0092-8674(00)81852-8; Zhang YN, 1999, GLYCOBIOLOGY, V9, P815, DOI 10.1093/glycob/9.8.815	49	698	718	1	42	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 27	2000	406	6794					369	375		10.1038/35019000	http://dx.doi.org/10.1038/35019000			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	337WC	10935626				2022-12-28	WOS:000088383800036
J	Bork, K; Barnstedt, SE; Koch, P; Traupe, H				Bork, K; Barnstedt, SE; Koch, P; Traupe, H			Hereditary angioedema with normal C1-inhibitor activity in women	LANCET			English	Article							C1 INHIBITOR; DEFICIENCY; EDEMA; AUTOANTIBODY; MANAGEMENT; ENALAPRIL; URTICARIA	Background Hereditary angioedema (HAE) is a well defined autosomal dominant disease (Mendelian Inheritance in Man #106100) that results from an inherited deficiency of C1 (the activated first component of complement) inhibitor function. We report an unusual variant of HAE with normal biochemical C1-inhibitor function, occurring only in women. Methods We screened 574 patients with recurrent angioedema of the skin for presence of HAE. 283 patients were selected, in whom angioedema was associated with abdominal pain attacks or recurrent life-threatening episodes of upper-airway obstruction, or both, rather than with urticaria. We measured C1-inhibitor concentration and functional activity as well as complement C4 concentration and took pedigrees to characterise patients. Findings 94 HAE cases with C1-inhibitor deficiency, positive family history, or both were identified. Biochemical testing showed that 84 patients from 49 families had a functional C1-inhibitor deficiency. 11 of these patients had no affected family members (probably representing de-novo mutations), Ten women with HAE, from ten families, had normal C1-inhibitor protein concentrations and function, and normal C4 concentration. A more detailed study of these families identified another 26 affected members, who were also ail women. Of those women, 14 could be studied and also had normal C1-inhibitor concentration and function. The disease was seen in successive generations, and in offspring of affected mothers, the sex ratio (M/F) was shifted to 1/1.5. Interpretation HAE with normal C1-inhibitor concentration and function represents a unique genetic disease arising only in women. The formal genetics of this entity are suggestive of an X-linked dominant mode of inheritance. For this disorder we propose the term hereditary angioedema type 3 (HAE III).	Univ Mainz, Hautklin, Dept Dermatol, D-55131 Mainz, Germany; Univ Munster, Dept Dermatol, D-4400 Munster, Germany	Johannes Gutenberg University of Mainz; University of Munster	Bork, K (corresponding author), Univ Mainz, Hautklin, Dept Dermatol, Langenbeckstr 1, D-55131 Mainz, Germany.		Bork, Konrad/AAE-4985-2022	Bork, Konrad/0000-0002-6084-4577				AGOSTONI A, 1992, MEDICINE, V71, P206, DOI 10.1097/00005792-199207000-00003; ALSENZ J, 1987, NEW ENGL J MED, V316, P1360, DOI 10.1056/NEJM198705283162202; Bissler JJ, 1997, P ASSOC AM PHYSICIAN, V109, P164; BOCKERS M, 1989, DEUT MED WOCHENSCHR, V112, P507; Bork K, 2000, MAYO CLIN PROC, V75, P349, DOI 10.4065/75.4.349; Bork K, 1997, DEUT MED WOCHENSCHR, V122, P1347, DOI 10.1055/s-2008-1047770; BORRADORI L, 1990, DERMATOLOGICA, V181, P78, DOI 10.1159/000247874; CHAMPION RH, 1969, BRIT J DERMATOL, V81, P588, DOI 10.1111/j.1365-2133.1969.tb16041.x; Cicardi M, 1999, AM J MED, V106, P650, DOI 10.1016/S0002-9343(99)00123-0; Cicardi M, 1996, NEW ENGL J MED, V334, P1666, DOI 10.1056/NEJM199606203342510; DONALDSON VH, 1963, AM J MED, V35, P37, DOI 10.1016/0002-9343(63)90162-1; Eckes B, 1999, EUR J INTERN MED S1, V10, P187; FRANK MM, 1976, ANN INTERN MED, V84, P580, DOI 10.7326/0003-4819-84-5-580; GIANNOCCARO PJ, 1989, CAN J CARDIOL, V5, P335; GREAVES M, 1991, J AM ACAD DERMATOL, V25, P155, DOI 10.1016/0190-9622(91)70183-3; JACKSON J, 1986, NATURE, V323, P722, DOI 10.1038/323722a0; JASON DR, 1992, J FORENSIC SCI, V37, P1418; LANDERMAN NS, 1962, J ALLERGY, V33, P330, DOI 10.1016/0021-8707(62)90032-1; Nielsen Erik Waage, 1995, Tidsskrift for den Norske Laegeforening, V115, P43; Nussberger J, 1998, LANCET, V351, P1693, DOI 10.1016/S0140-6736(97)09137-X; OIKE Y, 1993, INTERNAL MED, V32, P308, DOI 10.2169/internalmedicine.32.308; Osler W, 1888, AM J MED SCI, V95, P362; SHEFFER AL, 1989, ALLERGY PROC, V10, P237, DOI 10.2500/108854189778960126; SOTER NA, 1991, J AM ACAD DERMATOL, V25, P146, DOI 10.1016/0190-9622(91)70180-A; Tosi M, 1998, IMMUNOBIOLOGY, V199, P358, DOI 10.1016/S0171-2985(98)80040-5; ULMER JL, 1992, ANN PHARMACOTHER, V26, P1245, DOI 10.1177/106002809202601012; Yip J, 1992, Australas J Dermatol, V33, P35, DOI 10.1111/j.1440-0960.1992.tb00050.x	27	390	403	1	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 15	2000	356	9225					213	217		10.1016/S0140-6736(00)02483-1	http://dx.doi.org/10.1016/S0140-6736(00)02483-1			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	334GQ	10963200				2022-12-28	WOS:000088179100013
J	Eu, JP; Sun, JH; Xu, L; Stamler, JS; Meissner, G				Eu, JP; Sun, JH; Xu, L; Stamler, JS; Meissner, G			The skeletal muscle calcium release channel: Coupled O-2 sensor and NO signaling functions	CELL			English	Article							CARDIAC SARCOPLASMIC-RETICULUM; NITRIC-OXIDE; RYANODINE RECEPTOR; CA2+ RELEASE; CAROTID-BODY; TRANSCRIPTION FACTOR; S-NITROSOHEMOGLOBIN; NITROSATIVE STRESS; HYDROGEN-PEROXIDE; OXYGEN	Ion channels have been studied extensively in ambient O-2 tension (pO(2)), whereas tissue pO(2) is much lower. The skeletal muscle calcium release channel/ryanodine receptor (RyR1) is one prominent example. Here we report that pO(2) dynamically controls the redox state of 6-8 out of 50 thiols in each RyR1 subunit and thereby tunes the response to NO. At physiological pO(2), nanomolar NO activates the channel by S-nitrosylating a single cysteine residue. Among sarcoplasmic reticulum proteins, S-nitrosylation is specific to RyR1 and its effect on the channel is calmodulin dependent. Neither activation nor S-nitrosylation of the channel occurs at ambient pO(2). The demonstration that channel cysteine residues subserve coupled O-2 sensor and NO regulatory functions and that these operate through the prototypic allosteric effector calmodulin may have general implications for the regulation of redox-related systems.	Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Med,Div Pulm Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Med,Div Cardiovasc Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Duke University; Howard Hughes Medical Institute; Duke University; Howard Hughes Medical Institute; Duke University	Meissner, G (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.		Sun, Junhui/C-3499-2011	Stamler, Jonathan/0000-0002-6866-1572	NHLBI NIH HHS [HL52529, HL04053] Funding Source: Medline; NIEHS NIH HHS [ES-09206] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052529] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009206] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ABRAMSON JJ, 1989, J BIOENERG BIOMEMBR, V21, P283, DOI 10.1007/BF00812073; Aghdasi B, 1997, J BIOL CHEM, V272, P25462, DOI 10.1074/jbc.272.41.25462; Archer SL, 1999, P NATL ACAD SCI USA, V96, P7944, DOI 10.1073/pnas.96.14.7944; Aslund F, 1999, P NATL ACAD SCI USA, V96, P6161, DOI 10.1073/pnas.96.11.6161; Bader M, 1999, CELL, V98, P217, DOI 10.1016/S0092-8674(00)81016-8; BALON TW, 1994, J APPL PHYSIOL, V77, P2519, DOI 10.1152/jappl.1994.77.6.2519; BOLOTINA VM, 1994, NATURE, V368, P850, DOI 10.1038/368850a0; Drummond HA, 1998, NEURON, V21, P1435, DOI 10.1016/S0896-6273(00)80661-3; Eu JP, 2000, BIOCHEMISTRY-US, V39, P1040, DOI 10.1021/bi992046e; FAVERO TG, 1995, J BIOL CHEM, V270, P25557, DOI 10.1074/jbc.270.43.25557; FranziniArmstrong C, 1997, PHYSIOL REV, V77, P699, DOI 10.1152/physrev.1997.77.3.699; GARG UC, 1988, BIOTECHNIQUES, V6, P294; Gbadegesin M, 1999, AM J PHYSIOL-CELL PH, V277, pC673, DOI 10.1152/ajpcell.1999.277.4.C673; GOLDBERG MA, 1988, SCIENCE, V242, P1412, DOI 10.1126/science.2849206; GORCZYNSKI RJ, 1978, AM J PHYSIOL, V235, pH505, DOI 10.1152/ajpheart.1978.235.5.H505; Hausladen A, 1996, CELL, V86, P719, DOI 10.1016/S0092-8674(00)80147-6; HONIG CR, 1993, AM J PHYSIOL, V265, pH868, DOI 10.1152/ajpheart.1993.265.3.H868; Huang LE, 1999, J BIOL CHEM, V274, P9038, DOI 10.1074/jbc.274.13.9038; Jakob U, 1999, CELL, V96, P341, DOI 10.1016/S0092-8674(00)80547-4; JAYARAMAN T, 1992, J BIOL CHEM, V267, P9474; Jia L, 1996, NATURE, V380, P221, DOI 10.1038/380221a0; Kawakami M, 1998, MOL PHARMACOL, V53, P497, DOI 10.1124/mol.53.3.497; Kim WK, 1999, NEURON, V24, P461, DOI 10.1016/S0896-6273(00)80859-4; KIRCHGESSER M, 1990, J CLIN CHEM CLIN BIO, V28, P407; KOBZIK L, 1994, NATURE, V372, P546, DOI 10.1038/372546a0; Kourie JI, 1997, AM J PHYSIOL-CELL PH, V272, pC324, DOI 10.1152/ajpcell.1997.272.1.C324; LAI FA, 1988, NATURE, V331, P315, DOI 10.1038/331315a0; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Li Z, 1998, NEURON, V20, P1039, DOI 10.1016/S0896-6273(00)80484-5; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; Liu XP, 1998, P NATL ACAD SCI USA, V95, P2175, DOI 10.1073/pnas.95.5.2175; LOPEZBARNEO J, 1988, SCIENCE, V241, P580, DOI 10.1126/science.2456613; Malinski T, 1996, METHOD ENZYMOL, V268, P58; Mannick JB, 1999, SCIENCE, V284, P651, DOI 10.1126/science.284.5414.651; MEISSNER G, 1994, ANNU REV PHYSIOL, V56, P485, DOI 10.1146/annurev.ph.56.030194.002413; Meszaros LG, 1996, FEBS LETT, V380, P49, DOI 10.1016/0014-5793(96)00003-8; Perez-Mato I, 1999, J BIOL CHEM, V274, P17075, DOI 10.1074/jbc.274.24.17075; Poderoso JJ, 1998, AM J PHYSIOL-CELL PH, V274, pC112, DOI 10.1152/ajpcell.1998.274.1.C112; Prabhakar NR, 1999, RESP PHYSIOL, V115, P161, DOI 10.1016/S0034-5687(99)00019-5; RUPPERSBERG JP, 1991, NATURE, V352, P711, DOI 10.1038/352711a0; SCHOENMAKERS TJM, 1992, BIOTECHNIQUES, V12, P870; Semenza GL, 1999, CELL, V98, P281, DOI 10.1016/S0092-8674(00)81957-1; Stamler JS, 1998, NAT STRUCT BIOL, V5, P247, DOI 10.1038/nsb0498-247; Stamler JS, 1997, SCIENCE, V276, P2034, DOI 10.1126/science.276.5321.2034; Stamler JS, 1997, NEURON, V18, P691, DOI 10.1016/S0896-6273(00)80310-4; STAMLER JS, 1994, CELL, V78, P931, DOI 10.1016/0092-8674(94)90269-0; Stone JR, 1996, BIOCHEMISTRY-US, V35, P1093, DOI 10.1021/bi9519718; Stoyanovsky D, 1997, CELL CALCIUM, V21, P19, DOI 10.1016/S0143-4160(97)90093-2; Summers BA, 1999, J NEUROPHYSIOL, V81, P1449, DOI 10.1152/jn.1999.81.4.1449; TAKESHIMA H, 1989, NATURE, V339, P439, DOI 10.1038/339439a0; TRIPATHY A, 1995, BIOPHYS J, V69, P106, DOI 10.1016/S0006-3495(95)79880-0; Viner RI, 1999, BIOCHEM J, V340, P657, DOI 10.1042/0264-6021:3400657; WINK DA, 1994, CHEM RES TOXICOL, V7, P519, DOI 10.1021/tx00040a007; Xu KY, 1999, P NATL ACAD SCI USA, V96, P657, DOI 10.1073/pnas.96.2.657; Xu L, 1998, SCIENCE, V279, P234, DOI 10.1126/science.279.5348.234; YOUNGSON C, 1993, NATURE, V365, P153, DOI 10.1038/365153a0; ZAIDI NF, 1989, J BIOL CHEM, V264, P21725; Zhang JZ, 1999, AM J PHYSIOL-CELL PH, V276, pC46; Zhao Y, 1999, P NATL ACAD SCI USA, V96, P14753, DOI 10.1073/pnas.96.26.14753	60	343	356	0	21	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 18	2000	102	4					499	509		10.1016/S0092-8674(00)00054-4	http://dx.doi.org/10.1016/S0092-8674(00)00054-4			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	347BX	10966111	Bronze			2022-12-28	WOS:000088908000011
J	Funabiki, H; Murray, AW				Funabiki, H; Murray, AW			The Xenopus chromokinesin Xkid is essential for metaphase chromosome alignment and must be degraded to allow anaphase chromosome movement	CELL			English	Article							KINESIN-LIKE PROTEIN; SISTER-CHROMATID COHESION; MATURATION-PROMOTING FACTOR; NEWT LUNG-CELLS; B-TYPE CYCLINS; MITOTIC SPINDLE; EGG EXTRACTS; CENP-E; MICROTUBULE FLUX; BUDDING YEAST	At anaphase, the linkage between sister chromatids is dissolved and the separated sisters move toward opposite poles of the spindle. We developed a method to purify metaphase and anaphase chromosomes from frog egg extracts and identified proteins that leave chromosomes at anaphase using a new form of expression screening. This approach identified Xkid, a Xenopus homolog of human Kid (kinesin-like DNA binding protein) as a protein that is degraded in anaphase by ubiquitin-mediated proteolysis. Immunodepleting Xkid from egg extracts prevented normal chromosome alignment on the metaphase spindle. Adding a mild excess of wild-type or nondegradable Xkid to egg extracts prevented the separated chromosomes from moving toward the poles. We propose that Xkid provides the metaphase force that pushes chromosome arms toward the equator of the spindle and that its destruction is needed for anaphase chromosome movement.	Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Funabiki, H (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.			Funabiki, Hironori/0000-0003-4831-4087				AFSHAR K, 1995, CELL, V81, P129, DOI 10.1016/0092-8674(95)90377-1; Antonio C, 2000, CELL, V102, P425, DOI 10.1016/S0092-8674(00)00048-9; BERNAT RL, 1990, J CELL BIOL, V111, P1519, DOI 10.1083/jcb.111.4.1519; Biggins S, 1998, CURR OPIN CELL BIOL, V10, P769, DOI 10.1016/S0955-0674(98)80120-8; Desai A, 1999, CELL, V96, P69, DOI 10.1016/S0092-8674(00)80960-5; Desai A, 1998, J CELL BIOL, V141, P703, DOI 10.1083/jcb.141.3.703; Desai A, 1997, P NATL ACAD SCI USA, V94, P12378, DOI 10.1073/pnas.94.23.12378; Desai A, 1999, METHOD CELL BIOL, V61, P385; EARNSHAW WC, 1991, J CELL SCI, V98, P443; Furuya K, 1998, GENE DEV, V12, P3408, DOI 10.1101/gad.12.21.3408; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Harlow E., 1988, ANTIBODIES LAB MANUA; Heald R, 1999, CURR OPIN STRUC BIOL, V9, P268, DOI 10.1016/S0959-440X(99)80037-2; HIRANO T, 1993, J CELL BIOL, V120, P601, DOI 10.1083/jcb.120.3.601; HIRANO T, 1994, CELL, V79, P449, DOI 10.1016/0092-8674(94)90254-2; HOLLOWAY SL, 1993, CELL, V73, P1393, DOI 10.1016/0092-8674(93)90364-V; Juang YL, 1997, SCIENCE, V275, P1311, DOI 10.1126/science.275.5304.1311; KELLOGG DR, 1995, J CELL BIOL, V130, P661, DOI 10.1083/jcb.130.3.661; Khodjakov A, 1996, J CELL BIOL, V135, P315, DOI 10.1083/jcb.135.2.315; Khodjakov A, 1996, J CELL BIOL, V132, P1093, DOI 10.1083/jcb.132.6.1093; KING RW, 1995, CELL, V81, P279, DOI 10.1016/0092-8674(95)90338-0; Klotzbucher A, 1996, EMBO J, V15, P3053, DOI 10.1002/j.1460-2075.1996.tb00668.x; KURIYAMA R, 1995, J CELL BIOL, V129, P1049, DOI 10.1083/jcb.129.4.1049; LOMBILLO VA, 1995, J CELL BIOL, V128, P107, DOI 10.1083/jcb.128.1.107; Losada A, 1998, GENE DEV, V12, P1986, DOI 10.1101/gad.12.13.1986; Lustig KD, 1997, METHOD ENZYMOL, V283, P83; MASUI Y, 1971, J EXP ZOOL, V177, P129, DOI 10.1002/jez.1401770202; MINSHULL J, 1994, CELL, V79, P475, DOI 10.1016/0092-8674(94)90256-9; MITCHISON TJ, 1992, J CELL BIOL, V119, P569, DOI 10.1083/jcb.119.3.569; MITCHISON TJ, 1989, J CELL BIOL, V109, P637, DOI 10.1083/jcb.109.2.637; Molina I, 1997, J CELL BIOL, V139, P1361, DOI 10.1083/jcb.139.6.1361; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Murray A, 1993, CELL CYCLE INTRO; MURRAY AW, 1989, NATURE, V339, P280, DOI 10.1038/339280a0; MURRAY AW, 1989, NATURE, V339, P275, DOI 10.1038/339275a0; MURRAY AW, 1994, CURR BIOL, V4, P38, DOI 10.1016/S0960-9822(00)00007-5; MURRAY AW, 1991, METHOD CELL BIOL, V36, P573; PFARR CM, 1990, NATURE, V345, P263, DOI 10.1038/345263a0; RIEDER CL, 1990, J CELL BIOL, V110, P81, DOI 10.1083/jcb.110.1.81; RIEDER CL, 1992, J CELL SCI, V102, P387; RIEDER CL, 1994, J CELL BIOL, V124, P223, DOI 10.1083/jcb.124.3.223; RIEDER CL, 1986, J CELL BIOL, V103, P581, DOI 10.1083/jcb.103.2.581; Rieder CL, 1998, TRENDS CELL BIOL, V8, P310, DOI 10.1016/S0962-8924(98)01299-9; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Ruden DM, 1997, DEV BIOL, V191, P284, DOI 10.1006/dbio.1997.8726; Salmon E. D., 1989, CELL MOVEMENT, P431; SAWIN KE, 1991, J CELL BIOL, V112, P941, DOI 10.1083/jcb.112.5.941; SAWIN KE, 1991, J CELL BIOL, V112, P925, DOI 10.1083/jcb.112.5.925; Schaar BT, 1997, J CELL BIOL, V139, P1373, DOI 10.1083/jcb.139.6.1373; SHAMU CE, 1992, J CELL BIOL, V117, P921, DOI 10.1083/jcb.117.5.921; SIMERLY C, 1990, J CELL BIOL, V111, P1491, DOI 10.1083/jcb.111.4.1491; SKIBBENS RV, 1995, J CELL SCI, V108, P2537; SKIBBENS RV, 1993, J CELL BIOL, V122, P859, DOI 10.1083/jcb.122.4.859; STEUER ER, 1990, NATURE, V345, P266, DOI 10.1038/345266a0; Straight AF, 1996, CURR BIOL, V6, P1599, DOI 10.1016/S0960-9822(02)70783-5; SURANA U, 1993, EMBO J, V12, P1969, DOI 10.1002/j.1460-2075.1993.tb05846.x; Takizawa CG, 1999, P NATL ACAD SCI USA, V96, P7938, DOI 10.1073/pnas.96.14.7938; THEURKAUF WE, 1992, J CELL BIOL, V116, P1167, DOI 10.1083/jcb.116.5.1167; Tokai N, 1996, EMBO J, V15, P457, DOI 10.1002/j.1460-2075.1996.tb00378.x; TUGENDREICH S, 1995, CELL, V81, P261, DOI 10.1016/0092-8674(95)90336-4; VERNOS I, 1995, TRENDS CELL BIOL, V5, P297, DOI 10.1016/S0962-8924(00)89045-5; VERNOS I, 1995, CELL, V81, P117, DOI 10.1016/0092-8674(95)90376-3; Walczak CE, 1997, J CELL BIOL, V136, P859, DOI 10.1083/jcb.136.4.859; Walczak CE, 1998, CURR BIOL, V8, P903, DOI 10.1016/S0960-9822(07)00370-3; WANG SZ, 1995, J CELL BIOL, V128, P761, DOI 10.1083/jcb.128.5.761; Waters JC, 1996, J CELL SCI, V109, P2823; Wood KW, 1997, CELL, V91, P357, DOI 10.1016/S0092-8674(00)80419-5; Yamamoto A, 1996, J CELL BIOL, V133, P99, DOI 10.1083/jcb.133.1.99; YEN TJ, 1991, EMBO J, V10, P1245, DOI 10.1002/j.1460-2075.1991.tb08066.x; Zachariae W, 1999, GENE DEV, V13, P2039, DOI 10.1101/gad.13.16.2039; ZHANG P, 1990, CELL, V62, P1053, DOI 10.1016/0092-8674(90)90383-P; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418	72	247	253	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 18	2000	102	4					411	424		10.1016/S0092-8674(00)00047-7	http://dx.doi.org/10.1016/S0092-8674(00)00047-7			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	347BX	10966104	Bronze			2022-12-28	WOS:000088908000004
J	Sherr, CJ; DePinho, RA				Sherr, CJ; DePinho, RA			Cellular senescence: Mitotic clock or culture shock?	CELL			English	Review							ONCOGENIC RAS; TELOMERASE; CELLS; APOPTOSIS; P53; IMMORTALIZATION; SUPPRESSION; P16(INK4A); P19(ARF); LOCUS		St Jude Childrens Res Hosp, Howard Hughes Med Inst, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Dept Tumor Cell Biol, Memphis, TN 38105 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Howard Hughes Medical Institute; St Jude Children's Research Hospital; St Jude Children's Research Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Sherr, CJ (corresponding author), St Jude Childrens Res Hosp, Howard Hughes Med Inst, Memphis, TN 38105 USA.	sherr@stjude.org	Sherr, Charles J/N-8074-2018	Sherr, Charles J/0000-0002-5516-6206; DePinho, Ronald/0000-0002-5625-577X				Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Carnero A, 2000, NAT CELL BIOL, V2, P148, DOI 10.1038/35004020; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; Greider CW, 1996, SCI AM, V274, P92, DOI 10.1038/scientificamerican0296-92; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; Kiyono T, 1998, NATURE, V396, P84, DOI 10.1038/23962; LOO DT, 1987, SCIENCE, V236, P200, DOI 10.1126/science.3494308; Pantoja C, 1999, ONCOGENE, V18, P4974, DOI 10.1038/sj.onc.1202880; PROWSE KR, 1995, P NATL ACAD SCI USA, V92, P4818, DOI 10.1073/pnas.92.11.4818; ROHME D, 1981, P NATL ACAD SCI-BIOL, V78, P5009, DOI 10.1073/pnas.78.8.5009; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Westphal CH, 1997, NAT GENET, V16, P397, DOI 10.1038/ng0897-397; WRIGHT WE, 1992, EXP GERONTOL, V27, P383, DOI 10.1016/0531-5565(92)90069-C; Zhang SL, 1998, P NATL ACAD SCI USA, V95, P2429, DOI 10.1073/pnas.95.5.2429; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	20	601	622	2	69	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 18	2000	102	4					407	410		10.1016/S0092-8674(00)00046-5	http://dx.doi.org/10.1016/S0092-8674(00)00046-5			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	347BX	10966103	Bronze			2022-12-28	WOS:000088908000003
J	Edman, RL; Klaus, SN				Edman, RL; Klaus, SN			Is routine screening for melanoma a benign practice?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CUTANEOUS MALIGNANT-MELANOMA; HISTOPATHOLOGIC DIAGNOSIS; EXPERT PATHOLOGISTS; MELANOCYTIC NEVI; DYSPLASTIC NEVI; SKIN-CANCER; RISK; SURVEILLANCE; DISCORDANCE; LESIONS		Dartmouth Hitchcock Med Ctr, Dept Med Dermatol, Lebanon, NH 03766 USA	Dartmouth College	Edman, RL (corresponding author), 6 Asher St, IL-32297 Haifa, Israel.							Ackerman AB, 1996, HUM PATHOL, V27, P1115, DOI 10.1016/S0046-8177(96)90301-9; ALBERT VA, 1990, J AM ACAD DERMATOL, V23, P308, DOI 10.1016/0190-9622(90)70214-3; AUSTOKER J, 1994, BRIT MED J, V308, P1682, DOI 10.1136/bmj.308.6945.1682; Brandt TP, 1996, MED CLIN N AM, V80, P99, DOI 10.1016/S0025-7125(05)70429-6; *CAN TASK FORC PER, 1994, CAN GUID CLIN PREV H, P850; Corona R, 1996, J CLIN ONCOL, V14, P1218, DOI 10.1200/JCO.1996.14.4.1218; EDMAN RL, IN PRESS AM FAM PHYS; Farmer ER, 1996, HUM PATHOL, V27, P528, DOI 10.1016/S0046-8177(96)90157-4; HALL WH, 1992, JAMA-J AM MED ASSOC, V268, P1314, DOI 10.1001/jama.1992.03490100112037; KANG SW, 1994, ARCH DERMATOL, V130, P999, DOI 10.1001/archderm.130.8.999; KOH HK, 1991, J AM ACAD DERMATOL, V24, P271, DOI 10.1016/0190-9622(91)70041-Y; MACKIE RM, 1993, LANCET, V341, P1618, DOI 10.1016/0140-6736(93)90758-9; MACKIE RM, 1992, BRIT MED J, V304, P1012, DOI 10.1136/bmj.304.6833.1012; Meyer LJ, 1996, J AM ACAD DERMATOL, V34, P618, DOI 10.1016/S0190-9622(96)80061-2; Piepkorn M, 1997, ARCH DERMATOL, V133, P1393, DOI 10.1001/archderm.133.11.1393; RIGEL DS, 1989, CANCER, V63, P386, DOI 10.1002/1097-0142(19890115)63:2<386::AID-CNCR2820630231>3.0.CO;2-6; SCHNEIDER JS, 1994, ARCH DERMATOL, V130, P1002, DOI 10.1001/archderm.130.8.1002; SLADE J, 1995, J AM ACAD DERMATOL, V32, P479, DOI 10.1016/0190-9622(95)90073-X; SOX HC, 1993, JAMA-J AM MED ASSOC, V269, P2678, DOI 10.1001/jama.269.20.2678; Swerlick RA, 1996, ARCH DERMATOL, V132, P881, DOI 10.1001/archderm.132.8.881; US Preventive Services Task Force, 1996, GUID CLIN PREV SERV, P18; VANDERESCH EP, 1991, INT J CANCER, V47, P483, DOI 10.1002/ijc.2910470402; Weinstock MA, 1997, ARCH DERMATOL, V133, P953, DOI 10.1001/archderm.133.8.953	23	13	13	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 16	2000	284	7					883	886		10.1001/jama.284.7.883	http://dx.doi.org/10.1001/jama.284.7.883			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	342PM	10938180				2022-12-28	WOS:000088654400033
J	Yellon, DM; Baxter, GF				Yellon, DM; Baxter, GF			Sodium-hydrogen exchange in myocardial reperfusion injury	LANCET			English	Editorial Material							NA+-H+ EXCHANGE; CARIPORIDE; INHIBITOR; HOE-642		UCL Hosp, Dept Acad & Clin Cardiol, Hatter Inst, London WC1E 6DB, England	University College London Hospitals NHS Foundation Trust; University of London; University College London	Yellon, DM (corresponding author), UCL Hosp, Dept Acad & Clin Cardiol, Hatter Inst, London WC1E 6DB, England.		Yellon, Derek M/ABD-5110-2021	Yellon, Derek/0000-0001-7791-9320; Baxter, Gary/0000-0002-7887-6841				Ambrosio G, 1999, AM HEART J, V138, pS69, DOI 10.1016/S0002-8703(99)70323-6; Avkiran M, 1999, AM J CARDIOL, V83, p10G; Aye NN, 1999, BRIT J PHARMACOL, V127, P1048, DOI 10.1038/sj.bjp.0702566; Baines CP, 1999, J CARDIOVASC ELECTR, V10, P741, DOI 10.1111/j.1540-8167.1999.tb00251.x; FARB A, 1993, J AM COLL CARDIOL, V21, P1245, DOI 10.1016/0735-1097(93)90253-W; Ferguson JJ, 1999, CIRCULATION, V100, P570, DOI 10.1161/01.CIR.100.6.570; Gumina RJ, 1999, CIRCULATION, V100, P2519, DOI 10.1161/01.CIR.100.25.2519; Karmazyn M, 1999, CIRC RES, V85, P777, DOI 10.1161/01.RES.85.9.777; Linz W, 1998, CLIN EXP HYPERTENS, V20, P733, DOI 10.3109/10641969809052116; Matsumura K, 1998, CIRCULATION, V97, P795, DOI 10.1161/01.CIR.97.8.795; Miura T, 1997, J AM COLL CARDIOL, V29, P693, DOI 10.1016/S0735-1097(96)00522-0; Rupprecht HJ, 2000, CIRCULATION, V101, P2902, DOI 10.1161/01.CIR.101.25.2902; SIMOONS ML, 1999, LANCET S2, V353, P1; Stromer H, 2000, CIRCULATION, V101, P2749, DOI 10.1161/01.CIR.101.23.2749; VandenHoek TL, 1996, AM J PHYSIOL-HEART C, V270, pH1334, DOI 10.1152/ajpheart.1996.270.4.H1334; Yellon DM, 2000, HEART, V83, P381, DOI 10.1136/heart.83.4.381	16	20	21	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 12	2000	356	9229					522	523		10.1016/S0140-6736(00)02570-8	http://dx.doi.org/10.1016/S0140-6736(00)02570-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	345MY	10950222				2022-12-28	WOS:000088820800002
J	Luijendijk, RW; Hop, WCJ; van den Tol, P; de Lange, DCD; Braaksma, MMJ; Ijzermans, JNM; Boelhouwer, RU; de Vries, BC; Salu, MKM; Wereldsma, JCJ; Bruijninckx, CMA; Jeekel, J				Luijendijk, RW; Hop, WCJ; van den Tol, P; de Lange, DCD; Braaksma, MMJ; Ijzermans, JNM; Boelhouwer, RU; de Vries, BC; Salu, MKM; Wereldsma, JCJ; Bruijninckx, CMA; Jeekel, J			A comparison of suture repair with mesh repair for incisional hernia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ABDOMINAL AORTIC-ANEURYSM; RECURRENCE; DISEASE; WALL; POLYPROPYLENE; DEGRADATION; EXPERIENCE; COLLAGEN; RISK	Background Incisional hernia is an important complication of abdominal surgery. Procedures for the repair of these hernias with sutures and with mesh have been reported, but there is no consensus about which type of procedure is best. Methods Between March 1992 and February 1998, we performed a multicenter trial in which we randomly assigned to suture repair or mesh repair 200 patients who were scheduled to undergo repair of a primary hernia or a first recurrence of hernia at the site of a vertical midline incision of the abdomen of less than 6 cm in length or width. The patients were followed up by physical examination at 1, 6, 12, 18, 24, and 36 months. Recurrence rates and potential risk factors for recurrent incisional hernia were analyzed with the use of life-table methods. Results Among the 154 patients with primary hernias and the 27 patients with first-time recurrent hernias who were eligible for the study, 56 had recurrences during the follow-up period. The three-year cumulative rates of recurrence among patients who had suture repair and those who had mesh repair were 43 percent and 24 percent, respectively, with repair of a primary hernia (P=0.02; difference, 19 percentage points; 95 percent confidence interval, 3 to 35 percentage points). The recurrence rates were 58 percent and 20 percent with repair of a first recurrence of hernia (P=0.10; difference, 38 percentage points; 95 percent confidence interval, -1 to 78 percentage points). The risk factors for recurrence were suture repair, infection, prostatism ( in men), and previous surgery for abdominal aortic aneurysm. The size of the hernia did not affect the rate of recurrence. Conclusions Among patients with midline abdominal incisional hernias, mesh repair is superior to suture repair with regard to the recurrence of hernia, regardless of the size of the hernia. (N Engl J Med 2000; 343:392-8.) (C) 2000, Massachusetts Medical Society.	Univ Hosp Rotterdam Dijkzigt, Dept Gen Surg, NL-3015 GD Rotterdam, Netherlands; Vrije Univ Amsterdam, Univ Hosp, Dept Plast & Reconstruct Surg, Amsterdam, Netherlands; Erasmus Univ, Sch Med, Dept Epidemiol & Biostat, NL-3000 DR Rotterdam, Netherlands; Ikazia Hosp, Dept Gen Surg, Rotterdam, Netherlands; Westeinde Ziekenhuis, Med Centrum Haaglanden, Dept Gen Surg, The Hague, Netherlands; Zuiderziekenhuis, Dept Gen Surg, Rotterdam, Netherlands; St Franciscus Gasthuis, Dept Gen Surg, Rotterdam, Netherlands; Leyenburg Ziekenhuis, Dept Gen Surg, The Hague, Netherlands	Erasmus University Rotterdam; Erasmus MC; Vrije Universiteit Amsterdam; Erasmus University Rotterdam; Ikazia Hospital; Franciscus Gasthuis	Jeekel, J (corresponding author), Univ Hosp Rotterdam Dijkzigt, Dept Gen Surg, Dr Molewaterplein 40, NL-3015 GD Rotterdam, Netherlands.	spek@hlkd.azr.nl						Adye B, 1998, AM J SURG, V175, P400; AMID PK, 1994, J BIOMED MATER RES, V28, P373, DOI 10.1002/jbm.820280312; Anthony T, 2000, WORLD J SURG, V24, P95, DOI 10.1007/s002689910018; Bendavid R, 1997, HERNIA, V1, P5, DOI [10.1007/BF02426380, DOI 10.1007/BF02426380]; CAMPA JS, 1987, ATHEROSCLEROSIS, V65, P13, DOI 10.1016/0021-9150(87)90003-7; CANNON DJ, 1984, ARCH SURG-CHICAGO, V119, P387; Dasika UK, 1998, AM SURGEON, V64, P817; FRIEDMAN DW, 1993, ANN SURG, V218, P754, DOI 10.1097/00000658-199312000-00009; GEORGE CD, 1986, ANN ROY COLL SURG, V68, P185; HALL KA, 1995, AM J SURG, V170, P572, DOI 10.1016/S0002-9610(99)80018-X; HESSELINK VJ, 1993, SURG GYNECOL OBSTET, V176, P228; Holland AJA, 1996, EUR J VASC ENDOVASC, V12, P196, DOI 10.1016/S1078-5884(96)80106-7; Israelsson LA, 1999, EUR J VASC ENDOVASC, V17, P133, DOI 10.1053/ejvs.1998.0726; Johnson B, 1995, J CARDIOVASC SURG, V36, P487; Klinge U, 2000, EUR SURG RES, V32, P43, DOI 10.1159/000008740; Leber GE, 1998, ARCH SURG-CHICAGO, V133, P378, DOI 10.1001/archsurg.133.4.378; LEWIS RT, 1989, CAN J SURG, V32, P196; LIAKAKOS T, 1994, BRIT J SURG, V81, P248, DOI 10.1002/bjs.1800810230; LICHTENSTEIN IL, 1991, AM SURGEON, V57, P730; LOURY JN, 1983, PRESSE MED, V12, P2116; Luijendijk RW, 1997, WORLD J SURG, V21, P62, DOI 10.1007/s002689900194; LUIJENDIJK RW, 2000, THESIS ERASMUS U ROT; MANNINEN MJ, 1991, ACTA CHIR-EUR J SURG, V157, P29; MENASHI S, 1987, J VASC SURG, V6, P578, DOI 10.1067/mva.1987.avs0060578; Morris-Stiff GJ, 1998, J AM COLL SURGEONS, V186, P352, DOI 10.1016/S1072-7515(98)00002-7; MUDGE M, 1985, BRIT J SURG, V72, P70, DOI 10.1002/bjs.1800720127; Paul A, 1998, EUR J SURG, V164, P361; READ RC, 1989, ARCH SURG-CHICAGO, V124, P485; Read RC, 1998, HERNIA, V2, P51, DOI DOI 10.1007/BF01207484; RIVES J, 1985, CHIRURGIE, V111, P215; SOLER M, 1993, ANN CHIR, V47, P598; STEVICK CA, 1988, AM SURGEON, V54, P287; Stoppa R, 1999, HERNIA, V3, P1; STOPPA RE, 1989, WORLD J SURG, V13, P545, DOI 10.1007/BF01658869; Sugerman HJ, 1996, AM J SURG, V171, P80, DOI 10.1016/S0002-9610(99)80078-6; TILSON MD, 1983, SURGERY, V94, P134; USHER FC, 1962, ARCH SURG-CHICAGO, V84, P325, DOI 10.1001/archsurg.1962.01300210059012; VANDERLINDEN FTPM, 1988, NETH J SURG, V40, P127; Vrijland WW, 2000, BRIT J SURG, V87, P348, DOI 10.1046/j.1365-2168.2000.01364.x; Wantz, 1999, J AM COLL SURGEONS, V188, P429	40	1156	1213	1	46	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 10	2000	343	6					392	398		10.1056/NEJM200008103430603	http://dx.doi.org/10.1056/NEJM200008103430603			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	342DT	10933738				2022-12-28	WOS:000088630500003
J	Norwitz, ER; Hoyte, LPJ; Jenkins, KJ; van der Velde, ME; Ratiu, P; Rodriguez-Thompson, D; Wilkins-Haug, L; Tempany, CMC; Fishman, SJ				Norwitz, ER; Hoyte, LPJ; Jenkins, KJ; van der Velde, ME; Ratiu, P; Rodriguez-Thompson, D; Wilkins-Haug, L; Tempany, CMC; Fishman, SJ			Separation of conjoined twins with the twin reversed-arterial-perfusion sequence after prenatal planning with three-dimensional modeling	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACARDIAC-ACEPHALUS TWIN; SELECTIVE DELIVERY; UMBILICAL-CORD; DIAGNOSIS; LIGATION; HYSTEROTOMY; PREGNANCIES; MR		Childrens Hosp, Dept Surg, Boston, MA 02115 USA; Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Radiol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Fishman, SJ (corresponding author), Childrens Hosp, Dept Surg, 300 Longwood Ave, Boston, MA 02115 USA.		Rodriguez, Diana/AAX-1532-2020; Rodriguez, Diana/R-5528-2019					BENIRSCHKE K, 1981, PRINCIPLES PRACTICE, P1165; CHIU CT, 1994, J CARDIOVASC SURG, V35, P459; EDMONDS LD, 1982, TERATOLOGY, V25, P301, DOI 10.1002/tera.1420250306; FAGAN CJ, 1977, AM J ROENTGENOL, V129, P921, DOI 10.2214/ajr.129.5.921; FOLEY MR, 1995, AM J OBSTET GYNECOL, V172, P212, DOI 10.1016/0002-9378(95)90117-5; FRIES MH, 1992, OBSTET GYNECOL, V79, P601; GERING D, 1999, INTEGRATED VISUALIZA; GILLIM DL, 1953, OBSTET GYNECOL, V2, P647; GINSBERG NA, 1992, AM J OBSTET GYNECOL, V167, P33, DOI 10.1016/S0002-9378(11)91620-2; GORE RM, 1982, JAMA-J AM MED ASSOC, V247, P3351, DOI 10.1001/jama.247.24.3351; GRAIVIER L, 1980, TEX MED, V76, P60; HEMPEL S, 1907, MORPHOLOGIE MISBILDU; Hubbard AM, 1999, RADIOLOGY, V212, P43, DOI 10.1148/radiology.212.1.r99jl3143; Klein DJ, 1998, J PEDIATR SURG, V33, P354, DOI 10.1016/S0022-3468(98)90461-4; MCCURDY CM, 1993, OBSTET GYNECOL, V82, P708; MOORE TR, 1990, AM J OBSTET GYNECOL, V163, P907, DOI 10.1016/0002-9378(90)91094-S; NOONAN JA, 1987, AM J DIS CHILD, V132, P17; PATEL R, 1977, BRIT HEART J, V39, P1254; PORRECO RP, 1991, LANCET, V337, P326, DOI 10.1016/0140-6736(91)90946-M; Quinn TM, 1998, J PEDIATR SURG, V33, P553, DOI 10.1016/S0022-3468(98)90315-3; QUINTERO RA, 1994, NEW ENGL J MED, V330, P469, DOI 10.1056/NEJM199402173300705; ROBIE GF, 1989, NEW ENGL J MED, V320, P512, DOI 10.1056/NEJM198902233200808; Rodeck C, 1998, NEW ENGL J MED, V339, P1293, DOI 10.1056/NEJM199810293391805; Romero R, 1987, PRENATAL DIAGNOSIS C, P405; SEPULVEDA W, 1995, OBSTET GYNECOL, V86, P680, DOI 10.1016/0029-7844(95)00171-M; VANALLEN MI, 1983, SEMIN PERINATOL, V7, P285; WEINREB JC, 1986, RADIOLOGY, V159, P717, DOI 10.1148/radiology.159.3.3517956	27	30	38	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 10	2000	343	6					399	402		10.1056/NEJM200008103430604	http://dx.doi.org/10.1056/NEJM200008103430604			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	342DT	10933739				2022-12-28	WOS:000088630500004
J	Royant, A; Edman, K; Ursby, T; Pebay-Peyroula, E; Landau, EM; Neutze, R				Royant, A; Edman, K; Ursby, T; Pebay-Peyroula, E; Landau, EM; Neutze, R			Helix deformation is coupled to vectorial proton transport in the photocycle of bacteriorhodopsin	NATURE			English	Article							LIPIDIC CUBIC PHASES; TO-M TRANSITION; ANGSTROM RESOLUTION; CONFORMATIONAL-CHANGES; STRUCTURAL-CHANGES; MEMBRANE-PROTEINS; SCHIFF-BASE; RELEASE; INTERMEDIATE; CRYSTALS	A wide variety of mechanisms are used to generate a protonmotive potential across cell membranes, a function lying at the heart of bioenergetics. Bacteriorhodopsin, the simplest known proton pump(1), provides a paradigm for understanding this process. Here we report, at 2.1 Angstrom resolution, the structural changes in bacteriorhodopsin immediately preceding the primary proton transfer event in its photocycle. The early structural rearrangements(2) propagate from the protein's core towards the extracellular surface, disrupting the network of hydrogen-bonded water molecules that stabilizes helix C in the ground state. Concomitantly, a bend of this helix enables the negatively charged(3) primary proton acceptor, Asp 85, to approach closer to the positively charged primary proton donor, the Schiff base. The primary proton transfer event would then neutralize these two groups, cancelling their electrostatic attraction and facilitating a relaxation of helix C to a less strained geometry. Reprotonation of the Schiff base by Asp 85 would thereby be impeded, ensuring vectorial proton transport. Structural rearrangements also occur near the protein's surface, aiding proton release to the extracellular medium.	Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; Univ Grenoble 1, Inst Biol Struct, CEA, CNRS,UMR 5075, F-38027 Grenoble 1, France; Uppsala Univ, Biomed Ctr, Dept Biochem, S-75123 Uppsala, Sweden; European Synchrotron Radiat Facil, F-38043 Grenoble, France	University of Basel; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Uppsala University; European Synchrotron Radiation Facility (ESRF)	Landau, EM (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.		Neutze, Richard/A-7573-2010; Royant, Antoine/G-3684-2012	Neutze, Richard/0000-0003-0986-6153; Royant, Antoine/0000-0002-1919-8649				Althaus T, 1998, BIOCHEMISTRY-US, V37, P2807, DOI 10.1021/bi9714969; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Balashov SP, 1996, BIOPHYS J, V70, P473, DOI 10.1016/S0006-3495(96)79591-7; Balashov SP, 1997, BIOCHEMISTRY-US, V36, P8671, DOI 10.1021/bi970744y; Belrhali H, 1999, STRUCTURE, V7, P909, DOI 10.1016/S0969-2126(99)80118-X; Bourgeois D, 1999, ACTA CRYSTALLOGR D, V55, P1733, DOI 10.1107/S0907444999008355; BRAIMAN MS, 1988, BIOCHEMISTRY-US, V27, P8516, DOI 10.1021/bi00423a002; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chandra N, 1999, ACTA CRYSTALLOGR D, V55, P1750, DOI 10.1107/S0907444999009968; Edman K, 1999, NATURE, V401, P822, DOI 10.1038/44623; Esnouf R. M., 1997, J MOL GRAPHICS, V15, P133; GAT Y, 1993, J AM CHEM SOC, V115, P3772, DOI 10.1021/ja00062a052; Genick UK, 1998, NATURE, V392, P206, DOI 10.1038/32462; HADFIELD A, 1993, J APPL CRYSTALLOGR, V26, P839, DOI 10.1107/S0021889893005552; HEBERLE J, 1993, EMBO J, V12, P3721, DOI 10.1002/j.1460-2075.1993.tb06049.x; Hendrickson FM, 1998, BIOPHYS J, V75, P1446, DOI 10.1016/S0006-3495(98)74063-9; Hu JGG, 1997, BIOCHEMISTRY-US, V36, P9316, DOI 10.1021/bi970416y; KHORANA HG, 1993, P NATL ACAD SCI USA, V90, P1166, DOI 10.1073/pnas.90.4.1166; Landau EM, 1996, P NATL ACAD SCI USA, V93, P14532, DOI 10.1073/pnas.93.25.14532; Luecke H, 1999, SCIENCE, V286, P255, DOI 10.1126/science.286.5438.255; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; MAEDA A, 1994, BIOCHEMISTRY-US, V33, P1713, DOI 10.1021/bi00173a013; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Nollert P, 1998, BIOCHEM SOC T, V26, P709, DOI 10.1042/bst0260709; OESTERHELT D, 1971, NATURE-NEW BIOL, V233, P149, DOI 10.1038/newbio233149a0; OTWINOWSKI Z, 1993, DATA COLLECTION PROC, P55; SCHLICHTING I, 1994, NATURE, V371, P808, DOI 10.1038/371808a0; Subramaniam S, 1999, J MOL BIOL, V287, P145, DOI 10.1006/jmbi.1999.2589; SUBRAMANIAM S, 1993, EMBO J, V12, P1; TAKEI H, 1994, J BIOL CHEM, V269, P7387	30	221	228	1	24	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 10	2000	406	6796					645	648		10.1038/35020599	http://dx.doi.org/10.1038/35020599			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	342PF	10949307				2022-12-28	WOS:000088653800052
J	Alivisatos, AP				Alivisatos, AP			Biomineralization - Naturally aligned nanocrystals	SCIENCE			English	Editorial Material									Univ Calif Berkeley, Dept Chem & Mat Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Alivisatos, AP (corresponding author), Univ Calif Berkeley, Dept Chem & Mat Sci, Berkeley, CA 94720 USA.	alivis@uclink4.berkeley.edu	Alivisatos, Paul/N-8863-2015	Alivisatos, Paul/0000-0001-6895-9048				[Anonymous], 1998, SCIENCE, V281; Banfield JF, 2000, SCIENCE, V289, P751, DOI 10.1126/science.289.5480.751; BANFIELD JF, 1996, PHIL MAG LETT, V73, P27; Bruchez M, 1998, SCIENCE, V281, P2013, DOI 10.1126/science.281.5385.2013; Dunin-Borkowski RE, 1998, SCIENCE, V282, P1868, DOI 10.1126/science.282.5395.1868; GLEITER H, 1989, PROG MATER SCI, V33, P223, DOI 10.1016/0921-5093(89)90083-X; Grundmann M, 1999, PHYSICA E, V5, P167, DOI 10.1016/S1386-9477(99)00041-7; LEON R, 1995, SCIENCE, V267, P1966, DOI 10.1126/science.267.5206.1966; MATIJEVIC E, 1989, MAT RES SOC B, V14; Penn RL, 1998, SCIENCE, V281, P969, DOI 10.1126/science.281.5379.969; Penn RL, 1999, GEOCHIM COSMOCHIM AC, V63, P1549, DOI 10.1016/S0016-7037(99)00037-X; Sun SH, 2000, SCIENCE, V287, P1989, DOI 10.1126/science.287.5460.1989; Yeadon M, 1998, APPL PHYS LETT, V73, P3208, DOI 10.1063/1.122720	13	401	422	0	205	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 4	2000	289	5480					736	737		10.1126/science.289.5480.736	http://dx.doi.org/10.1126/science.289.5480.736			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	341FZ	10950719				2022-12-28	WOS:000088581500027
J	Clapham, JC; Arch, JRS; Chapman, H; Haynes, A; Lister, C; Moore, GBT; Piercy, V; Carter, SA; Lehner, I; Smith, SA; Beeley, LJ; Godden, RJ; Herrity, N; Skehel, M; Changani, KK; Hockings, PD; Reid, DG; Squires, SM; Hatcher, J; Trail, B; Latcham, J; Rastan, S; Harper, AJ; Cadenas, S; Buckingham, JA; Brand, MD; Abuin, A				Clapham, JC; Arch, JRS; Chapman, H; Haynes, A; Lister, C; Moore, GBT; Piercy, V; Carter, SA; Lehner, I; Smith, SA; Beeley, LJ; Godden, RJ; Herrity, N; Skehel, M; Changani, KK; Hockings, PD; Reid, DG; Squires, SM; Hatcher, J; Trail, B; Latcham, J; Rastan, S; Harper, AJ; Cadenas, S; Buckingham, JA; Brand, MD; Abuin, A			Mice overexpressing human uncoupling protein-3 in skeletal muscle are hyperphagic and lean	NATURE			English	Article							SELECTIVE BETA(3)-ADRENOCEPTOR AGONIST; BROWN ADIPOSE-TISSUE; INSULIN ACTION; FAT OXIDATION; THERMOGENESIS; OBESITY; GENE; PALATABILITY; CL-316,243; PRODUCT	Uncoupling protein-3 (UCP-3) is a recently identified member of the mitochondrial transporter superfamily(1,2) that is expressed predominantly in skeletal muscle(1,2). However, its close relative UCP-1 is expressed exclusively in brown adipose tissue, a tissue whose main function is fat combustion and thermogenesis. Studies on the expression of UCP-3 in animals and humans in different physiological situations support a role for UCP-3 in energy balance and lipid metabolism(3,4). However, direct evidence for these roles is lacking. Here we describe the creation of transgenic mice that overexpress human UCP-3 in skeletal muscle. These mice are hyperphagic but weigh less than their wild-type littermates. Magnetic resonance imaging shows a striking reduction in adipose tissue mass. The mice also exhibit lower fasting plasma glucose and insulin levels and an increased glucose clearance rate. This provides evidence that skeletal muscle UCP-3 has the potential to influence metabolic rate and glucose homeostasis in the whole animal.	Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; MRC, Dunn Human Nutr Unit, Cambridge CB2 2XY, England; Dept Safety Assessment, Welwyn Garden City AL6 9AR, Herts, England; Lab Anim Sci, Welwyn Garden City AL6 9AR, Herts, England; SmithKline Beecham Pharmaceut, Dept Vasc Biol, Harlow CM19 5AW, Essex, England; SmithKline Beecham Pharmaceut, Dept Bioinformat, Harlow CM19 5AW, Essex, England; SmithKline Beecham Pharmaceut, Dept Mol Biol, Harlow CM19 5AW, Essex, England; SmithKline Beecham Pharmaceut, Dept Gene Express Sci, Harlow CM19 5AW, Essex, England; SmithKline Beecham Pharmaceut, Dept Bioanalyt Sci, Harlow CM19 5AW, Essex, England; SmithKline Beecham Pharmaceut, Dept Neurobehav Res, Harlow CM19 5AW, Essex, England; SmithKline Beecham Pharmaceut, Dept Comparat Genet, Harlow CM19 5AW, Essex, England	University of Cambridge; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline	Clapham, JC (corresponding author), Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1QW, England.		Clapham, John/AAK-4715-2020; Cadenas, Susana/D-1523-2016; Hockings, Paul/C-1629-2010; Hockings, Paul D/AAM-7950-2020; Brand, Martin D/A-9423-2012	Hockings, Paul/0000-0002-7154-9047; Hockings, Paul D/0000-0002-7154-9047; Brand, Martin D/0000-0003-4418-6153; Cadenas, Susana/0000-0003-0726-0369				ARCH JRS, 1984, INT J OBESITY, V8, P1; Argyropoulos G, 1998, J CLIN INVEST, V102, P1345, DOI 10.1172/JCI4115; BELLISLE F, 1985, AM J PHYSIOL, V249, pE639, DOI 10.1152/ajpendo.1985.249.6.E639; Boss O, 1997, FEBS LETT, V408, P39, DOI 10.1016/S0014-5793(97)00384-0; BRENNAN KJ, 1993, J BIOL CHEM, V268, P719; Cadenas S, 1999, FEBS LETT, V462, P257, DOI 10.1016/S0014-5793(99)01540-9; Chung WK, 1999, INT J OBESITY, V23, pS49, DOI 10.1038/sj.ijo.0800945; DIAMOND P, 1985, AM J PHYSIOL, V248, pE75, DOI 10.1152/ajpendo.1985.248.1.E75; Ernster L., 1967, METHOD ENZYMOL, V10, P86; Gordon CJ, 1993, TEMPERATURE REGULATI, DOI 10.1017/CBO9780511565595; GRUNNING P, 1987, MOL CELL BIOL, V7, P4100; Hogan B, 1994, MANIPULATING MOUSE E; HOLLAND PM, 1991, P NATL ACAD SCI USA, V88, P7276, DOI 10.1073/pnas.88.16.7276; JONES BJ, 1968, J PHARM PHARMACOL, V20, P302, DOI 10.1111/j.2042-7158.1968.tb09743.x; LARGIS EE, 1994, DRUG DEVELOP RES, V32, P69, DOI 10.1002/ddr.430320203; LEBLANC J, 1985, AM J PHYSIOL, V248, pE333, DOI 10.1152/ajpendo.1985.248.3.E333; Liu XL, 1998, AM J PHYSIOL-REG I, V274, pR1212, DOI 10.1152/ajpregu.1998.274.5.R1212; LIVAK KJ, 1995, PCR METH APPL, V4, P357; Otabe S, 2000, DIABETOLOGIA, V43, P245, DOI 10.1007/s001250050037; Rogers DC, 1999, BEHAV BRAIN RES, V105, P207, DOI 10.1016/S0166-4328(99)00072-8; Samec S, 1999, DIABETES, V48, P436, DOI 10.2337/diabetes.48.2.436; Samec S, 1998, FASEB J, V12, P715, DOI 10.1096/fasebj.12.9.715; Stock MJ, 1999, INT J OBESITY, V23, P1105, DOI 10.1038/sj.ijo.0801108; VidalPuig A, 1997, BIOCHEM BIOPH RES CO, V235, P79, DOI 10.1006/bbrc.1997.6740; Weyer C, 1998, DIABETES, V47, P1555, DOI 10.2337/diabetes.47.10.1555; Widdowson PS, 1997, DIABETES, V46, P1782, DOI 10.2337/diabetes.46.11.1782; YOUNG PW, 1995, DIABETES, V44, P1087, DOI 10.2337/diabetes.44.9.1087	27	498	518	1	30	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 27	2000	406	6794					415	418		10.1038/35019082	http://dx.doi.org/10.1038/35019082			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	337WC	10935638				2022-12-28	WOS:000088383800048
J	Hesselbo, SP; Grocke, DR; Jenkyns, HC; Bjerrum, CJ; Farrimond, P; Bell, HSM; Green, OR				Hesselbo, SP; Grocke, DR; Jenkyns, HC; Bjerrum, CJ; Farrimond, P; Bell, HSM; Green, OR			Massive dissociation of gas hydrate during a Jurassic oceanic anoxic event	NATURE			English	Article							SEA-LEVEL CHANGE; TOARCIAN; CLIMATE	In the Jurassic period, the Early Toarcian oceanic anoxic event (about 183 million years ago) is associated with exceptionally high rates of organic-carbon burial, high palaeotemperatures and significant mass extinction(1-4). Heavy carbon-isotope compositions in rocks and fossils of this age have been linked to the global burial of organic carbon, which is isotopically light. In contrast, examples of light carbon-isotope values from marine organic matter of Early Toarcian age have been explained principally in terms of localized upwelling of bottom water enriched in C-12 versus C-13 (refs 1,2,5,6). Here, however, we report carbon-isotope analyses of fossil wood which demonstrate that isotopically light carbon dominated all the upper oceanic, biospheric and atmospheric carbon reservoirs, and that this occurred despite the enhanced burial of organic carbon. We propose that-as has been suggested for the Late Palaeocene thermal maximum, some 55 million years ago(7)-the observed patterns were produced by voluminous and extremely rapid release of methane from gas hydrate contained in marine continental-margin sediments.	Univ Oxford, Dept Earth Sci, Oxford OX1 3PR, England; Univ Copenhagen, Danish Ctr Earth Syst Sci, DK-2100 Copenhagen, Denmark; Newcastle Univ, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Univ Copenhagen, Inst Geol, DK-1168 Copenhagen, Denmark	University of Oxford; University of Copenhagen; Newcastle University - UK; University of Copenhagen	Hesselbo, SP (corresponding author), Univ Oxford, Dept Earth Sci, Parks Rd, Oxford OX1 3PR, England.	stephen.hesselbo@earth.ox.ac.uk	Bjerrum, Christian Jannik/AAZ-5488-2021; Bjerrum, Christian/A-4247-2015; Grocke, Darren/F-4799-2015	Bjerrum, Christian Jannik/0000-0002-7804-1633; Bjerrum, Christian/0000-0002-7804-1633; Grocke, Darren/0000-0003-2296-7530; Jenkyns, Hugh/0000-0002-2728-0984				Abbott GD, 1998, GEOCHIM COSMOCHIM AC, V62, P1407, DOI 10.1016/S0016-7037(98)00078-7; BJERRUM CJ, 1999, THESIS U COPENHAGEN; Cope JCW, 1998, J GEOL SOC LONDON, V155, P421; DICKENS GR, 1995, PALEOCEANOGRAPHY, V10, P965, DOI 10.1029/95PA02087; Dickens GR, 2000, B SOC GEOL FR, V171, P37; Duarte, 1998, CUAD GEOL IBER, V24, P69; Duncan RA, 1997, J GEOPHYS RES-SOL EA, V102, P18127, DOI 10.1029/97JB00972; Fiet N, 2000, B SOC GEOL FR, V171, P103; Grocke DR, 1999, GEOLOGY, V27, P155, DOI 10.1130/0091-7613(1999)027<0155:CICOLC>2.3.CO;2; Hallam A, 1997, J GEOL SOC LONDON, V154, P773, DOI 10.1144/gsjgs.154.5.0773; Harries PJ, 1999, PALAEOGEOGR PALAEOCL, V154, P39, DOI 10.1016/S0031-0182(99)00086-3; Hesselbo SP, 1995, FIELD GEOLOGY OF THE BRITISH JURASSIC, P105; HESSELBO SP, 1998, MESOZOIC CENOZOIC SE, P560; Howarth M. K., 1992, MONOGRAPH PALAEONT S, V145, P1; JAHREN AH, 1998, GEOL SOC AM ABS PROG, V30, P53; Jenkyns HC, 1997, SEDIMENTOLOGY, V44, P687, DOI 10.1046/j.1365-3091.1997.d01-43.x; JENKYNS HC, 1988, AM J SCI, V288, P101, DOI 10.2475/ajs.288.2.101; Jenkyns HC, 1999, AM J SCI, V299, P341, DOI 10.2475/ajs.299.5.341; Jimenez AP, 1996, J GEOL, V104, P399, DOI 10.1086/629836; Knoll AH, 1996, SCIENCE, V273, P452, DOI 10.1126/science.273.5274.452; Koppelhus Eva Bundgaard, 1994, Palynology, V18, P139; Kuspert W., 1982, CYCLIC EVENT STRATIF, P482, DOI DOI 10.1007/978-3-642-75829-4_36; Kvenvolden KA, 1998, GEOL SOC SPEC PUBL, V137, P9, DOI 10.1144/GSL.SP.1998.137.01.02; Norris RD, 1999, NATURE, V401, P775, DOI 10.1038/44545; Palfy J, 1997, EARTH PLANET SC LETT, V146, P659, DOI 10.1016/S0012-821X(96)00241-5; Schouten S, 2000, AM J SCI, V300, P1, DOI 10.2475/ajs.300.1.1; SHAFFER G, 1994, NATURE, V367, P354, DOI 10.1038/367354a0; Smith A.G., 1994, ATLAS MESOZOIC CENOZ; Vakhrameev V.A., 1991, JURASSIC CRETACEOUS; Ziegler P. A., 1990, GEOLOGICAL ATLAS W C	30	733	803	3	216	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 27	2000	406	6794					392	395		10.1038/35019044	http://dx.doi.org/10.1038/35019044			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	337WC	10935632				2022-12-28	WOS:000088383800042
J	Bundred, PE; Levitt, C				Bundred, PE; Levitt, C			Medical migration: who are the real losers?	LANCET			English	Editorial Material							HEALTH		Univ Liverpool, Dept Primary Care, Liverpool L69 3GB, Merseyside, England; Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; McMaster Univ, Dept Family Med, Hamilton, ON L8S 4L8, Canada	University of Liverpool; Liverpool School of Tropical Medicine; University of Liverpool; McMaster University	Bundred, PE (corresponding author), Univ Liverpool, Dept Primary Care, Whelan Bldg, Liverpool L69 3GB, Merseyside, England.							[Anonymous], 1998, OECD HLTH DAT; BARER ML, 1991, FED PROV TERR C DEP; Evans RG, 1998, CAN MED ASSOC J, V158, P757; Kavalier F, 1998, LANCET, V352, P141; Lohr KN, 1996, JAMA-J AM MED ASSOC, V275, P748; Mullan F, 1997, NEW ENGL J MED, V336, P1601, DOI 10.1056/NEJM199705293362212; Ncayiyana DJ, 1999, S AFR MED J, V89, P1107; PETERSDORF RG, 1978, NEW ENGL J MED, V299, P628, DOI 10.1056/NEJM197809212991204; Ryten E, 1998, CAN MED ASSOC J, V158, P723; Sims P, 1997, J PUBLIC HEALTH MED, V19, P137, DOI 10.1093/oxfordjournals.pubmed.a024600; Walt G, 1998, LANCET, V351, P434, DOI 10.1016/S0140-6736(97)05546-3; WILLIAMS K, 1998, BMA NEWS REV    1010, P16; *WORLD BANK, 1994, 13515UG WORLD BANK; 1997, 2 WORLD RUR HLTH C C	14	126	126	1	10	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 15	2000	356	9225					245	246		10.1016/S0140-6736(00)02492-2	http://dx.doi.org/10.1016/S0140-6736(00)02492-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	334GQ	10963214				2022-12-28	WOS:000088179100039
J	Kahan, BD				Kahan, BD		Rapamune US Study Grp	Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study	LANCET			English	Article							MYCOPHENOLATE-MOFETIL; LONG-TERM; KIDNEY-TRANSPLANTATION; CYCLOSPORINE REGIMENS; TACROLIMUS FK506; RECIPIENTS; RAPAMYCIN; GRAFT; IMMUNOSUPPRESSION; PREVENTION	Background Acute rejection episodes after renal transplantation are an important clinical challenge, despite use of multidrug immunosuppressive regimens. We did a prospective, multicentre, randomised, double-blind trial to investigate the impact of the addition of sirolimus, compared with azathioprine, to a ciclosporin and prednisone regimen. Methods 719 recipients of primary HLA-mismatched cadaveric or living-donor renal allografts who displayed initial graft function were randomly assigned, after transplantation, sirolimus 2 mg daily (n=284) or 5 mg daily (n=274), or azathioprine (n=161). We assessed the primary composite endpoint of efficacy failure, occurrence of biopsy-confirmed acute rejection episodes, graft loss, or death, and various secondary endpoints that characterise these episodes at 6 months and 12 months. Analyses were done by intention to treat. Findings The rate of efficacy failure at 6 months was lower in the two sirolimus groups (2 mg 18.7%, p=0.002; 5 mg 16.8%, p<0.001) than in the azathioprine group (32.3%). The frequency of biopsy-confirmed acute rejection episodes was also lower (2 mg 16.9%, p=0.002; 5 mg 12.0%, p<0.001; azathioprine 29.8%). At 12 months, survival was similar in ail groups for grafts (97.2%, 96.0%, and 98.1%) and patients (94.7%, 92.7%, and 93.8%). Patients on sirolimus showed a delay in the time to first acute rejection episode and decreased frequency of moderate and severe histological grades of rejection episodes and related antibody treatment, compared with the azathioprine group. Rates of infection and malignant disorders were similar in all groups. Interpretation Use of sirolimus reduced occurrence and severity of biopsy-confirmed acute rejection episodes with no increase in complications. Further studies are needed to establish the optimum doses for the combined regimen.	Univ Texas, Sch Med, Dept Surg, Div Immunol & Organ Transplantat, Houston, TX 77030 USA	University of Texas System	Kahan, BD (corresponding author), Univ Texas, Sch Med, Dept Surg, Div Immunol & Organ Transplantat, 6431 Fannin,Suite 6-240, Houston, TX 77030 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038016] Funding Source: NIH RePORTER; NIDDK NIH HHS [NIDDK 38016-11] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Andoh TF, 1996, TRANSPLANTATION, V62, P311, DOI 10.1097/00007890-199608150-00002; CALNE RY, 1989, LANCET, V2, P227; CECKA MJ, 1995, CLIN TRANSPLANT, P1; CHIU MI, 1994, P NATL ACAD SCI USA, V91, P12574, DOI 10.1073/pnas.91.26.12574; Dantal J, 1998, LANCET, V351, P623, DOI 10.1016/S0140-6736(97)08496-1; Denton MD, 1999, LANCET, V353, P1083, DOI 10.1016/S0140-6736(98)07493-5; DIJOSEPH JF, 1992, TRANSPLANTATION, V53, P507, DOI 10.1097/00007890-199203000-00002; FLANAGAN WM, 1991, NATURE, V352, P803, DOI 10.1038/352803a0; FLEISS JL, 1981, STAT METHODS RATES P, P44; Groth CG, 1999, TRANSPLANTATION, V67, P1036, DOI 10.1097/00007890-199904150-00017; Halloran P, 1997, TRANSPLANTATION, V63, P39, DOI 10.1097/00007890-199701150-00008; Kahan BD, 1999, TRANSPLANTATION, V68, P1526, DOI 10.1097/00007890-199911270-00016; KAHAN BD, 1989, NEW ENGL J MED, V321, P1725; Kahan BD, 2000, CLIN TRANSPLANT, V14, P97, DOI 10.1034/j.1399-0012.2000.140201.x; Kahan BD, 1998, TRANSPLANTATION, V66, P1040, DOI 10.1097/00007890-199810270-00013; KAHAN BD, 1991, TRANSPLANTATION, V51, P232, DOI 10.1097/00007890-199101000-00038; KAHAN BD, 1998, GRAFT S2, V1, P93; Kaplan B, 1998, CLIN PHARMACOL THER, V63, P48, DOI 10.1016/S0009-9236(98)90120-5; Keown P, 1998, KIDNEY INT, V54, P938, DOI 10.1046/j.1523-1755.1998.00042.x; LANDIS RJ, 1978, INT STAT REV, V46, P237; Lechevallier E, 1998, AM J KIDNEY DIS, V32, P984, DOI 10.1016/S0272-6386(98)70073-3; Lin HM, 1998, JAMA-J AM MED ASSOC, V280, P1153, DOI 10.1001/jama.280.13.1153; LINDHOLM A, 1993, CLIN PHARMACOL THER, V54, P205, DOI 10.1038/clpt.1993.132; LINDHOLM A, 1993, TRANSPLANTATION, V56, P307, DOI 10.1097/00007890-199308000-00010; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Mathew TH, 1998, TRANSPLANTATION, V65, P1450, DOI 10.1097/00007890-199806150-00007; Mayer AD, 1997, TRANSPLANTATION, V64, P436, DOI 10.1097/00007890-199708150-00012; NANKIVELL BJ, 1995, TRANSPLANTATION, V59, P1683, DOI 10.1097/00007890-199506270-00007; Napoli KL, 1998, THER DRUG MONIT, V20, P123, DOI 10.1097/00007691-199804000-00001; OJO AO, 1995, KIDNEY INT, V48, P1592, DOI 10.1038/ki.1995.452; Pirsch JD, 1997, TRANSPLANTATION, V63, P977, DOI 10.1097/00007890-199704150-00013; Shapiro R, 1999, TRANSPLANTATION, V67, P411, DOI 10.1097/00007890-199902150-00012; SOLEZ K, 1993, KIDNEY INT, V44, P411, DOI 10.1038/ki.1993.259; SOLLINGER HW, 1995, TRANSPLANTATION, V60, P225, DOI 10.1097/00007890-199508000-00003	34	759	778	1	26	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 15	2000	356	9225					194	202		10.1016/S0140-6736(00)02480-6	http://dx.doi.org/10.1016/S0140-6736(00)02480-6			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	334GQ	10963197				2022-12-28	WOS:000088179100010
J	Grainger, D				Grainger, D			A votre sante?	LANCET			English	Editorial Material							MORTALITY; DISEASE		Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England	Addenbrooke's Hospital; University of Cambridge	Grainger, D (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England.							Iijima K, 2000, CIRCULATION, V101, P805, DOI 10.1161/01.CIR.101.7.805; Law M, 1999, BRIT MED J, V318, P1471, DOI 10.1136/bmj.318.7196.1471; Mackenbach JP, 1999, BRIT MED J, V318, P1478; MCMICHAEL J, 1979, LANCET, V1, P1186; Stein JH, 1999, CIRCULATION, V100, P1050, DOI 10.1161/01.CIR.100.10.1050; STLEGER AS, 1979, LANCET, V1, P1017, DOI 10.1016/S0140-6736(79)92765-X; Weissberg PL, 1996, LANCET, V347, P305, DOI 10.1016/S0140-6736(96)90472-9; *WHO, 1986, WORLD HLTH STAT ANN	8	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 8	2000	356	9224					92	92		10.1016/S0140-6736(00)02467-3	http://dx.doi.org/10.1016/S0140-6736(00)02467-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	331UG	10963243				2022-12-28	WOS:000088036600007
J	Kroll, TG; Sarraf, P; Pecciarini, L; Chen, CJ; Mueller, E; Spiegelman, BM; Fletcher, JA				Kroll, TG; Sarraf, P; Pecciarini, L; Chen, CJ; Mueller, E; Spiegelman, BM; Fletcher, JA			PAX8-PPAR gamma 1 fusion in oncogene human thyroid carcinoma	SCIENCE			English	Article							ACTIVATED RECEPTOR-GAMMA; ACUTE PROMYELOCYTIC LEUKEMIA; HUMAN BREAST-CANCER; PPAR-GAMMA; TRANSACTIVATION PROPERTIES; ALVEOLAR RHABDOMYOSARCOMA; TERMINAL DIFFERENTIATION; TRANSCRIPTION FACTORS; COLON-CANCER; IN-VITRO	Chromosomal translocations that encode fusion oncoproteins have been observed consistently in leukemias/lymphomas and sarcomas but not in carcinomas, the most common human cancers. Here, we report that t(2;3)(q13;p25), a translocation identified in a subset of human thyroid follicular carcinomas, results in fusion of the DNA binding domains of the thyroid transcription factor PAX8 to domains A to F of the peroxisome proliferator-activated receptor (PPAR) gamma 1. PAX8-PPAR gamma 1 mRNA and protein were detected in 5 of 8 thyroid follicular carcinomas but not in 20 follicular adenomas, 10 papillary carcinomas, or 10 multinodular hyperplasias. PAX8-PPAR gamma 1 inhibited thiazolidinedione-induced transactivation by PPAR gamma 1 in a dominant negative manner. The experiments demonstrate an oncogenic role for PPAR gamma and suggest that PAX8-PPAR gamma 1 may be useful in the diagnosis and treatment of thyroid carcinoma.	Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Childrens Hosp, Dept Pathol, Boston, MA 02115 USA; Childrens Hosp, Dept Pediat Oncol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital	Kroll, TG (corresponding author), Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.		Pecciarini, Lorenza/GQI-3544-2022		NATIONAL CANCER INSTITUTE [K08CA075425] Funding Source: NIH RePORTER; NCI NIH HHS [CA75425] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALCALAY M, 1991, P NATL ACAD SCI USA, V88, P1977, DOI 10.1073/pnas.88.5.1977; Barr FG, 1998, NAT GENET, V19, P121, DOI 10.1038/475; Barr FG, 1999, CANCER RES, V59, p1711S; BONDESON L, 1989, CANCER, V64, P680, DOI 10.1002/1097-0142(19890801)64:3<680::AID-CNCR2820640319>3.0.CO;2-I; Brun RP, 1996, GENE DEV, V10, P974, DOI 10.1101/gad.10.8.974; DE H, 1990, NATURE, V347, P558; Demetri GD, 1999, P NATL ACAD SCI USA, V96, P3951, DOI 10.1073/pnas.96.7.3951; Elstner E, 1998, P NATL ACAD SCI USA, V95, P8806, DOI 10.1073/pnas.95.15.8806; Enver T, 1998, CELL, V94, P9, DOI 10.1016/S0092-8674(00)81215-5; FUSCO A, 1987, NATURE, V328, P170, DOI 10.1038/328170a0; GALILI N, 1993, NAT GENET, V5, P230, DOI 10.1038/ng1193-230; GEMMILL RM, 1995, NATURE, V377, P299; GODDARD AD, 1991, SCIENCE, V254, P1371, DOI 10.1126/science.1720570; GRANT CS, 1989, SURGERY, V106, P980; Greene M. E., 1995, Gene Expression, V4, P281; HAMBERGER B, 1982, AM J MED, V73, P381, DOI 10.1016/0002-9343(82)90731-8; HEDINGER C, 1998, HISTOLOGIC TYPING TH, P2; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; HUDSON TJ, 1995, SCIENCE, V270, P1945, DOI 10.1126/science.270.5244.1945; JENKINS RB, 1990, CANCER-AM CANCER SOC, V66, P1213, DOI 10.1002/1097-0142(19900915)66:6<1213::AID-CNCR2820660622>3.0.CO;2-9; KOZMIK Z, 1993, MOL CELL BIOL, V13, P6024, DOI 10.1128/MCB.13.10.6024; KROLL TG, 1994, J BIOL CHEM, V269, P9270; Kubota T, 1998, CANCER RES, V58, P3344; Mansouri A, 1998, NAT GENET, V19, P87, DOI 10.1038/ng0598-87; Melnick A, 1999, BLOOD, V93, P3167, DOI 10.1182/blood.V93.10.3167.410k44_3167_3215; Mueller E, 1998, MOL CELL, V1, P465, DOI 10.1016/S1097-2765(00)80047-7; Nothwang HG, 1998, GENOMICS, V47, P276, DOI 10.1006/geno.1997.5102; Nothwang HG, 1997, GENOMICS, V41, P370, DOI 10.1006/geno.1997.4654; NOWELL PC, 1960, SCIENCE, V132, P1497; PANDOLFI PP, 1991, ONCOGENE, V6, P1285; POLEEV A, 1992, DEVELOPMENT, V116, P611; Poleev A, 1997, EUR J BIOCHEM, V247, P860, DOI 10.1111/j.1432-1033.1997.00860.x; Rabbitts TH, 1998, NEW ENGL J MED, V338, P192, DOI 10.1056/NEJM199801153380311; Rabbitts TH, 1999, CANCER RES, V59, p1794S; RABBITTS TH, 1994, NATURE, V372, P143, DOI 10.1038/372143a0; ROQUE L, 1993, CANCER GENET CYTOGEN, V67, P1, DOI 10.1016/0165-4608(93)90036-L; ROQUE L, 1993, GENE CHROMOSOME CANC, V8, P199, DOI 10.1002/gcc.2870080311; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; Rowley JD, 1998, ANNU REV GENET, V32, P495, DOI 10.1146/annurev.genet.32.1.495; Sarraf P, 1998, NAT MED, V4, P1046, DOI 10.1038/2030; Sarraf P, 1999, MOL CELL, V3, P799, DOI 10.1016/S1097-2765(01)80012-5; SHAPIRO DN, 1993, CANCER RES, V53, P5108; Sinnett D, 1998, BIOTECHNIQUES, V24, P752, DOI 10.2144/98245bm12; SOZZI G, 1992, CANCER GENET CYTOGEN, V64, P38, DOI 10.1016/0165-4608(92)90320-8; SPURR N, 1996, CYTOGENET CELL GENET, V7, P255; TEYSSIER JR, 1990, CANCER GENET CYTOGEN, V50, P249, DOI 10.1016/0165-4608(90)90184-C; Tontonoz P, 1997, P NATL ACAD SCI USA, V94, P237, DOI 10.1073/pnas.94.1.237; XIAO S, 1995, AM J PATHOL, V147, P896; [No title captured]	49	638	677	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 25	2000	289	5483					1357	1360		10.1126/science.289.5483.1357	http://dx.doi.org/10.1126/science.289.5483.1357			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347RF	10958784				2022-12-28	WOS:000088942400041
J	Collier, CP; Mattersteig, G; Wong, EW; Luo, Y; Beverly, K; Sampaio, J; Raymo, FM; Stoddart, JF; Heath, JR				Collier, CP; Mattersteig, G; Wong, EW; Luo, Y; Beverly, K; Sampaio, J; Raymo, FM; Stoddart, JF; Heath, JR			A [2]catenane-based solid state electronically reconfigurable switch	SCIENCE			English	Article							TETRATHIAFULVALENE; FILMS; UNIT	A solid state, electronically addressable, bistable [2]catenane-based molecular switching device was fabricated from a single monolayer of the [2]catenane, anchored with phospholipid counterions, and sandwiched between an n-type polycrystalline silicon bottom electrode and a metallic top electrode. The device exhibits hysteretic (bistable) current/voltage characteristics. The switch is opened at +2 volts, closed at -2 volts, and read at similar to 0.1 volt and may be recycled many times under ambient conditions. A mechanochemical mechanism for the action of the switch is presented and shown to be consistent with temperature-dependent measurements of the device operation.	Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Stoddart, JF (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90095 USA.	stoddart@chem.ucla.edu; heath@chem.ucla.edu	Parvazi, Mahnaz/AFR-8320-2022; omidi, nabi/AHE-4217-2022; Castro, Marta Rocha/GPK-6080-2022; Collier, Charles/C-9206-2016; Stoddart, James Fraser/H-1518-2011; Khorshidi, Abbas/ABF-1479-2021; S, KAYALVIZHI/ABI-8087-2020	omidi, nabi/0000-0001-6841-8743; Collier, Charles/0000-0002-8198-793X; Stoddart, James Fraser/0000-0003-3161-3697; Khorshidi, Abbas/0000-0001-8807-3543; S, KAYALVIZHI/0000-0002-6080-2801; Raymo, Francisco/0000-0002-6163-6606				AHUJA RC, 1993, LANGMUIR, V9, P1534, DOI 10.1021/la00030a019; Asakawa M, 1999, EUR J ORG CHEM, V1999, P985, DOI 10.1002/(SICI)1099-0690(199905)1999:5<985::AID-EJOC985>3.0.CO;2-O; Asakawa M, 1998, ANGEW CHEM INT EDIT, V37, P333, DOI 10.1002/(SICI)1521-3773(19980216)37:3<333::AID-ANIE333>3.0.CO;2-P; AVIRAM A, 1974, CHEM PHYS LETT, V29, P277, DOI 10.1016/0009-2614(74)85031-1; Balzani V, 2000, J ORG CHEM, V65, P1924, DOI 10.1021/jo991781t; Brown CL, 2000, LANGMUIR, V16, P1924, DOI 10.1021/la990791m; Chen J, 1999, SCIENCE, V286, P1550, DOI 10.1126/science.286.5444.1550; Collier CP, 1999, SCIENCE, V285, P391, DOI 10.1126/science.285.5426.391; Fyfe MCT, 1997, ANGEW CHEM INT EDIT, V36, P2068, DOI 10.1002/anie.199720681; Gase T, 1999, ADV MATER, V11, P1303, DOI 10.1002/(SICI)1521-4095(199910)11:15<1303::AID-ADMA1303>3.0.CO;2-4; Heath JR, 1998, SCIENCE, V280, P1716, DOI 10.1126/science.280.5370.1716; KAMINS T, 1988, POLYCRYSTALLINE SILI, pCH4; LINES ME, 1977, PRINCIPLES APPL FERR, P103; Metzger RM, 2000, J MATER CHEM, V10, P55, DOI 10.1039/a903888d; SZE SM, 1981, PHYSICS SEMICONDUCTO; Wong EW, 2000, J AM CHEM SOC, V122, P5831, DOI 10.1021/ja993890v	16	1214	1253	4	303	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 18	2000	289	5482					1172	1175		10.1126/science.289.5482.1172	http://dx.doi.org/10.1126/science.289.5482.1172			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	346JE	10947980				2022-12-28	WOS:000088866600036
J	De La Rocha, CL; DePaolo, DJ				De La Rocha, CL; DePaolo, DJ			Isotopic evidence for variations in the marine calcium cycle over the cenozoic	SCIENCE			English	Article							ATMOSPHERIC CARBON-DIOXIDE; CHEMICAL-COMPOSITION; MIOCENE; OCEAN; SEAWATER; FRACTIONATION; CONSTRAINTS; CALIFORNIA; WATERS; RECORD	Significant variations in the isotopic composition of marine calcium have occurred over the Last 80 million years. These variations reflect deviations in the balance between inputs of calcium to the ocean from weathering and outputs due to carbonate sedimentation, processes that are important in controlling the concentration of carbon dioxide in the atmosphere and, hence, global climate. The calcium isotopic ratio of paleo-seawater is an indicator of past changes in atmospheric carbon dioxide when coupled with determinations of paleo-pH.	Univ Calif Berkeley, Dept Geol & Geophys, Berkeley Ctr Isotope Geochem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Earth Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	De La Rocha, CL (corresponding author), Univ Cambridge, Dept Earth Sci, Downing St, Cambridge CB2 3EQ, England.							Berner R.A., 2012, GLOBAL ENV WATER AIR, Vsecond; BERNER RA, 1983, AM J SCI, V283, P641, DOI 10.2475/ajs.283.7.641; Broecker W.S., 1982, TRACERS SEA; Chen CH, 1996, EARTH PLANET SC LETT, V143, P125, DOI 10.1016/0012-821X(96)00122-7; COPELAND P, 1987, EARTH PLANET SC LETT, V86, P240, DOI 10.1016/0012-821X(87)90224-X; DEPAOLO DJ, 1991, GEOL SOC AM BULL, V103, P112, DOI 10.1130/0016-7606(1991)103<0112:HRSISA>2.3.CO;2; Drever JI, 1982, GEOCHEMISTRY NATURAL; Elderfield H, 1996, ANNU REV EARTH PL SC, V24, P191, DOI 10.1146/annurev.earth.24.1.191; ERSKIAN MG, 1987, J FORAMIN RES, V17, P240, DOI 10.2113/gsjfr.17.3.240; GIESKES JM, 1981, GEOCHIM COSMOCHIM AC, V45, P1687, DOI 10.1016/0016-7037(81)90004-1; Guillard R.R.L., 1975, CULTURE MARINE INVER, P26, DOI DOI 10.1007/978-1-4615-8714-9_3; GUILLOT S, 1994, GEOLOGY, V22, P559, DOI 10.1130/0091-7613(1994)022<0559:NCOTAO>2.3.CO;2; HARRISON TM, 1992, SCIENCE, V255, P1663, DOI 10.1126/science.255.5052.1663; HODELL DA, 1994, PALEOCEANOGRAPHY, V9, P405, DOI 10.1029/94PA00292; KEMPE S, 1985, CHEM GEOL, V53, P95, DOI 10.1016/0009-2541(85)90023-3; LASAGA AC, 1985, CARBON CYCLE ATMOSPH, P397; Lipps JH., 1986, SCI NEW GUINEA, V11, P126; MARSHALL BD, 1982, GEOCHIM COSMOCHIM AC, V46, P2537, DOI 10.1016/0016-7037(82)90376-3; MEYBECK M, 1979, REV GEOL DYN GEOGR, V21, P215; Miller KG, 1987, PALEOCEANOGRAPHY, V2, P1, DOI 10.1029/PA002i001p00001; MILLIMAN JD, 1993, GLOBAL BIOGEOCHEM CY, V7, P927, DOI 10.1029/93GB02524; Opdyke BN, 1988, PALEOCEANOGRAPHY, V3, P685, DOI 10.1029/PA003i006p00685; OSLICK JS, 1994, PALEOCEANOGRAPHY, V9, P427, DOI 10.1029/94PA00249; Pagani M, 1999, SCIENCE, V285, P876, DOI 10.1126/science.285.5429.876; Pearson PN, 1999, SCIENCE, V284, P1824, DOI 10.1126/science.284.5421.1824; RAYMO ME, 1988, GEOLOGY, V16, P649, DOI 10.1130/0091-7613(1988)016<0649:IOLCMB>2.3.CO;2; RICHTER FM, 1992, EARTH PLANET SC LETT, V109, P11, DOI 10.1016/0012-821X(92)90070-C; RUSSELL WA, 1978, GEOCHIM COSMOCHIM AC, V42, P1075, DOI 10.1016/0016-7037(78)90105-9; Skulan J, 1997, GEOCHIM COSMOCHIM AC, V61, P2505, DOI 10.1016/S0016-7037(97)00047-1; Skulan J, 1999, P NATL ACAD SCI USA, V96, P13709, DOI 10.1073/pnas.96.24.13709; SONG Y, 1994, PALEOBIOLOGY, V20, P14, DOI 10.1017/S0094837300011106; SORKHABI RB, 1993, GSA TODAY, V3, P85; Spencer R.J., 1990, FLUID MINERAL INTERA, V2, P409; SPIVACK AJ, 1993, NATURE, V363, P149, DOI 10.1038/363149a0; STANLEY SM, 1998, PALAEOGEOGR PALAEOCL, V107, P243; UREY C, 1952, PLANETS THEIR ORIGIN; WILKINSON BH, 1989, AM J SCI, V289, P1158, DOI 10.2475/ajs.289.10.1158; WILKINSON BH, 1986, J GEOL, V94, P321, DOI 10.1086/629032; Zhu P, 1998, GEOCHIM COSMOCHIM AC, V62, P1691, DOI 10.1016/S0016-7037(98)00110-0	39	190	193	3	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 18	2000	289	5482					1176	1178		10.1126/science.289.5482.1176	http://dx.doi.org/10.1126/science.289.5482.1176			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	346JE	10947981				2022-12-28	WOS:000088866600037
J	Karlinsey, JE; Lonner, J; Brown, KL; Hughes, KT				Karlinsey, JE; Lonner, J; Brown, KL; Hughes, KT			Translation/secretion coupling by type III secretion systems	CELL			English	Article							ANTI-SIGMA FACTOR; FLAGELLUM-SPECIFIC SIGMA; MESSENGER-RNA SIGNAL; SALMONELLA-TYPHIMURIUM; YERSINIA-ENTEROCOLITICA; TRANSCRIPTIONAL CONTROL; NEGATIVE REGULATOR; TERMINAL REGIONS; MASTER OPERON; FLGM	Type III secretion systems mediate export of virulence proteins and flagellar assembly subunits in Gram-negative bacteria. Chaperones specific to each class of secreted protein are believed to prevent degradation of the secreted substrates. We show that an additional role of chaperones may be to regulate translation of secreted proteins. We show that the chaperone FlgN is required for translation of the flgM gene transcribed from one mRNA transcript (a flagellar class 3 transcript), but not from another (a flagellar class 2 transcript). FlgM translated from the class 3 transcript is primarily secreted whereas FlgM translated from the class 2 transcript is primarily retained in the cytoplasm. These results suggest FlgM and other type III secretion substrates possess both mRNA and amino acid secretion signals, and supports a new role for type III chaperones in translation/secretion coupling.	Univ Washington, Dept Microbiol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Hughes, KT (corresponding author), Univ Washington, Dept Microbiol, Seattle, WA 98195 USA.	hughes@u.washington.edu		Karlinsey, Joyce E/0000-0002-3585-8301	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056141, R01GM043149] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM56141, GM43149] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AIZAWA SI, 1990, J MOL BIOL, V211, P673, DOI 10.1016/0022-2836(90)90064-S; Anderson DM, 1999, MOL MICROBIOL, V31, P1139, DOI 10.1046/j.1365-2958.1999.01254.x; Anderson DM, 1997, SCIENCE, V278, P1140, DOI 10.1126/science.278.5340.1140; Bennett JCQ, 2000, TRENDS MICROBIOL, V8, P202, DOI 10.1016/S0966-842X(00)01751-0; Bonas U, 1994, Curr Top Microbiol Immunol, V192, P79; CHADSEY MS, 1998, EMBO J, V17, P3123; Cheng LW, 2000, TRENDS MICROBIOL, V8, P214, DOI 10.1016/S0966-842X(99)01665-0; Cheng LW, 1997, MOL MICROBIOL, V24, P757, DOI 10.1046/j.1365-2958.1997.3831750.x; Chilcott GS, 1998, MOL MICROBIOL, V30, P1029, DOI 10.1046/j.1365-2958.1998.01131.x; Collmer A, 1994, Curr Top Microbiol Immunol, V192, P43; Daughdrill GW, 1997, NAT STRUCT BIOL, V4, P285, DOI 10.1038/nsb0497-285; ELLIS RJ, 1991, ANNU REV BIOCHEM, V60, P321, DOI 10.1146/annurev.bi.60.070191.001541; Fraser GM, 1999, MOL MICROBIOL, V32, P569, DOI 10.1046/j.1365-2958.1999.01372.x; FRITHZLINDSTEN E, 1995, MOL MICROBIOL, V16, P635, DOI 10.1111/j.1365-2958.1995.tb02426.x; Fu YX, 1998, J BACTERIOL, V180, P3393, DOI 10.1128/JB.180.13.3393-3399.1998; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; GILLEN KL, 1993, J BACTERIOL, V175, P7006, DOI 10.1128/jb.175.21.7006-7015.1993; GILLEN KL, 1991, J BACTERIOL, V173, P2301, DOI 10.1128/JB.173.7.2301-2310.1991; GILLEN KL, 1991, J BACTERIOL, V173, P6453, DOI 10.1128/jb.173.20.6453-6459.1991; GROISMAN EA, 1991, METHOD ENZYMOL, V204, P180; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; HUGHES KT, 1993, SCIENCE, V262, P1277, DOI 10.1126/science.8235660; HUGHES KT, 1985, GENETICS, V109, P263; Hughes KT, 1998, ANNU REV MICROBIOL, V52, P231, DOI 10.1146/annurev.micro.52.1.231; KALMAN S, 1990, J BACTERIOL, V172, P5575, DOI 10.1128/jb.172.10.5575-5585.1990; Karlinsey JE, 1998, J BACTERIOL, V180, P5384, DOI 10.1128/JB.180.20.5384-5397.1998; KARLINSEY JE, 2000, IN PRESS MOL MICROBI; Kjemtrup S, 2000, CURR OPIN MICROBIOL, V3, P73, DOI 10.1016/S1369-5274(99)00054-5; KOMEDA Y, 1986, J BACTERIOL, V168, P1315, DOI 10.1128/jb.168.3.1315-1318.1986; KUTSUKAKE K, 1990, J BACTERIOL, V172, P741, DOI 10.1128/jb.172.2.741-747.1990; KUTSUKAKE K, 1994, MOL GEN GENET, V243, P605, DOI 10.1007/BF00279569; KUTSUKAKE K, 1994, GENE, V143, P49; KUTSUKAKE K, 1994, EMBO J, V13, P4568, DOI 10.1002/j.1460-2075.1994.tb06778.x; Kutsukake K, 1997, MOL GEN GENET, V254, P440, DOI 10.1007/s004380050437; LIU XY, 1994, J BACTERIOL, V176, P7345, DOI 10.1128/JB.176.23.7345-7351.1994; Macnab R., 1996, ESCHERICHIA COLI SAL, V2nd ed, P119; Macnab RM, 1999, J BACTERIOL, V181, P7149, DOI 10.1128/JB.181.23.7149-7153.1999; Maloy S.R., 1990, EXPT TECHNIQUES BACT; MENARD R, 1994, CELL, V79, P515, DOI 10.1016/0092-8674(94)90260-7; Neyt C, 1999, MOL MICROBIOL, V31, P143, DOI 10.1046/j.1365-2958.1999.01154.x; OHNISHI K, 1992, MOL MICROBIOL, V6, P3149, DOI 10.1111/j.1365-2958.1992.tb01771.x; Sauer FG, 2000, SEMIN CELL DEV BIOL, V11, P27, DOI 10.1006/scdb.1999.0348; SCHMITT CK, 1994, J BACTERIOL, V176, P368, DOI 10.1128/JB.176.2.368-377.1994; Sory MP, 1995, P NATL ACAD SCI USA, V92, P11998, DOI 10.1073/pnas.92.26.11998; Tucker SC, 2000, J BACTERIOL, V182, P2262, DOI 10.1128/JB.182.8.2262-2268.2000; VONDERVISZT F, 1991, J MOL BIOL, V221, P1461, DOI 10.1016/0022-2836(91)90946-4; VONDERVISZT F, 1992, J MOL BIOL, V226, P575, DOI 10.1016/0022-2836(92)90616-R; VONDERVISZT F, 1989, J MOL BIOL, V209, P127, DOI 10.1016/0022-2836(89)90176-9; Yanagihara S, 1999, GENES GENET SYST, V74, P105, DOI 10.1266/ggs.74.105	49	107	110	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 18	2000	102	4					487	497		10.1016/S0092-8674(00)00053-2	http://dx.doi.org/10.1016/S0092-8674(00)00053-2			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	347BX	10966110	Bronze			2022-12-28	WOS:000088908000010
J	Yokoyama, Y; Lambeck, K; De Deckker, P; Johnston, P; Fifield, LK				Yokoyama, Y; Lambeck, K; De Deckker, P; Johnston, P; Fifield, LK			Timing of the Last Glacial Maximum from observed sea-level minima	NATURE			English	Article							ICE-SHEET; YOUNGER DRYAS; C-14 AGES; CORALS; CALIBRATION; BARBADOS; SAMPLES; RECORD; OCEAN	During the Last Glacial Maximum, ice sheets covered large areas in northern latitudes and global temperatures were significantly lower than today. But few direct estimates exist of the volume of the ice sheets, or the timing and rates of change during their advance and retreat(1,2). Here we analyse four distinct sediment facies in the shallow, tectonically stable Bonaparte Gulf, Australia-each of which is characteristic of a distinct range in sea level-to estimate the maximum volume of land-based ice during the last glaciation and the timing of the initial melting phase. We use faunal assemblages and preservation status of the sediments to distinguish open marine, shallow marine, marginal marine and brackish conditions, and estimate the timing and the mass of the ice sheets using radiocarbon dating and glacio-hydroisostatic modelling. Our results indicate that from at least 22,000 to 19,000 (calendar) years before present, land-based ice volume was at its maximum, exceeding today's grounded ice sheets by 52.5 x 10(6) km(3). A rapid decrease in ice volume by about 10% within a few hundred years terminated the Last Glacial Maximum at 19, 000 +/- 250 years.	Australian Natl Univ, Res Sch Phys Sci & Engn, Dept Nucl Phys, Canberra, ACT 0200, Australia; Australian Natl Univ, Res Sch Phys Sci & Engn, Dept Geol, Canberra, ACT 0200, Australia; Australian Natl Univ, Res Sch Phys Sci & Engn, Res Sch Earth Sci, Canberra, ACT 0200, Australia	Australian National University; Australian National University; Australian National University	Lambeck, K (corresponding author), Australian Natl Univ, Res Sch Phys Sci & Engn, Dept Nucl Phys, Canberra, ACT 0200, Australia.		Johnston, Paul/N-7117-2018; Yokoyama, Yusuke/N-9623-2013; Johnston, Paul/C-2449-2013	Johnston, Paul/0000-0001-8605-0620; Yokoyama, Yusuke/0000-0001-7869-5891; Fifield, Leslie/0000-0003-2866-4944				ANDREWS JT, 1992, NATURE, V358, P281, DOI 10.1038/358281a0; Bard E, 1998, RADIOCARBON, V40, P1085, DOI 10.1017/S0033822200019135; BARD E, 1990, NATURE, V346, P456, DOI 10.1038/346456a0; Bard E, 1999, SCIENCE, V284, P1133, DOI 10.1126/science.284.5417.1133; Clark PU, 1999, SCIENCE, V286, P1104, DOI 10.1126/science.286.5442.1104; CLIMAP Climate: Long-Range Investigation Mapping and Prediction Project Members, 1981, GEOL SOC AM MAP CHAR, V36, P1; Colonna M, 1996, QUATERNARY RES, V46, P335, DOI 10.1006/qres.1996.0071; DEDECKKER P, 1988, PALAEOGEOGR PALAEOCL, V62, P463, DOI 10.1016/0031-0182(88)90067-3; EDWARDS RL, 1993, SCIENCE, V260, P962, DOI 10.1126/science.260.5110.962; FAIRBANKS RG, 1989, NATURE, V342, P637, DOI 10.1038/342637a0; Farrell W. E, 1976, GEOPHYS J, V46, P79; FERLAND MA, 1995, QUATERNARY RES, V44, P294, DOI 10.1006/qres.1995.1074; Fleming K, 1998, EARTH PLANET SC LETT, V163, P327, DOI 10.1016/S0012-821X(98)00198-8; JOHNSTON P, 2000, J GEOPHYS RES, P13179; Kleman J, 1999, NATURE, V402, P63, DOI 10.1038/47005; Lambeck K, 1998, GEOPHYS J INT, V134, P102, DOI 10.1046/j.1365-246x.1998.00541.x; Lambeck K, 1996, GLOBAL PLANET CHANGE, V12, P41, DOI 10.1016/0921-8181(95)00011-9; LAMBECK K, 1990, GLOBAL PLANET CHANGE, V89, P143, DOI 10.1016/0921-8181(90)90060-P; Licciardi JM, 1998, QUATERNARY SCI REV, V17, P427, DOI 10.1016/S0277-3791(97)00044-9; NAKADA M, 1987, GEOPHYS J INT, V90, P171, DOI 10.1111/j.1365-246X.1987.tb00680.x; NAKADA M, 1988, NATURE, V333, P36, DOI 10.1038/333036a0; Ota Y., 1982, QUATERNARY RES, V21, P133; PELTIER WR, 1994, SCIENCE, V265, P195, DOI 10.1126/science.265.5169.195; STUIVER M, 1993, RADIOCARBON, V35, P137; STUIVER M, 1993, RADIOCARBON, V35, P215, DOI 10.1017/S0033822200013904; TUSHINGHAM AM, 1991, J GEOPHYS RES-SOLID, V96, P4497, DOI 10.1029/90JB01583; VANANDEL TH, 1967, AM J SCI, V265, P737; Yassini I., 1995, RECENT FORAMINIFERA; ZWARTZ D, 1997, ANTARCTIC REGION GEO	29	720	760	1	110	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 17	2000	406	6797					713	716		10.1038/35021035	http://dx.doi.org/10.1038/35021035			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	344PH	10963593				2022-12-28	WOS:000088767700040
J	Barroso, PF; Schechter, M; Gupta, P; Melo, MF; Vieira, M; Murta, FC; Souza, Y; Harrison, LH				Barroso, PF; Schechter, M; Gupta, P; Melo, MF; Vieira, M; Murta, FC; Souza, Y; Harrison, LH			Effect of antiretroviral therapy on HIV shedding in semen	ANNALS OF INTERNAL MEDICINE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; INHIBITOR THERAPY; DISEASE STAGE; INFECTION; PROTEASE; MEN; ZIDOVUDINE	Background: The effect of antiretroviral therapy on seminal HIV shedding in the community remains unknown. Objective: To evaluate the effect of antiretroviral therapy on HIV shedding in semen. Design: Prospective cohort study. Setting: University hospital in Rio de Janeiro, Brazil. Patients: 93 HIV-infected men. Intervention: Antiretroviral therapy as prescribed by each patient's physician. Measurement: HIV RNA in semen and blood plasma before and after introduction of therapy. Results: At baseline, HIV RNA was detected in 69 semen samples (74%) and 89 blood samples (96%), Six months after introduction of therapy, HIV RNA was detected in 29 semen samples (33%) and 33 blood samples (38%). The mean reduction in levels of HIV RNA in semen at 6 months was 1.65 log(10) units. Conclusions: Antiretroviral therapy reduces shedding of HIV in semen, which probably in turn reduces HIV transmissibility. However, a substantial proportion of patients may still be infectious and may have drug-resistant strains of the virus.	Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Serv Doencas Infecciosase Parasitarias, Sch Med, BR-21941950 Rio De Janeiro, Brazil; Johns Hopkins Univ, Sch Hyg & Publ Hlth, Baltimore, MD USA; Univ Pittsburgh, Pittsburgh, PA USA	Universidade Federal do Rio de Janeiro; Johns Hopkins University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Barroso, PF (corresponding author), Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Serv Doencas Infecciosase Parasitarias, Sch Med, Ave Brigadeiro Trompowski S-N,Cidade Univ,Ilha Fu, BR-21941950 Rio De Janeiro, Brazil.				FOGARTY INTERNATIONAL CENTER [D43TW000010] Funding Source: NIH RePORTER; FIC NIH HHS [2D43TW00010] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))		ANDERSON DJ, 1992, JAMA-J AM MED ASSOC, V267, P2769, DOI 10.1001/jama.267.20.2769; Blower SM, 2000, SCIENCE, V287, P650, DOI 10.1126/science.287.5453.650; Carpenter CCJ, 2000, JAMA-J AM MED ASSOC, V283, P381, DOI 10.1001/jama.283.3.381; Detels R, 1998, JAMA-J AM MED ASSOC, V280, P1497, DOI 10.1001/jama.280.17.1497; Fatkenheuer G, 1998, AIDS, V12, P1402, DOI 10.1097/00002030-199811000-00031; Gilliam BL, 1997, J ACQ IMMUN DEF SYND, V15, P54, DOI 10.1097/00042560-199705010-00009; Gulick RM, 1997, NEW ENGL J MED, V337, P734, DOI 10.1056/NEJM199709113371102; Gupta P, 1997, J VIROL, V71, P6271, DOI 10.1128/JVI.71.8.6271-6275.1997; GUPTA P, 1995, J CLIN MICROBIOL, V33, P1670, DOI 10.1128/JCM.33.6.1670-1673.1995; HAMED KA, 1993, J INFECT DIS, V167, P798, DOI 10.1093/infdis/167.4.798; KRIEGER JN, 1991, J INFECT DIS, V163, P386, DOI 10.1093/infdis/163.2.386; PAGESHAFER KA, 1999, MMWR-MORBID MORTAL W, V48, P45; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Royce RA, 1997, NEW ENGL J MED, V336, P1072, DOI 10.1056/NEJM199704103361507; Salomon H, 2000, AIDS, V14, pF17, DOI 10.1097/00002030-200001280-00003; Schechter M, 1999, AIDS, V13, P97, DOI 10.1097/00002030-199901140-00013; Sodora DL, 1998, AIDS RES HUM RETROV, V14, pS119; Vernazza PL, 1997, AIDS, V11, P1249, DOI 10.1097/00002030-199710000-00008; Zhang H, 1998, NEW ENGL J MED, V339, P1803, DOI 10.1056/NEJM199812173392502	19	81	82	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 15	2000	133	4					280	284		10.7326/0003-4819-133-4-200008150-00012	http://dx.doi.org/10.7326/0003-4819-133-4-200008150-00012			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	346NG	10929169				2022-12-28	WOS:000088877500005
J	Bettendorf, M; Schmidt, KG; Grulich-Henn, J; Ulmer, HE; Heinrich, UE				Bettendorf, M; Schmidt, KG; Grulich-Henn, J; Ulmer, HE; Heinrich, UE			Tri-iodothyronine treatment in children after cardiac surgery: a double-blind, randomised, placebo-controlled study	LANCET			English	Article; Proceedings Paper	81st Annual Meeting of the Endocrine-Society	JUN 12-16, 1999	SAN DIEGO, CALIFORNIA	Endocrine Soc			THYROID-HORMONE; CARDIOPULMONARY BYPASS; NONTHYROIDAL ILLNESS; HYPOTHYROIDISM; HYPERTHYROIDISM; INFANTS	Background Serum thyroid hormone concentrations decline transiently during critical illness and after surgical procedures. We investigated prospectively the endocrine and haemodynamic effects of tri-iodothyronine treatment after cardiopulmonary bypass operations in children with congenital cardiac malformations. Methods We did a randomised, double-blind, placebo-controlled trial, in which 40 children (median age 0.6 years; range 2 days to 10.4 years) were randomly assigned placebo (saline) or one daily infusion of tri-iodothyronine (2 mu g/kg bodyweight on day 1 after surgery and 1 mu g/kg bodyweight on subsequent postoperative days up to 12 days after surgery. Before and 2 h, 24 h, and 72 h after the first infusion, plasma concentrations of thyroid hormones were measured by RIA, and systolic cardiac function was evaluated by echocardiography. During the postoperative course intensive-care measures were assessed by use of the therapeutic intervention scoring system, Findings In all patients, postoperative plasma concentrations of thyrotropin, thyroxine, free thyroxine, tri-iodothyronine were abnormally low and plasma concentrations of reverse tri-iodothyronine were raised. After start of treatment, tri-iodothyronine was significantly higher in patients given tri-iodothyronine than in those receiving placebo, whereas thyrotropin, thyroxine, free thyroxine, and reverse tri-iodothyronine remained similar in the two groups. At discharge, thyroid hormones of all patients were within the normal range, but thyrotropin secretion increased to plasma concentrations higher than those seen before treatment. The mean change of cardiac index was significantly higher in children given tri-iodothyronine (20.4% [SD 19.6] vs 10.0% [15.2]; p=0.004). Systolic cardiac function improved most in patients given tri-iodothyronine after longer cardiopulmonary bypass operations. Overall, patients given tri-iodothyronine had significantly lower mean treatment scores. Interpretation Treatment of children with tri-iodothyronine after cardiopulmonary bypass operations raises tri-iodothyronine plasma concentrations and improves myocardial function especially in patients with low postoperative cardiac output without adverse events, and without delaying postoperative recovery of thyroid function, Furthermore, tri-iodothyronine reduces the need for postoperative intensive care.	Univ Heidelberg, Kinderklin, D-69120 Heidelberg, Germany; Univ Heidelberg, Dept Paediat, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Bettendorf, M (corresponding author), Univ Heidelberg, Kinderklin, Neuenheimer Feld 150, D-69120 Heidelberg, Germany.							Bettendorf M, 1997, PEDIATR RES, V41, P375, DOI 10.1203/00006450-199703000-00012; Bialkowski J, 1998, CARDIOL YOUNG, V8, P139, DOI 10.1017/S1047951100004832; BILEZIKIAN JP, 1983, ENDOCR REV, V4, P378, DOI 10.1210/edrv-4-4-378; CASTANEDA AR, 1994, CARDIAC SURG NEONATE, P65; Chopra IJ, 1997, J CLIN ENDOCR METAB, V82, P329, DOI 10.1210/jc.82.2.329; Davis PJ, 1996, THYROID, V6, P497, DOI 10.1089/thy.1996.6.497; De Groot LJ, 1999, J CLIN ENDOCR METAB, V84, P151, DOI 10.1210/jc.84.1.151; FABER J, 1987, J CLIN ENDOCR METAB, V65, P315, DOI 10.1210/jcem-65-2-315; FROHNAUER MK, 1999, P 81 ANN M END SOC J, P529; GOTZSCHE LBH, 1994, EUR J ENDOCRINOL, V130, P171, DOI 10.1530/eje.0.1300171; KATZEFF HL, 1997, AM J PHYSIOL, V273, P951; Khoury SF, 1996, CIRC RES, V79, P727, DOI 10.1161/01.RES.79.4.727; KLEIN I, 1990, AM J MED, V88, P631, DOI 10.1016/0002-9343(90)90531-H; KLEMPERER JD, 1995, J THORAC CARDIOV SUR, V109, P457, DOI 10.1016/S0022-5223(95)70276-8; KLEMPERER JD, 1995, NEW ENGL J MED, V333, P1522, DOI 10.1056/NEJM199512073332302; Larsen PR, 1992, WILLIAMS TXB ENDOCRI, P357; Mainwaring RD, 1997, CARDIOL YOUNG, V7, P194, DOI 10.1017/S104795110000946X; MITCHELL IM, 1992, J THORAC CARDIOV SUR, V103, P800; MURZI B, 1995, ANN THORAC SURG, V59, P481, DOI 10.1016/0003-4975(94)00879-C; POLLACK MM, 1985, PEDIATRICS, V76, P719; SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072; UTIGER RD, 1995, NEW ENGL J MED, V333, P1562, DOI 10.1056/NEJM199512073332310; VANDENBERGHE G, 1994, CRIT CARE MED, V22, P1747, DOI 10.1097/00003246-199422110-00008	23	157	165	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 12	2000	356	9229					529	534		10.1016/S0140-6736(00)02576-9	http://dx.doi.org/10.1016/S0140-6736(00)02576-9			6	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	345MY	10950228				2022-12-28	WOS:000088820800008
J	Bellocchio, EE; Reimer, RJ; Fremeau, RT; Edwards, RH				Bellocchio, EE; Reimer, RJ; Fremeau, RT; Edwards, RH			Uptake of glutamate into synaptic vesicles by an inorganic phosphate transporter	SCIENCE			English	Article							GAMMA-AMINOBUTYRIC ACID; SIALIC-ACID; FUNCTIONAL RECONSTITUTION; NEUROTRANSMITTER TRANSPORTERS; CAENORHABDITIS-ELEGANS; ENERGY-DEPENDENCE; XENOPUS OOCYTES; RAT-BRAIN; EXPRESSION; COTRANSPORTER	Previous work has identified two families of proteins that transport classical neurotransmitters into synaptic vesicles, but the protein responsible for vesicular transport of the principal excitatory transmitter glutamate has remained unknown. We demonstrate that a protein that is unrelated to any known neurotransmitter transporters and that was previously suggested to mediate the Na+-dependent uptake of inorganic phosphate across the plasma membrane transports glutamate into synaptic vesicles. In addition, we show that this vesicular glutamate transporter, VGLUT1, exhibits a conductance for chloride that is blocked by glutamate.	Univ Calif San Francisco, Grad Program Neurosci, Dept Neurol, Sch Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Grad Program Neurosci, Dept Neurol, Sch Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Grad Program Cell Biol, Sch Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Grad Program Biomed Sci, Sch Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Edwards, RH (corresponding author), Univ Calif San Francisco, Grad Program Neurosci, Dept Neurol, Sch Med, 513 Parnassus Ave, San Francisco, CA 94143 USA.	edwards@itsa.usf.edu						Aihara Y, 2000, J NEUROCHEM, V74, P2622, DOI 10.1046/j.1471-4159.2000.0742622.x; AMARA SG, 1993, ANNU REV NEUROSCI, V16, P73, DOI 10.1146/annurev.ne.16.030193.000445; ANDERSON GC, 1982, RES NURS HEALTH, V5, P21, DOI 10.1002/nur.4770050105; AVERY L, 1993, GENETICS, V133, P897; Barger AJ, 1998, J NEUROSCI, V18, P2871; Bellocchio EE, 1998, J NEUROSCI, V18, P8648; Broer S, 1998, J MEMBRANE BIOL, V164, P71, DOI 10.1007/s002329900394; Busch AE, 1996, P NATL ACAD SCI USA, V93, P5347, DOI 10.1073/pnas.93.11.5347; CARLSON MD, 1989, J BIOL CHEM, V264, P7369; Chaudhry FA, 1999, CELL, V99, P769, DOI 10.1016/S0092-8674(00)81674-8; CURTHOYS NP, 1995, ANNU REV NUTR, V15, P133, DOI 10.1146/annurev.nu.15.070195.001025; Forgac M, 2000, J EXP BIOL, V203, P71; Glinn M, 1998, J NEUROCHEM, V70, P1850; GLINN M, 1995, J NEUROCHEM, V65, P2358; HAMBERGER AC, 1979, BRAIN RES, V168, P513, DOI 10.1016/0006-8993(79)90306-8; HARTINGER J, 1993, J BIOL CHEM, V268, P23122; HELL JW, 1990, J BIOL CHEM, V265, P2111; KANNER BI, 1993, FEBS LETT, V325, P95, DOI 10.1016/0014-5793(93)81421-U; KISH PE, 1989, P NATL ACAD SCI USA, V86, P3877, DOI 10.1073/pnas.86.10.3877; KNOTH J, 1981, BIOCHEMISTRY-US, V20, P6625, DOI 10.1021/bi00526a016; Lee RYN, 1999, J NEUROSCI, V19, P159, DOI 10.1523/JNEUROSCI.19-01-00159.1999; Liu YJ, 1997, ANNU REV NEUROSCI, V20, P125; MANCINI GMS, 1992, P NATL ACAD SCI USA, V89, P6609, DOI 10.1073/pnas.89.14.6609; MANCINI GMS, 1989, J BIOL CHEM, V264, P15247; MAYCOX PR, 1988, J BIOL CHEM, V263, P15423; McIntire SL, 1997, NATURE, V389, P870, DOI 10.1038/39908; MIYAMOTO KI, 1995, BIOCHEM J, V305, P81, DOI 10.1042/bj3050081; MORIYAMA Y, 1995, J BIOL CHEM, V270, P22314, DOI 10.1074/jbc.270.38.22314; NAITO S, 1983, J BIOL CHEM, V258, P696; NI BH, 1995, J NEUROSCI, V15, P5789; NI BH, 1994, P NATL ACAD SCI USA, V91, P5607, DOI 10.1073/pnas.91.12.5607; Reimer RJ, 2000, P NATL ACAD SCI USA, V97, P7715, DOI 10.1073/pnas.140152797; RENLUND M, 1986, SCIENCE, V232, P759, DOI 10.1126/science.3961501; ROSETH S, 1995, J NEUROCHEM, V65, P96; SCHULDINER S, 1995, PHYSIOL REV, V75, P369, DOI 10.1152/physrev.1995.75.2.369; Sugawara M, 2000, J BIOL CHEM, V275, P16473, DOI 10.1074/jbc.C000205200; TABB JS, 1992, J BIOL CHEM, V267, P15412; TIETZE F, 1989, J BIOL CHEM, V264, P15316; Varoqui H, 2000, J BIOL CHEM, V275, P4049, DOI 10.1074/jbc.275.6.4049; Verheijen FW, 1999, NAT GENET, V23, P462, DOI 10.1038/70585; WARD HK, 1983, J NEUROCHEM, V40, P855, DOI 10.1111/j.1471-4159.1983.tb08058.x; WERNER A, 1991, P NATL ACAD SCI USA, V88, P9608, DOI 10.1073/pnas.88.21.9608; Wolosker H, 1996, J BIOL CHEM, V271, P11726, DOI 10.1074/jbc.271.20.11726	43	611	637	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 11	2000	289	5481					957	960		10.1126/science.289.5481.957	http://dx.doi.org/10.1126/science.289.5481.957			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	343KH	10938000				2022-12-28	WOS:000088701200034
J	Mulvey, MA; Hultgren, SJ				Mulvey, MA; Hultgren, SJ			Cell biology - Bacterial spelunkers	SCIENCE			English	Editorial Material							FIMH-EXPRESSING ENTEROBACTERIA; ESCHERICHIA-COLI; CAVEOLAE; MICRODOMAINS; MACROPHAGES; ALPHA		Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Mulvey, MA (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, 660 S Euclid Ave, St Louis, MO 63110 USA.			Mulvey, Matthew/0000-0002-6016-7510				Anderson HA, 1996, MOL BIOL CELL, V7, P1825, DOI 10.1091/mbc.7.11.1825; Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Baorto DM, 1997, NATURE, V389, P636, DOI 10.1038/39376; CONRAD PA, 1995, J CELL BIOL, V131, P1421, DOI 10.1083/jcb.131.6.1421; FALKOW S, 1992, ANNU REV CELL BIOL, V8, P333, DOI 10.1146/annurev.cb.08.110192.002001; FRA AM, 1995, P NATL ACAD SCI USA, V92, P8655, DOI 10.1073/pnas.92.19.8655; JONES CH, 1995, P NATL ACAD SCI USA, V92, P2081, DOI 10.1073/pnas.92.6.2081; Kurzchalia TV, 1999, CURR OPIN CELL BIOL, V11, P424, DOI 10.1016/S0955-0674(99)80061-1; Lin TJ, 1999, J LEUKOCYTE BIOL, V66, P1031, DOI 10.1002/jlb.66.6.1031; Malaviya R, 1996, NATURE, V381, P77, DOI 10.1038/381077a0; MALAVIYA R, 1994, J CLIN INVEST, V93, P1645, DOI 10.1172/JCI117146; MALAVIYA R, 1994, J IMMUNOL, V152, P1907; Malaviya R, 1996, J IMMUNOL, V156, P1490; Malaviya R, 1999, P NATL ACAD SCI USA, V96, P8110, DOI 10.1073/pnas.96.14.8110; Matveev S, 1999, J LIPID RES, V40, P1647; RUSSELL PW, 1992, J BACTERIOL, V174, P5923, DOI 10.1128/jb.174.18.5923-5935.1992; SCHNITZER JE, 1995, SCIENCE, V269, P1435, DOI 10.1126/science.7660128; Shin JS, 2000, SCIENCE, V289, P785, DOI 10.1126/science.289.5480.785; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Wooldridge KG, 1996, MICROB PATHOGENESIS, V21, P299, DOI 10.1006/mpat.1996.0063; YAMADA E, 1955, J BIOPHYS BIOCHEM CY, V1, P445, DOI 10.1083/jcb.1.5.445	21	13	15	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 4	2000	289	5480					732	733		10.1126/science.289.5480.732	http://dx.doi.org/10.1126/science.289.5480.732			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	341FZ	10950716				2022-12-28	WOS:000088581500024
J	Bittner, M; Meitzer, P; Chen, Y; Jiang, Y; Seftor, E; Hendrix, M; Radmacher, M; Simon, R; Yakhini, Z; Ben-Dor, A; Sampas, N; Dougherty, E; Wang, E; Marincola, F; Gooden, C; Lueders, J; Glatfelter, A; Pollock, P; Carpten, J; Gillanders, E; Leja, D; Dietrich, K; Beaudry, C; Berens, M; Alberts, D; Sondak, V; Hayward, N; Trent, J				Bittner, M; Meitzer, P; Chen, Y; Jiang, Y; Seftor, E; Hendrix, M; Radmacher, M; Simon, R; Yakhini, Z; Ben-Dor, A; Sampas, N; Dougherty, E; Wang, E; Marincola, F; Gooden, C; Lueders, J; Glatfelter, A; Pollock, P; Carpten, J; Gillanders, E; Leja, D; Dietrich, K; Beaudry, C; Berens, M; Alberts, D; Sondak, V; Hayward, N; Trent, J			Molecular classification of cutaneous malignant melanoma by gene expression profiling	NATURE			English	Article							EXTRACELLULAR-MATRIX; CDNA MICROARRAYS; CELL-ADHESION; IN-VITRO; MIGRATION; PATTERNS; MOTILITY; INTEGRIN; CANCER; ASSAY	The most common human cancers are malignant neoplasms of the skin(1,2). Incidence of cutaneous melanoma is rising especially steeply, with minimal progress in non-surgical treatment of advanced disease(3,4). Despite significant effort to identify independent predictors of melanoma outcome, no accepted histopathological, molecular or immunohistochemical marker defines subsets of this neoplasm(2,3). Accordingly, though melanoma is thought to present with different 'taxonomic' forms, these are considered part of a continuous spectrum rather than discrete entities(2). Here we report the discovery of a subset of melanomas identified by mathematical analysis of gene expression in a series of samples. Remarkably, many genes underlying the classification of this subset are differentially regulated in invasive melanomas that form primitive tubular networks in vitro, a feature of some highly aggressive metastatic melanomas(5). Global transcript analysis can identify unrecognized subtypes of cutaneous melanoma and predict experimentally verifiable phenotypic characteristics that may be of importance to disease progression.	Natl Human Genome Res Inst, Canc Genet Branch, NIH, Bethesda, MD 20892 USA; Univ Iowa, Ctr Canc, Dept Anat & Cell Biol, Iowa City, IA 52242 USA; NCI, DCTDC, NIH, Bethesda, MD 20852 USA; Agilent Labs, Chem & Biol Syst Dept, Palo Alto, CA 94304 USA; Univ Washington, Dept Comp Sci & Engn, Seattle, WA 98105 USA; Texas A&M Univ, Dept Elect Engn, College Stn, TX 77843 USA; NCI, Surg Branch, NIH, Bethesda, MD 20850 USA; Queensland Inst Med Res, Herston, Qld 4029, Australia; Barrow Neurol Inst, Neurooncol Lab, Phoenix, AZ 85013 USA; Univ Arizona, Arizona Canc Ctr, Tucson, AZ 85724 USA; Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Iowa; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Agilent Technologies; University of Washington; University of Washington Seattle; Texas A&M University System; Texas A&M University College Station; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); QIMR Berghofer Medical Research Institute; Barrow Neurological Institute; Arizona Center Cancer Care; University of Arizona; University of Michigan System; University of Michigan	Bittner, M (corresponding author), Natl Human Genome Res Inst, Canc Genet Branch, NIH, Bethesda, MD 20892 USA.	mbittner@nhgri.nih.gov; jtrent@nih.gov	hayward, nick/AAV-8802-2020; hayward, nicholas k/C-1367-2015	hayward, nicholas k/0000-0003-4760-1033; Pollock, Pamela/0000-0001-8420-1026; Yakhini, Zohar/0000-0002-0420-5412				Adams JC, 1997, MOL BIOL CELL, V8, P2345, DOI 10.1091/mbc.8.11.2345; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Ben-Dor A, 1999, J COMPUT BIOL, V6, P281, DOI 10.1089/106652799318274; BERENS ME, 1994, CLIN EXP METASTAS, V12, P405, DOI 10.1007/BF01755884; Bittner M, 1999, NAT GENET, V22, P213, DOI 10.1038/10265; Byers HR, 1998, HEMATOL ONCOL CLIN N, V12, P717, DOI 10.1016/S0889-8588(05)70020-4; DeRisi J, 1996, NAT GENET, V14, P457; Duggan DJ, 1999, NAT GENET, V21, P10, DOI 10.1038/4434; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; EVERITT BS, 1992, APPL MULTIVARIATE AN; Giese A, 1996, J CELL SCI, V109, P2161; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Hall HI, 1999, J AM ACAD DERMATOL, V40, P35, DOI 10.1016/S0190-9622(99)70562-1; Helige C, 1997, INVAS METAST, V17, P26; HENDRIX MJC, 1987, CANCER LETT, V38, P137, DOI 10.1016/0304-3835(87)90209-6; Hendrix MJC, 1996, CANCER METAST REV, V15, P507, DOI 10.1007/BF00054016; HIEKEN TJ, 1995, SURGERY, V118, P669, DOI 10.1016/S0039-6060(05)80034-0; Janji B, 1999, INT J CANCER, V83, P255, DOI 10.1002/(SICI)1097-0215(19991008)83:2<255::AID-IJC18>3.3.CO;2-O; Khan J, 1998, CANCER RES, V58, P5009; Khan J, 1999, BIOCHIM BIOPHYS ACTA, V1423, P17; Maniotis AJ, 1999, AM J PATHOL, V155, P739, DOI 10.1016/S0002-9440(10)65173-5; Maung K, 1999, ONCOGENE, V18, P6824, DOI 10.1038/sj.onc.1203094; McMasters KM, 1999, ANN SURG ONCOL, V6, P467, DOI 10.1007/s10434-999-0467-8; Perou CM, 1999, P NATL ACAD SCI USA, V96, P9212, DOI 10.1073/pnas.96.16.9212; SCOTT G, 1995, EXP CELL RES, V219, P197, DOI 10.1006/excr.1995.1219; Silletti S, 1998, INT J CANCER, V76, P120, DOI 10.1002/(SICI)1097-0215(19980330)76:1<120::AID-IJC19>3.3.CO;2-G; Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614; Van Belle PA, 1999, HUM PATHOL, V30, P562, DOI 10.1016/S0046-8177(99)90202-2; Weyers W, 1999, CANCER-AM CANCER SOC, V86, P288, DOI 10.1002/(SICI)1097-0142(19990715)86:2<288::AID-CNCR13>3.0.CO;2-S; Woods A, 2000, ARCH BIOCHEM BIOPHYS, V374, P66, DOI 10.1006/abbi.1999.1607	30	1540	1664	1	106	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 3	2000	406	6795					536	540		10.1038/35020115	http://dx.doi.org/10.1038/35020115			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	340ML	10952317	Green Published			2022-12-28	WOS:000088538000051
J	Yau, ST; Vekilov, PG				Yau, ST; Vekilov, PG			Quasi-planar nucleus structure in apoferritin crystallization	NATURE			English	Article							ATOMIC-FORCE-MICROSCOPY; MACROMOLECULAR SYSTEMS; CRYSTAL NUCLEATION; LIGHT-SCATTERING; HUMAN-H; PROTEIN; GROWTH; WORK; SIZE	First-order phase transitions of matter, such as condensation and crystallization, proceed through the formation and subsequent growth of 'critical nuclei' of the new phase. The thermodynamics and kinetics of the formation of these critical nuclei depend on their structure, which is often assumed to be a compact, three-dimensional arrangement of the constituent molecules or atoms(5,6). Recent molecular dynamics simulations have predicted compact nucleus structures for matter made up of building blocks with a spherical interaction field(7,8), whereas strongly anisotropic, dipolar molecules may form nuclei consisting of single chains of molecules(9). Here we show, using direct atomic force microscopy observations, that the near-critical-size clusters formed during the crystallization of apoferritin, a quasi-spherical protein, and which are representative of the critical nucleus of this system, consist of planar arrays of one or two monomolecular layers that contain 5-10 rods of up to 7 molecules each. We rnd that these clusters contain between 20 and 50 molecules each, and that the arrangement of the constituent molecules is identical to that found in apoferritin crystals. We anticipate that similarly unexpected critical nucleus structures may be quite common, particularly with anisotropic molecules, suggesting that advanced nucleation theories should treat the critical nucleus structure as a variable.	Univ Alabama, Ctr Micrograv & Mat Res, Huntsville, AL 35899 USA; Univ Alabama, Dept Chem, Huntsville, AL 35899 USA	University of Alabama System; University of Alabama Huntsville; University of Alabama System; University of Alabama Huntsville	Vekilov, PG (corresponding author), Univ Alabama, Ctr Micrograv & Mat Res, Huntsville, AL 35899 USA.							Atkins P., 1998, PHYS CHEM, P834; Chernov A.A., 1984, MODERN CRYSTALLOGRAP; Galkin O, 2000, J AM CHEM SOC, V122, P156, DOI 10.1021/ja9930869; Galkin O, 1999, J PHYS CHEM B, V103, P10965, DOI 10.1021/jp992786x; Galkin O, 2000, P NATL ACAD SCI USA, V97, P6277, DOI 10.1073/pnas.110000497; Georgalis Y, 1997, ACTA CRYSTALLOGR D, V53, P691, DOI 10.1107/S0907444997006847; Gibbs J. W., 1961, COLLECTED WORKS JW G; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; Hempstead PD, 1997, J MOL BIOL, V268, P424, DOI 10.1006/jmbi.1997.0970; Hill T.L., 1963, THERMODYNAMICS SMALL; KAISCHEW R, 1937, Z PHYS CHEM B LPZ, V35, P427; KASHCHIEV D, 1982, J CHEM PHYS, V76, P5098, DOI 10.1063/1.442808; Kuznetsov YG, 1998, PHYS REV B, V58, P6097, DOI 10.1103/PhysRevB.58.6097; LAWSON DM, 1991, NATURE, V349, P541, DOI 10.1038/349541a0; LIN H, 1995, J CRYST GROWTH, V151, P153, DOI 10.1016/0022-0248(95)00016-X; MALKIN A, 1994, ACTA CRYSTALLOGR D, V50, P385, DOI 10.1107/S0907444993013319; Malkin AJ, 1996, PROTEINS, V24, P247, DOI 10.1002/(SICI)1097-0134(199602)24:2<247::AID-PROT11>3.3.CO;2-C; Malkin AJ, 1996, J STRUCT BIOL, V117, P124, DOI 10.1006/jsbi.1996.0077; MALKIN AJ, 1995, PHYS REV LETT, V75, P2778, DOI 10.1103/PhysRevLett.75.2778; MILCHEV A, 1991, CONTEMP PHYS, V32, P321, DOI 10.1080/00107519108223705; MUTAFTSCHIEV B, 1993, HDB CRYSTAL GROWTH, P189; OXTOBY DW, 1994, J CHEM PHYS, V100, P7665, DOI 10.1063/1.466859; Petsev DN, 2000, BIOPHYS J, V78, P2060, DOI 10.1016/S0006-3495(00)76753-1; Petsev DN, 2000, PHYS REV LETT, V84, P1339, DOI 10.1103/PhysRevLett.84.1339; Stranski IN, 1934, Z PHYS CHEM B-CHEM E, V26, P100; Talanquer V, 1998, J CHEM PHYS, V109, P223, DOI 10.1063/1.476554; ten Wolde PR, 1998, PHYS REV LETT, V81, P3695, DOI 10.1103/PhysRevLett.81.3695; tenWolde PR, 1997, SCIENCE, V277, P1975, DOI 10.1126/science.277.5334.1975; THOMAS BR, 1997, J CRYST GROWTH, V187, P499; UZNETSOV YG, 1999, J CRYST GROWTH, V196, P489; Vekilov PG, 1996, ACTA CRYSTALLOGR D, V52, P785, DOI 10.1107/S0907444996003265; Volmer M, 1939, KINETIK PHASENBILDUN; Yau ST, 2000, PHYS REV LETT, V85, P353, DOI 10.1103/PhysRevLett.85.353	34	215	219	3	69	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 3	2000	406	6795					494	497		10.1038/35020035	http://dx.doi.org/10.1038/35020035			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	340ML	10952306				2022-12-28	WOS:000088538000040
J	Treguer, P; Pondaven, P				Treguer, P; Pondaven, P			Global change - Silica control of carbon dioxide	NATURE			English	Editorial Material							OCEAN		Univ Bretagne Occidentale, Inst Univ Europeen Mer, Technopole Brest Iroise, CNRS,UMR 6539, F-29280 Plouzane, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Bretagne Occidentale; Institut Universitaire Europeen de la Mer (IUEM)	Treguer, P (corresponding author), Univ Bretagne Occidentale, Inst Univ Europeen Mer, Technopole Brest Iroise, CNRS,UMR 6539, Pl Copernic, F-29280 Plouzane, France.		Treguer, Paul/H-6064-2012	Pondaven, Philippe/0000-0002-3427-7767				Broecker WS, 1998, PALEOCEANOGRAPHY, V13, P352, DOI 10.1029/98PA00920; Dugdale RC, 1998, NATURE, V391, P270, DOI 10.1038/34630; Froelich PN, 1992, PALEOCEANOGRAPHY, V7, P739, DOI 10.1029/92PA02090; Harrison KG, 2000, PALEOCEANOGRAPHY, V15, P292, DOI 10.1029/1999PA000427; Martin F, 1996, GESTA, V35, P177, DOI 10.2307/767181; NELSON DM, 1995, GLOBAL BIOGEOCHEM CY, V9, P359, DOI 10.1029/95GB01070; Toggweiler JR, 1999, NATURE, V400, P511, DOI 10.1038/22892; TREGUER P, 1995, SCIENCE, V268, P375, DOI 10.1126/science.268.5209.375; Tyrrell T, 1999, NATURE, V400, P525, DOI 10.1038/22941	9	164	171	1	58	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 27	2000	406	6794					358	359		10.1038/35019236	http://dx.doi.org/10.1038/35019236			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	337WC	10935620				2022-12-28	WOS:000088383800027
J	Ihle, JN				Ihle, JN			The challenges of translating knockout phenotypes into gene function	CELL			English	Review							HYPOXIA; CELLS; MOUSE; ERYTHROPOIETIN; ACTIVATION		St Jude Childrens Res Hosp, Dept Biochem, Howard Hughes Med Inst, Memphis, TN 38105 USA	Howard Hughes Medical Institute; St Jude Children's Research Hospital	Ihle, JN (corresponding author), St Jude Childrens Res Hosp, Dept Biochem, Howard Hughes Med Inst, 332 N Lauderdale St, Memphis, TN 38105 USA.							ADAMS RH, 2000, IN PRESS MOL CELL; Allen M, 2000, J EXP MED, V191, P859, DOI 10.1084/jem.191.5.859; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Conrad PW, 1999, J BIOL CHEM, V274, P23570, DOI 10.1074/jbc.274.33.23570; Cross JC, 1998, ANN NY ACAD SCI, V857, P23, DOI 10.1111/j.1749-6632.1998.tb10104.x; Ebert BL, 1999, BLOOD, V94, P1864; Ichijo H, 1999, ONCOGENE, V18, P6087, DOI 10.1038/sj.onc.1203129; Kotlyarov A, 1999, NAT CELL BIOL, V1, P94, DOI 10.1038/10061; LABASTIE MC, 1984, P NATL ACAD SCI-BIOL, V81, P1453, DOI 10.1073/pnas.81.5.1453; Lu HT, 1999, EMBO J, V18, P1845, DOI 10.1093/emboj/18.7.1845; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; MUDGETT JS, 2000, IN PRESS P NATL ACAD; NAGY A, 1990, DEVELOPMENT, V110, P815; Nebreda AR, 2000, TRENDS BIOCHEM SCI, V25, P257, DOI 10.1016/S0968-0004(00)01595-4; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; Rousseau S, 1997, ONCOGENE, V15, P2169, DOI 10.1038/sj.onc.1201380; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Yang JH, 2000, NAT GENET, V24, P309, DOI 10.1038/73550; Yasuda Y, 1996, DEV DYNAM, V207, P184	19	60	61	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 21	2000	102	2					131	134		10.1016/S0092-8674(00)00017-9	http://dx.doi.org/10.1016/S0092-8674(00)00017-9			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	337NA	10943832	Bronze			2022-12-28	WOS:000088366800002
J	Martling, AL; Holm, T; Rutqvist, LE; Moran, BJ; Heald, RJ; Cedermark, B				Martling, AL; Holm, T; Rutqvist, LE; Moran, BJ; Heald, RJ; Cedermark, B		Stockholm Colorectal Canc Study Gr; Basingstoke Bowel Canc Res Project	Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm	LANCET			English	Article							PROSPECTIVE RANDOMIZED TRIAL; TOTAL MESORECTAL EXCISION; PREOPERATIVE RADIOTHERAPY; ANTERIOR RESECTION; LOCAL RECURRENCE; CARCINOMA; EXPERIENCE; SURGERY	Background The Stockholm I and II randomised trials demonstrated the value of preoperative radiotherapy in preventing local recurrence in rectal cancer. This study investigated the potential for further improvement by introduction of the concept of total mesorectal excision (TME) to surgeons in Stockholm, Sweden. Methods Workshops started in 1994 and included 11 television-based demonstrations and two histopathology sessions. The study population consisted of all patients who underwent abdominal operations for rectal cancer in Stockholm County during 1995-96 (TME project; n=447). Outcomes at 2 years were compared with those from the Stockholm I (n=790) and 11 (n=542) trials as historical controls. Findings For patients with curative abdominal resections, there were no differences between the Stockholm 1 (n=686), Stockholm II (n=481), and TME project (n=381) groups in 30-day mortality (30 [4%], six [1%], and 12 [3%]), anastomotic leakage (27 [10%], 18 [9%], and 23 [9%]), or all complications (204 [30%], 169 [35%], and 134 [35%]). This similarity was achieved despite a decrease in the proportion of abdominoperineal procedures from 55-60% to 27%. Local recurrence occurred in significantly fewer of the TME group than of the Stockholm I and II groups (21 [6%] vs 103 [15%] and 66 [14%], p<0.001) as did cancer-related death (35 [9%] vs 104 [15%] and 77 [16%], p<0.002). Interpretation A surgical teaching initiative had a major effect on cancer outcomes. The proportion of abdominoperineal procedures and the local recurrence rate decreased by more than 50% and there is already evidence of a decline in rectal-cancer mortality.	Karolinska Hosp, Dept Surg, SE-17176 Stockholm, Sweden; N Hampshire Hosp NHS Trust, Colorectal Res Unit, Basingstoke, Hants, England	Karolinska Institutet; Karolinska University Hospital	Holm, T (corresponding author), Karolinska Hosp, Dept Surg, SE-17176 Stockholm, Sweden.			Martling, Anna/0000-0001-5998-4735				[Anonymous], 1990, Cancer, V66, P49; [Anonymous], 1987, AM J CLIN ONCOL-CANC, V10, P369; BOULISWASSIF S, 1984, CANCER-AM CANCER SOC, V53, P1811, DOI 10.1002/1097-0142(19840501)53:9<1811::AID-CNCR2820530902>3.0.CO;2-H; Cedermark B, 1996, ANN SURG ONCOL, V3, P423; CEDERMARK B, 1995, CANCER-AM CANCER SOC, V75, P2269, DOI 10.1002/1097-0142(19950501)75:9<2269::AID-CNCR2820750913>3.0.CO;2-I; Dahlberg M, 1999, ANN SURG, V229, P493, DOI 10.1097/00000658-199904000-00007; DIXON AR, 1991, BRIT J SURG, V78, P308, DOI 10.1002/bjs.1800780314; HEALD RJ, 1986, LANCET, V1, P1479; Heald RJ, 1998, ARCH SURG-CHICAGO, V133, P894, DOI 10.1001/archsurg.133.8.894; HOLM T, 1995, BRIT J SURG, V82, P1213, DOI 10.1002/bjs.1800820920; Kapiteijn E, 1999, EUR J SURG, V165, P410, DOI 10.1080/110241599750006613; KARANJIA ND, 1991, BRIT J SURG, V78, P196, DOI 10.1002/bjs.1800780221; KARANJIA ND, 1992, BRIT J SURG, V79, P114, DOI 10.1002/bjs.1800790206; MACFARLANE JK, 1993, LANCET, V341, P457, DOI 10.1016/0140-6736(93)90207-W; Pahlman L, 1996, EUR J SURG, V162, P397; PAHLMAN L, 1990, ANN SURG, V211, P187, DOI 10.1097/00000658-199002000-00011; Pahlman L, 1997, NEW ENGL J MED, V336, P980; PAHLMAN L, 1984, ACTA CHIR SCAND, V150, P331; PHILLIPS RKS, 1984, BRIT J SURG, V71, P17, DOI 10.1002/bjs.1800710105; QUIRKE P, 1986, LANCET, V2, P996, DOI 10.1016/s0140-6736(86)92612-7; Quirke P, 1992, SURG ONCOL CLIN N AM, V3, P1	21	596	624	0	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 8	2000	356	9224					93	96		10.1016/S0140-6736(00)02469-7	http://dx.doi.org/10.1016/S0140-6736(00)02469-7			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	331UG	10963244				2022-12-28	WOS:000088036600008
J	Clark, PU; Mix, AC				Clark, PU; Mix, AC			Global change - Ice sheets by volume	NATURE			English	Editorial Material							LAST GLACIAL MAXIMUM; CLIMATE-CHANGE; SEA; TEMPERATURE; DEGLACIATION; OCEAN; LEVEL		Oregon State Univ, Dept Geosci, Corvallis, OR 97331 USA; Oregon State Univ, Coll Ocean & Atmospher Sci, Corvallis, OR 97331 USA	Oregon State University; Oregon State University	Clark, PU (corresponding author), Oregon State Univ, Dept Geosci, Corvallis, OR 97331 USA.							BARD E, 1990, NATURE, V345, P405, DOI 10.1038/345405a0; Clark PU, 1999, SCIENCE, V286, P1104, DOI 10.1126/science.286.5442.1104; Clark PU, 1996, PALEOCEANOGRAPHY, V11, P563, DOI 10.1029/96PA01419; DUPLESSY JC, 1991, EARTH PLANET SC LETT, V103, P27, DOI 10.1016/0012-821X(91)90147-A; Fleming K, 1998, EARTH PLANET SC LETT, V163, P327, DOI 10.1016/S0012-821X(98)00198-8; Grosswald M.G., 1999, POLAR GEOGRAPHY, V23, P23, DOI DOI 10.1080/10889379909377663; GUILDERSON TP, 1994, SCIENCE, V263, P663, DOI 10.1126/science.263.5147.663; Hewitt CD, 1997, CLIM DYNAM, V13, P821, DOI 10.1007/s003820050199; LAMBECK K, IN PRESS EARTH PLANE; Mix AC, 1999, GEOPH MONOG SERIES, V112, P127; MIX AC, 1988, NATURE, V331, P249, DOI 10.1038/331249a0; MIX AC, IN PRESS QUAT SCI RE; Peltier WR, 1998, REV GEOPHYS, V36, P603, DOI 10.1029/98RG02638; Schrag DP, 1996, SCIENCE, V272, P1930, DOI 10.1126/science.272.5270.1930; SHACKLETON N, 1967, NATURE, V215, P15, DOI 10.1038/215015a0; SOWERS T, 1995, SCIENCE, V269, P210, DOI 10.1126/science.269.5221.210; Svendsen JI, 1999, BOREAS, V28, P234, DOI 10.1111/j.1502-3885.1999.tb00217.x; Yokoyama Y, 2000, NATURE, V406, P713, DOI 10.1038/35021035	18	45	46	0	16	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 17	2000	406	6797					689	690		10.1038/35021176	http://dx.doi.org/10.1038/35021176			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	344PH	10963583				2022-12-28	WOS:000088767700030
J	Harris, DJ; Douglas, PS				Harris, DJ; Douglas, PS			Enrollment of women in cardiovascular clinical trials funded by the national heart, lung, and blood institute.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DISEASE; HEALTH; CARE	Background: With the recognition that certain aspects of cardiovascular disease are specific to sex, the U.S. government has sought to ensure that federally funded clinical research yields adequate high-quality information about heart disease in women. Methods: We tabulated the numbers of men and women in cardiovascular clinical trials funded by the National Heart, Lung, and Blood Institute (NHLBI) between 1965 and 1998, recording both total numbers and the numbers for each type of cardiovascular disease. We analyzed the data according to the sex-specific prevalence of disease and assessed changes in enrollment over time. We performed a similar analysis after excluding all single-sex trials. Results: A total of 398,801 subjects (215,796 women and 183,005 men) were enrolled in NHLBI-funded studies of cardiovascular disease. The overall enrollment rate for women (54 percent) exceeded the prevalence of cardiovascular disease in women in the general population (49 percent) and increased over time (P=0.002). With single-sex trials excluded, the enrollment rate for women was 38 percent, which did not change significantly over time. In studies of coronary artery disease and hypertension the rates of enrollment of women were similar to or exceeded the prevalence of these disorders in women. The enrollment rate increased significantly over time in studies of coronary artery disease (P<0.001) but not in studies of hypertension or arrhythmia. Women were underenrolled in studies of heart failure, and the rate of enrollment did not change significantly over time. When single-sex trials were excluded from the analysis of enrollment rates according to the prevalence of disease, the results were similar. There was no change in enrollment rates over time for any category of disease. Conclusions: Federal efforts to increase the representation of women in clinical trials have been moderately successful primarily because of the institution of a small number of large, single-sex trials involving coronary artery disease. There has been no change in the sex composition of cohorts in the majority of studies of cardiovascular disease. (N Engl J Med 2000;343:475-80.) (C)2000, Massachusetts Medical Society.	Univ Wisconsin, Sch Med, Sect Cardiovasc Med, Madison, WI 53792 USA; Yale Coll, New Haven, CT USA	University of Wisconsin System; University of Wisconsin Madison; Yale University	Douglas, PS (corresponding author), Univ Wisconsin, Sch Med, Sect Cardiovasc Med, 600 Highland Ave, Madison, WI 53792 USA.			Douglas, Pamela/0000-0001-9876-4049				ANGELL M, 1993, NEW ENGL J MED, V329, P271, DOI 10.1056/NEJM199307223290409; DOUGLAS PS, 1986, CIRCULATION, V74, P917, DOI 10.1161/01.CIR.74.5.917; Helmuth L, 2000, SCIENCE, V288, P1562, DOI 10.1126/science.288.5471.1562; MASON JO, 1992, JAMA-J AM MED ASSOC, V267, P482; Mendelsohn ME, 1999, NEW ENGL J MED, V340, P1801, DOI 10.1056/NEJM199906103402306; Mosca L, 1997, CIRCULATION, V96, P2468; National Institutes of Health, 1994, FED REGISTER, V59, P11146; *NIH, 1987, NIH GUID GRANTS CONT, V16; *NIH, 1990, NIH GUID GRANTS CONT, V19; Roger VL, 1999, MAYO CLIN PROC, V74, P651, DOI 10.4065/74.7.651; *TASK FORC WOM HLT, 1985, DHHS PUBL PHS; Taylor Carol, 1994, J Womens Health, V3, P143, DOI 10.1089/jwh.1994.3.143	12	194	197	2	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 17	2000	343	7					475	480		10.1056/NEJM200008173430706	http://dx.doi.org/10.1056/NEJM200008173430706			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	344FC	10944565				2022-12-28	WOS:000088747700006
J	Samuelson, JC; Chen, MY; Jiang, FL; Moller, I; Wiedmann, M; Kuhn, A; Phillips, GJ; Dalbey, RE				Samuelson, JC; Chen, MY; Jiang, FL; Moller, I; Wiedmann, M; Kuhn, A; Phillips, GJ; Dalbey, RE			YidC mediates membrane protein insertion in bacteria	NATURE			English	Article							SIGNAL RECOGNITION PARTICLE; ESCHERICHIA-COLI; ENDOPLASMIC-RETICULUM; TARGETING PATHWAY; NUCLEAR GENE; MITOCHONDRIA; TRANSLOCATION; EXPORT; BIOGENESIS; MACHINERY	The basic machinery for the translocation of proteins into or across membranes is remarkably conserved from Escherichia coli to humans. In eukaryotes, proteins are inserted into the endoplasmic reticulum using the signal recognition particle (SRP) and the SRP receptor, as well as the integral membrane Sec61 trimeric complex (composed of alpha, beta and gamma subunits)(1). In bacteria, most proteins are inserted by a related pathway that includes the SRP homologue Ffh(2-5), the SRP receptor FtsY(6,7), and the SecYEG trimeric complex(8), where Y and E are related to the Sec61 alpha and gamma subunits, respectively. Proteins in bacteria that exhibit no dependence on the Sec translocase were previously thought to insert into the membrane directly without the aid of a protein machinery(9,10). Here we show that membrane insertion of two Sec-independent proteins requires YidC. YidC is essential for E. coli viability and homologues are present in mitochondria and chloroplasts. Depletion of YidC also interferes with insertion of Sec-dependent membrane proteins, but it has only a minor effect on the export of secretory proteins. These results provide evidence for an additional component of the translocation machinery that is specialized for the integration of membrane proteins.	Ohio State Univ, Dept Chem, Columbus, OH 43210 USA; Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, New York, NY 10021 USA; Univ Hohenheim, Inst Microbiol & Mol Biol, D-70599 Stuttgart, Germany; Iowa State Univ, Dept Microbiol, Ames, IA 50011 USA	University System of Ohio; Ohio State University; Memorial Sloan Kettering Cancer Center; University Hohenheim; Iowa State University	Dalbey, RE (corresponding author), Ohio State Univ, Dept Chem, 120 W 18th Ave, Columbus, OH 43210 USA.	dalbey@chemistry.ohio-state.edu						BERNSTEIN HD, 1993, P NATL ACAD SCI USA, V90, P5229, DOI 10.1073/pnas.90.11.5229; BONNEFOY N, 1994, J MOL BIOL, V239, P201, DOI 10.1006/jmbi.1994.1363; Brunner J, 1996, TRENDS CELL BIOL, V6, P154, DOI 10.1016/0962-8924(96)40001-0; Cload ST, 1996, CHEM BIOL, V3, P1033, DOI 10.1016/S1074-5521(96)90169-6; Cristobal S, 1999, J BIOL CHEM, V274, P20068, DOI 10.1074/jbc.274.29.20068; de Gier JWL, 1998, P NATL ACAD SCI USA, V95, P14646, DOI 10.1073/pnas.95.25.14646; deGier JWL, 1996, FEBS LETT, V399, P307, DOI 10.1016/S0014-5793(96)01354-3; Do H, 1996, CELL, V85, P369, DOI 10.1016/S0092-8674(00)81115-0; GELLER BL, 1985, J BIOL CHEM, V260, P3281; GILMORE R, 1991, METHOD CELL BIOL, V34, P223; Glick BS, 1996, PROTEIN SCI, V5, P2651, DOI 10.1002/pro.5560051229; GOLD LM, 1971, METHOD ENZYMOL, V20, P537; GORLICH D, 1992, NATURE, V357, P47, DOI 10.1038/357047a0; Graf R, 1998, CELL BIOLOGY - A LABOARATORY HANDBOOK, 2ND EDITION, VOL 4, P495; HAMILTON CM, 1989, J BACTERIOL, V171, P4617, DOI 10.1128/jb.171.9.4617-4622.1989; Hell K, 1998, P NATL ACAD SCI USA, V95, P2250, DOI 10.1073/pnas.95.5.2250; Hell K, 1997, FEBS LETT, V418, P367, DOI 10.1016/S0014-5793(97)01412-9; LUIRINK J, 1994, EMBO J, V13, P2289, DOI 10.1002/j.1460-2075.1994.tb06511.x; MARTOGLIO B, 1995, CELL, V81, P207, DOI 10.1016/0092-8674(95)90330-5; Moore M, 2000, J BIOL CHEM, V275, P1529, DOI 10.1074/jbc.275.3.1529; PHILLIPS GJ, 1992, NATURE, V359, P744, DOI 10.1038/359744a0; Platt R, 2000, PLASMID, V43, P12, DOI 10.1006/plas.1999.1433; Rapoport TA, 1996, ANNU REV BIOCHEM, V65, P271; Scotti PA, 2000, EMBO J, V19, P542, DOI 10.1093/emboj/19.4.542; Seluanov A, 1997, J BIOL CHEM, V272, P2053; Stuart RA, 1996, TRENDS BIOCHEM SCI, V21, P261, DOI 10.1016/S0968-0004(96)10035-9; Sundberg E, 1997, PLANT CELL, V9, P717, DOI 10.1105/tpc.9.5.717; Ulbrandt ND, 1997, CELL, V88, P187, DOI 10.1016/S0092-8674(00)81839-5; WHITLEY P, 1994, EMBO J, V13, P4653, DOI 10.1002/j.1460-2075.1994.tb06788.x; Wickner W, 1996, J BIOL CHEM, V271, P29514, DOI 10.1074/jbc.271.47.29514	30	416	423	9	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 10	2000	406	6796					637	641		10.1038/35020586	http://dx.doi.org/10.1038/35020586			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	342PF	10949305				2022-12-28	WOS:000088653800050
J	Saxena, SS; Agarwal, P; Ahilan, K; Grosche, FM; Haselwimmer, RKW; Steiner, MJ; Pugh, E; Walker, IR; Julian, SR; Monthoux, P; Lonzarich, GG; Huxley, A; Sheikin, I; Braithwaite, D; Flouquet, J				Saxena, SS; Agarwal, P; Ahilan, K; Grosche, FM; Haselwimmer, RKW; Steiner, MJ; Pugh, E; Walker, IR; Julian, SR; Monthoux, P; Lonzarich, GG; Huxley, A; Sheikin, I; Braithwaite, D; Flouquet, J			Superconductivity on the border of itinerant-electron ferromagnetism in UGe2	NATURE			English	Article							HIGH-TEMPERATURE SUPERCONDUCTIVITY; HEAVY-FERMION COMPOUNDS; HYDROSTATIC-PRESSURE; SPIN FLUCTUATIONS; PHASE-TRANSITION; METALS; SYSTEMS; STATES; CRYSTAL; HE-3	The absence of simple examples of superconductivity adjoining itinerant-electron ferromagnetism in the phase diagram has for many years cast doubt on the validity of conventional models of magnetically mediated superconductivity. On closer examination, however, very few systems have been studied in the extreme conditions of purity, proximity to the ferromagnetic state and very low temperatures required to test the theory definitively. Here we report the observation of superconductivity on the border of ferromagnetism in a pure system, UGe2, which is known to be qualitatively similar to the classic d-electron ferromagnets. The superconductivity that we observe below 1 K, in a limited pressure range on the border of ferromagnetism, seems to arise from the same electrons that produce band magnetism. In this case, superconductivity is most naturally understood in terms of magnetic as opposed to lattice interactions, and by a spin-triplet rather than the spin-singlet pairing normally associated with nearly antiferromagnetic metals.	Univ Cambridge, Cavendish Lab, Dept Phys, Cambridge CB3 0HE, England; Univ Groningen, Ctr Mat Sci, NL-9747 AG Groningen, Netherlands; CEA Grenoble, Dept Rech Fondamentale & Mat Condensee, SPSMS, F-38054 Grenoble, France	University of Cambridge; University of Groningen; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Lonzarich, GG (corresponding author), Univ Cambridge, Cavendish Lab, Dept Phys, Madingley Rd, Cambridge CB3 0HE, England.		Grosche, Malte/A-7117-2012; Saxena, Siddharth/AAA-9120-2020; Saxena, Siddharth S/D-2025-2012; Grosche, Friedrich Malte/AAP-1734-2020; braithwaite, Daniel/V-1234-2019	Grosche, Malte/0000-0002-3912-9819; Saxena, Siddharth/0000-0002-6321-5629; Saxena, Siddharth S/0000-0002-6321-5629; Grosche, Friedrich Malte/0000-0002-3912-9819; braithwaite, Daniel/0000-0002-9012-4255; Sheikin, Ilya/0000-0002-3704-1848				Agarwal P., 2000, THESIS U CAMBRIDGE; BARDEEN J, 1957, PHYS REV, V108, P1175, DOI 10.1103/PhysRev.108.1175; BICKERS NE, 1989, PHYS REV LETT, V62, P961, DOI 10.1103/PhysRevLett.62.961; Blagoev KB, 1999, PHYS REV LETT, V82, P133, DOI 10.1103/PhysRevLett.82.133; Boulet P, 1997, J ALLOY COMPD, V247, P104, DOI 10.1016/S0925-8388(96)02600-X; BRINKMAN WF, 1974, PHYS REV A, V10, P2386, DOI 10.1103/PhysRevA.10.2386; BRUECKNER KA, 1960, PHYS REV, V118, P1442, DOI 10.1103/PhysRev.118.1442; BULAEVSKII LN, 1985, ADV PHYS, V34, P175, DOI 10.1080/00018738500101741; BULUT N, 1990, PHYS REV B, V41, P1797, DOI 10.1103/PhysRevB.41.1797; FEY D, 1980, PHYS REV B, V22, P3173; FISK Z, 1988, SCIENCE, V239, P33, DOI 10.1126/science.239.4835.33; Fukuyama H., 1998, REV HIGH PRESSURE SC, V7, P465; Grosche FM, 1995, PHYSICA B, V206, P20, DOI 10.1016/0921-4526(94)00356-Z; HIRSCH JE, 1985, PHYS REV LETT, V54, P1317, DOI 10.1103/PhysRevLett.54.1317; Huxley A, 2000, PHYSICA B, V284, P1277, DOI 10.1016/S0921-4526(99)02545-4; ISHIGURO T, 1990, ORGANIC CONDUCTORS, pCH3; JACCARD D, 1992, PHYS LETT A, V163, P475, DOI 10.1016/0375-9601(92)90860-O; JEROME D, 1994, ORGANIC CONDUCTORS; Jourdan M, 1999, NATURE, V398, P47, DOI 10.1038/17977; Julian SR, 1996, J PHYS-CONDENS MAT, V8, P9675, DOI 10.1088/0953-8984/8/48/002; KADOWAKI K, 1986, SOLID STATE COMMUN, V58, P507, DOI 10.1016/0038-1098(86)90785-4; KOLODZIEJCZYK A, 1980, J PHYS F MET PHYS, V10, pL333, DOI 10.1088/0305-4608/10/12/003; KRACHEV NI, 1999, CONDMAT9911489; Lee IJ, 1997, PHYS REV LETT, V78, P3555, DOI 10.1103/PhysRevLett.78.3555; LEGGETT AJ, 1975, REV MOD PHYS, V47, P331, DOI 10.1103/RevModPhys.47.331; LEVIN K, 1978, PHYS REV B, V17, P191, DOI 10.1103/PhysRevB.17.191; Lonzarich G. G., 1997, ELECTRON; LONZARICH GG, 1984, J MAGN MAGN MATER, V45, P43, DOI 10.1016/0304-8853(84)90371-8; Mackenzie AP, 1998, PHYS REV LETT, V80, P161, DOI 10.1103/PhysRevLett.80.161; MAENO Y, 1994, NATURE, V372, P532, DOI 10.1038/372532a0; Mathur ND, 1998, NATURE, V394, P39, DOI 10.1038/27838; Menovsky A., 1983, High Field Magnetism. Proceedings of the International Symposium, P189; MILLIS AJ, 1988, PHYS REV B, V37, P4975, DOI 10.1103/PhysRevB.37.4975; MIYAKE K, 1986, PHYS REV B, V34, P6554, DOI 10.1103/PhysRevB.34.6554; Monthoux P, 1999, PHYS REV B, V59, P14598, DOI 10.1103/PhysRevB.59.14598; MONTHOUX P, 1991, PHYS REV LETT, V67, P3448, DOI 10.1103/PhysRevLett.67.3448; MORIYA T, 1990, J PHYS SOC JPN, V59, P2905, DOI 10.1143/JPSJ.59.2905; Movshovich R, 1996, PHYS REV B, V53, P8241, DOI 10.1103/PhysRevB.53.8241; NAKAJIMA S, 1973, PROG THEOR PHYS, V50, P1101, DOI 10.1143/PTP.50.1101; NISHIMURA K, 1994, J ALLOY COMPD, V213, P383, DOI 10.1016/0925-8388(94)90939-3; OHMI T, 1993, PHYS REV LETT, V71, P625, DOI 10.1103/PhysRevLett.71.625; Oikawa K, 1996, J PHYS SOC JPN, V65, P3229, DOI 10.1143/JPSJ.65.3229; Oomi G, 1998, J ALLOY COMPD, V271, P482, DOI 10.1016/S0925-8388(98)00122-4; OTT HR, 1983, PHYS REV LETT, V50, P1595, DOI 10.1103/PhysRevLett.50.1595; Pfleiderer C, 1997, PHYS REV B, V55, P8330, DOI 10.1103/PhysRevB.55.8330; Pickett WE, 1999, PHYS REV LETT, V83, P3713, DOI 10.1103/PhysRevLett.83.3713; PINES D, 1990, PHYSICA B, V163, P78, DOI 10.1016/0921-4526(90)90133-F; Rice M, 1998, NATURE, V396, P627, DOI 10.1038/25241; ROUSSEV R, 2000, CONDMAT0006208; SATOH K, 1992, J PHYS SOC JPN, V61, P1827, DOI 10.1143/JPSJ.61.1827; SAXENA S, 1998, THESIS U CAMBRIDGE; SCALAPINO DJ, 1986, PHYS REV B, V34, P8190, DOI 10.1103/PhysRevB.34.8190; SCHRIEFFER JR, 1988, PHYS REV LETT, V60, P944, DOI 10.1103/PhysRevLett.60.944; Sidis Y, 1999, PHYS REV LETT, V83, P3320, DOI 10.1103/PhysRevLett.83.3320; SINHAM KP, 1989, MAGNETIC SUPERCONDUC; STEGLICH F, 1979, PHYS REV LETT, V43, P1892, DOI 10.1103/PhysRevLett.43.1892; STEWART GR, 1984, REV MOD PHYS, V56, P755, DOI 10.1103/RevModPhys.56.755; TAILLEFER L, 1988, PHYS REV LETT, V60, P1570, DOI 10.1103/PhysRevLett.60.1570; Takimoto TT, 1996, SOLID STATE COMMUN, V99, P457, DOI 10.1016/0038-1098(96)00262-1; Tallon JL, 1999, IEEE T APPL SUPERCON, V9, P1696, DOI 10.1109/77.784779; Thessieu C, 1997, PHYSICA B, V239, P67, DOI 10.1016/S0921-4526(97)00380-3; Walker IR, 1997, PHYSICA C, V282, P303, DOI 10.1016/S0921-4534(97)00267-0; Walker IR, 1999, REV SCI INSTRUM, V70, P3402, DOI 10.1063/1.1149927; YAMAGAMI H, 1993, PHYSICA B, V186-88, P182, DOI 10.1016/0921-4526(93)90529-F; [No title captured]	65	1325	1335	4	235	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 10	2000	406	6796					587	592		10.1038/35020500	http://dx.doi.org/10.1038/35020500			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	342PF	10949292				2022-12-28	WOS:000088653800037
J	Subramaniam, S; Henderson, R				Subramaniam, S; Henderson, R			Molecular mechanism of vectorial proton translocation by bacteriorhodopsin	NATURE			English	Article							X-RAY-DIFFRACTION; STRUCTURAL-CHANGES; CRYSTAL-STRUCTURE; PHOTOCYCLE; CHROMOPHORE; INTERMEDIATE; RESOLUTION; MODEL; NMR	Bacteriorhodopsin, a membrane protein with a relative molecular mass of 27,000, is a light driven pump which transports protons across the cell membrane of the halophilic organism Halobacterium salinarum. The chromophore retinal is covalently attached to the protein via a protonated Schiff base. Upon illumination, retinal is isomerized. The Schiff base then releases a proton to the extracellular medium, and is subsequently reprotonated from the cytoplasm. An atomic model for bacteriorhodopsin was first determined by Henderson et al(1), and has been confirmed and extended by work in a number of laboratories in the last few years(2). Here we present an atomic model for structural changes involved in the vectorial, light-driven transport of protons by bacteriorhodopsin. A 'switch' mechanism ensures the vectorial nature of pumping. First, retinal unbends, triggered by loss of the Schiff base proton, and second, a protein conformational change occurs. This conformational change, which we have determined by electron crystallography at atomic (3.2 Angstrom in-plane and 3.6 Angstrom vertical) resolution, is largely localized to helices F and G, and provides an 'opening' of the protein to protons on the cytoplasmic side of the membrane.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England; NCI, Biochem Lab, Bethesda, MD 20892 USA	MRC Laboratory Molecular Biology; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Subramaniam, S (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.							Altenbach C, 1996, BIOCHEMISTRY-US, V35, P12470, DOI 10.1021/bi960849l; Brown LS, 1997, P NATL ACAD SCI USA, V94, P5040, DOI 10.1073/pnas.94.10.5040; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DENCHER NA, 1989, P NATL ACAD SCI USA, V86, P7876, DOI 10.1073/pnas.86.20.7876; Elia GR, 1996, CAN J CHEM, V74, P591, DOI 10.1139/v96-063; Essen LO, 1998, P NATL ACAD SCI USA, V95, P11673, DOI 10.1073/pnas.95.20.11673; Faruqi AR, 1999, ULTRAMICROSCOPY, V75, P235, DOI 10.1016/S0304-3991(98)00056-4; FODOR SPA, 1988, BIOCHEMISTRY-US, V27, P7097, DOI 10.1021/bi00418a064; Griffiths JM, 2000, BIOCHEMISTRY-US, V39, P362, DOI 10.1021/bi991106d; Grigorieff N, 1996, J MOL BIOL, V259, P393, DOI 10.1006/jmbi.1996.0328; HAMANAKA T, 1972, ACTA CRYSTALL B-STRU, VB 28, P214, DOI 10.1107/S0567740872002092; Hoff WD, 1997, ANNU REV BIOPH BIOM, V26, P223, DOI 10.1146/annurev.biophys.26.1.223; Kamikubo H, 1997, BIOCHEMISTRY-US, V36, P12282, DOI 10.1021/bi9712302; KOCH MHJ, 1991, EMBO J, V10, P521, DOI 10.1002/j.1460-2075.1991.tb07978.x; Luecke H, 1999, SCIENCE, V286, P255, DOI 10.1126/science.286.5438.255; Moltke S, 1999, BIOCHEMISTRY-US, V38, P11762, DOI 10.1021/bi990593u; Oka T, 1999, BIOPHYS J, V76, P1018, DOI 10.1016/S0006-3495(99)77266-8; SANTARSIERO BD, 1990, J AM CHEM SOC, V112, P9416, DOI 10.1021/ja00181a067; Sass HJ, 2000, NATURE, V406, P649, DOI 10.1038/35020607; SCHOBERT B, 1982, J BIOL CHEM, V257, P306; SIMMONS CJ, 1981, ACTA CRYSTALLOGR B, V37, P2197, DOI 10.1107/S0567740881008388; SIMMONS CJ, 1986, ACTA CRYSTALLOGR C, V42, P711, DOI 10.1107/S0108270186094829; STAM CH, 1972, ACTA CRYSTALL B-STRU, VB 28, P2936, DOI 10.1107/S0567740872007253; Subramaniam S, 1999, CURR OPIN STRUC BIOL, V9, P462, DOI 10.1016/S0959-440X(99)80065-7; Subramaniam S, 1999, J MOL BIOL, V287, P145, DOI 10.1006/jmbi.1999.2589; SUBRAMANIAM S, 1993, EMBO J, V12, P1; Vonck J, 2000, EMBO J, V19, P2152, DOI 10.1093/emboj/19.10.2152	28	386	396	0	77	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 10	2000	406	6796					653	657		10.1038/35020614	http://dx.doi.org/10.1038/35020614			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	342PF	10949309				2022-12-28	WOS:000088653800054
J	McCabe, H				McCabe, H			France may bid for fusion reactor	NATURE			English	News Item																			0	0	0	0	1	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 3	2000	406	6795					447	447		10.1038/35020229	http://dx.doi.org/10.1038/35020229			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	340ML	10952280	Bronze			2022-12-28	WOS:000088538000008
J	Nicol, S; Pauly, T; Bindoff, NL; Wright, S; Thiele, D; Hosie, GW; Strutton, PG; Woehler, E				Nicol, S; Pauly, T; Bindoff, NL; Wright, S; Thiele, D; Hosie, GW; Strutton, PG; Woehler, E			Ocean circulation off east Antarctica affects ecosystem structure and sea-ice extent	NATURE			English	Article							CIRCUMPOLAR CURRENT; SOUTHERN-OCEAN; KRILL; PHOTOSYNTHESIS; PACIFIC	Sea ice and oceanic boundaries have a dominant effect in structuring Antarctic marine ecosystems. Satellite imagery and historical data have identified the southern boundary of the Antarctic Circumpolar Current(1) as a site of enhanced biological productivity(2). Meso-scale surveys off the Antarctic peninsula have related the abundances of Antarctic krill (Euphausia superba) and salps (Salpa thompsoni) to inter-annual variations in sea-ice extent(3). Here we have examined the ecosystem structure and oceanography spanning 3,500 km of the east Antarctic coastline, linking the scales of local surveys and global observations. Between 80 degrees and 150 degrees E there is a threefold variation in the extent of annual sea-ice cover, enabling us to examine the regional effects of sea ice and ocean circulation on biological productivity. Phytoplankton, primary productivity, Antarctic krill, whales and seabirds were concentrated where winter sea-ice extent is maximal, whereas salps were located where the sea-ice extent is minimal. We found enhanced biological activity south of the southern boundary of the Antarctic Circumpolar Current rather than in association with it(2). We propose that along this coastline ocean circulation determines both the sea-ice conditions and the level of biological productivity at all trophic levels.	Australian Antarctic Div, Dept Environm & Heritage, Kingston, Tas 7050, Australia; Univ Tasmania, Antarctic Cooperat Res Ctr, Hobart, Tas 7001, Australia; Sch Ecol & Environm, Warrnambool, Vic 3280, Australia; Flinders Univ S Australia, Sch Biol, Adelaide, SA 5001, Australia	Australian Antarctic Division; University of Tasmania; Flinders University South Australia	Nicol, S (corresponding author), Australian Antarctic Div, Dept Environm & Heritage, Channel Highway, Kingston, Tas 7050, Australia.	stephe_nik@antdiv.gov.au	Strutton, Peter G/C-4466-2011; Bindoff, Nathaniel L/C-8050-2011	Strutton, Peter G/0000-0002-2395-9471; Bindoff, Nathaniel L/0000-0001-5662-9519; Woehler, Eric/0000-0002-1125-0748				BISHOP JKB, 1991, J GEOPHYS RES-OCEANS, V96, P16839, DOI 10.1029/91JC01754; COMISO JC, 1993, J GEOPHYS RES-OCEANS, V98, P2419, DOI 10.1029/92JC02505; delaMare WK, 1997, NATURE, V389, P57, DOI 10.1038/37956; GREENE CH, 1991, NATURE, V349, P110, DOI 10.1038/349110a0; Heil P, 1999, J GEOPHYS RES-OCEANS, V104, P15789, DOI 10.1029/1999JC900076; HOSIE GW, 1994, SOUTHERN OCEAN ECOLOGY: THE BIOMASS PERSPECTIVE, P93; JACKA TJ, 1997, ANTARCTIC CRC AUSTR; Jeffrey S.W., 1997, PHYTOPLANKTON PIGMEN; JOLLY GM, 1990, CAN J FISH AQUAT SCI, V47, P1282, DOI 10.1139/f90-147; Kawaguchi S., 1998, CCAMLR Science, V5, P205; Le Fevre J, 1998, J MARINE SYST, V17, P325, DOI 10.1016/S0924-7963(98)00047-5; LEWIS MR, 1983, MAR ECOL PROG SER, V13, P99, DOI 10.3354/meps013099; Loeb V, 1997, NATURE, V387, P897, DOI 10.1038/43174; MACKEY DJ, 1995, DEEP-SEA RES PT II, V42, P499, DOI 10.1016/0967-0645(95)00038-R; Mackintosh N, 1973, DISCOVERY REP, V36, P1; MIZROCH SA, 1985, CCAMLR SELECTED SCI, P113; Nicol S, 1999, AQUAT LIVING RESOUR, V12, P105, DOI 10.1016/S0990-7440(99)80020-5; NICOL S, IN PRESS DEEP SEA RE, V47; NISHIKAWA J, 1995, POLAR BIOL, V15, P31; ORSI AH, 1995, DEEP-SEA RES PT I, V42, P641, DOI 10.1016/0967-0637(95)00021-W; Perissinotto R, 1998, J MARINE SYST, V17, P361, DOI 10.1016/S0924-7963(98)00049-9; PLATT T, 1980, J MAR RES, V38, P687; Priddle J., 1988, P169; Quetin Langdon B., 1996, Antarctic Research Series, V70, P357; Tchernia P., 1984, POLAR REC, V22, P263, DOI [DOI 10.1017/, 10.1017/S0032247400005386, DOI 10.1017/S0032247400005386]; THIELE D, IN PRESS DEEP SEA RE, V47; Tynan CT, 1998, NATURE, V392, P708, DOI 10.1038/33675; VEIT RR, 1993, J ANIM ECOL, V62, P551, DOI 10.2307/5204; Weber L.H., 1985, P284; White WB, 1996, NATURE, V380, P699, DOI 10.1038/380699a0; 1984, MAR ORNITHOL, V20, P51	31	237	252	2	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 3	2000	406	6795					504	507		10.1038/35020053	http://dx.doi.org/10.1038/35020053			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	340ML	10952309				2022-12-28	WOS:000088538000043
J	Holzheid, A; Sylvester, P; O'Neill, HSC; Rubie, DC; Palme, H				Holzheid, A; Sylvester, P; O'Neill, HSC; Rubie, DC; Palme, H			Evidence for a late chondritic veneer in the Earth's mantle from high-pressure partitioning of palladium and platinum	NATURE			English	Article							SILICATE MELTS; SIDEROPHILE ELEMENTS; ACCRETING EARTH; CORE FORMATION; EARLY HISTORY; SOLUBILITY; NICKEL; ORIGIN; MOON; FEO	The high-pressure solubility in silicate liquids of moderately siderophile 'iron-loving' elements (such as nickel and cobalt) has been used to suggest that, in the early Earth, an equilibrium between core-forming metals and the silicate mantle was established at the bottom of a magma ocean(1,2). But observed concentrations of the highly siderophile elements-such as the platinum-group elements platinum, palladium, rhenium, iridium, ruthenium and osmium-in the Earth's upper mantle can be explained by such a model only if their metal-silicate partition coefficients at high pressure are orders of magnitude lower than those determined experimentally at one atmosphere (refs 3-8). Here we present an experimental determination of the solubility of palladium and platinum in silicate melts as a function of pressure to 16 GPa (corresponding to about 500 km depth in the Earth). We find that both the palladium and platinum metal-silicate partition coefficients, derived from solubility, do not decrease with pressure-that is, palladium and platinum retain a strong preference for the metal phase even at high pressures. Consequently the observed abundances of palladium and platinum in the upper mantle seem to be best explained by a 'late veneer' addition of chondritic material to the upper mantle following the cessation of core formation.	Univ Cologne, Inst Mineral & Geochem, D-50674 Cologne, Germany; Mem Univ Newfoundland, Dept Earth Sci, St Johns, NF A1B 3X4, Canada; Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia; Univ Bayreuth, Bayer Geoinst, D-95440 Bayreuth, Germany	University of Cologne; Memorial University Newfoundland; Australian National University; University of Bayreuth	Holzheid, A (corresponding author), Univ Munster, Inst Mineral, Corrensstr 24, D-48149 Munster, Germany.		O'Neill, Hugh S/G-2302-2011; Holzheid, Astrid/S-5513-2018	O'Neill, Hugh S/0000-0001-7018-9783; Holzheid, Astrid/0000-0001-5154-9886				Borisov A, 1997, GEOCHIM COSMOCHIM AC, V61, P4349, DOI 10.1016/S0016-7037(97)00268-8; BORISOV A, 1995, GEOCHIM COSMOCHIM AC, V59, P481, DOI 10.1016/0016-7037(94)00358-S; BORISOV A, 1994, GEOCHIM COSMOCHIM AC, V58, P705, DOI 10.1016/0016-7037(94)90500-2; BORISOV A, 1997, EUR J MINERAL S, V9, P59; Ertel W, 1999, GEOCHIM COSMOCHIM AC, V63, P2439, DOI 10.1016/S0016-7037(99)00136-2; HILLGREN VJ, 1994, SCIENCE, V264, P1442, DOI 10.1126/science.264.5164.1442; Holzheid A, 1997, CHEM GEOL, V139, P21, DOI 10.1016/S0009-2541(97)00030-2; Holzheid A, 1996, GEOCHIM COSMOCHIM AC, V60, P1181, DOI 10.1016/0016-7037(96)00023-3; Hultgren R., 1973, SELECTED VALUES THER; Jagoutz E., 1979, P LUNAR PLANET SCI, V2, P2031; Li J, 1996, NATURE, V381, P686, DOI 10.1038/381686a0; Meisel T, 1996, NATURE, V383, P517, DOI 10.1038/383517a0; MORGAN JW, 1981, TECTONOPHYSICS, V75, P47, DOI 10.1016/0040-1951(81)90209-2; MORGAN JW, 1986, J GEOPHYS RES-SOLID, V91, P2375, DOI 10.1029/JB091iB12p12375; MURTHY VR, 1991, SCIENCE, V253, P1467; O'Neill H.S.C., 1998, EARTHS MANTLE COMPOS, P3; ONEILL HSC, 1995, CHEM GEOL, V120, P255, DOI 10.1016/0009-2541(94)00141-T; Righter K, 1997, EARTH PLANET SC LETT, V146, P541, DOI 10.1016/S0012-821X(96)00243-9; RINGWOOD AE, 1984, P ROY SOC LOND A MAT, V395, P1, DOI 10.1098/rspa.1984.0088; RUBIE DC, 1993, PHYS CHEM MINER, V20, P315; SECKENDORFF V, 1993, CONTRIB MINERAL PETR, V113, P196; Sylvester PJ, 1997, GEOSTANDARD NEWSLETT, V21, P215, DOI 10.1111/j.1751-908X.1997.tb00672.x; Walter M, 1996, NATURE, V381, P646, DOI 10.1038/381646a0; Walter MJ, 1999, NATURE, V398, P563, DOI 10.1038/19200; Wanke H., 1984, ARCHAEAN GEOCHEMISTR, P1, DOI [10.1007/978-3-642-70001-9_1, DOI 10.1007/978-3-642-70001-9_1]	27	111	116	0	37	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 27	2000	406	6794					396	399		10.1038/35019050	http://dx.doi.org/10.1038/35019050			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	337WC	10935633				2022-12-28	WOS:000088383800043
J	Bardin, AJ; Visintin, R; Amon, A				Bardin, AJ; Visintin, R; Amon, A			A mechanism for coupling exit from mitosis to partitioning of the nucleus	CELL			English	Article							SPINDLE POLE BODY; SISTER-CHROMATID SEPARATION; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; CELL-CYCLE; GAMMA-TUBULIN; MITOTIC EXIT; MICROTUBULE ORGANIZATION; ANAPHASE TRANSITION; CHECKPOINT PATHWAY	Exit from mitosis must not occur prior to partitioning of chromosomes between daughter cells. We find that the GTP binding protein Tem1, a regulator of mitotic exit, is present on the spindle pole body that migrates into the bud during S phase and mitosis. Tem1's exchange factor, Lte1, localizes to the bud. Thus, Tem1 and Lte1 are present in the same cellular compartment (the bud) only after the nucleus enters the bud during nuclear division. We also find that the presence of Tem1 and Ltel in the bud is required for mitotic exit. Our results suggest that the spatial segregation of Tem1 and Ltel ensures that exit from mitosis only occurs after the genetic material is partitioned between mother and daughter cell.	MIT, Ctr Canc Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Amon, A (corresponding author), MIT, Ctr Canc Res, E17 40 Ames St, Cambridge, MA 02139 USA.		Bardin, Amy/AFW-5158-2022; Visintin, Rosella/J-9690-2012	Amon, Angelika/0000-0001-9837-0314; Visintin, Rosella/0000-0001-6758-9946; Bardin, Allison J./0000-0002-0200-4465	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM056800, R01GM056800] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 56800] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams IR, 1999, J CELL BIOL, V145, P809, DOI 10.1083/jcb.145.4.809; Alexandru G, 1999, EMBO J, V18, P2707, DOI 10.1093/emboj/18.10.2707; AMON A, 1993, CELL, V74, P993, DOI 10.1016/0092-8674(93)90722-3; Carminati JL, 1997, J CELL BIOL, V138, P629, DOI 10.1083/jcb.138.3.629; Cerutti L, 1999, J CELL SCI, V112, P2313; Ciosk R, 1998, CELL, V93, P1067, DOI 10.1016/S0092-8674(00)81211-8; Cohen-Fix O, 1999, GENE DEV, V13, P1950, DOI 10.1101/gad.13.15.1950; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; Fesquet D, 1999, EMBO J, V18, P2424, DOI 10.1093/emboj/18.9.2424; Fraschini R, 1999, J CELL BIOL, V145, P979, DOI 10.1083/jcb.145.5.979; Geissler S, 1996, EMBO J, V15, P3899, DOI 10.1002/j.1460-2075.1996.tb00764.x; GOVINDAN B, 1995, J CELL BIOL, V128, P1055, DOI 10.1083/jcb.128.6.1055; Guacci V, 1997, CELL, V91, P47, DOI 10.1016/S0092-8674(01)80008-8; HOYT MA, 1991, CELL, V66, P507, DOI 10.1016/0092-8674(81)90014-3; Jansen RP, 1996, CELL, V84, P687, DOI 10.1016/S0092-8674(00)81047-8; Jaspersen SL, 1999, CURR BIOL, V9, P227, DOI 10.1016/S0960-9822(99)80111-0; Jaspersen SL, 1998, MOL BIOL CELL, V9, P2803, DOI 10.1091/mbc.9.10.2803; JOHNSTON GC, 1991, J CELL BIOL, V113, P539, DOI 10.1083/jcb.113.3.539; King RW, 1996, SCIENCE, V274, P1652, DOI 10.1126/science.274.5293.1652; Knop M, 1997, EMBO J, V16, P1550, DOI 10.1093/emboj/16.7.1550; Li R, 1999, P NATL ACAD SCI USA, V96, P4989, DOI 10.1073/pnas.96.9.4989; MCGREW JT, 1992, MOL BIOL CELL, V3, P1443, DOI 10.1091/mbc.3.12.1443; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Morgan DO, 1999, NAT CELL BIOL, V1, pE47, DOI 10.1038/10039; Muhua L, 1998, NATURE, V393, P487, DOI 10.1038/31014; ROUT MP, 1990, J CELL BIOL, V111, P1913, DOI 10.1083/jcb.111.5.1913; SAUNDERS WS, 1995, J CELL BIOL, V128, P617, DOI 10.1083/jcb.128.4.617; Schmidt S, 1997, GENE DEV, V11, P1519, DOI 10.1101/gad.11.12.1519; SCHNEIDER BL, 1995, YEAST, V11, P1265, DOI 10.1002/yea.320111306; Shaw SL, 1997, J CELL BIOL, V139, P985, DOI 10.1083/jcb.139.4.985; SHIRAYAMA M, 1994, MOL CELL BIOL, V14, P7476, DOI 10.1128/MCB.14.11.7476; SHIRAYAMA M, 1994, YEAST, V10, P451, DOI 10.1002/yea.320100404; Shirayama M, 1999, NATURE, V402, P203, DOI 10.1038/46080; Shou WY, 1999, CELL, V97, P233, DOI 10.1016/S0092-8674(00)80733-3; Sobel SG, 1995, J CELL BIOL, V131, P1775, DOI 10.1083/jcb.131.6.1775; Straight AF, 1999, CELL, V97, P245, DOI 10.1016/S0092-8674(00)80734-5; SURANA U, 1993, EMBO J, V12, P1969, DOI 10.1002/j.1460-2075.1993.tb05846.x; Theesfeld CL, 1999, J CELL BIOL, V146, P1019, DOI 10.1083/jcb.146.5.1019; Tinker-Kulberg RL, 1999, GENE DEV, V13, P1936, DOI 10.1101/gad.13.15.1936; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Visintin R, 1999, NATURE, V398, P818, DOI 10.1038/19775; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; YEH E, 1995, J CELL BIOL, V130, P687, DOI 10.1083/jcb.130.3.687	44	267	270	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 7	2000	102	1					21	31		10.1016/S0092-8674(00)00007-6	http://dx.doi.org/10.1016/S0092-8674(00)00007-6			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	332UL	10929710	Bronze			2022-12-28	WOS:000088091700005
J	Spence, J; Gali, RR; Dittmar, G; Sherman, F; Karin, M; Finley, D				Spence, J; Gali, RR; Dittmar, G; Sherman, F; Karin, M; Finley, D			Cell cycle-regulated modification of the ribosome by a variant multiubiquitin chain	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; TRANSLATION INITIATION; POLYUBIQUITIN CHAINS; CONJUGATING ENZYMES; DOWN-REGULATION; MESSENGER-RNA; DNA-REPAIR; PROTEIN; UBIQUITIN; YEAST	Ubiquitin is ligated to L28, a component of the large ribosomal subunit, to form the most abundant ubiquitin-protein conjugate in S. cerevisiae. The human ortholog of L28 is also ubiquitinated, indicating that this modification is highly conserved in evolution. During S phase of the yeast cell cycle, L28 is strongly ubiquitinated, while reduced levels of L28 ubiquitination are observed in G(1) cells. L28 ubiquitination is inhibited by a Lys63 to Arg substitution in ubiquitin, indicating that L28 is modified by a variant, Lys63-linked multiubiquitin chain. The K63R mutant of ubiquitin displays defects in ribosomal function in vivo and in vitro, including a dramatic sensitivity to translational inhibitors. L28, like other ribosomal proteins, is metabolically stable. Therefore, these data suggest a regulatory role for multiubiquitin chains that is reversible and does not function to target the acceptor protein for degradation.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Univ Rochester, Sch Med, Dept Biochem & Biophys, Rochester, NY 14642 USA; Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA	Harvard University; Harvard Medical School; University of Rochester; University of California System; University of California San Diego	Finley, D (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.		Dittmar, Gunnar/C-6333-2019; Dittmar, Gunnar/B-6383-2016	Dittmar, Gunnar/0000-0003-3647-8623; Dittmar, Gunnar/0000-0003-3647-8623	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM043601, R01GM043601] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM12702, GM43601] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARNASON T, 1994, MOL CELL BIOL, V14, P7876, DOI 10.1128/MCB.14.12.7876; Baboshina OV, 1996, J BIOL CHEM, V271, P2823, DOI 10.1074/jbc.271.5.2823; Barbet NC, 1996, MOL BIOL CELL, V7, P25, DOI 10.1091/mbc.7.1.25; BEERS EP, 1993, J BIOL CHEM, V268, P21645; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; CIECHANOVER A, 1984, CELL, V37, P57, DOI 10.1016/0092-8674(84)90300-3; Dubiel W, 1999, CURR BIOL, V9, pR554, DOI 10.1016/S0960-9822(99)80353-4; FINLEY D, 1989, NATURE, V338, P394, DOI 10.1038/338394a0; FINLEY D, 1994, MOL CELL BIOL, V14, P5501, DOI 10.1128/MCB.14.8.5501; Fisk HA, 1999, J CELL BIOL, V145, P1199, DOI 10.1083/jcb.145.6.1199; FRIED HM, 1981, P NATL ACAD SCI-BIOL, V78, P238, DOI 10.1073/pnas.78.1.238; Galan JM, 1997, EMBO J, V16, P5847, DOI 10.1093/emboj/16.19.5847; GORENSTEIN C, 1977, MOL GEN GENET, V157, P327, DOI 10.1007/BF00268670; GORENSTEIN C, 1976, P NATL ACAD SCI USA, V73, P1547, DOI 10.1073/pnas.73.5.1547; HAAS AL, 1985, J BIOL CHEM, V260, P2464; HARLOW E, 1988, ANTIBODIES; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 1997, FASEB J, V11, P1215, DOI 10.1096/fasebj.11.14.9409540; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; HUTTER KJ, 1979, J GEN MICROBIOL, V113, P369, DOI 10.1099/00221287-113-2-369; JIMENEZ A, 1975, BIOCHIM BIOPHYS ACTA, V383, P427, DOI 10.1016/0005-2787(75)90312-3; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; KAUFER NF, 1983, NUCLEIC ACIDS RES, V11, P3123; King RW, 1996, SCIENCE, V274, P1652, DOI 10.1126/science.274.5293.1652; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Koepp DM, 1999, CELL, V97, P431, DOI 10.1016/S0092-8674(00)80753-9; Laney JD, 1999, CELL, V97, P427, DOI 10.1016/S0092-8674(00)80752-7; Mager WH, 1997, NUCLEIC ACIDS RES, V25, P4872, DOI 10.1093/nar/25.24.4872; MAICAS E, 1988, MOL CELL BIOL, V8, P169, DOI 10.1128/MCB.8.1.169; Mastrandrea LD, 1999, J BIOL CHEM, V274, P27299, DOI 10.1074/jbc.274.38.27299; MASUREKAR M, 1981, J MOL BIOL, V147, P381, DOI 10.1016/0022-2836(81)90490-3; Mondesert G, 1996, J CELL BIOL, V132, P137, DOI 10.1083/jcb.132.1.137; NELSON RJ, 1992, CELL, V71, P97, DOI 10.1016/0092-8674(92)90269-I; PETERS JM, 1998, UBIQUITIN BIOL CELL; Pickart CM, 1997, FASEB J, V11, P1055, DOI 10.1096/fasebj.11.13.9367341; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; RODRIGUEZFONSECA C, 1995, J MOL BIOL, V247, P224, DOI 10.1006/jmbi.1994.0135; Sagliocco F A, 1996, Methods Mol Biol, V53, P297; Sancho E, 1998, MOL CELL BIOL, V18, P576, DOI 10.1128/MCB.18.1.576; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; SPENCE J, 1995, MOL CELL BIOL, V15, P1265; Springael JY, 1999, J CELL SCI, V112, P1375; SWEENEY R, 1991, GENETICS, V127, P327; TARUN SZ, 1995, GENE DEV, V9, P2997, DOI 10.1101/gad.9.23.2997; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Wang PJ, 1997, MOL CELL BIOL, V17, P6114, DOI 10.1128/MCB.17.10.6114; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; WARNER JR, 1985, MOL CELL BIOL, V5, P1512, DOI 10.1128/MCB.5.6.1512; WINTERMEYER W, 1990, RIBOSOME, P348; XIANG RH, 1989, J BIOL CHEM, V264, P10542; Xiao W, 1998, NUCLEIC ACIDS RES, V26, P3908, DOI 10.1093/nar/26.17.3908	52	298	316	0	18	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 7	2000	102	1					67	76		10.1016/S0092-8674(00)00011-8	http://dx.doi.org/10.1016/S0092-8674(00)00011-8			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	332UL	10929714	Bronze			2022-12-28	WOS:000088091700009
J	Chen, FE; Ooi, C; Ha, SY; Cheung, BMY; Todd, D; Liang, R; Chan, TK; Chan, V				Chen, FE; Ooi, C; Ha, SY; Cheung, BMY; Todd, D; Liang, R; Chan, TK; Chan, V			Genetic and clinical features of hemoglobin H disease in Chinese patients	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEPATIC IRON OVERLOAD; ALPHA-THALASSEMIA; HYDROPS-FETALIS; MOLECULAR-BASIS; LIVER IRON; HEMOCHROMATOSIS; FORM; QUANTIFICATION; PREVALENCE; EXPRESSION	Background: Normally, one pair of each of the two alpha-globin genes, alpha 1 and alpha 2, resides on each copy of chromosome 16. In hemoglobin H disease, three of these four alpha-globin genes are affected by a deletion, a mutation, or both. We studied the alpha-globin gene abnormalities and the clinical and hematologic features of Chinese patients with hemoglobin H disease in Hong Kong. Methods: We assessed the clinical features, hematologic values, serum ferritin levels, and liver function of 114 patients with hemoglobin H disease. We also performed echocardiography and magnetic resonance imaging of the liver and examined the two pairs of alpha-globin genes. Results: Hemoglobin H disease in 87 of the 114 patients (76 percent) was due to the deletion of three of the four alpha-globin genes (--/-alpha), a combination termed the deletional type of hemoglobin H. The remaining 27 patients (24 percent) had the nondeletional type of hemoglobin H disease, in which two alpha-globin genes are deleted and a third is mutated (--/alpha alpha(T)). All 87 patients with the deletional type of hemoglobin H were double heterozygotes in whom there was a deletion of both alpha-globin genes from one chromosome, plus a deletion of the alpha 1 or alpha 2 gene from the other chromosome (--/alpha- or --/-alpha). A variety of mutated alpha-globin genes was found in the patients with nondeletional type of hemoglobin H disease. Patients with the nondeletional type of the H disease had more symptoms at a younger age, more severe hemolytic anemia, and larger spleens and were more likely to require transfusions than patients with deletional hemoglobin H disease. The severity of iron overload was not related to the genotype. Conclusions: Chinese patients in Hong Kong with the nondeletional type of hemoglobin H disease have more severe disease than those with the deletional type of the disease. Iron overload is a major cause of disability in both forms of the disease. (N Engl J Med 2000;343:544-50.) (C)2000, Massachusetts Medical Society.	Queen Mary Hosp, Univ Dept Med, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, Dept Radiol, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, Dept Paediat, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong	Chan, V (corresponding author), Queen Mary Hosp, Univ Dept Med, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.		Liang, Raymond Hin Suen/C-4346-2009; Chan, Vivian/C-4217-2009; /E-9829-2010	Chen, Frederick E./0000-0002-1455-2231; HA, Shau Yin/0000-0002-9191-8743; /0000-0001-9106-7363				AGER JAM, 1958, BMJ-BRIT MED J, V1, P929, DOI 10.1136/bmj.1.5076.929; Angelucci E, 1997, BLOOD, V90, P4736, DOI 10.1182/blood.V90.12.4736.4736_4736_4742; Bonetti MG, 1996, PEDIATR RADIOL, V26, P650, DOI 10.1007/BF01356827; Chan V, 1999, BRIT J HAEMATOL, V104, P513, DOI 10.1046/j.1365-2141.1999.01221.x; CHAN V, 1988, HEMOGLOBIN, V12, P499, DOI 10.3109/03630268808991638; Chan V, 1997, BRIT J HAEMATOL, V96, P224, DOI 10.1046/j.1365-2141.1997.d01-2017.x; CHAN V, 1985, BLOOD, V66, P224; CHAN V, 1986, BRIT J HAEMATOL, V64, P97, DOI 10.1111/j.1365-2141.1986.tb07577.x; CHEN P, 1998, 2 INT C THAL CHIN TH, P14; CHEZMAR JL, 1990, GASTROINTEST RADIOL, V15, P27, DOI 10.1007/BF01888728; Chim CS, 1998, AM J HEMATOL, V57, P160, DOI 10.1002/(SICI)1096-8652(199802)57:2<160::AID-AJH12>3.0.CO;2-G; CHUAANUSORN W, 1994, HYPERFINE INTERACT, V91, P905, DOI 10.1007/BF02064626; Cullen LM, 1998, AM J HUM GENET, V62, P1403, DOI 10.1086/301878; FUCHAROEN S, 1998, 2 INT C THAL CHIN TH, P3; GALANELLO R, 1983, J MED GENET, V20, P425, DOI 10.1136/jmg.20.6.425; GANDON Y, 1994, RADIOLOGY, V193, P533, DOI 10.1148/radiology.193.2.7972774; GOOSSENS M, 1982, NATURE, V296, P864, DOI 10.1038/296864a0; GUYADER D, 1992, J HEPATOL, V15, P304, DOI 10.1016/0168-8278(92)90060-3; HSU HC, 1990, AM J HEMATOL, V34, P287, DOI 10.1002/ajh.2830340410; Jazwinska EC, 1996, NAT GENET, V14, P249, DOI 10.1038/ng1196-249; KATTAMIS C, 1988, LANCET, V1, P442; Lau YL, 1997, NEW ENGL J MED, V336, P1298, DOI 10.1056/NEJM199705013361805; LIEBHABER SA, 1986, J BIOL CHEM, V261, P5327; LIU TC, 1994, AM J HEMATOL, V45, P293, DOI 10.1002/ajh.2830450405; Mura C, 1999, BLOOD, V93, P2502, DOI 10.1182/blood.V93.8.2502.408k27_2502_2505; Ooi GC, 1999, CLIN RADIOL, V54, P98, DOI 10.1016/S0009-9260(99)91068-1; ORKIN SH, 1981, CELL, V24, P345, DOI 10.1016/0092-8674(81)90324-X; PAGLIETTI E, 1986, BRIT J HAEMATOL, V63, P485, DOI 10.1111/j.1365-2141.1986.tb07525.x; PEERAPITTAYAMON.C, 1996, J SCI SOC THAILAND, V22, P117; PIPPARD MJ, 1979, LANCET, V2, P819; RIGAS DA, 1955, SCIENCE, V121, P372, DOI 10.1126/science.121.3141.372; Schrier SL, 1997, BLOOD, V89, P1762, DOI 10.1182/blood.V89.5.1762.1762_1762_1769; Senior R, 1990, Indian Heart J, V42, P73; SIEGELMAN ES, 1993, RADIOLOGY, V188, P637, DOI 10.1148/radiology.188.3.8351325; St Pierre TG, 1998, BBA-MOL BASIS DIS, V1407, P51, DOI 10.1016/S0925-4439(98)00026-X; Torcharus K, 1995, Southeast Asian J Trop Med Public Health, V26 Suppl 1, P275; TSO SC, 1984, SCAND J HAEMATOL, V32, P391; WEATHERALL D, 1995, MOL MED TODAY, V1, P15, DOI 10.1016/1357-4310(95)80014-X; WICKRAMASINGHE SN, 1980, BRIT J HAEMATOL, V45, P401, DOI 10.1111/j.1365-2141.1980.tb07160.x; Yaprak I, 1998, TURKISH J PEDIATR, V40, P201	40	165	181	1	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 24	2000	343	8					544	550		10.1056/NEJM200008243430804	http://dx.doi.org/10.1056/NEJM200008243430804			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	346QM	10954762	Green Published, Green Submitted			2022-12-28	WOS:000088882600004
J	Satcher, D				Satcher, D			Injury: An overlooked global health concern	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article																			0	4	5	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 23	2000	284	8					950	950		10.1001/jama.284.8.950	http://dx.doi.org/10.1001/jama.284.8.950			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	344PX	10944623				2022-12-28	WOS:000088769000006
J	Davies, R; Bedi, R; Scully, C				Davies, R; Bedi, R; Scully, C			ABC of oral health - Oral health care for patients with special needs	BMJ-BRITISH MEDICAL JOURNAL			English	Review																		Aartman IHA, 1999, BRIT DENT J, V186, P467, DOI 10.1038/sj.bdj.4800142a; *AC DENT PERS DIS, 1998, SPEC CARE DENT, V18, P180; Bedi R, 1995, BRIT DENT J, V179, P421, DOI 10.1038/sj.bdj.4808946; CARTER EF, 1978, AUST DENT J, V23, P308, DOI 10.1111/j.1834-7819.1978.tb03528.x; Hakeberg M, 1999, SCAND CARDIOVASC J, V33, P5; PORTER SR, 1995, ORAL HEALTH CARE THO; SCULLY C, 1996, ORAL DIS; Yilmaz S, 1999, J DENT CHILD, V66, P188	8	16	16	2	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 19	2000	321	7259					495	498		10.1136/bmj.321.7259.495	http://dx.doi.org/10.1136/bmj.321.7259.495			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	347MC	10948035	Green Published			2022-12-28	WOS:000088932800025
J	Zheng, N; Wang, P; Jeffrey, PD; Pavletich, NP				Zheng, N; Wang, P; Jeffrey, PD; Pavletich, NP			Structure of a c-Cbl-UbcH7 complex: RING domain function in ubiquitin-protein ligases	CELL			English	Article							GROWTH-FACTOR RECEPTOR; PROTOONCOGENE C-CBL; TYROSINE KINASE; NEGATIVE REGULATOR; SYSTEM; PHOSPHORYLATION; DEGRADATION; INSIGHTS; PRODUCT; HOMOLOG	Ubiquitin-protein ligases (E3s) regulate diverse cellular processes by mediating protein ubiquitination. The c-Cbl proto-oncogene is a RING family E3 that recognizes activated receptor tyrosine kinases, promotes their ubiquitination by a ubiquitin-conjugating enzyme (E2) and terminates signaling. The crystal structure of c-Cbl bound to a cognate E2 and a kinase peptide shows how the RING domain recruits the E2. A comparison with a HECT family E3-E2 complex indicates that a common E2 motif is recognized by the two E3 families. The structure reveals a rigid coupling between the peptide binding and the E2 binding domains and a conserved surface channel leading from the peptide to the E2 active site, suggesting that RING E3s may function as scaffolds that position the substrate and the E2 optimally for ubiquitin transfer.	Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center	Pavletich, NP (corresponding author), Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, 1275 York Ave, New York, NY 10021 USA.	nikola@xray2.mskcc.org		Jeffrey, Philip/0000-0002-4351-5341				ANDONIOU CE, 1994, EMBO J, V13, P4515, DOI 10.1002/j.1460-2075.1994.tb06773.x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bellon SF, 1997, NAT STRUCT BIOL, V4, P586, DOI 10.1038/nsb0797-586; BLAKE TJ, 1991, ONCOGENE, V6, P653; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; COOK WJ, 1992, J BIOL CHEM, V267, P15116; Duprez E, 1999, J CELL SCI, V112, P381; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hime GR, 1997, ONCOGENE, V14, P2709, DOI 10.1038/sj.onc.1201223; HOCHESTRASSER M, 1988, UBIQUITIN BIOL CELL, P279; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kamura T, 1999, GENE DEV, V13, P2928, DOI 10.1101/gad.13.22.2928; Koepp DM, 1999, CELL, V97, P431, DOI 10.1016/S0092-8674(00)80753-9; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Laney JD, 1999, CELL, V97, P427, DOI 10.1016/S0092-8674(00)80752-7; Lee PSW, 1999, EMBO J, V18, P3616, DOI 10.1093/emboj/18.13.3616; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Lupher ML, 1997, J BIOL CHEM, V272, P33140, DOI 10.1074/jbc.272.52.33140; Meng WY, 1999, NATURE, V398, P84, DOI 10.1038/18050; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Miyake S, 1998, P NATL ACAD SCI USA, V95, P7927, DOI 10.1073/pnas.95.14.7927; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Ohta T, 1999, MOL CELL, V3, P535, DOI 10.1016/S1097-2765(00)80482-7; Ota S, 2000, J BIOL CHEM, V275, P414, DOI 10.1074/jbc.275.1.414; Ota Y, 1997, SCIENCE, V276, P418, DOI 10.1126/science.276.5311.418; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; SCHEFFNER M, 1995, NATURE, V373, P81, DOI 10.1038/373081a0; Schwarz SE, 1998, J BIOL CHEM, V273, P12148, DOI 10.1074/jbc.273.20.12148; Skowyra D, 1999, SCIENCE, V284, P662, DOI 10.1126/science.284.5414.662; Suzuki T, 1999, EMBO J, V18, P6017, DOI 10.1093/emboj/18.21.6017; Xie YM, 1999, EMBO J, V18, P6832, DOI 10.1093/emboj/18.23.6832; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874; Yokouchi M, 1999, J BIOL CHEM, V274, P31707, DOI 10.1074/jbc.274.44.31707; YOON CH, 1995, SCIENCE, V269, P1102, DOI 10.1126/science.7652556; Yu HT, 1998, SCIENCE, V279, P1219, DOI 10.1126/science.279.5354.1219; Zachariae W, 1998, SCIENCE, V279, P1216, DOI 10.1126/science.279.5354.1216	39	696	723	2	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 18	2000	102	4					533	539		10.1016/S0092-8674(00)00057-X	http://dx.doi.org/10.1016/S0092-8674(00)00057-X			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	347BX	10966114	Bronze			2022-12-28	WOS:000088908000014
J	Jones, TD; Farlow, JO; Ruben, JA; Henderson, DM; Hillenius, WJ				Jones, TD; Farlow, JO; Ruben, JA; Henderson, DM; Hillenius, WJ			Cursoriality in bipedal archosaurs	NATURE			English	Article							HIND-LIMB FUNCTION; DINOSAURS; LOCOMOTION; EVOLUTION; CHINA	Modern birds have markedly foreshortened tails and their body mass is centred anteriorly, near the wings(1-5). To provide stability during powered flight, the avian centre of mass is far from the pelvis, which poses potential balance problems for cursorial birds. To compensate, avians adapted to running maintain the femur subhorizontally, with its distal end situated anteriorly, close to the animal's centre of mass; stride generation stems largely from parasagittal rotation of the lower leg about the knee joint(6-12). In contrast, bipedal dinosaurs had a centre of mass near the hip joint and rotated the entire hindlimb during stride generation(4-8,11-13). Here we show that these contrasting styles of cursoriality are tightly linked to longer relative total hindlimb length in cursorial birds than in bipedal dinosaurs. Surprisingly, Caudipteryx, described as a theropod dinosaur(14,15), possessed an anterior centre of mass and hindlimb proportions resembling those of cursorial birds. Accordingly, Caudipteryx probably used a running mechanism more similar to that of modern cursorial birds than to that of all other bipedal dinosaurs. These observations provide valuable clues about cursoriality in Caudipteryx, but may also have implications for interpreting the locomotory status of its ancestors.	Indiana Univ Purdue Univ, Dept Geosci, Ft Wayne, IN 46805 USA; Johns Hopkins Univ, Sch Med, Dept Cell Biol & Anat, Baltimore, MD 21205 USA; Coll Charleston, Dept Biol, Charleston, SC 29424 USA; Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA	Purdue University System; Indiana University Purdue University Fort Wayne; Johns Hopkins University; College of Charleston; Oregon State University	Jones, TD (corresponding author), Stephen F Austin State Univ, Dept Biol, Nacogdoches, TX 75962 USA.							Alexander R.M., 1989, DYNAMICS DINOSAURS O; ALEXANDER RM, 1985, ZOOL J LINN SOC-LOND, V83, P1, DOI 10.1111/j.1096-3642.1985.tb00871.x; Burnham David A., 2000, University of Kansas Paleontological Contributions New Series, V13, P1; Carrano MT, 1998, PALEOBIOLOGY, V24, P450, DOI 10.1017/S0094837300020108; FARLOW JO, IN PRESS AM ZOOL; Feduccia A., 1999, ORIGIN EVOLUTION BIR, V2; Foster John R., 1999, Journal of Vertebrate Paleontology, V19, p45A; GALTON P M, 1970, Journal of Paleontology, V44, P464; Gatesy SM, 1999, J MORPHOL, V240, P127, DOI 10.1002/(SICI)1097-4687(199905)240:2<127::AID-JMOR4>3.0.CO;2-Q; GATESY SM, 1990, PALEOBIOLOGY, V16, P170, DOI 10.1017/S0094837300009866; Gatesy SM, 1999, J MORPHOL, V240, P115, DOI 10.1002/(SICI)1097-4687(199905)240:2<115::AID-JMOR3>3.0.CO;2-Y; GATESY SM, 1991, J MORPHOL, V209, P83, DOI 10.1002/jmor.1052090107; Gatesy SM, 1999, NATURE, V399, P141, DOI 10.1038/20167; GATESY SM, 1991, J ZOOL LOND, V224, P129; Henderson DM, 1999, PALEOBIOLOGY, V25, P88; Ji Q, 1998, NATURE, V393, P753, DOI 10.1038/31635; MANION BL, 1984, THESIS U ILLINOIS CH; NORBERG UM, 1990, VERTEBRATE FLIGHT, P1; PAUL GS, 1985, PREDATORY DINOSAURS; Pennycuick CJ, 1986, ORIGIN BIRDS EVOLUTI, P83; PERRY SF, 1990, J COMP PHYSIOL B, V159, P761, DOI 10.1007/BF00691722; Roberts TJ, 1999, AM ZOOL, V39, p65A; RUSSELL DA, 1993, CAN J EARTH SCI, V30, P2163, DOI 10.1139/e93-187; RUSSELL DA, 1970, NATL MUS NAT HIST PU, V1, P1; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; Zhou Zhong-He, 2000, Vertebrata Palasiatica, V38, P111	26	53	58	0	24	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 17	2000	406	6797					716	718		10.1038/35021041	http://dx.doi.org/10.1038/35021041			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	344PH	10963594	Green Published			2022-12-28	WOS:000088767700041
J	Stjernberg, L				Stjernberg, L			Garlic as an insect repellent	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							BITES		Univ Lund, Malmo, Sweden	Lund University	Stjernberg, L (corresponding author), Univ Lund, Malmo, Sweden.		Stjernberg, Louise/GXG-5465-2022; Sanmartin Berglund, Johan/HGB-0471-2022	Stjernberg, Louise/0000-0002-8673-5109; 				BERGLUND J, 1995, NEW ENGL J MED, V333, P1319, DOI 10.1056/NEJM199511163332004; Brown M, 1997, J AM ACAD DERMATOL, V36, P243, DOI 10.1016/S0190-9622(97)70289-5; Keystone JS, 1996, LANCET, V347, P1423, DOI 10.1016/S0140-6736(96)91678-5; MWASE ET, 1991, CONTROL DIS VECTOR C, P93; SCHMUTZHARD E, 1988, INFECTION, V16, P269, DOI 10.1007/BF01645068	5	22	25	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 16	2000	284	7					831	831		10.1001/jama.284.7.831	http://dx.doi.org/10.1001/jama.284.7.831			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	342PM	10938169				2022-12-28	WOS:000088654400021
J	Godkin, A; Thompson, M; Summerfield, J				Godkin, A; Thompson, M; Summerfield, J			Abdominal pain and melaena: an unusual cause	LANCET			English	Article							HENOCH-SCHONLEIN-PURPURA		St Marys Hosp, Imperial Coll, Sch Med, Dept Med, London W2 1NY, England; St Marys Hosp, Imperial Coll, Sch Med, Dept Histopathol, London W2 1NY, England	Imperial College London; Imperial College London	Godkin, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, St Marys Campus, London W2 1PG, England.							Blanco R, 1997, ARTHRITIS RHEUM, V40, P859, DOI 10.1002/art.1780400513; CAMILLERI M, 1983, Q J MED, V206, P141; CREAM JJ, 1970, Q J MED, V156, P461; Lasseur C, 1996, REV MED INTERNE, V17, P381, DOI 10.1016/0248-8663(96)83738-6	4	3	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 12	2000	356	9229					562	562		10.1016/S0140-6736(00)02582-4	http://dx.doi.org/10.1016/S0140-6736(00)02582-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	345MY	10950234				2022-12-28	WOS:000088820800014
J	Mohler, ER				Mohler, ER			Are atherosclerotic processes involved in aortic-valve calcification?	LANCET			English	Editorial Material							BONE-FORMATION; DISEASE; CELLS		Univ Penn, Sch Med, Dept Med, Div Cardiovasc Dis, Philadelphia, PA 19104 USA	University of Pennsylvania	Mohler, ER (corresponding author), Univ Penn, Sch Med, Dept Med, Div Cardiovasc Dis, Philadelphia, PA 19104 USA.							Callister TQ, 1998, NEW ENGL J MED, V339, P1972, DOI 10.1056/NEJM199812313392703; Chan KA, 2000, LANCET, V355, P2185, DOI 10.1016/S0140-6736(00)02400-4; EDWARDS JE, 1962, CIRCULATION, V26, P17; MAHER ER, 1987, NEPHRON, V47, P119, DOI 10.1159/000184472; Mohler ER, 1998, J AM COLL CARDIOL, V31, p503A, DOI 10.1016/S0735-1097(97)88192-2; Mohler ER, 1999, J HEART VALVE DIS, V8, P254; Mohler ER, 1997, ARTERIOSCL THROM VAS, V17, P547, DOI 10.1161/01.ATV.17.3.547; Monckeberg JG, 1904, VIRCHOWS ARCH A, V176, P472, DOI 10.1007/BF02041318; Mundy G, 1999, SCIENCE, V286, P1946, DOI 10.1126/science.286.5446.1946; Palta S, 2000, CIRCULATION, V101, P2497, DOI 10.1161/01.CIR.101.21.2497; SARIG S, 1994, LAB INVEST, V71, P782; STRICKBERGER SA, 1987, AM J MED, V82, P953, DOI 10.1016/0002-9343(87)90157-4; WATSON KE, 1994, J CLIN INVEST, V93, P2106, DOI 10.1172/JCI117205	13	112	114	1	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 12	2000	356	9229					524	525		10.1016/S0140-6736(00)02572-1	http://dx.doi.org/10.1016/S0140-6736(00)02572-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	345MY	10950224				2022-12-28	WOS:000088820800004
J	Ross, SE; Hemati, N; Longo, KA; Bennett, CN; Lucas, PC; Erickson, RL; MacDougald, OA				Ross, SE; Hemati, N; Longo, KA; Bennett, CN; Lucas, PC; Erickson, RL; MacDougald, OA			Inhibition of adipogenesis by Wnt signaling	SCIENCE			English	Article							BINDING-PROTEIN-ALPHA; BETA-CATENIN; ADIPOCYTE DIFFERENTIATION; GENE-EXPRESSION; TRANSCRIPTIONAL ACTIVATION; 3T3-L1 ADIPOCYTES; PPAR-GAMMA; FAT PADS; FIBROBLASTS; REGULATOR	Wnts are secreted signaling proteins that regulate developmental processes. Here we show that Wnt signaling, Likely mediated by Wnt-10b, is a molecular switch that governs adipogenesis. Wnt signaling maintains preadipocytes in an undifferentiated state through inhibition of the adipogenic transcription factors CCAAT/enhancer binding protein alpha (C/EBP alpha) and peroxisome proliferator-activated receptor gamma (PPAR gamma). When Wnt signaling in preadipocytes is prevented by overexpression of Axin or dominant-negative TCF4, these cells differentiate into adipocytes. Disruption of Wnt signaling also causes transdifferentiation of myoblasts into adipocytes in vitro, highlighting the importance of this pathway not only in adipocyte differentiation but also in mesodermal cell fate determination.	Univ Michigan, Sch Med, Dept Physiol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	MacDougald, OA (corresponding author), Univ Michigan, Sch Med, Dept Physiol, Ann Arbor, MI 48109 USA.		Longo, Kenneth A/A-5631-2010; Erickson, Robin/AAV-3405-2020	Erickson, Robin/0000-0002-3945-6158; Lucas, Peter/0000-0003-4880-7172; MacDougald, Ormond/0000-0001-6907-7960	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572, R01DK051563, T32DK007245] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01-DK51563, T32-DK07245, T32 DK007245, 5P60 DK20572] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bafico A, 1998, ONCOGENE, V16, P2819, DOI 10.1038/sj.onc.1201797; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Cho EA, 1998, MECH DEVELOP, V77, P9; CHRISTIAN JL, 1991, DEV BIOL, V143, P230, DOI 10.1016/0012-1606(91)90073-C; CORNELIUS P, 1994, ANNU REV NUTR, V14, P99, DOI 10.1146/annurev.nu.14.070194.000531; Cossu G, 1999, EMBO J, V18, P6867, DOI 10.1093/emboj/18.24.6867; Darlington GJ, 1998, J BIOL CHEM, V273, P30057, DOI 10.1074/jbc.273.46.30057; GREEN H, 1979, J CELL PHYSIOL, V101, P169, DOI 10.1002/jcp.1041010119; Hemati N, 1997, J BIOL CHEM, V272, P25913, DOI 10.1074/jbc.272.41.25913; Hoppler S, 1996, GENE DEV, V10, P2805, DOI 10.1101/gad.10.21.2805; JULIUS MH, UNPUB; Kikuchi A, 1999, CYTOKINE GROWTH F R, V10, P255, DOI 10.1016/S1359-6101(99)00017-9; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Kolligs FT, 1999, MOL CELL BIOL, V19, P5696; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; LIN FT, 1993, P NATL ACAD SCI USA, V90, P9606, DOI 10.1073/pnas.90.20.9606; Lowell BB, 1999, CELL, V99, P239, DOI 10.1016/S0092-8674(00)81654-2; MACDOUGALD OA, 1995, P NATL ACAD SCI USA, V92, P9034, DOI 10.1073/pnas.92.20.9034; MACDOUGALD OA, 1995, ANNU REV BIOCHEM, V64, P345, DOI 10.1146/annurev.bi.64.070195.002021; Mandrup S, 1997, P NATL ACAD SCI USA, V94, P4300, DOI 10.1073/pnas.94.9.4300; MILLER AD, 1989, BIOTECHNIQUES, V7, P980; Miller JR, 1999, ONCOGENE, V18, P7860, DOI 10.1038/sj.onc.1203245; Ross SE, 1999, MOL CELL BIOL, V19, P8433; Shao DL, 1997, J BIOL CHEM, V272, P21473, DOI 10.1074/jbc.272.34.21473; Spiegelman BM, 1998, DIABETES, V47, P507, DOI 10.2337/diabetes.47.4.507; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Van den Berg DJ, 1998, BLOOD, V92, P3189, DOI 10.1182/blood.V92.9.3189.421k45_3189_3202; WANG ND, 1995, SCIENCE, V269, P1108, DOI 10.1126/science.7652557; Young CS, 1998, MOL CELL BIOL, V18, P2474, DOI 10.1128/MCB.18.5.2474	29	1290	1372	5	112	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 11	2000	289	5481					950	953		10.1126/science.289.5481.950	http://dx.doi.org/10.1126/science.289.5481.950			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	343KH	10937998				2022-12-28	WOS:000088701200032
J	Yeh, AT; Shank, CV; McCusker, JK				Yeh, AT; Shank, CV; McCusker, JK			Ultrafast electron localization dynamics following photo-induced charge transfer	SCIENCE			English	Article							TRANSITION-METAL COMPLEXES; EXCITED-STATE; SOLVATION DYNAMICS; RUTHENIUM(II); SPECTROSCOPY; ANISOTROPY; TRIS(BIPYRIDINE)RUTHENIUM(II); <RU(BPY)(3)>(2+); LUMINESCENT; OSMIUM(II)	Molecular dynamics occurring in the earliest stages following photo-induced charge transfer were investigated. Femtosecond time-resolved absorption anisotropy measurements on [Ru(bpy)(3)](2+), where bpy is 2,2'-bipyridine, reveal a time dependence in nitrile solutions attributed to initial delocalization of the excited state over all three Ligands followed by charge Localization onto a single Ligand. The localization process is proposed to be coupled to nondiffusive solvation dynamics. In contrast, measurements sampling population dynamics show spectral evolution associated with wave packet motion on the excited state surface that is independent of solvent. The results therefore reveal two important contributions to the evolution of charge transfer states in condensed phase, one that is strongly coupled to the surrounding environment and another that follows a potential internal to the molecule.	Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	McCusker, JK (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.							Balzani V, 1996, CHEM REV, V96, P759, DOI 10.1021/cr941154y; BRADLEY PG, 1981, J AM CHEM SOC, V103, P7441, DOI 10.1021/ja00415a007; BRAUN D, 1994, J PHYS CHEM-US, V98, P8044, DOI 10.1021/j100084a021; BRAUN D, 1990, CHEM PHYS LETT, V171, P122, DOI 10.1016/0009-2614(90)80061-H; CARROLL PJ, 1987, J AM CHEM SOC, V109, P7613, DOI 10.1021/ja00259a005; COOLEY LF, 1990, J AM CHEM SOC, V112, P2612, DOI 10.1021/ja00163a022; Damrauer NH, 1997, SCIENCE, V275, P54, DOI 10.1126/science.275.5296.54; DAUL C, 1994, INORG CHEM, V33, P3538, DOI 10.1021/ic00094a017; Deb SK, 1998, CURR OPIN SOLID ST M, V3, P51, DOI 10.1016/S1359-0286(98)80065-X; DEMAS JN, 1971, J AM CHEM SOC, V93, P2841, DOI 10.1021/ja00741a003; DEMAS JN, 1979, INORG CHEM, V18, P3177, DOI 10.1021/ic50201a044; FERGUSON J, 1987, J PHYS CHEM-US, V91, P3161, DOI 10.1021/j100296a012; Fleming GR, 1996, ANNU REV PHYS CHEM, V47, P109, DOI 10.1146/annurev.physchem.47.1.109; FORK RL, 1987, OPT LETT, V12, P483, DOI 10.1364/OL.12.000483; FORSTER M, 1981, CHEM PHYS LETT, V81, P42, DOI 10.1016/0009-2614(81)85323-7; GALLI C, 1993, CHEM PHYS LETT, V206, P493, DOI 10.1016/0009-2614(93)80174-N; GOLD JS, 1985, J AM CHEM SOC, V107, P8285, DOI 10.1021/ja00312a092; GORDON RG, 1966, J CHEM PHYS, V45, P1643, DOI 10.1063/1.1727807; HIRATSUKA H, 1987, CAN J CHEM, V65, P1185, DOI 10.1139/v87-198; Jonas DM, 1996, J PHYS CHEM-US, V100, P12660, DOI 10.1021/jp960708t; Kalyanasundaram K, 1998, COORDIN CHEM REV, V177, P347, DOI 10.1016/S0010-8545(98)00189-1; KOBER EM, 1984, INORG CHEM, V23, P2098, DOI 10.1021/ic00182a023; MALONE RA, 1991, J CHEM PHYS, V95, P8970, DOI 10.1063/1.461228; MARONCELLI M, 1993, J MOL LIQ, V57, P1, DOI 10.1016/0167-7322(93)80045-W; OH DH, 1991, J AM CHEM SOC, V113, P6880, DOI 10.1021/ja00018a026; Passino SA, 1997, J CHEM PHYS, V107, P6094, DOI 10.1063/1.474277; Raineri FO, 1999, ADV CHEM PHYS, V107, P81, DOI 10.1002/9780470141663.ch2; Riesen H, 1996, INORG CHEM, V35, P6908, DOI 10.1021/ic960590v; SCHOENLEIN RW, 1991, APPL PHYS LETT, V58, P801, DOI 10.1063/1.104494; Stratt RM, 1996, J PHYS CHEM-US, V100, P12981, DOI 10.1021/jp9608483; Sutin N, 1978, ADV CHEM SER, V168, P1; Voth GA, 1996, J PHYS CHEM-US, V100, P13034, DOI 10.1021/jp960317e; WELDON BT, UNPUB; WYNNE K, 1993, CHEM PHYS, V171, P179, DOI 10.1016/0301-0104(93)85142-U; YABE T, 1990, J PHYS CHEM-US, V94, P7128, DOI 10.1021/j100381a034; Yersin H, 1997, COORDIN CHEM REV, V159, P325, DOI 10.1016/S0010-8545(96)01318-5; [No title captured]	38	352	352	5	214	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 11	2000	289	5481					935	938		10.1126/science.289.5481.935	http://dx.doi.org/10.1126/science.289.5481.935			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	343KH	10937993	Green Submitted			2022-12-28	WOS:000088701200027
J	Burch, CL; Chao, L				Burch, CL; Chao, L			Evolvability of an RNA virus is determined by its mutational neighbourhood	NATURE			English	Article							EVOLUTION; FITNESS; PHI-6		Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Burch, CL (corresponding author), Univ Calif San Diego, Dept Biol, 9500 Gilman Dr, La Jolla, CA 92093 USA.							Burch CL, 1999, GENETICS, V151, P921; Chao L, 1997, GENE, V205, P301, DOI 10.1016/S0378-1119(97)00405-8; CHAO L, 1992, EVOLUTION, V46, P289, DOI 10.1111/j.1558-5646.1992.tb02038.x; CHAO L, 1990, NATURE, V348, P454, DOI 10.1038/348454a0; Domingo Esteban, 1994, P161; EIGEN M, 1987, COLD SPRING HARB SYM, V52, P307, DOI 10.1101/SQB.1987.052.01.036; EIGEN M, 1996, TRENDS MICROBIOL, V4, P212; Fenster CB, 1997, TRENDS ECOL EVOL, V12, P282, DOI 10.1016/S0169-5347(97)81027-0; Fraile A, 1997, J VIROL, V71, P8316, DOI 10.1128/JVI.71.11.8316-8320.1997; HOLLAND J, 1982, SCIENCE, V215, P1577, DOI 10.1126/science.7041255; Kauffman S. A., 1993, ORIGINS ORDER; MINDICH L, 1976, VIROLOGY, V75, P218, DOI 10.1016/0042-6822(76)90020-9; Nijhuis M, 1999, AIDS, V13, P2349, DOI 10.1097/00002030-199912030-00006; Radman M, 1999, ANN NY ACAD SCI, V870, P146, DOI 10.1111/j.1749-6632.1999.tb08874.x; SCHUSTER P, 1988, B MATH BIOL, V56, P636; Sokal RR, 1995, BIOMETRY; VIDAVER AK, 1973, J VIROL, V11, P799, DOI 10.1128/JVI.11.5.799-805.1973; Wagner GP, 1999, J EXP ZOOL, V285, P116, DOI 10.1002/(SICI)1097-010X(19990815)285:2<116::AID-JEZ3>3.0.CO;2-P; [No title captured]	19	214	215	2	35	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 10	2000	406	6796					625	628		10.1038/35020564	http://dx.doi.org/10.1038/35020564			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	342PF	10949302				2022-12-28	WOS:000088653800047
J	Zharkov, D				Zharkov, D			Wise fool left Hussars for career in science admin	NATURE			English	Letter									SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Zharkov, D (corresponding author), SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA.		Zharkov, Dmitry/K-2158-2012	Zharkov, Dmitry/0000-0001-5013-0194				PRUTKOV K, 2000, NATURE, V405, P743	1	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 10	2000	406	6796					560	560		10.1038/35020749	http://dx.doi.org/10.1038/35020749			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	342PF	10949275	Bronze			2022-12-28	WOS:000088653800015
J	Eisenberg, L				Eisenberg, L			Seymour S. Kety (1915-2000) - Obituary	NATURE			English	Biographical-Item									Harvard Univ, Sch Med, Dept Social Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Eisenberg, L (corresponding author), Harvard Univ, Sch Med, Dept Social Med, 641 Huntington Ave,2nd Floor, Boston, MA 02115 USA.							KETY SS, PUBLICATION LIST	1	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 3	2000	406	6795					472	472						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	340ML	10952297				2022-12-28	WOS:000088538000031
J	Doron-Mor, H; Hatzor, A; Vaskevich, A; van der Boom-Moav, T; Shanzer, A; Rubinstein, I; Cohen, H				Doron-Mor, H; Hatzor, A; Vaskevich, A; van der Boom-Moav, T; Shanzer, A; Rubinstein, I; Cohen, H			Controlled surface charging as a depth-profiling probe for mesoscopic layers	NATURE			English	Article							GOLD SURFACES; THIN-FILMS; XPS; SPECTROSCOPY	Probing the structure of material layers just a few nanometres thick requires analytical techniques with high depth sensitivity. X-ray photoelectron spectroscopy(1) (XPS) provides one such method, but obtaining vertically resolved structural information from the raw data is not straightforward. There are several XPS depth-profiling methods, including ion etching(2), angle-resolved XPS (ref. 2) and Tougaard's approach(3), but all suffer various limitations(2-5). Here we report a simple, non-destructive XPS depth-profiling method that yields accurate depth information with nanometre resolution. We demonstrate the technique using self-assembled multilayers on gold surfaces; the former contain 'marker' monolayers that have been inserted at predetermined depths. A controllable potential gradient is established vertically through the sample by charging the surface of the dielectric overlayer with an electron flood gun. The local potential is probed by measuring XPS line shifts, which correlate directly with the vertical position of atoms. We term the method 'controlled surface charging', and expect it to be generally applicable to a large variety of mesoscopic heterostructures.	Weizmann Inst Sci, Dept Mat & Interfaces, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Dept Organ Chem, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Dept Chem Serv, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science	Rubinstein, I (corresponding author), Weizmann Inst Sci, Dept Mat & Interfaces, IL-76100 Rehovot, Israel.		Vaskevich, Alexander/G-9019-2011	Vaskevich, Alexander/0000-0002-9147-4150; Cohen, Hagai/0000-0001-8488-0727				BARR TL, 1989, J VAC SCI TECHNOL A, V7, P1677, DOI 10.1116/1.576069; BARR TL, 1990, PRACTICAL SURFACE AN, V1, P370; Beamson G, 1996, SURF INTERFACE ANAL, V24, P204, DOI 10.1002/(SICI)1096-9918(199603)24:3<204::AID-SIA90>3.0.CO;2-C; BRIGGS D, 1990, PRACTICAL SURFACE AN, V1; Frydman E, 1997, LANGMUIR, V13, P5089, DOI 10.1021/la962058q; Hatzor A, 2000, LANGMUIR, V16, P4420, DOI 10.1021/la0001979; Hatzor A, 1998, J AM CHEM SOC, V120, P13469, DOI 10.1021/ja9828307; HOFMANN S, 1990, DEPTH PROFILING AES, P00143; LEWIS RT, 1980, J ELECTRON SPECTROSC, V20, P105, DOI 10.1016/0368-2048(80)85010-9; MILLER JD, 1993, SURF INTERFACE ANAL, V20, P977, DOI 10.1002/sia.740201208; Moav T, 1998, CHEM-EUR J, V4, P502, DOI 10.1002/(SICI)1521-3765(19980310)4:3<502::AID-CHEM502>3.3.CO;2-2; SEAH MP, 1990, PRACTICAL SURFACE AN, V1, P541; Shabtai K, 2000, J AM CHEM SOC, V122, P4959, DOI 10.1021/ja993710h; Tielsch BJ, 1996, SURF INTERFACE ANAL, V24, P459, DOI 10.1002/(SICI)1096-9918(199607)24:7<459::AID-SIA139>3.0.CO;2-5; TOUGAARD S, 1988, SURF INTERFACE ANAL, V11, P453, DOI 10.1002/sia.740110902; TYLER BJ, 1989, SURF INTERFACE ANAL, V14, P443, DOI 10.1002/sia.740140804; Umemura Y, 1997, B CHEM SOC JPN, V70, P2399, DOI 10.1246/bcsj.70.2399; YANG HC, 1993, J AM CHEM SOC, V115, P11855, DOI 10.1021/ja00078a025	18	140	140	12	90	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 27	2000	406	6794					382	385		10.1038/35019025	http://dx.doi.org/10.1038/35019025			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	337WC	10935629				2022-12-28	WOS:000088383800039
J	Insley, SJ				Insley, SJ			Long-term vocal recognition in the northern fur seal	NATURE			English	Article							FIDELITY	The ability to recognize and remember individual identities for long periods of time has important implications for the evolution of animal social behaviour, particularly complex interactions such as cooperation or mate choice(1-7). Despite this importance, there is only a single example of long-term individual recognition in nature, the 8-month retention of neighbour's song among male hooded warblers, Wilsonia citrina(7), and there is none for a nonhuman mammal. Associations between individuals spanning years, which are especially prevalent in carnivores(8), primates(9) and seabirds(10,) and evidence of mate rdelity(11,12) provide indirect support for the ability of long-term recognition. In many of these instances, however, individuals do not separate for extended periods, and thus long-term recognition, although often assumed, may be both unnecessary and nonexistent. Furthermore, site fidelity rather than individual recognition may explain many instances of mate fidelity(10). Here I show that mother-offspring pairs of a migratory otariid pinniped-the northern fur seal (Callorhinus ursinus)-not only have the ability to recognize each other's vocalizations during the course of a breeding season, but are also able to retain these memories for at least 4 years.	Univ Calif Davis, Anim Behav Grp, Davis, CA 95616 USA; Smithsonian Inst, Natl Zool Pk, Dept Zool Res, Washington, DC 20008 USA	University of California System; University of California Davis; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute	Insley, SJ (corresponding author), Univ Calif Davis, Anim Behav Grp, Davis, CA 95616 USA.							AMOS B, 1995, SCIENCE, V268, P1897, DOI 10.1126/science.268.5219.1897; BAKER JD, 1995, ANIM BEHAV, V50, P237, DOI 10.1006/anbe.1995.0236; Beecher M.D., 1991, P94; BLACK J, 1996, PARTNERSHIP BIRDS ST; Colgan PW, 1983, COMP SOCIAL RECOGNIT; Falls JB., 1982, ACOUSTIC COMMUNICATI, P237; Gentry R.L., 1998, BEHAV ECOLOGY NO SEA; GODARD R, 1991, NATURE, V350, P228, DOI 10.1038/350228a0; INSLEY SJ, 1992, BEHAVIOUR, V120, P103, DOI 10.1163/156853992X00237; INSLEY SJ, IN PRESS ANIMAL BEHA; LEGER DW, 1994, ANIM BEHAV, V48, P823, DOI 10.1006/anbe.1994.1306; Mateo JM, 2000, ANIM BEHAV, V59, P491, DOI 10.1006/anbe.1999.1363; REGAN T, 1995, J MAMMAL, V76, P1137; Sherman Paul W., 1997, P69; Smuts B. B., 1987, PRIMATE SOC; Stoddard Philip Kraft, 1996, P356; Uy JAC, 2000, P ROY SOC B-BIOL SCI, V267, P251, DOI 10.1098/rspb.2000.0994; [No title captured]	18	116	120	0	36	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 27	2000	406	6794					404	405		10.1038/35019064	http://dx.doi.org/10.1038/35019064			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	337WC	10935635				2022-12-28	WOS:000088383800045
J	Marszalek, JR; Liu, XR; Roberts, EA; Chui, D; Marth, JD; Williams, DS; Goldstein, LSB				Marszalek, JR; Liu, XR; Roberts, EA; Chui, D; Marth, JD; Williams, DS; Goldstein, LSB			Genetic evidence for selective transport of opsin and arrestin by kinesin-II in mammalian photoreceptors	CELL			English	Article							DOMINANT RETINITIS-PIGMENTOSA; LEFT-RIGHT ASYMMETRY; DYNEIN LIGHT-CHAIN; RETINAL DEGENERATION; TRANSGENIC MICE; RHODOPSIN GENE; OUTER SEGMENT; MUTANT MICE; OLIGOSACCHARIDE BIOSYNTHESIS; CAENORHABDITIS-ELEGANS	To test whether kinesin-II is important for transport in the mammalian photoreceptor cilium, and to identify its potential cargoes, we used Cre-loxP mutagenesis to remove the kinesin-II subunit, KIF3A, specifically from photoreceptors. Complete loss of KIF3A caused large accumulations of opsin, arrestin, and membranes within the photoreceptor inner segment, while the localization of cu-transducin was unaffected. Other membrane, organelle, and transport markers, as well as opsin processing appeared normal. Loss of KIF3A ultimately caused apoptotic photoreceptor cell death similar to a known opsin transport mutant. The data suggest that kinesin-II is required to transport opsin and arrestin from the inner to the outer segment and that blocks in this transport pathway lead to photoreceptor cell death as found in retinitis pigmentosa.	Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego	Goldstein, LSB (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.				NEI NIH HHS [R01 EY007042, EY07042] Funding Source: Medline; NICHD NIH HHS [N01-HD-6-2915] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [N01HD062915] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY007042] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Beech PL, 1996, J CELL SCI, V109, P889; BESHARSE JC, 1995, J NEUROCYTOL, V24, P371, DOI 10.1007/BF01189064; BLOODGOOD RA, 1992, BIOL CELL, V76, P291, DOI 10.1016/0248-4900(92)90431-Y; BOBOLA N, 1995, J BIOL CHEM, V270, P1289, DOI 10.1074/jbc.270.3.1289; CANTERA R, 1990, EXP BIOL, V48, P305; CHANG GQ, 1993, NEURON, V11, P595, DOI 10.1016/0896-6273(93)90072-Y; Chui D, 1997, CELL, V90, P157, DOI 10.1016/S0092-8674(00)80322-0; Cole DG, 1998, J CELL BIOL, V141, P993, DOI 10.1083/jcb.141.4.993; COLE DG, 1993, NATURE, V366, P268, DOI 10.1038/366268a0; COLLEY NJ, 1995, P NATL ACAD SCI USA, V92, P3070, DOI 10.1073/pnas.92.7.3070; DERETIC D, 1991, J CELL BIOL, V113, P1281, DOI 10.1083/jcb.113.6.1281; Deretic D, 1996, J BIOL CHEM, V271, P2279, DOI 10.1074/jbc.271.4.2279; Fariss RN, 1997, J COMP NEUROL, V387, P148, DOI 10.1002/(SICI)1096-9861(19971013)387:1<148::AID-CNE12>3.0.CO;2-Q; HUANG PC, 1993, P NATL ACAD SCI USA, V90, P8484, DOI 10.1073/pnas.90.18.8484; Humphries MM, 1997, NAT GENET, V15, P216, DOI 10.1038/ng0297-216; ISHIGURO S, 1987, CELL STRUCT FUNCT, V12, P141, DOI 10.1247/csf.12.141; Jeon CJ, 1998, J NEUROSCI, V18, P8936; KOZMINSKI KG, 1995, J CELL BIOL, V131, P1517, DOI 10.1083/jcb.131.6.1517; KOZMINSKI KG, 1993, P NATL ACAD SCI USA, V90, P5519, DOI 10.1073/pnas.90.12.5519; Le Bot N, 1998, J CELL BIOL, V143, P1559, DOI 10.1083/jcb.143.6.1559; Lem J, 1999, P NATL ACAD SCI USA, V96, P736, DOI 10.1073/pnas.96.2.736; LI TS, 1995, P NATL ACAD SCI USA, V92, P3551, DOI 10.1073/pnas.92.8.3551; Li TS, 1996, P NATL ACAD SCI USA, V93, P14176, DOI 10.1073/pnas.93.24.14176; LINSTEDT AD, 1993, MOL BIOL CELL, V4, P679, DOI 10.1091/mbc.4.7.679; Liu XR, 1999, J NEUROSCI, V19, P6267; Liu XR, 1997, CELL MOTIL CYTOSKEL, V37, P240, DOI 10.1002/(SICI)1097-0169(1997)37:3<240::AID-CM6>3.3.CO;2-2; Marszalek JR, 1999, P NATL ACAD SCI USA, V96, P5043, DOI 10.1073/pnas.96.9.5043; Marszalek JR, 2000, BBA-MOL CELL RES, V1496, P142, DOI 10.1016/S0167-4889(00)00015-X; Marth JD, 1996, GLYCOBIOLOGY, V6, P701, DOI 10.1093/glycob/6.7.701; Muresan V, 1997, EXP EYE RES, V64, P895, DOI 10.1006/exer.1996.0261; NIR I, 1989, EXP EYE RES, V49, P403, DOI 10.1016/0014-4835(89)90050-X; NIR I, 1990, EXP EYE RES, V51, P257, DOI 10.1016/0014-4835(90)90022-M; Nir I, 1989, Prog Clin Biol Res, V314, P251; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; OLSSON JE, 1992, NEURON, V9, P815, DOI 10.1016/0896-6273(92)90236-7; PAPERMASTER DS, 1985, INVEST OPHTH VIS SCI, V26, P1386; Pazour GJ, 1999, J CELL BIOL, V144, P473, DOI 10.1083/jcb.144.3.473; Pazour GJ, 1998, J CELL BIOL, V141, P979, DOI 10.1083/jcb.141.4.979; Piperno G, 1998, J CELL BIOL, V143, P1591, DOI 10.1083/jcb.143.6.1591; Piperno G, 1997, P NATL ACAD SCI USA, V94, P4457, DOI 10.1073/pnas.94.9.4457; Ray K, 1999, J CELL BIOL, V147, P507, DOI 10.1083/jcb.147.3.507; RIM J, 1995, BIOCHEMISTRY-US, V34, P11938, DOI 10.1021/bi00037a035; ROOF DJ, 1994, INVEST OPHTH VIS SCI, V35, P4049; Rosenbaum JL, 1999, J CELL BIOL, V144, P385, DOI 10.1083/jcb.144.3.385; Signor D, 1999, J CELL BIOL, V147, P519, DOI 10.1083/jcb.147.3.519; SUNG CH, 1994, J NEUROSCI, V14, P5818; Tai AW, 1999, CELL, V97, P877, DOI 10.1016/S0092-8674(00)80800-4; Takeda S, 2000, J CELL BIOL, V148, P1255, DOI 10.1083/jcb.148.6.1255; Takeda S, 1999, J CELL BIOL, V145, P825, DOI 10.1083/jcb.145.4.825; TROUTT LL, 1988, J NEUROSCI, V8, P2371; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; Whitehead JL, 1999, EXP EYE RES, V69, P491, DOI 10.1006/exer.1999.0724	52	323	332	0	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 21	2000	102	2					175	187		10.1016/S0092-8674(00)00023-4	http://dx.doi.org/10.1016/S0092-8674(00)00023-4			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	337NA	10943838	Bronze			2022-12-28	WOS:000088366800008
J	Cellier, C; Delabesse, E; Helmer, C; Patey, N; Matuchansky, C; Jabri, B; Macintyre, E; Cerf-Bensussan, N; Brousse, N				Cellier, C; Delabesse, E; Helmer, C; Patey, N; Matuchansky, C; Jabri, B; Macintyre, E; Cerf-Bensussan, N; Brousse, N		French Coeliac Dis Study Grp	Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma	LANCET			English	Article							CELIAC SPRUE; INTRAEPITHELIAL LYMPHOCYTES; ULCERATIVE JEJUNITIS; MALABSORPTION; CAVITATION; CLONALITY	Background Adult refractory sprue is a poorly defined disorder. We did a multicentre national study of patients with refractory sprue to characterise their clinical and pathological profile and outcome, and to assess the frequency and prognostic significance of phenotypic and molecular abnormalities in the intraepithelial T-cell population. Methods Patients with severe symptomatic villous atrophy mimicking coeliac disease but refractory to a strict gluten-free diet, and with no initial evidence of overt lymphoma, were diagnosed at gastrointestinal referral centres between 1974 and 1998. Fixed and/or frozen duodenojejunal biopsy samples were reanalysed and immunostained with CD3 and CD8 monoclonal antibodies to find out the phenotype of intraepithelial lymphocytes (IEL). TCR gamma gene rearrangements were assessed on frozen biopsy samples by multiplex fluorescent PCR. Findings There were 21 patients with refractory sprue and 20 controls with coeliacs disease. 16 (84%) of 19 assessed patients had an aberrant intraepithelial lymphoid intestinal population expressing intracytoplasmic CD3 but not surface CD8. Clonal intestinal TCR gamma gene rearrangements were found in 13 (76%) of 17 patients assessed; four (out of 12 assessed) had clonal dissemination to the blood. The 16 patients with an aberrant phenotype all had uncontrolled malabsorption; three subsequently developed overt T-cell lymphoma, and eight died. The three (16%) patients without aberrant clonal IEL made a complete clinical and histological recovery with steroid therapy plus a gluten-free diet. Interpretation An immunophenotypically aberrant clonal intraepithelial T-cell population (similar to that of most cases of enteropathy-associated T-cell lymphoma) can be found in up to 75% of patients with refractory coeliac sprue; its identification by simple diagnostic techniques represents a marker of poor outcome (including occurrence of overt T-cell lymphoma). We suggest that refractory sprue associated with an aberrant clonal IEL may be the missing link between coeliac disease and T-cell lymphoma and may be classified as cryptic enteropathy-associated T-cell lymphoma.	Hop Laennec, Dept Gastroenterol, F-75340 Paris, France; Hop Lariboisiere, Dept Gastroenterol, F-75475 Paris, France; Univ Paris 05, Fac Necker, Dept Pathol, Paris, France; Univ Paris 05, Fac Necker, Dept Biol Hematol, Paris, France; Univ Paris 05, Fac Necker, INSERM, E9925, Paris, France; Univ Paris 05, Fac Necker, CNRS, UMR 8603, Paris, France; Hop Paris, Assistance Publ, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP)	Cellier, C (corresponding author), Hop Europeen Georges Pompidou, Hop Laennec, Serv Gastroenterol, 42 Rue Sevres, F-75007 Paris, France.	christophe.cellier@egp.ap-hop-paris.fr	Cerf-Bensussan, nadine/H-9505-2017; DELABESSE, Eric/I-5221-2016	Cerf-Bensussan, nadine/0000-0003-0665-1245; DELABESSE, Eric/0000-0002-0928-0753; Macintyre-Davi, Elizabeth Anne/0000-0003-0520-0493				Alexander JO., 1975, MAJOR PROBLEMS DERMA, P236; AshtonKey M, 1997, AM J PATHOL, V151, P493; BAER AN, 1980, GASTROENTEROLOGY, V79, P754; Bagdi E, 1999, BLOOD, V94, P260, DOI 10.1182/blood.V94.1.260.413k40_260_264; BROUSSE N, 1989, LANCET, V2, P1107; Carbonnel F, 1998, BLOOD, V92, P3879, DOI 10.1182/blood.V92.10.3879.422k34_3879_3886; Cellier C, 1998, GASTROENTEROLOGY, V114, P471, DOI 10.1016/S0016-5085(98)70530-X; Cellier C, 1999, GASTROINTEST ENDOSC, V50, P613, DOI 10.1016/S0016-5107(99)80007-8; CERFBENSUSSAN N, 1993, CURR OPIN GASTROEN, V9, P953, DOI 10.1097/00001574-199309060-00011; CERFBENSUSSAN N, 1983, J IMMUNOL, V130, P2615; Delabesse E, 2000, LEUKEMIA, V14, P1143, DOI 10.1038/sj.leu.2401750; FREEMAN HJ, 1986, GASTROENTEROLOGY, V90, P2008, DOI 10.1016/0016-5085(86)90275-1; HOURIHANE DO, 1970, GASTROENTEROLOGY, V59, P130; MATUCHANSKY C, 1984, GASTROENTEROLOGY, V87, P606; MURRAY A, 1995, AM J PATHOL, V146, P509; OMahony S, 1996, ALIMENT PHARM THERAP, V10, P671, DOI 10.1046/j.1365-2036.1996.66237000.x; TRIER JS, 1978, GASTROENTEROLOGY, V75, P307; Trier JS, 1998, GASTROENTEROLOGY, V115, P211, DOI 10.1016/S0016-5085(98)70383-X; TRIER JS, 1991, NEW ENGL J MED, V325, P1709, DOI 10.1056/NEJM199112123252406; WEINSTEI.WM, 1970, NEW ENGL J MED, V283, P1297, DOI 10.1056/NEJM197012102832401; WEINSTEIN WM, 1994, DIFFICULT DECISIONS, P257; WRIGHT DH, 1991, LANCET, V337, P1373, DOI 10.1016/0140-6736(91)93059-I; WRIGHT DH, 1995, BAILLIERE CLIN GASTR, V9, P351, DOI 10.1016/0950-3528(95)90035-7	23	500	515	0	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 15	2000	356	9225					203	208		10.1016/S0140-6736(00)02481-8	http://dx.doi.org/10.1016/S0140-6736(00)02481-8			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	334GQ	10963198				2022-12-28	WOS:000088179100011
J	Fawcett, AJ				Fawcett, AJ			Mono-ocular occlusion for treatment of dylexia	LANCET			English	Editorial Material							MONOCULAR OCCLUSION		Univ Sheffield, Dept Psychol, Sheffield S10 2TP, S Yorkshire, England	University of Sheffield	Fawcett, AJ (corresponding author), Univ Sheffield, Dept Psychol, Sheffield S10 2TP, S Yorkshire, England.		Fawcett, Angela/AAA-6600-2021					Adams, 1990, BEGINNING READ THINK; BISHOP DVM, 1989, BRIT J OPHTHALMOL, V73, P209, DOI 10.1136/bjo.73.3.209; Cornelissen PL, 1998, VISION RES, V38, P471, DOI 10.1016/S0042-6989(97)00199-5; Nicolson RI, 1999, BRIT J EDUC PSYCHOL, V69, P47, DOI 10.1348/000709999157563; Nicolson RI, 1999, LANCET, V353, P1662, DOI 10.1016/S0140-6736(98)09165-X; STEIN J, 1985, LANCET, V2, P69; Stein JF, 2000, BRAIN, V123, P164, DOI 10.1093/brain/123.1.164; Wilkins A, 1996, PERCEPTION, V25, P1372	8	2	2	1	8	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 8	2000	356	9224					89	90		10.1016/S0140-6736(00)02464-8	http://dx.doi.org/10.1016/S0140-6736(00)02464-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	331UG	10963240				2022-12-28	WOS:000088036600004
J	Verhagen, AM; Ekert, PG; Pakusch, M; Silke, J; Connolly, LM; Reid, GE; Moritz, RL; Simpson, RJ; Vaux, DL				Verhagen, AM; Ekert, PG; Pakusch, M; Silke, J; Connolly, LM; Reid, GE; Moritz, RL; Simpson, RJ; Vaux, DL			Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins	CELL			English	Article							PROGRAMMED CELL-DEATH; BCL-X-L; DROSOPHILA CASPASE; INHIBIT APOPTOSIS; SIGNALING COMPLEX; BACULOVIRUS IAP; CYTOCHROME-C; GENE; APAF-1; ACTIVATION	To identify proteins that bind mammalian IAP homolog A (MIHA, also known as XIAP), we used coimmunoprecipitation and 2D immobilized pH gradient/SDS PAGE, followed by electrospray ionization tandem mass spectrometry. DIABLO (direct IAP binding protein with low pi) is a novel protein that can bind MIHA and can also interact with MIHB and MIHC and the baculoviral IAP, OpIAP. The N-terminally processed, IAP-interacting form of DIABLO is concentrated in membrane fractions in healthy cells but released into the MIHA-containing cytosolic fractions upon UV irradiation. As transfection of cells with DIABLO was able to counter the protection afforded by MIHA against UV irradiation, DIABLO may promote apoptosis by binding to IAPs and preventing them from inhibiting caspases.	Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; Ludwig Inst Canc Res, Joint Prot Struct Lab, Melbourne, Vic, Australia; Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia	Walter & Eliza Hall Institute; Ludwig Institute for Cancer Research; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne	Vaux, DL (corresponding author), Walter & Eliza Hall Inst Med Res, PO Royal Melbourne Hosp, Melbourne, Vic 3050, Australia.		Silke, John/B-7622-2008; Vaux, David L/C-7249-2013; Ekert, Paul G/C-7247-2013; Ekert, Paul/Q-1842-2015; Moritz, Robert L/B-9222-2011	Silke, John/0000-0002-7611-5774; Vaux, David L/0000-0003-2703-1651; Ekert, Paul G/0000-0002-2976-8617; Ekert, Paul/0000-0002-2976-8617; Reid, Gavin/0000-0002-9675-1444; Simpson, Richard/0000-0002-9834-0796				Alnemri ES, 1996, CELL, V87, P171, DOI 10.1016/S0092-8674(00)81334-3; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Chen P, 1996, GENE DEV, V10, P1773, DOI 10.1101/gad.10.14.1773; CROOK NE, 1993, J VIROL, V67, P2168, DOI 10.1128/JVI.67.4.2168-2174.1993; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Deveraux QL, 1998, EMBO J, V17, P2215, DOI 10.1093/emboj/17.8.2215; Dorstyn L, 1999, P NATL ACAD SCI USA, V96, P4307, DOI 10.1073/pnas.96.8.4307; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Duckett CS, 1996, EMBO J, V15, P2685, DOI 10.1002/j.1460-2075.1996.tb00629.x; Ekert PG, 1999, EMBO J, V18, P330, DOI 10.1093/emboj/18.2.330; GRETHER ME, 1995, GENE DEV, V9, P1694, DOI 10.1101/gad.9.14.1694; Hawkins CJ, 1999, P NATL ACAD SCI USA, V96, P2885, DOI 10.1073/pnas.96.6.2885; Hawkins CJ, 1996, P NATL ACAD SCI USA, V93, P13786, DOI 10.1073/pnas.93.24.13786; Hay BA, 1995, CELL, V83, P1253, DOI 10.1016/0092-8674(95)90150-7; Hu YM, 1998, P NATL ACAD SCI USA, V95, P4386, DOI 10.1073/pnas.95.8.4386; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Ji H, 1997, ELECTROPHORESIS, V18, P605, DOI 10.1002/elps.1150180344; Kaiser WJ, 1998, FEBS LETT, V440, P243, DOI 10.1016/S0014-5793(98)01465-3; Liston P, 1996, NATURE, V379, P349, DOI 10.1038/379349a0; Moriishi K, 1999, P NATL ACAD SCI USA, V96, P9683, DOI 10.1073/pnas.96.17.9683; MORITZ RL, 1992, J CHROMATOGR, V599, P119; Moritz RL, 1996, ELECTROPHORESIS, V17, P907, DOI 10.1002/elps.1150170512; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Pan GH, 1998, J BIOL CHEM, V273, P5841, DOI 10.1074/jbc.273.10.5841; Reid GE, 1998, ELECTROPHORESIS, V19, P946, DOI 10.1002/elps.1150190610; ROEPSTORFF P, 1984, BIOMED MASS SPECTROM, V11, P601, DOI 10.1002/bms.1200111109; Rothe M, 1995, CELL, V83, P1243, DOI 10.1016/0092-8674(95)90149-3; Seshagiri S, 1997, P NATL ACAD SCI USA, V94, P13606, DOI 10.1073/pnas.94.25.13606; Uren AG, 1996, P NATL ACAD SCI USA, V93, P4974, DOI 10.1073/pnas.93.10.4974; Vaux DL, 1999, CELL, V96, P245, DOI 10.1016/S0092-8674(00)80564-4; Wang SL, 1999, CELL, V98, P453, DOI 10.1016/S0092-8674(00)81974-1; WHITE K, 1994, SCIENCE, V264, P677, DOI 10.1126/science.8171319; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	34	1842	1973	4	127	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 7	2000	102	1					43	53		10.1016/S0092-8674(00)00009-X	http://dx.doi.org/10.1016/S0092-8674(00)00009-X			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	332UL	10929712	Bronze			2022-12-28	WOS:000088091700007
J	Kemler, MA; Barendse, GAM; Van Kleef, M; De Vet, HCW; Rijks, CPM; Furnee, CA; Van den Wildenberg, FAJM				Kemler, MA; Barendse, GAM; Van Kleef, M; De Vet, HCW; Rijks, CPM; Furnee, CA; Van den Wildenberg, FAJM			Spinal cord stimulation in patients with chronic reflex sympathetic dystrophy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SICKNESS IMPACT PROFILE; SHORT GENERIC VERSION; CHRONIC PAIN; MANAGEMENT; RELIABILITY; EXPERIENCE	Background Chronic reflex sympathetic dystrophy (also called the complex regional pain syndrome) is a painful, disabling disorder for which there is no proven treatment. In observational studies, spinal cord stimulation has reduced the pain associated with the disorder. Methods We performed a randomized trial involving patients who had had reflex sympathetic dystrophy for at least six months. Thirty-six patients were assigned to receive treatment with spinal cord stimulation plus physical therapy, and 18 were assigned to receive physical therapy alone. The spinal cord stimulator was implanted only if a test stimulation was successful. We assessed the intensity of pain (on a visual-analogue scale from 0 cm [no pain] to 10 cm [ very severe pain]), the global perceived effect (on a scale from 1 [worst ever] to 7 [best ever]), functional status, and the health-related quality of life. Results The test stimulation of the spinal cord was successful in 24 patients; the other 12 patients did not receive implanted stimulators. In an intention-to-treat analysis, the group assigned to receive spinal cord stimulation plus physical therapy had a mean reduction of 2.4 cm in the intensity of pain at six months, as compared with an increase of 0.2 cm in the group assigned to receive physical therapy alone (P<0.001 for the comparison between the two groups). In addition, the proportion of patients with a score of 6 ("much improved") for the global perceived effect was much higher in the spinal cord stimulation group than in the control group (39 percent vs. 6 percent, P=0.01). There was no clinically important improvement in functional status. The health-related quality of life improved only in the 24 patients who actually underwent implantation of a spinal cord stimulator. Six of the 24 patients had complications that required additional procedures, including removal of the device in 1 patient. Conclusions In carefully selected patients with chronic reflex sympathetic dystrophy, electrical stimulation of the spinal cord can reduce pain and improve health-related quality of life. (N Engl J Med 2000; 343:618-24.) (C) 2000, Massachusetts Medical Society.	Maastricht Univ Hosp, Dept Surg, NL-6202 AZ Maastricht, Netherlands; Maastricht Univ Hosp, Dept Anesthesiol, NL-6202 AZ Maastricht, Netherlands; Maastricht Univ Hosp, Dept Phys Therapy, NL-6202 AZ Maastricht, Netherlands; Maastricht Univ, Dept Epidemiol, Maastricht, Netherlands; Maastricht Univ, Fac Econ & Business Adm, Dept Econ, Maastricht, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University	Kemler, MA (corresponding author), Maastricht Univ Hosp, Dept Surg, POB 5800, NL-6202 AZ Maastricht, Netherlands.	mkeml@shee.azm.nl		Kemler, Marius/0000-0003-0306-1565				ARRINDELL WA, 1986, SCL90 HANDLEIDING BI; BAROLAT G, 1989, STEREOT FUNCT NEUROS, V53, P29, DOI 10.1159/000099515; BROGGI G, 1994, STEREOT FUNCT NEUROS, V62, P273, DOI 10.1159/000098632; CROSBY CA, 1994, J HAND SURG-AM, V19A, P665, DOI 10.1016/0363-5023(94)90280-1; DEBRUIN AF, 1994, J CLIN EPIDEMIOL, V47, P863, DOI 10.1016/0895-4356(94)90189-9; DEBRUIN AF, 1994, J CLIN EPIDEMIOL, V47, P407, DOI 10.1016/0895-4356(94)90162-7; DIJKSTRA P, 1974, STEMMING ONTSTEMMING, P98; FEINSTEIN AR, 1987, CLINIMETRICS, P91; Holsheimer J, 1997, NEUROSURGERY, V40, P990, DOI 10.1097/0006123-199705000-00023; HUNT SM, 1985, J ROY COLL GEN PRACT, V35, P185; JEBSEN R H, 1969, Archives of Physical Medicine and Rehabilitation, V50, P311; JENSEN MP, 1993, PAIN, V55, P195, DOI 10.1016/0304-3959(93)90148-I; Kemler MA, 1999, J NEUROSURG, V90, P79, DOI 10.3171/spi.1999.90.1.0079; Kemler MA, 2000, EPIDEMIOLOGY, V11, P228, DOI 10.1097/00001648-200003000-00025; KEMLER MA, IN PRESS ARCH PHYS M; Kumar K, 1997, NEUROSURGERY, V40, P503, DOI 10.1097/00006123-199703000-00014; KUPERS RC, 1994, PAIN, V56, P211, DOI 10.1016/0304-3959(94)90096-5; MEGLIO M, 1989, J NEUROSURG, V70, P519, DOI 10.3171/jns.1989.70.4.0519; MELZACK R, 1975, PAIN, V1, P277, DOI 10.1016/0304-3959(75)90044-5; Merskey H., 1994, CLASSIFICATION CHRON, P40; MEYERSON BA, 1990, MANAGEMENT PAIN, V2, P1862; North RB, 1996, NEUROSURGERY, V39, P301, DOI 10.1097/00006123-199608000-00013; NORTH RB, 1993, NEUROSURGERY, V32, P384, DOI 10.1227/00006123-199303000-00008; North RB, 1997, NEUROSURGICAL MANAGE, P271; OCHOA JL, 1993, MUSCLE NERVE, V16, P997, DOI 10.1002/mus.880161002; PLEWES LW, 1956, J BONE JOINT SURG BR, V38, P195, DOI 10.1302/0301-620X.38B1.195; ROBAINA FJ, 1989, STEREOT FUNCT NEUROS, V52, P53, DOI 10.1159/000099486; SCHWARTZMAN RJ, 1987, ARCH NEUROL-CHICAGO, V44, P555, DOI 10.1001/archneur.1987.00520170081028; SHEALY CN, 1967, ANESTH ANAL CURR RES, V46, P489; SUBBARAO J, 1981, ARCH PHYS MED REHAB, V62, P549; Turner K M, 1994, J Med Screen, V1, P199; VANDERPLOEG RJO, 1991, J NEUROL NEUROSUR PS, V54, P244, DOI 10.1136/jnnp.54.3.244; VANEIJK JTM, 1987, RELIABILITY VALIDITY; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008	35	487	516	1	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 31	2000	343	9					618	624		10.1056/NEJM200008313430904	http://dx.doi.org/10.1056/NEJM200008313430904			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	348RE	10965008				2022-12-28	WOS:000088999600004
J	Chandler, JM; Zimmerman, SI; Girman, CJ; Martin, AR; Hawkes, W; Hebel, JR; Sloane, PD; Holder, L; Magaziner, J				Chandler, JM; Zimmerman, SI; Girman, CJ; Martin, AR; Hawkes, W; Hebel, JR; Sloane, PD; Holder, L; Magaziner, J			Low bone mineral density and risk of fracture in white female nursing home residents	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MINIMUM DATA SET; HIP FRACTURE; OSTEOPOROTIC FRACTURES; ELDERLY WOMEN; OLDER-PEOPLE; PREVALENCE; FALLS; MASS; AGE	Context Low bone mineral density (BMD) is a strong risk factor for fracture in community-dwelling white women, but the relationship in white female nursing home residents, for whom fracture rates are highest, is less clear, Objective To assess the relative contribution of low BMD to fracture risk in nursing home residents. Design Prospective cohort study with baseline data collected April 1995 to June 1997, with 18 months of follow-up. Setting Forty-seven randomly selected nursing homes in Maryland. Patients A total of 1427 white female nursing home residents aged 65 years or older. Main Outcome Measure Documented osteoporotic fracture occurring during follow-up as a function of baseline BMD measurements higher vs lower than the median, and after controlling for demographic, functional, cognitive, psychosocial, and medical factors. Results A total of 223 osteoporotic fractures occurred among 180 women. Low BMD and transfer independence were significant independent risk factors for fracture in this nursing home sample (P<.001) and the 2 factors acted synergistically (P=.06) to further increase fracture risk. Compared with women whose BMD was higher than the median (0.296 g/cm(2)), those whose BMD was lower than the median had an unadjusted hazard ratio for risk of fracture of 2.1 (95% confidence interval [CI], 1.5-2.8); women who were independent in transfer had a hazard ratio of 1.6 (95% CI, 1.2-2.2) compared with women dependent in transfer. Among residents independent in transfer, those with BMD below the median had a more than 3-fold increase in fracture risk compared with those with higher BMD (unadjusted hazard ratio, 3.1; 95% CI, 2.2-4.4). Among residents dependent in transfer, those with BMD below the median had a 60% increase in fracture risk (unadjusted hazard ratio, 1.6; 95% CI, 1.1-2.3). Adjustment for covariates did not alter the BMD-fracture relationship, Conclusions Our data indicate that low BMD and independence in transfer are significant predictors of osteoporotic fracture in white female nursing home residents.	Merck Res Labs, Dept Epidemiol, Blue Bell, PA USA; Univ Maryland, Dept Epidemiol & Prevent Med, Baltimore, MD 21201 USA; Univ Maryland, Med Ctr, Dept Diagnost Radiol, Baltimore, MD 21201 USA; Univ N Carolina, Cecil G Sheps Ctr Hlth Serv Res, Chapel Hill, NC USA; Univ N Carolina, Sch Social Work, Chapel Hill, NC USA; Univ N Carolina, Dept Family Med, Chapel Hill, NC 27514 USA	Merck & Company; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Chandler, JM (corresponding author), Merck Res Labs, Dept Epidemiol, BL1-7,POB 4, West Point, PA 19486 USA.	julie_chandler@merck.com			NATIONAL INSTITUTE ON AGING [R29AG011407, R01AG008211] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AGO8211, R29 AG11407] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ALEXOPOULOS GS, 1988, BIOL PSYCHIAT, V23, P271, DOI 10.1016/0006-3223(88)90038-8; BLACK DM, 1992, J BONE MINER RES, V7, P633; CALI CM, 1995, J AM GERIATR SOC, V43, P1336, DOI 10.1111/j.1532-5415.1995.tb06610.x; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; CHRISCHILLES E, 1994, BONE, V15, P377, DOI 10.1016/8756-3282(94)90813-3; CUMMINGS SR, 1985, EPIDEMIOL REV, V7, P178, DOI 10.1093/oxfordjournals.epirev.a036281; CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202; DargentMolina P, 1996, LANCET, V348, P145, DOI 10.1016/S0140-6736(96)01440-7; DEY AN, 1997, 289 NAT CTR HLTH STA; ENSRUD KE, 1995, J BONE MINER RES, V10, P1778; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GREENLAND S, 1998, MODERN EPIDEMIOLOGY, P255; GREENSPAN SL, 1994, JAMA-J AM MED ASSOC, V271, P128, DOI 10.1001/jama.271.2.128; Greenspan SL, 1998, AM J MED, V104, P539, DOI 10.1016/S0002-9343(98)00115-6; Guo ZC, 1998, AM J EPIDEMIOL, V148, P887; HAWES C, 1995, GERONTOLOGIST, V35, P172, DOI 10.1093/geront/35.2.172; Kiely DK, 1998, J AM GERIATR SOC, V46, P551, DOI 10.1111/j.1532-5415.1998.tb01069.x; Koski K, 1996, AGE AGEING, V25, P29, DOI 10.1093/ageing/25.1.29; Lawton MP, 1998, J AM GERIATR SOC, V46, P736, DOI 10.1111/j.1532-5415.1998.tb03809.x; LOOKER AC, 1995, J BONE MINER RES, V10, P796; Magaziner J, 1997, AM J PUBLIC HEALTH, V87, P1630, DOI 10.2105/AJPH.87.10.1630; Marshall D, 1996, BRIT MED J, V312, P1254, DOI 10.1136/bmj.312.7041.1254; Martin AR, 1999, J CLIN DENSITOM, V2, P381, DOI 10.1016/S1094-6950(06)60403-4; Melton LJ, 1996, BONE, V18, pS121, DOI 10.1016/8756-3282(95)00492-0; MELTON LJ, 1992, J BONE MINER RES, V7, P1005, DOI 10.1002/jbmr.5650070902; MORRIS JN, 1990, GERONTOLOGIST, V30, P293, DOI 10.1093/geront/30.3.293; NEVITT MC, 1994, OSTEOPOROSIS INT, V4, P325, DOI 10.1007/BF01622192; ROSS PD, 1990, CALCIFIED TISSUE INT, V46, P149, DOI 10.1007/BF02555036; SEELEY DG, 1991, ANN INTERN MED, V115, P837, DOI 10.7326/0003-4819-115-11-837; STEIGER P, 1992, J BONE MINER RES, V7, P625; Takahashi M, 1999, BRIT J OBSTET GYNAEC, V106, P427, DOI 10.1111/j.1471-0528.1999.tb08295.x; TINETTI ME, 1987, J AM GERIATR SOC, V35, P644, DOI 10.1111/j.1532-5415.1987.tb04341.x; VISENTIN P, 1995, GERONTOLOGY, V41, P273; Young Y, 1997, J AM GERIATR SOC, V45, P288, DOI 10.1111/j.1532-5415.1997.tb00942.x; Zimmerman SI, 1999, OSTEOPOROSIS INT, V9, P151	35	117	118	2	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 23	2000	284	8					972	977		10.1001/jama.284.8.972	http://dx.doi.org/10.1001/jama.284.8.972			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	344PX	10944642	Bronze			2022-12-28	WOS:000088769000023
J	McQuibban, GA; Gong, JH; Tam, EM; McCulloch, CAG; Clark-Lewis, I; Overall, CM				McQuibban, GA; Gong, JH; Tam, EM; McCulloch, CAG; Clark-Lewis, I; Overall, CM			Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3	SCIENCE			English	Article							72-KDA GELATINASE; TISSUE INHIBITOR; HUMAN FIBROBLASTS; IV COLLAGENASE; METALLOPROTEINASES; ACTIVATION; BINDING; DOMAIN; PROGELATINASE; ANTAGONISTS	Tissue degradation by the matrix metalloproteinase gelatinase A is pivotal to inflammation and metastases. Recognizing the catalytic importance of substrate-binding exosites outside the catalytic domain, we screened for extracellular substrates using the gelatinase A hemopexin domain as bait in the yeast two-hybrid system. Monocyte chemoattractant protein-3 (MCP-3) was identified as a physiological substrate of gelatinase A. Cleaved MCP-3 binds to CC-chemokine receptors-1, -2, and -3, but no Longer induces calcium fluxes or promotes chemotaxis, and instead acts as a general chemokine antagonist that dampens inflammation. This suggests that matrix metalloproteinases are both effecters and regulators of the inflammatory response.	Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Biomed Res Ctr, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Dept Oral Biol & Med Sci, Vancouver, BC V6T 1Z3, Canada; Univ Toronto, MRC, Periodontal Physiol Grp, Toronto, ON M5S 3E8, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of Toronto	Overall, CM (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada.							FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; GEARING AJH, 1994, NATURE, V370, P555, DOI 10.1038/370555a0; GomisRuth FX, 1996, J MOL BIOL, V264, P556, DOI 10.1006/jmbi.1996.0661; Gong JH, 1996, J BIOL CHEM, V271, P10521, DOI 10.1074/jbc.271.18.10521; GONG JH, 1995, J EXP MED, V181, P631, DOI 10.1084/jem.181.2.631; HOWARD EW, 1991, J BIOL CHEM, V266, P13064; Letterio JJ, 1998, ANNU REV IMMUNOL, V16, P137, DOI 10.1146/annurev.immunol.16.1.137; MCQUIBBAN GA, UNPUB; NETZELARNETT S, 1993, BIOCHEMISTRY-US, V32, P6427, DOI 10.1021/bi00076a016; NGUYEN Q, 1994, BIOCHEMISTRY-US, V33, P2089, DOI 10.1021/bi00174a015; OPDENAKKER G, 1993, BIOCHEM BIOPH RES CO, V191, P535, DOI 10.1006/bbrc.1993.1251; OPENAKKER G, 1991, LYMPHOKINE CYTOK RES, V10, P317; OVERALL CM, 1991, J BIOL CHEM, V266, P14064; OVERALL CM, 1990, J BIOL CHEM, V265, P21141; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; STEFFENSEN B, 1995, J BIOL CHEM, V270, P11555, DOI 10.1074/jbc.270.19.11555; Van Damme J, 1999, Chem Immunol, V72, P42, DOI 10.1159/000058725; WALLON UM, 1997, J BIOL CHEM, V272, P747; WARD RV, 1994, BIOCHEM J, V304, P263, DOI 10.1042/bj3040263; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113; YOUNG TN, 1995, J BIOL CHEM, V270, P999, DOI 10.1074/jbc.270.3.999	21	607	625	2	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 18	2000	289	5482					1202	1206		10.1126/science.289.5482.1202	http://dx.doi.org/10.1126/science.289.5482.1202			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	346JE	10947989				2022-12-28	WOS:000088866600045
J	Aderem, A; Ulevitch, RJ				Aderem, A; Ulevitch, RJ			Toll-like receptors in the induction of the innate immune response	NATURE			English	Review							PROTEIN-KINASE-C; CUTTING EDGE; SIGNAL-TRANSDUCTION; DROSOPHILA TOLL; BINDING-PROTEIN; HOST-DEFENSE; CELL-WALL; KAPPA-B; LIPOPOLYSACCHARIDE; ACTIVATION	The innate immune response is the first line of defence against infectious disease. The principal challenge for the host is to detect the pathogen and mount a rapid defensive response. A group of proteins that comprise the Toll or Toll-like family of receptors perform this role in vertebrate and invertebrate organisms. This reflects a remarkable conservation of function and it is therefore not surprising that studies of the mechanism by which they act has revealed new and important insights into host defence.	Univ Washington, Dept Immunol, Seattle, WA 98195 USA; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA	University of Washington; University of Washington Seattle; Scripps Research Institute	Aderem, A (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98195 USA.		Reis-Silva, Thiago M./E-6318-2013; Ulevitch, Richard J/Q-3393-2017					Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Anderson KV, 2000, CURR OPIN IMMUNOL, V12, P13, DOI 10.1016/S0952-7915(99)00045-X; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Chaffin WL, 1998, MICROBIOL MOL BIOL R, V62, P130, DOI 10.1128/MMBR.62.1.130-180.1998; Chaudhary PM, 1998, BLOOD, V91, P4020, DOI 10.1182/blood.V91.11.4020.411a44_4020_4027; Darveau RP, 1998, CURR OPIN MICROBIOL, V1, P36, DOI 10.1016/S1369-5274(98)80140-9; DESCOTEAUX A, 1992, J IMMUNOL, V149, P3008; Flo TH, 2000, J IMMUNOL, V164, P2064, DOI 10.4049/jimmunol.164.4.2064; Heine H, 1999, J IMMUNOL, V162, P6971; Henderson B, 1996, MICROBIOL REV, V60, P316, DOI 10.1128/MMBR.60.2.316-341.1996; Hirschfeld M, 1999, J IMMUNOL, V163, P2382; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Hoshino K, 1999, J IMMUNOL, V162, P3749; Imler JL, 2000, CURR OPIN MICROBIOL, V3, P16, DOI 10.1016/S1369-5274(99)00045-4; Irie T, 2000, FEBS LETT, V467, P160, DOI 10.1016/S0014-5793(00)01146-7; Janeway CA, 1998, SEMIN IMMUNOL, V10, P349, DOI 10.1006/smim.1998.0142; Kalambaheti T, 1999, MICROB PATHOGENESIS, V27, P105, DOI 10.1006/mpat.1999.0285; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kirschning CJ, 1998, J EXP MED, V188, P2091, DOI 10.1084/jem.188.11.2091; Kopp E, 1999, GENE DEV, V13, P2059, DOI 10.1101/gad.13.16.2059; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Levashina EA, 1999, SCIENCE, V285, P1917, DOI 10.1126/science.285.5435.1917; Lien E, 2000, J CLIN INVEST, V105, P497, DOI 10.1172/JCI8541; Lien E, 1999, J BIOL CHEM, V274, P33419, DOI 10.1074/jbc.274.47.33419; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Means TK, 1999, J IMMUNOL, V163, P3920; Means TK, 1999, J IMMUNOL, V163, P6748; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; MEEZHITOV R, 2000, IMMUNOL REV, V173, P89; Mitchison M, 1997, J BACTERIOL, V179, P1262, DOI 10.1128/jb.179.4.1262-1267.1997; Muzio M, 1998, J EXP MED, V187, P2097, DOI 10.1084/jem.187.12.2097; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Ohashi K, 2000, J IMMUNOL, V164, P558, DOI 10.4049/jimmunol.164.2.558; Poltorak A, 2000, P NATL ACAD SCI USA, V97, P2163, DOI 10.1073/pnas.040565397; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Qureshi ST, 1999, J EXP MED, V189, P1519; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; RAETZ CRH, 1990, ANNU REV BIOCHEM, V59, P129, DOI 10.1146/annurev.biochem.59.1.129; Rock FL, 1998, P NATL ACAD SCI USA, V95, P588, DOI 10.1073/pnas.95.2.588; SCHUMANN RR, 1990, SCIENCE, V249, P1429, DOI 10.1126/science.2402637; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Tachado SD, 1997, P NATL ACAD SCI USA, V94, P4022, DOI 10.1073/pnas.94.8.4022; Takeuchi O, 1999, GENE, V231, P59, DOI 10.1016/S0378-1119(99)00098-0; Takeuchi O, 2000, J IMMUNOL, V164, P554, DOI 10.4049/jimmunol.164.2.554; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Thomas JA, 1999, J IMMUNOL, V163, P978; ULEVITCH RJ, 1995, ANNU REV IMMUNOL, V13, P437, DOI 10.1146/annurev.iy.13.040195.002253; Ulevitch RJ, 1999, CURR OPIN IMMUNOL, V11, P19, DOI 10.1016/S0952-7915(99)80004-1; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Underhill DM, 1999, P NATL ACAD SCI USA, V96, P14459, DOI 10.1073/pnas.96.25.14459; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1; Wesche H, 1999, J BIOL CHEM, V274, P19403, DOI 10.1074/jbc.274.27.19403; Williams MJ, 1997, EMBO J, V16, P6120, DOI 10.1093/emboj/16.20.6120; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Yang RB, 1999, J IMMUNOL, V163, P639; Yang RB, 1998, NATURE, V395, P284, DOI 10.1038/26239	59	2434	2653	4	222	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 17	2000	406	6797					782	787		10.1038/35021228	http://dx.doi.org/10.1038/35021228			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	344PH	10963608				2022-12-28	WOS:000088767700055
J	Rakow, NA; Suslick, KS				Rakow, NA; Suslick, KS			A colorimetric sensor array for odour visualization	NATURE			English	Article							CHEMICAL SENSORS; DENDRIMER-METALLOPORPHYRINS; ELECTRONIC NOSE; COMPLEXES; RECEPTORS; COATINGS	Array-based vapour-sensing devices are used to detect and differentiate between chemically diverse analytes. These systems- based on cross-responsive sensor elements-aim to mimic the mammalian olfactory system(1-3) by producing composite responses unique to each odorant. Previous work has concentrated on a variety of non-specific chemical interactions(4-11) to detect non-coordinating organic vapours. But the most odiferous, toxic compounds often bind readily to metal ions. Here we report a simple optical chemical sensing method that utilizes the colour change induced in an array of metalloporphyrin dyes upon ligand binding while minimizing the need for extensive signal transduction hardware. The chemoselective response of a library of immobilized vapour-sensing metalloporphyrin dyes permits the visual identification of a wide range of ligating (alcohols, amines, ethers, phosphines, phosphites, thioethers and thiols) and even weakly ligating (arenes, halocarbons and ketones) vapours. Water geometrical correlation length), and consequently a purely diffusive large-scale behaviour for the force. Therefore, we conclude that our results are certainly applicable to disordered packings such as cohesionless soils or sand piles. In contrast, for the particular case of non-random, textured packings, biased and long-range correlated q-series along the force transmission tree are likely to be encountered, thus altering the previous purely diffusive behaviour.	Univ Illinois, Dept Chem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Suslick, KS (corresponding author), Univ Illinois, Dept Chem, 600 S Mathews Ave, Urbana, IL 61801 USA.		Suslick, Kenneth S/A-1841-2010	Suslick, Kenneth S/0000-0001-5422-0701				ADLER AD, 1970, J INORG NUCL CHEM, V32, P2443, DOI 10.1016/0022-1902(70)80535-8; ADLER AD, 1967, J ORG CHEM, V32, P476, DOI 10.1021/jo01288a053; AXEL R, 1995, SCI AM, V273, P154, DOI 10.1038/scientificamerican1095-154; BARLEY M, 1983, CAN J CHEM, V61, P2389, DOI 10.1139/v83-414; BARON AE, 1993, REV SCI INSTRUM, V64, P3394, DOI 10.1063/1.1144310; Bhyrappa P, 1996, J AM CHEM SOC, V118, P5708, DOI 10.1021/ja953474k; Bhyrappa P, 1999, J AM CHEM SOC, V121, P262, DOI 10.1021/ja983411c; BLAUER G, 1985, OPTICAL PROPERTIES S; Brunink JAJ, 1996, ANAL CHIM ACTA, V325, P53, DOI 10.1016/0003-2670(96)00017-7; CHOU JH, 2000, PORPHYRIN HDB, V6, P43; Crooks RM, 1998, ACCOUNTS CHEM RES, V31, P219, DOI 10.1021/ar970246h; DATTAGUPTA N, 1968, J PHARM SCI-US, V57, P300, DOI 10.1002/jps.2600570211; Di Natale C, 1998, MAT SCI ENG C-BIOMIM, V5, P209, DOI 10.1016/S0928-4931(97)00045-3; Dickinson TA, 1996, NATURE, V382, P697, DOI 10.1038/382697a0; Dryer L, 1999, TRENDS PHARMACOL SCI, V20, P413, DOI 10.1016/S0165-6147(99)01381-4; FREUND MS, 1995, P NATL ACAD SCI USA, V92, P2652, DOI 10.1073/pnas.92.7.2652; GARDNER JW, 1992, SENSOR ACTUAT B-CHEM, V6, P71, DOI 10.1016/0925-4005(92)80033-T; Gelperin A, 2000, J NEUROPHYSIOL, V83, P116, DOI 10.1152/jn.2000.83.1.116; GRATE JW, 1991, SENSOR ACTUAT B-CHEM, V3, P85, DOI 10.1016/0925-4005(91)80202-U; Heilig A, 1997, SENSOR ACTUAT B-CHEM, V43, P45, DOI 10.1016/S0925-4005(97)00096-8; LANCET D, 1993, CURR BIOL, V3, P668, DOI 10.1016/0960-9822(93)90064-U; LEE WWS, 1993, J MATER CHEM, V3, P1031, DOI 10.1039/jm9930301031; Lonergan MC, 1996, CHEM MATER, V8, P2298, DOI 10.1021/cm960036j; NAPPA M, 1978, J AM CHEM SOC, V100, P5075, DOI 10.1021/ja00484a027; SEN A, IN PRESS J AM CHEM S; Suslick KS, 1996, COMPREHENSIVE SUPRAM, V5, P141; Vaughan AA, 1996, ANAL COMMUN, V33, P393, DOI 10.1039/ac9963300393; Walt DR, 1998, ACCOUNTS CHEM RES, V31, P267, DOI 10.1021/ar970069k; Yaws C.L., 1994, HDB VAPOR PRESSURE, VVolume 3	29	1157	1227	29	682	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 17	2000	406	6797					710	713		10.1038/35021028	http://dx.doi.org/10.1038/35021028			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	344PH	10963592				2022-12-28	WOS:000088767700039
J	Ohman, EM; Granger, CB; Harrington, RA; Lee, KL				Ohman, EM; Granger, CB; Harrington, RA; Lee, KL			Risk stratification and therapeutic decision making in acute coronary syndromes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							WAVE MYOCARDIAL-INFARCTION; REFRACTORY UNSTABLE ANGINA; ARTERY DISEASE; ENOXAPARIN; BENEFIT; TRIAL		Duke Univ, Med Ctr, Dept Med, Div Cardiol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Community & Family Med, Duke Clin Res Inst, Durham, NC 27710 USA	Duke University; Duke University	Ohman, EM (corresponding author), Duke Univ, Med Ctr, Dept Med, Div Cardiol, Box 3151, Durham, NC 27710 USA.	Ohman001@mc.duke.edu	Granger, Christopher B/D-3458-2014	Granger, Christopher B/0000-0002-0045-3291				[Anonymous], 1988, LANCET, V2, P349; Antman EM, 2000, JAMA-J AM MED ASSOC, V284, P835, DOI 10.1001/jama.284.7.835; Antman EM, 1999, CIRCULATION, V100, P1593, DOI 10.1161/01.CIR.100.15.1593; Antman EM, 1999, CIRCULATION, V100, P1602, DOI 10.1161/01.CIR.100.15.1602; Boersma E, 2000, CIRCULATION, V101, P2557, DOI 10.1161/01.CIR.101.22.2557; BRAUNWALD E, 1994, CIRCULATION, V90, P613, DOI 10.1161/01.CIR.90.1.613; Califf RM, 1997, AM HEART J, V133, P630, DOI 10.1016/S0002-8703(97)70164-9; Califf RM, 2000, CIRCULATION, V101, P2231, DOI 10.1161/01.CIR.101.19.2231; Cohen M, 1997, NEW ENGL J MED, V337, P447, DOI 10.1056/NEJM199708143370702; Cohen M, 2000, AM HEART J, V139, P962, DOI 10.1067/mhj.2000.106915; Eikelboom JW, 2000, LANCET, V355, P1936, DOI 10.1016/S0140-6736(00)02324-2; *FIBR THER TRIAL C, 1994, LANCET, V343, P742; Hamm CW, 1999, NEW ENGL J MED, V340, P1623, DOI 10.1056/NEJM199905273402103; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; Heeschen C, 1999, CIRCULATION, V100, P1509, DOI 10.1161/01.CIR.100.14.1509; Heeschen C, 1999, LANCET, V354, P1757, DOI 10.1016/S0140-6736(99)10285-X; Kaul S, 2000, J AM COLL CARDIOL, V35, P1699, DOI 10.1016/S0735-1097(00)00648-3; KILLIP T, 1967, AM J CARDIOL, V20, P457, DOI 10.1016/0002-9149(67)90023-9; Kong DF, 1998, CIRCULATION, V98, P2829, DOI 10.1161/01.CIR.98.25.2829; LEE KL, 1995, CIRCULATION, V91, P1659, DOI 10.1161/01.CIR.91.6.1659; Lindahl B, 1997, J AM COLL CARDIOL, V29, P43, DOI 10.1016/S0735-1097(96)00447-0; MARK DB, 1987, ANN INTERN MED, V106, P793, DOI 10.7326/0003-4819-106-6-793; OHMAN EM, 2000, 49 ANN SCI SESS AM C; Savonitto S, 1999, JAMA-J AM MED ASSOC, V281, P707, DOI 10.1001/jama.281.8.707; TOPOL E, 1993, NEW ENGL J MED, V329, P673, DOI 10.1056/nejm199309023291001	25	138	143	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 16	2000	284	7					876	878		10.1001/jama.284.7.876	http://dx.doi.org/10.1001/jama.284.7.876			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	342PM	10938178				2022-12-28	WOS:000088654400031
J	Van Cauter, E; Leproult, R; Plat, L				Van Cauter, E; Leproult, R; Plat, L			Age-related changes in slow wave sleep and REM sleep and relationship with growth hormone and cortisol levels in healthy men	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORTICOTROPIN-RELEASING HORMONE; PRIMARY ENDOGENOUS-DEPRESSION; ELECTROENCEPHALOGRAPHIC ACTIVITY; CIRCADIAN RHYTHMICITY; GLUCOSE REGULATION; 24-HOUR PROFILE; PLASMA-CORTISOL; SECRETION; HUMANS; YOUNG	Context In young adults, sleep affects the regulation of growth hormone (GH) and cortisol. The relationship between decreased sleep quality in older adults and age-related changes in the regulation of GH and cortisol is unknown. Objective To determine the chronology of age-related changes in sleep duration and quality (sleep stages) in healthy men and whether concomitant alterations occur in GH and cortisol levels. Design and Setting Data combined from a series of studies conducted between 1985 and 1999 at 4 laboratories. Subjects A total of 149 healthy men. aged 16 to 83 years, with a mean (SD) body mass index of 24.1 (2.3) kg/m(2), without sleep complaints or histories of endocrine, psychiatric, or sleep disorders. Main Outcome Measures Twenty-four-hour profiles of plasma GH and cortisol levels and polygraphic sleep recordings. Results The mean (SEM) percentage of deep slow wave sleep decreased from 18.9% (1.3%) during early adulthood (age 16-25 years) to 3.4% (1.0%) during midlife (age 36-50 years) and was replaced by lighter sleep (stages 1 and 2) without significant increases in sleep fragmentation or decreases in rapid eye movement (REM) sleep. The transition from midlife to late life (age 71-83 years) involved no further significant decrease in slow wave sleep but an increase in time awake of 28 minutes per decade at the expense of decreases in both light non-REM sleep (-24 minutes per decade; P<.001) and REM sleep (-10 minutes per decade; P<.001). The decline in slow wave sleep from early adulthood to midlife was paralleled by a major decline in GH secretion (-372 mu g per decade; P<.001). From midlife to late life, GH secretion further declined at a slower rate (-43 mu g per decade; P<.02). Independently of age, the amount of GH secretion was significantly associated with slow wave sleep (P<.001). Increasing age was associated with an elevation of evening cortisol levels (+19.3 nmol/L per decade; P<.001) that became significant only after age 50 years, when sleep became more fragmented and REM sleep declined. A trend for an association between lower amounts of REM sleep and higher evening cortisol concentrations independent of age was detected (P<.10). Conclusions In men, age-related changes in slow wave sleep and REM sleep occur with markedly different chronologies and are each associated with specific hormonal alterations. Future studies should evaluate whether strategies to enhance sleep quality may have beneficial hormonal effects.	Univ Chicago, Dept Med, Chicago, IL 60637 USA	University of Chicago	Van Cauter, E (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave,MC 1027, Chicago, IL 60637 USA.	evcauter@medicine.bsd.uchicago.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041814] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG011412] Funding Source: NIH RePORTER; NIA NIH HHS [AG-11412] Funding Source: Medline; NIDDK NIH HHS [DK-41814] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ASTROM C, 1995, ACTA NEUROL SCAND, V92, P281; BENCA RM, 1992, ARCH GEN PSYCHIAT, V49, P651; Bierwolf C, 1997, J NEUROENDOCRINOL, V9, P479, DOI 10.1046/j.1365-2826.1997.00605.x; Biston P, 1996, HYPERTENSION, V28, P863, DOI 10.1161/01.HYP.28.5.863; BLIWISE DL, 1994, PRINCIPLES PRACTICE, P26; Borbely AA, 1998, HORM RES, V49, P114, DOI 10.1159/000023156; BORN J, 1989, J CLIN ENDOCR METAB, V68, P904, DOI 10.1210/jcem-68-5-904; COOPER BG, 1995, SLEEP, V18, P172; Copinschi G, 1997, NEUROENDOCRINOLOGY, V66, P278, DOI 10.1159/000127249; COPINSCHI G, 1990, SLEEP, V13, P232; CORPAS E, 1993, ENDOCR REV, V14, P20, DOI 10.1210/er.14.1.20; CUNEO RC, 1992, CLIN ENDOCRINOL, V37, P387, DOI 10.1111/j.1365-2265.1992.tb02347.x; DALLMAN MF, 1993, FRONT NEUROENDOCRIN, V14, P303, DOI 10.1006/frne.1993.1010; DIJK DJ, 1995, J NEUROSCI, V15, P3526; DIJK DJ, 1989, SLEEP, V12, P500, DOI 10.1093/sleep/12.6.500; Ehlers CL, 1997, J SLEEP RES, V6, P211, DOI 10.1046/j.1365-2869.1997.00041.x; EHLERS CL, 1989, ELECTROEN CLIN NEURO, V72, P118, DOI 10.1016/0013-4694(89)90172-7; FEINBERG I, 1967, J PSYCHIAT RES, V5, P107, DOI 10.1016/0022-3956(67)90027-1; Feinberg I, 1976, NEUROBIOL AGING, P23; Frank SA, 1995, AM J PHYSIOL-ENDOC M, V269, pE1006, DOI 10.1152/ajpendo.1995.269.6.E1006; Gronfier C, 1996, SLEEP, V19, P817, DOI 10.1093/sleep/19.10.817; Gronfier C, 1997, ELECTROEN CLIN NEURO, V103, P405, DOI 10.1016/S0013-4694(97)00013-1; HO KY, 1987, J CLIN ENDOCR METAB, V64, P51, DOI 10.1210/jcem-64-1-51; HOLSBOER F, 1988, NEUROENDOCRINOLOGY, V48, P32, DOI 10.1159/000124986; JARRETT DB, 1991, BIOL PSYCHIAT, V29, P3, DOI 10.1016/0006-3223(91)90206-2; JARRETT DJ, 1988, 1 M SOC RES BIOL RHY; Kern W, 1996, J GERONTOL A-BIOL, V51, pM3, DOI 10.1093/gerona/51A.1.M3; Landolt HP, 1996, BRAIN RES, V738, P205, DOI 10.1016/S0006-8993(96)00770-6; Leproult R, 1997, SLEEP, V20, P865; LHermiteBaleriaux M, 1996, CLIN CHEM, V42, P1789; LINKOWSKI P, 1985, J CLIN ENDOCR METAB, V61, P429, DOI 10.1210/jcem-61-3-429; Linkowski P, 1998, AM J PHYSIOL-ENDOC M, V274, pE909, DOI 10.1152/ajpendo.1998.274.5.E909; McEwen BS, 1998, ANN NY ACAD SCI, V840, P33, DOI 10.1111/j.1749-6632.1998.tb09546.x; MCEWEN BS, 1995, CURR OPIN NEUROBIOL, V5, P205, DOI 10.1016/0959-4388(95)80028-X; MOURTAZAEV MS, 1995, SLEEP, V18, P557, DOI 10.1093/sleep/18.7.557; Plat L, 1999, J CLIN ENDOCR METAB, V84, P3082, DOI 10.1210/jc.84.9.3082; PRINZ PN, 1995, J CLIN NEUROPHYSIOL, V12, P139, DOI 10.1097/00004691-199503000-00004; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; ROSEN T, 1993, ACTA ENDOCRINOL-COP, V129, P201, DOI 10.1530/acta.0.1290201; RUBIN RT, 1990, BIOL PSYCHIAT, V27, P1065, DOI 10.1016/0006-3223(90)90044-3; RUBIN RT, 1987, ARCH GEN PSYCHIAT, V44, P328; SAINI J, 1993, HORM METAB RES, V25, P375, DOI 10.1055/s-2007-1002123; SEEMAN TE, 1994, ENDOCR REV, V15, P233, DOI 10.1210/er.15.2.233; SPATHSCHWALBE E, 1993, J CLIN ENDOCR METAB, V77, P1170, DOI 10.1210/jc.77.5.1170; SPATHSCHWALBE E, 1994, NEUROENDOCRINOLOGY, V60, P544, DOI 10.1159/000126793; Van Cauter E, 1998, SLEEP, V21, P553; VanCauter E, 1997, J CLIN INVEST, V100, P745, DOI 10.1172/JCI119587; VANCAUTER E, 1991, J CLIN INVEST, V88, P934, DOI 10.1172/JCI115396; VANCAUTER E, 1979, AM J PHYSIOL, V237, pE225, DOI 10.1152/ajpendo.1979.237.3.E255; VANCAUTER E, 1988, AM J PHYSIOL, V254, pE786, DOI 10.1152/ajpendo.1988.254.6.E786; VANCAUTER E, 1992, J CLIN ENDOCR METAB, V74, P1441, DOI 10.1210/jc.74.6.1441; VanCauter E, 1996, J CLIN ENDOCR METAB, V81, P2468, DOI 10.1210/jc.81.7.2468; VANCOEVORDEN A, 1991, AM J PHYSIOL, V260, pE651, DOI 10.1152/ajpendo.1991.260.4.E651; Vgontzas AN, 2000, J CLIN ENDOCR METAB, V85, P1151, DOI 10.1210/jc.85.3.1151; VIRASORO E, 1971, CLIN CHIM ACTA, V31, P294, DOI 10.1016/0009-8981(71)90392-5; WEBB WB, 1982, J GERONTOL, V37, P581, DOI 10.1093/geronj/37.5.581; WEITZMAN ED, 1983, J CLIN ENDOCR METAB, V56, P352, DOI 10.1210/jcem-56-2-352	57	454	458	1	43	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 16	2000	284	7					861	868		10.1001/jama.284.7.861	http://dx.doi.org/10.1001/jama.284.7.861			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	342PM	10938176	Bronze			2022-12-28	WOS:000088654400029
J	Ratanatharathorn, V; Carson, E; Reynolds, C; Ayash, LJ; Levine, J; Yanik, G; Silver, SM; Ferrara, JLM; Uberti, JP				Ratanatharathorn, V; Carson, E; Reynolds, C; Ayash, LJ; Levine, J; Yanik, G; Silver, SM; Ferrara, JLM; Uberti, JP			Anti-CD20 chimeric monoclonal antibody treatment of refractory immune-mediated thrombocytopenia in a patient with chronic graft-versus-host disease	ANNALS OF INTERNAL MEDICINE			English	Article							BONE-MARROW TRANSPLANTATION; STEM-CELL TRANSPLANTATION; HIGH-RISK; AUTOIMMUNITY; PREDNISONE; THERAPY	Background: Autoimmune thrombocytopenia in chronic graft-versus-host disease may represent an instance of B-cell dysregulation leading to clinical disease. Objective: To attempt to treat refractory immune-mediated thrombocytopenia in a patient with chronic graft-versus-host disease by using anti-CD20 chimeric monoclonal antibody. Design: Case report. Setting: Academic medical center. Patient: A patient with chronic graft-versus-host disease after allogeneic peripheral blood stem-cell transplantation who had severe refractory immune-mediated thrombocytopenia. Intervention: Weekly Infusion of rituximab, 375 mg/m(2), for 4 weeks. Measurements: Platelet count, CD3(+) cell count, and CD19(+) cell count. Results: Rituximab therapy resulted in marked depletion of B cells in the peripheral blood and decreased levels of platelet-associated antibody. The increase in platelet count persisted despite tapering and discontinuation of immunosuppressive therapy for chronic graft-versus-host disease. Conclusion: The efficacy of rituximab for the treatment of immune-mediated thrombocytopenia suggests that this drug may have activity in other autoimmune diseases or chronic graft-versus-host disease.	Univ Michigan, Med Ctr, Blood & Marrow Stem Cell Transplant Program, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Ratanatharathorn, V (corresponding author), Univ Michigan, Med Ctr, Canc Ctr B1 207, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	vratanat@umich.edu		Levine, John/0000-0002-5611-7828				ANASETTI C, 1989, BLOOD, V73, P1054; ATKINSON K, 1989, BONE MARROW TRANSPL, V4, P247; GERRITSEN EJA, 1993, BLOOD, V82, P3493; GOLDMAN M, 1991, IMMUNOL TODAY, V12, P223, DOI 10.1016/0167-5699(91)90034-Q; HAKIM FT, 1997, GRAFT VS HOST DIS, P257; Inaoki M, 1997, J EXP MED, V186, P1923, DOI 10.1084/jem.186.11.1923; Jacobson P, 1998, BONE MARROW TRANSPL, V22, P217, DOI 10.1038/sj.bmt.1701331; KIER P, 1990, BONE MARROW TRANSPL, V6, P93; Leget Gail A., 1998, Current Opinion in Oncology, V10, P548, DOI 10.1097/00001622-199811000-00012; McLaughlin P, 1998, J CLIN ONCOL, V16, P2825, DOI 10.1200/JCO.1998.16.8.2825; MITUS AJ, 1989, BLOOD, V74, P2764; REINER A, 1995, BLOOD, V85, P351; ROLINK AG, 1990, GRAFT VS HOST DISEAS, P161; Sato S, 1996, J IMMUNOL, V157, P4371; SAXON A, 1981, BLOOD, V58, P746; Storek J, 1997, BLOOD, V90, P4705, DOI 10.1182/blood.V90.12.4705.4705_4705_4709; STOREK J, 1992, BONE MARROW TRANSPL, V9, P395; SULLIVAN KM, 1991, SEMIN HEMATOL, V28, P250; SULLIVAN KM, 1988, BLOOD, V72, P546; SULLIVAN KM, 1988, BLOOD, V72, P555	20	117	138	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 15	2000	133	4					275	279		10.7326/0003-4819-133-4-200008150-00011	http://dx.doi.org/10.7326/0003-4819-133-4-200008150-00011			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	346NG	10929168				2022-12-28	WOS:000088877500004
J	Cohen, BA; Hewins, RH; Yu, Y				Cohen, BA; Hewins, RH; Yu, Y			Evaporation in the young solar nebula as the origin of 'just-right' melting of chondrules	NATURE			English	Article							COOLING RATES; FEO-RICH; CHONDRITES; CONSTRAINTS; OLIVINE	Chondrules(1-5) are millimetre-sized, solidified melt spherules formed in the solar nebula by an early widespread heating event of uncertain nature(6-8). They were accreted into chondritic asteroids, which formed about 4.56 billion years ago and have not experienced melting or differentiation since that time. Chondrules have diverse chemical compositions, corresponding to liquidus temperatures(1,4,9) in the range 1,350-1,800 degrees C. Most chondrules, however, show porphyritic textures (consisting of large crystals in a distinctly finer grained or glassy matrix), indicative of melting within the narrow range 0-50 degrees C below the liquidus(9,10). This suggests an unusual heating mechanism for chondrule precursors, which would raise each individual chondrule to just the right temperature (particular to individual bulk composition) in order to form porphyritic textures. Here we report the results of isothermal melting of a chondritic composition at nebular pressures. Our results suggest that evaporation stabilizes porphyritic textures over a wider range of temperatures below the liquidus (about 200 degrees C) than previously believed, thus removing the need for individual chondrule temperature buffering. In addition, we show that evaporation explains many chondrule bulk and mineral compositions that have hitherto been difficult to understand.	Rutgers State Univ, Dept Geol Sci, Piscataway, NJ 08855 USA	Rutgers State University New Brunswick	Cohen, BA (corresponding author), Rutgers State Univ, Dept Geol Sci, Piscataway, NJ 08855 USA.		IMPMC, ROCKS @/U-8478-2017					ALEXANDER CMO, 1996, CHONDRULES PROTOPLAN, P233; ANDERS E, 1989, GEOCHIM COSMOCHIM AC, V53, P197, DOI 10.1016/0016-7037(89)90286-X; CONNOLLY HC, 1995, GEOCHIM COSMOCHIM AC, V59, P3231, DOI 10.1016/0016-7037(95)00207-G; CUZZI JN, 1996, CHONDRULES PROTOPLAN, P35; Grossman J.N., 1988, METEORITES EARLY SOL, P680; Grossman J. N., 1988, METEORITES EARLY SOL, P619; HEWINS RH, 1990, METEORITICS, V25, P309, DOI 10.1111/j.1945-5100.1990.tb00715.x; Hewins RH, 1997, ANNU REV EARTH PL SC, V25, P61, DOI 10.1146/annurev.earth.25.1.61; HEWINS RH, 1997, ANTARCT MET RES, V10, P294; Jones RH, 1996, GEOCHIM COSMOCHIM AC, V60, P3115, DOI 10.1016/0016-7037(96)00152-4; JONES RH, 1993, METEORITICS, V28, P213, DOI 10.1111/j.1945-5100.1993.tb00759.x; Lofgren G., 1996, CHONDRULES PROTOPLAN, P187; MCSWEEN HY, 1977, GEOCHIM COSMOCHIM AC, V41, P1843, DOI 10.1016/0016-7037(77)90216-2; NAGAHARA H, 1994, GEOCHIM COSMOCHIM AC, V58, P1951, DOI 10.1016/0016-7037(94)90426-X; Scott E. R. D., 1996, CHONDRULES PROTOPLAN, P87; Sears DWG, 1996, INT C CHONDRULES PRO, P221; WALKER D, 1988, CONTRIB MINERAL PETR, V99, P306, DOI 10.1007/BF00375364; Weinbruch S, 2000, METEORIT PLANET SCI, V35, P161, DOI 10.1111/j.1945-5100.2000.tb01983.x; WEINBRUCH S, 1995, GEOCHIM COSMOCHIM AC, V59, P3221, DOI 10.1016/0016-7037(95)00210-Q; Weinbruch S, 1998, METEORIT PLANET SCI, V33, P65, DOI 10.1111/j.1945-5100.1998.tb01608.x; WOOD JA, 1993, GEOCHIM COSMOCHIM AC, V57, P2377, DOI 10.1016/0016-7037(93)90575-H; Yu Y, 1998, GEOCHIM COSMOCHIM AC, V62, P159, DOI 10.1016/S0016-7037(97)00321-9; YU Y, 1998, LUNAR PLANET SCI, V29	23	36	36	0	3	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 10	2000	406	6796					600	602		10.1038/35020514	http://dx.doi.org/10.1038/35020514			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	342PF	10949294				2022-12-28	WOS:000088653800039
J	Schomig, A; Kastrati, A; Dirschinger, J; Mehilli, J; Schricke, U; Pache, J; Martinoff, S; Neumann, FJ; Schwaiger, M				Schomig, A; Kastrati, A; Dirschinger, J; Mehilli, J; Schricke, U; Pache, J; Martinoff, S; Neumann, FJ; Schwaiger, M		Stent Versus Thyrombolysis Occlude	Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							THROMBOLYTIC THERAPY; PRIMARY ANGIOPLASTY; ANTICOAGULANT-THERAPY; RECEPTOR BLOCKADE; ARTERY STENTS; TRIAL; PLACEMENT; SIZE; RISK; ANTIPLATELET	Background Prevention of myocardial damage is the main goal of all reperfusion therapies in patients with acute myocardial infarction. The relative efficacy of various reperfusion strategies is under intensive investigation. We assessed whether coronary stenting combined with the blockade of platelet glycoprotein IIb/IIIa receptors produces a greater degree of myocardial salvage than fibrinolysis with an accelerated infusion of alteplase, a tissue plasminogen activator. Methods A total of 140 patients were enrolled in the randomized trial; 71 were assigned to receive a stent plus abciximab, and 69 to receive intravenous alteplase. The primary end point was the degree of myocardial salvage, determined by means of serial scintigraphic studies with technetium Tc 99m sestamibi. The secondary end point was a composite of death, reinfarction, and stroke within six months after randomization. Results In the group that received a stent plus abciximab, the median size of the final infarct was 14.3 percent of the left ventricle (25th and 75th percentiles, 6.8 and 24.5 percent), as compared with a median of 19.4 percent (25th and 75th percentiles, 7.9 and 34.2 percent) in the alteplase group (P=0.02). This difference was due to the larger salvage index (the percentage of the left ventricle that was salvaged, divided by the percentage that was compromised by the initial perfusion defect) in the stent group: 0.57 ( 25th and 75th percentiles, 0.35 and 0.69), as compared with 0.26 (25th and 75th percentiles, 0.09 and 0.61; P<0.001). The cumulative incidence of death, reinfarction, or stroke at six months was lower in the stent group than in the alteplase group (8.5 vs. 23.2 percent, P=0.02; relative risk, 0.34; 95 percent confidence interval, 0.13 to 0.88). Conclusions In patients with acute myocardial infarction, coronary stenting plus abciximab leads to a greater degree of myocardial salvage and a better clinical outcome than does fibrinolysis with a tissue plasminogen activator. (N Engl J Med 2000; 343: 385-91.) (C) 2000, Massachusetts Medical Society.	Tech Univ Munich, Deutsch Herzzentrum, D-80636 Munich, Germany; Tech Univ Munich, Med Klin Rechts der Isar 1, D-80636 Munich, Germany; Tech Univ Munich, Klin & Poliklin Nukl Med Rechts der Isar, D-80636 Munich, Germany	German Heart Center Berlin; German Heart Centre Munich; Technical University of Munich; Technical University of Munich; Technical University of Munich	Schomig, A (corresponding author), Tech Univ Munich, Deutsch Herzzentrum, Lazarettstr 36, D-80636 Munich, Germany.	aschoemig@dhm.mhn.de	, Kastrati/Y-2389-2019; Mehilli, Julinda/F-2629-2016	schwaiger, markus/0000-0002-2305-7144				[Anonymous], 1987, LANCET, V2, P871; [Anonymous], 1988, LANCET, V2, P349; Antman EM, 1999, CIRCULATION, V99, P2720, DOI 10.1161/01.CIR.99.21.2720; Betriu A, 1997, NEW ENGL J MED, V336, P1621; Betriu A, 1997, NEW ENGL J MED, V337, P287; BRAUNWALD E, 1989, CIRCULATION, V79, P441, DOI 10.1161/01.CIR.79.2.441; Brener SJ, 1998, CIRCULATION, V98, P734, DOI 10.1161/01.CIR.98.8.734; Christian TF, 1997, J AM COLL CARDIOL, V30, P1633, DOI 10.1016/S0735-1097(97)00409-9; ELASHOFF JD, 1999, QUERY ADVISOR VERSIO; Every NR, 1996, NEW ENGL J MED, V335, P1253, DOI 10.1056/NEJM199610243351701; GIBBONS RJ, 1993, NEW ENGL J MED, V328, P685, DOI 10.1056/NEJM199303113281003; Gibbons RJ, 2000, CIRCULATION, V101, P101, DOI 10.1161/01.CIR.101.1.101; GIBBONS RJ, 1989, CIRCULATION, V80, P1277, DOI 10.1161/01.CIR.80.5.1277; GIBBONS RJ, 1994, J AM COLL CARDIOL, V24, P616, DOI 10.1016/0735-1097(94)90005-1; Grines CL, 1999, NEW ENGL J MED, V341, P1949, DOI 10.1056/NEJM199912233412601; GRINES CL, 1993, NEW ENGL J MED, V328, P673, DOI 10.1056/NEJM199303113281001; Kastrati A, 2000, AM HEART J, V139, P208, DOI 10.1067/mhj.2000.102198; Lincoff AM, 1999, NEW ENGL J MED, V341, P319, DOI 10.1056/NEJM199907293410503; McGuire DK, 2000, AM HEART J, V139, P934, DOI 10.1067/mhj.2000.105700; Nekolla SG, 1998, EUR J NUCL MED, V25, P1313, DOI 10.1007/s002590050301; Neumann FJ, 1996, HEART, V75, P121, DOI 10.1136/hrt.75.2.121; Neumann FJ, 1999, J AM COLL CARDIOL, V34, P1420, DOI 10.1016/S0735-1097(99)00350-2; Neumann FJ, 1998, CIRCULATION, V98, P2695, DOI 10.1161/01.CIR.98.24.2695; Nunn CM, 1999, J AM COLL CARDIOL, V33, P640, DOI 10.1016/S0735-1097(98)00622-6; OCONNOR MK, 1995, J NUCL MED, V36, P1130; OKADA RD, 1988, CIRCULATION, V77, P491, DOI 10.1161/01.CIR.77.2.491; Schomig A, 1996, NEW ENGL J MED, V334, P1084, DOI 10.1056/NEJM199604253341702; Schomig A, 1997, J AM COLL CARDIOL, V29, P28, DOI 10.1016/S0735-1097(96)00450-0; SINUSAS AJ, 1990, CIRCULATION, V82, P1424, DOI 10.1161/01.CIR.82.4.1424; Tiefenbrunn AJ, 1998, J AM COLL CARDIOL, V31, P1240, DOI 10.1016/S0735-1097(98)00094-1; Topol E, 1997, NEW ENGL J MED, V337, P1118; TOPOL E, 1993, NEW ENGL J MED, V329, P673, DOI 10.1056/nejm199309023291001; Topol EJ, 1998, LANCET, V352, P87, DOI 10.1016/S0140-6736(98)85010-1; Topol EJ, 2000, CIRCULATION, V101, P570, DOI 10.1161/01.CIR.101.5.570; TOPOL EJ, 1998, TXB CARDIOVASCULAR M, P395; Van de Werf F, 1999, LANCET, V354, P716, DOI 10.1016/S0140-6736(99)07403-6; VandeWerf F, 1997, NEW ENGL J MED, V337, P1124; Zijlstra F, 1999, NEW ENGL J MED, V341, P1413, DOI 10.1056/NEJM199911043411901; ZIJLSTRA F, 1993, NEW ENGL J MED, V328, P680, DOI 10.1056/NEJM199303113281002	39	342	358	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 10	2000	343	6					385	391		10.1056/NEJM200008103430602	http://dx.doi.org/10.1056/NEJM200008103430602			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	342DT	10933737				2022-12-28	WOS:000088630500002
J	Smaglik, P				Smaglik, P			United States backs soil strategy in fight against global warming	NATURE			English	News Item																			0	2	2	0	2	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 10	2000	406	6796					549	550		10.1038/35020711	http://dx.doi.org/10.1038/35020711			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	342PF	10949263	Bronze			2022-12-28	WOS:000088653800003
J	Peck, JR; Waxman, D				Peck, JR; Waxman, D			Mutation and sex in a competitive world	NATURE			English	Article							DELETERIOUS MUTATIONS; SYNERGISTIC EPISTASIS; MULLERS RATCHET; SELECTION; EVOLUTION; FITNESS; RECOMBINATION; REPRODUCTION; ADAPTATION; RATES	How do deleterious mutations interact to affect fitness? The answer to this question has substantial implications for a variety of important problems in population biology, including the evolution of sex(1-3), the rate of adaptation(4,5) and the conservation of small populations(3,6-8). Here we analyse a mathematical model of competition for food in which deleterious mutations affect competitive ability. We show that, if individuals usually compete in small groups, then competition can easily lead to a type of genetic interaction known as synergistic epistasis. This means that a deleterious mutation is most damaging in a genome that already has many other deleterious mutations. We also show that competition in small groups can produce a large advantage for sexual populations, both in mean fitness and in ability to resist invasion by asexual lineages. One implication of our findings is that experimental efforts to demonstrate synergistic epistasis may not succeed unless the experiments are redesigned to make them much more naturalistic.	Univ Sussex, Ctr Study Evolut, Brighton BN1 9QG, E Sussex, England	University of Sussex	Peck, JR (corresponding author), Univ Sussex, Ctr Study Evolut, Brighton BN1 9QG, E Sussex, England.			Peck, Joel/0000-0003-0421-8739				Bell G., 1982, MASTERPIECE NATURE; BUTCHER D, 1995, GENETICS, V141, P431; CHARLESWORTH B, 1993, GENET RES, V61, P205, DOI 10.1017/S0016672300031372; CHARLESWORTH B, 1990, GENET RES, V55, P199, DOI 10.1017/S0016672300025532; Crow J.F., 1970, MATH TOPICS POPULATI; de Visser JAGM, 1998, GENET RES, V71, P39, DOI 10.1017/S0016672397003091; deVisser JAGM, 1997, GENETICS, V145, P815; Elena SF, 1997, NATURE, V390, P395, DOI 10.1038/37108; Eyre-Walker A, 1999, NATURE, V397, P344, DOI 10.1038/16915; Eyre-Walker A, 1999, GENETICS, V152, P675; Fry JD, 1999, P NATL ACAD SCI USA, V96, P574, DOI 10.1073/pnas.96.2.574; GRADSHTEYN IS, 1980, TABLE INTEGRALS SERI; HAMILTON WD, 1990, P NATL ACAD SCI USA, V87, P3566, DOI 10.1073/pnas.87.9.3566; KIMURA M, 1966, GENETICS, V54, P1337; KING JL, 1967, GENETICS, V55, P483; Koelewijn HP, 1998, EVOLUTION, V52, P692, DOI 10.1111/j.1558-5646.1998.tb03694.x; KONDRASHOV AS, 1992, GENETICS, V132, P603; KONDRASHOV AS, 1995, J THEOR BIOL, V175, P583, DOI 10.1006/jtbi.1995.0167; KONDRASHOV AS, 1988, NATURE, V336, P435, DOI 10.1038/336435a0; KONDRASHOV AS, 1994, GENETICS, V136, P1469; Krebs CJ., 1994, ECOLOGY; MAYNARD SMITH J., 1978, EVOLUTION SEX; NYGREN A, 1954, BOT REV, V20, P577, DOI 10.1007/BF02958805; PARKER ED, 2000, EVOL GENET, P450; Peck JR, 1997, NATURE, V387, P135, DOI 10.1038/387135a0; Peck JR, 1997, GENETICS, V145, P1171; SVED JA, 1967, GENETICS, V55, P469; Waxman D, 1999, GENETICS, V153, P1041; West SA, 1998, GENETICS, V149, P435; WILLIS JH, 1993, EVOLUTION, V47, P864, DOI 10.2307/2410190	30	40	40	0	13	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 27	2000	406	6794					399	404		10.1038/35019055	http://dx.doi.org/10.1038/35019055			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	337WC	10935634				2022-12-28	WOS:000088383800044
J	Vanag, VK; Yang, LF; Dolnik, M; Zhabotinsky, AM; Epstein, IR				Vanag, VK; Yang, LF; Dolnik, M; Zhabotinsky, AM; Epstein, IR			Oscillatory cluster patterns in a homogeneous chemical system with global feedback	NATURE			English	Article							CHAOTIC NEURONS; STANDING WAVES; SPIRAL WAVES; EVOLUTION; DYNAMICS; MEDIA	Oscillatory clusters are sets of domains in which nearly all elements in a given domain oscillate with the same amplitude and phase(1-4). They play an important role in understanding coupled neuron systems(5-8). In the simplest case, a system consists of two clusters that oscillate in antiphase and can each occupy multiple fixed spatial domains. Examples of cluster behaviour in extended chemical systems are rare, but have been shown to resemble standing waves(9-13), except that they lack a characteristic wavelength. Here we report the observation of so-called 'localized clusters'-periodic antiphase oscillations in one part of the medium, while the remainder appears uniform-in the Belousov-Zhabotinsky reaction-diffusion system with photochemical global feedback. We also observe standing clusters with fixed spatial domains that oscillate periodically in time and occupy the entire medium, and irregular clusters with no periodicity in either space or time, with standing clusters transforming into irregular clusters and then into localized clusters as the strength of the global negative feedback is gradually increased. By incorporating the effects of global feedback into a model of the reaction, we are able to simulate successfully the experimental data.	Brandeis Univ, Dept Chem, Waltham, MA 02454 USA; Brandeis Univ, Volen Ctr Complex Syst, Waltham, MA 02454 USA	Brandeis University; Brandeis University	Zhabotinsky, AM (corresponding author), Brandeis Univ, Dept Chem, MS 015, Waltham, MA 02454 USA.			Vanag, Vladimir/0000-0002-9521-6650				Amemiya T, 1998, CHAOS, V8, P872, DOI 10.1063/1.166373; Belousov B.P., 1959, COLLECTION SHORT PAP, V147, P1; Bugrim AE, 1996, J PHYS CHEM-US, V100, P19017, DOI 10.1021/jp961603t; CORDONIER GA, 1989, J CHEM PHYS, V91, P5374, DOI 10.1063/1.457586; FALCKE M, 1995, PHYS REV E, V52, P763, DOI 10.1103/PhysRevE.52.763; GAO Y, 1995, J PHYS CHEM-US, V99, P8638, DOI 10.1021/j100021a031; GOLOMB D, 1992, PHYS REV A, V45, P3516, DOI 10.1103/PhysRevA.45.3516; GOLOMB D, 1994, PHYSICA D, V72, P259, DOI 10.1016/0167-2789(94)90214-3; GRILL S, 1995, PHYS REV LETT, V75, P3368, DOI 10.1103/PhysRevLett.75.3368; HAKIM V, 1992, PHYS REV A, V46, pR7347, DOI 10.1103/PhysRevA.46.R7347; Huerta R, 1998, EUROPHYS LETT, V43, P719, DOI 10.1209/epl/i1998-00423-y; JAKUBITH S, 1990, PHYS REV LETT, V65, P3013, DOI 10.1103/PhysRevLett.65.3013; Kadar S, 1997, J PHYS CHEM A, V101, P8200, DOI 10.1021/jp971937y; Kapral R., 1995, CHEM WAVES PATTERNS; KUHNERT L, 1989, NATURE, V337, P244, DOI 10.1038/337244a0; LEV O, 1988, NATURE, V336, P458, DOI 10.1038/336458a0; Petrov V, 1997, NATURE, V388, P655, DOI 10.1038/41732; Rabinovich MI, 1999, PHYSICA A, V263, P405, DOI 10.1016/S0378-4371(98)00528-7; ROSS J, 1988, SCIENCE, V240, P460, DOI 10.1126/science.240.4851.460; Somani M, 1997, CHEM ENG SCI, V52, P2331, DOI 10.1016/S0009-2509(97)00004-3; TERMAN D, 1995, PHYSICA D, V81, P148, DOI 10.1016/0167-2789(94)00205-5; Wang W, 2000, CHAOS, V10, P248, DOI 10.1063/1.166470; WINFREE AT, 1972, SCIENCE, V175, P634, DOI 10.1126/science.175.4022.634; YAMAGUCHI T, 1991, J PHYS CHEM-US, V95, P5831, DOI 10.1021/j100168a024; ZAIKIN AN, 1970, NATURE, V225, P535, DOI 10.1038/225535b0; ZHABOTIN.AM, 1964, DOKL AKAD NAUK SSSR+, V157, P392; ZHABOTINSKY AM, 1993, J PHYS CHEM-US, V97, P7578, DOI 10.1021/j100131a030	27	262	267	0	58	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 27	2000	406	6794					389	391		10.1038/35019038	http://dx.doi.org/10.1038/35019038			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	337WC	10935631				2022-12-28	WOS:000088383800041
J	Carek, PJ; Mainous, AG				Carek, PJ; Mainous, AG			Preparticipation cardiovascular screening for young athletes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									Med Univ S Carolina, Charleston, SC 29425 USA	Medical University of South Carolina	Carek, PJ (corresponding author), Med Univ S Carolina, Charleston, SC 29425 USA.			Mainous, Arch/0000-0002-2535-7685				*AM AC FAM PHYS AM, 1997, PREP PHYS EV MON; Pfister GC, 2000, JAMA-J AM MED ASSOC, V283, P1597, DOI 10.1001/jama.283.12.1597; US Preventive Services Task Force, 1996, GUID CLIN PREV SERV, P18	3	7	7	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 23	2000	284	8					957	957		10.1001/jama.284.8.957	http://dx.doi.org/10.1001/jama.284.8.957			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	344PX	10944633				2022-12-28	WOS:000088769000013
J	Ensor, JE; Grana, JR; Diamond, CC				Ensor, JE; Grana, JR; Diamond, CC			Managed care insurance and use of higher-mortality hospitals	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									Aetna US Healthcare, USQA, Blue Bell, PA USA		Ensor, JE (corresponding author), Aetna US Healthcare, USQA, Blue Bell, PA USA.			Ensor, Joe/0000-0003-3533-4388				Erickson LC, 2000, JAMA-J AM MED ASSOC, V283, P1976, DOI 10.1001/jama.283.15.1976; 1997, MED PRACTICE COMMUNI, V4, P3	2	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 16	2000	284	7					829	829		10.1001/jama.284.7.829	http://dx.doi.org/10.1001/jama.284.7.829			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	342PM	10938165				2022-12-28	WOS:000088654400017
J	Mariotto, A				Mariotto, A			Managed care insurance and use of higher-mortality hospitals - Reply	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							CORONARY		Univ Padua, Padua, Italy	University of Padua	Mariotto, A (corresponding author), Univ Padua, Padua, Italy.			Ensor, Joe/0000-0003-3533-4388				Erickson LC, 2000, JAMA-J AM MED ASSOC, V283, P1976, DOI 10.1001/jama.283.15.1976; NAYLOR CD, 1991, CAN J CARDIOL, V7, P207; SHOWSTACK JA, 1987, JAMA-J AM MED ASSOC, V257, P785, DOI 10.1001/jama.257.6.785	3	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 16	2000	284	7					829	830		10.1001/jama.284.7.829	http://dx.doi.org/10.1001/jama.284.7.829			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	342PM	10938165				2022-12-28	WOS:000088654400018
